"Uniprot PDB Group State Color Inhi Reso X_Phi X_Psi X_Chi D_Phi D_Psi D_Chi Phe_Phi Phe_Psi Phe_Chi Gly_Phi Gly_Psi Gly_Chi Strain XDFG ASP PHE GLY"
"AAK1_HUMAN t_4WSQA.pdb OTHER Active 1 KSA 1.95 -126.22 -179.67 65.82 69.67 90.74 -170.72 -108.13 19.71 -66.45 -69.57 -19.29 999.00 Allowed CYS ASP PHE GLY"
"AAK1_HUMAN t_4WSQB.pdb OTHER Active 1 KSA 1.95 -125.16 -178.62 63.94 72.01 91.87 -167.84 -111.12 20.77 -62.33 -70.29 -20.69 999.00 Allowed CYS ASP PHE GLY"
"AAK1_HUMAN t_5L4QA.pdb OTHER Active 1 LKB 1.97 -132.80 -177.94 71.59 63.88 92.39 -170.20 -114.29 19.33 -58.90 -80.70 -11.60 999.00 Allowed CYS ASP PHE GLY"
"AAK1_HUMAN t_5L4QB.pdb OTHER Active 1 LKB 1.97 -132.30 -178.12 71.66 64.07 92.64 -169.10 -114.64 18.38 -59.59 -80.26 -11.34 999.00 Allowed CYS ASP PHE GLY"
"AAK1_HUMAN t_5TE0A.pdb OTHER Active 1 XIN 1.90 -133.95 173.94 75.20 66.53 103.33 -155.52 -110.20 22.68 -55.15 -65.73 -20.86 999.00 Outlier CYS ASP PHE GLY"
"AAPK1_HUMAN t_4REDA.pdb CAMK DFGinter 5 Apo 2.95 -76.35 -39.83 999.00 -91.26 104.68 -178.00 -101.35 16.65 55.35 124.82 -0.27 999.00 Favored ALA ASP PHE GLY"
"AAPK1_HUMAN t_4REDB.pdb CAMK DFGinter 5 Apo 2.95 -76.58 -36.37 999.00 -94.10 106.96 -179.74 -98.61 14.04 52.09 121.59 -8.45 999.00 Favored ALA ASP PHE GLY"
"AAPK1_HUMAN t_4RERA.pdb CAMK Active 1 STU 4.05 -104.44 -74.43 999.00 -70.60 123.20 -164.83 -111.40 7.08 -88.61 -64.28 -25.70 999.00 Favored ALA ASP PHE GLY"
"AAPK1_HUMAN t_4REWA.pdb CAMK Active 1 STU 4.58 -107.01 -78.31 999.00 -80.01 116.63 -171.32 -98.64 4.73 -93.30 -52.57 -49.48 999.00 Favored ALA ASP PHE GLY"
"AAPK2_HUMAN t_2H6DA.pdb NA NA 0 Apo 1.85 -152.14 154.49 999.00 -117.10 79.85 -179.36 -110.35 -10.35 -76.06 70.97 25.94 999.00 Allowed ALA ASP PHE GLY"
"AAPK2_HUMAN t_2YZAA.pdb NA NA 0 Apo 3.02 -149.16 154.49 999.00 -108.84 78.75 -170.22 -105.70 -18.56 -66.28 70.92 51.47 999.00 Allowed ALA ASP PHE GLY"
"AAPK2_HUMAN t_3AQVA.pdb CAMK DFGup 3 TAK 2.08 -77.59 137.48 999.00 -58.35 143.42 56.00 -127.88 21.45 46.23 -78.79 -145.73 999.00 Favored ALA ASP PHE GLY"
"AAPK2_HUMAN t_4CFFA.pdb CAMK Active 1 STU 3.92 -149.80 179.98 999.00 57.28 81.92 -162.39 -95.26 37.95 -70.37 -75.46 -19.20 999.00 Allowed ALA ASP PHE GLY"
"AAPK2_HUMAN t_4CFFC.pdb CAMK Active 1 C1V 3.92 -150.65 -172.51 999.00 53.70 68.23 -171.18 -65.20 -76.28 -77.98 54.44 -69.25 999.00 Allowed ALA ASP PHE GLY"
"AAPK2_HUMAN t_4ZHXA.pdb CAMK Active 1 4O7 2.99 -135.92 174.73 999.00 63.61 78.78 -141.68 -96.46 25.89 -80.52 -67.03 -42.41 999.00 Allowed ALA ASP PHE GLY"
"AAPK2_HUMAN t_4ZHXC.pdb CAMK Active 1 C1V 2.99 -118.57 -65.81 999.00 -66.91 99.09 -142.46 -101.34 23.36 -82.87 -65.36 -32.79 999.00 Allowed ALA ASP PHE GLY"
"AAPK2_HUMAN t_5EZVA.pdb CAMK Active 1 C1V 2.99 -121.05 -63.08 999.00 -68.70 101.94 -146.49 -100.18 25.33 -80.67 -68.14 -44.72 999.00 Allowed ALA ASP PHE GLY"
"AAPK2_HUMAN t_5EZVC.pdb CAMK Active 1 STU 2.99 -121.93 -67.17 999.00 -69.30 103.90 -145.10 -103.97 30.28 -79.72 -70.53 -44.84 999.00 Favored ALA ASP PHE GLY"
"AAPK2_HUMAN t_5ISOA.pdb CAMK Active 1 992 2.63 -124.02 -69.60 999.00 -91.72 113.84 -175.00 -98.39 8.31 -75.99 -52.08 -32.79 999.00 Favored ALA ASP PHE GLY"
"AAPK2_HUMAN t_5ISOC.pdb CAMK Active 1 992 2.63 -118.95 -65.00 999.00 -97.91 114.35 -167.54 -100.81 6.06 -77.19 -57.50 -20.14 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_1OPLA.pdb TYR DFGout 6 P16 3.42 -65.60 134.16 999.00 -115.99 33.19 41.48 -83.47 159.93 53.23 66.99 8.10 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_1OPLB.pdb TYR DFGout 6 P16 3.42 -63.85 141.41 999.00 -115.92 33.21 41.64 -83.53 159.99 53.09 67.03 7.97 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_2E2BA.pdb TYR DFGout 6 406 2.20 -135.06 -171.45 999.00 -153.79 101.44 -175.16 -92.54 5.92 -51.79 52.64 55.12 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_2E2BB.pdb TYR DFGout 6 406 2.20 -143.54 -176.38 999.00 -149.84 101.41 -172.73 -87.95 0.34 -54.62 55.29 49.54 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_2F4JA.pdb TYR Active 1 VX6 1.91 -139.15 -163.89 999.00 46.90 83.91 -54.60 -101.66 25.38 -50.52 -54.62 -28.10 999.00 Outlier ALA ASP PHE GLY"
"ABL1_HUMAN t_2FO0A.pdb TYR DFGout 6 P16 2.27 -76.55 118.23 999.00 -95.45 43.05 40.05 -89.93 155.23 62.29 62.21 26.16 999.00 Allowed ALA ASP PHE GLY"
"ABL1_HUMAN t_2G1TA.pdb TYR DFGup 3 Apo 1.80 -129.56 174.87 999.00 49.66 38.77 -64.16 -73.01 132.29 38.49 68.28 5.01 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_2G1TB.pdb TYR DFGup 3 Apo 1.80 -123.21 174.01 999.00 52.07 35.10 -63.76 -71.04 126.99 40.57 70.78 9.14 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_2G1TC.pdb TYR DFGup 3 Apo 1.80 -120.75 170.38 999.00 50.78 37.09 -63.38 -72.11 126.29 41.56 72.45 10.33 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_2G1TD.pdb TYR DFGup 3 Apo 1.80 -127.28 170.72 999.00 53.33 36.31 -66.22 -70.43 129.01 38.06 67.17 13.67 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_2G2FA.pdb TYR DFGinter 5 Apo 2.70 -62.04 127.99 999.00 -87.40 -14.52 62.79 -64.37 -9.87 -175.89 -103.34 15.09 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_2G2FB.pdb TYR DFGout 6 AGS 2.70 -73.10 151.23 999.00 -78.33 -31.66 -62.23 -2.74 -74.20 167.05 -90.76 24.68 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_2G2HA.pdb TYR DFGinter 5 P16 2.00 -69.82 139.78 999.00 -117.04 21.61 33.34 -74.77 -30.69 -177.01 -83.71 28.01 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_2G2HB.pdb TYR DFGout 6 P16 2.00 -60.13 139.31 999.00 -83.02 -16.54 -82.25 -75.21 165.16 56.00 79.15 12.58 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_2G2IA.pdb TYR Active 1 ADP 3.12 -148.43 173.74 999.00 80.31 76.26 -151.94 -98.53 37.89 -51.65 -64.97 -55.29 999.00 Outlier ALA ASP PHE GLY"
"ABL1_HUMAN t_2G2IB.pdb TYR Active 1 ADP 3.12 -144.72 -170.15 999.00 58.65 49.45 -150.14 -73.14 23.68 -53.03 -58.19 -50.41 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_2GQGA.pdb TYR Active 1 1N1 2.40 -125.85 -162.51 999.00 50.09 80.27 -170.87 -101.94 13.61 -55.89 -55.57 -28.12 999.00 Allowed ALA ASP PHE GLY"
"ABL1_HUMAN t_2GQGB.pdb TYR Active 1 1N1 2.40 -132.99 -163.47 999.00 57.83 75.17 -175.27 -98.76 6.64 -57.35 -52.42 -32.81 999.00 Allowed ALA ASP PHE GLY"
"ABL1_HUMAN t_2HIWA.pdb TYR DFGout 6 7MP 2.20 -142.68 -168.31 999.00 -158.00 107.73 -170.87 -97.34 2.37 -47.60 65.31 50.77 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_2HIWB.pdb TYR DFGout 6 7MP 2.20 -144.49 -168.69 999.00 -161.13 102.67 -169.67 -97.36 4.94 -41.35 56.33 54.12 999.00 Allowed ALA ASP PHE GLY"
"ABL1_HUMAN t_2HYYA.pdb TYR DFGout 6 STI 2.40 -136.72 -169.51 999.00 -156.88 107.64 -178.43 -99.34 1.49 -52.09 66.40 52.12 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_2HYYB.pdb TYR DFGout 6 STI 2.40 -140.44 -179.89 999.00 -145.36 104.85 -173.94 -87.97 -4.18 -57.81 68.27 47.39 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_2HYYC.pdb TYR DFGout 6 STI 2.40 -136.57 -170.39 999.00 -156.14 102.69 179.42 -91.13 -2.21 -53.25 61.34 49.09 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_2HYYD.pdb TYR DFGout 6 STI 2.40 -135.15 -170.83 999.00 -155.11 109.42 -178.11 -96.60 9.48 -50.28 60.06 43.10 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_2HZ0A.pdb TYR DFGout 6 GIN 2.10 -150.83 -160.52 999.00 -160.40 120.02 -168.04 -81.85 -18.35 -83.02 -92.48 170.30 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_2HZ0B.pdb TYR DFGout 6 GIN 2.10 -144.15 -165.08 999.00 -157.27 107.12 -176.55 -67.75 -17.61 -83.56 51.60 32.36 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_2HZ4A.pdb TYR Active 1 4ST 2.80 -141.11 -179.07 999.00 61.47 74.68 -170.38 -93.24 11.06 -61.49 -47.31 -45.63 999.00 Allowed ALA ASP PHE GLY"
"ABL1_HUMAN t_2HZ4B.pdb TYR Active 1 4ST 2.80 -136.31 178.01 999.00 62.63 92.29 -160.44 -99.10 17.07 -53.36 -49.67 -38.73 999.00 Allowed ALA ASP PHE GLY"
"ABL1_HUMAN t_2HZ4C.pdb TYR Active 1 4ST 2.80 -106.85 179.42 999.00 68.79 75.99 -158.66 -90.83 7.92 -64.58 -43.82 -23.09 999.00 Allowed ALA ASP PHE GLY"
"ABL1_HUMAN t_2HZIA.pdb TYR DFGout 6 JIN 1.70 -64.66 136.56 999.00 -117.46 21.91 42.09 -67.45 155.89 48.77 74.70 2.26 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_2HZIB.pdb TYR DFGout 6 JIN 1.70 -64.82 139.57 999.00 -123.45 22.39 40.74 -72.30 154.15 44.54 81.46 -10.50 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_2V7AA.pdb TYR Active 1 627 2.50 -145.03 -170.76 999.00 64.04 66.72 -137.79 -92.53 17.40 -64.05 -56.66 -27.08 999.00 Allowed ALA ASP PHE GLY"
"ABL1_HUMAN t_2V7AB.pdb TYR Active 1 627 2.50 -120.30 -166.47 999.00 59.75 67.60 -143.54 -85.21 11.08 -62.27 -52.32 -48.66 999.00 Allowed ALA ASP PHE GLY"
"ABL1_HUMAN t_3CS9A.pdb TYR DFGout 6 NIL 2.21 -145.37 -175.16 999.00 -153.54 95.63 -172.48 -79.45 2.65 -51.35 60.18 48.08 999.00 Allowed ALA ASP PHE GLY"
"ABL1_HUMAN t_3CS9B.pdb TYR DFGout 6 NIL 2.21 -143.98 -176.66 999.00 -148.15 110.38 -170.15 -103.78 0.75 -50.80 150.32 999.00 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_3CS9C.pdb TYR DFGout 6 NIL 2.21 -141.39 177.78 999.00 -141.40 100.57 -169.97 -84.05 -4.96 -55.84 61.68 999.00 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_3CS9D.pdb TYR DFGout 6 NIL 2.21 -137.25 -170.71 999.00 -151.80 104.82 -175.26 -89.14 0.28 -53.70 63.12 44.72 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_3PYYA.pdb TYR DFGout 6 STI 1.85 -130.46 -173.47 999.00 -148.78 100.49 178.58 -87.28 -2.90 -58.24 62.24 50.81 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_3PYYB.pdb TYR DFGout 6 STI 1.85 -132.60 -172.36 999.00 -152.94 105.35 -176.78 -94.35 -50.89 -47.00 93.23 999.00 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_3QRIA.pdb TYR DFGout 6 919 2.10 -140.29 -177.68 999.00 -143.73 111.11 -179.51 -85.65 -1.22 -74.32 64.86 45.15 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_3QRIB.pdb TYR DFGout 6 919 2.10 -138.04 -177.06 999.00 -143.58 113.55 -179.08 -88.43 -2.00 -72.91 64.70 47.41 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_3QRJA.pdb TYR DFGout 6 919 1.82 -140.11 177.49 999.00 -140.76 104.11 -169.64 -86.95 4.76 -76.15 63.27 48.66 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_3QRJB.pdb TYR DFGout 6 919 1.82 -139.42 169.11 999.00 -133.52 106.16 -179.74 -82.08 0.42 -76.88 61.15 48.11 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_3QRKA.pdb TYR DFGout 6 9DP 2.30 -128.71 -174.71 999.00 -147.09 106.12 178.15 -83.70 7.99 -78.93 56.17 46.77 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_3UE4A.pdb TYR DFGout 6 DB8 2.42 -73.53 139.67 999.00 -129.49 18.74 51.64 -70.02 -27.20 71.98 -97.86 45.89 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_3UE4B.pdb TYR DFGout 6 DB8 2.42 -68.43 143.70 999.00 -139.92 24.39 58.20 -73.57 -36.62 65.12 -93.69 7.15 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_4TWPA.pdb TYR Active 1 AXI 2.40 -126.09 -169.38 999.00 57.30 73.69 -164.69 -93.28 9.72 -52.07 -48.91 -36.81 999.00 Allowed ALA ASP PHE GLY"
"ABL1_HUMAN t_4TWPB.pdb TYR Active 1 AXI 2.40 -138.15 -168.49 999.00 59.73 66.47 -162.63 -88.47 8.00 -52.01 -49.31 -39.90 999.00 Allowed ALA ASP PHE GLY"
"ABL1_HUMAN t_4WA9A.pdb NA NA 0 AXI 2.20 -73.86 149.35 999.00 -77.90 -21.10 -72.73 -66.14 121.82 -169.25 115.25 -11.10 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_4WA9B.pdb TYR DFGout 6 AXI 2.20 -75.96 149.45 999.00 -77.78 -15.71 -83.92 -59.12 118.07 -168.17 106.97 -1.52 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_4XEYA.pdb TYR DFGinter 5 1N1 2.89 -70.85 123.46 999.00 -90.91 18.34 -5.94 -87.32 -11.99 -160.56 -96.52 13.70 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_4XEYB.pdb TYR DFGinter 5 1N1 2.89 -70.99 121.61 999.00 -84.69 7.53 -10.49 -91.79 101.28 -152.21 143.14 -1.74 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_4YC8A.pdb TYR DFGinter 5 4B7 2.90 -68.72 128.68 999.00 -122.32 46.04 50.99 -98.33 2.92 -38.85 -137.04 20.87 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_4YC8B.pdb TYR DFGinter 5 4B7 2.90 -74.11 129.27 999.00 -121.29 39.84 53.07 -90.86 -3.87 -42.55 -153.93 45.64 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_4ZOGA.pdb TYR DFGinter 5 VX6 2.30 -67.97 132.09 999.00 -127.80 25.64 52.98 -66.68 -66.53 164.01 -79.32 45.33 999.00 Favored ALA ASP PHE GLY"
"ABL1_HUMAN t_4ZOGB.pdb TYR DFGout 6 VX6 2.30 -72.51 126.73 999.00 -115.77 44.87 48.31 -59.71 -111.32 30.04 -63.44 48.41 999.00 Allowed ALA ASP PHE GLY"
"ABL1_HUMAN t_5HU9A.pdb TYR DFGout 6 66K 1.53 -145.40 -177.25 999.00 -141.78 111.17 -167.99 -69.30 -26.03 -76.87 93.44 13.87 999.00 Favored ALA ASP PHE GLY"
"ABL2_HUMAN t_2XYNA.pdb TYR Active 1 VX6 2.81 -141.97 -170.24 999.00 61.30 77.49 -65.92 -101.98 23.60 -56.73 -52.45 -36.83 999.00 Allowed ALA ASP PHE GLY"
"ABL2_HUMAN t_2XYNB.pdb TYR Active 1 VX6 2.81 -138.52 -171.97 999.00 61.92 76.65 -55.13 -98.45 37.07 -52.49 -56.67 -28.96 999.00 Allowed ALA ASP PHE GLY"
"ABL2_HUMAN t_2XYNC.pdb TYR Active 1 VX6 2.81 -141.43 -177.45 999.00 57.58 72.00 -59.15 -90.09 30.81 -52.34 -59.72 -48.19 999.00 Allowed ALA ASP PHE GLY"
"ABL2_HUMAN t_3GVUA.pdb TYR DFGout 6 STI 2.05 -129.18 -178.97 999.00 -150.57 104.05 -176.29 -86.10 -7.87 -52.25 64.91 42.91 999.00 Favored ALA ASP PHE GLY"
"ABL2_HUMAN t_3HMIA.pdb TYR DFGinter 5 DKI 1.65 -59.43 142.61 999.00 -137.24 25.20 51.04 -75.01 160.50 -61.88 70.50 20.31 999.00 Favored ALA ASP PHE GLY"
"ACK1_HUMAN t_1U46A.pdb TYR Active 1 Apo 2.00 -105.05 -15.81 999.00 -135.24 148.53 153.36 -140.75 24.35 -59.28 -66.88 -16.88 999.00 Favored GLY ASP PHE GLY"
"ACK1_HUMAN t_1U46B.pdb TYR Active 1 Apo 2.00 -106.82 -162.40 999.00 39.72 86.14 -169.08 -96.98 26.26 -60.87 -73.63 -16.50 999.00 Outlier GLY ASP PHE GLY"
"ACK1_HUMAN t_1U4DA.pdb TYR Active 1 DBQ 2.10 -127.17 -169.63 999.00 54.14 72.70 -154.63 -87.14 24.60 -49.51 -62.55 -20.21 999.00 Allowed GLY ASP PHE GLY"
"ACK1_HUMAN t_1U4DB.pdb TYR Active 1 DBQ 2.10 -120.45 -165.38 999.00 55.06 77.37 -160.90 -96.16 18.82 -60.76 -61.45 -28.66 999.00 Allowed GLY ASP PHE GLY"
"ACK1_HUMAN t_1U54A.pdb TYR Active 1 ACP 2.80 -129.46 -12.07 999.00 -146.49 102.95 170.92 -102.85 23.35 -55.36 -57.01 -37.47 999.00 Favored GLY ASP PHE GLY"
"ACK1_HUMAN t_1U54B.pdb TYR Active 1 ACP 2.80 -120.44 -155.17 999.00 27.88 85.72 -155.23 -104.34 38.69 -50.03 -67.70 -28.76 999.00 Outlier GLY ASP PHE GLY"
"ACK1_HUMAN t_3EQPA.pdb TYR Active 1 T95 2.30 -122.27 -169.42 999.00 49.96 85.78 -168.69 -103.52 29.18 -61.94 -65.89 -22.55 999.00 Outlier GLY ASP PHE GLY"
"ACK1_HUMAN t_3EQPB.pdb TYR Active 1 T95 2.30 -135.01 176.50 999.00 61.94 90.23 -168.16 -110.14 23.78 -62.28 -58.96 -17.74 999.00 Allowed GLY ASP PHE GLY"
"ACK1_HUMAN t_3EQRA.pdb TYR Active 1 T74 2.00 -128.92 39.53 999.00 -159.66 137.54 -171.75 -136.78 17.91 -57.36 -47.68 -35.83 999.00 Favored GLY ASP PHE GLY"
"ACK1_HUMAN t_3EQRB.pdb TYR Active 1 T74 2.00 -120.29 36.40 999.00 -155.56 142.42 175.17 -140.12 20.33 -55.97 -61.13 -29.71 999.00 Favored GLY ASP PHE GLY"
"ACK1_HUMAN t_4EWHA.pdb TYR Active 1 T77 2.50 -112.35 -10.25 999.00 -128.02 158.61 -162.35 -163.99 19.09 -62.87 -51.93 -22.08 999.00 Favored GLY ASP PHE GLY"
"ACK1_HUMAN t_4EWHB.pdb TYR Active 1 T77 2.50 -114.01 0.09 999.00 -132.35 146.41 -165.10 -142.81 20.72 -56.80 -48.06 -26.50 999.00 Favored GLY ASP PHE GLY"
"ACK1_HUMAN t_4HZRA.pdb TYR Active 1 Apo 1.31 -116.62 0.08 999.00 -140.47 143.49 -169.14 -137.82 28.96 -56.89 -63.67 -22.88 999.00 Favored GLY ASP PHE GLY"
"ACK1_HUMAN t_4HZRB.pdb TYR Active 1 Apo 1.31 -114.00 -2.23 999.00 -142.30 141.22 -168.69 -136.94 28.97 -56.31 -65.40 -14.93 999.00 Favored GLY ASP PHE GLY"
"ACK1_HUMAN t_4HZSA.pdb TYR DFGup 3 Apo 3.23 -128.50 177.57 999.00 76.02 0.02 -102.74 -64.55 114.85 48.70 91.74 5.90 999.00 Favored GLY ASP PHE GLY"
"ACK1_HUMAN t_4HZSB.pdb TYR DFGup 3 Apo 3.23 -127.74 176.97 999.00 75.41 0.59 -102.10 -63.74 113.75 49.64 93.89 5.14 999.00 Favored GLY ASP PHE GLY"
"ACK1_HUMAN t_4HZSC.pdb TYR DFGup 3 Apo 3.23 -131.13 178.06 999.00 74.15 -0.15 -101.31 -64.43 114.41 48.23 92.65 7.12 999.00 Favored GLY ASP PHE GLY"
"ACK1_HUMAN t_4HZSD.pdb TYR DFGup 3 Apo 3.23 -127.52 176.16 999.00 76.34 -0.16 -102.14 -64.37 115.24 47.58 91.48 5.37 999.00 Favored GLY ASP PHE GLY"
"ACK1_HUMAN t_4ID7A.pdb TYR Active 1 1G0 3.00 -100.90 -42.00 999.00 -119.96 142.95 156.52 -136.81 28.98 -55.61 -64.20 -28.59 999.00 Favored GLY ASP PHE GLY"
"ACVL1_HUMAN t_3MY0A.pdb TKL Active 1 LDN 2.65 -125.39 179.61 999.00 64.18 80.20 -170.57 -93.05 16.18 -79.57 -60.42 -25.81 999.00 NA ALA ASP LEU GLY"
"ACVL1_HUMAN t_3MY0B.pdb TKL Active 1 LDN 2.65 -125.49 176.95 999.00 65.28 80.73 -170.10 -94.34 16.93 -79.23 -60.74 -22.50 999.00 NA ALA ASP LEU GLY"
"ACVL1_HUMAN t_3MY0C.pdb TKL Active 1 LDN 2.65 -125.32 179.96 999.00 63.22 82.07 -171.20 -96.28 18.25 -80.84 -59.55 -26.98 999.00 NA ALA ASP LEU GLY"
"ACVL1_HUMAN t_3MY0D.pdb TKL Active 1 LDN 2.65 -124.98 176.54 999.00 67.55 82.42 -170.91 -95.49 17.13 -79.92 -61.63 -24.00 999.00 NA ALA ASP LEU GLY"
"ACVL1_HUMAN t_3MY0E.pdb TKL Active 1 LDN 2.65 -126.50 175.90 999.00 66.50 79.49 -170.67 -94.69 19.26 -78.91 -60.85 -27.08 999.00 NA ALA ASP LEU GLY"
"ACVL1_HUMAN t_3MY0F.pdb TKL Active 1 LDN 2.65 -125.61 177.38 999.00 64.96 84.06 -171.34 -97.88 17.90 -79.36 -59.05 -26.63 999.00 NA ALA ASP LEU GLY"
"ACVL1_HUMAN t_3MY0G.pdb TKL Active 1 LDN 2.65 -125.87 178.83 999.00 65.55 83.10 -167.68 -96.88 17.14 -80.97 -59.78 -26.35 999.00 NA ALA ASP LEU GLY"
"ACVL1_HUMAN t_3MY0H.pdb TKL Active 1 LDN 2.65 -127.10 175.18 999.00 67.42 80.94 -170.29 -93.50 17.01 -79.55 -58.70 -26.04 999.00 NA ALA ASP LEU GLY"
"ACVL1_HUMAN t_3MY0I.pdb TKL Active 1 LDN 2.65 -127.43 177.77 999.00 64.40 81.55 -169.11 -95.75 18.16 -80.50 -61.72 -24.11 999.00 NA ALA ASP LEU GLY"
"ACVL1_HUMAN t_3MY0J.pdb TKL Active 1 LDN 2.65 -127.37 177.44 999.00 65.46 81.12 -169.65 -94.93 16.50 -79.41 -59.74 -24.67 999.00 NA ALA ASP LEU GLY"
"ACVL1_HUMAN t_3MY0K.pdb TKL Active 1 LDN 2.65 -128.09 176.74 999.00 65.44 82.74 -169.00 -95.70 16.43 -78.94 -60.20 -25.18 999.00 NA ALA ASP LEU GLY"
"ACVL1_HUMAN t_3MY0L.pdb TKL Active 1 LDN 2.65 -127.77 177.50 999.00 64.89 80.45 -171.42 -93.81 16.92 -79.56 -60.26 -23.74 999.00 NA ALA ASP LEU GLY"
"ACVL1_HUMAN t_3MY0M.pdb TKL Active 1 LDN 2.65 -124.51 176.17 999.00 66.22 82.38 -169.68 -94.82 15.41 -79.81 -60.14 -22.55 999.00 NA ALA ASP LEU GLY"
"ACVL1_HUMAN t_3MY0N.pdb TKL Active 1 LDN 2.65 -125.99 176.35 999.00 64.38 84.21 -171.07 -94.96 15.99 -81.73 -58.21 -28.26 999.00 NA ALA ASP LEU GLY"
"ACVL1_HUMAN t_3MY0O.pdb TKL Active 1 LDN 2.65 -124.38 177.90 999.00 63.73 82.52 -169.82 -95.13 16.70 -79.12 -59.28 -25.61 999.00 NA ALA ASP LEU GLY"
"ACVL1_HUMAN t_3MY0P.pdb TKL Active 1 LDN 2.65 -126.80 176.70 999.00 66.23 80.08 -171.13 -94.48 17.67 -78.91 -59.60 -26.74 999.00 NA ALA ASP LEU GLY"
"ACVL1_HUMAN t_3MY0Q.pdb TKL Active 1 LDN 2.65 -126.68 177.00 999.00 66.00 82.29 -170.00 -96.37 17.56 -79.00 -60.75 -24.18 999.00 NA ALA ASP LEU GLY"
"ACVL1_HUMAN t_3MY0R.pdb TKL Active 1 LDN 2.65 -126.22 177.55 999.00 66.35 80.95 -169.09 -95.45 16.67 -80.07 -60.41 -24.57 999.00 NA ALA ASP LEU GLY"
"ACVL1_HUMAN t_3MY0S.pdb TKL Active 1 LDN 2.65 -126.76 175.49 999.00 68.09 78.52 -170.37 -91.82 12.94 -79.95 -55.75 -27.44 999.00 NA ALA ASP LEU GLY"
"ACVL1_HUMAN t_3MY0T.pdb TKL Active 1 LDN 2.65 -124.05 174.88 999.00 67.64 81.32 -171.56 -94.10 15.63 -80.09 -61.22 -23.31 999.00 NA ALA ASP LEU GLY"
"ACVL1_HUMAN t_3MY0U.pdb TKL Active 1 LDN 2.65 -127.05 176.85 999.00 65.57 81.96 -170.94 -94.06 14.90 -79.70 -59.63 -25.27 999.00 NA ALA ASP LEU GLY"
"ACVL1_HUMAN t_3MY0V.pdb TKL Active 1 LDN 2.65 -128.60 175.30 999.00 67.38 81.83 -170.04 -94.45 15.25 -80.57 -58.72 -25.87 999.00 NA ALA ASP LEU GLY"
"ACVL1_HUMAN t_3MY0W.pdb TKL Active 1 LDN 2.65 -125.84 178.20 999.00 63.76 80.79 -170.01 -94.35 16.64 -80.33 -60.98 -22.83 999.00 NA ALA ASP LEU GLY"
"ACVL1_HUMAN t_3MY0X.pdb TKL Active 1 LDN 2.65 -126.45 177.22 999.00 65.57 81.17 -169.63 -94.65 16.89 -79.39 -60.40 -25.35 999.00 NA ALA ASP LEU GLY"
"ACVR1_HUMAN t_3H9RA.pdb TKL Active 1 TAK 2.35 -122.27 172.88 999.00 70.70 76.37 -167.83 -93.45 23.85 -50.57 -63.29 -18.65 999.00 NA ALA ASP LEU GLY"
"ACVR1_HUMAN t_3MTFA.pdb TKL Active 1 A3F 2.15 -126.07 157.67 999.00 76.82 82.69 -175.95 -86.04 21.34 -53.78 -61.62 -25.01 999.00 NA ALA ASP LEU GLY"
"ACVR1_HUMAN t_3MTFB.pdb TKL Active 1 A3F 2.15 -114.44 160.09 999.00 82.30 87.52 -176.60 -104.82 25.82 -68.82 -75.24 -13.57 999.00 NA ALA ASP LEU GLY"
"ACVR1_HUMAN t_3OOMA.pdb TKL Active 1 507 2.00 -119.71 175.80 999.00 64.96 85.24 -174.99 -99.70 23.28 -63.28 -72.69 -17.81 999.00 NA ALA ASP LEU GLY"
"ACVR1_HUMAN t_3Q4UA.pdb TKL Active 1 LDN 1.82 -120.85 173.99 999.00 68.97 74.18 -167.04 -93.93 15.56 -48.63 -71.14 -14.69 999.00 NA ALA ASP LEU GLY"
"ACVR1_HUMAN t_3Q4UB.pdb TKL Active 1 LDN 1.82 -120.35 167.14 999.00 70.26 85.21 -166.15 -102.54 24.29 -49.81 -65.41 -24.16 999.00 NA ALA ASP LEU GLY"
"ACVR1_HUMAN t_3Q4UC.pdb TKL Active 1 LDN 1.82 -120.19 175.42 999.00 62.80 82.10 -166.13 -94.62 16.97 -61.88 -63.35 -27.42 999.00 NA ALA ASP LEU GLY"
"ACVR1_HUMAN t_3Q4UD.pdb TKL Active 1 LDN 1.82 -125.10 175.27 999.00 65.51 81.22 -165.26 -96.16 21.65 -55.44 -68.03 -22.84 999.00 NA ALA ASP LEU GLY"
"ACVR1_HUMAN t_4BGGA.pdb TKL Active 1 844 2.56 -123.71 169.69 999.00 65.73 89.31 -169.91 -103.06 23.28 -57.65 -60.21 -27.34 999.00 NA ALA ASP LEU GLY"
"ACVR1_HUMAN t_4BGGB.pdb TKL Active 1 844 2.56 -126.69 170.19 999.00 64.88 86.83 -167.56 -96.90 22.55 -56.85 -60.43 -29.59 999.00 NA ALA ASP LEU GLY"
"ACVR1_HUMAN t_4BGGC.pdb TKL Active 1 844 2.56 -121.50 168.36 999.00 69.06 89.26 -171.15 -103.53 23.55 -57.91 -58.84 -29.25 999.00 NA ALA ASP LEU GLY"
"ACVR1_HUMAN t_4BGGD.pdb TKL Active 1 844 2.56 -123.22 170.47 999.00 65.54 87.93 -169.15 -101.95 23.72 -58.79 -57.65 -28.63 999.00 NA ALA ASP LEU GLY"
"ACVR1_HUMAN t_4C02A.pdb TKL Active 1 TAK 2.17 -123.17 176.22 999.00 69.67 70.69 -59.98 -93.27 15.03 -55.44 -66.56 -15.92 999.00 NA ALA ASP LEU GLY"
"ACVR1_HUMAN t_4DYMA.pdb TKL Active 1 IYZ 2.42 -95.08 171.58 999.00 68.47 94.28 -170.73 -112.55 21.28 -66.62 -72.10 -14.94 999.00 NA ALA ASP LEU GLY"
"AKT1_HUMAN t_3CQUA.pdb AGC Active 1 CQU 2.20 -125.24 173.03 -15.69 74.80 101.42 -146.86 -111.52 14.47 -50.55 -55.85 -32.76 999.00 Allowed THR ASP PHE GLY"
"AKT1_HUMAN t_3CQWA.pdb AGC Active 1 CQW 2.00 -122.40 167.12 55.03 74.15 82.69 -71.93 -100.77 9.23 -64.24 -67.18 -25.12 999.00 Allowed THR ASP PHE GLY"
"AKT1_HUMAN t_3MV5A.pdb AGC Active 1 XFE 2.47 -110.70 173.86 74.44 55.61 106.14 -59.84 -116.09 8.14 -67.98 -68.84 -21.85 999.00 Outlier THR ASP PHE GLY"
"AKT1_HUMAN t_3MVHA.pdb AGC Active 1 WFE 2.01 -120.33 157.62 87.60 77.22 89.80 -60.17 -109.17 14.38 -64.98 -62.87 -24.97 999.00 Allowed THR ASP PHE GLY"
"AKT1_HUMAN t_3O96A.pdb AGC DFGout 6 IQO 2.70 -84.10 164.16 59.46 -139.00 67.66 179.81 -114.58 18.42 -65.89 -57.04 121.08 999.00 Allowed THR ASP PHE GLY"
"AKT1_HUMAN t_3OCBA.pdb AGC Active 1 XM1 2.70 -116.89 176.30 51.41 66.88 80.26 -50.95 -101.77 15.04 -68.85 -62.91 -27.15 999.00 Allowed THR ASP PHE GLY"
"AKT1_HUMAN t_3OCBB.pdb AGC Active 1 XM1 2.70 -134.08 162.43 -161.19 65.60 102.30 -62.59 -117.73 11.71 -63.48 -59.05 -28.18 999.00 Outlier THR ASP PHE GLY"
"AKT1_HUMAN t_3OW4A.pdb AGC Active 1 SMY 2.60 -119.31 159.70 175.61 79.69 82.82 -148.14 -104.83 4.05 -61.20 -54.97 -24.35 999.00 Allowed THR ASP PHE GLY"
"AKT1_HUMAN t_3OW4B.pdb AGC Active 1 SMY 2.60 -110.58 166.73 44.96 74.69 94.68 -156.16 -107.80 10.58 -62.10 -53.28 -30.54 999.00 Allowed THR ASP PHE GLY"
"AKT1_HUMAN t_3QKKA.pdb AGC Active 1 SMH 2.30 -116.52 -179.44 69.39 52.68 84.96 -68.67 -101.99 14.35 -56.66 -66.49 -22.98 999.00 Outlier THR ASP PHE GLY"
"AKT1_HUMAN t_3QKLA.pdb AGC Active 1 SMR 1.90 -120.69 173.16 70.35 64.99 75.80 -67.44 -95.67 13.63 -57.15 -65.35 -24.62 999.00 Allowed THR ASP PHE GLY"
"AKT1_HUMAN t_3QKMA.pdb AGC Active 1 SM9 2.20 -120.79 163.76 71.65 70.68 92.04 -84.54 -106.64 15.30 -59.05 -62.39 -28.26 999.00 Allowed THR ASP PHE GLY"
"AKT1_HUMAN t_4EJNA.pdb AGC DFGout 6 0R4 2.19 -86.75 154.00 -111.99 -129.53 54.97 -169.56 -106.76 23.81 -54.55 -69.12 128.41 999.00 Allowed THR ASP PHE GLY"
"AKT1_HUMAN t_4EKKA.pdb AGC Active 1 ANP 2.80 -112.54 -177.30 176.13 66.49 90.68 -161.04 -111.93 23.32 -63.72 -69.23 -23.96 999.00 Allowed THR ASP PHE GLY"
"AKT1_HUMAN t_4EKKB.pdb AGC Active 1 ANP 2.80 -112.99 175.61 -177.93 60.16 116.98 -162.66 -127.69 18.69 -55.22 -54.89 -36.31 999.00 Outlier THR ASP PHE GLY"
"AKT1_HUMAN t_4EKLA.pdb AGC Active 1 0RF 2.00 -130.05 156.47 179.06 77.18 99.76 -157.63 -112.66 14.18 -61.35 -61.30 -31.02 999.00 Allowed THR ASP PHE GLY"
"AKT1_HUMAN t_4GV1A.pdb AGC Active 1 0XZ 1.49 -122.45 161.98 63.13 68.51 91.63 -76.92 -104.92 11.19 -63.01 -63.40 -24.57 999.00 Allowed THR ASP PHE GLY"
"AKT1_HUMAN t_5KCVA.pdb AGC DFGout 6 6S1 2.70 -66.10 150.41 -95.48 -131.80 48.41 -175.33 -109.24 34.51 -58.86 -73.66 124.83 999.00 Favored THR ASP PHE GLY"
"AKT2_HUMAN t_1GZKA.pdb AGC DFGout 6 Apo 2.3 -88.27 169.78 -123.74 -121.31 63.06 -150.84 159.24 151.56 56.43 -112.25 146.18 999.00 Allowed THR ASP PHE GLY"
"AKT2_HUMAN t_1GZNA.pdb AGC DFGout 6 Apo 2.5 -86.11 145.10 -146.47 -87.70 45.91 -159.08 -175.92 163.17 41.37 -85.99 112.81 999.00 Allowed THR ASP PHE GLY"
"AKT2_HUMAN t_1GZOA.pdb AGC DFGout 6 Apo 2.75 -89.02 165.48 -125.93 -112.00 63.47 -167.45 173.35 174.77 48.36 -110.87 136.86 999.00 Allowed THR ASP PHE GLY"
"AKT2_HUMAN t_1MRYA.pdb AGC DFGout 6 Apo 2.80 -121.35 168.71 62.83 -126.99 50.47 -175.03 -103.48 -121.57 -49.22 172.32 79.64 999.00 Allowed THR ASP PHE GLY"
"AKT2_HUMAN t_1O6KA.pdb AGC Active 1 ANP 1.7 -120.79 -176.04 -166.83 56.80 82.94 -173.32 -98.85 24.48 -60.65 -61.36 -25.27 999.00 Allowed THR ASP PHE GLY"
"AKT2_HUMAN t_1O6LA.pdb AGC Active 1 ANP 1.6 -121.53 -178.19 -164.41 58.42 83.31 -172.64 -98.80 24.67 -62.41 -63.48 -19.94 999.00 Allowed THR ASP PHE GLY"
"AKT2_HUMAN t_2JDOA.pdb AGC Active 1 I5S 1.8 -127.40 177.58 67.70 60.40 72.25 -67.86 -91.20 6.74 -60.87 -60.13 -25.04 999.00 Allowed THR ASP PHE GLY"
"AKT2_HUMAN t_2JDRA.pdb AGC Active 1 L20 2.3 -140.77 154.57 -130.04 67.89 87.50 -163.00 -95.93 16.78 -64.85 -47.82 -46.63 999.00 Allowed THR ASP PHE GLY"
"AKT2_HUMAN t_2UW9A.pdb AGC Active 1 GVP 2.1 -123.15 167.75 -175.00 65.49 89.38 -84.30 -103.34 13.59 -65.28 -64.72 -30.61 999.00 Allowed THR ASP PHE GLY"
"AKT2_HUMAN t_2X39A.pdb AGC Active 1 X39 1.93 -126.65 166.39 68.44 70.87 82.87 -66.87 -98.48 13.90 -62.61 -64.86 -22.31 999.00 Allowed THR ASP PHE GLY"
"AKT2_HUMAN t_2XH5A.pdb AGC Active 1 X37 2.72 -110.02 164.58 37.87 66.52 108.71 -68.40 -126.26 14.50 -60.97 -57.39 -39.52 999.00 Outlier THR ASP PHE GLY"
"AKT2_HUMAN t_3D0EA.pdb AGC Active 1 G93 2.00 -125.67 168.92 68.11 61.86 84.13 -154.29 -95.50 25.79 -67.71 -76.94 1.69 999.00 Allowed THR ASP PHE GLY"
"AKT2_HUMAN t_3D0EB.pdb AGC Active 1 G93 2.00 -120.59 168.98 66.29 62.55 83.71 -158.20 -96.73 28.59 -65.85 -76.09 -2.14 999.00 Allowed THR ASP PHE GLY"
"AKT2_HUMAN t_3E87A.pdb AGC Active 1 G95 2.30 -126.03 163.81 58.08 68.92 90.61 -148.97 -105.65 33.50 -57.48 -71.01 -31.02 999.00 Allowed THR ASP PHE GLY"
"AKT2_HUMAN t_3E87B.pdb AGC Active 1 G95 2.30 -125.63 164.30 57.09 67.62 91.39 -150.34 -106.10 33.36 -57.07 -70.61 -30.73 999.00 Allowed THR ASP PHE GLY"
"AKT2_HUMAN t_3E88A.pdb AGC Active 1 G96 2.50 -128.79 173.66 -161.49 61.98 93.97 -176.73 -108.85 31.72 -62.21 -73.83 -16.26 999.00 Outlier THR ASP PHE GLY"
"AKT2_HUMAN t_3E88B.pdb AGC Active 1 G96 2.50 -128.81 173.12 -162.38 62.17 94.11 -176.46 -108.64 31.62 -61.04 -73.92 -15.92 999.00 Outlier THR ASP PHE GLY"
"AKT2_HUMAN t_3E8DA.pdb AGC Active 1 G98 2.70 -131.97 161.19 -23.85 63.93 96.16 -170.44 -108.90 28.68 -63.74 -84.51 5.75 999.00 Outlier THR ASP PHE GLY"
"AKT2_HUMAN t_3E8DB.pdb AGC Active 1 G98 2.70 -130.76 161.76 -16.18 64.60 95.09 -171.01 -108.93 28.34 -63.48 -84.85 6.02 999.00 Allowed THR ASP PHE GLY"
"ALK_HUMAN t_2XB7A.pdb TYR Active 1 GUI 2.50 -132.41 -0.19 999.00 -141.44 142.16 175.58 -131.06 43.79 -67.11 -72.33 -38.54 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_2XBAA.pdb TYR Active 1 571 1.95 -122.73 -16.26 999.00 -123.08 138.10 -178.90 -132.18 31.49 -66.26 -70.59 -36.10 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_2XP2A.pdb TYR Active 1 VGH 1.90 -116.88 -30.28 999.00 -113.62 135.37 179.32 -129.38 33.27 -69.11 -68.91 -36.66 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_2YFXA.pdb TYR Active 1 VGH 1.70 -122.19 -28.60 999.00 -114.92 132.68 -179.90 -127.09 33.53 -66.91 -65.90 -37.73 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_2YHVA.pdb TYR Active 1 Apo 1.90 -123.68 -1.09 999.00 -136.06 135.38 179.54 -132.06 27.90 -70.97 -68.13 -28.81 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_2YJRA.pdb TYR DFGin-inactive 2 Apo 1.90 -109.23 -156.63 999.00 -24.55 131.47 72.99 -106.46 12.42 -65.07 -54.98 -56.34 999.00 Outlier GLY ASP PHE GLY"
"ALK_HUMAN t_2YJSA.pdb TYR Active 1 Apo 1.90 -121.86 -11.49 999.00 -129.49 132.48 179.72 -129.60 30.06 -69.96 -67.46 -32.69 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_3AOXA.pdb TYR Active 1 EMH 1.75 -137.11 23.28 999.00 -158.45 139.10 -174.91 -133.37 27.23 -68.56 -65.71 -43.12 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_3L9PA.pdb TYR Active 1 Apo 1.80 -126.01 -1.98 999.00 -131.10 131.23 -170.80 -131.42 25.37 -68.75 -59.72 -44.18 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_3LCSA.pdb TYR Active 1 STU 1.95 -115.61 -37.77 999.00 -102.70 114.15 -166.36 -112.40 20.00 -70.83 -56.01 -38.22 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_3LCTA.pdb TYR Active 1 ADP 2.10 -127.21 10.25 999.00 -136.36 129.70 -172.17 -130.20 18.67 -68.58 -49.72 -46.70 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_4ANLA.pdb TYR Active 1 Apo 1.70 -122.56 -44.07 999.00 -97.44 124.76 -172.71 -122.53 30.74 -67.48 -66.49 -36.86 999.00 Favored ALA ASP PHE GLY"
"ALK_HUMAN t_4ANQA.pdb TYR Active 1 VGH 1.76 -128.28 -36.37 999.00 -101.81 127.45 -175.08 -123.58 32.01 -71.68 -69.18 -35.82 999.00 Favored ALA ASP PHE GLY"
"ALK_HUMAN t_4ANSA.pdb TYR Active 1 VGH 1.85 -128.21 -41.47 999.00 -98.11 120.89 -175.39 -117.50 30.58 -72.18 -66.47 -38.32 999.00 Favored ALA ASP PHE GLY"
"ALK_HUMAN t_4CCBA.pdb TYR Active 1 OFG 2.03 -119.24 -9.21 999.00 -133.46 139.20 178.29 -130.64 36.23 -67.15 -70.74 -32.97 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_4CCUA.pdb TYR Active 1 AWF 2.00 -118.73 -9.74 999.00 -132.16 139.04 179.62 -133.55 37.43 -64.59 -74.48 -27.92 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_4CD0A.pdb TYR Active 1 AWJ 2.23 -124.48 -7.50 999.00 -131.68 141.50 -178.12 -133.88 29.79 -69.15 -65.38 -35.15 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_4CLIA.pdb TYR Active 1 5P8 2.05 -126.24 -5.02 999.00 -135.38 136.48 178.85 -131.91 38.94 -66.55 -79.84 -27.01 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_4CLJA.pdb TYR Active 1 5P8 1.66 -125.62 0.00 999.00 -140.08 135.09 179.30 -130.43 32.30 -64.53 -65.97 -39.46 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_4CMOA.pdb TYR Active 1 YPW 1.83 -120.98 -9.17 999.00 -132.12 138.83 179.99 -131.65 32.19 -67.43 -67.48 -36.79 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_4CMTA.pdb TYR Active 1 GWH 1.73 -123.26 -5.40 999.00 -133.45 138.98 -177.52 -132.83 32.18 -68.30 -66.84 -37.53 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_4CMUA.pdb TYR Active 1 IV7 1.80 -119.05 -15.63 999.00 -129.55 137.47 178.62 -129.88 35.57 -67.62 -72.10 -34.28 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_4CNHA.pdb TYR Active 1 3U9 1.90 -121.36 -13.53 999.00 -134.76 134.27 -179.71 -127.09 24.82 -68.13 -58.38 -37.07 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_4CNHB.pdb TYR DFGin-inactive 2 3U9 1.90 -115.53 -14.16 999.00 -164.84 163.73 -163.69 -86.37 -10.46 -57.46 53.39 -130.65 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_4CTBA.pdb TYR Active 1 KVC 1.79 -119.64 -9.23 999.00 -135.81 135.49 178.59 -130.09 34.94 -66.11 -68.89 -36.75 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_4CTCA.pdb TYR Active 1 J99 2.03 -113.79 -13.96 999.00 -127.93 134.84 179.74 -130.18 34.39 -63.06 -69.58 -32.87 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_4DCEA.pdb TYR DFGin-inactive 2 0JF 2.03 -137.26 16.46 999.00 -161.52 152.17 -155.11 -94.76 164.25 -68.25 -76.13 999.00 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_4DCEB.pdb TYR DFGin-inactive 2 0JF 2.03 -141.07 18.78 999.00 -165.26 150.03 -155.73 -96.49 167.37 -73.19 -70.40 999.00 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_4FNWA.pdb TYR Active 1 Apo 1.75 -118.49 -25.30 999.00 -118.24 130.14 -175.15 -123.98 30.37 -70.80 -66.15 -35.56 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_4FNXA.pdb TYR DFGin-inactive 2 Apo 1.70 -115.60 -17.62 999.00 -132.34 141.56 -171.78 -132.08 50.20 -65.65 -81.71 -11.74 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_4FNZA.pdb TYR DFGin-inactive 2 NZF 2.60 -135.43 11.96 999.00 -152.71 153.62 -162.75 -83.94 -38.56 -76.67 73.61 999.00 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_4FOBA.pdb TYR Active 1 0US 1.90 -121.89 -5.86 999.00 -135.35 135.60 -174.43 -128.50 34.09 -63.86 -69.72 -38.84 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_4FOCA.pdb TYR Active 1 0UU 1.70 -123.49 -7.28 999.00 -132.62 134.77 -177.38 -129.46 36.54 -66.29 -70.16 -37.65 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_4FODA.pdb TYR Active 1 0UV 2.00 -126.20 8.88 999.00 -148.64 139.11 -168.35 -133.75 30.46 -65.28 -67.10 -41.13 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_4JOAA.pdb TYR Active 1 3DK 2.70 -99.23 -25.50 999.00 -116.95 136.22 -171.89 -132.07 28.53 -70.88 -66.19 -40.47 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_4MKCA.pdb TYR Active 1 4MK 2.01 -119.13 7.33 999.00 -142.68 137.30 -170.46 -134.48 29.54 -60.97 -59.57 -42.67 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_4TT7A.pdb TYR Active 1 COM 2.10 -129.35 13.90 999.00 -143.37 136.27 -173.49 -133.43 29.11 -72.17 -61.03 -46.12 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_4Z55A.pdb TYR Active 1 4LO 1.55 -123.59 13.84 999.00 -145.93 137.89 -170.76 -133.02 27.33 -64.54 -57.58 -49.94 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_5A9UA.pdb TYR Active 1 5P8 1.60 -124.51 -3.08 999.00 -136.21 135.65 -179.35 -131.13 34.69 -68.59 -72.62 -25.02 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_5AA8A.pdb TYR Active 1 5P8 1.86 -121.07 -8.74 999.00 -130.70 131.72 -175.49 -128.03 33.54 -71.81 -75.91 -22.58 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_5AA9A.pdb TYR Active 1 5P8 1.93 -123.83 -6.87 999.00 -134.60 136.54 178.05 -132.05 29.85 -70.46 -66.01 -35.66 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_5AAAA.pdb TYR Active 1 VGH 0 -119.08 -27.27 999.00 -116.18 136.75 -179.16 -130.58 32.52 -70.53 -67.69 -37.17 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_5AABA.pdb TYR Active 1 VGH 0 -122.07 -28.39 999.00 -115.25 132.25 -171.39 -127.28 26.80 -70.62 -65.10 -33.89 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_5AACA.pdb TYR Active 1 VGH 0 -115.23 -31.76 999.00 -111.77 134.20 -178.63 -128.43 30.24 -69.90 -65.59 -32.83 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_5FTOA.pdb TYR Active 1 YMX 2.22 -123.34 0.00 999.00 -137.70 139.62 -175.76 -135.48 24.87 -70.88 -60.36 -46.30 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_5FTQA.pdb TYR Active 1 U4W 1.70 -118.69 -8.37 999.00 -138.54 135.07 -173.46 -126.77 26.71 -64.30 -58.59 -49.77 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_5IMXA.pdb TYR DFGin-inactive 2 CZ4 2.12 -109.55 -14.12 999.00 -148.25 147.06 -163.03 -105.68 146.53 -76.04 -67.38 -107.72 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_5IUGA.pdb TYR DFGout 6 729 1.93 -131.09 -161.01 999.00 -160.89 113.54 -168.05 -82.67 -13.54 -81.54 82.24 14.96 999.00 Allowed GLY ASP PHE GLY"
"ALK_HUMAN t_5IUHA.pdb TYR DFGout 6 34Y 2.10 -138.55 -161.58 999.00 -159.16 110.90 -166.08 -77.25 -9.51 -80.08 78.08 14.42 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_5IUIA.pdb TYR Active 1 45Q 1.88 -116.00 -40.54 999.00 -98.04 131.37 -172.28 -128.90 29.99 -69.83 -67.07 -40.39 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_5J7HA.pdb TYR Active 1 6GY 1.96 -122.40 -21.50 999.00 -116.16 138.09 -173.56 -133.04 29.26 -72.28 -69.03 -28.44 999.00 Favored GLY ASP PHE GLY"
"ALK_HUMAN t_5KZ0A.pdb TYR Active 1 6YL 2.30 -133.15 -11.58 999.00 -127.12 138.04 178.44 -132.88 29.13 -67.80 -79.97 -2.43 999.00 Favored GLY ASP PHE GLY"
"ARBK1_HUMAN t_3CIKA.pdb AGC Active 1 Apo 2.75 -113.37 -84.34 -161.85 -77.45 106.50 -161.91 -85.24 5.52 -87.40 -54.38 -34.28 999.00 NA SER ASP LEU GLY"
"ARBK1_HUMAN t_3KRWA.pdb AGC Active 1 BA1 2.90 -124.43 -70.02 -167.51 -70.76 103.10 -147.02 -103.15 18.77 -78.37 -63.69 -46.76 999.00 NA SER ASP LEU GLY"
"ARBK1_HUMAN t_3KRXA.pdb AGC Active 1 BA1 3.10 -125.42 -77.97 -169.41 -69.63 105.59 -151.54 -105.59 33.02 -78.60 -76.26 -41.06 999.00 NA SER ASP LEU GLY"
"ARBK1_HUMAN t_3V5WA.pdb AGC Active 1 8PR 2.07 -135.72 166.75 -175.36 63.48 84.46 -67.06 -90.07 8.78 -75.14 -55.77 -32.10 999.00 NA SER ASP LEU GLY"
"ARBK1_HUMAN t_4MK0A.pdb AGC Active 1 29X 2.40 -114.27 159.32 178.77 62.50 95.09 -155.90 -99.06 26.82 -45.22 -55.22 -46.18 999.00 NA SER ASP LEU GLY"
"ARBK1_HUMAN t_4PNKA.pdb AGC Active 1 KZQ 2.56 -131.90 150.62 150.81 73.28 94.13 -160.34 -104.41 20.28 -83.66 -49.26 -48.99 999.00 NA SER ASP LEU GLY"
"ARBK1_HUMAN t_5HE1A.pdb AGC Active 1 ZS2 3.15 -136.45 161.17 -173.12 63.18 92.14 -73.37 -104.95 24.34 -64.44 -54.14 -39.69 999.00 NA SER ASP LEU GLY"
"ARBK1_HUMAN t_5UKKA.pdb AGC Active 1 8DJ 2.60 -148.48 179.65 86.99 57.75 73.56 -108.07 -88.04 9.00 -85.96 -60.02 -18.89 999.00 NA SER ASP LEU GLY"
"ARBK1_HUMAN t_5UKLA.pdb AGC Active 1 SIX 2.15 -136.12 162.40 104.25 65.32 90.76 -176.69 -91.03 16.10 -72.68 -44.46 -43.33 999.00 NA SER ASP LEU GLY"
"AURKA_HUMAN t_1MQ4A.pdb OTHER Active 1 ADP 1.90 -132.62 179.34 999.00 62.49 72.26 -165.47 -91.06 21.51 -80.10 -61.33 -27.72 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_1MUOA.pdb OTHER DFGinter 5 ADN 2.90 -137.22 91.66 999.00 -102.70 104.17 -66.32 -141.99 -158.03 -42.57 -72.89 -80.71 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_1OL5A.pdb OTHER Active 1 ADP 2.5 -139.17 -172.08 999.00 52.21 80.17 -163.54 -90.88 24.71 -77.39 -49.86 -44.22 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_1OL6A.pdb OTHER Active 1 ATP 3 -135.88 178.50 999.00 52.41 77.02 -45.76 -92.17 24.51 -67.79 -61.17 -14.49 999.00 Allowed ALA ASN PHE GLY"
"AURKA_HUMAN t_1OL7A.pdb OTHER Active 1 ADP 2.75 -133.08 -167.55 999.00 48.98 74.14 -173.17 -88.95 32.43 -74.09 -57.67 -36.10 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_2BMCA.pdb OTHER DFGinter 5 MPY 2.60 -120.19 2.72 999.00 -79.72 177.88 50.03 -120.47 28.67 -80.68 -63.41 54.97 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_2BMCB.pdb OTHER DFGinter 5 MPY 2.60 -121.31 0.30 999.00 -78.18 179.91 51.44 -122.08 26.85 -78.24 -64.75 57.79 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_2BMCC.pdb OTHER DFGinter 5 MPY 2.60 -111.70 -8.12 999.00 -77.98 176.79 56.83 -119.79 27.04 -76.33 -62.65 57.18 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_2BMCD.pdb OTHER DFGinter 5 MPY 2.60 -115.72 -0.94 999.00 -79.83 179.39 59.48 -120.09 22.53 -75.52 -64.02 59.54 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_2BMCE.pdb OTHER DFGinter 5 MPY 2.60 -115.43 -3.53 999.00 -77.33 179.54 58.34 -120.28 21.71 -75.42 -63.53 61.08 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_2BMCF.pdb OTHER DFGinter 5 MPY 2.60 -115.61 -5.94 999.00 -78.55 177.35 60.24 -122.15 28.31 -77.78 -65.78 60.76 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_2C6DA.pdb OTHER DFGup 3 ANP 2.2 -70.12 150.12 999.00 -40.49 101.21 38.95 -55.13 131.84 61.79 98.64 -164.81 999.00 Outlier ALA ASP PHE GLY"
"AURKA_HUMAN t_2C6EA.pdb OTHER DFGout 6 HPM 2.1 -107.47 166.43 999.00 -107.99 77.20 -162.19 -86.38 -35.16 -72.04 -90.98 43.14 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_2DWBA.pdb OTHER Active 1 ANP 2.50 -136.08 177.40 999.00 60.86 78.39 -178.53 -89.16 29.24 -73.10 -66.23 -4.04 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_2J4ZA.pdb OTHER DFGinter 5 626 2.0 -134.70 62.94 999.00 -108.01 40.85 76.53 -66.11 -23.24 173.79 87.28 -158.40 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_2J4ZB.pdb OTHER DFGinter 5 626 2.0 -135.91 74.19 999.00 -114.30 33.38 72.24 -89.44 114.87 -57.82 -8.54 159.31 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_2J50A.pdb OTHER DFGinter 5 627 3.0 -113.55 -10.94 999.00 -64.25 174.02 56.43 -114.89 30.26 -54.21 -88.36 66.85 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_2J50B.pdb OTHER DFGinter 5 627 3.0 -113.61 -10.78 999.00 -64.35 174.05 56.40 -114.90 30.11 -54.20 -88.27 66.85 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_2NP8A.pdb OTHER DFGin-inactive 2 CC3 2.25 -73.92 -44.34 999.00 -158.48 -167.75 60.66 -112.01 8.61 -77.11 66.13 -157.48 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_2W1CA.pdb OTHER Active 1 L0C 3.24 -97.53 -171.61 999.00 46.90 95.06 -150.85 -107.93 39.74 -78.08 -60.66 -63.30 999.00 Outlier ALA ASP PHE GLY"
"AURKA_HUMAN t_2W1DA.pdb OTHER Active 1 L0D 2.97 -98.73 177.07 999.00 59.74 110.81 -139.76 -129.81 40.43 -76.96 -60.82 -58.21 999.00 Outlier ALA ASP PHE GLY"
"AURKA_HUMAN t_2W1EA.pdb OTHER Active 1 L0E 2.93 -88.44 176.41 999.00 54.42 134.07 -133.76 -145.65 35.42 -71.47 -59.99 -38.48 999.00 Outlier ALA ASP PHE GLY"
"AURKA_HUMAN t_2W1FA.pdb OTHER Active 1 L0F 2.85 -96.29 172.43 999.00 62.07 107.70 -156.59 -118.89 38.88 -70.83 -59.62 -48.39 999.00 Outlier ALA ASP PHE GLY"
"AURKA_HUMAN t_2W1GA.pdb OTHER Active 1 L0G 2.71 -102.41 -172.26 999.00 37.87 92.25 -161.32 -96.83 32.78 -79.43 -53.01 -62.68 999.00 Outlier ALA ASP PHE GLY"
"AURKA_HUMAN t_2WTVA.pdb OTHER DFGinter 5 ZZL 2.40 -75.26 156.03 999.00 -105.17 157.02 -45.99 57.55 45.34 -40.97 -59.60 -21.71 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_2WTVB.pdb OTHER DFGinter 5 ZZL 2.40 -74.73 158.61 999.00 -101.79 146.27 -52.00 63.98 49.33 -42.71 -55.61 -26.35 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_2WTVC.pdb OTHER DFGinter 5 ZZL 2.40 -73.46 155.34 999.00 -96.91 146.25 -50.91 67.11 43.88 -43.83 -46.73 -31.96 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_2WTVD.pdb OTHER DFGinter 5 ZZL 2.40 -74.45 159.39 999.00 -108.45 161.10 -44.82 55.07 43.33 -42.83 -58.51 -27.31 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_2WTWA.pdb OTHER Active 1 ZZL 3.30 -106.42 -45.37 999.00 -104.14 150.13 177.50 -135.40 26.60 -72.09 -51.84 -25.56 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_2X6DA.pdb OTHER Active 1 X6D 2.80 -133.33 178.93 999.00 66.09 63.22 -151.28 -78.83 41.17 -69.85 -67.22 -32.22 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_2X6EA.pdb OTHER Active 1 YM4 3.35 -133.55 -165.42 999.00 46.97 97.45 -173.74 -106.93 55.26 -69.45 -55.53 -43.87 999.00 Outlier ALA ASP PHE GLY"
"AURKA_HUMAN t_2XNEA.pdb OTHER Active 1 ASH 2.80 -132.15 -174.52 999.00 57.91 85.26 -61.37 -105.94 29.83 -64.85 -63.43 -29.39 999.00 Allowed ALA ASN PHE GLY"
"AURKA_HUMAN t_2XNGA.pdb OTHER Active 1 A0H 2.60 -120.46 176.58 999.00 56.36 70.38 -169.41 -73.58 38.13 -78.61 -44.78 -64.34 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_2XRUA.pdb OTHER Active 1 400 2.90 -125.18 155.42 999.00 69.36 129.40 -94.15 -125.82 -55.41 -83.69 -8.07 69.59 999.00 Outlier ALA ASP PHE GLY"
"AURKA_HUMAN t_3E5AA.pdb OTHER Active 1 VX6 2.30 -111.14 -40.73 999.00 -107.68 114.81 -155.10 -109.11 20.37 -73.55 -57.33 -21.14 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_3FDNA.pdb OTHER DFGinter 5 MMH 1.90 -113.85 -12.24 999.00 -83.93 149.99 88.21 -89.89 27.34 -71.67 -77.57 62.14 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_3H0YA.pdb OTHER DFGinter 5 48B 2.50 -109.45 -26.44 999.00 -75.35 137.25 57.07 -77.09 162.48 -66.19 -85.30 155.37 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_3H0ZA.pdb OTHER DFGin-inactive 2 45B 2.92 -89.98 161.48 999.00 64.56 -172.91 -46.21 -163.15 -57.23 -79.08 171.23 120.62 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_3H10A.pdb OTHER DFGinter 5 97B 2.20 -85.73 156.33 999.00 -96.88 153.49 -40.11 66.81 45.27 -42.18 -57.92 -32.94 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_3H10B.pdb OTHER DFGinter 5 97B 2.20 -84.11 155.69 999.00 -96.36 147.82 -49.73 67.74 46.99 -46.87 -65.01 -29.76 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_3H10D.pdb OTHER DFGinter 5 97B 2.20 -78.36 156.21 999.00 -102.04 146.34 -51.70 61.53 46.31 -39.55 -53.28 -35.92 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_3HA6A.pdb OTHER Active 1 2JZ 2.36 -141.58 -150.56 999.00 44.94 71.09 -70.29 -95.96 24.40 -84.65 -69.78 -23.80 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_3K5UA.pdb OTHER DFGinter 5 PFQ 2.35 -107.52 -18.98 999.00 -91.44 151.11 58.97 -94.10 23.55 -61.30 -72.04 54.90 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_3M11A.pdb OTHER Active 1 AKI 2.75 -121.87 165.28 999.00 64.29 67.30 -174.62 -73.84 6.74 -71.67 -59.92 -23.22 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_3MYGA.pdb OTHER Active 1 EML 2.40 -122.32 -179.46 999.00 56.94 60.99 -56.95 -81.35 19.83 -78.41 -60.90 -48.62 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_3NRMA.pdb OTHER Active 1 NRM 3.05 -130.09 -178.22 999.00 51.18 66.84 -43.98 -80.61 35.57 -82.73 -64.11 -46.79 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_3O50A.pdb OTHER DFGinter 5 LJE 2.00 -120.49 57.49 999.00 -126.57 83.91 -155.70 -51.30 45.90 -54.20 -47.92 167.60 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_3P9JA.pdb OTHER DFGinter 5 P9J 2.80 -102.39 -6.05 999.00 -81.84 156.25 82.38 -90.40 17.17 -70.48 -77.53 34.79 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_3R21A.pdb OTHER Active 1 D36 2.90 -119.23 169.04 999.00 74.54 71.15 -150.97 -87.23 26.33 -68.66 -45.70 -73.94 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_3R22A.pdb OTHER DFGinter 5 D37 2.90 -142.76 -34.48 999.00 -91.78 -141.27 -130.42 -154.70 60.24 -83.20 -152.25 21.18 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_3UNZA.pdb OTHER DFGinter 5 0BZ 2.80 -84.47 -63.79 999.00 54.99 -138.14 -123.51 56.37 -120.98 -144.94 -49.63 129.62 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_3UNZB.pdb OTHER DFGinter 5 0BZ 2.80 -84.48 -63.75 999.00 55.15 -138.04 -123.41 56.43 -120.92 -144.98 -49.65 129.45 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_3UO4A.pdb OTHER Active 1 0C0 2.45 -126.05 -172.64 999.00 52.96 69.76 -140.54 -90.34 6.12 -90.39 -48.01 -48.68 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_3UO5A.pdb OTHER Active 1 0BX 2.70 -112.47 -174.85 999.00 56.03 75.98 -172.81 -85.67 17.57 -85.19 -44.30 -44.32 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_3UO6A.pdb OTHER DFGinter 5 0BY 2.80 -92.08 -63.22 999.00 55.82 -136.46 -136.41 58.39 -117.76 -155.53 -58.78 166.89 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_3UO6B.pdb OTHER DFGinter 5 0BY 2.80 -92.31 -63.25 999.00 55.66 -136.67 -136.44 58.87 -118.34 -155.26 -58.96 166.82 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_3UODA.pdb OTHER Active 1 0C3 2.50 -104.17 -60.75 999.00 -102.11 108.06 -171.08 -93.67 11.03 -87.05 -44.04 -46.61 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_3UOHA.pdb OTHER DFGinter 5 0C4 2.80 -93.22 -63.34 999.00 54.83 -130.22 -156.84 58.52 -116.06 -157.53 -59.87 169.93 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_3UOHB.pdb OTHER DFGinter 5 0C4 2.80 -93.18 -63.39 999.00 54.70 -130.87 -156.23 58.95 -116.27 -157.27 -60.05 170.49 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_3UOJA.pdb OTHER DFGinter 5 0C5 2.90 -89.00 -64.25 999.00 49.65 -140.50 -157.62 55.63 -113.79 -178.58 -48.60 138.88 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_3UOJB.pdb OTHER DFGinter 5 0C5 2.90 -88.84 -64.59 999.00 49.65 -140.48 -157.85 55.63 -113.74 -178.94 -48.46 138.57 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_3UOKA.pdb OTHER DFGinter 5 0C6 2.95 -87.42 -71.38 999.00 58.99 -135.38 -165.44 54.65 -117.03 -164.49 -55.89 122.72 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_3UOKB.pdb OTHER DFGinter 5 0C6 2.95 -88.98 -71.51 999.00 59.10 -134.85 -165.25 54.31 -116.97 -164.56 -56.02 122.88 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_3UOLA.pdb OTHER DFGinter 5 0C7 2.40 -80.66 -49.95 999.00 38.74 -132.07 -162.32 60.56 -110.72 -162.13 -76.72 23.34 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_3UOLB.pdb OTHER DFGinter 5 0C7 2.40 -80.77 -49.41 999.00 38.09 -131.73 -162.48 60.38 -110.55 -161.77 -77.05 23.23 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_3UP2A.pdb OTHER Active 1 0C8 2.30 -108.11 -50.88 999.00 -103.26 118.74 -166.72 -107.46 26.63 -80.50 -56.15 -30.64 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_3UP7A.pdb OTHER Active 1 0C9 3.05 -130.14 178.74 999.00 54.47 64.08 -49.09 -79.26 24.73 -75.36 -53.82 -49.47 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_3VAPA.pdb OTHER DFGin-inactive 2 0FY 2.66 -124.23 172.42 999.00 53.88 74.51 -59.70 -90.42 3.74 -81.48 -61.18 -14.69 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_3W10A.pdb OTHER DFGinter 5 RO9 2.70 -119.05 54.38 999.00 -98.56 30.03 66.53 -138.69 164.78 58.17 47.81 16.64 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_3W16A.pdb OTHER DFGinter 5 P9J 2.80 -121.71 15.14 999.00 -95.95 166.09 63.57 -111.11 78.29 -47.84 -146.89 73.23 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_3W18B.pdb NA NA 0 N13 2.50 -134.47 -22.55 999.00 -99.48 108.98 -161.23 24.20 -97.45 999.00 76.77 11.54 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_4B0GA.pdb NA NA 0 VEK 2.50 -124.74 65.73 999.00 -126.07 153.36 -100.62 -100.54 32.78 999.00 -102.64 15.90 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_4BN1A.pdb OTHER Active 1 ADP 2.50 -135.70 176.69 999.00 57.30 85.46 -179.06 -97.02 20.62 -76.71 -48.27 -40.44 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_4BYIA.pdb OTHER Active 1 FH3 2.6 -141.70 21.61 999.00 -149.09 143.65 -155.15 -145.22 27.76 -63.51 -78.36 -3.41 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_4C3PA.pdb OTHER Active 1 ACP 2.69 -143.17 44.14 999.00 -117.36 -72.68 -157.31 63.18 22.35 -50.47 -71.02 -27.42 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_4C3PD.pdb OTHER Active 1 ACP 2.69 -119.79 -23.93 999.00 -110.97 146.32 -153.58 -144.29 22.54 -71.27 -63.40 -34.25 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_4C3RA.pdb OTHER DFGinter 5 ACP 2.79 -114.29 -7.41 999.00 -87.67 130.59 111.22 -72.80 -47.14 -74.58 69.26 138.63 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_4CEGA.pdb OTHER Active 1 ADP 2.10 -126.74 -176.42 999.00 60.88 65.85 -164.49 -88.75 20.28 -83.93 -62.74 -30.18 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_4DEAA.pdb OTHER Active 1 NHI 2.45 -117.08 -34.07 999.00 -114.55 105.92 -163.00 -93.82 27.84 -71.88 -50.14 -53.78 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_4DEBA.pdb OTHER Active 1 NHJ 3.05 -117.97 177.65 999.00 55.24 79.43 -146.91 -92.09 27.07 -77.89 -55.44 -60.76 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_4DEDA.pdb OTHER Active 1 NHU 3.05 -138.73 173.26 999.00 68.31 60.02 -70.30 -87.91 21.54 -68.91 -64.01 -43.36 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_4DEEA.pdb OTHER Active 1 ADP 2.30 -131.52 -177.89 999.00 61.38 72.15 -163.42 -88.35 17.45 -81.44 -56.72 -24.26 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_4DHFA.pdb OTHER Active 1 0K6 2.80 -124.97 -165.38 999.00 70.64 -102.36 177.53 69.57 140.85 -69.70 63.90 95.40 999.00 Outlier ALA ASP PHE GLY"
"AURKA_HUMAN t_4DHFB.pdb OTHER Active 1 0K6 2.80 -129.29 -166.61 999.00 71.77 -102.88 -171.89 78.35 163.39 -82.41 43.85 85.36 999.00 Outlier ALA ASP PHE GLY"
"AURKA_HUMAN t_4J8MA.pdb OTHER DFGup 3 CAF 1.85 -146.26 170.23 999.00 51.59 44.76 -76.09 -105.94 -3.02 55.02 -73.51 148.14 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_4J8NA.pdb OTHER Active 1 Apo 3.13 -129.56 -176.96 999.00 54.94 81.06 -55.13 -100.43 18.22 -82.13 -55.53 -42.58 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_4J8NB.pdb OTHER Active 1 Apo 3.13 -129.54 -174.73 999.00 53.19 81.30 -53.95 -99.27 18.16 -82.72 -54.46 -45.20 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_4J8NC.pdb OTHER Active 1 Apo 3.13 -130.99 -172.91 999.00 51.52 76.65 -56.58 -93.60 21.08 -82.56 -50.39 -43.64 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_4J8ND.pdb OTHER Active 1 Apo 3.13 -130.75 -174.80 999.00 51.84 76.23 -57.79 -93.32 22.07 -82.91 -52.21 -43.56 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_4JAJA.pdb OTHER Active 1 XU1 2.70 -130.81 -179.25 999.00 60.81 74.26 -72.27 -92.93 19.33 -80.66 -57.08 -30.91 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_4JBOA.pdb OTHER Active 1 WPH 2.49 -121.92 170.21 999.00 69.47 92.48 -166.09 -109.11 25.99 -77.52 -73.37 -12.51 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_4JBPA.pdb OTHER Active 1 YPH 2.45 -117.35 167.71 999.00 63.38 95.54 -170.29 -104.03 27.02 -77.74 -62.02 -18.65 999.00 Outlier ALA ASP PHE GLY"
"AURKA_HUMAN t_4JBQA.pdb OTHER DFGinter 5 VX6 2.30 -117.18 -3.78 999.00 -81.56 -172.61 53.18 -125.30 20.28 -82.51 -74.71 56.22 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_4O0SA.pdb OTHER Active 1 ADN 2.50 -149.64 -178.04 999.00 57.73 66.01 -72.01 -83.70 4.50 -99.93 -48.31 -52.57 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_4O0UA.pdb OTHER DFGup 3 ADN 2.60 -100.70 -17.10 999.00 -134.58 128.99 -171.77 -80.58 -37.60 28.77 64.51 -126.45 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_4O0WA.pdb OTHER Active 1 ADN 2.60 -99.28 -54.61 999.00 -80.03 -74.24 -104.85 72.79 -1.52 -80.67 -53.76 -20.48 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_4PRJA.pdb OTHER Active 1 2VU 2.80 -87.83 -78.91 999.00 -67.26 132.08 -110.71 -130.02 25.76 -86.46 -59.96 -22.75 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_4UTDA.pdb OTHER Active 1 ACP 2.36 -134.50 -175.14 999.00 46.25 72.25 -169.56 -78.37 7.55 -96.54 -22.75 -63.64 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_4UYNA.pdb OTHER DFGinter 5 Y3M 1.90 -129.70 33.30 999.00 -11.90 -124.03 106.65 104.63 86.60 36.80 29.99 999.00 999.00 Outlier ALA ASP PHE GLY"
"AURKA_HUMAN t_4UZDA.pdb OTHER DFGinter 5 QMN 3.20 -129.81 37.04 999.00 -50.57 -30.95 -169.97 -53.57 125.58 -34.67 118.09 999.00 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_4UZDB.pdb OTHER DFGinter 5 QMN 3.20 -129.51 39.36 999.00 -48.34 -42.16 -161.48 -43.36 138.95 -33.65 97.76 -168.36 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_4ZS0A.pdb OTHER Active 1 4QV 3.00 -135.77 -170.31 999.00 51.68 73.89 -60.27 -87.92 25.13 -79.45 -52.38 -36.18 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_4ZTQA.pdb OTHER DFGinter 5 4RM 2.80 -128.91 86.41 999.00 -158.63 -178.02 61.40 -107.11 35.47 -62.09 -105.36 22.92 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_4ZTRA.pdb OTHER DFGinter 5 4RJ 2.85 -145.73 66.01 999.00 -113.53 176.69 62.16 -135.68 26.63 -148.71 -104.44 142.81 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_4ZTSA.pdb OTHER DFGinter 5 4RK 2.90 -142.96 93.02 999.00 -162.42 -179.70 59.40 -105.31 64.86 -69.47 159.82 107.62 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_5AADA.pdb OTHER Active 1 5GX 3.10 -160.18 -169.75 999.00 46.41 81.25 -174.29 -88.90 36.77 -78.17 -69.21 -12.17 999.00 Outlier ALA ASP PHE GLY"
"AURKA_HUMAN t_5AAEA.pdb OTHER Active 1 7HD 3.11 -95.89 -104.89 999.00 -82.23 148.80 44.93 -122.77 23.17 -69.03 -53.72 -36.38 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_5AAFA.pdb OTHER Active 1 NL4 2.78 -104.32 -69.40 999.00 -80.92 136.22 -151.00 -128.30 19.05 -77.73 -69.21 -0.32 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_5AAGA.pdb OTHER Active 1 6F2 2.85 -109.02 -72.67 999.00 -67.07 138.02 -177.33 -133.77 27.30 -82.96 -59.88 -35.77 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_5DN3A.pdb OTHER Active 1 ATP 2.05 -130.89 -174.40 999.00 55.28 74.83 -170.80 -89.01 14.16 -84.51 -51.89 -35.20 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_5DNRA.pdb OTHER Active 1 ATP 1.95 -132.26 -179.70 999.00 60.74 76.62 -171.52 -90.15 18.72 -84.09 -56.65 -35.90 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_5DOSA.pdb OTHER Active 1 5DN 2.98 -141.16 -178.46 999.00 56.48 85.62 -175.21 -101.46 29.51 -77.35 -61.48 -42.66 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_5DPVA.pdb OTHER Active 1 SKE 2.29 -110.94 -43.25 999.00 -110.84 101.04 -73.65 -87.45 23.47 -81.18 -59.54 -51.27 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_5DR2A.pdb OTHER Active 1 5E1 2.46 -112.81 -178.27 999.00 59.16 85.91 -159.48 -103.73 31.07 -77.52 -64.78 -39.94 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_5DR6A.pdb OTHER Active 1 SKE 2.53 -109.16 -45.29 999.00 -112.37 100.23 -79.19 -88.78 25.05 -81.82 -61.54 -50.51 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_5DR9A.pdb OTHER Active 1 SKE 2.47 -123.36 -163.75 999.00 43.64 60.50 -72.12 -66.56 -12.27 -99.87 -59.79 149.04 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_5DRDA.pdb OTHER Active 1 ATP 2.13 -124.75 -173.06 999.00 54.29 73.06 -159.21 -91.88 14.85 -83.61 -60.52 -27.83 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_5DT0A.pdb OTHER Active 1 SKE 2.15 -112.60 -43.66 999.00 -110.13 94.56 -76.15 -84.53 17.18 -80.53 -58.46 -46.48 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_5DT3A.pdb OTHER Active 1 ATP 2.33 -138.47 178.44 999.00 59.61 78.34 -171.30 -90.83 24.80 -78.56 -61.05 -31.64 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_5DT4A.pdb OTHER Active 1 5DN 2.86 -131.58 -179.09 999.00 56.54 87.02 176.63 -103.89 25.72 -77.91 -59.26 -42.35 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_5EW9A.pdb OTHER DFGinter 5 5VC 2.18 -125.78 68.00 999.00 -116.10 111.16 166.84 -114.05 30.21 -60.20 76.48 31.15 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_5G1XA.pdb OTHER Active 1 ADP 1.72 -132.85 -170.59 999.00 52.69 76.46 -152.00 -90.89 13.92 -80.85 -59.54 -20.42 999.00 Allowed ALA ASP PHE GLY"
"AURKA_HUMAN t_5L8JA.pdb OTHER DFGinter 5 ADP 1.68 -121.43 -0.82 999.00 -92.80 -3.48 64.79 60.94 19.47 -62.84 -77.81 60.21 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_5L8KA.pdb OTHER DFGinter 5 ADP 1.79 -123.51 3.82 999.00 -94.87 4.10 68.18 51.15 25.41 -52.40 -83.21 69.33 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_5L8LA.pdb OTHER DFGinter 5 ADP 1.67 -117.79 6.61 999.00 -92.87 -1.12 55.42 53.24 20.40 -70.39 -83.98 68.42 999.00 Favored ALA ASP PHE GLY"
"AURKA_HUMAN t_5LXMA.pdb OTHER Active 1 ADP 2.08 -135.42 -179.75 999.00 54.75 80.94 -175.96 -90.81 30.15 -76.82 -72.41 -3.12 999.00 Allowed ALA ASP PHE GLY"
"AURKB_HUMAN t_4AF3A.pdb OTHER DFGinter 5 VX6 2.75 -112.40 112.13 999.00 -127.45 99.79 999.00 -141.88 168.72 -74.32 155.44 999.00 999.00 Favored ALA ASP PHE GLY"
"AVR2A_HUMAN t_3Q4TA.pdb TKL Active 1 TAK 1.96 -123.53 165.58 999.00 68.53 85.67 -154.80 -104.05 23.68 -59.41 -61.24 -27.19 999.00 Allowed ALA ASP PHE GLY"
"AVR2A_HUMAN t_3Q4TB.pdb TKL Active 1 TAK 1.96 -128.74 167.36 999.00 69.00 93.19 -157.66 -108.03 19.78 -55.58 -60.63 -27.40 999.00 Allowed ALA ASP PHE GLY"
"AVR2A_HUMAN t_3SOCA.pdb TKL Active 1 GVD 1.95 -129.58 162.97 999.00 71.24 89.99 -163.96 -103.83 25.00 -57.86 -63.89 -23.67 999.00 Allowed ALA ASP PHE GLY"
"AVR2A_HUMAN t_3SOCB.pdb TKL Active 1 GVD 1.95 -125.19 161.31 999.00 74.62 92.68 -158.33 -105.43 25.81 -51.22 -59.93 -27.54 999.00 Allowed ALA ASP PHE GLY"
"AVR2A_HUMAN t_4ASXA.pdb TKL Active 1 6OJ 2.05 -124.21 158.36 999.00 76.63 95.81 -157.47 -110.57 27.07 -56.21 -64.05 -28.39 999.00 Allowed ALA ASP PHE GLY"
"AVR2A_HUMAN t_4ASXB.pdb TKL Active 1 6OJ 2.05 -125.18 162.23 999.00 70.70 90.83 -149.34 -105.82 23.25 -59.39 -60.77 -32.55 999.00 Allowed ALA ASP PHE GLY"
"AVR2B_HUMAN t_2QLUA.pdb TKL Active 1 Apo 2.00 -143.64 166.04 999.00 72.05 78.25 -120.43 -102.89 27.27 -59.03 -72.21 -17.92 999.00 Allowed ALA ASP PHE GLY"
"BMP2K_HUMAN t_4W9WA.pdb OTHER Active 1 YDJ 1.72 -139.20 -173.86 68.33 58.90 80.27 -164.18 -96.98 16.55 -62.73 -77.92 -7.81 999.00 Allowed CYS ASP PHE GLY"
"BMP2K_HUMAN t_4W9XA.pdb OTHER Active 1 3JW 2.14 -134.68 171.75 73.96 65.14 87.83 -167.39 -97.18 19.72 -56.22 -58.30 -30.64 999.00 Allowed CYS ASP PHE GLY"
"BMP2K_HUMAN t_5I3OA.pdb OTHER Active 1 IDV 2.40 -120.10 -5.05 68.13 -132.30 129.96 -166.81 -127.41 29.07 -57.22 -66.77 -26.70 999.00 Favored CYS ASP PHE GLY"
"BMP2K_HUMAN t_5I3OB.pdb OTHER Active 1 IDV 2.40 -120.63 -6.81 68.71 -129.61 129.53 -164.36 -126.93 28.38 -57.02 -62.00 -28.58 999.00 Favored CYS ASP PHE GLY"
"BMP2K_HUMAN t_5I3RA.pdb OTHER Active 1 IDK 2.40 -120.84 4.13 68.38 -140.05 134.02 -159.86 -133.37 24.79 -57.02 -60.73 -27.10 999.00 Favored CYS ASP PHE GLY"
"BMP2K_HUMAN t_5I3RB.pdb OTHER Active 1 IDK 2.40 -120.46 2.49 69.42 -138.33 133.11 -157.44 -133.04 26.32 -57.04 -59.28 -28.23 999.00 Favored CYS ASP PHE GLY"
"BMP2K_HUMAN t_5IKWA.pdb OTHER Active 1 6BU 2.41 -119.40 -5.02 67.19 -129.37 129.38 -174.22 -129.12 20.56 -62.03 -68.46 -10.21 999.00 Favored CYS ASP PHE GLY"
"BMPR2_HUMAN t_3G2FA.pdb TKL Active 1 ADP 2.35 -131.62 -179.23 48.31 66.07 79.88 -170.83 -102.79 27.44 -55.75 -59.99 -25.23 999.00 Allowed SER ASP PHE GLY"
"BMPR2_HUMAN t_3G2FB.pdb TKL Active 1 CAS 2.35 -149.70 179.94 36.33 61.06 87.16 -163.31 -102.58 11.96 -66.22 -56.68 -17.95 999.00 Allowed SER ASP PHE GLY"
"BMR1B_HUMAN t_3MDYA.pdb TKL Active 1 LDN 2.05 -133.21 178.84 999.00 67.01 77.55 -130.99 -104.30 15.51 -47.72 -70.23 -20.05 999.00 NA ALA ASP LEU GLY"
"BMR1B_HUMAN t_3MDYC.pdb TKL Active 1 LDN 2.05 -127.09 179.72 999.00 70.64 73.15 -128.62 -100.86 10.20 -48.95 -64.79 -24.65 999.00 NA ALA ASP LEU GLY"
"BMX_HUMAN t_3SXRA.pdb TYR DFGinter 5 1N1 2.40 -93.55 121.22 172.74 -103.26 -9.03 59.71 -51.26 114.48 -175.26 62.67 18.93 999.00 Favored SER ASP PHE GLY"
"BMX_HUMAN t_3SXRB.pdb TYR DFGinter 5 1N1 2.40 -92.84 121.29 53.87 -96.70 -12.13 57.59 -49.03 115.53 -173.00 61.76 19.28 999.00 Favored SER ASP PHE GLY"
"BMX_HUMAN t_3SXSA.pdb TYR DFGinter 5 PP2 1.89 -95.66 121.23 -177.20 -113.80 -1.35 62.76 -56.55 124.15 176.42 70.61 15.31 999.00 Favored SER ASP PHE GLY"
"BRAF_HUMAN t_1UWHA.pdb TKL DFGout 6 BAX 2.95 -173.89 -166.76 999.00 -121.29 89.11 -147.93 -83.19 16.37 -58.63 -83.77 148.10 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_1UWHB.pdb TKL DFGout 6 BAX 2.95 -173.53 -167.04 999.00 -121.31 88.70 -148.08 -83.12 16.43 -58.51 -83.57 148.38 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_1UWJA.pdb TKL DFGout 6 BAX 3.5 -166.49 179.40 999.00 -106.44 74.97 -159.14 -68.35 24.72 -63.90 -94.41 168.91 999.00 Allowed GLY ASP PHE GLY"
"BRAF_HUMAN t_1UWJB.pdb TKL DFGout 6 BAX 3.5 -165.37 177.82 999.00 -106.41 76.03 -158.98 -68.16 23.13 -64.31 -92.86 169.17 999.00 Allowed GLY ASP PHE GLY"
"BRAF_HUMAN t_2FB8A.pdb TKL Active 1 215 2.90 -146.28 -176.91 999.00 62.65 94.54 -148.52 -116.54 20.32 -85.13 -45.59 -44.49 999.00 Outlier GLY ASP PHE GLY"
"BRAF_HUMAN t_2FB8B.pdb TKL Active 1 215 2.90 -111.07 -173.68 999.00 45.16 91.90 -136.05 -99.40 30.48 -71.03 -44.69 -52.28 999.00 Outlier GLY ASP PHE GLY"
"BRAF_HUMAN t_3C4CA.pdb TKL DFGup 3 324 2.57 -139.26 -169.84 999.00 64.63 39.84 -163.79 -103.63 171.89 60.33 83.94 999.00 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_3D4QA.pdb TKL Active 1 SM5 2.80 -119.56 176.82 999.00 67.80 95.96 -151.93 -114.06 16.77 -69.38 -53.24 -35.91 999.00 Allowed GLY ASP PHE GLY"
"BRAF_HUMAN t_3D4QB.pdb TKL Active 1 SM5 2.80 -115.69 179.45 999.00 64.54 97.82 -153.17 -118.25 22.89 -70.02 -51.29 -41.26 999.00 Outlier GLY ASP PHE GLY"
"BRAF_HUMAN t_3IDPA.pdb TKL DFGout 6 L1E 2.70 -154.29 -166.41 999.00 -118.09 93.36 -170.68 -83.16 -5.45 -71.11 -65.70 144.09 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_3IDPB.pdb TKL DFGout 6 L1E 2.70 -170.29 -168.42 999.00 -119.74 97.37 -167.55 -90.29 6.51 -68.88 -97.92 157.04 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_3II5A.pdb TKL DFGout 6 831 2.79 -155.58 -166.64 999.00 -127.65 99.59 -156.50 -98.30 13.94 -52.99 -79.67 131.64 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_3II5B.pdb TKL DFGout 6 831 2.79 -134.76 -174.77 999.00 -130.72 93.66 -162.62 -95.93 18.88 -46.78 -68.73 112.33 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_3OG7A.pdb TKL DFGup 3 032 2.45 -137.59 -179.01 999.00 76.94 18.23 -151.72 -89.25 -11.04 54.06 -42.47 999.00 999.00 Allowed GLY ASP PHE GLY"
"BRAF_HUMAN t_3OG7B.pdb TKL Active 1 Apo 2.45 -166.95 -137.58 999.00 40.94 51.50 -152.65 -52.92 -84.62 -76.46 68.62 -46.60 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_3PPJA.pdb TKL Active 1 FOI 3.70 -118.66 162.11 999.00 70.55 93.10 -168.70 -108.76 36.05 -68.00 -65.93 -21.33 999.00 Allowed GLY ASP PHE GLY"
"BRAF_HUMAN t_3PPJB.pdb TKL Active 1 FOI 3.70 -117.70 161.14 999.00 71.68 92.40 -169.67 -107.45 34.92 -67.48 -64.17 -21.39 999.00 Allowed GLY ASP PHE GLY"
"BRAF_HUMAN t_3PPKA.pdb TKL Active 1 FNI 3.00 -124.02 -178.14 999.00 61.59 97.13 -151.43 -118.15 23.62 -74.86 -61.74 -35.11 999.00 Outlier GLY ASP PHE GLY"
"BRAF_HUMAN t_3PPKB.pdb TKL Active 1 FNI 3.00 -125.49 174.46 999.00 62.24 98.57 -160.00 -113.05 20.89 -73.90 -56.24 -29.45 999.00 Outlier GLY ASP PHE GLY"
"BRAF_HUMAN t_3PRFA.pdb TKL DFGin-inactive 2 FP3 2.90 -158.37 65.75 999.00 -149.52 120.08 -157.69 -122.96 49.77 -62.80 -80.98 85.20 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_3PRFB.pdb TKL DFGin-inactive 2 FP3 2.90 -169.56 116.88 999.00 168.48 123.70 -176.25 -125.81 47.04 -76.30 -70.38 82.90 999.00 Outlier GLY ASP PHE GLY"
"BRAF_HUMAN t_3PRIA.pdb TKL Active 1 FP4 3.50 -135.24 167.27 999.00 72.91 95.63 -172.06 -113.66 26.28 -68.57 -64.21 -12.27 999.00 Allowed GLY ASP PHE GLY"
"BRAF_HUMAN t_3PRIB.pdb TKL Active 1 FP4 3.50 -135.50 166.80 999.00 73.85 93.51 -171.71 -111.58 27.69 -69.21 -64.11 -14.39 999.00 Allowed GLY ASP PHE GLY"
"BRAF_HUMAN t_3PSBA.pdb TKL Active 1 SM6 3.40 -125.30 175.14 999.00 70.20 91.06 -150.54 -111.96 31.46 -71.62 -63.48 -33.06 999.00 Allowed GLY ASP PHE GLY"
"BRAF_HUMAN t_3PSBB.pdb TKL Active 1 SM6 3.40 -122.44 177.15 999.00 60.24 95.46 -158.87 -106.31 23.23 -77.42 -49.58 -41.73 999.00 Outlier GLY ASP PHE GLY"
"BRAF_HUMAN t_3PSDA.pdb TKL Active 1 SM7 3.60 -124.82 -173.13 999.00 58.08 92.45 -161.04 -113.76 30.00 -74.19 -69.40 -23.16 999.00 Outlier GLY ASP PHE GLY"
"BRAF_HUMAN t_3PSDB.pdb TKL Active 1 SM7 3.60 -119.73 -174.72 999.00 61.10 89.77 -165.21 -111.00 26.32 -74.40 -65.62 -24.55 999.00 Allowed GLY ASP PHE GLY"
"BRAF_HUMAN t_3Q4CA.pdb TKL Active 1 RSW 3.20 -146.61 -170.55 999.00 63.49 77.07 -166.29 -100.14 34.37 -71.41 -64.73 -40.97 999.00 Allowed GLY ASP PHE GLY"
"BRAF_HUMAN t_3Q4CB.pdb TKL Active 1 Apo 3.20 -146.14 -159.82 999.00 35.91 93.47 -157.68 -110.90 27.68 -70.35 -62.65 -9.95 999.00 Outlier GLY ASP PHE GLY"
"BRAF_HUMAN t_3Q96A.pdb TKL DFGout 6 0NF 3.10 -160.15 -172.51 999.00 -118.15 91.93 -159.42 -79.06 12.39 -65.97 -59.88 141.28 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_3Q96B.pdb TKL DFGout 6 0NF 3.10 -158.99 -168.19 999.00 -117.43 81.58 -157.80 -79.65 17.50 -63.99 -26.78 105.48 999.00 Allowed GLY ASP PHE GLY"
"BRAF_HUMAN t_3SKCA.pdb TKL DFGin-inactive 2 BR2 3.20 -140.29 168.98 999.00 94.86 74.82 -132.25 -82.47 -134.14 -74.31 -102.40 999.00 999.00 Outlier GLY ASP PHE GLY"
"BRAF_HUMAN t_3SKCB.pdb TKL DFGup 3 BR2 3.20 -135.99 171.08 999.00 86.41 39.52 -127.45 -114.79 -0.88 58.51 -75.66 174.81 999.00 Outlier GLY ASP PHE GLY"
"BRAF_HUMAN t_3TV4A.pdb TKL DFGup 3 TV4 3.40 -142.80 -171.51 999.00 46.77 47.18 -150.55 -119.18 -6.40 69.32 -75.55 165.81 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_3TV4B.pdb TKL DFGup 3 TV4 3.40 -121.62 -159.20 999.00 14.59 74.26 -166.56 -129.63 -2.41 64.61 -64.03 -82.40 999.00 Outlier GLY ASP PHE GLY"
"BRAF_HUMAN t_3TV6A.pdb TKL DFGup 3 B0R 3.30 -121.95 -177.72 999.00 69.21 15.64 -102.25 -85.50 -8.40 60.99 -77.52 161.64 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_3TV6B.pdb TKL DFGup 3 B0R 3.30 -125.05 -169.83 999.00 54.99 38.89 -138.49 -104.32 -19.21 56.16 -40.72 -81.14 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_4CQEA.pdb TKL DFGup 3 CQE 2.30 -125.93 -177.54 999.00 65.78 47.03 -164.75 -122.69 7.62 61.32 -91.73 999.00 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_4CQEB.pdb TKL DFGin-inactive 2 CQE 2.30 -125.24 -175.90 999.00 54.14 61.69 -153.86 -63.91 129.85 -53.46 133.00 999.00 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_4DBNA.pdb TKL DFGout 6 0JA 3.15 -154.45 -162.63 999.00 -150.67 90.42 -161.06 -97.43 13.99 -45.73 -74.52 142.31 999.00 Allowed GLY ASP PHE GLY"
"BRAF_HUMAN t_4DBNB.pdb TKL DFGout 6 0JA 3.15 -127.96 -174.97 999.00 -129.82 81.73 -154.46 -87.88 -34.49 -54.20 69.97 -76.13 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_4E26A.pdb TKL Active 1 734 2.55 -123.06 -155.86 999.00 45.32 82.32 -170.19 -99.48 28.46 -72.86 -65.79 -23.13 999.00 Outlier GLY ASP PHE GLY"
"BRAF_HUMAN t_4E26B.pdb TKL Active 1 734 2.55 -129.21 -167.90 999.00 46.52 96.12 -177.10 -111.59 -138.64 -66.44 80.85 -62.69 999.00 Outlier GLY ASP PHE GLY"
"BRAF_HUMAN t_4E4XA.pdb TKL DFGup 3 T1Q 3.60 -131.90 173.20 999.00 75.12 30.64 -164.73 -101.89 -9.96 55.81 -117.55 134.81 999.00 Allowed GLY ASP PHE GLY"
"BRAF_HUMAN t_4E4XB.pdb TKL DFGup 3 T1Q 3.60 -132.27 173.30 999.00 74.52 29.58 -164.65 -99.48 -9.47 56.21 -121.91 128.25 999.00 Allowed GLY ASP PHE GLY"
"BRAF_HUMAN t_4EHEA.pdb TKL DFGup 3 RI8 3.30 -126.00 -178.46 999.00 62.88 29.15 -151.16 -94.39 -4.71 59.77 -101.01 165.49 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_4EHEB.pdb TKL DFGup 3 RI8 3.30 -127.24 -168.49 999.00 56.47 32.78 -143.56 -102.49 8.61 61.35 -68.27 -97.56 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_4EHGA.pdb TKL DFGup 3 RI9 3.50 -113.93 175.47 999.00 73.88 70.64 -165.00 -143.15 -8.98 47.54 -62.50 153.50 999.00 Allowed GLY ASP PHE GLY"
"BRAF_HUMAN t_4EHGB.pdb TKL DFGup 3 RI9 3.50 -135.02 -176.54 999.00 68.02 27.29 -151.41 -89.31 -32.40 52.06 -56.00 153.24 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_4FC0A.pdb TKL DFGout 6 0T2 2.95 -153.57 -164.36 999.00 -132.75 92.66 -162.30 -91.23 26.43 -61.87 -114.26 999.00 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_4FC0B.pdb TKL DFGout 6 0T2 2.95 -154.93 -168.84 999.00 -117.98 93.75 -165.38 -95.70 51.29 -58.81 -51.20 96.41 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_4FK3A.pdb TKL DFGup 3 325 2.65 -133.90 -167.58 999.00 58.86 45.83 -160.15 -124.08 12.29 65.30 -122.06 999.00 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_4FK3B.pdb TKL Active 1 Apo 2.65 -140.83 -152.44 999.00 49.24 52.94 -128.79 -56.33 -72.60 -87.32 47.28 -79.63 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_4G9CA.pdb TKL DFGout 6 0WP 3.50 -161.82 -178.09 999.00 -114.68 68.26 -156.01 -59.97 -23.70 -54.65 75.78 -130.25 999.00 Allowed GLY ASP PHE GLY"
"BRAF_HUMAN t_4G9CB.pdb TKL DFGout 6 0WP 3.50 -162.66 -177.87 999.00 -114.08 70.67 -155.78 -59.03 -42.39 -59.62 -27.25 128.68 999.00 Allowed GLY ASP PHE GLY"
"BRAF_HUMAN t_4G9RA.pdb TKL DFGout 6 B1E 3.20 -140.42 -166.76 999.00 -124.57 91.07 -151.83 -84.61 2.35 -52.15 -62.57 139.52 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_4G9RB.pdb TKL DFGout 6 B1E 3.20 -147.94 -171.24 999.00 -121.54 97.77 -155.71 -91.52 -5.12 -50.48 -58.09 149.43 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_4H58A.pdb TKL Active 1 10Z 3.10 -110.58 -118.32 999.00 -39.38 108.26 -152.24 -95.88 11.55 -82.53 -35.75 -74.75 999.00 Allowed GLY ASP PHE GLY"
"BRAF_HUMAN t_4H58B.pdb TKL Active 1 Apo 3.10 -98.85 -88.11 999.00 -93.35 121.18 -134.35 -119.34 28.64 -57.69 -55.82 -57.26 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_4H58C.pdb TKL DFGout 6 Apo 3.10 -160.57 -161.96 999.00 -123.73 93.44 -178.08 -89.24 -0.30 -67.32 37.01 -133.78 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_4JVGA.pdb TKL DFGout 6 B96 3.09 -152.04 -179.20 999.00 -108.51 103.07 -154.28 -89.16 -11.65 -62.34 -65.46 135.74 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_4JVGB.pdb TKL DFGout 6 B96 3.09 -174.76 179.45 999.00 -102.43 106.39 -152.09 -90.84 -4.19 -62.46 -65.84 122.14 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_4JVGC.pdb TKL DFGout 6 B96 3.09 -170.59 179.82 999.00 -107.22 105.49 -150.55 -90.75 -7.35 -66.56 -62.11 118.93 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_4JVGD.pdb TKL DFGout 6 B96 3.09 -151.03 -178.98 999.00 -114.25 104.94 -157.56 -92.94 -5.79 -57.66 -58.24 124.24 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_4KSPA.pdb TKL DFGout 6 1SU 2.93 -149.82 -149.04 999.00 -154.86 89.99 -177.64 -92.69 5.46 -48.23 -47.05 999.00 999.00 Allowed GLY ASP PHE GLY"
"BRAF_HUMAN t_4KSPB.pdb TKL DFGout 6 1SU 2.93 -174.07 -155.71 999.00 -118.59 108.72 -158.75 -113.97 66.66 -51.21 -51.89 -77.15 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_4KSQA.pdb TKL DFGout 6 1SW 3.30 -139.07 -156.00 999.00 -144.97 102.79 -161.67 -100.71 20.98 -45.23 -88.30 145.74 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_4KSQB.pdb TKL DFGout 6 1SW 3.30 -150.58 -156.55 999.00 -118.95 105.55 -169.24 -118.02 19.02 -53.89 -60.40 126.33 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_4MBJA.pdb TKL DFGup 3 DFS 3.60 -105.14 -97.57 999.00 -92.84 45.20 -179.38 -92.15 -5.11 71.82 -66.18 168.52 999.00 Allowed GLY ASP PHE GLY"
"BRAF_HUMAN t_4MBJB.pdb TKL DFGup 3 DFS 3.60 -106.42 -95.10 999.00 -95.13 47.37 -176.10 -92.81 -5.69 72.49 -66.17 170.04 999.00 Allowed GLY ASP PHE GLY"
"BRAF_HUMAN t_4MNEB.pdb TKL Active 1 Apo 2.85 -125.77 -157.32 999.00 46.59 85.84 -155.71 -103.01 25.54 -77.71 -59.94 -20.43 999.00 Outlier GLY ASP PHE GLY"
"BRAF_HUMAN t_4MNEC.pdb TKL Active 1 Apo 2.85 -116.31 -150.43 999.00 30.77 90.62 -153.37 -104.13 27.82 -82.73 -70.75 -9.98 999.00 Outlier GLY ASP PHE GLY"
"BRAF_HUMAN t_4MNEF.pdb TKL Active 1 Apo 2.85 -130.33 -157.71 999.00 45.09 83.43 -153.88 -99.63 25.56 -77.83 -60.30 -26.40 999.00 Outlier GLY ASP PHE GLY"
"BRAF_HUMAN t_4MNEG.pdb TKL Active 1 Apo 2.85 -133.51 -159.55 999.00 39.45 81.18 -149.74 -97.23 35.04 -77.09 -73.30 -12.15 999.00 Outlier GLY ASP PHE GLY"
"BRAF_HUMAN t_4MNFA.pdb TKL Active 1 29L 2.80 -138.15 -173.61 999.00 64.82 78.34 -154.79 -102.28 29.98 -69.74 -66.35 -51.53 999.00 Allowed GLY ASP PHE GLY"
"BRAF_HUMAN t_4MNFB.pdb TKL Active 1 29L 2.80 -122.71 -176.89 999.00 63.66 92.50 -145.81 -110.63 27.27 -71.47 -50.35 -45.32 999.00 Allowed GLY ASP PHE GLY"
"BRAF_HUMAN t_4PP7A.pdb TKL DFGup 3 2VX 3.40 -144.37 -179.41 999.00 70.85 11.80 -87.22 -79.41 -18.34 63.98 -64.80 163.11 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_4PP7B.pdb TKL DFGup 3 2VX 3.40 -143.26 -178.27 999.00 56.79 45.92 -136.93 -107.89 -13.37 54.83 -65.62 171.35 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_4R5YA.pdb TKL DFGout 6 3K3 3.50 -178.67 -170.93 999.00 -107.01 94.70 -154.79 -95.77 9.91 -70.04 -115.31 999.00 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_4R5YB.pdb TKL DFGout 6 3K3 3.50 -171.62 -169.79 999.00 -112.39 105.84 171.84 -99.53 4.25 -69.71 -85.76 129.54 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_4RZVA.pdb TKL DFGup 3 032 2.99 -130.95 -172.91 999.00 60.57 24.81 -133.32 -98.53 -10.68 57.70 -69.22 172.65 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_4RZVB.pdb TKL DFGup 3 032 2.99 -121.16 178.70 999.00 56.66 36.72 -70.67 -99.26 -19.08 59.26 -68.83 172.56 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_4RZWA.pdb TKL DFGout 6 B1E 3.49 -156.35 -171.75 999.00 -123.23 113.59 -174.18 -116.13 177.62 -41.69 -121.28 999.00 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_4WO5A.pdb TKL DFGup 3 324 2.83 -113.43 171.87 999.00 60.41 25.86 -87.15 -88.60 -20.79 62.18 -76.86 162.28 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_4WO5B.pdb TKL DFGup 3 324 2.83 -140.90 168.81 999.00 84.06 47.55 -142.31 -114.72 82.33 38.70 -44.20 -77.24 999.00 Outlier GLY ASP PHE GLY"
"BRAF_HUMAN t_4XV1A.pdb TKL DFGup 3 904 2.47 -125.99 -170.12 999.00 68.09 24.32 -95.74 -98.72 -10.94 52.31 -65.73 999.00 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_4XV1B.pdb TKL Active 1 Apo 2.47 -145.79 -149.46 999.00 45.87 66.48 -93.30 -86.27 28.66 -101.05 -56.20 -27.51 999.00 Allowed GLY ASP PHE GLY"
"BRAF_HUMAN t_4XV2A.pdb TKL DFGin-inactive 2 P06 2.50 -133.93 -165.66 999.00 64.09 52.37 -154.96 -64.05 158.05 -65.12 -66.35 999.00 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_4XV2B.pdb TKL DFGin-inactive 2 P06 2.50 -141.75 -167.01 999.00 57.08 61.55 -161.36 -73.63 172.90 -62.48 -94.26 999.00 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_4XV3A.pdb TKL DFGup 3 P02 2.80 -134.42 -171.71 999.00 61.18 48.40 -161.13 -114.60 -11.80 46.69 -64.97 999.00 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_4XV9A.pdb TKL DFGout 6 1OO 2.00 -160.02 -146.28 999.00 -134.52 69.13 -177.29 -82.81 -64.15 -59.46 60.63 38.47 999.00 Allowed GLY ASP PHE GLY"
"BRAF_HUMAN t_4YHTA.pdb TKL Active 1 4EF 3.05 -130.94 -175.72 999.00 59.90 88.59 -147.85 -101.82 16.90 -78.38 -54.18 -26.09 999.00 Allowed GLY ASP PHE GLY"
"BRAF_HUMAN t_4YHTB.pdb TKL Active 1 4EF 3.05 -128.73 -172.55 999.00 54.12 90.95 -149.58 -103.01 13.70 -78.18 -49.43 -28.93 999.00 Outlier GLY ASP PHE GLY"
"BRAF_HUMAN t_5C9CA.pdb TKL DFGout 6 4Z5 2.70 -152.77 -152.07 999.00 -130.20 99.29 177.11 -91.14 12.77 -53.59 -100.29 162.75 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_5C9CB.pdb TKL DFGout 6 4Z5 2.70 -164.89 -156.18 999.00 -132.53 106.19 -160.83 -105.66 12.13 -62.93 -118.65 173.83 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_5CSWB.pdb TKL DFGin-inactive 2 P06 2.66 -145.41 -140.89 999.00 43.12 61.80 -162.12 -68.29 137.12 -75.37 -76.10 152.68 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_5CSXA.pdb TKL DFGout 6 54J 2.51 -150.59 -157.46 999.00 -140.48 94.86 -161.28 -94.05 9.58 -66.23 -76.43 136.86 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_5CT7A.pdb TKL DFGout 6 55J 3.17 -138.47 -161.88 999.00 -136.54 63.32 -161.54 -70.71 0.76 -52.04 -84.24 147.12 999.00 Allowed GLY ASP PHE GLY"
"BRAF_HUMAN t_5FD2A.pdb TKL DFGup 3 5XJ 2.89 -131.35 -172.89 999.00 52.38 39.85 -168.27 -105.52 -8.50 56.09 -63.59 167.17 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_5FD2B.pdb TKL DFGup 3 5XJ 2.89 -160.34 172.84 999.00 88.46 33.71 -161.13 -111.95 12.79 60.16 -69.02 999.00 999.00 Outlier GLY ASP PHE GLY"
"BRAF_HUMAN t_5HI2A.pdb TKL DFGout 6 BAX 2.51 -149.97 -163.11 999.00 -123.47 99.26 -162.81 -92.23 0.49 -68.63 -68.91 152.85 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_5HIDA.pdb TKL DFGout 6 B1E 2.50 -148.03 -170.34 999.00 -131.27 92.61 -168.14 -86.51 -2.97 -61.46 -68.85 147.02 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_5HIDB.pdb TKL DFGout 6 B1E 2.50 -150.13 -165.40 999.00 -136.17 98.11 -169.61 -93.21 7.74 -57.99 -74.13 131.99 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_5HIEA.pdb TKL DFGin-inactive 2 P06 3.00 -141.80 -164.79 999.00 53.27 57.87 -162.85 -65.94 138.20 -74.83 -69.25 130.10 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_5HIEB.pdb TKL DFGin-inactive 2 P06 3.00 -142.85 -164.63 999.00 53.51 58.36 -162.99 -66.54 138.82 -74.55 -70.03 128.56 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_5HIEC.pdb TKL DFGin-inactive 2 P06 3.00 -142.17 -163.89 999.00 53.80 57.53 -163.23 -66.08 139.51 -74.88 -75.39 148.76 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_5HIED.pdb TKL DFGin-inactive 2 P06 3.00 -142.00 -164.95 999.00 54.00 58.43 -162.89 -66.94 145.69 -75.26 -81.82 146.44 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_5ITAA.pdb TKL DFGup 3 6DC 1.95 -120.10 -173.00 999.00 68.68 46.06 -166.07 -122.36 5.84 57.95 -59.23 -177.19 999.00 Allowed GLY ASP PHE GLY"
"BRAF_HUMAN t_5JRQA.pdb TKL DFGup 3 TMA 2.29 -128.10 -173.09 999.00 63.41 15.35 -77.77 -89.21 -1.56 61.50 -61.67 159.36 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_5JRQB.pdb TKL DFGup 3 6N9 2.29 -133.14 -173.76 999.00 67.64 13.31 -87.25 -87.29 -1.89 62.06 -64.05 169.09 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_5JSMA.pdb TKL DFGup 3 Apo 2.19 -138.41 -174.43 999.00 69.44 19.31 -98.70 -96.63 -11.22 60.50 -70.17 170.41 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_5JSMB.pdb TKL DFGup 3 6NB 2.19 -131.29 -176.99 999.00 63.38 23.28 -90.10 -93.62 -10.60 60.20 -76.10 171.26 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_5JSMC.pdb TKL DFGup 3 6NB 2.19 -129.73 -173.21 999.00 63.35 21.37 -87.11 -96.71 -12.51 57.74 -77.11 167.57 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_5JSMD.pdb TKL DFGup 3 Apo 2.19 -131.14 -174.05 999.00 61.09 20.49 -97.24 -90.60 -7.94 60.49 -77.95 170.41 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_5JT2A.pdb TKL DFGup 3 6NC 2.70 -131.82 -179.78 999.00 60.45 27.47 -81.93 -91.81 -15.24 60.82 -76.07 163.60 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_5JT2B.pdb TKL DFGup 3 Apo 2.70 -132.03 -178.45 999.00 60.47 26.67 -83.31 -91.34 -16.42 56.93 -74.95 161.76 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_5JT2C.pdb TKL DFGup 3 6NC 2.70 -132.61 179.43 999.00 60.56 25.32 -86.08 -92.01 -16.72 59.95 -73.38 163.09 999.00 Favored GLY ASP PHE GLY"
"BRAF_HUMAN t_5JT2D.pdb TKL DFGup 3 Apo 2.70 -136.06 -175.19 999.00 61.43 23.09 -85.52 -96.43 -13.68 60.07 -72.11 160.89 999.00 Favored GLY ASP PHE GLY"
"BTK_HUMAN t_1K2PA.pdb TYR DFGup 3 Apo 2.10 -137.23 -161.71 33.07 45.82 46.06 -69.52 -111.56 23.49 52.21 -57.82 -62.17 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_1K2PB.pdb TYR DFGup 3 Apo 2.10 -139.61 -161.13 -168.91 59.03 26.69 -90.88 -105.10 158.13 56.57 152.19 -71.89 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_3GENA.pdb TYR DFGup 3 B43 1.60 -134.68 169.58 -170.77 56.23 25.42 -84.34 -64.78 122.87 36.07 78.24 -5.96 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_3K54A.pdb TYR DFGup 3 1N1 1.94 -132.70 -179.19 -173.95 50.33 30.95 -76.54 -93.43 -0.38 58.10 -82.67 999.00 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_3OCSA.pdb TYR DFGup 3 746 1.80 -114.91 147.94 53.77 62.93 29.84 -65.54 -55.42 130.74 36.99 87.05 -21.32 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_3OCTA.pdb TYR DFGinter 5 1N1 1.95 -83.46 139.03 -179.85 -103.94 15.92 57.06 -87.03 132.90 -178.67 77.84 27.03 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_3P08A.pdb TYR DFGup 3 Apo 2.30 -128.07 -177.46 47.71 61.17 39.23 -70.21 -106.09 150.25 54.53 80.57 -131.43 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_3P08B.pdb TYR DFGup 3 Apo 2.30 -127.18 -176.73 50.97 62.05 37.82 -70.56 -105.42 144.28 55.25 69.80 -51.59 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_3PIXA.pdb TYR DFGup 3 027 1.85 -129.98 -152.35 -166.70 55.87 45.99 -166.18 -136.80 147.51 66.78 55.39 -135.05 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_3PIYA.pdb TYR DFGin-inactive 2 585 2.55 -86.43 116.29 175.07 -39.13 -55.83 -54.41 -103.54 159.78 -67.17 -55.53 135.32 999.00 Allowed SER ASP PHE GLY"
"BTK_HUMAN t_3PIZA.pdb TYR DFGup 3 03C 2.21 -126.32 -179.56 -153.10 57.07 22.71 -99.38 -85.33 -11.73 58.55 -83.55 -14.99 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_3PJ1A.pdb TYR DFGup 3 LHL 2.00 -125.22 -177.95 -164.58 47.52 37.50 -77.45 -91.29 -16.20 57.74 -84.89 -7.70 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_4NWMA.pdb TYR DFGup 3 2P5 2.03 -124.39 162.17 54.48 58.06 30.73 -67.64 -65.83 131.67 37.44 75.73 -5.81 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_4NWMB.pdb TYR DFGup 3 2P5 2.03 -123.65 161.46 54.48 58.48 30.73 -67.78 -65.97 131.24 37.41 74.51 -3.42 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_4OT5A.pdb TYR DFGup 3 481 1.55 -124.33 153.15 -169.19 64.35 22.86 -65.61 -60.22 134.63 35.59 78.10 -11.08 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_4OT6A.pdb TYR DFGup 3 2V1 2.05 -120.92 154.99 176.93 54.88 30.03 -60.26 -59.69 128.71 35.37 78.93 -1.32 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_4OTFA.pdb TYR DFGup 3 2VL 1.95 -117.54 150.51 170.29 61.71 28.57 -67.87 -55.08 129.78 38.11 83.03 -13.54 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_4OTQA.pdb TYR DFGup 3 2V2 1.55 -120.47 151.20 -178.89 61.11 26.70 -62.33 -61.60 135.38 39.56 81.06 -13.64 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_4OTRA.pdb TYR DFGup 3 2V3 1.95 -119.52 149.91 176.38 64.47 21.97 -60.64 -55.93 130.37 40.24 83.38 -9.14 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_4RFYA.pdb TYR DFGup 3 3OU 1.70 -125.41 155.08 -178.12 59.51 29.59 -59.22 -67.88 135.61 36.15 80.76 -11.12 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_4RFZA.pdb TYR DFGup 3 3OV 1.17 -122.29 154.39 -174.73 62.36 26.56 -59.64 -61.76 133.27 37.12 80.09 -12.69 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_4RG0A.pdb TYR DFGup 3 3P0 2.50 -111.66 164.28 -175.47 48.50 22.73 -46.88 -55.16 122.24 47.17 89.47 -9.27 999.00 Allowed SER ASP PHE GLY"
"BTK_HUMAN t_4RX5A.pdb TYR DFGup 3 3YO 1.36 -122.82 158.55 57.23 63.65 23.63 -44.91 -58.54 129.56 37.65 82.45 -13.44 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_4YHFA.pdb TYR DFGup 3 4C9 2.20 -141.39 166.81 179.52 57.06 26.74 -74.38 -70.30 122.46 37.59 87.96 -7.26 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_4YHFB.pdb TYR DFGup 3 4C9 2.20 -143.83 171.02 175.60 56.18 27.85 -76.63 -72.24 122.56 39.34 83.57 -7.46 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_4Z3VA.pdb TYR DFGup 3 4L6 1.60 -121.79 164.51 -173.19 60.71 27.25 -70.02 -65.05 131.70 31.19 74.09 -7.12 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_4ZLYA.pdb TYR DFGup 3 4RU 1.65 -121.15 160.04 -171.99 59.51 31.16 -75.65 -62.35 130.02 31.69 79.10 -10.83 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_4ZLZA.pdb TYR DFGup 3 4RV 2.00 -122.54 170.07 83.62 52.61 30.15 -63.81 -62.22 131.09 34.69 74.54 -3.54 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_5BPYA.pdb TYR DFGup 3 4UQ 2.31 -124.67 164.89 -170.91 51.26 37.76 -54.21 -69.98 127.33 35.18 69.76 12.92 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_5BPYB.pdb TYR DFGup 3 4UQ 2.31 -124.21 164.41 -170.78 49.54 38.93 -53.14 -70.07 125.96 33.56 69.00 10.72 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_5BQ0A.pdb TYR DFGup 3 4US 1.57 -117.60 165.10 82.36 53.92 38.70 -62.98 -59.80 121.33 28.45 75.47 -0.24 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_5FBNC.pdb TYR DFGup 3 5WF 1.80 -138.93 172.99 -155.96 64.38 21.20 -71.69 -64.90 134.89 43.35 78.23 -17.05 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_5FBND.pdb TYR DFGup 3 5WF 1.80 -137.76 172.64 -153.88 65.63 19.18 -71.22 -62.28 135.53 45.56 74.25 -16.74 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_5FBOA.pdb TYR DFGup 3 5WH 1.89 -127.31 -179.27 -152.47 51.15 30.63 -65.58 -63.38 107.21 34.65 57.26 50.22 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_5J87A.pdb TYR DFGup 3 N42 1.59 -121.65 149.43 178.01 64.54 28.87 -67.93 -63.88 130.72 36.72 84.01 -10.53 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_5J87B.pdb TYR DFGup 3 N42 1.59 -116.23 147.14 -168.90 64.47 33.46 -61.18 -63.73 133.35 37.05 70.55 9.29 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_5J87C.pdb TYR DFGup 3 N42 1.59 -126.47 157.37 172.73 65.86 26.38 -42.35 -68.74 129.58 36.83 64.83 13.17 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_5J87D.pdb TYR DFGup 3 N42 1.59 -123.81 170.46 -133.60 74.81 20.55 -64.02 -71.68 132.65 44.65 89.15 -16.57 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_5JRSA.pdb TYR DFGup 3 6MV 1.97 -124.66 170.11 83.02 56.00 34.17 -77.27 -67.60 128.43 35.87 69.71 6.14 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_5JRSB.pdb TYR DFGup 3 6MV 1.97 -124.12 171.02 81.90 56.24 32.60 -75.09 -67.71 127.58 36.28 68.68 6.75 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_5KUPA.pdb TYR DFGup 3 6XL 1.39 -118.69 150.05 176.06 63.73 26.97 -63.68 -58.46 133.68 38.01 79.52 -12.97 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_5T18A.pdb TYR DFGup 3 73T 1.50 -128.36 165.56 93.20 60.93 25.90 -73.36 -63.41 127.90 36.74 80.57 -10.25 999.00 Favored SER ASP PHE GLY"
"BTK_HUMAN t_5U9DA.pdb TYR DFGup 3 83P 1.33 -123.63 150.09 179.47 56.00 32.58 -77.51 -61.57 136.75 103.12 73.77 -3.54 999.00 Favored SER ASP PHE GLY"
"BUB1_HUMAN t_4QPMA.pdb OTHER Active 1 ADP 2.20 -120.67 -179.50 53.34 71.41 87.53 -166.47 -106.58 23.42 -51.02 -66.88 -34.17 999.00 NA ILE ASP LEU GLY"
"BUB1_HUMAN t_4QPMB.pdb OTHER Active 1 ADP 2.20 -119.59 -176.41 55.39 67.17 86.65 -174.52 -105.78 27.37 -49.99 -71.00 -28.58 999.00 NA ILE ASP LEU GLY"
"BUB1_HUMAN t_4R8QA.pdb OTHER Active 1 ADP 2.31 -126.00 -174.80 56.25 66.76 90.79 -166.88 -108.82 15.71 -53.61 -63.10 -30.69 999.00 NA ILE ASP LEU GLY"
"BUB1_HUMAN t_5DMZA.pdb OTHER Active 1 ADP 2.40 -133.46 -169.90 66.27 60.80 85.15 -160.43 -106.57 14.61 -57.80 -62.74 -37.35 999.00 NA ILE ASP LEU GLY"
"BUB1_HUMAN t_5DMZB.pdb OTHER Active 1 ADP 2.40 -128.69 -170.28 63.95 62.21 89.41 -159.16 -111.01 16.24 -58.17 -67.21 -36.25 999.00 NA ILE ASP LEU GLY"
"CDC7_HUMAN t_4F99A.pdb OTHER Active 1 ADP 2.33 -125.03 176.54 -70.96 71.94 86.33 -168.91 -103.76 20.68 -68.43 -65.90 -16.42 999.00 Allowed VAL ASP PHE GLY"
"CDC7_HUMAN t_4F9AA.pdb OTHER Active 1 ADP 2.17 -128.63 175.53 -54.44 70.39 88.05 -168.67 -103.96 21.02 -65.94 -65.34 -14.75 999.00 Allowed VAL ASP PHE GLY"
"CDC7_HUMAN t_4F9AC.pdb OTHER Active 1 ADP 2.17 -118.90 -178.60 -55.07 68.73 81.27 -166.93 -98.68 26.53 -72.61 -66.39 -28.93 999.00 Allowed VAL ASP PHE GLY"
"CDC7_HUMAN t_4F9BA.pdb OTHER Active 1 0SY 2.50 -127.88 167.60 -58.32 73.18 98.38 -149.80 -107.23 18.49 -64.05 -66.49 -7.95 999.00 Allowed VAL ASP PHE GLY"
"CDC7_HUMAN t_4F9BC.pdb OTHER Active 1 0SY 2.50 -121.22 173.08 -54.86 67.78 82.82 -146.88 -85.82 14.06 -66.71 -53.72 -26.99 999.00 Allowed VAL ASP PHE GLY"
"CDC7_HUMAN t_4F9CA.pdb OTHER Active 1 0SX 2.08 -130.14 163.67 -63.92 79.48 87.07 -161.06 -94.31 18.64 -70.08 -73.03 -7.69 999.00 Allowed VAL ASP PHE GLY"
"CDK12_HUMAN t_4CXAA.pdb CMGC Active 1 ANP 3.15 -127.48 178.68 999.00 59.74 84.83 -171.28 -103.39 39.60 -68.40 -78.99 -14.52 999.00 Allowed ALA ASP PHE GLY"
"CDK12_HUMAN t_4CXAC.pdb CMGC Active 1 Apo 3.15 -126.06 177.26 999.00 58.70 82.96 -170.36 -102.37 37.63 -73.44 -80.79 -14.02 999.00 Allowed ALA ASP PHE GLY"
"CDK12_HUMAN t_4NSTA.pdb CMGC Active 1 ADP 2.20 -127.53 179.88 999.00 60.50 76.10 -160.33 -95.29 23.73 -76.25 -65.44 -16.75 999.00 Allowed ALA ASP PHE GLY"
"CDK12_HUMAN t_4NSTC.pdb CMGC Active 1 ADP 2.20 -122.51 -178.62 999.00 55.99 75.38 -160.69 -92.80 20.66 -76.73 -56.99 -20.11 999.00 Allowed ALA ASP PHE GLY"
"CDK12_HUMAN t_4UN0C.pdb CMGC Active 1 Apo 3.15 -124.26 -178.58 999.00 61.66 76.73 -141.29 -100.85 26.95 -73.93 -65.72 -44.71 999.00 Allowed ALA ASP PHE GLY"
"CDK12_HUMAN t_4UN0D.pdb CMGC Active 1 Apo 3.15 -124.00 -178.32 999.00 62.13 76.99 -142.07 -101.16 26.43 -73.32 -66.14 -44.75 999.00 Allowed ALA ASP PHE GLY"
"CDK12_HUMAN t_5ACBC.pdb CMGC Active 1 5I1 2.70 -120.79 171.11 999.00 69.12 68.39 -154.06 -91.06 27.48 -71.31 -57.11 -52.49 999.00 Allowed ALA ASP PHE GLY"
"CDK12_HUMAN t_5ACBD.pdb CMGC Active 1 5I1 2.70 -121.13 171.69 999.00 68.85 69.22 -154.92 -92.36 27.20 -71.21 -58.43 -50.07 999.00 Allowed ALA ASP PHE GLY"
"CDK13_HUMAN t_5EFQA.pdb CMGC Active 1 ADP 2.00 -141.89 177.80 999.00 70.22 48.65 -167.84 -74.59 17.50 -81.71 -61.07 -20.13 999.00 Allowed ALA ASP PHE GLY"
"CDK13_HUMAN t_5EFQC.pdb CMGC Active 1 ADP 2.00 -141.55 176.33 999.00 69.37 51.51 -167.96 -75.76 17.59 -79.48 -60.59 -20.32 999.00 Allowed ALA ASP PHE GLY"
"CDK16_HUMAN t_3MTLA.pdb CMGC DFGout 6 FEF 2.40 -75.17 154.30 999.00 -88.86 77.72 179.14 -154.63 116.57 -132.47 78.07 21.87 999.00 Favored ALA ASP PHE GLY"
"CDK16_HUMAN t_5G6VA.pdb CMGC DFGout 6 919 2.20 -121.32 168.87 999.00 -136.02 99.11 -176.33 -71.76 -18.87 -78.93 81.35 -120.32 999.00 Favored ALA ASP PHE GLY"
"CDK16_HUMAN t_5G6VB.pdb CMGC DFGout 6 919 2.20 -133.78 174.99 999.00 -147.57 99.49 -175.89 -161.83 159.46 69.15 -118.15 117.72 999.00 Favored ALA ASP PHE GLY"
"CDK1_HUMAN t_4Y72A.pdb CMGC Active 1 LZ9 2.30 -147.77 167.44 999.00 62.02 80.15 -161.69 -98.26 20.97 -76.21 -65.01 -13.04 999.00 Allowed ALA ASP PHE GLY"
"CDK1_HUMAN t_4YC3A.pdb CMGC Active 1 Apo 2.70 -148.63 167.60 999.00 61.11 77.29 -161.16 -94.09 22.14 -74.46 -64.12 -17.42 999.00 Allowed ALA ASP PHE GLY"
"CDK1_HUMAN t_4YC6A.pdb CMGC DFGup 3 Apo 2.60 -114.81 155.09 999.00 69.41 17.48 -62.78 -57.06 138.15 50.40 59.06 8.49 999.00 Favored ALA ASP PHE GLY"
"CDK1_HUMAN t_4YC6C.pdb CMGC DFGup 3 Apo 2.60 -115.84 155.54 999.00 64.45 17.91 -61.53 -56.54 138.22 50.42 57.26 8.28 999.00 Favored ALA ASP PHE GLY"
"CDK1_HUMAN t_4YC6E.pdb CMGC DFGup 3 Apo 2.60 -117.16 155.07 999.00 65.42 17.46 -60.40 -54.85 140.61 49.75 56.70 7.43 999.00 Favored ALA ASP PHE GLY"
"CDK1_HUMAN t_4YC6G.pdb CMGC DFGup 3 Apo 2.60 -115.52 155.54 999.00 64.59 18.91 -61.06 -56.30 139.47 50.32 55.51 7.53 999.00 Favored ALA ASP PHE GLY"
"CDK1_HUMAN t_5HQ0A.pdb CMGC Active 1 LZ9 2.30 -147.77 167.44 999.00 62.02 80.15 -161.69 -98.26 20.97 -76.21 -65.01 -13.04 999.00 Allowed ALA ASP PHE GLY"
"CDK1_HUMAN t_5LQFA.pdb CMGC Active 1 4SP 2.06 -138.12 169.23 999.00 61.11 76.30 -164.24 -94.64 25.96 -79.62 -71.57 -17.76 999.00 Allowed ALA ASP PHE GLY"
"CDK1_HUMAN t_5LQFD.pdb CMGC Active 1 4SP 2.06 -133.16 173.28 999.00 57.81 74.41 -151.87 -88.87 25.15 -68.94 -73.28 -15.43 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1AQ1A.pdb CMGC DFGup 3 STU 2.00 -138.29 166.16 999.00 50.96 60.95 -162.41 -140.98 149.70 67.39 86.83 1.12 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1B38A.pdb CMGC DFGin-trans 4 ATP 2.00 -95.64 156.50 999.00 60.59 25.97 -58.47 -58.05 132.68 -138.74 85.90 -14.49 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1B39A.pdb CMGC DFGin-trans 4 ATP 2.10 -100.99 147.70 999.00 73.21 23.90 -65.25 -63.87 137.54 -135.61 85.76 -27.65 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1BUHA.pdb CMGC DFGin-inactive 2 Apo 2.60 -112.93 155.38 999.00 66.60 26.11 -56.22 -71.31 139.50 -108.90 74.43 -2.41 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1CKPA.pdb CMGC DFGin-trans 4 PVB 2.05 -110.41 150.24 999.00 71.15 24.26 -65.55 -67.21 134.27 -130.97 76.45 -10.97 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1DI8A.pdb CMGC DFGup 3 DTQ 2.20 -114.56 155.43 999.00 79.26 -0.38 -86.33 -51.10 128.45 67.80 78.04 -4.21 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1DM2A.pdb CMGC DFGin-inactive 2 HMD 2.10 -135.39 165.15 999.00 60.58 59.71 -148.17 -72.36 120.69 -75.30 -63.10 154.84 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1E1VA.pdb CMGC DFGin-trans 4 CMG 1.95 -99.24 155.82 999.00 66.92 24.10 -56.64 -63.73 132.21 -130.41 83.39 -11.01 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1E1XA.pdb CMGC DFGin-trans 4 NW1 1.85 -97.64 157.74 999.00 73.11 19.26 -70.78 -55.23 128.76 -125.33 75.74 0.82 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1E9HA.pdb CMGC Active 1 INR 2.5 -132.20 -179.42 999.00 51.67 79.13 -156.28 -94.98 38.03 -77.99 -76.15 -20.18 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1E9HC.pdb CMGC Active 1 INR 2.5 -143.01 -176.08 999.00 46.27 80.95 -166.70 -96.98 27.75 -69.11 -66.59 -7.84 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_1F5QA.pdb CMGC Active 1 Apo 2.50 -138.05 171.76 999.00 53.29 74.55 -165.95 -86.35 38.30 -68.54 -69.53 -17.16 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1F5QC.pdb CMGC Active 1 Apo 2.50 -141.47 164.86 999.00 64.16 73.44 -156.26 -87.87 33.20 -64.61 -63.05 -25.50 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1FINA.pdb CMGC Active 1 ATP 2.30 -145.62 175.41 999.00 60.16 70.46 -152.95 -88.70 22.36 -72.72 -62.84 -23.62 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1FINC.pdb CMGC Active 1 ATP 2.30 -126.26 177.07 999.00 60.10 80.32 -132.94 -100.36 24.92 -79.34 -64.90 -37.22 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1FQ1B.pdb CMGC Active 1 ATP 3.00 -151.22 -169.51 999.00 37.64 67.63 -163.42 -81.14 26.84 -85.73 -66.71 -18.37 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1FVTA.pdb CMGC DFGup 3 106 2.20 -112.23 152.94 999.00 73.60 11.26 -96.81 -57.85 138.26 65.30 69.89 -6.81 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1FVVA.pdb CMGC Active 1 107 2.80 -137.65 171.99 999.00 57.98 81.06 -162.74 -95.78 36.93 -75.48 -69.63 -41.14 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1FVVC.pdb CMGC Active 1 107 2.80 -137.03 174.16 999.00 49.48 89.06 -163.55 -101.59 27.15 -74.03 -55.32 -31.16 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_1G5SA.pdb CMGC DFGin-inactive 2 I17 2.61 -133.51 166.39 999.00 48.49 70.72 -139.68 -65.01 -169.31 -71.32 -113.61 -144.91 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1GIHA.pdb CMGC DFGup 3 1PU 2.80 -132.42 162.90 999.00 73.42 36.61 -150.00 -132.47 -179.35 76.83 79.77 -17.29 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1GIIA.pdb CMGC DFGup 3 1PU 2.00 -114.57 156.06 999.00 67.78 18.06 -93.90 -74.01 143.72 77.57 80.62 -16.43 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1GIJA.pdb CMGC DFGin-trans 4 2PU 2.20 -133.89 175.61 999.00 55.59 39.85 -150.54 -99.33 167.54 -144.44 35.61 17.17 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1GY3A.pdb CMGC Active 1 ATP 2.70 -148.83 -171.88 999.00 44.32 78.09 -176.02 -91.51 12.53 -79.16 -49.53 -35.56 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1GY3C.pdb CMGC Active 1 ATP 2.70 -159.42 -172.38 999.00 46.53 69.85 -177.54 -88.20 18.74 -81.86 -63.29 -3.47 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1GZ8A.pdb CMGC DFGin-trans 4 MBP 1.30 -98.52 152.55 999.00 68.89 22.49 -65.86 -64.14 134.12 -140.34 81.08 -7.19 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1H00A.pdb CMGC DFGin-inactive 2 FAP 1.6 -123.53 168.91 999.00 43.91 64.60 -151.69 -77.11 -143.40 -107.79 -42.57 11.77 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1H01A.pdb NA NA 0 FBL 1.79 -111.45 156.30 999.00 70.44 18.01 -79.21 -61.53 133.22 -136.63 84.99 -12.89 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1H07A.pdb CMGC DFGin-trans 4 MFP 1.85 -119.45 153.85 999.00 65.02 29.96 -74.38 -72.59 131.33 -146.24 81.14 -11.13 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1H08A.pdb CMGC DFGin-trans 4 BWP 1.8 -121.34 159.37 999.00 65.27 23.39 -73.51 -67.57 133.80 -139.54 72.56 -5.87 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1H0VA.pdb CMGC DFGin-trans 4 UN4 1.9 -95.89 153.63 999.00 60.54 23.01 -59.59 -56.31 130.24 -132.05 85.52 -9.08 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1H0WA.pdb CMGC DFGin-trans 4 207 2.1 -110.89 152.17 999.00 71.28 19.62 -64.06 -62.58 131.74 -125.00 83.06 -13.68 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1H1PA.pdb CMGC Active 1 CMG 2.10 -138.89 -178.72 999.00 49.02 86.95 -165.54 -98.56 14.05 -81.53 -55.81 -28.73 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_1H1PC.pdb CMGC Active 1 CMG 2.10 -139.72 176.85 999.00 52.01 85.56 -160.36 -98.35 22.43 -74.98 -70.31 -22.36 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_1H1QA.pdb CMGC Active 1 2A6 2.50 -132.06 176.22 999.00 56.27 86.86 -156.12 -91.91 16.08 -79.05 -52.80 -44.95 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1H1QC.pdb CMGC Active 1 2A6 2.50 -137.56 168.02 999.00 63.69 81.05 -154.44 -88.79 14.49 -79.23 -57.62 -25.23 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1H1RA.pdb CMGC Active 1 6CP 2.00 -141.16 176.29 999.00 52.49 80.30 -162.11 -92.54 20.95 -83.79 -61.77 -20.58 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1H1RC.pdb CMGC Active 1 6CP 2.00 -148.00 -175.91 999.00 41.45 81.21 -161.61 -90.01 20.08 -77.24 -58.82 -29.59 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_1H1SA.pdb CMGC Active 1 4SP 2.00 -138.27 176.53 999.00 54.41 75.94 -157.73 -86.38 16.43 -80.11 -60.96 -21.62 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1H1SC.pdb CMGC Active 1 4SP 2.00 -139.71 -179.40 999.00 46.76 76.48 -150.29 -88.50 15.00 -84.63 -49.49 -23.13 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1H24A.pdb CMGC Active 1 Apo 2.5 -149.08 176.11 999.00 58.54 82.72 -153.43 -98.98 22.43 -75.86 -57.84 -40.83 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1H24C.pdb CMGC Active 1 Apo 2.5 -133.46 175.33 999.00 53.74 89.73 -156.42 -103.39 21.62 -84.57 -62.88 -37.80 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_1H25A.pdb CMGC Active 1 Apo 2.5 -140.41 174.01 999.00 67.63 67.86 -147.78 -81.26 30.26 -76.09 -68.11 -35.93 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1H25C.pdb CMGC Active 1 Apo 2.5 -141.52 -162.93 999.00 43.25 68.33 -144.90 -81.48 26.77 -82.97 -64.84 -42.05 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1H26A.pdb CMGC Active 1 Apo 2.24 -130.77 179.89 999.00 50.06 80.75 -162.65 -90.95 22.62 -81.40 -55.95 -33.31 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1H26C.pdb CMGC Active 1 Apo 2.24 -129.58 -170.99 999.00 38.15 89.19 -159.97 -96.15 16.87 -77.21 -51.79 -27.21 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_1H27A.pdb CMGC Active 1 Apo 2.20 -140.74 165.55 999.00 63.63 80.08 -159.12 -94.96 27.99 -78.20 -81.21 -9.66 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1H27C.pdb CMGC Active 1 Apo 2.20 -141.02 -170.99 999.00 48.52 73.92 -88.26 -90.70 21.56 -82.04 -70.17 -20.70 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1H28A.pdb CMGC Active 1 Apo 2.80 -153.50 -159.90 999.00 20.54 88.59 -161.15 -91.78 11.37 -88.52 -25.83 -52.81 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_1H28C.pdb CMGC Active 1 Apo 2.80 -122.15 -174.09 999.00 31.85 98.80 164.23 -105.10 25.56 -83.56 -56.57 -37.84 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_1HCKA.pdb CMGC DFGin-trans 4 ATP 1.90 -101.60 156.70 999.00 59.04 28.20 -59.79 -65.00 120.19 -142.05 87.04 -4.19 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1HCLA.pdb CMGC DFGin-trans 4 Apo 1.80 -104.52 152.89 999.00 61.32 30.40 -64.19 -66.41 137.41 -145.66 78.72 -14.65 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1JSTA.pdb CMGC Active 1 ATP 2.60 -139.83 179.49 999.00 48.93 78.72 -167.10 -92.23 30.32 -75.91 -70.06 -30.44 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1JSTC.pdb CMGC Active 1 ATP 2.60 -133.81 179.74 999.00 53.88 86.31 -162.17 -100.05 15.60 -80.86 -59.91 -21.94 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_1JSUA.pdb CMGC Active 1 Apo 2.30 -124.78 164.30 999.00 63.38 89.04 -171.09 -107.20 29.25 -74.19 -70.69 -21.68 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1JSVA.pdb CMGC DFGin-trans 4 U55 1.96 -102.99 155.91 999.00 63.76 22.43 -55.38 -61.93 118.35 -140.64 94.77 -3.68 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1JVPP.pdb CMGC DFGin-trans 4 LIG 1.53 -124.58 159.52 999.00 66.27 29.80 -94.55 -72.35 131.40 -142.37 68.32 5.40 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1KE5A.pdb CMGC DFGup 3 LS1 2.20 -119.01 152.57 999.00 68.55 27.62 -86.57 -68.16 143.81 65.51 56.33 8.80 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1KE6A.pdb CMGC DFGup 3 LS2 2.00 -114.39 150.80 999.00 81.80 9.50 -87.71 -58.79 131.86 64.83 77.93 -15.76 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1KE7A.pdb CMGC DFGup 3 LS3 2.00 -114.07 154.63 999.00 70.77 22.68 -87.70 -68.97 139.14 60.36 71.54 -3.54 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1KE8A.pdb CMGC DFGup 3 LS4 2.00 -116.00 152.64 999.00 68.03 23.97 -81.37 -65.52 134.94 55.59 71.58 -0.10 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1KE9A.pdb CMGC DFGup 3 LS5 2.00 -114.55 155.42 999.00 79.29 -0.40 -86.32 -51.16 128.42 67.78 78.05 -4.15 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1OGUA.pdb CMGC Active 1 ST8 2.6 -132.50 178.71 999.00 58.19 82.74 -156.32 -102.90 24.80 -87.22 -74.06 -24.66 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1OGUC.pdb CMGC Active 1 ST8 2.6 -132.87 -172.41 999.00 44.42 85.96 -156.48 -97.66 18.43 -80.99 -53.41 -25.71 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_1OI9A.pdb CMGC Active 1 N20 2.1 -137.11 176.75 999.00 49.36 80.06 -156.75 -92.00 19.13 -79.55 -55.56 -24.91 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1OI9C.pdb CMGC Active 1 N20 2.1 -152.15 175.56 999.00 44.18 85.94 -169.20 -92.42 17.12 -81.36 -60.58 -28.93 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_1OIQA.pdb CMGC DFGin-trans 4 HDU 2.31 -139.56 159.65 999.00 69.06 6.47 -75.24 -54.75 137.74 -123.22 72.22 -12.11 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1OIRA.pdb NA NA 0 HDY 1.91 -105.16 158.91 999.00 70.83 20.33 -74.49 -62.06 126.78 -124.76 88.68 -8.73 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1OITA.pdb CMGC DFGin-trans 4 HDT 1.60 -105.03 152.80 999.00 71.09 24.78 -73.10 -65.61 139.59 -122.13 71.25 -1.83 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1OIUA.pdb CMGC Active 1 N76 2.0 -137.34 178.83 999.00 51.54 77.99 -157.59 -91.83 21.52 -81.45 -62.47 -30.54 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1OIUC.pdb CMGC Active 1 N76 2.0 -135.75 -176.93 999.00 45.28 77.47 -157.86 -86.35 20.32 -82.88 -64.25 -25.35 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1OIYA.pdb CMGC Active 1 N41 2.4 -127.42 -178.65 999.00 52.23 79.07 -160.23 -92.24 22.74 -77.95 -64.22 -22.66 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1OIYC.pdb CMGC Active 1 N41 2.4 -139.88 175.09 999.00 52.34 94.71 -151.92 -103.35 15.69 -78.12 -49.37 -37.57 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_1OKVA.pdb CMGC Active 1 Apo 2.40 -120.77 -179.73 999.00 52.59 72.64 -72.73 -88.11 19.07 -82.15 -53.87 -33.17 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1OKVC.pdb CMGC Active 1 Apo 2.40 -143.82 -172.62 999.00 54.41 65.17 -92.47 -88.54 20.26 -83.62 -64.41 -24.08 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1OKWA.pdb CMGC Active 1 Apo 2.50 -137.83 174.82 999.00 68.58 68.01 -139.36 -98.09 26.25 -82.31 -68.51 -22.77 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1OKWC.pdb CMGC Active 1 Apo 2.50 -139.64 173.05 999.00 64.91 70.62 -117.07 -95.34 23.49 -87.65 -64.28 -22.09 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1OL1A.pdb CMGC Active 1 Apo 2.90 -140.80 172.30 999.00 59.16 80.77 -151.02 -93.25 29.93 -88.69 -67.95 -40.35 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1OL1C.pdb CMGC Active 1 Apo 2.90 -161.99 173.42 999.00 66.20 69.00 -152.34 -93.40 29.69 -84.41 -61.87 -36.82 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1OL2A.pdb CMGC Active 1 Apo 2.60 -120.83 -174.45 999.00 48.93 74.13 -139.01 -88.85 27.70 -78.12 -74.51 -21.65 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1OL2C.pdb CMGC Active 1 Apo 2.60 -136.05 -168.53 999.00 52.43 72.80 -148.07 -90.45 24.98 -80.88 -65.33 -29.13 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1P2AA.pdb CMGC DFGin-inactive 2 5BN 2.50 -135.86 154.93 999.00 66.07 45.16 -141.55 -52.64 139.65 -75.86 -91.53 168.00 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1P5EA.pdb CMGC Active 1 TBS 2.22 -134.08 174.38 999.00 61.37 86.28 -158.15 -103.62 17.60 -82.30 -59.59 -33.56 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1P5EC.pdb CMGC Active 1 TBS 2.22 -138.77 179.22 999.00 54.45 79.30 -155.97 -94.71 19.85 -79.48 -62.68 -27.56 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1PF8A.pdb CMGC DFGin-inactive 2 SU9 2.51 -129.69 146.63 999.00 62.73 69.95 -165.05 -68.63 116.08 -75.17 -69.62 152.73 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1PKDA.pdb CMGC Active 1 UCN 2.30 -133.86 171.84 999.00 54.24 84.12 -160.19 -93.24 24.66 -79.93 -58.70 -37.62 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1PKDC.pdb CMGC Active 1 UCN 2.30 -135.91 172.38 999.00 57.27 84.67 -162.07 -94.15 24.16 -80.86 -65.68 -30.21 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1PW2A.pdb CMGC DFGin-trans 4 Apo 1.95 -101.46 154.62 999.00 61.27 26.56 -65.00 -64.34 136.92 -140.26 77.58 -3.12 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1PXIA.pdb CMGC DFGin-trans 4 CK1 1.95 -102.26 152.73 999.00 60.72 30.40 -59.57 -65.05 133.43 -139.10 83.55 -9.59 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1PXJA.pdb CMGC DFGin-trans 4 CK2 2.30 -108.14 154.69 999.00 59.47 34.47 -61.31 -70.22 130.24 -147.96 84.26 -11.26 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1PXKA.pdb CMGC DFGin-trans 4 CK3 2.80 -120.48 149.98 999.00 70.74 20.96 -65.55 -68.57 140.32 -151.47 68.20 6.43 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1PXLA.pdb CMGC DFGin-trans 4 CK4 2.50 -106.80 159.29 999.00 54.44 36.42 -62.97 -71.02 141.67 -142.20 61.63 0.32 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1PXMA.pdb CMGC DFGin-trans 4 CK5 2.53 -127.10 145.48 999.00 72.56 39.48 -81.51 -81.18 137.27 -137.86 81.64 -25.06 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1PXNA.pdb CMGC DFGin-trans 4 CK6 2.50 -124.74 142.12 999.00 73.38 24.63 -74.12 -66.04 112.34 -154.44 91.11 -4.71 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1PXOA.pdb CMGC DFGin-inactive 2 CK7 1.96 -110.76 143.94 999.00 77.58 24.95 -66.88 -67.83 134.30 -115.89 81.86 -11.43 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1PXPA.pdb CMGC DFGin-trans 4 CK8 2.30 -113.08 154.88 999.00 70.72 32.65 -67.71 -74.62 130.54 -133.13 82.87 -5.55 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1QMZA.pdb CMGC Active 1 ATP 2.20 -146.27 -172.65 999.00 47.50 78.46 -167.22 -93.97 24.31 -79.74 -74.16 -4.34 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1QMZC.pdb CMGC Active 1 ATP 2.20 -147.63 -170.01 999.00 41.16 80.46 -167.47 -95.46 25.65 -76.88 -79.11 -0.28 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_1R78A.pdb CMGC DFGup 3 FMD 2.00 -148.24 162.41 999.00 66.73 48.24 -153.73 -146.18 177.70 71.70 103.56 999.00 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1URCA.pdb CMGC Active 1 Apo 2.60 -129.92 175.59 999.00 55.11 83.91 -147.16 -97.62 32.32 -68.15 -71.26 -27.19 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1URCC.pdb CMGC Active 1 Apo 2.60 -139.25 168.38 999.00 67.79 71.54 -156.75 -90.13 30.24 -75.36 -56.18 -36.80 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1URWA.pdb CMGC DFGin-trans 4 I1P 1.6 -128.88 152.69 999.00 71.89 33.27 -125.14 -81.58 142.76 -135.82 67.52 -23.03 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1V1KA.pdb CMGC DFGin-trans 4 3FP 2.31 -125.56 168.63 999.00 54.59 23.08 -89.92 -54.41 -165.84 -146.37 -28.34 96.36 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1VYWA.pdb CMGC Active 1 292 2.30 -142.10 -179.49 999.00 62.10 67.98 -144.17 -93.03 26.71 -76.72 -60.61 -37.45 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1VYWC.pdb CMGC Active 1 292 2.30 -146.28 178.92 999.00 56.13 83.80 -151.88 -105.73 25.61 -78.08 -64.07 -29.54 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1VYZA.pdb CMGC DFGin-trans 4 N5B 2.21 -109.46 154.87 999.00 64.92 32.73 -62.03 -74.03 129.60 -132.44 79.97 -3.57 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1W0XC.pdb CMGC DFGin-trans 4 OLO 2.20 -104.51 149.93 999.00 70.92 24.09 -70.49 -67.81 122.96 -142.43 85.62 -3.93 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1W8CA.pdb CMGC DFGin-trans 4 N69 2.05 -101.19 151.27 999.00 67.49 27.95 -63.18 -61.58 133.83 -133.21 85.05 -14.34 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1W98A.pdb CMGC Active 1 Apo 2.15 -132.32 179.28 999.00 46.80 78.38 -156.08 -90.79 21.72 -75.15 -61.80 -18.63 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1WCCA.pdb CMGC DFGin-trans 4 Apo 2.2 -101.27 153.76 999.00 65.26 26.60 -60.44 -65.24 135.38 -134.29 81.99 -16.25 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1Y8YA.pdb CMGC DFGin-trans 4 CT7 2.00 -93.03 152.30 999.00 68.17 20.16 -61.83 -59.36 132.25 -128.54 87.03 -10.05 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_1Y91A.pdb CMGC DFGin-trans 4 CT9 2.15 -125.44 148.25 999.00 61.54 68.00 -149.79 -127.33 99.77 -172.04 96.60 4.73 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_1YKRA.pdb CMGC DFGin-trans 4 628 1.80 -123.66 150.23 999.00 67.88 31.80 -98.43 -75.62 128.84 -143.38 83.54 -17.57 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2A0CX.pdb CMGC DFGin-trans 4 CK9 1.95 -121.45 148.75 999.00 74.51 23.60 -72.66 -63.77 126.43 -133.65 76.71 -2.47 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2A4LA.pdb CMGC DFGin-trans 4 RRC 2.40 -113.56 145.45 999.00 72.42 28.78 -78.59 -70.82 127.39 -134.76 92.04 -16.08 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2B52A.pdb CMGC DFGin-inactive 2 D42 1.88 -141.60 169.68 999.00 53.50 46.35 -166.80 -53.78 159.77 -74.58 -81.51 93.69 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2B53A.pdb CMGC DFGin-trans 4 D23 2.00 -105.02 159.11 999.00 64.06 24.70 -73.60 -63.00 128.95 -134.09 75.87 -23.86 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2B54A.pdb CMGC DFGin-trans 4 D05 1.85 -108.10 148.53 999.00 65.15 25.94 -59.35 -58.04 130.22 -140.49 68.05 -12.71 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2B55A.pdb CMGC DFGin-inactive 2 D31 1.85 -144.01 166.22 999.00 55.31 53.34 -169.13 -57.88 157.14 -77.44 -67.55 999.00 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2BHEA.pdb CMGC DFGin-inactive 2 BRY 1.9 -119.97 159.78 999.00 54.95 56.84 -159.11 -56.90 138.55 -68.18 -95.43 153.43 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2BHHA.pdb CMGC DFGin-inactive 2 RYU 2.6 -89.96 171.15 999.00 32.32 80.07 179.23 -64.55 114.57 -96.46 -60.67 123.81 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_2BKZA.pdb CMGC Active 1 SBC 2.6 -142.83 175.80 999.00 58.35 77.98 -151.96 -96.57 27.54 -75.43 -62.27 -30.17 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2BKZC.pdb CMGC Active 1 SBC 2.6 -143.89 175.32 999.00 58.45 79.05 -151.92 -98.12 27.32 -76.18 -62.04 -28.86 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2BPMA.pdb CMGC Active 1 529 2.4 -142.22 176.14 999.00 58.90 80.99 -159.94 -97.82 30.57 -75.78 -65.95 -17.25 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2BPMC.pdb CMGC Active 1 529 2.4 -139.12 -176.97 999.00 50.25 82.06 -162.28 -99.00 24.68 -80.38 -62.39 -20.90 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2BTRA.pdb CMGC DFGin-trans 4 U73 1.85 -121.83 148.53 999.00 71.66 41.30 -88.88 -85.72 127.52 -150.30 68.86 10.34 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2BTSA.pdb CMGC DFGin-inactive 2 U32 1.99 -131.22 144.04 999.00 57.34 68.77 -170.31 -62.56 135.65 -80.43 -81.03 150.39 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2C4GA.pdb CMGC Active 1 514 2.7 -137.96 -179.16 999.00 56.77 81.55 -151.80 -100.20 24.23 -79.24 -55.96 -30.59 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2C4GC.pdb CMGC Active 1 514 2.7 -139.85 -179.84 999.00 56.92 82.43 -152.97 -100.77 22.79 -80.22 -55.11 -30.64 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2C5NA.pdb CMGC Active 1 CK8 2.1 -134.70 179.53 999.00 48.70 86.34 -161.77 -97.51 25.14 -84.11 -63.89 -28.61 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_2C5NC.pdb CMGC Active 1 CK8 2.1 -141.14 171.59 999.00 67.96 76.40 -163.63 -96.70 28.54 -76.85 -68.16 -31.47 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2C5OA.pdb CMGC Active 1 CK2 2.1 -137.73 173.06 999.00 58.50 80.79 -150.89 -92.93 19.88 -76.85 -51.33 -36.43 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2C5OC.pdb CMGC Active 1 CK2 2.1 -144.66 177.93 999.00 57.44 72.79 -155.97 -89.53 21.00 -79.44 -66.47 -25.39 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2C5VA.pdb CMGC Active 1 CK4 2.9 -152.62 173.70 999.00 50.46 81.91 -148.10 -96.59 19.88 -85.97 -61.35 -20.20 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2C5VC.pdb CMGC Active 1 CK4 2.9 -154.20 176.86 999.00 55.11 76.98 -152.61 -96.71 24.35 -84.93 -59.61 -21.97 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2C5XA.pdb CMGC Active 1 MTW 2.9 -147.09 173.65 999.00 64.85 81.11 -153.43 -99.80 31.94 -79.98 -72.16 -29.06 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2C5XC.pdb CMGC Active 1 MTW 2.9 -137.82 171.42 999.00 74.50 81.93 -179.01 -98.90 18.64 -83.35 -59.32 -18.22 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2C5YA.pdb CMGC DFGin-inactive 2 MTW 2.25 -119.32 163.13 999.00 63.94 25.04 -79.24 -37.90 176.99 -78.21 32.34 -5.36 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2C68A.pdb CMGC DFGin-trans 4 CT6 1.95 -94.65 152.25 999.00 66.71 20.97 -60.22 -56.32 137.22 -129.13 83.51 -14.93 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2C69A.pdb CMGC DFGin-trans 4 CT8 2.1 -90.62 151.58 999.00 62.59 28.00 -59.35 -62.33 129.67 -137.78 87.78 -11.92 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2C6IA.pdb CMGC DFGin-trans 4 DT1 1.8 -99.49 150.69 999.00 63.74 25.34 -57.61 -61.42 132.28 -136.84 80.67 -8.00 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2C6KA.pdb CMGC DFGin-trans 4 DT2 1.9 -95.85 155.39 999.00 61.92 21.95 -63.61 -57.38 133.35 -136.03 83.03 -10.47 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2C6LA.pdb CMGC DFGin-trans 4 DT4 2.3 -100.44 154.55 999.00 54.49 33.34 -60.94 -59.31 133.97 -139.15 78.25 -11.93 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2C6MA.pdb CMGC DFGin-trans 4 DT5 1.9 -99.60 151.60 999.00 64.86 22.98 -66.57 -61.31 135.85 -136.30 83.83 -17.18 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2C6OA.pdb CMGC DFGin-inactive 2 4SP 2.1 -115.52 145.11 999.00 66.95 16.12 -54.78 -33.55 128.23 -100.08 77.51 -4.48 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2C6TA.pdb CMGC Active 1 DT5 2.61 -134.08 177.10 999.00 50.34 82.93 -165.88 -96.15 18.41 -82.64 -53.54 -36.12 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_2C6TC.pdb CMGC Active 1 DT5 2.61 -131.55 -175.78 999.00 56.85 80.20 -156.17 -95.46 27.14 -78.96 -80.49 -20.01 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2CCHA.pdb CMGC Active 1 ATP 1.7 -138.16 -178.92 999.00 48.59 75.85 -162.89 -87.90 16.70 -78.37 -63.72 -23.38 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2CCHC.pdb CMGC Active 1 ATP 1.7 -137.70 179.24 999.00 55.78 74.00 -87.46 -93.10 22.00 -80.90 -65.42 -25.97 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2CCIA.pdb CMGC Active 1 ATP 2.7 -128.74 -173.88 999.00 47.98 81.48 -164.81 -98.76 25.27 -78.01 -66.91 -20.66 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_2CCIC.pdb CMGC Active 1 ATP 2.7 -129.32 167.20 999.00 64.06 86.76 -173.97 -100.18 28.58 -83.15 -63.25 -37.36 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2CJMA.pdb CMGC Active 1 ATP 2.3 -133.47 174.29 999.00 59.10 80.75 -163.49 -93.09 17.34 -79.80 -51.11 -37.85 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2CJMC.pdb CMGC Active 1 ATP 2.3 -136.23 -173.17 999.00 48.45 78.80 -161.99 -89.98 21.15 -79.66 -53.73 -24.51 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2CLXA.pdb CMGC DFGin-trans 4 F18 1.8 -102.34 162.03 999.00 57.50 23.44 -62.24 -58.08 132.31 -133.93 84.33 -12.62 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2DS1A.pdb CMGC DFGin-trans 4 1CD 2.00 -116.59 153.39 999.00 67.48 18.75 176.92 -63.20 129.42 -145.51 81.76 -11.84 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2DUVA.pdb CMGC DFGin-trans 4 371 2.20 -116.26 145.75 999.00 75.27 33.39 -63.53 -79.00 116.33 -140.29 90.90 -5.88 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2EXMA.pdb CMGC DFGin-trans 4 ZIP 1.80 -100.65 151.11 999.00 60.24 32.06 -61.43 -66.40 135.86 -140.34 75.86 -5.30 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2FVDA.pdb CMGC DFGin-inactive 2 LIA 1.85 -129.09 161.76 999.00 54.66 55.23 -158.05 -58.15 137.13 -88.19 -100.72 151.67 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2G9XA.pdb CMGC Active 1 NU5 2.50 -124.81 176.55 999.00 48.87 82.19 -161.83 -91.61 23.95 -78.96 -59.45 -35.07 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_2G9XC.pdb CMGC Active 1 NU5 2.50 -139.23 -169.75 999.00 32.05 84.37 -163.10 -85.53 21.70 -85.33 -61.21 -32.45 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_2I40A.pdb CMGC Active 1 BLZ 2.80 -136.89 178.31 999.00 54.68 74.50 -158.44 -89.52 33.18 -71.05 -65.38 -27.39 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2I40C.pdb CMGC Active 1 BLZ 2.80 -135.29 178.44 999.00 51.52 77.56 -158.95 -89.67 25.79 -75.40 -62.00 -32.78 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2IW6A.pdb CMGC Active 1 QQ2 2.3 -137.06 -179.87 999.00 52.43 77.16 -156.08 -90.60 20.01 -73.73 -65.56 -20.53 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2IW6C.pdb CMGC Active 1 QQ2 2.3 -148.37 175.52 999.00 55.39 74.42 -152.66 -89.02 21.37 -81.18 -66.47 -21.24 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2IW8A.pdb CMGC Active 1 4SP 2.3 -128.92 178.15 999.00 45.77 77.81 -155.75 -89.54 20.75 -81.73 -62.80 -23.52 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2IW8C.pdb CMGC Active 1 4SP 2.3 -119.13 -171.65 999.00 36.55 74.79 -160.98 -81.03 23.02 -79.43 -62.31 -19.27 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2IW9A.pdb CMGC Active 1 4SP 2.0 -131.24 177.11 999.00 50.46 78.44 -157.87 -89.17 19.07 -80.69 -63.07 -21.88 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2IW9C.pdb CMGC Active 1 4SP 2.0 -133.06 -178.79 999.00 46.11 77.70 -164.40 -88.25 25.12 -80.32 -66.25 -29.77 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2J9MA.pdb CMGC DFGin-inactive 2 PY8 2.50 -117.90 155.76 999.00 63.53 57.99 -127.87 -58.73 135.57 -71.69 -84.12 156.10 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2JGZA.pdb CMGC Active 1 Apo 2.9 -119.14 -174.92 999.00 51.60 74.63 -154.22 -88.77 26.72 -79.67 -52.39 -56.60 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2R3FA.pdb CMGC DFGin-trans 4 SC8 1.50 -98.44 153.74 999.00 67.06 23.80 -65.29 -63.25 134.93 -137.52 84.14 -12.63 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2R3GA.pdb CMGC DFGin-trans 4 SC9 1.55 -103.03 155.63 999.00 64.05 23.96 -65.32 -61.25 131.62 -128.77 83.96 -10.28 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2R3HA.pdb CMGC DFGin-trans 4 SCE 1.50 -103.48 151.94 999.00 66.45 22.96 -67.99 -59.15 127.50 -134.19 85.93 -12.35 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2R3IA.pdb CMGC DFGin-trans 4 SCF 1.28 -100.60 149.51 999.00 71.49 21.61 -59.38 -58.15 134.85 -128.89 83.18 -10.52 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2R3JA.pdb CMGC DFGin-trans 4 SCJ 1.65 -114.12 146.34 999.00 72.90 23.16 -64.53 -65.24 137.07 -132.79 77.61 -8.73 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2R3KA.pdb CMGC DFGin-trans 4 SCQ 1.70 -112.41 153.22 999.00 66.63 25.08 -70.47 -65.23 140.36 -132.45 67.90 -4.83 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2R3LA.pdb CMGC DFGin-trans 4 SCW 1.65 -114.10 141.97 999.00 80.71 16.89 -61.73 -62.64 137.10 -123.66 77.57 -11.17 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2R3MA.pdb CMGC DFGin-trans 4 SCX 1.70 -114.46 154.52 999.00 64.36 27.19 -66.60 -64.72 129.56 -140.17 75.82 0.53 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2R3NA.pdb CMGC DFGin-inactive 2 SCZ 1.63 -121.47 161.75 999.00 41.12 69.04 -153.93 -57.70 139.23 -74.17 -52.96 -108.84 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2R3OA.pdb CMGC DFGin-trans 4 2SC 1.80 -106.80 151.07 999.00 69.27 20.60 -64.27 -59.50 130.76 -126.66 83.35 -14.33 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2R3PA.pdb CMGC DFGin-trans 4 3SC 1.66 -103.68 154.56 999.00 64.53 27.73 -63.81 -66.14 127.14 -140.87 87.18 -11.81 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2R3QA.pdb CMGC DFGin-trans 4 5SC 1.35 -100.65 151.77 999.00 68.67 21.38 -62.86 -59.59 132.73 -140.15 84.68 -10.32 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2R3RA.pdb CMGC DFGin-trans 4 6SC 1.47 -106.76 151.66 999.00 74.37 19.57 -69.01 -59.75 136.11 -122.46 82.53 -14.59 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2R64A.pdb CMGC DFGin-trans 4 740 2.30 -120.35 149.32 999.00 72.41 29.08 -62.18 -75.96 125.75 -139.26 86.23 -16.84 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2UUEA.pdb CMGC Active 1 MTZ 2.06 -136.51 -179.68 999.00 55.09 76.07 -157.25 -99.45 27.02 -83.14 -71.98 -20.90 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2UUEC.pdb CMGC Active 1 MTZ 2.06 -139.65 174.68 999.00 63.14 72.36 -160.73 -91.09 24.56 -82.39 -71.25 -27.73 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2UZBA.pdb CMGC Active 1 C75 2.7 -129.27 -178.51 999.00 56.66 88.52 -161.07 -107.39 15.35 -89.73 -60.52 -29.43 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_2UZBC.pdb CMGC Active 1 C75 2.7 -140.31 177.95 999.00 49.08 95.67 -147.28 -109.51 12.63 -81.86 -52.08 -27.98 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_2UZDA.pdb CMGC Active 1 C85 2.72 -133.15 177.10 999.00 54.79 85.28 -155.55 -101.66 20.95 -75.89 -61.28 -24.84 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2UZDC.pdb CMGC Active 1 C85 2.72 -139.71 179.82 999.00 41.45 92.26 -175.07 -104.19 11.91 -76.21 -55.34 -17.26 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_2UZEA.pdb CMGC Active 1 C95 2.4 -135.85 179.98 999.00 54.00 78.88 -152.13 -93.30 19.11 -78.00 -61.64 -33.77 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2UZEC.pdb CMGC Active 1 C95 2.4 -135.13 177.99 999.00 57.57 75.36 -151.40 -89.12 22.32 -75.47 -59.90 -39.05 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2UZLA.pdb CMGC Active 1 C94 2.4 -137.37 -179.95 999.00 48.48 89.19 -150.42 -104.90 15.73 -77.74 -53.04 -35.25 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_2UZLC.pdb CMGC Active 1 C94 2.4 -136.40 166.25 999.00 64.07 80.48 -155.23 -92.03 24.91 -70.96 -64.75 -35.29 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2UZNA.pdb CMGC DFGin-trans 4 C96 2.3 -111.13 157.19 999.00 69.91 16.94 -63.27 -64.77 137.44 -138.02 72.30 -22.14 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2UZOA.pdb CMGC DFGin-inactive 2 C62 2.3 -103.80 148.02 999.00 79.40 16.08 -62.74 -56.34 131.48 -107.68 85.44 -16.55 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2V0DA.pdb CMGC DFGin-trans 4 C53 2.2 -90.76 153.43 999.00 63.42 25.75 -55.28 -65.78 136.10 -135.30 80.35 -11.55 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2V22A.pdb CMGC Active 1 Apo 2.60 -132.39 178.14 999.00 60.47 75.28 -154.44 -95.36 22.97 -84.41 -49.48 -38.45 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2V22C.pdb CMGC Active 1 Apo 2.60 -146.82 177.36 999.00 52.97 76.38 -153.22 -87.73 21.70 -82.58 -51.15 -39.63 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2VTAA.pdb CMGC DFGin-trans 4 Apo 2.0 -104.49 152.95 999.00 66.29 26.30 -67.76 -69.67 124.44 -139.73 88.34 -5.62 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2VTHA.pdb CMGC DFGin-trans 4 LZ2 1.9 -106.66 150.68 999.00 70.59 25.59 -69.66 -66.90 134.29 -139.48 73.30 -7.88 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2VTIA.pdb CMGC DFGin-trans 4 LZ3 2.0 -110.41 147.76 999.00 74.47 17.06 -72.70 -59.79 132.82 -131.62 79.35 -10.32 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2VTJA.pdb CMGC DFGin-trans 4 LZ4 2.2 -112.52 145.26 999.00 93.08 19.64 -83.13 -86.06 134.29 -142.98 75.42 13.46 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_2VTLA.pdb CMGC DFGin-trans 4 LZ5 2.0 -95.18 158.52 999.00 63.60 21.30 -57.41 -61.26 134.20 -135.33 78.26 -9.61 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2VTMA.pdb CMGC DFGin-trans 4 Apo 2.25 -101.28 161.34 999.00 52.35 30.14 -56.63 -66.41 132.51 -135.47 84.37 -8.88 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2VTNA.pdb CMGC DFGin-inactive 2 LZ7 2.2 -130.56 169.70 999.00 58.99 44.40 -124.19 -45.03 149.43 -85.48 -46.73 999.00 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2VTOA.pdb CMGC DFGin-trans 4 LZ8 2.19 -108.95 161.81 999.00 70.69 16.99 -102.96 -63.86 134.80 -135.85 82.48 -17.58 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2VTPA.pdb CMGC DFGin-trans 4 LZ9 2.15 -104.52 153.03 999.00 65.08 24.04 -64.64 -59.64 134.30 -139.60 73.65 -15.54 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2VTQA.pdb CMGC DFGin-inactive 2 LZA 1.9 -129.80 168.05 999.00 58.99 49.98 -152.30 -59.95 124.11 -58.68 -69.90 999.00 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2VTRA.pdb CMGC DFGin-trans 4 LZB 1.9 -103.82 155.98 999.00 69.45 14.68 -65.91 -61.23 110.06 -137.61 106.33 -13.58 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2VTSA.pdb CMGC DFGin-trans 4 LZC 1.9 -119.13 159.29 999.00 60.87 24.41 -72.70 -70.35 115.82 -140.04 104.28 -22.22 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2VTTA.pdb CMGC DFGin-inactive 2 LZD 1.68 -133.81 163.13 999.00 58.78 49.56 -153.68 -50.84 118.96 -93.31 -61.31 131.92 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2VU3A.pdb CMGC DFGin-inactive 2 LZE 1.85 -139.58 167.06 999.00 59.00 42.12 -156.93 -48.53 136.06 -86.38 -89.59 999.00 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2VV9A.pdb CMGC DFGin-inactive 2 IM9 1.90 -132.34 168.30 999.00 58.58 53.52 -166.47 -56.54 120.88 -88.28 -71.53 67.61 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2W05A.pdb CMGC DFGin-inactive 2 FRT 1.9 -128.24 165.04 999.00 62.24 43.67 -151.80 -62.23 -101.27 -85.15 96.48 -134.08 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2W06A.pdb CMGC DFGin-trans 4 FRV 2.04 -114.92 157.58 999.00 70.96 19.40 -93.51 -66.23 137.97 -133.07 76.66 -14.89 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2W17A.pdb CMGC DFGin-inactive 2 I19 2.15 -141.58 164.06 999.00 56.30 54.71 -178.65 -55.99 126.33 -84.74 -57.86 112.22 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_2W1HA.pdb CMGC DFGin-trans 4 L0F 2.15 -130.04 151.49 999.00 79.54 18.72 -84.44 -69.89 141.60 -133.21 69.65 -12.08 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2WEVA.pdb CMGC Active 1 CK7 2.30 -137.43 168.52 999.00 60.05 89.75 -152.07 -102.98 17.95 -80.46 -57.14 -35.19 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2WEVC.pdb CMGC Active 1 CK7 2.30 -133.82 172.17 999.00 61.25 84.37 -151.38 -99.43 26.29 -76.63 -63.92 -37.78 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2WFYA.pdb CMGC Active 1 Apo 2.53 -129.81 175.75 999.00 62.45 74.13 -81.77 -93.98 21.10 -78.58 -60.75 -22.42 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2WFYC.pdb CMGC Active 1 Apo 2.53 -141.19 179.79 999.00 59.68 73.15 -83.45 -96.80 21.05 -86.09 -56.39 -28.63 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2WHBA.pdb CMGC Active 1 Apo 2.90 -121.96 168.73 999.00 63.84 89.68 -159.29 -110.63 19.56 -78.80 -54.26 -25.06 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2WHBC.pdb CMGC Active 1 Apo 2.90 -146.01 -173.35 999.00 41.97 75.44 -148.56 -92.69 20.48 -78.63 -59.18 -37.47 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2WIHA.pdb CMGC Active 1 P48 2.50 -141.50 174.41 999.00 62.06 78.82 -164.13 -96.32 30.02 -77.42 -63.80 -17.48 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2WIHC.pdb CMGC Active 1 P48 2.50 -139.54 171.31 999.00 64.58 87.82 -168.72 -105.07 25.11 -80.44 -58.53 -37.45 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2WIPA.pdb CMGC Active 1 P49 2.80 -142.49 178.93 999.00 56.29 81.85 -158.08 -99.02 23.64 -76.15 -56.03 -33.23 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2WIPC.pdb CMGC Active 1 P49 2.80 -141.27 -179.49 999.00 53.85 83.34 -161.66 -100.32 23.93 -76.13 -55.38 -33.17 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2WMAA.pdb CMGC Active 1 Apo 2.80 -133.57 177.02 999.00 58.79 73.70 -155.12 -85.92 28.40 -77.48 -59.10 -39.30 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2WMAC.pdb CMGC Active 1 Apo 2.80 -145.30 179.77 999.00 48.14 83.17 -157.09 -99.36 24.42 -73.51 -57.15 -31.48 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_2WMBA.pdb CMGC Active 1 Apo 2.60 -140.78 -179.03 999.00 50.24 83.41 -152.00 -90.09 17.06 -77.14 -48.56 -40.00 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_2WMBC.pdb CMGC Active 1 Apo 2.60 -121.16 -178.38 999.00 51.44 79.77 -158.21 -90.21 12.60 -78.82 -54.67 -15.82 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2WPAA.pdb CMGC Active 1 889 2.51 -135.25 176.55 999.00 57.91 88.78 -149.11 -107.74 28.04 -77.33 -64.17 -28.32 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2WPAC.pdb CMGC Active 1 889 2.51 -144.74 174.32 999.00 58.48 90.92 -153.43 -109.10 19.56 -82.03 -59.79 -26.42 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_2WXVA.pdb CMGC Active 1 WXV 2.60 -142.13 179.35 999.00 61.23 75.60 -163.29 -95.72 30.17 -71.56 -64.47 -20.83 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2WXVC.pdb CMGC Active 1 WXV 2.60 -137.29 178.16 999.00 57.29 77.12 -166.17 -93.22 25.52 -79.81 -57.70 -33.53 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2X1NA.pdb CMGC Active 1 X1N 2.75 -128.92 173.77 999.00 57.33 81.17 -156.45 -96.87 24.07 -78.33 -56.00 -34.97 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2X1NC.pdb CMGC Active 1 X1N 2.75 -140.65 175.55 999.00 56.15 80.34 -155.28 -98.48 27.29 -78.81 -63.04 -37.31 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2XMYA.pdb CMGC DFGin-trans 4 CDK 1.90 -117.72 160.44 999.00 71.76 41.54 -131.75 -108.27 125.33 -167.22 70.01 4.63 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_2XNBA.pdb CMGC DFGup 3 Y8L 1.85 -137.61 161.99 999.00 73.42 53.28 -175.51 -152.52 158.57 82.97 81.70 -19.59 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3BHTA.pdb CMGC Active 1 MFR 2.00 -135.30 171.85 999.00 58.83 90.16 -163.81 -106.01 17.25 -80.89 -57.87 -30.45 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3BHTC.pdb CMGC Active 1 MFR 2.00 -135.50 175.70 999.00 54.15 83.05 -158.97 -97.01 23.82 -76.68 -60.59 -30.28 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3BHUA.pdb CMGC Active 1 MHR 2.30 -134.77 170.92 999.00 59.62 89.96 -158.74 -106.95 20.15 -76.34 -60.15 -32.42 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3BHUC.pdb CMGC Active 1 MHR 2.30 -135.56 171.61 999.00 58.79 89.31 -154.39 -103.73 20.05 -78.94 -60.25 -27.80 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3BHVA.pdb CMGC Active 1 VAR 2.10 -132.55 171.27 999.00 53.87 86.12 -162.42 -97.22 18.96 -75.67 -58.53 -31.54 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_3BHVC.pdb CMGC Active 1 VAR 2.10 -131.35 176.42 999.00 52.18 85.58 -158.07 -95.97 17.77 -80.72 -62.28 -27.96 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_3DDPA.pdb CMGC Active 1 RC8 2.70 -127.89 179.42 999.00 46.49 81.39 -160.78 -92.18 22.21 -83.64 -62.99 -31.48 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_3DDPC.pdb CMGC Active 1 RC8 2.70 -118.83 173.95 999.00 46.59 94.23 -149.33 -104.10 18.77 -76.69 -50.58 -37.24 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_3DDQA.pdb CMGC Active 1 RRC 1.80 -132.74 169.77 999.00 57.46 82.02 -158.90 -94.86 22.93 -79.41 -62.57 -27.71 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3DDQC.pdb CMGC Active 1 RRC 1.80 -135.07 174.72 999.00 51.22 81.26 -157.07 -92.27 22.03 -79.72 -61.18 -31.76 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3DOGA.pdb CMGC Active 1 NNN 2.70 -123.87 171.93 999.00 56.47 94.47 -149.47 -105.51 13.85 -83.53 -61.38 -24.91 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_3DOGC.pdb CMGC Active 1 NNN 2.70 -127.99 179.31 999.00 44.51 89.69 -145.71 -97.24 22.41 -79.40 -60.24 -33.85 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_3EIDA.pdb CMGC Active 1 PO5 3.15 -132.84 -177.54 999.00 48.95 84.45 -178.42 -100.73 28.71 -82.09 -64.93 -34.56 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_3EIDC.pdb CMGC Active 1 Apo 3.15 -134.07 176.14 999.00 56.34 81.44 -179.56 -98.16 27.52 -79.32 -62.83 -36.85 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3EJ1A.pdb CMGC Active 1 5BP 3.22 -120.42 -170.61 999.00 34.59 102.80 -159.11 -117.63 33.22 -82.07 -74.51 -26.88 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_3EJ1C.pdb CMGC Active 1 5BP 3.22 -144.32 -176.77 999.00 46.40 77.09 -166.91 -94.52 19.83 -77.74 -58.38 -21.40 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3EOCA.pdb CMGC Active 1 T2A 3.20 -139.41 178.91 999.00 46.69 88.41 -163.90 -103.08 38.95 -79.81 -77.55 -25.29 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_3EOCC.pdb CMGC Active 1 T2A 3.20 -134.64 174.05 999.00 57.30 76.76 -156.83 -94.64 37.33 -78.00 -70.56 -37.20 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3EZVA.pdb CMGC DFGin-inactive 2 EZV 1.99 -136.57 166.86 999.00 64.11 47.25 -131.47 -55.26 135.64 -81.21 -82.61 149.86 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3F5XA.pdb CMGC Active 1 EZV 2.40 -134.60 -179.52 999.00 51.75 79.15 -150.09 -97.87 23.07 -76.04 -60.88 -38.30 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3F5XC.pdb CMGC Active 1 EZV 2.40 -135.20 179.27 999.00 51.94 80.82 -155.32 -99.82 26.03 -80.18 -63.22 -36.48 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3FZ1A.pdb CMGC DFGin-trans 4 B98 1.90 -118.61 152.18 999.00 64.16 33.27 -100.38 -73.55 125.10 -145.26 83.74 -5.78 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3IG7A.pdb CMGC DFGin-trans 4 EFP 1.80 -132.41 159.99 999.00 82.34 -1.98 -79.24 -50.86 132.60 -163.00 72.17 -15.59 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3IGGA.pdb CMGC DFGin-inactive 2 EFQ 1.80 -105.85 154.30 999.00 67.51 24.18 -57.07 -61.56 141.39 -108.90 77.88 -9.42 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3LE6A.pdb CMGC DFGin-trans 4 2BZ 2.00 -102.45 158.83 999.00 69.24 14.77 -80.79 -61.58 127.27 -141.35 90.66 -11.48 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3LFNA.pdb CMGC DFGin-trans 4 A27 2.28 -125.42 160.33 999.00 76.98 10.81 -111.34 -63.40 141.89 -124.87 61.93 -8.50 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3LFQA.pdb CMGC DFGin-trans 4 A28 2.03 -102.94 158.26 999.00 67.03 16.29 -89.75 -65.33 123.22 -138.58 95.16 -12.67 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3LFSA.pdb CMGC DFGin-trans 4 A07 2.40 -100.97 160.63 999.00 60.15 21.09 -82.65 -66.79 119.14 -141.35 99.67 -14.07 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3MY5A.pdb CMGC Active 1 RFZ 2.10 -135.54 -178.06 999.00 53.58 76.52 -156.87 -97.00 15.69 -83.36 -59.55 -26.48 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3MY5C.pdb CMGC Active 1 RFZ 2.10 -140.82 -171.87 999.00 49.54 71.41 -162.38 -88.03 20.88 -80.89 -63.15 -26.34 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3NS9A.pdb CMGC DFGin-trans 4 NS9 1.78 -104.92 159.90 999.00 69.14 14.31 -75.19 -58.32 131.09 -131.15 85.39 -14.64 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3PJ8A.pdb CMGC DFGin-trans 4 404 1.96 -107.85 156.86 999.00 69.08 18.01 -74.06 -67.00 133.81 -135.41 71.62 7.97 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3PXFA.pdb CMGC DFGin-inactive 2 2AN 1.80 -157.00 169.66 999.00 57.70 49.38 -167.38 -58.80 147.91 -73.30 -84.99 33.22 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3PXQA.pdb CMGC DFGin-inactive 2 2AN 1.90 -156.13 172.19 999.00 56.44 48.42 -162.12 -58.21 145.77 -79.26 -81.08 -171.96 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3PXRA.pdb CMGC DFGin-inactive 2 Apo 2.00 -108.66 148.56 999.00 74.21 20.69 -63.84 -60.76 145.94 -112.00 71.74 -11.31 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3PXYA.pdb CMGC DFGin-inactive 2 JWS 1.80 -122.67 154.77 999.00 71.05 42.13 -79.32 -72.87 173.55 -80.83 35.68 27.61 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3PXZA.pdb CMGC DFGin-inactive 2 JWS 1.70 -155.64 166.50 999.00 60.33 50.56 -166.01 -60.24 145.79 -75.09 -84.49 38.41 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3PY0A.pdb CMGC DFGin-inactive 2 SU9 1.75 -126.72 148.86 999.00 64.26 62.28 -147.95 -73.09 -162.72 -78.53 38.41 -126.17 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3PY1A.pdb CMGC DFGin-inactive 2 2AN 2.05 -156.41 165.11 999.00 55.88 55.33 -145.79 -63.33 145.26 -74.20 -95.29 141.57 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3QHRA.pdb CMGC Active 1 ADP 2.17 -129.64 -176.28 999.00 55.30 75.35 -165.79 -97.05 17.76 -79.50 -60.79 -23.59 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3QHRC.pdb CMGC Active 1 ADP 2.17 -133.23 -174.72 999.00 53.93 72.69 -162.69 -93.30 15.88 -78.79 -60.58 -21.43 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3QHWA.pdb CMGC Active 1 ADP 1.91 -134.12 -174.07 999.00 54.41 75.19 -171.37 -91.29 13.17 -78.66 -60.67 -23.11 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3QHWC.pdb CMGC Active 1 ADP 1.91 -135.34 -175.57 999.00 57.57 71.65 -175.04 -89.82 9.68 -79.22 -55.88 -26.77 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3QL8A.pdb CMGC DFGin-inactive 2 X01 1.90 -122.26 168.88 999.00 72.44 -145.10 -137.70 131.38 -129.82 -104.48 -62.10 95.09 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_3QQFA.pdb CMGC DFGin-inactive 2 X07 1.75 -112.67 145.97 999.00 75.35 24.28 -63.23 -63.97 139.14 -111.83 74.30 -5.06 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3QQGA.pdb CMGC DFGin-inactive 2 X06 1.90 -121.56 152.34 999.00 74.44 40.06 -73.47 -71.32 157.62 -89.55 47.91 32.15 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3QQHA.pdb CMGC DFGin-inactive 2 X0A 1.87 -119.13 155.20 999.00 72.30 39.10 -71.28 -73.31 170.09 -94.96 51.92 3.91 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3QQJA.pdb CMGC DFGin-inactive 2 X11 1.70 -118.57 158.92 999.00 68.73 32.78 -63.06 -72.09 149.42 -107.94 65.73 11.61 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3QQKA.pdb CMGC DFGin-inactive 2 X02 1.86 -132.46 171.26 999.00 44.72 61.08 -161.02 -59.64 145.20 -79.84 -55.55 -65.36 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3QQLA.pdb CMGC DFGin-trans 4 X03 1.85 -115.24 159.35 999.00 71.15 15.48 -92.81 -57.22 133.94 -129.93 81.04 -8.19 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3QRTA.pdb CMGC DFGin-inactive 2 X14 1.75 -133.91 161.17 999.00 62.92 54.19 -140.64 -62.71 112.06 -67.87 -59.90 -51.96 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3QRUA.pdb CMGC DFGin-inactive 2 X19 1.95 -141.55 159.84 999.00 61.02 51.88 -157.28 -57.31 130.17 -69.16 -92.88 162.67 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3QTQA.pdb CMGC DFGin-inactive 2 X35 1.80 -134.05 169.78 999.00 50.21 51.62 -169.25 -54.90 133.56 -80.47 -45.44 -64.54 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3QTRA.pdb CMGC DFGin-inactive 2 X36 1.85 -136.00 168.36 999.00 49.07 56.33 -157.68 -59.00 137.46 -79.79 -84.89 137.39 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3QTSA.pdb CMGC DFGin-inactive 2 X46 1.90 -114.84 146.69 999.00 82.29 20.69 -60.94 -64.06 138.53 -107.12 78.01 -5.57 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3QTUA.pdb CMGC DFGin-inactive 2 X44 1.82 -124.14 155.50 999.00 50.23 63.33 -156.06 -57.44 137.73 -77.07 -85.45 -45.11 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3QTWA.pdb CMGC DFGin-inactive 2 X3A 1.85 -131.37 171.81 999.00 40.94 66.72 179.17 -61.59 26.47 -81.59 55.92 3.95 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3QTXA.pdb CMGC DFGin-inactive 2 X43 1.95 -128.83 166.51 999.00 48.55 62.29 -163.35 -60.65 139.87 -80.78 -50.90 -58.11 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3QTZA.pdb CMGC DFGin-inactive 2 X42 2.00 -133.20 164.28 999.00 53.05 54.72 -156.76 -56.96 134.87 -80.86 -100.74 4.70 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3QU0A.pdb CMGC DFGin-inactive 2 X40 1.95 -137.74 171.15 999.00 51.16 48.87 -169.91 -48.06 22.18 -83.12 71.04 -93.37 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3QWJA.pdb CMGC DFGin-trans 4 X6A 1.75 -114.34 147.01 999.00 65.53 42.12 -60.31 -53.52 -101.23 -128.10 -68.72 30.40 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3QWKA.pdb CMGC DFGin-inactive 2 X62 1.85 -127.95 169.36 999.00 39.67 71.83 -177.08 -70.71 133.49 -69.78 -108.77 49.87 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3QX2A.pdb CMGC DFGin-inactive 2 X63 1.75 -109.55 148.72 999.00 71.83 23.56 -59.69 -63.31 136.61 -116.95 79.90 -9.91 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3QX4A.pdb CMGC DFGin-trans 4 X4B 1.92 -117.49 147.66 999.00 64.54 41.47 -62.99 -55.78 -90.13 -125.01 -76.28 28.89 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3QXOA.pdb CMGC DFGin-inactive 2 X65 1.75 -110.17 147.44 999.00 74.31 21.35 -61.49 -62.69 143.04 -112.12 75.66 -10.31 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3QXPA.pdb CMGC DFGin-inactive 2 X64 1.75 -135.48 164.66 999.00 52.43 57.41 -155.89 -62.98 142.62 -82.06 -96.40 145.58 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3QZFA.pdb CMGC DFGin-trans 4 X66 2.00 -112.74 156.46 999.00 66.23 28.60 -63.80 -69.72 139.25 -127.82 75.42 -9.88 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3QZGA.pdb CMGC DFGin-inactive 2 X67 1.75 -119.27 148.15 999.00 78.50 29.58 -71.47 -71.04 140.27 -119.64 70.98 -7.45 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3QZHA.pdb CMGC DFGin-inactive 2 X69 1.95 -110.02 146.99 999.00 77.52 20.69 -64.77 -62.86 134.81 -109.98 79.61 -11.78 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3QZIA.pdb CMGC DFGin-trans 4 X72 1.75 -119.89 143.48 999.00 80.17 23.63 -67.50 -68.65 125.86 -121.41 88.78 -15.01 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3R1QA.pdb CMGC DFGin-inactive 2 X75 1.85 -115.67 139.46 999.00 82.31 27.96 -63.60 -68.29 134.47 -108.71 76.91 -4.36 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3R1SA.pdb CMGC DFGin-inactive 2 X73 1.80 -112.30 145.37 999.00 77.73 20.95 -65.05 -61.34 140.89 -110.28 70.86 -5.99 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3R1YA.pdb CMGC DFGin-inactive 2 X76 1.80 -109.35 144.42 999.00 74.92 25.22 -57.90 -61.61 142.02 -110.20 72.44 -3.57 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3R28A.pdb CMGC DFGin-inactive 2 XA0 1.75 -114.83 140.60 999.00 83.60 19.65 -68.02 -63.56 141.75 -104.38 75.71 -16.09 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3R6XA.pdb CMGC DFGin-inactive 2 X84 1.75 -112.71 145.26 999.00 76.97 24.29 -63.60 -64.91 138.46 -108.84 78.91 -11.43 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3R71A.pdb CMGC DFGin-inactive 2 X86 1.75 -105.71 148.58 999.00 72.17 22.72 -60.81 -59.51 139.95 -111.05 80.86 -15.22 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3R73A.pdb CMGC DFGin-inactive 2 X87 1.70 -113.72 142.28 999.00 80.48 22.76 -61.80 -63.97 138.76 -106.36 78.07 -8.78 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3R7EA.pdb CMGC DFGin-inactive 2 X88 1.90 -107.57 147.91 999.00 71.91 27.85 -63.83 -65.11 136.20 -116.34 76.51 -6.15 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3R7IA.pdb CMGC DFGin-inactive 2 X9I 1.85 -113.01 148.31 999.00 76.27 21.18 -68.09 -64.59 139.25 -114.58 76.79 -11.15 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3R7UA.pdb CMGC DFGin-inactive 2 X96 1.75 -111.20 145.35 999.00 75.55 26.02 -58.04 -64.57 137.62 -115.06 77.94 -11.73 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3R7VA.pdb CMGC DFGin-inactive 2 Z02 1.95 -110.20 148.47 999.00 73.00 23.03 -62.94 -62.92 137.37 -117.77 77.51 -10.41 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3R7YA.pdb CMGC DFGin-inactive 2 Z04 1.90 -106.06 149.27 999.00 72.23 22.76 -59.80 -60.55 141.53 -117.13 77.08 -15.37 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3R83A.pdb CMGC DFGin-inactive 2 Z14 1.75 -108.41 152.34 999.00 71.87 22.85 -57.42 -60.13 136.28 -113.15 84.49 -13.18 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3R8LA.pdb CMGC DFGin-trans 4 Z30 1.90 -134.72 146.35 999.00 77.60 31.37 -80.93 -69.96 121.16 -139.45 79.38 10.81 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3R8MA.pdb CMGC DFGin-inactive 2 Z19 1.80 -122.43 152.40 999.00 73.11 33.36 -73.42 -69.28 151.48 -104.78 58.04 16.69 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3R8PA.pdb CMGC DFGin-trans 4 Z46 1.80 -109.83 156.55 999.00 70.80 17.82 -82.62 -61.22 140.31 -129.30 77.70 -12.28 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3R8UA.pdb CMGC DFGin-inactive 2 Z31 2.00 -107.60 143.40 999.00 81.20 22.00 -64.35 -61.97 141.84 -110.00 78.34 -11.91 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3R8VA.pdb CMGC DFGin-inactive 2 Z62 1.90 -108.00 152.24 999.00 77.14 17.74 -61.68 -60.62 141.14 -109.01 79.64 -8.79 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3R8ZA.pdb CMGC DFGin-inactive 2 Z63 1.85 -130.92 171.61 999.00 46.79 58.93 -162.28 -55.60 142.94 -83.18 -58.54 -18.33 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3R9DA.pdb CMGC DFGin-inactive 2 X6B 1.95 -121.18 171.38 999.00 50.73 77.18 -172.45 -81.45 59.24 -78.02 42.23 -95.40 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3R9HA.pdb CMGC DFGin-inactive 2 Z67 2.10 -120.02 168.82 999.00 77.08 -84.16 177.80 71.53 122.54 -80.16 -46.30 -69.12 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_3R9NA.pdb CMGC DFGin-inactive 2 Z68 1.75 -111.03 151.84 999.00 80.88 16.02 -65.02 -60.61 141.85 -106.04 77.94 -10.07 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3R9OA.pdb CMGC DFGin-inactive 2 Z71 1.90 -124.90 169.15 999.00 49.31 74.12 179.98 -72.51 33.52 -80.36 59.09 -27.51 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3RAHA.pdb CMGC DFGin-inactive 2 O1Z 1.75 -110.28 153.01 999.00 77.95 18.04 -62.20 -61.86 142.51 -108.01 76.59 -9.75 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3RAIA.pdb CMGC DFGin-inactive 2 X85 1.70 -111.95 145.87 999.00 74.75 25.68 -58.84 -65.33 141.74 -107.91 75.26 -8.23 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3RAKA.pdb CMGC DFGin-inactive 2 03Z 1.75 -133.12 166.10 999.00 51.77 55.45 -157.54 -59.79 137.03 -83.33 -91.81 143.24 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3RALA.pdb CMGC DFGin-inactive 2 04Z 1.75 -135.51 167.58 999.00 50.32 56.61 -161.19 -59.13 143.28 -80.97 -92.16 138.38 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3RJCA.pdb CMGC DFGin-inactive 2 06Z 1.85 -135.33 172.86 999.00 50.09 54.54 -159.73 -59.08 124.86 -82.09 -88.39 2.90 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3RK5A.pdb CMGC DFGin-inactive 2 07Z 2.00 -135.71 162.55 999.00 80.10 -66.75 -168.66 62.58 4.91 -76.97 53.27 -132.53 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3RK7A.pdb CMGC DFGin-inactive 2 08Z 1.80 -129.69 167.90 999.00 74.53 -59.75 -167.77 60.94 15.18 -78.22 53.85 -103.41 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3RK9A.pdb CMGC DFGin-inactive 2 09Z 1.85 -131.86 170.17 999.00 48.71 55.26 -167.44 -57.82 135.96 -80.60 -79.83 138.91 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3RKBA.pdb CMGC DFGin-inactive 2 12Z 2.00 -136.35 169.67 999.00 52.73 57.57 -163.85 -64.12 -102.20 -81.61 -78.58 125.76 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3RM6A.pdb CMGC DFGin-inactive 2 18Z 1.60 -127.27 175.25 999.00 70.28 -63.28 -164.78 64.37 17.53 -75.86 61.93 14.36 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3RM7A.pdb CMGC DFGin-inactive 2 19Z 1.85 -110.59 146.93 999.00 75.19 22.59 -62.81 -62.08 138.87 -115.76 74.52 -5.04 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3RMFA.pdb CMGC DFGin-inactive 2 20Z 1.75 -129.82 164.77 999.00 49.31 60.40 -162.82 -59.89 137.08 -80.16 -89.43 127.61 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3RNIA.pdb CMGC DFGin-inactive 2 21Z 1.95 -134.94 174.03 999.00 47.05 52.74 -168.18 -58.87 133.54 -80.42 -91.90 141.65 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3ROYA.pdb CMGC DFGin-inactive 2 22Z 1.75 -113.41 143.96 999.00 78.37 23.64 -63.29 -63.29 140.68 -107.07 73.47 -8.33 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3RPOA.pdb CMGC DFGin-inactive 2 24Z 1.75 -105.81 149.37 999.00 71.46 21.73 -59.10 -61.33 139.84 -117.47 76.42 -10.73 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3RPRA.pdb CMGC DFGin-inactive 2 25Z 1.75 -111.98 154.75 999.00 77.55 17.44 -64.29 -61.59 142.52 -109.19 78.31 -12.32 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3RPVA.pdb CMGC DFGin-inactive 2 26Z 1.80 -129.45 164.67 999.00 51.88 56.86 -157.91 -59.86 141.68 -83.30 -91.44 141.12 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3RPYA.pdb CMGC DFGin-inactive 2 27Z 1.90 -132.05 172.71 999.00 52.84 48.20 -65.87 -55.91 137.30 -78.81 -87.69 136.43 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3RZBA.pdb CMGC DFGin-inactive 2 02Z 1.90 -134.01 177.26 999.00 47.06 50.35 -58.12 -50.05 -22.27 -80.03 71.55 17.14 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3S00A.pdb CMGC DFGin-inactive 2 Z60 1.80 -113.02 158.18 999.00 73.08 19.11 -61.10 -62.78 138.04 -115.16 75.92 -1.64 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3S1HA.pdb CMGC DFGin-inactive 2 56Z 1.75 -130.78 169.31 999.00 45.10 59.37 -162.12 -59.78 144.03 -80.19 -93.98 139.71 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3S2PA.pdb CMGC DFGin-trans 4 PMU 2.30 -115.59 143.64 999.00 80.48 18.94 -72.67 -63.22 135.95 -127.53 83.95 -19.50 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3SQQA.pdb CMGC DFGin-inactive 2 99Z 1.85 -133.89 167.80 999.00 51.72 56.66 -151.85 -62.00 141.70 -83.49 -97.54 141.21 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3SW4A.pdb CMGC DFGin-inactive 2 18K 1.70 -115.35 149.90 999.00 75.81 22.30 -71.17 -62.22 138.19 -105.97 74.53 -5.67 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3SW7A.pdb CMGC DFGin-inactive 2 19K 1.80 -125.05 148.25 999.00 57.99 72.48 -165.45 -63.02 133.77 -68.11 -87.92 155.04 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3TI1A.pdb CMGC DFGin-inactive 2 B49 1.99 -138.52 165.90 999.00 55.21 50.84 -161.25 -54.72 138.13 -77.24 -95.48 15.82 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3TIYA.pdb CMGC DFGin-inactive 2 TIY 1.84 -126.01 167.50 999.00 54.79 63.37 -179.31 -71.44 -6.93 -76.45 76.63 -119.89 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3TIZA.pdb CMGC DFGin-inactive 2 3TI 2.02 -121.86 153.78 999.00 71.69 29.26 -66.81 -62.44 138.81 -107.23 73.11 -2.14 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3TNWA.pdb CMGC Active 1 F18 2.00 -128.61 -178.27 999.00 47.90 84.35 -161.32 -97.80 26.04 -78.69 -65.03 -21.35 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_3TNWC.pdb CMGC Active 1 F18 2.00 -134.93 -174.41 999.00 47.71 80.83 -156.61 -94.46 22.72 -82.97 -61.63 -28.63 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_3ULIA.pdb CMGC DFGin-trans 4 1N3 2.00 -122.41 161.12 999.00 57.16 61.45 -168.47 -118.71 96.87 -162.69 93.32 2.40 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_3UNJA.pdb CMGC DFGin-inactive 2 0BX 1.90 -126.22 158.42 999.00 62.92 62.38 -150.56 -77.42 -172.62 -76.35 54.10 -145.30 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3UNKA.pdb CMGC DFGin-inactive 2 0BY 2.10 -114.58 154.56 999.00 71.99 37.13 -109.84 -66.59 159.39 -75.30 68.12 3.61 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_3WBLA.pdb CMGC DFGin-trans 4 PDY 2.00 -103.81 149.15 999.00 67.26 26.99 -74.54 -65.29 140.51 -132.66 72.84 -9.33 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_4ACMA.pdb CMGC DFGin-trans 4 7YG 1.63 -126.17 176.72 999.00 53.35 42.77 -174.60 -98.68 145.01 -142.75 55.37 -1.28 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_4BCKA.pdb CMGC Active 1 T3E 2.05 -140.97 173.72 999.00 58.45 83.63 -159.52 -95.20 19.90 -76.62 -69.80 -20.59 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4BCKC.pdb CMGC Active 1 T3E 2.05 -148.77 176.82 999.00 54.29 81.47 -161.93 -98.58 19.61 -85.47 -77.01 -1.91 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4BCMA.pdb CMGC Active 1 T7Z 2.45 -139.62 174.21 999.00 58.63 79.08 -154.51 -93.60 24.75 -77.33 -67.70 -29.32 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4BCMC.pdb CMGC Active 1 T7Z 2.45 -144.91 174.58 999.00 58.34 79.88 -148.03 -94.03 24.46 -73.73 -53.03 -36.69 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4BCNA.pdb CMGC Active 1 T9N 2.10 -132.44 173.07 999.00 59.44 82.58 -160.44 -96.18 22.61 -78.56 -64.88 -22.02 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4BCNC.pdb CMGC Active 1 T9N 2.10 -138.85 178.10 999.00 52.90 85.41 -158.05 -99.97 21.81 -83.37 -66.83 -15.20 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_4BCOA.pdb CMGC Active 1 T6Q 2.05 -135.78 171.96 999.00 56.88 82.77 -151.95 -96.42 24.73 -79.74 -60.95 -26.59 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4BCOC.pdb CMGC Active 1 T6Q 2.05 -138.04 175.95 999.00 55.78 82.39 -154.41 -98.48 30.30 -78.52 -70.24 -23.65 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4BCPA.pdb CMGC Active 1 T3C 2.26 -134.08 171.25 999.00 58.95 82.51 -149.96 -95.68 26.89 -79.84 -65.06 -23.03 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4BCPC.pdb CMGC Active 1 T3C 2.26 -138.62 173.92 999.00 55.85 79.51 -156.94 -94.54 33.08 -74.86 -71.12 -20.21 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4BCQA.pdb CMGC Active 1 TJF 2.40 -145.95 170.48 999.00 62.79 85.03 -155.15 -99.36 29.58 -77.75 -71.17 -18.66 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4BCQC.pdb CMGC Active 1 TJF 2.40 -147.34 170.24 999.00 59.19 86.28 -154.25 -98.92 28.18 -81.55 -71.40 -12.41 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4BGHA.pdb CMGC DFGup 3 3I6 1.95 -115.48 148.94 999.00 82.97 18.81 -58.58 -106.58 167.41 59.77 69.44 -14.36 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4BZDA.pdb CMGC DFGin-inactive 2 D6I 1.83 -126.39 162.24 999.00 68.76 43.63 -152.92 -68.89 -46.65 -82.43 -49.65 999.00 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4CFMA.pdb CMGC Active 1 4QE 2.85 -138.85 -176.19 999.00 51.53 75.91 -163.68 -84.66 19.12 -77.59 -49.69 -36.45 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4CFMC.pdb CMGC Active 1 4QE 2.85 -142.96 -178.83 999.00 51.09 76.14 -153.70 -84.17 19.73 -76.23 -51.98 -31.38 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4CFNA.pdb CMGC Active 1 JYM 2.20 -143.00 176.42 999.00 52.29 83.60 -161.08 -94.69 16.22 -75.85 -57.20 -25.81 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4CFNC.pdb CMGC Active 1 JYM 2.20 -142.50 176.41 999.00 51.74 85.69 -162.29 -98.32 18.69 -78.94 -56.11 -22.81 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_4CFUA.pdb CMGC Active 1 2WC 2.20 -143.88 -176.47 999.00 47.01 77.88 -155.65 -92.02 16.09 -79.92 -62.91 -22.84 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4CFUC.pdb CMGC Active 1 2WC 2.20 -141.49 -176.08 999.00 45.06 77.74 -157.68 -88.60 18.28 -79.45 -62.83 -25.20 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4CFVA.pdb CMGC Active 1 75X 2.00 -137.59 177.53 999.00 52.91 79.73 -160.78 -90.19 13.93 -80.53 -62.73 -24.75 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4CFVC.pdb CMGC Active 1 75X 2.00 -134.84 -178.52 999.00 49.43 77.96 -161.75 -89.90 17.93 -81.77 -62.87 -26.71 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4CFWA.pdb CMGC Active 1 SQ9 2.45 -137.00 -173.99 999.00 45.60 77.07 -159.71 -83.57 21.26 -78.25 -61.49 -31.13 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4CFWC.pdb CMGC Active 1 SQ9 2.45 -142.01 -176.49 999.00 44.05 78.23 -157.95 -86.55 15.74 -76.80 -50.64 -33.09 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4CFXA.pdb CMGC Active 1 G6T 3.50 -137.94 169.04 999.00 56.33 77.85 -162.63 -94.38 27.08 -76.47 -55.96 -34.30 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4CFXC.pdb CMGC Active 1 G6T 3.50 -142.34 170.08 999.00 55.53 71.59 -158.21 -85.68 23.34 -74.62 -51.54 -29.66 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4D1XA.pdb CMGC DFGin-inactive 2 ESJ 2.10 -113.23 150.67 999.00 79.12 24.02 -62.89 -66.77 134.10 -114.28 76.43 -5.49 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4D1ZA.pdb CMGC DFGin-inactive 2 WG8 1.85 -138.66 166.71 999.00 53.64 62.09 -165.62 -66.34 146.29 -70.89 -62.66 999.00 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_4EK3A.pdb CMGC DFGin-trans 4 Apo 1.34 -101.18 151.51 999.00 67.45 22.05 -62.35 -57.84 133.82 -131.73 82.45 -9.30 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_4EK4A.pdb CMGC DFGin-trans 4 1CK 1.26 -100.46 149.83 999.00 72.51 21.31 -69.34 -57.52 137.22 -125.95 81.06 -10.72 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_4EK5A.pdb CMGC DFGin-trans 4 03K 1.60 -103.78 152.45 999.00 71.00 21.09 -64.31 -60.98 129.98 -123.31 85.80 -10.79 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_4EK6A.pdb CMGC DFGin-trans 4 10K 1.52 -108.08 151.96 999.00 70.36 25.25 -67.65 -61.94 130.71 -127.65 80.44 -8.67 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_4EK8A.pdb CMGC DFGin-trans 4 16K 1.70 -109.47 155.94 999.00 67.91 29.36 -86.26 -68.12 131.40 -126.83 75.36 -2.71 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_4EOIA.pdb CMGC Active 1 1RO 2.00 -136.10 178.10 999.00 51.94 76.22 -155.84 -88.75 18.89 -77.16 -58.60 -31.42 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4EOIC.pdb CMGC Active 1 1RO 2.00 -147.50 173.24 999.00 55.99 74.42 -161.12 -88.59 22.53 -76.05 -63.65 -26.70 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4EOJA.pdb CMGC Active 1 ATP 1.65 -134.06 177.55 999.00 53.96 78.03 -168.51 -94.34 17.75 -82.13 -65.22 -18.56 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4EOJC.pdb CMGC Active 1 ATP 1.65 -136.43 -177.78 999.00 51.68 75.52 -161.58 -89.78 20.13 -79.97 -59.21 -28.69 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4EOKA.pdb CMGC Active 1 4SP 2.57 -134.28 -179.83 999.00 46.43 76.30 -149.14 -85.24 26.99 -77.22 -63.18 -40.96 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4EOKC.pdb CMGC Active 1 4SP 2.57 -133.76 176.59 999.00 49.71 77.35 -153.57 -90.86 27.27 -77.80 -59.20 -42.49 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4EOLA.pdb CMGC Active 1 1RO 2.40 -135.34 178.72 999.00 52.75 78.67 -157.70 -93.77 24.66 -80.29 -67.63 -22.77 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4EOLC.pdb CMGC Active 1 1RO 2.40 -145.27 177.28 999.00 50.95 76.95 -156.63 -90.22 25.77 -72.59 -65.25 -28.60 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4EOMA.pdb CMGC Active 1 ATP 2.10 -135.90 -179.91 999.00 56.66 76.40 -165.71 -93.71 18.31 -78.26 -64.99 -17.09 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4EOMC.pdb CMGC Active 1 ATP 2.10 -134.31 179.41 999.00 56.92 73.64 -165.48 -89.35 27.11 -71.72 -61.61 -29.45 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4EONA.pdb CMGC Active 1 1RO 2.40 -132.16 -177.67 999.00 48.82 80.56 -152.46 -94.82 18.23 -79.60 -57.85 -34.86 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4EONC.pdb CMGC Active 1 1RO 2.40 -139.82 -179.05 999.00 50.47 76.33 -150.68 -91.39 25.01 -74.26 -64.01 -29.22 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4EOOA.pdb CMGC Active 1 ATP 2.10 -137.34 -178.27 999.00 51.93 74.46 -170.52 -88.72 23.68 -76.41 -66.82 -17.34 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4EOOC.pdb CMGC Active 1 ATP 2.10 -132.94 -176.38 999.00 50.21 74.16 -165.22 -84.25 27.38 -76.10 -62.63 -24.02 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4EOPA.pdb CMGC Active 1 1RO 1.99 -142.21 176.94 999.00 53.78 81.45 -156.08 -94.43 24.18 -76.69 -63.26 -27.42 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4EOPC.pdb CMGC Active 1 1RO 1.99 -141.54 -178.44 999.00 53.20 82.14 -160.32 -98.67 23.25 -80.33 -60.43 -30.02 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4EOQA.pdb CMGC Active 1 ATP 2.15 -136.19 -179.05 999.00 55.17 77.28 -162.77 -91.45 19.41 -77.77 -64.26 -18.91 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4EOQC.pdb CMGC Active 1 ATP 2.15 -140.92 -177.15 999.00 51.02 73.00 -161.88 -85.26 24.68 -75.68 -63.96 -27.59 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4EORA.pdb CMGC Active 1 4SP 2.20 -134.33 175.74 999.00 52.56 78.16 -156.51 -90.67 21.50 -82.10 -65.84 -25.48 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4EORC.pdb CMGC Active 1 4SP 2.20 -138.61 178.48 999.00 45.82 76.17 -160.66 -84.97 25.42 -76.17 -63.16 -30.00 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4EOSA.pdb CMGC Active 1 1RO 2.57 -142.00 173.35 999.00 61.80 76.98 -158.78 -94.92 23.87 -72.74 -62.10 -29.59 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4EOSC.pdb CMGC Active 1 1RO 2.57 -142.15 172.76 999.00 60.65 72.59 -160.76 -88.34 30.62 -73.42 -72.70 -28.90 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4ERWA.pdb CMGC DFGin-inactive 2 STU 2.00 -125.33 160.60 999.00 52.55 61.75 -168.23 -60.61 138.57 -80.89 -74.86 135.42 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_4EZ3A.pdb CMGC DFGin-inactive 2 0S0 2.00 -134.03 164.69 999.00 51.80 51.77 -166.03 -53.32 139.93 -76.22 -91.21 154.83 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_4EZ7A.pdb CMGC DFGin-inactive 2 STU 2.49 -145.53 170.41 999.00 52.87 57.80 -155.05 -61.65 149.91 -72.69 -86.99 168.30 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_4FKGA.pdb CMGC DFGin-trans 4 4CK 1.51 -107.41 153.34 999.00 71.10 22.36 -69.37 -63.66 131.12 -124.83 82.00 -10.17 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_4FKIA.pdb CMGC DFGin-trans 4 09K 1.60 -106.32 156.62 999.00 67.75 23.14 -66.52 -61.40 126.13 -130.05 82.50 -7.59 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_4FKJA.pdb CMGC DFGin-trans 4 11K 1.63 -106.56 153.30 999.00 70.50 22.56 -68.80 -62.76 127.66 -129.67 77.73 -2.79 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_4FKLA.pdb CMGC DFGin-trans 4 CK2 1.26 -97.13 153.92 999.00 64.34 26.41 -63.59 -63.95 127.60 -146.86 88.37 -9.71 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_4FKOA.pdb CMGC DFGin-inactive 2 20K 1.55 -125.46 149.83 999.00 58.67 75.89 -165.76 -66.75 135.71 -67.55 -92.70 155.04 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4FKPA.pdb CMGC DFGin-trans 4 LS5 1.60 -109.13 148.68 999.00 68.54 31.40 -87.09 -65.98 130.00 -138.27 77.09 -6.90 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_4FKQA.pdb CMGC DFGin-inactive 2 42K 1.75 -107.42 146.48 999.00 78.68 22.12 -59.13 -63.69 140.63 -108.45 78.48 -10.57 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4FKRA.pdb CMGC DFGup 3 45K 1.90 -117.17 154.29 999.00 80.01 45.04 -153.05 -150.89 177.81 72.34 83.91 -11.94 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_4FKSA.pdb CMGC DFGup 3 46K 1.55 -129.32 166.79 999.00 60.64 50.12 -154.10 -144.12 161.73 101.81 80.60 -7.20 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_4FKTA.pdb CMGC DFGin-trans 4 48K 1.60 -109.43 151.07 999.00 67.50 31.14 -83.99 -67.74 128.25 -141.83 81.01 -8.65 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_4FKUA.pdb CMGC DFGup 3 60K 1.47 -135.19 172.92 999.00 58.33 56.24 -168.53 -149.16 168.17 70.34 101.66 -8.89 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_4FKVA.pdb CMGC DFGin-trans 4 61K 1.70 -116.21 166.40 999.00 56.69 49.13 -167.60 -66.25 -125.25 -125.49 -63.17 29.88 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_4FKWA.pdb CMGC DFGup 3 62K 1.80 -134.08 171.01 999.00 59.75 52.01 -176.04 -144.56 164.61 70.26 98.76 11.15 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_4FX3A.pdb CMGC Active 1 60K 2.75 -126.08 178.61 999.00 49.17 93.42 -156.39 -105.79 30.21 -83.71 -61.85 -45.01 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_4FX3C.pdb CMGC Active 1 60K 2.75 -134.17 -178.75 999.00 44.12 89.76 -156.14 -104.82 28.66 -79.56 -64.32 -46.71 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_4GCJA.pdb CMGC DFGin-inactive 2 X64 1.42 -128.81 165.11 999.00 55.35 52.43 -156.50 -58.30 140.93 -79.69 -88.25 148.77 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_4I3ZA.pdb CMGC Active 1 ADP 2.05 -137.58 -176.09 999.00 53.01 75.42 -167.51 -91.32 19.91 -79.29 -64.82 -19.44 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4I3ZC.pdb CMGC Active 1 ADP 2.05 -139.13 -175.02 999.00 51.70 79.14 -166.15 -95.14 18.90 -81.45 -64.66 -17.10 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4II5A.pdb CMGC Active 1 ADP 2.15 -136.85 -174.69 999.00 48.21 75.65 -162.45 -89.28 15.09 -78.26 -54.49 -30.01 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4II5C.pdb CMGC Active 1 ADP 2.15 -134.90 -171.62 999.00 44.91 79.89 -157.36 -96.16 16.05 -84.94 -60.88 -24.80 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_4KD1A.pdb CMGC DFGin-inactive 2 1QK 1.70 -103.76 151.94 999.00 77.64 19.21 -66.41 -58.14 138.94 -109.09 83.93 -15.14 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_4LYNA.pdb CMGC DFGin-trans 4 1YG 2.00 -119.41 150.83 999.00 73.49 17.18 -74.25 -63.02 136.41 -135.19 65.05 -1.78 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_4NJ3A.pdb CMGC DFGin-inactive 2 2KD 1.85 -130.78 172.54 999.00 45.09 81.36 -162.73 -88.92 3.27 -75.40 63.23 34.23 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_4RJ3A.pdb NA NA 0 ALY 1.63 -103.22 157.57 999.00 67.06 20.44 -73.26 -61.48 131.71 -130.13 88.11 -11.01 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_5A14A.pdb CMGC DFGout 6 LQ5 2.00 -142.69 171.69 999.00 -138.75 99.66 -167.57 -93.93 17.82 -164.93 -60.89 125.76 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_5ANDA.pdb CMGC DFGin-trans 4 5JE 2.30 -108.54 154.74 999.00 65.18 24.98 -68.74 -64.47 124.84 179.08 79.75 -8.43 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_5ANEA.pdb CMGC DFGin-trans 4 Apo 1.70 -98.70 153.43 999.00 62.81 28.14 -65.23 -66.67 130.54 -145.89 78.50 -1.91 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_5ANGA.pdb CMGC DFGin-inactive 2 WY3 1.90 -130.70 171.09 999.00 57.02 51.40 -165.57 -60.92 146.23 -78.62 -94.91 129.04 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_5ANIA.pdb CMGC DFGin-trans 4 Apo 1.90 -100.22 154.97 999.00 64.81 25.57 -63.56 -66.14 128.57 -174.81 81.80 -7.49 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_5ANJA.pdb CMGC DFGin-trans 4 ZXC 1.60 -96.16 156.01 999.00 57.85 34.12 -63.01 -67.30 127.00 -151.62 85.37 -7.10 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_5ANKA.pdb CMGC DFGin-trans 4 RJI 1.90 -94.47 160.52 999.00 54.31 28.11 -65.65 -69.04 123.46 -151.89 89.60 -12.34 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_5ANOA.pdb CMGC DFGin-trans 4 Apo 1.70 -109.26 158.75 999.00 58.93 30.88 -69.43 -72.86 133.97 -151.25 71.91 -0.68 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_5CYIA.pdb CMGC Active 1 55S 2.00 -137.62 176.64 999.00 47.13 80.49 -158.57 -91.39 21.67 -78.42 -67.04 -18.57 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_5CYIC.pdb CMGC Active 1 55S 2.00 -137.75 174.67 999.00 47.71 81.05 -159.52 -90.90 22.32 -78.38 -65.98 -19.77 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_5FP5A.pdb CMGC DFGin-inactive 2 1Y6 2.16 -126.46 168.65 999.00 54.28 57.16 -175.61 -56.06 146.66 -78.10 -71.19 108.51 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_5FP6A.pdb CMGC DFGin-inactive 2 MFZ 1.85 -139.16 164.09 999.00 57.46 56.86 -158.99 -61.37 140.84 -79.36 -62.28 999.00 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_5IEVA.pdb CMGC DFGup 3 R0N 2.03 -126.90 158.29 999.00 69.53 57.99 175.01 -153.42 -177.59 66.11 64.80 -27.05 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_5IEXA.pdb CMGC DFGin-trans 4 6AF 2.03 -105.59 149.54 999.00 71.39 22.61 -55.16 -61.84 135.14 -123.36 74.51 -10.58 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_5IEYA.pdb CMGC DFGin-trans 4 6AE 1.66 -114.62 154.98 999.00 62.42 29.51 -76.71 -64.64 133.18 -143.16 77.64 -6.65 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_5IF1A.pdb CMGC Active 1 Apo 2.61 -137.46 -174.57 999.00 43.73 86.52 -158.28 -101.87 23.64 -74.15 -54.61 -38.38 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_5IF1C.pdb CMGC Active 1 Apo 2.61 -139.19 -174.54 999.00 53.80 79.03 -125.06 -103.21 18.87 -79.82 -48.29 -37.78 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_5JQ5A.pdb CMGC DFGin-trans 4 I74 1.94 -98.25 154.47 999.00 69.17 17.55 -77.06 -59.31 137.78 -123.66 85.76 -18.22 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_5JQ8A.pdb CMGC DFGin-trans 4 I73 1.94 -111.85 145.88 999.00 71.11 24.04 -70.56 -62.21 135.45 -134.27 76.72 -12.85 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_5K4JA.pdb CMGC DFGin-trans 4 6QB 1.60 -110.54 159.69 999.00 77.36 19.32 -155.85 -71.28 128.08 -146.18 78.06 -4.62 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_5L2WA.pdb CMGC Active 1 1QK 2.80 -124.76 175.27 999.00 50.25 87.64 -146.26 -98.34 21.84 -80.26 -63.40 -34.96 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_5LMKA.pdb CMGC Active 1 6ZK 2.40 -137.47 165.61 999.00 58.34 86.38 -156.39 -95.63 20.71 -79.22 -57.65 -38.21 999.00 Allowed ALA ASP PHE GLY"
"CDK2_HUMAN t_5LMKC.pdb CMGC Active 1 6ZK 2.40 -133.23 168.50 999.00 55.37 88.47 -158.86 -97.76 24.86 -76.66 -61.18 -33.61 999.00 Outlier ALA ASP PHE GLY"
"CDK2_HUMAN t_5NEVA.pdb CMGC Active 1 72L 2.97 -138.45 -8.79 999.00 -130.23 91.19 -159.67 -84.60 13.86 -79.76 -70.52 -13.57 999.00 Favored ALA ASP PHE GLY"
"CDK2_HUMAN t_5NEVC.pdb CMGC Active 1 72L 2.97 -144.03 -12.12 999.00 -126.57 90.92 -159.24 -83.36 12.52 -82.26 -69.29 -11.36 999.00 Favored ALA ASP PHE GLY"
"CDK4_HUMAN t_2W96B.pdb CMGC DFGup 3 Apo 2.30 -130.54 159.67 999.00 70.53 19.80 -70.61 -84.16 138.38 49.64 81.93 16.95 999.00 Favored ALA ASP PHE GLY"
"CDK4_HUMAN t_2W99B.pdb CMGC DFGup 3 Apo 2.80 -145.48 169.45 999.00 48.60 20.33 -63.99 -49.23 153.44 41.89 63.80 -59.03 999.00 Allowed ALA ASP PHE GLY"
"CDK4_HUMAN t_2W9FB.pdb CMGC DFGup 3 Apo 2.85 -118.05 -62.54 999.00 -136.12 77.77 -82.23 -93.70 151.49 25.95 57.93 -6.86 999.00 Allowed ALA ASP PHE GLY"
"CDK4_HUMAN t_2W9ZB.pdb CMGC DFGup 3 Apo 2.45 -127.71 158.61 999.00 66.12 21.57 -76.64 -72.50 154.77 42.90 55.84 36.53 999.00 Favored ALA ASP PHE GLY"
"CDK4_HUMAN t_3G33A.pdb CMGC DFGup 3 Apo 3.00 -142.92 171.63 999.00 56.01 47.44 -72.99 -95.76 -74.88 39.76 -89.12 52.70 999.00 Favored ALA ASP PHE GLY"
"CDK4_HUMAN t_3G33C.pdb CMGC DFGup 3 Apo 3.00 -142.77 171.60 999.00 56.31 47.21 -73.14 -95.62 -74.93 39.74 -89.07 52.73 999.00 Favored ALA ASP PHE GLY"
"CDK4_HUMAN t_5FWKK.pdb NA NA 0 Apo 3.90 -149.89 165.23 999.00 70.71 78.38 -60.07 -92.73 75.40 -59.55 89.81 154.03 999.00 Allowed ALA ASP PHE GLY"
"CDK4_HUMAN t_5FWPK.pdb NA NA 0 Apo 7.20 -148.54 165.81 999.00 70.33 77.46 -59.30 -94.68 75.34 -60.43 90.94 152.92 999.00 Allowed ALA ASP PHE GLY"
"CDK5_HUMAN t_1H4LA.pdb CMGC Active 1 Apo 2.65 -143.57 176.21 999.00 53.18 75.87 -58.17 -87.17 17.57 -78.54 -52.59 -28.59 999.00 Allowed ALA ASP PHE GLY"
"CDK5_HUMAN t_1H4LB.pdb CMGC Active 1 Apo 2.65 -143.33 -179.12 999.00 52.74 73.31 -54.21 -87.40 23.95 -76.36 -58.04 -24.26 999.00 Allowed ALA ASP PHE GLY"
"CDK5_HUMAN t_1UNGA.pdb CMGC Active 1 ALH 2.30 -133.30 177.58 999.00 62.73 72.63 -63.26 -89.90 24.26 -76.72 -65.99 -18.38 999.00 Allowed ALA ASN PHE GLY"
"CDK5_HUMAN t_1UNGB.pdb CMGC Active 1 ALH 2.30 -136.02 174.00 999.00 60.44 78.05 -178.75 -103.92 21.88 -85.17 -65.03 -29.37 999.00 Allowed ALA ASN PHE GLY"
"CDK5_HUMAN t_1UNHA.pdb CMGC Active 1 IXM 2.35 -140.38 176.03 999.00 60.45 76.73 -62.34 -95.62 24.15 -78.10 -62.12 -29.87 999.00 Allowed ALA ASN PHE GLY"
"CDK5_HUMAN t_1UNHB.pdb CMGC Active 1 IXM 2.35 -141.39 178.64 999.00 60.45 76.28 -63.52 -98.32 21.68 -82.07 -63.95 -22.10 999.00 Allowed ALA ASN PHE GLY"
"CDK5_HUMAN t_1UNLA.pdb CMGC Active 1 RRC 2.2 -128.31 173.25 999.00 66.81 81.04 -57.22 -97.91 23.57 -76.81 -73.66 -20.58 999.00 Allowed ALA ASN PHE GLY"
"CDK5_HUMAN t_1UNLB.pdb CMGC Active 1 Apo 2.2 -135.81 173.43 999.00 59.95 81.06 -64.47 -98.23 33.35 -76.93 -75.69 -27.21 999.00 Allowed ALA ASN PHE GLY"
"CDK5_HUMAN t_3O0GA.pdb CMGC Active 1 Apo 1.95 -136.44 175.76 999.00 61.35 76.50 -63.82 -94.75 26.41 -80.88 -74.81 -15.10 999.00 Allowed ALA ASN PHE GLY"
"CDK5_HUMAN t_3O0GB.pdb CMGC Active 1 3O0 1.95 -129.47 175.96 999.00 62.66 84.25 -165.99 -100.95 30.37 -75.60 -62.99 -27.80 999.00 Allowed ALA ASN PHE GLY"
"CDK5_HUMAN t_4AU8A.pdb CMGC Active 1 Z3R 1.90 -135.32 172.88 999.00 64.93 77.02 -67.41 -97.55 18.88 -78.04 -65.99 -19.06 999.00 Allowed ALA ASP PHE GLY"
"CDK5_HUMAN t_4AU8B.pdb CMGC Active 1 Z3R 1.90 -136.28 169.40 999.00 66.38 80.11 -69.80 -99.74 21.43 -78.10 -66.21 -20.07 999.00 Allowed ALA ASP PHE GLY"
"CDK6_HUMAN t_1BI7A.pdb NA NA 0 Apo 3.40 -170.05 162.68 999.00 -136.16 134.86 168.77 -117.92 -15.29 -62.76 61.02 -10.10 999.00 Favored ALA ASP PHE GLY"
"CDK6_HUMAN t_1BI8A.pdb NA NA 0 Apo 2.80 -147.23 -176.69 999.00 -161.03 88.15 -164.84 -92.40 -13.53 -44.43 62.30 29.39 999.00 Allowed ALA ASP PHE GLY"
"CDK6_HUMAN t_1BI8C.pdb NA NA 0 Apo 2.80 -147.23 -176.71 999.00 -161.03 88.18 -164.85 -92.45 -13.51 -44.41 62.32 29.39 999.00 Allowed ALA ASP PHE GLY"
"CDK6_HUMAN t_1BLXA.pdb CMGC DFGup 3 Apo 1.90 -139.23 165.84 999.00 68.87 48.12 -69.45 -131.53 168.22 58.35 101.76 -5.41 999.00 Allowed ALA ASP PHE GLY"
"CDK6_HUMAN t_1G3NA.pdb CMGC DFGout 6 Apo 2.90 -115.49 -176.10 999.00 -168.59 74.02 -174.86 -75.98 -16.59 -52.84 72.32 14.16 999.00 Allowed ALA ASP PHE GLY"
"CDK6_HUMAN t_1G3NE.pdb CMGC DFGout 6 Apo 2.90 -121.75 -170.63 999.00 -172.42 69.15 -175.39 -70.10 -21.26 -51.08 77.13 17.52 999.00 Outlier ALA ASP PHE GLY"
"CDK6_HUMAN t_1JOWB.pdb CMGC Active 1 Apo 3.10 -143.13 -174.83 999.00 45.60 74.38 -174.86 -84.55 6.74 -87.59 -67.41 30.86 999.00 Allowed ALA ASP PHE GLY"
"CDK6_HUMAN t_1XO2B.pdb CMGC Active 1 FSE 2.90 -132.98 172.04 999.00 59.12 74.80 -158.22 -88.87 20.52 -76.71 -44.21 -35.24 999.00 Allowed ALA ASP PHE GLY"
"CDK6_HUMAN t_2EUFB.pdb CMGC Active 1 LQQ 3.00 -125.95 -175.21 999.00 38.76 92.31 -169.07 -97.79 21.94 -81.62 -77.60 -1.17 999.00 Outlier ALA ASP PHE GLY"
"CDK6_HUMAN t_2F2CB.pdb CMGC Active 1 AP9 2.80 -127.20 -179.22 999.00 48.56 92.40 -160.04 -107.14 18.46 -84.52 -71.79 1.29 999.00 Outlier ALA ASP PHE GLY"
"CDK6_HUMAN t_3NUPA.pdb CMGC DFGup 3 3NU 2.60 -142.85 177.11 999.00 54.91 45.63 -149.52 -131.60 163.80 59.76 87.60 3.95 999.00 Favored ALA ASP PHE GLY"
"CDK6_HUMAN t_3NUXA.pdb CMGC DFGup 3 3NV 2.70 -143.88 171.58 999.00 63.33 54.65 -147.83 -144.79 172.64 57.85 76.27 2.62 999.00 Allowed ALA ASP PHE GLY"
"CDK6_HUMAN t_4AUAA.pdb CMGC DFGup 3 4AU 2.31 -130.02 167.97 999.00 69.28 42.28 -130.52 -121.26 161.37 53.53 72.85 23.33 999.00 Allowed ALA ASP PHE GLY"
"CDK6_HUMAN t_4EZ5A.pdb CMGC DFGup 3 0RS 2.70 -119.93 171.33 999.00 64.53 58.03 -172.42 -141.65 162.82 58.38 70.15 17.97 999.00 Allowed ALA ASP PHE GLY"
"CDK6_HUMAN t_4TTHB.pdb CMGC Active 1 24V 2.90 -136.82 177.53 999.00 52.51 95.63 -168.74 -109.59 39.75 -73.87 -71.72 -40.82 999.00 Outlier ALA ASP PHE GLY"
"CDK6_HUMAN t_5L2IA.pdb CMGC DFGup 3 LQQ 2.75 -139.27 -177.10 999.00 58.32 50.78 -136.85 -135.50 155.73 57.96 79.25 67.15 999.00 Favored ALA ASP PHE GLY"
"CDK6_HUMAN t_5L2SA.pdb CMGC DFGup 3 6ZV 2.27 -129.65 174.39 999.00 56.44 62.39 -174.07 -144.41 164.86 59.60 77.07 4.33 999.00 Favored ALA ASP PHE GLY"
"CDK6_HUMAN t_5L2TA.pdb CMGC DFGup 3 6ZZ 2.37 -139.15 167.75 999.00 59.21 51.92 -146.09 -133.28 167.22 60.52 69.38 20.86 999.00 Favored ALA ASP PHE GLY"
"CDK7_HUMAN t_1UA2A.pdb CMGC DFGup 3 ATP 3.02 -72.37 176.58 999.00 -63.29 129.91 44.02 -58.49 61.34 34.14 62.97 -115.19 999.00 Favored ALA ASP PHE GLY"
"CDK7_HUMAN t_1UA2B.pdb CMGC DFGup 3 ATP 3.02 -83.43 -165.13 999.00 -43.28 135.34 -63.33 -79.42 27.11 49.44 128.29 -117.54 999.00 Favored ALA ASP PHE GLY"
"CDK7_HUMAN t_1UA2C.pdb CMGC DFGup 3 ATP 3.02 -69.50 164.88 999.00 -53.45 113.87 37.51 -55.11 81.40 35.59 38.09 -90.07 999.00 Allowed ALA ASP PHE GLY"
"CDK7_HUMAN t_1UA2D.pdb CMGC DFGup 3 ATP 3.02 -66.14 178.52 999.00 -65.97 128.58 52.64 -62.83 66.15 38.48 63.20 -97.85 999.00 Favored ALA ASP PHE GLY"
"CDK8_HUMAN t_3RGFA.pdb CMGC DFGout 6 BAX 2.20 -128.74 167.91 999.00 -135.84 84.16 -166.95 -83.26 -7.22 -55.27 -121.06 44.28 999.00 NA ALA ASP MET GLY"
"CDK8_HUMAN t_4CRLA.pdb CMGC DFGin-inactive 2 C1I 2.40 -130.83 167.17 999.00 41.24 61.39 -157.44 -57.61 143.26 -74.83 -56.10 77.42 999.00 NA ALA ASP MET GLY"
"CDK8_HUMAN t_4F6SA.pdb CMGC DFGout 6 0SQ 2.60 -143.37 174.28 999.00 -133.59 95.56 -166.03 -89.37 -12.53 -62.02 85.96 -154.08 999.00 NA ALA ASP MET GLY"
"CDK8_HUMAN t_4F6UA.pdb CMGC DFGout 6 0SR 2.10 -137.08 173.37 999.00 -132.49 97.98 -170.43 -82.12 -23.17 -56.89 89.54 -145.63 999.00 NA ALA ASP MET GLY"
"CDK8_HUMAN t_4F6WA.pdb CMGC DFGout 6 0SS 2.39 -133.98 175.80 999.00 -150.06 134.54 -167.25 -80.55 -17.77 -57.66 89.69 32.24 999.00 NA ALA ASP MET GLY"
"CDK8_HUMAN t_4F7JA.pdb CMGC DFGout 6 0SU 2.60 -131.60 -173.44 999.00 -148.12 95.29 -167.49 -72.39 -38.81 -48.11 104.34 -133.94 999.00 NA ALA ASP MET GLY"
"CDK8_HUMAN t_4F7LA.pdb CMGC DFGout 6 0SO 2.90 -144.45 166.89 999.00 -130.43 125.02 -165.08 -101.11 -66.91 -45.82 175.00 999.00 999.00 NA ALA ASP MET GLY"
"CDK8_HUMAN t_4F7NA.pdb CMGC DFGout 6 0SV 2.65 -139.79 176.55 999.00 -136.02 97.70 -172.30 -86.49 -26.07 -53.81 100.14 -136.94 999.00 NA ALA ASP MET GLY"
"CDK8_HUMAN t_4F7SA.pdb CMGC DFGin-inactive 2 0SW 2.20 -136.60 176.12 999.00 53.33 42.32 -70.50 -54.93 135.93 -79.80 -77.20 78.57 999.00 NA ALA ASP MET GLY"
"CDK8_HUMAN t_4G6LA.pdb CMGC DFGin-inactive 2 Apo 2.70 -140.31 170.43 999.00 60.11 39.69 -79.55 -64.96 139.82 -72.87 -72.68 84.65 999.00 NA ALA ASP MET GLY"
"CDK8_HUMAN t_5BNJA.pdb CMGC DFGin-inactive 2 4TV 2.64 -127.26 163.20 999.00 60.48 55.01 -167.81 -65.81 148.46 -69.12 -70.37 93.43 999.00 NA ALA ASP MET GLY"
"CDK8_HUMAN t_5CEIA.pdb CMGC DFGin-inactive 2 50R 2.24 -132.67 174.94 999.00 55.80 44.66 -160.10 -56.17 137.56 -79.83 -76.99 72.72 999.00 NA ALA ASP MET GLY"
"CDK8_HUMAN t_5FGKA.pdb CMGC DFGin-inactive 2 5XG 2.36 -133.52 169.35 999.00 57.51 42.29 -155.57 -55.85 144.79 -64.78 -70.32 91.63 999.00 NA ALA ASP MET GLY"
"CDK8_HUMAN t_5HBEA.pdb CMGC DFGin-inactive 2 5Y6 2.38 -150.55 174.89 999.00 54.90 46.97 -175.80 -64.37 138.78 -77.63 -73.72 83.11 999.00 NA ALA ASP MET GLY"
"CDK8_HUMAN t_5HBHA.pdb CMGC DFGup 3 5Y7 2.50 -129.12 169.88 999.00 65.08 34.75 -54.43 -89.34 139.56 54.20 88.56 16.74 999.00 NA ALA ASP MET GLY"
"CDK8_HUMAN t_5HBJA.pdb CMGC DFGin-inactive 2 5Y8 3.00 -106.89 176.96 999.00 71.10 89.27 -161.58 -114.94 61.85 -54.60 -100.82 -170.12 999.00 NA ALA ASP MET GLY"
"CDK8_HUMAN t_5HNBA.pdb CMGC DFGin-inactive 2 62M 2.35 -138.76 167.17 999.00 57.22 44.80 -157.04 -53.09 139.96 -75.62 -77.04 80.75 999.00 NA ALA ASP MET GLY"
"CDK8_HUMAN t_5HVYA.pdb CMGC DFGout 6 66X 2.39 -147.79 175.04 999.00 -130.66 103.78 -170.09 -80.13 9.78 -54.15 84.10 29.57 999.00 NA ALA ASP MET GLY"
"CDK8_HUMAN t_5I5ZA.pdb CMGC DFGin-inactive 2 68U 2.60 -146.16 175.24 999.00 51.06 37.28 -151.29 -51.45 128.03 -78.49 -69.47 65.95 999.00 NA ALA ASP MET GLY"
"CDK8_HUMAN t_5ICPA.pdb CMGC DFGin-inactive 2 69Z 2.18 -129.41 179.15 999.00 50.41 56.76 -161.81 -66.41 4.75 -103.78 56.94 53.42 999.00 NA ALA ASP MET GLY"
"CDK8_HUMAN t_5IDNA.pdb CMGC DFGin-inactive 2 6A7 2.26 -124.43 173.97 999.00 67.54 75.48 -158.88 -91.56 22.01 -65.47 -96.75 0.58 999.00 NA ALA ASP MET GLY"
"CDK8_HUMAN t_5IDPA.pdb CMGC DFGin-inactive 2 6A6 2.65 -136.21 172.09 999.00 59.16 45.23 -165.97 -61.58 132.53 -78.80 -74.91 80.05 999.00 NA ALA ASP MET GLY"
"CDK9_HUMAN t_3BLHA.pdb CMGC Active 1 Apo 2.48 -129.90 170.99 999.00 63.00 77.21 -73.64 -97.76 18.46 -75.05 -67.66 -17.07 999.00 Allowed ALA ASP PHE GLY"
"CDK9_HUMAN t_3BLQA.pdb CMGC Active 1 ATP 2.90 -137.29 167.71 999.00 61.76 82.78 -165.71 -101.60 27.57 -67.92 -68.37 -20.41 999.00 Allowed ALA ASP PHE GLY"
"CDK9_HUMAN t_3BLRA.pdb CMGC Active 1 CPB 2.80 -137.85 169.57 999.00 65.07 86.94 -156.51 -102.47 22.11 -77.29 -59.38 -27.75 999.00 Allowed ALA ASP PHE GLY"
"CDK9_HUMAN t_3LQ5A.pdb CMGC Active 1 SLQ 3.00 -142.27 175.92 999.00 56.61 82.09 -155.63 -95.25 28.79 -73.34 -69.94 -28.84 999.00 Allowed ALA ASP PHE GLY"
"CDK9_HUMAN t_3MI9A.pdb CMGC Active 1 Apo 2.10 -131.48 176.03 999.00 56.35 81.20 -173.77 -96.49 22.88 -76.75 -61.84 -15.19 999.00 Allowed ALA ASP PHE GLY"
"CDK9_HUMAN t_3MIAA.pdb CMGC Active 1 ANP 3.00 -137.76 176.36 999.00 64.55 75.02 -164.50 -96.60 26.51 -75.30 -67.21 -14.59 999.00 Allowed ALA ASP PHE GLY"
"CDK9_HUMAN t_3MY1A.pdb CMGC Active 1 RFZ 2.80 -138.56 -178.78 999.00 55.82 82.30 -162.64 -96.61 26.15 -73.83 -64.95 -23.04 999.00 Allowed ALA ASP PHE GLY"
"CDK9_HUMAN t_3TN8A.pdb CMGC Active 1 F18 2.95 -143.86 178.45 999.00 57.47 79.94 -154.82 -96.04 37.07 -76.82 -66.12 -47.36 999.00 Allowed ALA ASP PHE GLY"
"CDK9_HUMAN t_3TNHA.pdb CMGC Active 1 F18 3.20 -133.48 172.31 999.00 64.79 76.91 -158.87 -97.42 20.04 -76.91 -68.16 -17.75 999.00 Allowed ALA ASP PHE GLY"
"CDK9_HUMAN t_3TNIA.pdb CMGC Active 1 Apo 3.23 -129.68 172.07 999.00 64.94 76.48 -74.80 -99.15 16.88 -73.63 -68.16 -14.55 999.00 Allowed ALA ASP PHE GLY"
"CDK9_HUMAN t_4BCFA.pdb CMGC Active 1 T6Q 3.01 -130.81 175.90 999.00 58.20 78.23 -159.97 -93.92 21.00 -76.02 -69.06 -18.88 999.00 Allowed ALA ASP PHE GLY"
"CDK9_HUMAN t_4BCGA.pdb CMGC Active 1 T3C 3.08 -132.47 173.94 999.00 58.31 78.21 -148.93 -93.24 24.06 -75.75 -68.96 -23.32 999.00 Allowed ALA ASP PHE GLY"
"CDK9_HUMAN t_4BCHA.pdb CMGC Active 1 T7Z 2.96 -131.52 173.15 999.00 62.53 79.10 -158.03 -97.34 18.98 -75.33 -65.43 -18.17 999.00 Allowed ALA ASP PHE GLY"
"CDK9_HUMAN t_4BCIA.pdb CMGC Active 1 T3E 3.10 -131.09 172.89 999.00 63.14 77.84 -148.08 -97.76 24.26 -76.13 -66.91 -23.57 999.00 Allowed ALA ASP PHE GLY"
"CDK9_HUMAN t_4BCJA.pdb CMGC Active 1 T9N 3.16 -130.96 170.90 999.00 63.36 81.22 -160.19 -96.55 22.00 -72.62 -57.10 -37.12 999.00 Allowed ALA ASP PHE GLY"
"CDK9_HUMAN t_4EC8A.pdb CMGC Active 1 Apo 3.60 -136.33 174.49 999.00 61.53 81.69 -166.26 -97.50 24.14 -77.68 -54.61 -38.89 999.00 Allowed ALA ASP PHE GLY"
"CDK9_HUMAN t_4EC9A.pdb CMGC Active 1 Apo 3.21 -130.24 170.99 999.00 63.85 78.14 -164.48 -96.62 19.17 -74.97 -67.02 -16.07 999.00 Allowed ALA ASP PHE GLY"
"CDK9_HUMAN t_4IMYA.pdb CMGC Active 1 AMP 2.94 -140.18 178.00 999.00 57.37 78.19 -148.32 -96.62 19.80 -74.71 -68.90 -9.48 999.00 Allowed ALA ASP PHE GLY"
"CDK9_HUMAN t_4IMYC.pdb CMGC Active 1 AMP 2.94 -140.64 175.81 999.00 60.48 77.81 -148.99 -97.07 19.03 -75.38 -69.03 -8.49 999.00 Allowed ALA ASP PHE GLY"
"CDK9_HUMAN t_4IMYE.pdb CMGC Active 1 AMP 2.94 -141.39 175.75 999.00 59.71 77.95 -148.92 -96.69 19.67 -75.56 -69.66 -8.23 999.00 Allowed ALA ASP PHE GLY"
"CDK9_HUMAN t_4OGRA.pdb CMGC Active 1 ADN 3.00 -145.47 171.69 999.00 59.06 73.11 -164.81 -88.04 19.05 -77.80 -59.02 -25.79 999.00 Allowed ALA ASP PHE GLY"
"CDK9_HUMAN t_4OGRE.pdb CMGC Active 1 ADN 3.00 -145.92 172.34 999.00 59.39 72.17 -165.14 -89.87 19.30 -76.34 -58.93 -26.19 999.00 Allowed ALA ASP PHE GLY"
"CDK9_HUMAN t_4OGRI.pdb CMGC Active 1 ADN 3.00 -146.30 171.35 999.00 58.65 73.80 -165.12 -88.04 20.35 -76.62 -58.20 -25.18 999.00 Allowed ALA ASP PHE GLY"
"CDK9_HUMAN t_4OR5A.pdb CMGC Active 1 Apo 2.90 -124.33 168.54 999.00 68.97 76.10 -177.12 -97.34 28.70 -70.97 -68.50 -16.52 999.00 Allowed ALA ASP PHE GLY"
"CDK9_HUMAN t_4OR5F.pdb CMGC Active 1 Apo 2.90 -111.52 -176.73 999.00 51.06 89.51 -168.49 -102.81 24.74 -78.42 -49.33 -45.99 999.00 Outlier ALA ASP PHE GLY"
"CDK9_HUMAN t_5L1ZA.pdb CMGC Active 1 Apo 5.90 -125.74 -179.91 999.00 59.32 75.74 -175.82 -100.13 28.30 -72.17 -57.14 -57.01 999.00 Allowed ALA ASP PHE GLY"
"CDKL1_HUMAN t_4AGUA.pdb CMGC Active 1 D15 2.40 -125.38 -173.17 80.02 61.01 84.32 -172.21 -106.82 0.33 -85.82 -54.99 -33.88 999.00 Allowed CYS ASP PHE GLY"
"CDKL1_HUMAN t_4AGUB.pdb CMGC Active 1 D15 2.40 -123.19 -174.56 85.05 61.59 77.13 -153.63 -99.81 8.35 -81.98 -62.16 -31.07 999.00 Allowed CYS ASP PHE GLY"
"CDKL1_HUMAN t_4AGUC.pdb CMGC Active 1 D15 2.40 -126.23 -170.21 76.78 57.12 81.00 -174.30 -105.63 6.64 -78.47 -54.98 -37.12 999.00 Allowed CYS ASP PHE GLY"
"CDKL2_HUMAN t_4AAAA.pdb CMGC DFGin-inactive 2 DKI 1.53 -155.51 174.55 73.17 62.27 44.27 -159.44 -57.57 144.88 -77.21 -67.54 25.05 999.00 Favored CYS ASP PHE GLY"
"CDKL2_HUMAN t_4BBMA.pdb CMGC DFGup 3 TC0 2.00 -116.66 173.29 63.40 70.77 69.64 -154.42 -144.19 74.02 44.19 132.15 -46.53 999.00 Allowed CYS ASP PHE GLY"
"CDKL2_HUMAN t_4BBMB.pdb CMGC DFGup 3 TC0 2.00 -116.98 172.46 62.42 71.25 70.15 -155.09 -140.98 65.75 46.44 130.06 -39.27 999.00 Allowed CYS ASP PHE GLY"
"CDKL3_HUMAN t_3ZDUA.pdb CMGC Active 1 38R 2.20 -143.70 178.45 67.68 75.18 92.44 -176.92 -117.63 14.00 -47.37 -57.98 -32.14 999.00 Allowed CYS ASP PHE GLY"
"CDKL5_HUMAN t_4BGQA.pdb CMGC Active 1 38R 2.00 -146.49 -178.32 68.95 68.85 66.75 -164.36 -91.23 23.28 -78.00 -68.87 -22.56 999.00 Allowed CYS ASP PHE GLY"
"CHK1_HUMAN t_1IA8A.pdb CAMK Active 1 Apo 1.70 -124.22 154.42 174.08 68.86 97.00 -164.97 -102.09 26.71 -68.36 -65.06 -22.48 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_1NVQA.pdb CAMK Active 1 UCN 2.00 -125.90 163.90 179.10 66.02 91.74 -168.44 -101.23 28.12 -73.41 -68.01 -18.15 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_1NVRA.pdb CAMK Active 1 STU 1.80 -138.15 170.95 72.76 63.56 88.43 -165.31 -97.81 26.48 -75.68 -65.90 -21.38 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_1NVSA.pdb CAMK Active 1 UCM 1.80 -124.58 157.02 170.43 67.79 99.68 -159.20 -105.16 29.67 -69.10 -68.61 -19.97 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_1ZLTA.pdb CAMK Active 1 HYM 1.74 -126.34 168.90 81.67 65.13 92.19 -160.04 -102.78 29.37 -64.30 -65.40 -26.93 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_1ZYSA.pdb CAMK Active 1 199 1.70 -125.42 168.23 82.49 66.65 88.28 -167.25 -97.35 27.46 -67.62 -68.77 -18.74 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2AYPA.pdb CAMK Active 1 43A 2.90 -138.34 179.80 -177.05 49.33 90.61 -156.85 -98.26 15.50 -81.69 -54.35 -32.84 999.00 Outlier SER ASP PHE GLY"
"CHK1_HUMAN t_2BR1A.pdb CAMK Active 1 PFP 2.0 -130.60 159.93 76.67 73.94 93.38 -165.82 -102.23 21.96 -70.67 -62.45 -28.01 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2BRBA.pdb CAMK Active 1 PFQ 2.1 -124.88 167.17 76.92 62.18 91.61 -160.59 -103.59 28.55 -66.85 -71.37 -21.52 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2BRGA.pdb CAMK Active 1 DFY 2.1 -136.09 139.90 131.15 86.06 98.79 -162.17 -105.49 16.17 -70.18 -62.74 -23.98 999.00 Outlier SER ASP PHE GLY"
"CHK1_HUMAN t_2BRHA.pdb CAMK Active 1 DFW 2.1 -140.74 143.45 161.01 79.37 93.00 -162.09 -97.16 17.47 -71.13 -48.32 -29.97 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2BRMA.pdb CAMK Active 1 DFZ 2.2 -135.83 168.60 79.51 63.78 91.54 -164.88 -106.12 29.23 -64.85 -76.04 -17.35 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2BRNA.pdb CAMK Active 1 DF1 2.8 -116.29 147.53 -169.06 75.08 98.45 -145.88 -108.34 26.96 -66.79 -64.41 -36.91 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2BROA.pdb CAMK Active 1 DF2 2.2 -133.32 154.30 87.44 78.17 90.48 -165.07 -99.18 21.92 -63.75 -64.83 -25.64 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2C3JA.pdb CAMK Active 1 DBQ 2.1 -126.70 163.67 86.89 80.29 87.49 -166.00 -90.38 22.28 -65.20 -58.11 -33.48 999.00 Outlier SER ASP PHE GLY"
"CHK1_HUMAN t_2C3KA.pdb CAMK Active 1 ABO 2.6 -126.15 172.54 91.99 61.75 89.86 -165.87 -99.38 20.94 -69.09 -65.92 -17.14 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2C3LA.pdb CAMK Active 1 IDZ 2.35 -131.43 151.14 158.34 78.40 98.05 -173.77 -102.88 15.26 -65.67 -49.23 -41.05 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2CGUA.pdb CAMK Active 1 3A3 2.5 -124.69 156.67 156.81 64.51 90.01 -175.67 -96.85 19.35 -67.53 -51.68 -28.98 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2CGVA.pdb CAMK Active 1 3B3 2.6 -129.70 147.95 146.84 68.98 97.33 -169.85 -101.61 19.79 -71.23 -56.35 -31.13 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2CGWA.pdb CAMK Active 1 3C3 2.2 -126.26 150.56 178.37 70.29 91.51 -165.94 -95.70 25.64 -68.46 -65.62 -26.93 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2CGXA.pdb CAMK Active 1 3D3 2.2 -125.86 152.32 174.66 68.91 92.27 -169.58 -96.49 22.26 -64.23 -68.32 -25.81 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2E9NA.pdb CAMK Active 1 76A 2.50 -144.94 155.52 96.26 84.20 89.90 -161.84 -105.95 27.12 -62.75 -68.26 -13.16 999.00 Outlier SER ASP PHE GLY"
"CHK1_HUMAN t_2E9OA.pdb CAMK Active 1 A58 2.10 -128.26 168.42 76.91 64.15 94.24 -168.42 -103.48 34.07 -68.06 -71.64 -19.24 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2E9PA.pdb CAMK Active 1 77A 2.60 -133.17 178.71 69.68 63.55 82.94 -61.50 -105.74 27.46 -65.87 -69.79 -10.83 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2E9UA.pdb CAMK Active 1 A25 2.00 -132.00 172.64 79.44 62.83 89.43 -156.93 -101.15 30.49 -66.91 -73.01 -16.53 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2E9VA.pdb CAMK Active 1 85A 2.00 -131.53 177.80 82.67 55.34 98.02 -157.82 -109.59 30.42 -73.36 -62.63 -29.30 999.00 Outlier SER ASP PHE GLY"
"CHK1_HUMAN t_2E9VB.pdb CAMK Active 1 85A 2.00 -126.12 170.02 85.85 63.05 96.27 -158.41 -109.61 31.48 -61.03 -66.54 -19.85 999.00 Outlier SER ASP PHE GLY"
"CHK1_HUMAN t_2GDOA.pdb CAMK Active 1 12C 3.00 -127.88 159.12 74.54 71.34 115.50 -150.22 -130.00 14.01 -71.11 -55.90 -6.96 999.00 Outlier SER ASP PHE GLY"
"CHK1_HUMAN t_2GHGA.pdb CAMK Active 1 A53 3.50 -166.37 170.50 -174.41 70.20 71.90 -179.36 -86.99 41.41 -70.15 -75.11 -46.94 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2HOGA.pdb CAMK Active 1 710 1.90 -132.18 167.77 88.91 69.23 94.59 -166.21 -104.89 28.23 -68.31 -68.31 -20.74 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2HXLA.pdb CAMK Active 1 422 1.80 -130.73 166.73 81.79 70.39 92.58 -170.32 -103.84 30.09 -69.17 -70.98 -25.15 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2HXQA.pdb CAMK Active 1 373 2.00 -131.65 172.13 77.69 66.94 93.01 -168.61 -104.25 25.88 -70.58 -64.82 -25.51 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2HY0A.pdb CAMK Active 1 306 1.70 -129.72 171.10 74.94 67.17 87.52 -168.87 -100.91 29.62 -69.53 -69.53 -24.65 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2QHMA.pdb CAMK Active 1 7CS 2.00 -128.04 164.40 82.90 76.85 101.71 -160.00 -108.81 21.45 -67.26 -63.17 -31.57 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2QHNA.pdb CAMK Active 1 582 1.70 -126.53 161.84 -155.39 70.25 93.41 -167.40 -99.91 25.97 -67.93 -63.71 -34.98 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2R0UA.pdb CAMK Active 1 M54 1.90 -130.98 175.02 76.38 63.41 83.32 -161.34 -98.83 22.18 -71.34 -65.61 -26.84 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2WMQA.pdb CAMK Active 1 ZYQ 2.48 -129.06 145.72 152.46 85.99 84.91 -160.88 -97.25 15.64 -65.11 -58.60 -22.51 999.00 Outlier SER ASP PHE GLY"
"CHK1_HUMAN t_2WMRA.pdb CAMK Active 1 ZYR 2.43 -123.69 155.66 168.94 63.00 103.08 -162.52 -105.99 13.13 -67.21 -58.18 -20.21 999.00 Outlier SER ASP PHE GLY"
"CHK1_HUMAN t_2WMSA.pdb CAMK Active 1 ZYS 2.70 -120.54 146.48 178.03 79.21 90.90 -169.36 -98.32 31.24 -61.95 -65.08 -38.43 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2WMTA.pdb CAMK Active 1 ZYT 2.55 -125.64 146.22 152.27 75.41 98.62 -168.12 -104.02 17.99 -62.75 -49.27 -35.21 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2WMUA.pdb CAMK Active 1 ZYU 2.60 -124.55 149.67 159.56 73.50 98.19 -161.72 -107.21 22.27 -68.62 -63.37 -31.66 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2WMVA.pdb CAMK Active 1 ZYV 2.01 -124.98 150.64 160.43 73.23 97.32 -167.04 -104.82 26.93 -67.65 -64.23 -27.29 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2WMWA.pdb CAMK Active 1 ZYW 2.43 -138.43 150.76 135.53 76.40 89.41 -172.35 -98.02 21.60 -68.69 -55.01 -32.91 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2WMXA.pdb CAMK Active 1 ZY6 2.45 -138.38 150.77 135.53 76.32 89.39 -172.37 -97.90 21.54 -68.68 -54.95 -32.94 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2X8DA.pdb CAMK Active 1 X8D 1.90 -125.27 145.96 171.27 75.17 98.21 -162.89 -103.11 27.22 -69.48 -65.82 -25.94 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2X8EA.pdb CAMK Active 1 X8E 2.50 -124.03 146.38 -178.31 71.68 110.70 -154.79 -118.51 20.60 -65.92 -77.34 -5.50 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2X8IA.pdb CAMK Active 1 X8I 1.92 -129.99 149.82 166.06 73.33 96.29 -164.48 -103.41 27.66 -67.12 -65.78 -24.81 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2XEYA.pdb CAMK Active 1 YVQ 2.70 -120.49 134.89 151.41 92.89 102.46 -159.08 -108.31 19.49 -65.53 -58.64 -37.35 999.00 Outlier SER ASP PHE GLY"
"CHK1_HUMAN t_2XEZA.pdb CAMK Active 1 XEZ 2.25 -133.57 142.65 152.63 88.27 99.30 -168.51 -106.34 26.05 -69.08 -64.64 -27.18 999.00 Outlier SER ASP PHE GLY"
"CHK1_HUMAN t_2XF0A.pdb CAMK Active 1 4UB 2.40 -127.78 149.35 158.33 66.69 102.13 -160.94 -107.04 28.38 -66.70 -65.25 -24.57 999.00 Outlier SER ASP PHE GLY"
"CHK1_HUMAN t_2YDIA.pdb CAMK Active 1 YDI 1.60 -126.32 150.33 176.53 77.24 97.63 -168.72 -103.08 23.88 -71.37 -67.87 -26.54 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2YDJA.pdb CAMK Active 1 YDJ 1.85 -131.16 158.84 -176.26 66.65 79.12 -66.38 -91.38 22.16 -72.68 -65.86 -18.20 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2YDJB.pdb CAMK Active 1 CSS 1.85 -129.00 157.39 -168.39 65.71 84.34 -57.70 -94.20 20.45 -67.21 -58.01 -21.81 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2YDKA.pdb CAMK Active 1 YDK 1.90 -134.72 157.11 178.89 71.93 82.48 -70.53 -98.24 25.24 -71.00 -65.44 -21.36 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2YERA.pdb CAMK Active 1 TQ1 1.83 -124.55 145.70 174.06 75.35 98.68 -159.28 -104.17 25.73 -66.14 -62.82 -29.95 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2YEXA.pdb CAMK Active 1 YEX 1.30 -127.31 145.60 176.87 77.96 95.70 -159.50 -100.44 22.36 -69.18 -60.43 -34.48 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2YM3A.pdb CAMK Active 1 YM3 2.01 -124.54 145.78 175.46 77.79 96.17 -161.18 -105.99 30.01 -69.41 -72.12 -22.97 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2YM4A.pdb CAMK Active 1 4YM 2.35 -122.12 155.75 174.56 68.28 93.17 -166.84 -103.18 30.95 -70.46 -72.82 -19.76 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2YM5A.pdb CAMK Active 1 YM5 2.03 -123.61 147.21 -176.52 77.26 102.26 -169.60 -108.75 31.58 -69.57 -71.99 -24.75 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2YM6A.pdb CAMK Active 1 YM6 2.01 -125.84 165.30 72.67 71.74 92.09 -164.78 -105.44 25.75 -70.53 -68.26 -25.54 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2YM7A.pdb CAMK Active 1 YM7 1.81 -121.61 152.15 171.11 74.94 94.18 -164.99 -102.24 23.69 -72.92 -64.11 -27.27 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2YM8A.pdb CAMK Active 1 YM8 2.07 -119.82 160.75 176.64 69.43 92.64 -144.84 -106.22 26.82 -71.53 -68.05 -21.80 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_2YWPA.pdb CAMK Active 1 A42 2.90 -128.32 170.14 90.77 65.69 87.91 -167.18 -101.06 37.83 -66.03 -68.72 -18.37 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_3F9NA.pdb CAMK Active 1 38M 1.90 -120.25 153.84 169.06 73.20 93.53 -166.46 -100.47 25.65 -66.65 -66.46 -28.23 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_3JVRA.pdb CAMK Active 1 AGX 1.76 -127.98 150.65 177.51 73.28 94.81 -168.33 -103.57 30.05 -70.57 -69.17 -19.02 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_3JVSA.pdb CAMK Active 1 AGY 1.90 -125.12 149.23 176.58 74.49 96.17 -166.83 -103.33 29.37 -71.24 -69.18 -18.12 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_3NLBA.pdb CAMK Active 1 5BE 1.90 -124.59 157.33 -168.39 77.07 93.95 -161.50 -101.53 21.91 -65.08 -62.87 -34.66 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_3OT3A.pdb CAMK Active 1 22K 1.44 -119.36 162.39 80.45 68.21 101.87 -149.13 -107.33 22.13 -70.48 -65.92 -24.40 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_3OT8A.pdb CAMK Active 1 MI5 1.65 -120.25 163.64 79.80 66.25 100.85 -149.31 -107.89 26.52 -70.78 -67.82 -28.17 999.00 Outlier SER ASP PHE GLY"
"CHK1_HUMAN t_3PA3A.pdb CAMK Active 1 C70 1.40 -134.58 168.84 179.46 69.42 75.51 -68.06 -91.87 20.19 -70.03 -62.83 -19.42 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_3PA4A.pdb CAMK Active 1 C72 1.59 -132.21 169.13 175.67 65.64 76.29 -65.14 -92.08 21.90 -73.29 -63.10 -19.99 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_3PA5A.pdb CAMK Active 1 C73 1.70 -129.82 167.69 176.89 66.07 79.05 -65.53 -93.59 22.86 -70.58 -63.60 -21.04 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_3TKHA.pdb CAMK Active 1 07S 1.79 -125.49 167.62 78.96 65.12 90.50 -168.33 -95.71 21.09 -69.16 -61.03 -34.31 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_3TKIA.pdb CAMK Active 1 S25 1.60 -128.16 167.79 79.54 66.82 92.12 -169.15 -100.36 25.10 -69.97 -65.03 -26.23 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_3U9NA.pdb CAMK Active 1 09H 1.85 -129.35 168.32 79.32 66.99 89.36 -164.84 -103.15 30.53 -69.42 -69.94 -19.86 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_4FSMA.pdb CAMK Active 1 HK1 2.30 -131.54 171.53 79.21 65.41 98.30 -166.67 -106.32 22.63 -70.75 -66.84 -29.04 999.00 Outlier SER ASP PHE GLY"
"CHK1_HUMAN t_4FSNA.pdb CAMK Active 1 A58 2.10 -128.67 164.83 84.34 70.47 97.59 -169.12 -103.17 24.50 -73.90 -65.55 -27.81 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_4FSQA.pdb CAMK Active 1 HK3 2.40 -129.63 171.10 93.00 67.76 85.32 -156.11 -96.76 25.76 -71.97 -67.54 -27.86 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_4FSRA.pdb CAMK Active 1 HKC 2.50 -126.59 165.59 73.91 71.12 98.30 -149.10 -108.12 23.63 -67.34 -61.13 -36.30 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_4FSTA.pdb CAMK Active 1 HK4 1.90 -122.69 175.36 -165.20 54.96 88.85 -162.70 -99.33 24.56 -78.46 -64.91 -24.08 999.00 Outlier SER ASP PHE GLY"
"CHK1_HUMAN t_4FSUA.pdb CAMK Active 1 HK5 2.10 -128.48 162.00 -170.25 66.01 99.19 -159.78 -104.80 24.06 -71.39 -67.18 -26.86 999.00 Outlier SER ASP PHE GLY"
"CHK1_HUMAN t_4FSWA.pdb CAMK Active 1 HK6 2.30 -119.61 151.70 -179.48 67.72 103.94 -171.11 -105.97 25.96 -72.25 -67.68 -25.90 999.00 Outlier SER ASP PHE GLY"
"CHK1_HUMAN t_4FSYA.pdb CAMK Active 1 HK7 2.30 -133.88 170.89 79.31 64.38 92.38 -161.20 -102.37 28.41 -70.19 -65.49 -30.67 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_4FSZA.pdb CAMK Active 1 HK8 2.30 -119.86 153.41 175.38 66.31 106.26 -167.42 -107.65 26.47 -71.86 -66.46 -34.53 999.00 Outlier SER ASP PHE GLY"
"CHK1_HUMAN t_4FT0A.pdb CAMK Active 1 HK9 2.30 -121.33 156.18 171.29 66.47 99.57 -173.08 -103.82 23.38 -73.24 -67.75 -22.20 999.00 Outlier SER ASP PHE GLY"
"CHK1_HUMAN t_4FT3A.pdb CAMK Active 1 H1K 2.50 -125.79 166.70 74.00 67.63 100.01 -163.02 -109.20 27.97 -71.47 -68.33 -27.83 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_4FT5A.pdb CAMK Active 1 H2K 2.40 -127.20 165.84 81.31 68.81 94.50 -154.13 -104.17 26.57 -72.72 -67.41 -28.04 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_4FT7A.pdb CAMK Active 1 H3K 2.20 -123.21 155.00 169.17 65.61 104.64 -166.36 -106.95 24.95 -72.28 -63.47 -27.30 999.00 Outlier SER ASP PHE GLY"
"CHK1_HUMAN t_4FT9A.pdb CAMK Active 1 H4K 2.20 -122.72 158.90 179.88 64.09 98.66 -159.63 -102.73 25.91 -72.51 -63.74 -29.14 999.00 Outlier SER ASP PHE GLY"
"CHK1_HUMAN t_4FTAA.pdb CAMK Active 1 H5K 2.40 -115.20 157.11 -164.64 65.10 98.77 -166.98 -104.22 26.51 -72.03 -67.13 -28.19 999.00 Outlier SER ASP PHE GLY"
"CHK1_HUMAN t_4FTCA.pdb CAMK Active 1 H6K 2.00 -122.00 159.17 176.97 66.03 97.51 -163.76 -103.06 25.47 -72.02 -63.11 -32.32 999.00 Outlier SER ASP PHE GLY"
"CHK1_HUMAN t_4FTIA.pdb CAMK Active 1 H7K 2.20 -131.10 164.51 -169.78 68.43 90.86 -163.56 -99.83 27.32 -71.86 -66.79 -26.10 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_4FTJA.pdb CAMK Active 1 H8K 2.20 -126.08 172.25 73.04 64.23 94.01 -162.44 -103.15 23.88 -71.76 -63.50 -29.55 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_4FTKA.pdb CAMK Active 1 H9K 2.30 -130.79 170.37 85.52 67.64 91.41 -162.54 -102.45 26.29 -73.89 -70.68 -27.55 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_4FTLA.pdb CAMK Active 1 H0K 2.50 -129.65 168.11 86.76 67.85 93.65 -157.26 -104.99 27.17 -71.62 -69.20 -30.76 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_4FTMA.pdb CAMK Active 1 1HK 1.90 -125.31 168.46 -178.95 60.96 91.66 -160.56 -99.83 22.80 -75.94 -66.66 -24.16 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_4FTNA.pdb CAMK Active 1 2HK 2.02 -131.62 165.47 -176.32 64.33 92.94 -160.60 -102.36 24.36 -72.94 -68.64 -25.41 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_4FTOA.pdb CAMK Active 1 3HK 2.10 -125.52 162.31 -170.65 64.03 101.46 -158.10 -105.86 25.92 -70.50 -68.64 -25.04 999.00 Outlier SER ASP PHE GLY"
"CHK1_HUMAN t_4FTQA.pdb CAMK Active 1 4HK 2.00 -121.32 155.84 174.05 67.14 99.24 -168.27 -103.89 23.76 -70.55 -64.69 -29.37 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_4FTRA.pdb CAMK Active 1 5HK 2.25 -123.22 153.47 177.53 70.57 95.81 -169.16 -100.72 25.80 -70.31 -70.60 -24.39 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_4FTTA.pdb CAMK Active 1 6HK 2.30 -122.84 153.43 178.10 68.30 105.16 -166.25 -108.22 23.39 -72.06 -66.27 -24.51 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_4FTUA.pdb CAMK Active 1 7HK 2.10 -122.00 154.39 -179.43 66.71 96.57 -167.78 -100.98 26.08 -70.81 -66.20 -27.45 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_4GH2A.pdb CAMK Active 1 HK0 2.03 -123.35 153.90 -179.65 68.96 96.45 -165.24 -100.36 23.53 -71.34 -64.90 -27.33 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_4HYHA.pdb CAMK Active 1 1AM 1.70 -128.96 166.75 85.83 69.32 88.19 -171.27 -100.12 24.76 -70.92 -68.30 -20.41 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_4HYIA.pdb CAMK Active 1 1AO 1.40 -133.47 170.28 73.95 67.22 89.01 -168.56 -100.49 26.66 -71.33 -69.02 -20.78 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_4JIKA.pdb CAMK Active 1 1KO 1.90 -132.97 171.31 166.33 63.80 79.50 -58.37 -94.29 22.25 -72.68 -62.31 -21.36 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_4QYEA.pdb CAMK Active 1 3DL 2.05 -124.82 156.66 81.81 77.93 93.43 -167.29 -103.12 23.37 -69.73 -63.75 -29.56 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_4QYFA.pdb CAMK Active 1 3DV 2.15 -128.75 158.92 86.19 75.13 93.30 -169.20 -103.20 30.91 -69.17 -72.63 -24.16 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_4QYGA.pdb CAMK Active 1 3DW 1.75 -130.18 167.64 79.17 66.54 85.87 -166.30 -96.51 24.92 -67.51 -66.92 -20.27 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_4QYGB.pdb CAMK Active 1 3DW 1.75 -131.26 167.93 76.57 67.63 84.41 -167.69 -94.08 25.65 -69.40 -68.11 -18.38 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_4QYHA.pdb CAMK Active 1 3DX 1.90 -127.65 167.12 80.25 70.22 81.90 -164.26 -93.77 22.66 -66.62 -68.81 -21.85 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_4QYHB.pdb CAMK Active 1 3DX 1.90 -124.38 169.50 74.99 67.42 85.49 -164.15 -93.94 24.77 -67.77 -64.14 -25.76 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_4RVKA.pdb CAMK Active 1 3XK 1.85 -129.82 164.16 85.03 71.36 92.61 -162.55 -106.19 24.97 -76.49 -69.93 -19.73 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_4RVLA.pdb CAMK Active 1 3XL 1.85 -127.93 163.19 82.16 71.71 92.57 -164.79 -100.95 24.54 -71.10 -66.00 -26.18 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_4RVMA.pdb CAMK Active 1 3X7 1.86 -123.07 161.90 84.41 72.47 87.28 -162.14 -98.85 25.69 -69.61 -65.56 -25.27 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_5DLSA.pdb CAMK Active 1 5CV 2.15 -127.91 160.58 78.83 79.73 85.12 -170.00 -96.72 25.65 -69.64 -70.28 -28.97 999.00 Allowed SER ASP PHE GLY"
"CHK1_HUMAN t_5F4NA.pdb CAMK Active 1 5UY 1.91 -125.00 154.84 73.53 63.43 104.19 -155.22 -106.92 19.22 -72.83 -57.15 -35.19 999.00 Outlier SER ASP PHE GLY"
"CHK2_HUMAN t_2CN5A.pdb CAMK Active 1 ADP 2.25 -135.22 179.20 63.82 64.18 79.30 -167.71 -102.06 20.81 -76.96 -58.54 -25.29 999.00 Allowed THR ASP PHE GLY"
"CHK2_HUMAN t_2CN8A.pdb CAMK Active 1 DBQ 2.7 -126.20 -176.95 51.59 68.58 82.32 174.66 -102.35 19.49 -67.00 -53.79 -39.02 999.00 Allowed THR ASP PHE GLY"
"CHK2_HUMAN t_2W0JA.pdb CAMK Active 1 ZAT 2.05 -128.15 -176.59 -164.68 62.16 84.77 -176.96 -102.93 25.22 -74.42 -69.17 -14.69 999.00 Allowed THR ASP PHE GLY"
"CHK2_HUMAN t_2W7XA.pdb CAMK Active 1 D1A 2.07 -130.00 -177.28 -167.11 60.90 85.94 -174.06 -97.90 22.56 -73.13 -60.10 -24.08 999.00 Allowed THR ASP PHE GLY"
"CHK2_HUMAN t_2WTCA.pdb CAMK Active 1 VGM 3.00 -142.94 177.77 -178.34 62.30 76.21 -163.51 -93.54 17.15 -73.64 -50.11 -44.16 999.00 Allowed THR ASP PHE GLY"
"CHK2_HUMAN t_2WTDA.pdb CAMK Active 1 ZZK 2.75 -134.41 170.05 -155.03 69.57 79.29 -168.58 -98.99 23.60 -69.13 -56.24 -43.34 999.00 Allowed THR ASP PHE GLY"
"CHK2_HUMAN t_2WTIA.pdb CAMK Active 1 WTI 2.50 -139.27 171.00 -162.75 71.54 81.36 -154.47 -101.15 19.00 -70.82 -57.41 -38.13 999.00 Allowed THR ASP PHE GLY"
"CHK2_HUMAN t_2WTJA.pdb CAMK Active 1 WTJ 2.10 -143.21 -175.72 -166.59 63.92 70.89 -59.19 -94.85 21.39 -72.87 -65.13 -27.59 999.00 Allowed THR ASP PHE GLY"
"CHK2_HUMAN t_2XBJA.pdb CAMK Active 1 XBJ 2.30 -129.32 -178.36 64.34 67.22 77.44 -172.11 -97.29 21.02 -71.70 -62.70 -27.52 999.00 Allowed THR ASP PHE GLY"
"CHK2_HUMAN t_2XK9A.pdb CAMK Active 1 XK9 2.35 -130.90 176.18 -170.44 68.12 85.55 -175.21 -101.65 24.39 -77.75 -65.20 -20.55 999.00 Allowed THR ASP PHE GLY"
"CHK2_HUMAN t_2XM8A.pdb CAMK Active 1 B4W 3.40 -125.48 -159.16 65.20 52.70 71.93 -160.58 -93.73 25.86 -70.53 -69.47 -21.51 999.00 Allowed THR ASP PHE GLY"
"CHK2_HUMAN t_2XM9A.pdb CAMK Active 1 LWH 2.50 -125.43 -173.91 66.48 60.85 67.08 -77.51 -91.80 18.30 -74.32 -56.16 -47.23 999.00 Allowed THR ASP PHE GLY"
"CHK2_HUMAN t_2YCFA.pdb CAMK Active 1 YCF 1.77 -133.12 179.07 -169.33 68.93 89.26 178.41 -105.05 26.49 -69.83 -66.00 -23.22 999.00 Allowed THR ASP PHE GLY"
"CHK2_HUMAN t_2YCQA.pdb CAMK Active 1 UPX 2.05 -132.77 -177.14 -167.20 59.31 84.40 -173.96 -98.25 22.30 -78.90 -59.42 -26.84 999.00 Allowed THR ASP PHE GLY"
"CHK2_HUMAN t_2YCRA.pdb CAMK Active 1 HCW 2.20 -133.63 179.41 -165.53 64.43 83.35 -174.99 -100.06 25.94 -75.52 -69.17 -20.43 999.00 Allowed THR ASP PHE GLY"
"CHK2_HUMAN t_2YCSA.pdb CAMK Active 1 NXP 2.35 -132.87 -179.10 -165.42 64.93 82.34 -179.02 -101.46 26.50 -77.36 -68.89 -18.88 999.00 Allowed THR ASP PHE GLY"
"CHK2_HUMAN t_2YIQA.pdb CAMK Active 1 YIQ 1.89 -133.87 177.97 -170.68 71.15 88.06 178.73 -103.59 29.24 -68.98 -70.83 -18.27 999.00 Allowed THR ASP PHE GLY"
"CHK2_HUMAN t_2YIRA.pdb CAMK Active 1 YIR 2.10 -130.95 -176.95 -163.68 59.85 86.27 -171.47 -99.59 21.86 -77.30 -65.20 -21.28 999.00 Allowed THR ASP PHE GLY"
"CHK2_HUMAN t_2YITA.pdb CAMK Active 1 YIT 2.20 -133.33 -177.93 -169.71 62.95 85.15 -173.25 -102.31 23.66 -80.14 -62.51 -22.98 999.00 Allowed THR ASP PHE GLY"
"CHK2_HUMAN t_3I6UA.pdb CAMK DFGup 3 Apo 3.00 -145.61 171.60 15.64 61.22 49.17 -49.12 -102.29 -43.94 37.44 -103.77 -9.34 999.00 Favored THR ASP PHE GLY"
"CHK2_HUMAN t_3I6WB.pdb CAMK DFGin-inactive 2 Apo 3.25 -132.30 -176.90 -13.84 65.13 94.22 -74.78 -111.53 28.47 -58.12 -75.69 -15.23 999.00 Allowed THR ASP PHE GLY"
"CHK2_HUMAN t_3I6WD.pdb CAMK DFGin-inactive 2 Apo 3.25 -130.41 -175.78 -14.62 63.87 78.99 -72.69 -93.91 27.11 -58.09 -74.68 -15.72 999.00 Allowed THR ASP PHE GLY"
"CHK2_HUMAN t_3I6WF.pdb CAMK DFGin-inactive 2 Apo 3.25 -131.44 -176.38 -14.93 64.84 90.78 -73.99 -109.13 26.02 -57.05 -74.00 -16.11 999.00 Allowed THR ASP PHE GLY"
"CHK2_HUMAN t_3I6WH.pdb CAMK DFGin-inactive 2 Apo 3.25 -131.52 -176.78 -14.78 64.99 88.12 -73.25 -104.67 27.11 -56.51 -74.84 -16.35 999.00 Allowed THR ASP PHE GLY"
"CHK2_HUMAN t_4A9RA.pdb CAMK Active 1 RU5 2.85 -147.19 -178.57 -178.69 61.64 81.42 -171.24 -102.77 28.86 -64.42 -69.82 -27.46 999.00 Allowed THR ASP PHE GLY"
"CHK2_HUMAN t_4A9SA.pdb CAMK Active 1 RU9 2.66 -146.50 173.61 -178.58 72.14 88.10 -155.61 -109.59 21.74 -69.48 -55.79 -40.78 999.00 Allowed THR ASP PHE GLY"
"CHK2_HUMAN t_4A9TA.pdb CAMK Active 1 A9T 2.70 -140.57 174.88 -178.35 73.59 81.74 -159.63 -103.29 21.83 -63.71 -59.11 -31.91 999.00 Allowed THR ASP PHE GLY"
"CHK2_HUMAN t_4A9UA.pdb CAMK Active 1 A9U 2.48 -142.37 175.18 -172.27 71.75 86.23 -160.07 -106.35 25.67 -63.61 -63.00 -27.25 999.00 Allowed THR ASP PHE GLY"
"CHK2_HUMAN t_4BDAA.pdb CAMK Active 1 VFB 2.60 -132.25 -173.97 -160.38 57.15 71.27 -75.19 -86.71 12.35 -72.51 -55.79 -30.52 999.00 Allowed THR ASP PHE GLY"
"CHK2_HUMAN t_4BDBA.pdb CAMK Active 1 ODO 2.50 -136.36 178.51 -160.71 66.58 72.78 -165.42 -88.78 15.76 -77.18 -59.06 -39.75 999.00 Allowed THR ASP PHE GLY"
"CHK2_HUMAN t_4BDCA.pdb CAMK Active 1 ODH 3.00 -121.89 179.30 -162.34 58.65 81.15 176.59 -99.04 25.33 -74.58 -60.08 -42.81 999.00 Allowed THR ASP PHE GLY"
"CHK2_HUMAN t_4BDDA.pdb CAMK Active 1 Z0O 2.67 -132.94 -178.56 -160.25 62.85 71.20 -172.43 -90.57 15.20 -74.15 -56.39 -37.95 999.00 Allowed THR ASP PHE GLY"
"CHK2_HUMAN t_4BDEA.pdb CAMK Active 1 CWS 2.55 -131.59 -178.24 -148.54 58.92 73.99 -174.32 -89.62 22.62 -67.99 -63.67 -26.84 999.00 Allowed THR ASP PHE GLY"
"CHK2_HUMAN t_4BDFA.pdb CAMK Active 1 H3R 2.70 -125.44 175.50 -159.19 63.52 80.41 -177.25 -98.38 23.17 -68.22 -62.29 -35.48 999.00 Allowed THR ASP PHE GLY"
"CHK2_HUMAN t_4BDGA.pdb CAMK Active 1 P3J 2.84 -128.47 -179.28 -153.82 57.50 78.41 -73.86 -93.62 21.22 -72.34 -57.61 -46.69 999.00 Allowed THR ASP PHE GLY"
"CHK2_HUMAN t_4BDHA.pdb CAMK Active 1 WVI 2.70 -135.09 178.25 -162.96 66.99 74.03 -159.41 -95.22 22.24 -74.63 -69.47 -24.49 999.00 Allowed THR ASP PHE GLY"
"CHK2_HUMAN t_4BDIA.pdb CAMK Active 1 HAU 2.32 -137.37 -178.57 -164.99 62.51 75.99 -164.84 -93.76 21.18 -70.71 -63.97 -34.35 999.00 Allowed THR ASP PHE GLY"
"CHK2_HUMAN t_4BDJA.pdb CAMK Active 1 Z2M 3.01 -128.80 -172.28 23.51 57.48 67.47 -155.46 -85.27 22.34 -72.65 -58.42 -49.42 999.00 Allowed THR ASP PHE GLY"
"CHK2_HUMAN t_4BDKA.pdb CAMK Active 1 RQQ 3.30 -128.34 -174.76 -161.05 53.29 75.19 -172.45 -90.02 17.34 -82.19 -55.83 -43.64 999.00 Allowed THR ASP PHE GLY"
"CLK1_HUMAN t_1Z57A.pdb CMGC Active 1 DBQ 1.70 -125.81 172.57 -50.32 74.77 89.51 -155.80 -108.59 21.55 -63.43 -72.54 -21.16 999.00 Allowed VAL ASP PHE GLY"
"CLK1_HUMAN t_2VAGA.pdb CMGC Active 1 V25 1.80 -129.44 175.62 -51.50 66.15 86.03 -162.27 -105.01 23.25 -66.76 -73.69 -15.46 999.00 Allowed VAL ASP PHE GLY"
"CLK1_HUMAN t_5J1VA.pdb CMGC Active 1 6FD 2.52 -126.90 172.96 -57.15 72.77 87.90 -162.93 -109.95 21.96 -63.37 -77.70 -9.88 999.00 Allowed VAL ASP PHE GLY"
"CLK1_HUMAN t_5J1VB.pdb CMGC Active 1 6FD 2.52 -126.73 175.01 -57.46 70.20 87.70 -162.52 -108.49 20.08 -64.27 -77.71 -8.56 999.00 Allowed VAL ASP PHE GLY"
"CLK1_HUMAN t_5J1VC.pdb CMGC Active 1 6FD 2.52 -127.80 172.45 -56.18 72.00 87.97 -162.76 -108.86 22.87 -63.47 -79.82 -9.02 999.00 Allowed VAL ASP PHE GLY"
"CLK1_HUMAN t_5J1WA.pdb CMGC Active 1 6FB 2.42 -121.78 173.69 -51.52 71.88 86.56 -166.40 -105.05 20.97 -63.39 -77.51 -14.24 999.00 Allowed VAL ASP PHE GLY"
"CLK1_HUMAN t_5J1WB.pdb CMGC Active 1 6FB 2.42 -120.98 173.47 -51.82 72.39 86.20 -166.74 -105.40 21.92 -63.92 -74.98 -15.36 999.00 Allowed VAL ASP PHE GLY"
"CLK1_HUMAN t_5J1WC.pdb CMGC Active 1 6FB 2.42 -122.18 173.26 -51.56 71.94 86.74 -167.84 -106.78 22.01 -63.94 -77.19 -12.45 999.00 Allowed VAL ASP PHE GLY"
"CLK2_HUMAN t_3NR9A.pdb CMGC Active 1 NR9 2.89 -123.75 174.89 -50.57 72.03 86.15 -163.50 -109.61 27.29 -59.33 -62.13 -32.35 999.00 Allowed VAL ASP PHE GLY"
"CLK2_HUMAN t_3NR9B.pdb CMGC Active 1 NR9 2.89 -123.28 175.26 -48.17 70.07 85.78 -162.88 -107.90 26.09 -58.98 -62.17 -29.33 999.00 Allowed VAL ASP PHE GLY"
"CLK2_HUMAN t_3NR9C.pdb CMGC Active 1 NR9 2.89 -125.98 173.44 -49.40 73.73 82.96 -162.29 -105.58 25.92 -59.87 -61.59 -31.58 999.00 Allowed VAL ASP PHE GLY"
"CLK3_HUMAN t_2EU9A.pdb CMGC Active 1 Apo 1.53 -121.06 177.35 999.00 60.20 72.83 -160.81 -88.54 22.40 -70.95 -70.46 -13.88 999.00 Allowed ALA ASP PHE GLY"
"CLK3_HUMAN t_2EXEA.pdb NA NA 0 Apo 2.35 -120.68 177.42 999.00 63.23 75.61 -157.45 -91.66 15.56 -60.95 -54.16 -25.92 999.00 Allowed ALA ASP PHE GLY"
"CLK3_HUMAN t_2WU6A.pdb CMGC Active 1 DKI 1.92 -116.93 179.15 999.00 62.44 72.55 -155.32 -89.68 16.68 -64.96 -62.03 -34.01 999.00 Allowed ALA ASP PHE GLY"
"CLK3_HUMAN t_2WU7A.pdb CMGC Active 1 V25 2.25 -114.79 172.13 999.00 61.98 79.05 -165.01 -94.18 16.46 -68.47 -58.99 -25.26 999.00 Allowed ALA ASP PHE GLY"
"CLK3_HUMAN t_3RAWA.pdb CMGC Active 1 3RA 2.09 -124.38 169.52 999.00 70.39 85.38 -151.78 -106.06 17.23 -65.01 -60.20 -19.36 999.00 Allowed ALA ASP PHE GLY"
"CLK3_HUMAN t_3RAWB.pdb CMGC Active 1 3RA 2.09 -117.06 172.92 999.00 67.82 90.75 -150.72 -108.62 15.90 -65.24 -64.15 -12.18 999.00 Allowed ALA ASP PHE GLY"
"CSF1R_HUMAN t_2I0VA.pdb TYR DFGout 6 6C3 2.80 -168.20 -167.71 999.00 -128.80 119.11 179.73 -107.51 31.65 -50.74 -48.69 -53.39 999.00 Favored GLY ASP PHE GLY"
"CSF1R_HUMAN t_2I0YA.pdb TYR DFGout 6 5CN 1.90 -165.99 175.73 999.00 -91.88 106.45 -167.78 -107.88 6.53 -49.10 -49.44 -41.70 999.00 Favored GLY ASP PHE GLY"
"CSF1R_HUMAN t_2I1MA.pdb TYR DFGout 6 5CN 1.80 -165.21 169.46 999.00 -79.57 109.63 -168.75 -111.20 8.38 -51.54 -49.10 -52.96 999.00 Favored GLY ASP PHE GLY"
"CSF1R_HUMAN t_2OGVA.pdb TYR DFGout 6 Apo 2.70 -140.77 -152.31 999.00 -130.85 121.76 -161.17 -115.06 22.62 -138.41 -62.71 -27.04 999.00 Favored GLY ASP PHE GLY"
"CSF1R_HUMAN t_3BEAA.pdb TYR DFGout 6 IXH 2.02 -170.66 178.24 999.00 -91.74 96.69 -169.98 -101.52 5.00 -60.77 -40.87 -54.14 999.00 Favored GLY ASP PHE GLY"
"CSF1R_HUMAN t_3DPKA.pdb TYR DFGout 6 8C5 1.95 -161.70 175.57 999.00 -97.12 95.77 -173.09 -103.56 13.12 -49.04 -61.03 -28.43 999.00 Favored GLY ASP PHE GLY"
"CSF1R_HUMAN t_3KRJA.pdb TYR DFGout 6 KRJ 2.10 -160.74 -164.15 999.00 -134.34 114.05 -172.20 -119.52 31.10 -36.51 -51.13 -38.46 999.00 Favored GLY ASP PHE GLY"
"CSF1R_HUMAN t_3KRLA.pdb TYR DFGout 6 KRL 2.40 -166.34 -165.39 999.00 -128.00 118.96 -174.56 -124.50 33.51 -43.05 -67.45 -24.79 999.00 Favored GLY ASP PHE GLY"
"CSF1R_HUMAN t_3LCDA.pdb TYR Active 1 BDY 2.50 -120.87 -173.40 999.00 58.67 85.53 -167.98 -99.93 30.98 -73.95 -64.91 -35.16 999.00 Allowed GLY ASP PHE GLY"
"CSF1R_HUMAN t_3LCOA.pdb TYR DFGout 6 LC0 3.40 -158.86 -153.99 999.00 -154.53 102.62 -168.95 -48.65 -45.99 -83.89 73.86 -121.12 999.00 Favored GLY ASP PHE GLY"
"CSF1R_HUMAN t_4HW7A.pdb TYR DFGout 6 64M 2.90 -132.58 -168.71 999.00 -149.09 104.77 -167.16 -59.14 -36.93 -80.86 48.92 -107.71 999.00 Favored GLY ASP PHE GLY"
"CSF1R_HUMAN t_4R7HA.pdb TYR DFGout 6 P31 2.80 -137.92 -155.70 999.00 -162.11 119.59 -170.65 -64.15 -40.21 -77.75 54.14 -114.93 999.00 Favored GLY ASP PHE GLY"
"CSF1R_HUMAN t_4R7IA.pdb TYR DFGout 6 STI 2.75 -135.41 -165.72 999.00 -154.28 113.27 -168.95 -65.51 -32.27 -86.81 51.23 -116.48 999.00 Favored GLY ASP PHE GLY"
"CSK21_HUMAN t_1JWHA.pdb OTHER Active 1 ANP 3.10 -136.86 -165.57 63.10 40.67 74.26 -88.36 -89.27 13.15 -65.67 -66.73 -32.58 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_1JWHB.pdb OTHER Active 1 Apo 3.10 -136.98 -164.96 65.03 38.10 75.35 -91.01 -89.47 15.22 -65.27 -67.66 -33.27 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_1NA7A.pdb OTHER Active 1 Apo 2.40 -117.31 -169.27 61.59 47.05 81.92 -175.16 -99.11 34.17 -59.00 -74.11 -22.11 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_1PJKA.pdb OTHER Active 1 ANP 2.50 -115.93 -179.77 65.16 53.22 80.99 -169.61 -96.46 28.55 -64.37 -72.34 -30.61 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_2PVRA.pdb OTHER Active 1 ANP 1.60 -121.67 -179.59 63.98 56.36 70.28 -82.09 -89.00 17.55 -63.33 -72.85 -15.90 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_2ZJWA.pdb OTHER Active 1 REF 2.40 -109.14 -168.67 63.66 44.32 76.04 -156.43 -90.93 24.24 -62.55 -76.14 -7.11 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3AMYA.pdb OTHER Active 1 AGI 2.30 -112.66 -179.34 60.17 53.47 74.99 -154.74 -93.51 24.05 -66.52 -73.40 -19.92 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3AT2A.pdb OTHER Active 1 Apo 1.60 -116.73 -177.15 65.15 58.10 72.98 -153.25 -94.77 19.18 -66.92 -69.72 -17.33 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3AT3A.pdb OTHER Active 1 ATK 2.60 -111.71 -174.27 65.64 47.58 87.53 -167.00 -107.33 38.73 -53.87 -74.10 -18.35 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3AT4A.pdb OTHER Active 1 CCK 2.20 -113.84 -173.95 67.26 48.66 86.99 -163.87 -102.48 26.56 -60.68 -67.69 -22.01 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3AXWA.pdb OTHER Active 1 TID 2.50 -110.88 -176.61 75.81 48.69 87.61 -156.50 -99.92 22.53 -66.63 -62.35 -27.24 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3BQCA.pdb OTHER Active 1 EMO 1.50 -116.37 -178.29 62.70 51.27 76.19 -156.82 -88.57 18.27 -61.26 -69.98 -16.46 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3C13A.pdb OTHER Active 1 EMO 1.95 -121.75 -174.73 57.96 41.09 81.98 -153.12 -92.82 22.12 -65.06 -72.06 -20.53 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3FWQA.pdb OTHER Active 1 Apo 2.30 -127.11 -174.12 69.20 60.97 71.43 -97.64 -96.69 20.23 -65.27 -72.98 -12.02 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3FWQB.pdb OTHER Active 1 Apo 2.30 -122.59 -176.57 61.64 53.85 75.35 -62.21 -96.37 23.55 -68.80 -69.73 -22.49 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3H30A.pdb OTHER Active 1 RFZ 1.56 -122.08 -178.38 61.42 67.29 61.81 -147.29 -89.43 18.63 -61.20 -69.68 -23.88 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3H30B.pdb OTHER Active 1 RFZ 1.56 -121.15 -177.79 72.03 50.14 78.48 -161.91 -91.39 16.73 -65.56 -67.32 -17.26 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3JUHA.pdb OTHER Active 1 ANP 1.66 -115.64 -178.32 66.26 60.63 71.56 -90.15 -93.05 11.37 -64.89 -62.20 -22.16 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3JUHB.pdb OTHER Active 1 ANP 1.66 -124.75 -176.30 71.59 51.48 71.27 -156.43 -80.35 23.49 -61.00 -80.68 -22.43 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3MB6A.pdb OTHER Active 1 01I 1.75 -117.12 179.61 67.15 54.03 74.55 -156.15 -84.49 16.91 -62.80 -67.47 -20.26 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3MB7A.pdb OTHER Active 1 14I 1.65 -110.69 177.59 68.35 54.77 80.85 -167.13 -92.90 16.72 -63.10 -64.75 -23.20 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3NGAA.pdb OTHER Active 1 3NG 2.71 -109.95 -178.66 66.38 53.40 79.34 -149.15 -94.18 17.71 -63.35 -65.41 -22.83 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3NGAB.pdb OTHER Active 1 3NG 2.71 -109.80 -178.94 65.81 53.34 79.27 -149.20 -94.13 17.67 -63.52 -66.28 -22.71 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3NSZA.pdb OTHER Active 1 ANP 1.30 -116.95 -174.33 69.22 57.62 72.89 -167.33 -91.19 19.01 -64.55 -68.00 -19.37 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3OWJA.pdb OTHER Active 1 1EL 1.85 -117.09 -179.21 68.63 52.83 76.13 -158.22 -89.10 16.06 -63.68 -67.50 -16.56 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3OWKA.pdb OTHER Active 1 18E 1.80 -115.98 -178.67 62.99 54.95 78.50 -159.99 -92.73 19.91 -64.61 -67.84 -19.60 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3OWLA.pdb OTHER Active 1 19E 2.10 -111.50 -179.17 64.19 50.30 80.72 -165.93 -94.89 20.54 -63.57 -66.49 -24.34 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3PE1A.pdb OTHER Active 1 3NG 1.60 -112.48 -179.51 64.33 50.39 77.21 -157.14 -88.94 20.87 -63.25 -67.86 -19.50 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3PE2A.pdb OTHER Active 1 E1B 1.90 -114.25 -179.62 59.09 50.37 76.69 -153.86 -89.16 19.78 -61.48 -67.58 -18.81 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3Q04A.pdb OTHER Active 1 Apo 1.80 -119.52 -177.79 65.55 60.43 68.01 -76.39 -89.02 12.67 -65.14 -70.36 -16.36 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3Q9WA.pdb OTHER Active 1 EMO 1.70 -118.42 -177.21 60.12 54.05 71.22 -151.00 -86.79 17.50 -62.52 -73.37 -13.72 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3Q9XA.pdb OTHER Active 1 EMO 2.20 -117.27 -177.53 64.00 51.32 74.90 -149.40 -92.10 12.92 -69.40 -62.53 -17.14 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3Q9XB.pdb OTHER Active 1 EMO 2.20 -120.88 -177.50 64.23 58.83 69.97 -113.82 -92.15 11.38 -70.29 -67.53 -13.25 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3Q9YA.pdb OTHER Active 1 TXQ 1.80 -120.11 -173.92 62.56 45.86 73.04 -163.36 -85.05 12.88 -63.39 -65.90 -21.03 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3Q9ZA.pdb OTHER Active 1 TXQ 2.20 -120.41 -176.44 53.32 53.60 73.21 -152.49 -90.19 19.25 -66.79 -76.97 -10.24 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3Q9ZB.pdb OTHER Active 1 TXQ 2.20 -116.11 179.24 57.76 58.61 68.76 -151.13 -84.56 15.35 -62.74 -68.65 -14.57 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3QA0A.pdb OTHER Active 1 Apo 2.50 -124.16 -175.07 67.60 54.89 73.72 -83.54 -92.25 15.05 -70.05 -62.73 -20.00 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3QA0B.pdb OTHER Active 1 Apo 2.50 -125.50 -168.60 67.78 42.44 76.93 -71.08 -91.60 19.34 -69.46 -71.44 -13.47 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3R0TA.pdb OTHER Active 1 FU9 1.75 -117.12 -178.78 64.48 53.07 76.10 -160.07 -88.94 20.75 -61.96 -68.91 -19.72 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3RPSA.pdb OTHER Active 1 4B0 2.30 -111.22 178.67 73.42 55.29 84.44 -151.06 -100.28 15.58 -64.03 -72.03 -12.04 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3RPSB.pdb OTHER Active 1 Apo 2.30 -126.88 -173.86 65.22 65.34 61.81 -153.43 -91.46 23.10 -61.41 -69.72 -21.24 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3U4UA.pdb OTHER Active 1 LNH 2.20 -118.45 174.08 73.84 54.72 78.39 -158.14 -86.34 20.11 -64.41 -64.53 -21.78 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3U9CA.pdb OTHER Active 1 04G 3.20 -116.50 -173.07 66.73 53.40 78.35 -166.60 -99.96 25.32 -60.28 -71.46 -18.49 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3U9CB.pdb OTHER Active 1 04G 3.20 -116.42 -173.07 66.28 53.28 78.19 -86.60 -100.08 25.31 -60.08 -71.63 -18.61 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3W8LA.pdb OTHER Active 1 Apo 2.40 -122.43 -179.46 67.80 58.38 69.82 -97.33 -89.58 16.54 -63.52 -62.43 -19.52 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3W8LB.pdb OTHER Active 1 I6P 2.40 -117.98 178.61 70.51 63.97 74.06 -144.59 -97.55 23.34 -63.00 -68.80 -26.39 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3WARA.pdb OTHER Active 1 Apo 1.04 -118.02 -179.24 67.46 53.50 74.91 -155.37 -88.24 17.64 -64.34 -73.25 -11.46 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3WIKA.pdb OTHER Active 1 LCT 2.00 -121.98 -178.86 66.83 53.77 79.16 -165.32 -92.38 13.17 -67.40 -63.36 -21.13 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3WILA.pdb OTHER Active 1 LCD 2.90 -117.14 178.03 70.13 60.90 81.21 -151.30 -103.49 17.70 -57.48 -64.75 -20.89 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_3WOWA.pdb OTHER Active 1 ANP 2.50 -119.70 -164.31 76.98 31.09 87.72 -175.08 -91.30 15.77 -67.50 -76.60 -15.16 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_4DGLC.pdb OTHER Active 1 Apo 3.00 -119.61 -175.69 63.85 48.94 74.68 -78.48 -91.27 24.11 -59.34 -63.70 -18.60 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_4DGLD.pdb OTHER Active 1 Apo 3.00 -109.86 -171.59 64.39 50.91 71.42 -141.20 -90.34 25.46 -56.94 -68.14 -22.79 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_4FBXA.pdb OTHER Active 1 Apo 2.33 -127.38 -176.93 64.51 56.81 77.14 -156.29 -98.19 24.67 -64.20 -69.66 -21.96 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_4GRBA.pdb OTHER Active 1 0XG 2.15 -117.95 174.70 67.17 54.00 81.79 -164.61 -93.49 24.64 -62.03 -69.67 -22.83 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_4GUBA.pdb OTHER Active 1 0Y4 2.20 -115.12 -174.23 71.34 49.69 70.09 -140.26 -87.48 25.56 -65.11 -70.69 -13.67 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_4IB5A.pdb OTHER Active 1 Apo 2.20 -119.93 -178.45 63.80 53.67 80.89 -153.90 -98.84 23.28 -63.86 -69.20 -16.47 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_4IB5B.pdb OTHER Active 1 Apo 2.20 -120.50 -177.95 64.62 53.77 80.97 -153.98 -98.88 23.43 -63.97 -69.11 -16.21 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_4IB5C.pdb OTHER Active 1 Apo 2.20 -120.68 -178.08 64.17 53.62 80.98 -153.80 -98.62 23.44 -64.03 -69.18 -16.25 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_4KWPA.pdb OTHER Active 1 EXX 1.25 -116.87 179.72 68.32 59.24 71.49 -78.17 -90.29 13.52 -65.65 -69.96 -15.57 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_4MD7E.pdb OTHER Active 1 Apo 3.10 -109.50 -178.47 62.52 49.72 76.67 -153.73 -93.13 29.74 -52.49 -74.84 -11.49 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_4MD7F.pdb OTHER Active 1 Apo 3.10 -111.10 -174.83 62.99 47.66 75.41 -152.37 -93.24 28.71 -55.64 -75.49 -8.83 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_4MD7G.pdb OTHER Active 1 Apo 3.10 -110.42 -179.68 63.28 52.36 70.93 -153.27 -89.70 29.29 -52.96 -71.95 -13.76 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_4MD7H.pdb OTHER Active 1 Apo 3.10 -107.64 -179.27 63.99 51.92 73.52 -153.26 -92.44 29.74 -53.82 -72.50 -12.96 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_4MD8E.pdb OTHER Active 1 Apo 3.30 -112.19 178.43 59.89 53.22 77.75 -156.22 -92.57 28.73 -52.65 -69.82 -13.34 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_4MD8F.pdb OTHER Active 1 Apo 3.30 -114.49 -178.60 62.81 48.93 73.86 -153.62 -91.41 28.61 -55.85 -67.99 -14.10 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_4MD8G.pdb OTHER Active 1 Apo 3.30 -110.51 -179.49 60.73 52.57 73.58 -156.53 -87.79 26.94 -54.62 -68.62 -17.45 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_4MD8H.pdb OTHER Active 1 Apo 3.30 -107.60 178.09 63.26 54.19 73.28 -157.93 -87.48 27.29 -53.46 -66.62 -18.56 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_4MD9E.pdb OTHER Active 1 Apo 3.50 -99.95 -176.07 61.31 61.90 68.16 -143.06 -92.93 36.43 -57.15 -68.87 -34.24 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_4MD9F.pdb OTHER Active 1 Apo 3.50 -113.14 -175.49 61.67 58.90 72.42 -152.38 -97.74 30.21 -57.78 -64.01 -35.42 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_4MD9G.pdb OTHER Active 1 Apo 3.50 -114.67 -178.06 60.05 65.70 67.23 -145.62 -94.54 16.74 -59.48 -57.34 -29.75 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_4MD9H.pdb OTHER Active 1 Apo 3.50 -100.21 -178.48 62.60 56.79 74.39 -155.92 -95.60 26.80 -58.68 -59.29 -39.19 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_4MD9K.pdb OTHER Active 1 Apo 3.50 -100.44 -179.81 65.97 59.03 78.34 -102.43 -97.77 20.90 -59.04 -65.06 -30.25 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_4MD9L.pdb OTHER Active 1 Apo 3.50 -105.98 -173.15 57.58 57.80 77.41 -70.07 -104.45 26.49 -61.60 -67.86 -41.35 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_4MD9M.pdb OTHER Active 1 Apo 3.50 -109.01 -172.61 61.74 61.23 73.81 -108.00 -94.20 19.13 -56.86 -64.52 -29.46 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_4MD9P.pdb OTHER Active 1 Apo 3.50 -111.89 -179.27 57.62 62.50 64.49 -158.75 -90.25 28.89 -57.37 -64.26 -39.73 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_4NH1A.pdb OTHER Active 1 ACP 3.30 -114.38 -169.87 63.43 57.82 83.40 -159.88 -112.14 31.32 -60.37 -75.42 -39.87 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_4NH1B.pdb OTHER Active 1 ACP 3.30 -114.46 -169.82 63.48 57.85 82.96 -160.02 -112.36 30.78 -59.71 -75.35 -39.94 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_4RLLA.pdb OTHER Active 1 E91 1.85 -120.04 -176.19 65.95 46.89 81.77 -159.82 -93.67 22.39 -62.21 -69.77 -15.91 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_4UB7A.pdb OTHER Active 1 3G5 2.10 -119.65 -177.25 65.00 53.90 77.20 -159.47 -93.71 24.90 -63.09 -69.99 -20.61 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_4UBAA.pdb OTHER Active 1 3G5 3.00 -119.54 177.61 68.78 55.97 87.22 -171.10 -107.79 27.62 -57.61 -71.68 -14.72 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_4UBAB.pdb OTHER Active 1 3G5 3.00 -119.17 178.09 70.21 56.12 86.95 -171.12 -107.68 28.23 -57.61 -71.99 -14.72 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_5B0XA.pdb OTHER Active 1 HCK 2.30 -117.66 179.40 72.37 51.86 83.45 -163.30 -93.35 25.26 -63.54 -58.63 -24.98 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_5CLPA.pdb OTHER Active 1 42J 1.68 -114.93 -178.91 64.06 53.59 78.97 -159.01 -92.39 19.26 -65.20 -66.00 -23.42 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_5CLPB.pdb OTHER Active 1 42J 1.68 -116.00 -178.49 63.35 54.68 78.85 -158.38 -94.45 19.11 -66.50 -63.60 -25.36 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_5CQUA.pdb OTHER Active 1 JRJ 2.35 -118.88 -176.27 66.79 56.82 75.77 -80.51 -99.56 34.21 -59.61 -79.98 -18.80 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_5CQWA.pdb OTHER Active 1 JRJ 2.65 -114.02 -173.98 67.48 53.39 80.66 -80.85 -102.41 24.96 -63.38 -71.06 -19.32 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_5CQWB.pdb OTHER Active 1 JRJ 2.65 -114.06 -173.53 65.59 53.52 79.60 -77.62 -101.84 24.68 -63.85 -71.02 -18.68 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_5CS6A.pdb OTHER Active 1 K82 1.88 -111.93 -178.28 67.25 52.63 77.95 -157.40 -90.16 13.45 -67.17 -60.48 -26.40 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_5CS6B.pdb OTHER Active 1 Apo 1.88 -111.58 -178.81 67.67 52.13 77.01 -158.02 -88.15 14.83 -66.80 -63.09 -26.24 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_5CSHA.pdb OTHER Active 1 54E 1.59 -114.35 -175.50 68.37 50.15 77.82 -162.23 -91.65 16.90 -64.66 -64.55 -21.27 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_5CSHB.pdb OTHER Active 1 ATP 1.59 -115.17 -175.70 67.29 50.59 77.48 -161.80 -92.16 18.87 -65.12 -65.65 -21.95 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_5CSPA.pdb OTHER Active 1 Apo 1.50 -116.59 -179.25 68.13 51.58 76.79 -160.13 -89.38 18.47 -64.50 -67.52 -21.63 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_5CSVA.pdb OTHER Active 1 GAB 1.38 -118.81 -177.40 65.04 52.99 78.41 -154.36 -90.89 18.49 -62.87 -68.00 -21.04 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_5CT0A.pdb OTHER Active 1 54P 2.01 -114.88 -176.69 71.02 51.02 77.92 -159.44 -92.58 17.65 -65.51 -66.06 -19.42 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_5CT0B.pdb OTHER Active 1 54P 2.01 -112.22 -177.62 71.91 50.97 78.11 -161.03 -91.66 17.11 -65.97 -66.31 -20.18 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_5CTPA.pdb OTHER Active 1 54R 2.03 -109.35 179.55 68.35 51.91 77.76 -161.46 -90.40 19.17 -63.97 -64.53 -25.05 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_5CTPB.pdb OTHER Active 1 54R 2.03 -118.29 -178.17 68.80 52.12 76.84 -160.51 -90.65 19.24 -64.35 -65.35 -23.88 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_5CU0A.pdb OTHER Active 1 54R 2.18 -108.15 179.27 67.93 48.90 78.45 -161.88 -91.09 19.71 -63.71 -64.35 -23.36 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_5CU0B.pdb OTHER Active 1 54R 2.18 -107.21 178.26 68.16 49.19 76.64 -161.71 -87.01 19.84 -64.47 -66.51 -22.93 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_5CU2A.pdb OTHER Active 1 551 1.71 -113.65 -177.34 67.80 51.19 77.76 -158.50 -89.84 18.01 -65.43 -65.02 -23.47 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_5CU2B.pdb OTHER Active 1 551 1.71 -112.78 -177.29 67.22 50.31 74.99 -156.86 -87.29 18.64 -64.98 -65.42 -23.25 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_5CU3A.pdb OTHER Active 1 54S 1.79 -118.17 -179.96 66.94 48.72 78.78 -161.29 -88.60 19.22 -65.82 -64.74 -22.74 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_5CU3B.pdb OTHER Active 1 54S 1.79 -116.98 176.96 64.79 50.28 78.48 -159.05 -88.53 19.24 -65.40 -64.49 -23.70 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_5CU4A.pdb OTHER Active 1 54S 1.56 -114.98 179.47 61.97 49.59 79.00 -158.79 -89.95 16.49 -65.29 -64.43 -23.56 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_5CU6A.pdb OTHER Active 1 ATP 1.36 -117.98 -179.07 67.04 58.30 73.51 -84.33 -91.04 19.07 -63.64 -69.17 -18.91 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_5CVFA.pdb OTHER Active 1 54Z 1.63 -117.25 -174.75 65.99 54.69 71.72 -166.11 -90.76 22.74 -61.50 -69.86 -23.92 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_5CVGA.pdb OTHER Active 1 Apo 1.25 -117.49 -179.36 73.84 52.22 78.75 -156.81 -91.61 19.26 -64.58 -66.70 -22.70 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_5CVHA.pdb OTHER Active 1 ADP 1.85 -108.95 -174.91 68.70 56.91 75.37 -161.21 -94.52 15.00 -66.31 -64.68 -19.67 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_5CVHB.pdb OTHER Active 1 ADP 1.85 -108.99 -175.20 67.66 55.53 76.32 -163.50 -94.45 15.10 -67.01 -64.93 -20.47 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_5CX9A.pdb OTHER Active 1 551 1.73 -118.11 -178.05 68.65 51.66 77.71 -159.78 -91.33 18.57 -65.16 -63.78 -23.05 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_5CX9B.pdb OTHER Active 1 551 1.73 -114.11 -178.23 69.00 51.33 77.15 -158.75 -89.93 17.72 -64.88 -63.89 -22.63 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_5H8BA.pdb OTHER Active 1 5Y2 2.55 -114.18 -179.37 77.01 48.41 87.98 -149.40 -102.59 21.86 -65.68 -70.07 -20.01 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_5H8BB.pdb OTHER Active 1 5Y2 2.55 -106.12 179.69 74.45 51.14 84.18 -145.23 -96.55 19.29 -61.23 -62.49 -27.60 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_5H8EA.pdb OTHER Active 1 5Y3 2.15 -116.65 -176.76 74.38 50.48 79.40 -151.89 -89.91 17.65 -65.39 -63.18 -24.54 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_5H8EB.pdb OTHER Active 1 5Y3 2.15 -109.66 -177.76 72.78 50.78 80.42 -154.29 -90.29 20.58 -64.40 -65.61 -22.99 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_5H8GA.pdb OTHER Active 1 5Y4 2.00 -115.15 -178.25 74.24 46.95 81.41 -155.72 -92.42 20.80 -63.14 -68.76 -19.63 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_5M44A.pdb OTHER Active 1 7EY 2.71 -118.06 -174.71 67.80 54.45 79.02 -171.39 -98.39 23.96 -61.51 -66.02 -23.92 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_5M4CA.pdb OTHER Active 1 7EY 1.94 -122.84 -177.52 63.11 51.50 76.21 -159.55 -86.75 19.08 -62.94 -72.95 -15.66 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_5M4FA.pdb OTHER Active 1 7FC 1.52 -113.71 -179.79 67.23 53.24 78.31 -158.38 -90.15 18.19 -61.44 -68.55 -17.43 999.00 NA ILE ASP TRP GLY"
"CSK21_HUMAN t_5M4IA.pdb OTHER Active 1 7FC 2.22 -124.49 -173.30 65.35 56.26 71.77 -68.64 -95.61 20.91 -61.80 -68.00 -20.03 999.00 NA ILE ASP TRP GLY"
"CSK22_HUMAN t_3E3BX.pdb OTHER Active 1 CCK 3.20 -60.68 173.46 77.42 58.67 153.50 171.81 -167.79 24.34 -67.87 -71.54 -16.50 999.00 NA ILE ASP TRP GLY"
"CSK22_HUMAN t_3OFMA.pdb OTHER Active 1 4B0 2.00 -111.69 -178.50 65.64 48.97 84.49 -159.53 -96.72 22.09 -64.14 -71.17 -18.65 999.00 NA ILE ASP TRP GLY"
"CSK22_HUMAN t_3U87A.pdb NA NA 0 ANP 2.90 51.01 85.37 -164.86 -106.64 25.21 -60.48 -72.71 -19.37 999.00 -106.14 -4.28 -75.94 NA ASP TRP GLY LEU"
"CSK22_HUMAN t_3U87B.pdb NA NA 0 ANP 2.90 50.93 85.54 -164.90 -106.65 24.89 -60.40 -72.94 -19.73 999.00 -106.32 -4.31 -75.99 NA ASP TRP GLY LEU"
"CSK22_HUMAN t_5M4UA.pdb OTHER Active 1 7FC 2.20 -118.81 -178.09 66.41 56.41 80.53 -155.58 -98.69 21.05 -59.97 -68.01 -17.00 999.00 NA ILE ASP TRP GLY"
"CSK22_HUMAN t_5M56A.pdb OTHER Active 1 7FC 2.24 -120.50 -175.95 61.90 56.73 79.29 -156.17 -99.93 21.99 -63.66 -72.52 -18.87 999.00 NA ILE ASP TRP GLY"
"CSK22_HUMAN t_5M56B.pdb OTHER Active 1 7FC 2.24 -120.62 -176.01 62.98 56.34 79.50 -155.07 -99.10 22.67 -63.40 -72.79 -19.21 999.00 NA ILE ASP TRP GLY"
"CSKP_HUMAN t_3C0GA.pdb CAMK Active 1 3AM 2.19 -127.88 -156.94 999.00 71.62 38.87 999.00 -83.99 24.05 -79.46 -66.73 -16.29 999.00 NA GLY GLY PHE GLY"
"CSKP_HUMAN t_3C0GB.pdb CAMK Active 1 3AM 2.19 -125.13 -156.53 999.00 71.63 45.25 999.00 -92.41 28.53 -71.21 -64.71 -24.37 999.00 NA GLY GLY PHE GLY"
"CSKP_HUMAN t_3C0HA.pdb CAMK Active 1 AMP 2.30 -127.85 -151.84 999.00 62.46 48.03 999.00 -88.83 13.01 -80.30 -53.51 -27.31 999.00 NA GLY GLY PHE GLY"
"CSKP_HUMAN t_3C0HB.pdb CAMK Active 1 AMP 2.30 -120.63 -148.62 999.00 53.85 55.46 999.00 -94.13 23.69 -76.16 -57.91 -26.97 999.00 NA GLY GLY PHE GLY"
"CSKP_HUMAN t_3C0IA.pdb CAMK Active 1 3AM 1.85 -126.83 -156.61 999.00 68.69 42.73 999.00 -86.97 18.59 -81.36 -63.94 -14.22 999.00 NA GLY GLY PHE GLY"
"CSKP_HUMAN t_3MFRA.pdb CAMK Active 1 ANP 2.00 -130.00 -163.54 999.00 44.40 79.30 -164.40 -92.77 26.20 -79.06 -59.31 -25.56 999.00 NA GLY ASP PHE GLY"
"CSKP_HUMAN t_3MFSA.pdb CAMK Active 1 ANP 2.10 -132.51 -159.43 999.00 54.71 71.29 -159.44 -90.49 27.85 -74.33 -63.08 -24.80 999.00 NA GLY ASP PHE GLY"
"CSKP_HUMAN t_3MFTA.pdb CAMK Active 1 Apo 2.20 -131.36 -156.98 999.00 44.46 78.37 -163.20 -93.28 28.57 -76.50 -53.43 -36.47 999.00 NA GLY ASP PHE GLY"
"CSKP_HUMAN t_3MFUA.pdb CAMK Active 1 ANP 2.30 -132.50 -169.19 999.00 51.96 75.17 -161.30 -95.01 30.46 -76.53 -64.44 -32.14 999.00 NA GLY ASP PHE GLY"
"CSKP_HUMAN t_3TACA.pdb CAMK Active 1 Apo 2.20 -118.77 -153.25 999.00 70.22 38.75 999.00 -82.45 19.06 -79.65 -61.89 -22.67 999.00 NA GLY GLY PHE GLY"
"CSK_HUMAN t_1BYGA.pdb TYR DFGinter 5 STU 2.40 -99.21 153.05 -179.94 -105.83 -7.00 67.91 -68.61 146.19 156.38 -161.78 133.10 999.00 Favored SER ASP PHE GLY"
"CSK_HUMAN t_3D7TA.pdb TYR DFGin-inactive 2 STU 2.90 -129.85 -75.54 62.80 -112.51 120.19 -149.87 -68.39 132.55 -49.46 -108.94 999.00 999.00 Favored SER ASP PHE GLY"
"CSK_HUMAN t_3D7UA.pdb TYR Active 1 Apo 4.11 -139.71 -167.88 63.71 53.57 74.77 -161.18 -92.80 23.91 -53.79 -52.75 -52.03 999.00 Allowed SER ASP PHE GLY"
"CSK_HUMAN t_3D7UC.pdb TYR Active 1 Apo 4.11 -139.70 -167.84 63.61 53.60 74.81 -161.21 -92.82 23.90 -53.75 -52.81 -52.00 999.00 Allowed SER ASP PHE GLY"
"DAPK1_HUMAN t_1IG1A.pdb CAMK Active 1 ANP 1.80 -124.98 -172.09 64.33 54.92 85.09 -175.61 -99.29 28.42 -71.91 -63.73 -23.25 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_1JKKA.pdb CAMK Active 1 ANP 2.40 -129.06 -171.68 64.89 53.71 79.98 -173.34 -93.77 28.85 -73.99 -63.06 -25.75 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_1JKLA.pdb CAMK Active 1 ANP 1.62 -124.19 -176.98 63.27 56.35 83.99 -169.06 -97.91 28.59 -72.33 -64.47 -19.07 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_1JKSA.pdb CAMK Active 1 Apo 1.50 -127.70 -176.75 65.20 57.94 79.58 -162.15 -94.53 29.18 -74.44 -64.00 -21.75 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_1JKTA.pdb CAMK Active 1 Apo 3.50 -156.20 -168.07 28.40 66.72 42.28 -123.80 -71.89 62.19 -63.19 -87.88 -62.56 999.00 Favored ILE ASP PHE GLY"
"DAPK1_HUMAN t_1JKTB.pdb CAMK Active 1 Apo 3.50 -124.31 166.11 66.90 59.01 116.29 -163.36 -120.65 39.97 -66.13 -56.90 -21.30 999.00 Outlier ILE ASP PHE GLY"
"DAPK1_HUMAN t_1P4FA.pdb CAMK Active 1 DRG 1.90 -122.90 -178.47 65.82 56.21 80.95 -158.92 -92.09 25.52 -76.75 -64.35 -23.52 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_1WVWA.pdb CAMK Active 1 Apo 2.40 -117.75 -175.32 65.73 57.03 85.56 -164.65 -98.33 32.26 -71.31 -67.59 -24.58 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_1WVXA.pdb CAMK Active 1 BD4 2.60 -117.69 -176.69 57.17 58.37 90.17 -111.39 -102.01 21.36 -75.49 -61.46 -22.42 999.00 Outlier ILE ASP PHE GLY"
"DAPK1_HUMAN t_1WVYA.pdb CAMK Active 1 STU 2.80 -89.37 -23.13 60.90 -108.70 148.82 -162.96 -138.37 21.17 -80.88 -56.20 -46.66 999.00 Favored ILE ASP PHE GLY"
"DAPK1_HUMAN t_2W4JA.pdb CAMK Active 1 ADP 1.30 -123.29 -175.29 64.94 63.19 81.90 -166.70 -95.25 20.84 -72.00 -69.89 -15.22 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_2W4KA.pdb CAMK Active 1 ADP 1.90 -119.76 -176.16 63.86 66.40 79.86 -169.77 -97.35 22.40 -77.31 -63.60 -22.08 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_2X0GA.pdb CAMK Active 1 Apo 2.20 -128.99 176.29 65.57 69.29 82.70 -81.99 -99.32 16.43 -74.95 -59.73 -18.63 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_2XUUA.pdb CAMK Active 1 ADP 1.80 -117.03 179.94 62.96 67.98 81.78 -172.02 -97.63 27.59 -73.53 -75.93 -14.04 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_2XZSA.pdb CAMK Active 1 Apo 2.00 -120.25 177.90 71.15 68.10 75.02 -160.03 -91.74 14.63 -77.62 -54.17 -26.25 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_2XZSB.pdb CAMK Active 1 Apo 2.00 -119.06 177.52 69.58 61.28 82.29 -162.56 -96.10 15.25 -79.14 -58.10 -21.10 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_2Y0AA.pdb CAMK Active 1 Apo 2.60 -121.21 171.42 63.16 76.14 81.24 -157.80 -98.05 12.25 -70.36 -57.96 -12.31 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_2Y4PA.pdb CAMK Active 1 Apo 2.65 -122.36 -176.20 62.45 62.99 74.81 -152.66 -97.65 30.39 -74.46 -61.67 -33.86 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_2Y4PB.pdb NA NA 0 Apo 2.65 -128.20 -176.78 66.45 58.42 79.94 -154.90 -99.93 25.44 -75.79 -63.20 -25.88 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_2Y4PC.pdb CAMK Active 1 Apo 2.65 -126.11 168.57 71.35 77.32 81.61 -165.68 -103.94 25.91 -76.90 -61.22 -34.22 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_2Y4PD.pdb NA NA 0 Apo 2.65 -130.48 -172.18 59.31 53.92 73.57 -170.95 -97.01 30.65 -79.72 -62.96 -24.25 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_2YAKA.pdb CAMK Active 1 OSV 2.20 -121.41 175.95 62.17 66.84 86.40 -158.30 -102.40 30.04 -78.72 -69.15 -24.54 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_3DFCB.pdb CAMK Active 1 ANP 1.90 -118.30 -174.35 71.05 63.45 75.60 -173.68 -92.24 26.84 -73.68 -73.39 -15.21 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_3DGKA.pdb CAMK Active 1 Apo 1.70 -125.86 179.16 67.28 59.04 79.68 -162.32 -90.15 22.57 -76.52 -64.28 -25.24 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_3EH9A.pdb CAMK Active 1 ADP 1.70 -121.11 178.12 65.34 66.00 83.50 -171.02 -97.43 22.89 -75.89 -68.81 -21.44 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_3EHAA.pdb CAMK Active 1 ANP 1.60 -119.52 -175.60 65.64 63.59 76.38 -170.26 -92.01 24.06 -72.86 -66.01 -21.01 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_3F5GA.pdb CAMK Active 1 ADP 1.85 -120.44 179.21 69.21 65.09 83.13 -171.10 -97.07 24.31 -72.22 -68.50 -21.07 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_3F5UA.pdb CAMK Active 1 ANP 2.00 -122.62 -175.70 68.68 63.13 77.00 -173.37 -89.92 20.64 -74.96 -66.76 -20.94 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_3GU4A.pdb CAMK Active 1 ANP 1.35 -120.72 -178.26 64.03 63.75 79.47 -174.99 -95.14 25.39 -72.59 -69.51 -15.73 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_3GU5A.pdb CAMK Active 1 ANP 1.65 -118.62 -175.92 63.71 62.37 83.67 -169.67 -98.99 25.49 -74.21 -66.39 -22.09 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_3GU6A.pdb CAMK Active 1 ADP 1.49 -123.13 -179.18 62.79 62.00 78.33 -166.79 -92.61 24.22 -72.74 -68.68 -18.28 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_3GU7A.pdb CAMK Active 1 ADP 1.90 -119.61 -175.73 64.26 62.99 82.17 -172.49 -94.92 24.87 -75.43 -70.09 -20.38 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_3GU8A.pdb CAMK Active 1 3GU 1.60 -123.93 179.17 64.42 59.88 78.17 -163.02 -90.89 26.77 -74.06 -66.22 -23.83 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_3GUBA.pdb CAMK Active 1 GUB 1.71 -123.33 177.60 61.18 62.40 87.75 -162.26 -96.88 26.31 -73.70 -62.15 -27.99 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_3ZXTA.pdb CAMK Active 1 ACP 2.65 -116.53 -174.78 66.60 63.12 89.05 -176.10 -105.67 -162.70 -75.58 49.55 38.62 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_3ZXTB.pdb CAMK Active 1 ACP 2.65 -121.50 -170.81 68.22 56.12 80.81 -165.34 -103.94 17.25 -77.56 -56.30 -19.66 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_3ZXTC.pdb CAMK Active 1 ACP 2.65 -125.03 -178.40 72.10 64.52 79.36 -170.29 -91.91 24.60 -72.18 -66.12 -19.71 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_3ZXTD.pdb CAMK Active 1 ACP 2.65 -115.85 173.34 71.97 73.03 78.35 -177.49 -92.77 17.50 -76.12 -68.45 25.41 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_4B4LA.pdb CAMK Active 1 1PE 1.75 -119.53 174.10 67.96 66.65 85.05 -164.41 -96.23 25.04 -75.56 -64.81 -20.13 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_4PF4A.pdb CAMK Active 1 Apo 1.13 -124.05 179.55 68.97 63.07 80.65 -164.83 -92.70 22.36 -74.12 -66.32 -19.90 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_4TL0A.pdb CAMK Active 1 Apo 2.70 -124.81 -178.43 64.75 60.49 86.95 -153.41 -105.56 31.97 -73.36 -74.00 -9.61 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_4TXCA.pdb CAMK Active 1 38G 1.95 -120.95 -176.62 64.32 59.35 88.35 -165.13 -102.47 27.30 -78.69 -63.16 -27.66 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_4UV0A.pdb CAMK Active 1 Apo 2.49 -124.34 -170.21 67.95 58.05 77.40 -65.80 -90.34 23.50 -71.36 -54.08 -37.51 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_4YO4A.pdb CAMK Active 1 Apo 1.60 -122.40 179.53 66.73 62.91 79.23 -160.97 -93.36 23.04 -72.20 -61.83 -24.74 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_4YPDA.pdb CAMK Active 1 DKG 1.40 -122.98 179.40 68.10 63.27 78.61 -163.88 -93.26 23.74 -74.15 -62.84 -21.77 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_5AUTA.pdb CAMK Active 1 2AN 1.70 -114.86 -178.76 62.94 65.43 82.79 -157.77 -97.47 25.97 -75.01 -68.11 -18.36 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_5AUUA.pdb CAMK Active 1 LU2 1.70 -124.67 -174.59 59.56 60.99 72.59 -102.83 -94.53 24.99 -73.83 -66.34 -17.22 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_5AUVA.pdb CAMK Active 1 AGI 1.50 -121.01 -179.42 63.34 61.50 77.19 -162.78 -91.89 24.05 -74.07 -63.40 -20.11 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_5AUWA.pdb CAMK Active 1 QUE 1.50 -121.72 -178.05 60.19 59.17 78.45 -159.99 -94.30 26.69 -74.20 -64.33 -24.90 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_5AUXA.pdb CAMK Active 1 KMP 1.50 -121.41 -177.46 65.40 61.19 78.11 -162.05 -92.10 23.73 -73.38 -66.28 -16.02 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_5AUYA.pdb CAMK Active 1 MRI 2.00 -127.56 -178.89 63.51 62.76 89.29 -160.77 -104.89 29.15 -75.90 -67.48 -24.84 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_5AUZA.pdb CAMK Active 1 GEN 1.60 -123.22 176.53 62.62 68.91 80.66 -166.72 -95.13 25.25 -74.39 -64.61 -20.64 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_5AV0A.pdb CAMK Active 1 47X 1.85 -122.16 -178.33 63.45 64.34 84.56 -168.14 -98.97 26.16 -77.39 -68.11 -20.36 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_5AV1A.pdb CAMK Active 1 Apo 1.50 -119.67 -179.74 66.75 64.18 81.65 -162.81 -94.56 23.91 -75.45 -63.80 -21.35 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_5AV2A.pdb CAMK Active 1 KMP 1.50 -121.64 -178.09 66.22 60.10 79.41 -164.03 -92.42 25.72 -74.26 -66.08 -20.87 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_5AV3A.pdb CAMK Active 1 KMP 1.90 -122.20 -177.81 68.60 61.25 83.09 -162.71 -97.43 30.94 -75.92 -71.31 -18.27 999.00 Allowed ILE ASP PHE GLY"
"DAPK1_HUMAN t_5AV4A.pdb CAMK Active 1 GEN 1.40 -121.30 178.25 61.31 68.20 81.92 -163.66 -95.49 26.87 -74.15 -67.80 -18.38 999.00 Allowed ILE ASP PHE GLY"
"DAPK2_HUMAN t_1WMKA.pdb CAMK Active 1 Apo 3.60 -124.53 176.98 57.31 56.76 75.07 -160.75 -90.08 20.62 -80.37 -56.55 -39.42 999.00 Allowed ILE ASP PHE GLY"
"DAPK2_HUMAN t_1WMKB.pdb CAMK Active 1 Apo 3.60 -123.82 174.99 57.43 57.68 77.25 -160.47 -92.02 20.17 -81.61 -55.49 -38.82 999.00 Allowed ILE ASP PHE GLY"
"DAPK2_HUMAN t_1WMKC.pdb CAMK Active 1 Apo 3.60 -121.32 -179.77 55.93 54.34 74.99 -160.22 -92.18 24.35 -81.01 -58.73 -38.91 999.00 Allowed ILE ASP PHE GLY"
"DAPK2_HUMAN t_1WMKD.pdb CAMK Active 1 Apo 3.60 -122.96 177.71 57.96 55.30 77.64 -160.13 -92.84 23.79 -80.04 -58.99 -38.38 999.00 Allowed ILE ASP PHE GLY"
"DAPK2_HUMAN t_1WMKE.pdb CAMK Active 1 Apo 3.60 -122.59 176.75 56.86 57.86 76.92 -159.68 -91.67 22.22 -80.94 -58.70 -36.56 999.00 Allowed ILE ASP PHE GLY"
"DAPK2_HUMAN t_1WMKF.pdb CAMK Active 1 Apo 3.60 -126.72 176.11 56.75 57.50 77.56 -160.41 -93.02 22.05 -80.74 -57.45 -37.81 999.00 Allowed ILE ASP PHE GLY"
"DAPK2_HUMAN t_1WMKG.pdb CAMK Active 1 Apo 3.60 -124.03 175.76 56.84 58.42 75.33 -160.56 -91.77 23.12 -80.72 -58.03 -37.92 999.00 Allowed ILE ASP PHE GLY"
"DAPK2_HUMAN t_1WMKH.pdb CAMK Active 1 Apo 3.60 -123.99 176.46 57.45 56.09 75.93 -159.51 -91.09 20.79 -79.87 -56.38 -38.13 999.00 Allowed ILE ASP PHE GLY"
"DAPK2_HUMAN t_1Z9XA.pdb CAMK Active 1 Apo 3.93 -122.37 177.54 68.22 56.53 86.63 -163.06 -100.50 35.15 -76.97 -68.17 -25.47 999.00 Allowed ILE ASP PHE GLY"
"DAPK2_HUMAN t_1Z9XB.pdb CAMK Active 1 Apo 3.93 -121.44 177.60 68.41 56.47 86.84 -162.92 -100.53 34.69 -76.74 -67.52 -26.08 999.00 Allowed ILE ASP PHE GLY"
"DAPK2_HUMAN t_1Z9XC.pdb CAMK Active 1 Apo 3.93 -121.60 178.00 68.55 56.34 86.72 -162.82 -100.45 34.45 -77.16 -67.12 -25.95 999.00 Allowed ILE ASP PHE GLY"
"DAPK2_HUMAN t_1ZWSA.pdb CAMK Active 1 Apo 2.90 -132.15 -167.48 65.28 56.40 94.93 -159.34 -115.07 28.94 -77.32 -71.55 -39.99 999.00 Outlier ILE ASP PHE GLY"
"DAPK2_HUMAN t_1ZWSB.pdb CAMK Active 1 Apo 2.90 -137.16 -168.34 65.87 55.92 91.07 -162.65 -111.53 32.93 -76.15 -73.58 -40.29 999.00 Outlier ILE ASP PHE GLY"
"DAPK2_HUMAN t_1ZWSC.pdb CAMK Active 1 Apo 2.90 -132.48 -167.15 64.74 53.10 90.87 -162.06 -112.81 31.83 -75.27 -73.22 -38.03 999.00 Outlier ILE ASP PHE GLY"
"DAPK2_HUMAN t_1ZWSD.pdb CAMK Active 1 Apo 2.90 -134.14 -169.12 66.59 57.64 90.30 -161.75 -112.47 30.51 -75.39 -71.90 -40.63 999.00 Outlier ILE ASP PHE GLY"
"DAPK2_HUMAN t_1ZWSE.pdb CAMK Active 1 Apo 2.90 -135.60 -169.38 63.94 57.53 90.48 -160.07 -111.41 28.47 -75.03 -69.34 -41.48 999.00 Outlier ILE ASP PHE GLY"
"DAPK2_HUMAN t_1ZWSF.pdb CAMK Active 1 Apo 2.90 -134.86 -171.04 64.80 59.05 90.37 -164.32 -111.78 30.69 -75.07 -70.77 -42.25 999.00 Allowed ILE ASP PHE GLY"
"DAPK2_HUMAN t_1ZWSG.pdb CAMK Active 1 Apo 2.90 -135.80 -167.53 66.28 53.96 90.49 -160.77 -113.35 36.05 -74.44 -76.20 -40.16 999.00 Outlier ILE ASP PHE GLY"
"DAPK2_HUMAN t_1ZWSH.pdb CAMK Active 1 Apo 2.90 -133.44 -170.18 63.82 58.66 87.03 -161.23 -108.79 31.40 -74.17 -71.92 -40.29 999.00 Allowed ILE ASP PHE GLY"
"DAPK2_HUMAN t_2A27A.pdb CAMK Active 1 Apo 3.00 -127.75 179.32 64.41 58.66 91.31 -167.56 -105.86 29.65 -73.76 -61.58 -31.68 999.00 Outlier ILE ASP PHE GLY"
"DAPK2_HUMAN t_2A27B.pdb CAMK Active 1 Apo 3.00 -128.84 178.93 65.74 63.19 92.84 -162.30 -105.98 25.67 -75.97 -62.55 -24.41 999.00 Allowed ILE ASP PHE GLY"
"DAPK2_HUMAN t_2A27C.pdb CAMK Active 1 Apo 3.00 -119.57 179.47 62.75 60.27 93.28 -158.28 -105.71 28.62 -71.62 -56.84 -32.13 999.00 Outlier ILE ASP PHE GLY"
"DAPK2_HUMAN t_2A27D.pdb CAMK Active 1 Apo 3.00 -128.78 173.76 64.14 64.26 85.70 -163.17 -99.65 29.33 -71.63 -61.94 -24.03 999.00 Allowed ILE ASP PHE GLY"
"DAPK2_HUMAN t_2A27E.pdb CAMK Active 1 Apo 3.00 -127.76 177.58 62.17 62.31 86.64 -163.51 -102.34 30.06 -72.59 -63.41 -26.88 999.00 Allowed ILE ASP PHE GLY"
"DAPK2_HUMAN t_2A27F.pdb CAMK Active 1 Apo 3.00 -127.02 174.48 64.88 65.50 88.69 -161.32 -104.83 29.70 -73.78 -65.39 -24.08 999.00 Allowed ILE ASP PHE GLY"
"DAPK2_HUMAN t_2A27G.pdb CAMK Active 1 Apo 3.00 -124.06 178.34 62.64 60.60 89.93 -166.13 -103.65 28.73 -74.33 -60.19 -29.02 999.00 Allowed ILE ASP PHE GLY"
"DAPK2_HUMAN t_2A27H.pdb CAMK Active 1 Apo 3.00 -123.62 174.90 63.54 63.44 89.93 -164.21 -102.21 30.09 -74.48 -65.38 -21.90 999.00 Allowed ILE ASP PHE GLY"
"DAPK2_HUMAN t_2A2AA.pdb CAMK Active 1 Apo 1.47 -119.71 176.78 69.67 61.80 81.37 -165.36 -93.45 23.99 -80.07 -64.10 -23.53 999.00 Allowed ILE ASP PHE GLY"
"DAPK2_HUMAN t_2A2AB.pdb CAMK Active 1 Apo 1.47 -122.25 176.05 68.39 67.68 77.62 -164.20 -93.10 25.55 -77.21 -68.37 -22.12 999.00 Allowed ILE ASP PHE GLY"
"DAPK2_HUMAN t_2A2AC.pdb CAMK Active 1 Apo 1.47 -119.21 175.60 70.48 65.74 81.63 -167.40 -92.37 22.97 -75.46 -59.67 -25.65 999.00 Allowed ILE ASP PHE GLY"
"DAPK2_HUMAN t_2A2AD.pdb CAMK Active 1 Apo 1.47 -119.81 176.85 66.79 65.08 80.61 -163.62 -93.43 22.97 -79.43 -60.40 -26.01 999.00 Allowed ILE ASP PHE GLY"
"DAPK2_HUMAN t_2CKEA.pdb CAMK Active 1 IQU 2.8 -129.72 173.27 72.76 58.60 84.89 -176.69 -97.07 34.61 -69.74 -67.91 -24.67 999.00 Allowed ILE ASP PHE GLY"
"DAPK2_HUMAN t_2CKEB.pdb CAMK Active 1 IQU 2.8 -129.44 175.96 58.75 58.22 89.63 -163.61 -106.75 41.11 -69.13 -78.74 -13.60 999.00 Allowed ILE ASP PHE GLY"
"DAPK2_HUMAN t_2CKEC.pdb CAMK Active 1 IQU 2.8 -124.72 173.28 69.16 66.53 87.08 -166.13 -105.37 35.86 -72.83 -74.67 -17.19 999.00 Allowed ILE ASP PHE GLY"
"DAPK2_HUMAN t_2CKED.pdb CAMK Active 1 IQU 2.8 -124.46 -179.33 67.91 54.35 92.59 -160.99 -105.69 31.60 -74.75 -69.98 -19.91 999.00 Outlier ILE ASP PHE GLY"
"DAPK3_HUMAN t_1YRPA.pdb CAMK Active 1 Apo 3.10 -134.56 168.03 66.73 67.49 101.33 -167.13 -121.12 21.51 -67.49 -63.74 -8.89 999.00 Outlier ILE ASP PHE GLY"
"DAPK3_HUMAN t_1YRPB.pdb CAMK Active 1 Apo 3.10 -134.29 167.81 66.70 67.11 101.54 -166.55 -121.77 22.40 -67.53 -64.43 -8.59 999.00 Outlier ILE ASP PHE GLY"
"DAPK3_HUMAN t_2J90A.pdb CAMK Active 1 IZA 2.0 -125.26 179.25 66.10 61.51 82.27 -162.44 -98.37 26.80 -72.55 -60.41 -28.87 999.00 Allowed ILE ASP PHE GLY"
"DAPK3_HUMAN t_2J90B.pdb CAMK Active 1 IZA 2.0 -120.28 179.25 64.36 63.33 79.43 -165.44 -98.25 31.80 -69.36 -66.99 -24.77 999.00 Allowed ILE ASP PHE GLY"
"DAPK3_HUMAN t_3BHYA.pdb CAMK Active 1 7CP 1.24 -133.71 175.69 65.67 62.59 76.47 -88.28 -93.38 20.18 -75.89 -66.98 -18.97 999.00 Allowed ILE ASP PHE GLY"
"DAPK3_HUMAN t_3BQRA.pdb CAMK Active 1 4RB 1.75 -129.02 177.09 66.02 61.75 82.97 -164.29 -94.66 24.80 -70.32 -58.70 -30.83 999.00 Allowed ILE ASP PHE GLY"
"DAPK3_HUMAN t_5A6NA.pdb CAMK Active 1 U7E 1.70 -123.51 169.98 67.17 70.81 84.48 -160.84 -96.15 23.96 -71.95 -59.67 -27.47 999.00 Allowed ILE ASP PHE GLY"
"DAPK3_HUMAN t_5A6NB.pdb CAMK Active 1 Apo 1.70 -123.16 173.50 69.65 71.04 82.31 -166.27 -96.31 23.33 -71.83 -58.52 -28.15 999.00 Allowed ILE ASP PHE GLY"
"DAPK3_HUMAN t_5A6OA.pdb CAMK Active 1 Apo 1.60 -124.92 169.83 68.66 70.28 86.04 -163.07 -95.60 23.36 -70.50 -56.94 -30.81 999.00 Allowed ILE ASP PHE GLY"
"DAPK3_HUMAN t_5A6OB.pdb CAMK Active 1 Apo 1.60 -125.90 173.34 67.99 69.69 85.35 -169.03 -98.08 23.99 -72.22 -63.50 -22.57 999.00 Allowed ILE ASP PHE GLY"
"DCLK1_HUMAN t_5JZJA.pdb CAMK Active 1 AN2 1.71 -124.77 -164.48 999.00 49.76 81.37 -167.94 -91.57 27.73 -79.08 -62.62 -30.24 999.00 Allowed GLY ASP PHE GLY"
"DCLK1_HUMAN t_5JZJB.pdb CAMK Active 1 AN2 1.71 -126.18 -167.23 999.00 53.35 81.83 -165.06 -94.96 26.86 -78.13 -56.83 -35.17 999.00 Allowed GLY ASP PHE GLY"
"DCLK1_HUMAN t_5JZNA.pdb CAMK Active 1 GUI 2.85 -125.43 -165.28 999.00 48.88 82.25 -167.57 -91.68 28.82 -78.77 -62.01 -29.96 999.00 Outlier GLY ASP PHE GLY"
"DCLK1_HUMAN t_5JZNB.pdb CAMK Active 1 GUI 2.85 -125.36 -165.82 999.00 48.39 82.75 -167.59 -91.88 28.82 -77.52 -61.82 -29.58 999.00 Outlier GLY ASP PHE GLY"
"DDR1_HUMAN t_3ZOSA.pdb TYR DFGout 6 0LI 1.92 -140.00 179.92 999.00 -153.24 112.82 -177.13 -85.25 -13.52 -74.35 48.95 -126.08 999.00 Favored ALA ASP PHE GLY"
"DDR1_HUMAN t_3ZOSB.pdb TYR DFGout 6 0LI 1.92 -143.84 178.92 999.00 -153.30 114.41 -177.29 -82.66 -15.17 -72.48 52.13 -127.46 999.00 Favored ALA ASP PHE GLY"
"DDR1_HUMAN t_4BKJA.pdb TYR DFGout 6 STI 1.70 -135.59 -177.46 999.00 -150.25 104.35 -175.29 -97.21 -19.54 -50.07 76.22 -179.13 999.00 Favored ALA ASP PHE GLY"
"DDR1_HUMAN t_4BKJB.pdb TYR DFGout 6 STI 1.70 -134.82 -177.17 999.00 -150.31 104.54 -174.79 -98.11 -18.31 -51.10 76.26 -179.97 999.00 Favored ALA ASP PHE GLY"
"DDR1_HUMAN t_4CKRA.pdb TYR DFGout 6 DI1 2.20 -138.40 172.05 999.00 -152.01 104.00 -160.82 -83.40 -39.46 -52.82 70.36 17.42 999.00 Favored ALA ASP PHE GLY"
"DDR1_HUMAN t_5BVKA.pdb TYR DFGout 6 4VC 2.29 -129.56 -176.32 999.00 -140.64 98.64 -165.59 -92.49 131.12 -58.49 -55.55 -44.22 999.00 Favored ALA ASP PHE GLY"
"DDR1_HUMAN t_5BVNA.pdb TYR DFGout 6 4VD 2.21 -133.50 -169.55 999.00 -151.85 105.08 -171.92 -95.25 10.52 -55.40 72.06 -162.28 999.00 Favored ALA ASP PHE GLY"
"DDR1_HUMAN t_5BVOA.pdb TYR DFGout 6 4VE 1.98 -131.71 -169.88 999.00 -148.23 100.72 -174.81 -82.56 -2.94 -73.08 79.98 -173.73 999.00 Favored ALA ASP PHE GLY"
"DDR1_HUMAN t_5BVWA.pdb TYR DFGout 6 1N1 1.94 -113.13 175.58 999.00 -102.35 -21.70 -37.44 40.35 118.52 -138.75 -134.54 999.00 999.00 Favored ALA ASP PHE GLY"
"DDR1_HUMAN t_5FDPA.pdb TYR DFGout 6 5WR 2.25 -127.06 -169.55 999.00 -156.74 102.70 -160.54 -88.64 -15.88 -72.07 71.67 -126.64 999.00 Favored ALA ASP PHE GLY"
"DDR1_HUMAN t_5FDXA.pdb TYR DFGout 6 5X1 2.65 -121.12 -162.24 999.00 -166.81 109.22 -171.55 -90.53 -4.39 -74.30 70.33 -138.59 999.00 Allowed ALA ASP PHE GLY"
"DDR1_HUMAN t_5FDXB.pdb TYR DFGout 6 5X1 2.65 -145.34 -178.43 999.00 -150.73 112.03 -160.80 -97.06 1.57 -76.67 70.50 -149.96 999.00 Favored ALA ASP PHE GLY"
"DMPK_HUMAN t_2VD5A.pdb AGC Active 1 BI8 2.80 -135.49 173.04 999.00 64.16 82.60 -157.37 -103.74 18.18 -60.93 -77.93 10.30 999.00 Allowed ALA ASP PHE GLY"
"DMPK_HUMAN t_2VD5B.pdb AGC Active 1 BI8 2.80 -121.56 -178.40 999.00 55.12 76.33 -159.14 -92.52 18.35 -59.52 -63.84 -6.51 999.00 Allowed ALA ASP PHE GLY"
"DYR1A_HUMAN t_2VX3A.pdb CMGC Active 1 D15 2.40 -117.79 179.57 -52.20 65.96 72.61 -172.62 -91.64 22.57 -71.31 -64.57 -16.68 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_2VX3B.pdb CMGC Active 1 D15 2.40 -122.57 -178.08 -56.69 63.18 68.38 -172.81 -88.17 26.61 -73.79 -63.27 -25.29 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_2VX3C.pdb CMGC Active 1 D15 2.40 -121.47 178.95 -57.18 62.05 79.81 -172.58 -99.69 23.46 -73.54 -71.83 -9.11 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_2VX3D.pdb CMGC Active 1 P6G 2.40 -119.00 173.30 -55.60 66.08 79.97 -174.51 -97.89 24.63 -72.79 -62.49 -22.37 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_2WO6A.pdb CMGC Active 1 D15 2.50 -113.71 170.09 -51.93 69.22 79.02 -162.17 -93.28 30.91 -78.53 -74.88 -25.98 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_2WO6B.pdb CMGC Active 1 D15 2.50 -114.84 170.21 -55.77 64.98 84.72 -156.65 -96.28 34.42 -76.85 -78.19 -22.46 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_3ANQA.pdb CMGC Active 1 EHB 2.60 -121.64 -179.88 -58.84 58.82 88.73 -175.32 -108.07 22.92 -81.36 -73.95 -18.84 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_3ANQB.pdb CMGC Active 1 EHB 2.60 -120.48 177.47 -59.98 60.83 88.34 -174.90 -107.37 25.35 -80.64 -76.39 -18.62 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_3ANQC.pdb CMGC Active 1 EHB 2.60 -119.14 176.78 -58.82 62.42 87.38 -173.22 -107.94 27.54 -80.65 -77.03 -19.70 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_3ANQD.pdb CMGC Active 1 EHB 2.60 -117.53 176.97 -58.23 61.45 86.43 -173.45 -106.41 25.38 -80.87 -77.34 -17.80 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_3ANRA.pdb CMGC Active 1 HRM 2.60 -126.96 175.56 -50.09 62.34 87.07 -152.48 -103.97 24.04 -77.31 -67.76 -18.59 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_3ANRB.pdb CMGC Active 1 HRM 2.60 -127.34 175.32 -52.30 64.10 86.04 -154.11 -102.42 22.61 -76.87 -64.67 -20.77 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_3ANRC.pdb CMGC Active 1 HRM 2.60 -127.31 175.71 -51.48 63.89 86.99 -152.38 -105.94 24.66 -77.07 -68.48 -18.14 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_3ANRD.pdb CMGC Active 1 HRM 2.60 -126.79 174.71 -52.08 64.81 86.48 -152.76 -103.95 22.85 -76.75 -67.17 -18.00 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_4AZEA.pdb CMGC Active 1 3RA 3.15 -137.19 169.87 -71.05 67.54 90.43 -151.87 -106.40 23.95 -76.70 -55.71 -37.55 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_4AZEB.pdb CMGC Active 1 3RA 3.15 -138.16 169.51 -68.53 68.43 90.40 -152.84 -106.07 24.16 -76.49 -57.16 -36.05 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_4AZEC.pdb CMGC Active 1 3RA 3.15 -136.66 171.06 -69.80 67.02 92.32 -151.24 -107.75 25.12 -76.76 -57.48 -37.55 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_4MQ1A.pdb CMGC Active 1 2C3 2.35 -107.08 169.26 -57.04 64.39 86.53 -166.17 -96.38 23.13 -73.60 -52.41 -28.59 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_4MQ1B.pdb CMGC Active 1 1PE 2.35 -118.06 178.12 -53.95 65.51 78.13 -162.41 -95.15 21.14 -73.38 -53.57 -31.55 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_4MQ1C.pdb CMGC Active 1 2C3 2.35 -115.47 174.38 -58.03 57.91 89.00 -158.96 -100.48 19.76 -68.81 -59.16 -10.37 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_4MQ1D.pdb CMGC Active 1 2C3 2.35 -126.49 171.84 -60.59 66.41 87.22 -157.62 -103.97 24.10 -73.98 -66.55 -19.47 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_4MQ2A.pdb CMGC Active 1 1PE 2.80 -121.29 179.85 -47.69 65.25 80.68 -167.67 -100.31 34.08 -67.82 -77.48 -4.09 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_4MQ2B.pdb CMGC Active 1 2C4 2.80 -112.48 178.55 -50.44 64.90 72.08 -168.07 -90.58 21.47 -74.56 -54.36 -51.39 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_4MQ2C.pdb CMGC Active 1 1PE 2.80 -124.81 176.29 -53.92 61.30 87.36 -164.21 -103.33 27.19 -66.70 -80.87 14.71 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_4MQ2D.pdb CMGC Active 1 2C4 2.80 -125.93 172.65 -54.76 67.55 75.36 -157.91 -95.89 30.14 -68.32 -78.69 -5.85 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_4NCTA.pdb CMGC Active 1 2K2 2.60 -119.58 166.34 -61.40 66.72 85.66 -173.66 -102.65 26.77 -69.64 -64.15 -35.19 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_4NCTB.pdb CMGC Active 1 2K2 2.60 -112.80 170.11 -52.32 65.13 81.73 -171.35 -98.55 30.80 -74.43 -75.08 -33.66 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_4NCTC.pdb CMGC Active 1 2K2 2.60 -129.67 158.83 75.50 69.31 79.08 -164.48 -97.70 33.38 -75.26 -86.72 -36.34 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_4NCTD.pdb CMGC Active 1 2K2 2.60 -116.78 164.71 -81.14 65.42 84.00 -159.87 -98.79 30.68 -71.66 -82.48 -24.80 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_4YLJA.pdb CMGC Active 1 4E1 2.58 -120.80 179.00 -51.81 60.39 78.62 -155.73 -97.56 26.91 -68.82 -65.02 -15.46 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_4YLJB.pdb CMGC Active 1 4E1 2.58 -121.54 178.76 -51.50 61.04 77.23 -154.43 -96.22 26.83 -70.95 -67.79 -14.92 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_4YLJC.pdb CMGC Active 1 4E1 2.58 -122.27 179.50 -51.68 59.96 77.71 -155.04 -95.85 25.75 -70.14 -67.24 -13.83 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_4YLJD.pdb CMGC Active 1 4E1 2.58 -121.38 179.37 -51.33 58.82 78.49 -153.14 -97.14 26.23 -69.66 -66.08 -15.59 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_4YLKA.pdb CMGC Active 1 4E2 1.40 -121.26 173.26 -57.97 68.70 82.10 -162.74 -101.41 18.40 -72.09 -66.36 -24.83 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_4YLLA.pdb CMGC Active 1 4E3 1.40 -121.42 173.09 -59.74 67.64 81.86 -162.92 -100.09 19.56 -70.40 -67.99 -24.34 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_4YU2A.pdb CMGC Active 1 4H5 2.90 -128.45 169.70 -45.30 66.27 87.87 -162.10 -106.60 30.39 -71.50 -70.81 -21.24 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_4YU2B.pdb CMGC Active 1 4H5 2.90 -128.59 169.97 -45.75 65.21 90.94 -160.37 -106.40 30.60 -69.71 -70.12 -21.90 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_4YU2C.pdb CMGC Active 1 4H5 2.90 -129.99 170.41 -44.97 64.90 89.07 -160.57 -105.39 29.50 -71.32 -70.31 -20.43 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_4YU2D.pdb CMGC Active 1 4H5 2.90 -129.64 170.04 -44.75 63.83 89.40 -160.96 -106.15 30.02 -70.73 -69.80 -20.22 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_5A3XA.pdb CMGC Active 1 QIV 2.26 -121.32 168.42 -58.92 66.28 87.11 -170.83 -106.04 27.09 -76.81 -83.77 -17.68 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_5A3XB.pdb CMGC Active 1 QIV 2.26 -125.76 167.92 -64.19 65.96 85.46 -169.24 -101.57 31.91 -80.99 -86.05 -27.10 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_5A3XC.pdb CMGC Active 1 QIV 2.26 -120.78 156.41 147.05 72.70 88.86 -176.58 -105.02 41.99 -69.35 -98.94 -30.62 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_5A3XD.pdb CMGC Active 1 QIV 2.26 -112.38 164.72 -51.14 67.37 90.57 -166.31 -104.34 19.83 -74.97 -77.09 -18.41 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_5A4EA.pdb CMGC Active 1 7QQ 2.68 -126.60 177.14 -60.78 58.73 94.30 -163.76 -113.26 22.27 -73.82 -59.46 -31.21 999.00 Outlier VAL ASP PHE GLY"
"DYR1A_HUMAN t_5A4EB.pdb CMGC Active 1 7QQ 2.68 -121.28 173.57 -59.22 64.13 83.76 -168.68 -104.75 23.57 -72.33 -70.12 -36.49 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_5A4EC.pdb CMGC Active 1 7QQ 2.68 -138.09 157.64 131.60 68.67 87.29 -167.31 -107.71 30.92 -72.12 -77.46 -44.71 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_5A4ED.pdb CMGC Active 1 7QQ 2.68 -127.03 161.26 -66.00 72.94 98.04 -167.70 -113.68 26.73 -66.47 -71.74 -27.41 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_5A4LA.pdb CMGC Active 1 ZC3 2.73 -122.34 174.19 -60.27 65.05 93.48 -167.59 -114.69 26.76 -75.33 -79.93 -25.44 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_5A4LB.pdb CMGC Active 1 ZC3 2.73 -122.35 174.38 -57.94 63.35 78.84 -171.59 -100.65 29.60 -87.16 -76.47 -46.60 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_5A4LC.pdb CMGC Active 1 ZC3 2.73 -127.34 155.35 135.19 73.18 93.96 -162.91 -111.34 27.02 -74.98 -87.34 -7.30 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_5A4LD.pdb CMGC Active 1 ZC3 2.73 -132.94 164.12 -62.20 69.90 87.19 -166.95 -105.40 34.75 -68.46 -80.25 -34.67 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_5A4QA.pdb CMGC Active 1 Y3L 2.37 -121.91 169.14 -57.19 70.39 82.28 -166.61 -101.31 21.60 -78.85 -74.50 -27.63 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_5A4QB.pdb CMGC Active 1 Y3L 2.37 -119.04 169.99 -58.77 69.97 79.06 -163.66 -95.28 24.10 -71.16 -59.29 -40.15 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_5A4QC.pdb CMGC Active 1 Y3L 2.37 -123.75 162.74 130.81 68.57 86.64 -163.74 -104.43 24.63 -75.60 -79.34 -18.49 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_5A4QD.pdb CMGC Active 1 Y3L 2.37 -122.24 174.04 -49.05 62.30 86.42 -169.62 -97.65 23.52 -70.58 -75.34 -20.37 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_5A4TA.pdb CMGC Active 1 AJG 2.15 -112.28 -178.71 -61.21 54.58 84.94 -172.40 -104.06 18.96 -86.98 -59.73 -39.35 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_5A4TB.pdb CMGC Active 1 AJG 2.15 -134.36 173.11 -60.50 62.67 77.58 -166.71 -92.90 44.34 -67.09 -83.71 -36.39 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_5A4TC.pdb CMGC Active 1 AJG 2.15 -129.41 163.21 86.36 71.51 82.83 -168.86 -101.13 32.15 -72.80 -81.64 -18.22 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_5A4TD.pdb CMGC Active 1 AJG 2.15 -117.20 169.41 -53.09 64.46 80.58 -179.40 -95.84 25.32 -72.01 -68.22 -34.95 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_5A54A.pdb CMGC Active 1 5PW 2.63 -121.47 177.36 -60.24 61.33 86.81 -162.21 -106.47 25.26 -80.29 -65.22 -32.81 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_5A54B.pdb CMGC Active 1 5PW 2.63 -134.10 173.18 -64.90 68.69 67.54 -164.00 -87.67 26.51 -70.49 -78.53 -14.24 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_5A54C.pdb CMGC Active 1 5PW 2.63 -136.45 159.32 142.55 68.01 80.50 -164.07 -98.03 19.65 -73.21 -74.62 -18.07 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_5A54D.pdb CMGC Active 1 5PW 2.63 -116.91 166.37 -49.81 68.74 97.93 -173.48 -113.10 31.59 -73.37 -75.61 -31.95 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_5AIKA.pdb CMGC Active 1 AWR 2.70 -123.79 165.61 -59.29 68.97 89.30 -170.61 -99.50 20.39 -75.43 -68.32 -30.19 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_5AIKB.pdb CMGC Active 1 AWR 2.70 -125.30 165.10 -59.18 67.89 88.94 -169.50 -100.55 21.29 -74.49 -65.49 -31.47 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_5AIKC.pdb CMGC Active 1 AWR 2.70 -123.06 165.66 -59.61 69.36 87.67 -171.80 -99.24 19.79 -74.72 -64.73 -32.76 999.00 Allowed VAL ASP PHE GLY"
"DYR1A_HUMAN t_5AIKD.pdb CMGC Active 1 AWR 2.70 -124.83 165.63 -60.12 68.77 87.64 -170.32 -99.81 21.13 -75.17 -66.82 -31.29 999.00 Allowed VAL ASP PHE GLY"
"DYRK2_HUMAN t_3K2LA.pdb CMGC Active 1 Apo 2.36 -127.42 178.61 75.01 61.23 89.73 -173.85 -107.18 23.80 -82.16 -75.86 -16.59 999.00 Allowed ILE ASP PHE GLY"
"DYRK2_HUMAN t_3KVWA.pdb CMGC Active 1 IRB 2.28 -111.04 -179.03 64.85 64.30 75.66 -169.46 -93.62 22.50 -77.87 -72.29 -11.80 999.00 Allowed ILE ASP PHE GLY"
"DYRK2_HUMAN t_4AZFA.pdb CMGC Active 1 3RA 2.55 -118.83 179.62 69.78 61.31 77.58 -168.20 -93.60 30.44 -76.54 -76.65 -12.40 999.00 Allowed ILE ASP PHE GLY"
"DYRK2_HUMAN t_5LXCA.pdb CMGC Active 1 7AA 2.15 -127.69 168.26 60.24 65.72 89.29 -175.42 -103.97 15.31 -78.44 -66.86 -20.13 999.00 Allowed ILE ASP PHE GLY"
"DYRK2_HUMAN t_5LXCB.pdb CMGC Active 1 7AA 2.15 -125.14 171.00 63.91 62.63 89.25 -176.60 -105.24 19.46 -78.52 -66.91 -27.52 999.00 Allowed ILE ASP PHE GLY"
"DYRK2_HUMAN t_5LXDA.pdb CMGC Active 1 7A7 2.58 -123.93 173.63 64.80 67.76 85.86 -166.94 -103.27 19.97 -69.29 -60.73 -26.60 999.00 Allowed ILE ASP PHE GLY"
"DYRK2_HUMAN t_5LXDB.pdb CMGC Active 1 7A7 2.58 -125.16 174.12 65.11 66.88 85.80 -167.53 -102.38 18.62 -69.04 -60.58 -24.72 999.00 Allowed ILE ASP PHE GLY"
"E2AK2_HUMAN t_2A19B.pdb OTHER Active 1 ANP 2.50 -120.98 -28.72 999.00 -115.84 107.83 178.61 -103.06 22.12 -72.25 -61.95 -26.46 999.00 Favored GLY ASP PHE GLY"
"E2AK2_HUMAN t_2A19C.pdb OTHER Active 1 ANP 2.50 -118.27 -31.09 999.00 -99.55 112.77 -153.30 -116.24 24.91 -73.86 -61.14 -35.52 999.00 Favored GLY ASP PHE GLY"
"E2AK2_HUMAN t_2A1AB.pdb OTHER Active 1 Apo 2.80 -132.61 38.28 999.00 -152.57 121.74 -177.56 -125.69 22.07 -70.40 -59.08 -10.29 999.00 Favored GLY ASP PHE GLY"
"E2AK2_HUMAN t_3UIUA.pdb OTHER Active 1 Apo 2.90 179.66 47.65 999.00 -88.77 86.37 174.85 -91.13 -3.63 -56.33 -78.18 27.79 999.00 Favored GLY ASP PHE GLY"
"E2AK2_HUMAN t_3UIUB.pdb OTHER Active 1 Apo 2.90 179.61 47.62 999.00 -88.47 86.20 174.82 -90.98 -3.19 -56.18 -78.35 27.44 999.00 Favored GLY ASP PHE GLY"
"E2AK3_HUMAN t_4G31A.pdb OTHER DFGup 3 0WH 2.28 -84.49 -158.97 999.00 -56.01 133.54 -168.71 -155.01 170.45 66.22 78.40 175.84 999.00 Favored GLY ASP PHE GLY"
"E2AK3_HUMAN t_4G34A.pdb OTHER DFGup 3 924 2.70 -82.84 -161.08 999.00 -56.84 138.40 -163.55 -162.60 172.39 72.32 108.75 -50.44 999.00 Favored GLY ASP PHE GLY"
"E2AK3_HUMAN t_4M7IA.pdb OTHER DFGup 3 27D 2.34 -84.64 -156.90 999.00 -61.91 137.06 -172.02 -158.45 171.51 68.60 119.69 -36.57 999.00 Favored GLY ASP PHE GLY"
"E2AK3_HUMAN t_4X7HA.pdb OTHER DFGout 6 3Z2 2.00 -147.42 -165.18 999.00 -147.44 104.92 -169.93 -56.28 -41.74 -171.29 -79.40 999.00 999.00 Favored GLY ASP PHE GLY"
"E2AK3_HUMAN t_4X7JA.pdb OTHER DFGout 6 3Z1 2.30 -176.96 -166.73 999.00 -114.82 83.95 172.94 -76.26 -41.25 -69.68 65.48 38.36 999.00 Allowed GLY ASP PHE GLY"
"E2AK3_HUMAN t_4X7KA.pdb OTHER DFGout 6 3Z3 1.80 -164.32 -167.97 999.00 -113.85 89.87 -177.63 -77.26 -42.75 -76.03 66.30 40.53 999.00 Favored GLY ASP PHE GLY"
"E2AK3_HUMAN t_4X7LA.pdb OTHER DFGout 6 3Z4 1.90 -164.79 -167.27 999.00 -114.10 88.19 -178.02 -74.87 -43.13 -77.91 64.59 42.22 999.00 Favored GLY ASP PHE GLY"
"E2AK3_HUMAN t_4X7NA.pdb OTHER DFGout 6 3Z5 2.35 -159.96 -166.60 999.00 -113.91 86.88 -178.34 -73.63 -38.83 -75.53 62.06 46.13 999.00 Favored GLY ASP PHE GLY"
"E2AK3_HUMAN t_4X7OA.pdb OTHER DFGup 3 3Z6 2.65 -94.21 -155.14 999.00 -53.30 136.71 -159.76 -155.15 166.24 66.81 73.29 999.00 999.00 Favored GLY ASP PHE GLY"
"EGFR_HUMAN t_1M14A.pdb TYR Active 1 Apo 2.60 -137.08 -165.68 -160.54 56.56 80.61 -152.36 -98.39 22.59 -65.91 -65.36 -3.29 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_1M17A.pdb TYR Active 1 AQ4 2.60 -146.71 -165.23 -162.23 54.42 82.19 -166.46 -96.43 20.73 -65.74 -51.72 -26.81 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_1XKKA.pdb TYR DFGup 3 FMM 2.40 -142.40 -178.31 -167.46 66.62 16.08 -105.16 -82.57 163.33 49.95 85.17 -36.90 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_2EB2A.pdb TYR Active 1 Apo 2.50 -133.50 -171.03 -157.07 55.74 80.92 -156.33 -94.75 26.09 -64.07 -62.61 -8.57 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_2EB3A.pdb TYR Active 1 ANP 2.84 -146.36 -170.89 -166.14 55.70 31.63 -145.61 -96.56 44.17 45.60 -72.56 -59.12 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_2GS2A.pdb TYR Active 1 Apo 2.80 -138.72 -166.71 -168.89 52.61 91.58 -165.64 -108.24 27.73 -63.84 -69.51 15.45 999.00 Outlier THR ASP PHE GLY"
"EGFR_HUMAN t_2GS6A.pdb TYR Active 1 Apo 2.60 -137.48 -165.83 -168.29 53.40 83.44 -161.90 -103.34 27.07 -71.48 -65.97 -11.65 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_2GS7A.pdb TYR DFGin-trans 4 ANP 2.60 -99.50 171.05 -174.58 60.87 33.27 -77.30 -69.53 142.45 163.33 92.77 -41.52 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_2GS7B.pdb TYR DFGin-trans 4 ANP 2.60 -104.30 165.25 -156.96 71.89 26.98 -77.81 -62.02 139.67 163.91 85.01 -32.82 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_2ITNA.pdb TYR Active 1 ANP 2.47 -127.14 -173.34 -160.20 63.90 79.85 -145.43 -96.62 10.53 -64.59 -73.88 28.41 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_2ITOA.pdb TYR Active 1 IRE 3.25 -140.07 -168.64 -153.54 58.35 91.78 -93.40 -104.53 8.94 -59.56 -49.00 0.91 999.00 Outlier THR ASP PHE GLY"
"EGFR_HUMAN t_2ITPA.pdb TYR Active 1 AEE 2.74 -130.00 -162.88 -166.52 59.17 79.48 -140.28 -92.62 9.18 -61.87 -39.70 -19.97 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_2ITQA.pdb TYR Active 1 ITQ 2.68 -134.30 -154.85 -60.42 40.02 87.01 -153.33 -97.30 14.77 -73.29 -49.62 -18.38 999.00 Outlier THR ASP PHE GLY"
"EGFR_HUMAN t_2ITTA.pdb TYR Active 1 AEE 2.73 -130.72 -162.85 -164.73 54.13 78.31 -142.59 -91.00 8.59 -64.19 -44.59 3.13 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_2ITUA.pdb TYR Active 1 ITQ 2.8 -134.42 -171.26 -171.49 59.27 91.45 -166.14 -108.30 5.63 -67.70 -53.94 9.07 999.00 Outlier THR ASP PHE GLY"
"EGFR_HUMAN t_2ITVA.pdb TYR Active 1 ANP 2.47 -132.43 -173.65 -166.17 61.70 81.33 -162.13 -94.23 13.29 -66.47 -58.86 7.72 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_2ITWA.pdb TYR Active 1 ITQ 2.88 -142.09 -169.35 179.59 57.69 89.48 -148.84 -104.22 29.57 -64.74 -82.55 26.80 999.00 Outlier THR ASP PHE GLY"
"EGFR_HUMAN t_2ITXA.pdb TYR Active 1 ANP 2.98 -136.33 -171.94 -166.62 65.33 93.24 -148.14 -111.50 18.73 -61.68 -59.44 2.06 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_2ITYA.pdb TYR Active 1 IRE 3.42 -166.26 -170.92 -124.39 51.78 94.01 -117.17 -111.36 9.93 -55.48 -48.22 -2.74 999.00 Outlier THR ASP PHE GLY"
"EGFR_HUMAN t_2ITZA.pdb TYR Active 1 IRE 2.72 -131.01 -170.46 -158.11 64.99 76.03 -121.61 -93.09 24.16 -57.80 -48.56 -35.00 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_2J5EA.pdb TYR Active 1 CY0 3.10 -153.98 -164.53 -143.25 53.37 84.83 -134.47 -101.81 45.93 -57.51 -74.42 -25.77 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_2J5FA.pdb TYR Active 1 DJK 3.00 -144.75 -170.54 -159.16 63.91 79.09 -129.44 -97.73 23.97 -63.03 -43.92 -47.90 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_2J6MA.pdb TYR Active 1 AEE 3.1 -131.98 -171.34 -158.11 64.16 86.61 -141.97 -104.73 23.19 -58.01 -61.64 -5.70 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_2JITA.pdb TYR Active 1 Apo 3.10 -143.75 -163.54 62.51 58.37 96.78 -169.51 -111.34 23.76 -66.22 -42.69 -57.80 999.00 Outlier THR ASP PHE GLY"
"EGFR_HUMAN t_2JITB.pdb TYR DFGinter 5 Apo 3.10 -65.07 133.16 -70.88 -114.39 36.10 63.52 -84.27 149.79 -108.27 60.92 22.91 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_2JIUA.pdb TYR Active 1 AEE 3.05 -145.47 179.29 -169.54 63.57 89.68 -147.14 -108.65 24.16 -50.79 -34.62 -27.91 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_2JIUB.pdb TYR DFGinter 5 Apo 3.05 -62.50 140.79 78.58 -118.62 55.66 59.71 -100.19 143.93 -101.21 62.96 28.62 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_2JIVA.pdb TYR DFGup 3 HKI 3.5 -99.11 179.70 -110.70 43.12 110.41 -55.47 179.65 142.50 59.37 76.47 0.28 999.00 Outlier THR ASP PHE GLY"
"EGFR_HUMAN t_2JIVB.pdb TYR DFGup 3 HKI 3.5 -147.05 -173.41 26.47 50.12 19.42 -69.37 -76.09 164.07 47.99 34.88 16.96 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_2RF9A.pdb TYR DFGout 6 Apo 3.50 -121.79 171.56 -46.45 -138.79 149.62 173.80 -128.20 33.72 -72.12 57.47 26.73 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_2RF9B.pdb TYR DFGout 6 Apo 3.50 -135.46 135.37 -58.83 -89.58 173.51 -172.17 -159.19 36.82 -79.95 54.92 39.43 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_2RFDA.pdb TYR DFGin-trans 4 Apo 3.60 -126.62 163.07 -168.00 65.08 46.37 -64.82 -86.22 138.51 145.35 74.32 0.79 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_2RFDB.pdb TYR DFGin-trans 4 Apo 3.60 -162.63 174.06 -165.14 64.35 34.57 -89.22 -66.50 135.80 150.15 39.74 39.57 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_2RFEA.pdb TYR DFGin-trans 4 Apo 2.90 -126.11 179.90 -169.69 68.37 3.87 -81.76 -53.06 130.90 165.66 83.11 -16.61 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_2RFEB.pdb TYR DFGin-trans 4 Apo 2.90 -132.19 -179.97 -171.60 69.08 4.92 -82.00 -54.43 127.15 163.81 86.18 -10.83 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_2RFEC.pdb TYR DFGin-trans 4 Apo 2.90 -129.99 -176.44 -173.61 64.13 8.90 -71.50 -57.20 123.18 161.31 105.19 -30.21 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_2RFED.pdb TYR DFGin-trans 4 Apo 2.90 -125.66 174.96 -176.12 73.21 5.64 -82.36 -51.38 131.81 165.42 87.01 -8.40 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_2RGPA.pdb TYR DFGup 3 HYZ 2.00 -140.93 177.87 -169.22 65.41 21.15 -130.55 -77.75 153.74 43.66 83.05 -34.56 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_3BELA.pdb TYR DFGup 3 POX 2.30 -143.97 174.66 -171.12 70.43 15.82 -136.08 -72.90 152.06 48.88 82.20 -30.44 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_3GOPA.pdb TYR DFGup 3 Apo 2.80 -81.84 151.25 148.30 -44.38 144.99 -42.46 -81.82 77.35 22.44 178.29 999.00 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_3GT8A.pdb TYR DFGin-trans 4 ANP 2.96 -126.85 160.91 58.98 79.31 15.23 -77.63 -62.32 143.13 149.46 77.47 3.87 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_3GT8B.pdb TYR DFGin-trans 4 ANP 2.96 -113.68 -174.89 12.17 52.30 31.74 -66.65 -67.41 143.52 157.46 60.27 2.07 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_3GT8C.pdb TYR DFGin-trans 4 ANP 2.96 -111.03 -172.94 25.34 50.51 27.12 -62.07 -68.51 136.21 146.07 59.11 17.79 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_3GT8D.pdb TYR DFGin-trans 4 ANP 2.96 -129.92 167.43 -24.62 62.56 32.14 -67.55 -70.13 140.84 152.87 77.50 -20.55 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_3IKAA.pdb TYR Active 1 0UN 2.90 -126.12 -29.51 -164.33 -103.66 124.92 -154.12 -119.86 2.01 -65.77 -43.89 -35.48 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_3IKAB.pdb TYR DFGinter 5 Apo 2.90 -75.20 143.74 81.34 -113.66 39.21 61.55 -87.71 145.68 -95.32 65.56 19.18 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_3LZBA.pdb TYR DFGup 3 ITI 2.70 -125.07 176.43 -177.28 56.10 40.38 -43.81 -84.23 136.17 42.65 78.34 7.71 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_3LZBB.pdb TYR DFGup 3 ITI 2.70 -119.70 -179.34 178.48 54.94 41.30 -43.92 -86.84 133.55 41.51 73.50 9.06 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_3LZBC.pdb TYR DFGup 3 ITI 2.70 -132.55 174.79 -178.56 57.15 36.27 -46.94 -81.77 140.11 44.10 73.85 8.39 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_3LZBD.pdb TYR DFGup 3 ITI 2.70 -128.53 168.06 -172.45 64.64 28.60 -66.91 -76.09 143.41 45.15 72.44 3.50 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_3POZA.pdb TYR DFGup 3 03P 1.50 -134.00 177.93 -167.28 66.74 22.05 -138.60 -76.99 146.75 49.11 73.37 4.89 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_3UG1A.pdb TYR Active 1 Apo 2.75 -138.29 -170.11 -165.09 52.78 84.88 -176.75 -101.79 16.88 -67.45 -38.64 -36.00 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_3UG2A.pdb TYR Active 1 IRE 2.50 -131.79 -168.87 -159.28 59.63 80.04 -156.51 -93.00 13.80 -79.17 -52.23 -28.75 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_3VJNA.pdb TYR Active 1 ANP 2.34 -140.39 -172.56 -161.39 66.84 81.41 -154.83 -96.20 22.32 -74.72 -61.67 -24.36 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_3VJOA.pdb TYR Active 1 ANP 2.64 -140.24 -165.51 -173.04 56.52 77.00 -160.64 -90.25 19.04 -74.08 -60.99 -7.62 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_3W2OA.pdb TYR Active 1 03P 2.35 -137.00 -170.60 -163.02 62.28 87.72 -164.89 -101.43 18.91 -68.59 -57.48 -26.36 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_3W2PA.pdb TYR Active 1 W2P 2.05 -131.75 -170.03 -165.16 61.74 87.12 -166.74 -100.13 22.28 -71.12 -59.86 -24.48 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_3W2QA.pdb TYR Active 1 HKI 2.20 -130.62 -173.42 -167.95 61.58 82.73 -165.38 -98.16 22.08 -72.56 -65.29 -18.01 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_3W2RA.pdb TYR DFGup 3 W2R 2.05 -137.59 178.06 -163.35 54.92 38.10 -133.02 -65.56 155.85 47.33 -65.45 174.29 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_3W2SA.pdb TYR DFGup 3 W2R 1.90 -137.20 -178.37 -162.52 61.07 30.64 -74.74 -95.03 163.06 54.52 79.37 159.33 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_3W32A.pdb TYR DFGup 3 W32 1.80 -134.95 174.76 -168.29 75.65 15.70 -143.90 -74.58 135.96 48.36 85.13 3.49 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_3W33A.pdb TYR DFGup 3 W19 1.70 -137.50 -177.57 -163.43 63.44 25.27 -96.68 -82.15 140.52 46.67 72.37 8.80 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_4G5JA.pdb TYR Active 1 0WN 2.80 -144.89 -175.64 -157.65 68.29 78.28 -143.28 -100.63 32.31 -57.54 -64.27 -33.63 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_4G5PA.pdb TYR Active 1 0WN 3.17 -124.20 171.48 37.29 77.96 83.87 -166.09 -103.07 36.68 -57.94 -79.99 -21.25 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_4G5PB.pdb TYR DFGinter 5 Apo 3.17 -102.33 130.06 -76.40 -119.37 11.60 70.35 -56.19 139.52 -91.31 83.17 48.13 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_4HJOA.pdb TYR DFGin-trans 4 AQ4 2.75 -124.64 174.11 -153.17 69.38 22.19 -89.22 -65.96 132.45 169.63 88.50 -10.49 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_4I1ZA.pdb TYR DFGout 6 Apo 3.00 -123.85 156.97 -165.35 -117.63 154.19 142.53 -127.89 41.86 -153.72 82.23 13.29 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_4I20A.pdb TYR DFGout 6 Apo 3.34 -125.67 154.34 -167.68 -115.90 140.99 160.71 -109.47 14.55 -145.50 110.71 -3.62 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_4I21A.pdb TYR DFGout 6 Apo 3.37 -100.31 172.67 -165.42 -126.12 170.09 -168.57 -163.08 33.16 -149.52 95.37 -18.50 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_4I21B.pdb TYR DFGout 6 Apo 3.37 -99.82 173.30 -165.59 -125.80 171.22 -168.79 -163.83 32.73 -149.07 95.01 -18.27 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_4I22A.pdb TYR DFGin-trans 4 IRE 1.71 -123.08 -178.66 -168.42 68.35 18.90 -127.17 -65.26 136.29 169.38 94.32 -11.33 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_4I23A.pdb TYR Active 1 1C9 2.80 -136.95 -174.25 -161.75 62.71 72.41 -142.99 -94.89 21.36 -58.02 -66.85 22.77 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_4I24A.pdb TYR DFGin-trans 4 1C9 1.80 -124.79 -177.94 -165.53 65.97 19.28 -89.00 -65.92 134.74 167.41 100.68 -25.91 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_4I24B.pdb TYR DFGin-trans 4 1C9 1.80 -127.52 -179.75 -165.41 73.23 11.53 -109.44 -60.89 132.74 167.81 94.21 -14.80 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_4JQ7A.pdb TYR Active 1 KJQ 2.73 -142.57 -163.87 -165.35 57.93 63.36 -120.83 -87.16 23.64 -62.52 -62.28 -27.74 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_4JQ8A.pdb TYR Active 1 KJ8 2.83 -152.57 -167.94 -159.55 59.06 68.69 -84.91 -90.88 39.60 -42.01 -67.30 -22.20 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_4JR3A.pdb TYR Active 1 KJR 2.70 -140.10 -158.23 -169.73 57.47 55.15 -104.12 -81.22 25.30 -60.81 -63.69 -23.14 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_4JRVA.pdb TYR Active 1 KJV 2.80 -149.39 -166.40 -165.73 54.51 65.71 -100.49 -83.97 22.00 -59.39 -61.90 -15.58 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_4LI5A.pdb TYR Active 1 1WY 2.64 -131.00 -176.70 -169.18 65.74 86.46 -162.12 -104.41 23.53 -67.66 -61.39 -28.57 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_4LL0A.pdb TYR Active 1 YUN 4.00 -163.78 69.80 -170.99 -169.13 137.17 -153.20 -134.78 14.69 -81.72 -54.78 -37.98 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_4LL0B.pdb TYR Active 1 YUN 4.00 -150.58 21.70 -171.02 -117.56 135.66 -162.02 -123.02 27.80 -96.24 -54.74 -34.63 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_4LQMA.pdb TYR Active 1 DJK 2.50 -148.28 -172.90 -144.15 62.15 72.20 -135.16 -94.64 21.48 -63.33 -60.18 -37.73 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_4LRMA.pdb TYR Active 1 YUN 3.53 -158.56 -179.82 -75.86 59.49 67.71 -176.19 -73.32 -10.60 -55.11 -43.14 -43.94 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_4LRMB.pdb TYR Active 1 YUN 3.53 -142.17 -169.95 -24.36 61.40 66.04 -142.13 -84.70 8.74 -58.62 -51.07 -43.15 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_4LRMC.pdb TYR Active 1 YUN 3.53 -160.49 -176.43 -71.63 59.95 67.08 -176.78 -79.96 -1.66 -76.21 -59.03 -39.56 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_4LRMD.pdb TYR Active 1 YUN 3.53 -148.38 -162.16 -20.64 52.46 44.99 -156.71 -64.81 -16.22 -116.64 -40.20 -53.88 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_4LRME.pdb TYR Active 1 YUN 3.53 -149.12 177.78 -75.18 56.24 51.45 -151.62 -60.23 -36.05 -81.78 -54.00 140.39 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_4R3PA.pdb TYR Active 1 Apo 2.90 -146.91 -167.91 -171.20 65.01 63.51 -160.30 -93.35 28.95 -55.48 -64.08 -32.91 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_4R3RA.pdb TYR Active 1 Apo 3.25 -140.42 -167.27 -174.79 58.15 75.66 -162.80 -100.04 23.11 -64.43 -63.13 -27.49 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_4R5SA.pdb TYR Active 1 FI3 3.00 -157.19 -179.91 -109.82 56.98 47.31 -167.04 -82.15 60.04 -1.48 -65.05 -39.65 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_4RIWB.pdb TYR Active 1 ADP 3.10 -144.95 -140.88 39.39 60.61 -94.56 -161.63 67.72 16.38 -66.48 -72.73 -24.69 999.00 Outlier THR ASP PHE GLY"
"EGFR_HUMAN t_4RIWD.pdb TYR Active 1 ADP 3.10 -147.43 -141.56 171.73 60.22 -94.40 -160.96 68.10 17.38 -65.80 -72.19 -23.26 999.00 Outlier THR ASP PHE GLY"
"EGFR_HUMAN t_4RIXB.pdb TYR Active 1 ADP 3.10 -139.81 -153.46 39.24 71.82 -106.45 -148.51 74.55 12.87 -59.83 -72.99 -18.88 999.00 Outlier THR ASP PHE GLY"
"EGFR_HUMAN t_4RIXD.pdb TYR Active 1 ADP 3.10 -138.73 -155.77 -178.24 70.91 -102.21 -148.51 73.97 14.45 -60.90 -71.01 -17.99 999.00 Outlier THR ASP PHE GLY"
"EGFR_HUMAN t_4RIYB.pdb TYR Active 1 ADP 2.98 -154.95 131.24 -175.51 -173.15 -76.86 -168.58 64.93 12.48 -59.31 -71.97 -28.25 999.00 Outlier THR ASP PHE GLY"
"EGFR_HUMAN t_4RIYD.pdb TYR Active 1 ADP 2.98 -146.69 -160.65 -179.17 90.34 -82.59 -169.24 63.91 14.35 -62.75 -69.54 -27.11 999.00 Outlier THR ASP PHE GLY"
"EGFR_HUMAN t_4RJ4A.pdb TYR Active 1 3QW 2.78 -140.68 -172.60 -162.39 68.52 86.32 -161.39 -99.80 22.22 -63.99 -65.66 -16.32 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_4RJ5A.pdb TYR Active 1 3QY 3.10 -139.15 -171.99 -158.57 64.72 84.34 -151.11 -102.54 37.37 -65.05 -69.87 -22.48 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_4RJ6A.pdb TYR Active 1 3R0 2.70 -136.98 -168.03 -159.10 64.44 79.07 -146.09 -92.08 -167.12 -55.77 103.24 -12.26 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_4RJ7A.pdb TYR Active 1 3R1 2.55 -136.47 -172.33 -166.40 66.64 81.85 -161.23 -97.53 17.75 -65.85 -65.85 -16.96 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_4RJ8A.pdb TYR Active 1 3QS 2.50 -139.12 -167.48 -164.35 68.30 77.56 -144.37 -89.12 10.30 -65.91 -54.94 -20.89 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_4TKSA.pdb TYR Active 1 Apo 3.20 -158.54 -164.67 -176.88 57.02 87.22 -177.00 -106.21 31.60 -59.14 -73.30 -8.82 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_4WD5A.pdb TYR Active 1 3LH 3.30 -163.53 -174.21 -120.02 53.28 61.79 -163.75 -88.05 5.09 -67.80 -57.36 -39.63 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_4WD5B.pdb TYR DFGinter 5 Apo 3.30 -72.60 139.35 94.29 -100.72 10.08 50.49 -62.52 143.44 -99.33 58.65 39.06 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_4WKQA.pdb TYR Active 1 IRE 1.85 -136.94 -168.00 -162.24 60.83 77.91 -93.48 -98.45 20.72 -69.47 -58.22 -27.01 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_4WRGA.pdb TYR Active 1 Apo 1.90 -132.44 -176.95 -165.00 62.33 81.47 -159.71 -96.81 20.75 -66.97 -69.52 -16.66 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_4ZAUA.pdb TYR Active 1 YY3 2.80 -144.77 -170.18 -169.03 56.74 87.22 -149.93 -105.04 22.23 -68.38 -61.22 -22.95 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_4ZJVA.pdb TYR DFGout 6 Apo 2.70 -126.99 171.59 38.54 -126.43 148.69 -166.86 -117.74 34.55 -58.56 92.12 1.65 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_4ZJVB.pdb TYR DFGout 6 Apo 2.70 -124.85 -179.35 -160.72 -140.69 141.14 -173.08 -114.00 39.58 -49.17 73.82 21.15 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_4ZSEA.pdb TYR DFGin-trans 4 ANP 1.97 -132.95 171.35 -161.90 59.23 30.92 -83.55 -64.32 136.48 153.62 84.49 -7.13 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_4ZSEB.pdb TYR DFGin-trans 4 ANP 1.97 -132.19 168.86 -161.99 69.76 21.24 -82.49 -63.32 134.00 158.05 88.89 -12.65 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_4ZSEC.pdb TYR DFGin-trans 4 ANP 1.97 -132.03 169.70 -163.13 72.08 15.83 -84.37 -57.72 131.99 161.44 90.51 -14.79 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_4ZSED.pdb TYR DFGup 3 ANP 1.97 -139.55 164.74 -170.42 66.53 26.18 -76.06 -71.21 138.43 53.70 74.40 7.30 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_5C8KA.pdb TYR Active 1 4YV 3.00 -142.53 -168.76 -163.04 65.80 82.10 -144.61 -97.63 22.30 -59.26 -60.42 -26.10 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_5C8MA.pdb TYR Active 1 4YW 2.90 -139.90 -166.41 -164.35 62.50 82.82 -150.25 -104.22 35.11 -56.77 -71.46 -7.60 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_5C8NA.pdb TYR Active 1 4YX 2.40 -130.09 -164.06 -159.21 61.95 82.99 -165.48 -95.78 18.72 -58.87 -62.83 -10.05 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_5CALA.pdb TYR Active 1 4Z8 2.70 -137.36 -172.89 -164.17 65.78 89.62 -165.11 -103.25 18.79 -62.22 -65.04 -18.86 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_5CANA.pdb TYR Active 1 4ZB 2.80 -142.66 -174.89 -163.08 68.88 93.28 -167.37 -106.78 21.13 -63.22 -65.94 -14.89 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_5CAOA.pdb TYR Active 1 4ZG 2.60 -132.00 -172.71 -161.40 65.57 80.26 -162.54 -104.94 26.78 -36.15 -77.95 14.16 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_5CAPA.pdb TYR Active 1 4ZH 2.40 -134.49 -171.03 -167.35 72.05 88.35 -153.54 -110.47 24.88 -56.17 -72.35 -6.82 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_5CAQA.pdb TYR Active 1 4ZJ 2.50 -136.99 -170.05 -162.41 67.32 79.05 -146.76 -91.71 13.17 -65.74 -60.54 -10.01 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_5CASA.pdb TYR Active 1 4ZQ 2.10 -138.53 -167.79 -162.04 68.06 80.03 -153.36 -91.61 15.85 -63.86 -57.68 -21.98 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_5CAUA.pdb TYR Active 1 4ZR 2.25 -141.51 -166.29 -163.14 67.74 77.41 -149.59 -89.36 12.86 -64.92 -56.63 -14.59 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_5CAVA.pdb TYR Active 1 4ZQ 2.73 -144.15 -171.01 -159.81 62.21 83.10 -158.36 -95.57 29.46 -65.54 -62.26 -29.70 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_5CNNA.pdb TYR DFGup 3 ANP 1.90 -125.07 165.11 -164.70 65.78 30.65 -70.29 -73.23 142.49 57.26 61.04 28.86 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_5CNNB.pdb TYR DFGin-trans 4 ANP 1.90 -117.71 174.38 -172.74 67.17 24.14 -79.18 -60.92 135.44 168.19 97.25 -21.66 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_5CNOA.pdb TYR DFGin-trans 4 ANP 1.55 -118.06 171.22 -168.27 68.20 21.56 -77.60 -56.80 132.52 171.17 99.52 -19.85 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_5CNOB.pdb TYR DFGup 3 ANP 1.55 -128.74 161.65 -170.50 68.16 38.22 -72.34 -78.06 143.33 56.14 54.82 36.16 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_5CZHA.pdb TYR Active 1 Apo 2.80 -151.21 -172.36 -161.78 58.68 69.41 -168.58 -89.38 12.11 -75.06 -57.88 -36.96 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_5CZIA.pdb TYR Active 1 Apo 2.60 -151.91 -175.89 -146.36 60.53 74.38 -157.61 -93.43 17.69 -75.11 -59.34 -35.77 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_5D41A.pdb TYR DFGup 3 ANP 2.31 -130.32 169.19 -169.27 61.98 37.86 -73.21 -93.22 173.69 50.80 79.66 -10.56 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_5D41B.pdb TYR DFGup 3 ANP 2.31 -122.55 173.41 -168.56 56.75 40.27 -71.24 -84.44 150.40 61.49 79.86 -36.14 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_5EDPA.pdb TYR Active 1 Apo 2.90 -133.63 -173.53 -167.82 50.42 39.70 -117.59 -96.79 38.21 47.94 -95.64 31.38 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_5EDQA.pdb TYR DFGup 3 5N3 2.80 -140.43 178.61 -166.30 58.91 32.87 -141.13 -88.47 -6.62 42.12 -82.15 42.08 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_5EDRA.pdb TYR DFGup 3 5N4 2.60 -140.88 -176.90 -161.67 54.88 32.13 -151.48 -91.82 -13.06 46.92 -70.24 -16.54 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_5EM5A.pdb TYR Active 1 5Q2 2.65 -136.67 -176.73 -160.90 58.31 34.95 -123.93 -98.56 19.74 49.96 -81.66 -7.25 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_5EM6A.pdb TYR Active 1 5Q3 2.78 -133.37 -176.47 -152.38 60.76 93.43 -160.16 -103.38 -152.41 -63.58 86.50 -35.55 999.00 Outlier THR ASP PHE GLY"
"EGFR_HUMAN t_5EM7A.pdb TYR Active 1 5Q4 2.81 -135.49 -175.45 -162.31 63.27 90.17 -166.91 -107.30 25.17 -68.18 -73.86 -13.03 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_5EM8A.pdb TYR Active 1 5Q4 2.80 -136.53 -174.10 -154.10 61.59 87.31 -156.88 -100.84 25.49 -67.02 -58.04 -32.55 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_5FEDA.pdb TYR Active 1 5X4 2.65 -132.08 176.32 -167.97 73.45 78.94 -151.68 -101.42 14.24 -61.65 -61.64 -39.30 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_5FEEA.pdb TYR Active 1 5X4 2.70 -148.21 -167.34 -168.92 40.90 69.08 -175.52 -115.77 70.36 31.39 -71.53 -22.90 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_5FEQA.pdb TYR Active 1 5XH 3.40 -131.61 -168.92 -158.39 59.10 85.27 -150.64 -106.59 25.32 -69.63 -66.08 -31.11 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_5GNKA.pdb TYR DFGup 3 NO3 1.80 -124.45 161.05 68.00 73.52 15.52 -66.76 -61.72 132.90 35.62 87.33 -10.66 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_5HCXA.pdb TYR Active 1 60B 2.60 -134.69 -168.36 -160.32 67.29 84.04 -151.13 -96.98 11.59 -67.20 -56.19 -12.00 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_5HCYA.pdb TYR Active 1 60D 2.46 -135.18 -165.77 -160.66 65.89 78.28 -157.74 -90.97 13.19 -64.55 -55.11 -21.46 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_5HCZA.pdb TYR Active 1 60E 2.62 -138.51 -168.96 -163.00 67.64 84.66 -153.02 -98.70 22.03 -61.98 -59.73 -32.29 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_5HG5A.pdb TYR DFGout 6 633 1.52 -126.27 157.06 -48.77 -124.99 131.02 170.88 -111.47 16.09 -76.43 125.17 -6.95 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_5HG7A.pdb TYR DFGout 6 630 1.85 -132.65 173.32 -164.34 -137.72 131.91 166.25 -112.37 18.99 -70.99 120.51 -2.69 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_5HG8A.pdb TYR DFGout 6 634 1.42 -125.17 162.11 63.80 -128.71 135.61 169.59 -116.18 20.37 -74.30 125.66 -13.12 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_5HG9A.pdb TYR DFGout 6 63A 2.15 -124.50 175.20 -168.95 -143.26 132.26 168.92 -115.26 25.20 -69.06 118.59 -2.86 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_5HIBA.pdb TYR Active 1 63M 2.85 -131.06 178.87 69.01 58.61 91.88 -174.04 -106.95 30.43 -66.16 -65.75 -27.23 999.00 Outlier THR ASP PHE GLY"
"EGFR_HUMAN t_5HICA.pdb TYR Active 1 63N 2.60 -139.10 -164.07 -161.21 62.56 78.12 -153.56 -92.53 16.39 -64.68 -61.37 -14.79 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_5J9YA.pdb TYR Active 1 6HL 2.80 -143.42 -160.74 -167.74 48.31 85.23 -124.89 -101.28 18.99 -68.12 -49.60 -50.60 999.00 Outlier THR ASP PHE GLY"
"EGFR_HUMAN t_5J9ZA.pdb TYR Active 1 6HJ 2.50 -138.57 -164.54 -163.88 57.84 71.42 -76.84 -86.37 17.12 -50.54 -45.84 -60.49 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_5JEBA.pdb TYR Active 1 6JS 3.30 -139.57 -161.81 60.94 51.61 77.20 -174.69 -93.66 22.73 -61.49 -63.17 -12.28 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_5U8LA.pdb TYR DFGout 6 O44 1.60 -121.76 139.91 -57.39 -99.38 120.59 172.78 -99.33 -4.71 -74.90 141.83 -0.90 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_5UG8A.pdb TYR DFGout 6 8BP 1.46 -136.96 178.18 -165.56 -138.95 140.11 164.27 -122.37 24.08 -67.86 126.47 -17.28 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_5UG9A.pdb TYR DFGout 6 8AM 1.33 -137.57 179.34 -166.73 -140.84 137.61 162.62 -120.14 23.71 -69.22 126.21 -18.80 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_5UGAA.pdb TYR DFGout 6 8BM 1.82 -135.61 174.09 -168.29 -125.54 131.10 170.56 -113.26 24.67 -72.64 125.13 -19.28 999.00 Favored THR ASP PHE GLY"
"EGFR_HUMAN t_5UGBA.pdb TYR Active 1 8BM 2.53 -134.45 -178.87 -166.80 69.29 78.80 -145.37 -98.20 26.79 -58.51 -60.09 -9.08 999.00 Allowed THR ASP PHE GLY"
"EGFR_HUMAN t_5UGCA.pdb TYR DFGout 6 8BS 1.58 -131.20 172.07 -167.72 -138.25 139.66 163.82 -122.89 19.26 -72.30 122.83 -6.50 999.00 Favored THR ASP PHE GLY"
"EPHA2_HUMAN t_1MQBA.pdb TYR DFGin-inactive 2 ANP 2.30 -127.50 -172.02 -146.88 57.47 74.69 176.38 -110.02 122.67 -53.39 176.63 104.75 999.00 Allowed SER ASP PHE GLY"
"EPHA2_HUMAN t_1MQBB.pdb TYR Active 1 ANP 2.30 -139.66 -173.82 175.80 51.33 81.33 -159.23 -92.71 10.65 -67.04 -41.73 -44.68 999.00 Allowed SER ASP PHE GLY"
"EPHA2_HUMAN t_4P2KA.pdb TYR Active 1 Apo 1.50 -128.05 -172.82 -172.06 59.18 70.36 -115.55 -91.80 18.28 -74.19 -52.46 -41.18 999.00 Allowed SER ASP PHE GLY"
"EPHA2_HUMAN t_4TRLA.pdb TYR Active 1 Apo 2.45 -135.74 -21.41 101.15 -117.74 96.04 -144.99 -97.77 10.58 -60.59 -52.96 -46.19 999.00 Favored SER ASP PHE GLY"
"EPHA2_HUMAN t_5EK7A.pdb TYR DFGin-inactive 2 Apo 1.90 -130.65 -168.30 -177.77 62.04 69.61 -179.04 -99.86 88.16 -69.23 -94.61 141.70 999.00 Allowed SER ASP PHE GLY"
"EPHA2_HUMAN t_5EK7B.pdb TYR DFGin-inactive 2 Apo 1.90 -126.50 -164.92 176.61 55.71 72.14 -148.98 -96.76 90.27 -64.47 -90.83 136.50 999.00 Allowed SER ASP PHE GLY"
"EPHA2_HUMAN t_5I9UA.pdb TYR Active 1 Apo 1.89 -130.24 -168.87 -42.47 54.85 69.85 -72.45 -93.89 19.73 -62.47 -63.43 -27.52 999.00 Allowed SER ASP PHE GLY"
"EPHA2_HUMAN t_5I9VA.pdb TYR Active 1 AGS 1.46 -141.45 -177.66 -178.63 61.39 75.10 -161.92 -93.17 20.32 -60.45 -61.08 -30.94 999.00 Allowed SER ASP PHE GLY"
"EPHA2_HUMAN t_5I9WA.pdb TYR DFGin-inactive 2 ANP 1.36 -125.94 -162.34 -176.74 67.24 57.67 -178.72 -98.90 156.86 -65.64 164.47 175.48 999.00 Allowed SER ASP PHE GLY"
"EPHA2_HUMAN t_5I9XA.pdb TYR DFGin-inactive 2 DB8 1.43 -129.08 177.71 67.58 76.64 79.95 -168.20 -112.76 156.96 -62.70 146.96 -174.66 999.00 Allowed SER ASP PHE GLY"
"EPHA2_HUMAN t_5I9YA.pdb TYR DFGin-inactive 2 1N1 1.23 -124.31 -158.35 63.85 58.33 77.72 -164.05 -114.07 153.32 -64.08 147.69 -171.76 999.00 Allowed SER ASP PHE GLY"
"EPHA2_HUMAN t_5I9ZA.pdb TYR DFGin-inactive 2 627 1.70 -135.13 -162.14 177.85 63.35 62.32 -170.76 -99.33 153.92 -63.67 156.27 -159.68 999.00 Allowed SER ASP PHE GLY"
"EPHA2_HUMAN t_5IA0A.pdb TYR DFGin-inactive 2 A5B 1.95 -131.02 -155.72 179.34 61.62 69.46 -177.57 -104.73 92.01 -60.80 -172.84 999.00 999.00 Allowed SER ASP PHE GLY"
"EPHA2_HUMAN t_5IA0B.pdb TYR DFGin-inactive 2 A5B 1.95 -126.97 -156.55 177.98 64.05 67.01 -173.34 -103.79 142.26 -60.03 123.48 148.27 999.00 Allowed SER ASP PHE GLY"
"EPHA2_HUMAN t_5IA0C.pdb TYR DFGin-inactive 2 A5B 1.95 -132.97 -162.73 -174.07 63.93 70.18 -164.63 -105.45 159.59 -56.53 149.65 -160.55 999.00 Allowed SER ASP PHE GLY"
"EPHA2_HUMAN t_5IA1A.pdb TYR DFGin-inactive 2 ZZL 2.04 -130.49 -159.41 173.46 76.27 -65.90 -173.98 93.26 -3.67 -72.37 73.68 -159.40 999.00 Allowed SER ASP PHE GLY"
"EPHA2_HUMAN t_5IA2A.pdb TYR DFGin-inactive 2 L66 1.62 -134.45 -178.13 68.55 76.71 84.05 -165.73 -119.07 159.18 -56.55 144.33 -174.22 999.00 Allowed SER ASP PHE GLY"
"EPHA2_HUMAN t_5IA3A.pdb TYR DFGin-inactive 2 P17 1.79 -140.29 -177.99 61.98 75.10 87.39 -169.24 -118.91 162.93 -63.86 122.43 -162.95 999.00 Allowed SER ASP PHE GLY"
"EPHA2_HUMAN t_5IA4A.pdb TYR DFGout 6 88Z 1.80 -141.37 176.34 72.06 -148.47 94.61 -175.58 -58.81 -30.42 -172.41 105.07 22.92 999.00 Favored SER ASP PHE GLY"
"EPHA2_HUMAN t_5IA5A.pdb TYR DFGout 6 GV0 1.78 -143.34 173.20 66.53 -151.41 82.73 -172.80 -56.44 -33.04 175.69 110.23 32.24 999.00 Allowed SER ASP PHE GLY"
"EPHA3_HUMAN t_2GSFA.pdb TYR Active 1 Apo 1.77 -131.49 -172.56 -165.47 60.33 76.56 -160.29 -88.55 16.39 -66.87 -68.31 -25.67 999.00 Allowed SER ASP PHE GLY"
"EPHA3_HUMAN t_2QO2A.pdb TYR DFGin-inactive 2 Apo 1.60 -131.78 -165.30 -173.49 66.42 65.06 -172.70 -102.64 10.58 -64.53 -82.73 999.00 999.00 Allowed SER ASP PHE GLY"
"EPHA3_HUMAN t_2QO7A.pdb TYR DFGin-inactive 2 ANP 1.60 -130.77 -168.29 -172.06 68.61 58.51 178.15 -92.33 46.92 -62.38 -87.87 999.00 999.00 Allowed SER ASP PHE GLY"
"EPHA3_HUMAN t_2QO9A.pdb TYR Active 1 ANP 1.55 -133.31 -177.90 -166.66 59.01 80.20 -164.21 -92.69 15.73 -64.14 -55.83 -40.59 999.00 Allowed SER ASP PHE GLY"
"EPHA3_HUMAN t_2QOBA.pdb TYR Active 1 Apo 1.65 -134.73 -176.72 -177.85 61.41 83.97 -162.48 -96.41 20.47 -58.95 -60.35 -35.11 999.00 Allowed SER ASP PHE GLY"
"EPHA3_HUMAN t_2QOCA.pdb TYR Active 1 ANP 1.25 -132.63 178.47 -177.61 61.61 84.22 -163.56 -97.27 21.90 -62.90 -61.69 -31.74 999.00 Allowed SER ASP PHE GLY"
"EPHA3_HUMAN t_2QOKA.pdb TYR Active 1 Apo 1.20 -135.36 -175.83 74.79 63.15 78.83 -156.04 -100.20 55.39 -68.17 -103.96 -34.05 999.00 Allowed SER ASP PHE GLY"
"EPHA3_HUMAN t_2QONA.pdb TYR Active 1 Apo 1.79 -135.37 -176.79 83.00 60.61 74.49 -158.36 -94.44 24.37 -60.45 -58.68 -38.52 999.00 Allowed SER ASP PHE GLY"
"EPHA3_HUMAN t_2QOQA.pdb TYR DFGin-inactive 2 ANP 1.60 -132.41 -170.87 -175.34 64.30 72.55 -177.08 -105.47 56.49 -58.97 -101.24 999.00 999.00 Allowed SER ASP PHE GLY"
"EPHA3_HUMAN t_3DZQA.pdb TYR DFGout 6 IFC 1.75 -139.28 -173.72 -46.19 -161.04 114.40 -171.76 -97.66 3.87 -49.20 77.88 179.83 999.00 Allowed SER ASP PHE GLY"
"EPHA3_HUMAN t_3FXXA.pdb TYR Active 1 ANP 1.70 -135.08 -173.37 76.34 56.23 78.33 -159.20 -91.41 22.67 -61.46 -59.17 -30.29 999.00 Allowed SER ASP PHE GLY"
"EPHA3_HUMAN t_3FY2A.pdb TYR Active 1 Apo 1.80 -134.96 -176.32 -166.58 58.62 75.94 -153.79 -90.11 19.88 -61.78 -58.28 -34.41 999.00 Allowed SER ASP PHE GLY"
"EPHA3_HUMAN t_4G2FA.pdb TYR Active 1 C07 1.70 -131.68 -174.37 -174.07 59.67 79.43 -178.02 -98.94 31.73 -63.01 -73.91 -33.00 999.00 Allowed SER ASP PHE GLY"
"EPHA3_HUMAN t_4GK2A.pdb TYR DFGin-inactive 2 L66 2.19 -141.58 -172.14 82.11 65.24 79.02 -174.63 -100.71 30.31 -55.84 -69.10 -39.71 999.00 Allowed SER ASP PHE GLY"
"EPHA3_HUMAN t_4GK3A.pdb TYR Active 1 L87 1.90 -126.50 -169.47 -50.28 48.29 97.81 -163.84 -109.47 24.03 -65.56 -59.03 -35.35 999.00 Outlier SER ASP PHE GLY"
"EPHA3_HUMAN t_4GK4A.pdb TYR Active 1 L90 2.10 -141.60 -169.35 58.46 54.48 84.53 -167.17 -99.55 22.25 -55.57 -54.82 -38.22 999.00 Allowed SER ASP PHE GLY"
"EPHA3_HUMAN t_4P5QA.pdb TYR Active 1 Q0B 1.35 -133.74 -174.39 74.74 65.74 76.19 177.63 -99.62 30.68 -68.52 -83.87 -18.11 999.00 Allowed SER ASP PHE GLY"
"EPHA3_HUMAN t_4TWNA.pdb TYR DFGout 6 B96 1.71 -134.68 178.85 80.53 -131.05 59.68 -159.73 -53.31 -39.82 -170.87 -55.34 -51.29 999.00 Allowed SER ASP PHE GLY"
"EPHA3_HUMAN t_4TWOA.pdb TYR Active 1 37W 2.05 -137.28 -171.71 171.97 56.40 84.69 -158.64 -101.98 32.12 -61.36 -60.75 -52.63 999.00 Allowed SER ASP PHE GLY"
"EPHA5_HUMAN t_2R2PA.pdb TYR Active 1 Apo 2.40 -137.18 -176.54 -179.03 51.54 82.79 -169.18 -103.68 29.05 -51.98 -58.78 -41.83 999.00 Allowed SER ASP PHE GLY"
"EPHA7_HUMAN t_2REIA.pdb TYR DFGin-inactive 2 Apo 1.60 -132.66 -167.02 73.68 63.88 80.73 178.47 -109.80 15.46 -63.29 -73.33 178.41 999.00 Allowed SER ASP PHE GLY"
"EPHA7_HUMAN t_3DKOA.pdb TYR DFGout 6 IHZ 2.00 -143.07 -173.31 -40.82 -161.08 120.52 -165.90 -95.58 1.43 -71.94 75.54 999.00 999.00 Favored SER ASP PHE GLY"
"EPHA8_HUMAN t_3KULA.pdb TYR Active 1 Apo 2.15 -132.29 178.68 75.98 63.33 84.49 -157.90 -103.68 28.01 -63.89 -76.20 -31.31 999.00 Allowed SER ASP PHE GLY"
"EPHA8_HUMAN t_3KULB.pdb TYR Active 1 Apo 2.15 -134.30 -179.18 72.52 60.93 80.29 -156.79 -99.12 17.03 -61.26 -61.47 -32.86 999.00 Allowed SER ASP PHE GLY"
"EPHB1_HUMAN t_3ZFXA.pdb TYR Active 1 Apo 2.50 -137.27 176.32 165.54 70.33 72.82 -146.24 -91.90 22.78 -62.20 -73.09 -25.81 999.00 Allowed SER ASP PHE GLY"
"EPHB1_HUMAN t_3ZFXB.pdb TYR Active 1 Apo 2.50 -140.81 175.72 159.76 70.17 66.49 -134.72 -88.35 22.53 -63.36 -65.88 -37.45 999.00 Allowed SER ASP PHE GLY"
"EPHB1_HUMAN t_3ZFXC.pdb TYR Active 1 Apo 2.50 -137.70 173.71 163.29 69.13 70.22 -138.54 -91.33 24.04 -63.85 -69.43 -30.69 999.00 Allowed SER ASP PHE GLY"
"EPHB1_HUMAN t_3ZFXD.pdb TYR Active 1 Apo 2.50 -140.73 172.18 178.41 74.92 66.40 -139.29 -93.33 30.34 -62.06 -75.93 -27.42 999.00 Allowed SER ASP PHE GLY"
"EPHB1_HUMAN t_3ZFXE.pdb TYR Active 1 Apo 2.50 -138.15 178.46 163.23 66.81 71.49 -137.07 -93.89 20.11 -64.22 -66.39 -32.63 999.00 Allowed SER ASP PHE GLY"
"EPHB1_HUMAN t_3ZFXF.pdb TYR Active 1 Apo 2.50 -141.16 174.53 173.54 70.48 73.56 -144.89 -96.09 25.21 -61.11 -68.12 -33.67 999.00 Allowed SER ASP PHE GLY"
"EPHB1_HUMAN t_3ZFXG.pdb TYR Active 1 Apo 2.50 -137.36 174.47 166.67 71.01 70.54 -137.25 -95.86 25.69 -62.66 -71.71 -27.93 999.00 Allowed SER ASP PHE GLY"
"EPHB1_HUMAN t_3ZFXH.pdb TYR Active 1 Apo 2.50 -137.93 177.37 -178.96 70.48 70.52 -139.59 -91.80 19.66 -66.12 -66.30 -32.03 999.00 Allowed SER ASP PHE GLY"
"EPHB1_HUMAN t_3ZFXI.pdb TYR Active 1 Apo 2.50 -139.22 176.14 166.82 66.61 74.47 -138.71 -93.19 18.82 -64.63 -62.37 -38.47 999.00 Allowed SER ASP PHE GLY"
"EPHB3_HUMAN t_3ZFYA.pdb TYR DFGin-inactive 2 Apo 2.20 -135.82 169.46 171.47 -155.99 -162.69 -155.31 44.32 31.80 -34.74 -167.03 999.00 999.00 Allowed SER ASP PHE GLY"
"EPHB3_HUMAN t_3ZFYB.pdb TYR DFGin-inactive 2 Apo 2.20 -135.56 169.19 171.95 -156.18 -162.90 -156.03 45.05 29.50 -34.38 -172.32 999.00 999.00 Allowed SER ASP PHE GLY"
"EPHB3_HUMAN t_5L6OA.pdb TYR DFGin-inactive 2 6P6 1.88 -136.07 179.54 -178.00 -169.32 167.12 -159.11 61.98 34.72 -21.98 -115.43 -169.52 999.00 Favored SER ASP PHE GLY"
"EPHB3_HUMAN t_5L6PA.pdb TYR DFGin-inactive 2 6P8 2.26 -121.67 172.65 -173.02 -177.49 159.52 -155.58 60.87 39.02 -29.61 -99.34 -138.58 999.00 Allowed SER ASP PHE GLY"
"EPHB4_HUMAN t_2VWXA.pdb TYR DFGin-inactive 2 7X4 1.65 -131.69 175.27 72.29 83.16 89.56 -161.84 -120.94 136.22 -68.28 176.80 144.39 999.00 Outlier SER ASP PHE GLY"
"EPHB4_HUMAN t_2VWYA.pdb TYR DFGin-inactive 2 7X5 1.65 -130.20 178.96 73.96 77.73 88.44 -165.48 -121.38 135.91 -64.60 176.28 150.89 999.00 Allowed SER ASP PHE GLY"
"EPHB4_HUMAN t_2VWZA.pdb TYR DFGin-inactive 2 7X6 1.65 -131.70 178.06 71.49 81.06 89.01 -164.64 -120.59 135.26 -67.30 177.61 146.70 999.00 Outlier SER ASP PHE GLY"
"EPHB4_HUMAN t_2VX0A.pdb TYR DFGin-inactive 2 7X7 2.10 -143.83 173.42 77.77 80.07 86.51 -166.43 -119.91 137.84 -65.50 174.60 145.02 999.00 Allowed SER ASP PHE GLY"
"EPHB4_HUMAN t_2VX1A.pdb TYR DFGin-inactive 2 7X8 1.65 -129.17 177.77 73.98 80.54 88.44 -166.69 -119.66 136.31 -66.69 177.93 148.02 999.00 Outlier SER ASP PHE GLY"
"EPHB4_HUMAN t_2X9FA.pdb TYR DFGin-inactive 2 X9F 1.75 -134.11 -172.08 75.58 65.05 71.93 -166.26 -106.62 162.24 -58.61 163.12 158.84 999.00 Allowed SER ASP PHE GLY"
"EPHB4_HUMAN t_2XVDA.pdb TYR DFGin-inactive 2 AS6 1.70 -134.77 179.03 80.50 81.46 84.68 -170.94 -123.21 165.88 -59.55 155.10 172.62 999.00 Outlier SER ASP PHE GLY"
"EPHB4_HUMAN t_3ZEWA.pdb TYR Active 1 STU 2.50 -139.19 174.71 161.79 57.86 79.90 -151.34 -97.96 22.65 -60.48 -63.40 -45.16 999.00 Allowed SER ASP PHE GLY"
"EPHB4_HUMAN t_3ZEWB.pdb TYR DFGin-inactive 2 STU 2.50 -136.50 179.28 66.91 65.25 57.02 -163.00 -88.33 123.85 -53.27 132.25 999.00 999.00 Allowed SER ASP PHE GLY"
"EPHB4_HUMAN t_4AW5A.pdb TYR DFGin-inactive 2 30K 2.33 -115.62 -155.36 62.02 43.37 92.72 -133.95 -110.38 -176.15 -63.39 132.47 999.00 999.00 Outlier SER ASP PHE GLY"
"EPHB4_HUMAN t_4BB4A.pdb TYR DFGin-inactive 2 32W 1.65 -130.73 -169.53 -176.79 67.49 72.57 -178.56 -108.04 154.57 -62.13 -178.31 152.19 999.00 Allowed SER ASP PHE GLY"
"ERBB2_HUMAN t_3PP0A.pdb TYR Active 1 03Q 2.25 -143.28 -161.47 -167.03 73.99 -72.26 -167.04 62.71 12.18 -55.96 -53.52 -26.12 999.00 Allowed THR ASP PHE GLY"
"ERBB2_HUMAN t_3PP0B.pdb TYR Active 1 03Q 2.25 -149.08 -166.83 -172.00 85.40 -78.29 -158.41 67.09 11.90 -58.41 -51.92 -39.63 999.00 Outlier THR ASP PHE GLY"
"ERBB2_HUMAN t_3RCDA.pdb TYR DFGup 3 03P 3.21 -131.62 -178.33 -156.67 92.87 -78.85 -105.56 17.90 80.87 36.72 175.61 84.61 999.00 Outlier THR ASP PHE GLY"
"ERBB2_HUMAN t_3RCDB.pdb TYR DFGin-inactive 2 Apo 3.21 -162.53 -165.99 -172.86 69.12 34.01 -136.40 -51.39 70.60 -12.28 31.46 999.00 999.00 Favored THR ASP PHE GLY"
"ERBB2_HUMAN t_3RCDC.pdb TYR DFGup 3 03P 3.21 -129.47 -177.17 -158.40 93.52 -78.39 -103.85 17.50 81.69 36.41 174.08 84.09 999.00 Outlier THR ASP PHE GLY"
"ERBB2_HUMAN t_3RCDD.pdb TYR DFGin-inactive 2 Apo 3.21 -162.06 -166.01 -173.53 68.94 33.08 -135.50 -50.11 70.41 -11.92 32.90 999.00 999.00 Favored THR ASP PHE GLY"
"ERBB3_HUMAN t_3KEXA.pdb TYR DFGup 3 ANP 2.80 -136.98 172.90 999.00 58.17 40.22 -102.83 -96.09 155.02 48.14 69.62 -19.85 999.00 Favored ALA ASP PHE GLY"
"ERBB3_HUMAN t_3KEXB.pdb TYR DFGup 3 ANP 2.80 -137.46 172.26 999.00 58.53 39.16 -103.24 -94.12 155.33 47.88 68.90 -19.36 999.00 Favored ALA ASP PHE GLY"
"ERBB3_HUMAN t_3LMGA.pdb TYR DFGup 3 ANP 2.80 -117.81 170.87 999.00 63.57 24.73 -92.65 -69.24 132.00 43.96 70.89 7.12 999.00 Favored ALA ASP PHE GLY"
"ERBB3_HUMAN t_3LMGB.pdb TYR DFGup 3 ANP 2.80 -113.48 165.54 999.00 66.20 22.92 -88.26 -73.26 147.24 48.66 80.96 -18.44 999.00 Favored ALA ASP PHE GLY"
"ERBB3_HUMAN t_4OTWA.pdb TYR DFGup 3 DB8 2.51 -117.53 171.13 999.00 70.66 16.22 -148.99 -71.62 137.29 50.83 83.04 -15.74 999.00 Favored ALA ASP PHE GLY"
"ERBB3_HUMAN t_4RIWA.pdb TYR DFGup 3 ANP 3.10 -124.70 170.72 999.00 61.92 32.91 -75.04 -86.74 138.17 53.96 80.06 -6.45 999.00 Favored ALA ASP PHE GLY"
"ERBB3_HUMAN t_4RIWC.pdb TYR DFGup 3 ANP 3.10 -125.03 170.63 999.00 62.13 33.09 -74.97 -86.98 138.34 54.45 79.97 -6.34 999.00 Favored ALA ASP PHE GLY"
"ERBB3_HUMAN t_4RIXA.pdb TYR DFGup 3 ANP 3.10 -125.21 170.14 999.00 60.88 28.87 -80.82 -82.15 140.77 56.48 77.71 -6.23 999.00 Favored ALA ASP PHE GLY"
"ERBB3_HUMAN t_4RIXC.pdb TYR DFGup 3 ANP 3.10 -126.64 170.67 999.00 61.19 28.99 -81.88 -82.73 140.72 56.73 77.46 -6.26 999.00 Favored ALA ASP PHE GLY"
"ERBB3_HUMAN t_4RIYA.pdb TYR DFGup 3 ANP 2.98 -123.85 168.67 999.00 63.00 31.45 -82.01 -82.35 142.59 52.39 78.82 -6.83 999.00 Favored ALA ASP PHE GLY"
"ERBB3_HUMAN t_4RIYC.pdb TYR DFGup 3 ANP 2.98 -124.43 168.61 999.00 63.19 31.62 -82.95 -82.53 141.97 52.93 78.35 -7.03 999.00 Favored ALA ASP PHE GLY"
"ERBB4_HUMAN t_2R4BA.pdb TYR DFGup 3 GW7 2.40 -131.46 171.80 -167.89 72.49 19.00 -135.50 -72.31 139.71 46.33 97.03 -38.55 999.00 Favored THR ASP PHE GLY"
"ERBB4_HUMAN t_2R4BB.pdb TYR DFGup 3 GW7 2.40 -129.77 173.21 -169.11 73.78 11.79 -130.49 -69.90 143.79 45.65 93.58 -37.46 999.00 Favored THR ASP PHE GLY"
"ERBB4_HUMAN t_3BBTB.pdb TYR DFGup 3 FMM 2.80 -127.11 173.32 -167.19 66.28 23.68 -73.04 -69.78 136.83 43.81 52.47 43.04 999.00 Favored THR ASP PHE GLY"
"ERBB4_HUMAN t_3BBTD.pdb TYR DFGup 3 FMM 2.80 -120.18 168.77 28.06 64.17 29.11 -66.31 -72.90 132.72 41.77 49.42 51.58 999.00 Favored THR ASP PHE GLY"
"ERBB4_HUMAN t_3BBWA.pdb TYR DFGup 3 Apo 4.00 -127.53 175.97 179.51 65.70 20.43 -61.30 -67.90 137.17 37.60 60.15 23.63 999.00 Favored THR ASP PHE GLY"
"ERBB4_HUMAN t_3BBWB.pdb TYR DFGup 3 Apo 4.00 -125.64 179.62 -178.12 65.64 18.57 -62.70 -69.07 136.52 35.95 64.13 18.06 999.00 Favored THR ASP PHE GLY"
"ERBB4_HUMAN t_3BCEA.pdb TYR Active 1 Apo 2.50 -135.98 -161.88 -166.27 58.55 65.45 -100.91 -92.83 14.16 -59.48 -58.61 -27.38 999.00 Allowed THR ASP PHE GLY"
"ERBB4_HUMAN t_3BCEB.pdb TYR Active 1 Apo 2.50 -142.21 -168.32 -170.05 59.33 68.83 -84.55 -94.23 18.36 -53.66 -53.47 -33.43 999.00 Allowed THR ASP PHE GLY"
"ERBB4_HUMAN t_3BCEC.pdb TYR Active 1 Apo 2.50 -139.31 -169.98 -164.37 72.59 58.95 -115.35 -86.01 21.71 -45.06 -53.59 -43.31 999.00 Allowed THR ASP PHE GLY"
"ERN1_HUMAN t_3P23A.pdb OTHER DFGup 3 ADP 2.70 -135.44 176.13 175.32 64.74 22.44 -65.60 -82.83 150.60 49.70 86.39 10.89 999.00 Favored SER ASP PHE GLY"
"ERN1_HUMAN t_3P23B.pdb OTHER DFGup 3 ADP 2.70 -139.91 176.52 53.60 76.78 14.93 -77.61 -83.94 150.38 55.47 97.56 -33.76 999.00 Favored SER ASP PHE GLY"
"ERN1_HUMAN t_3P23C.pdb OTHER DFGup 3 ADP 2.70 -149.51 -176.41 61.40 65.19 18.92 -62.93 -69.96 144.06 39.63 97.02 -114.34 999.00 Favored SER ASP PHE GLY"
"ERN1_HUMAN t_3P23D.pdb OTHER DFGup 3 ADP 2.70 -138.90 177.03 40.92 72.31 10.79 -72.38 -71.49 154.70 51.00 83.37 -17.60 999.00 Favored SER ASP PHE GLY"
"ERN1_HUMAN t_4U6RA.pdb OTHER Active 1 3E4 2.50 -138.02 -174.57 75.31 66.93 71.21 -146.62 -95.75 12.90 -57.45 -59.26 -23.01 999.00 Allowed SER ASP PHE GLY"
"ERN1_HUMAN t_4YZ9A.pdb OTHER DFGout 6 4K7 2.46 -145.40 154.31 176.27 -79.25 -25.23 169.82 -113.11 147.21 74.96 -101.09 170.76 999.00 Favored SER ASP PHE GLY"
"ERN1_HUMAN t_4YZ9B.pdb OTHER DFGout 6 4K7 2.46 -150.39 164.45 170.78 -74.76 -40.85 159.25 -115.61 154.09 77.25 -102.61 170.52 999.00 Favored SER ASP PHE GLY"
"ERN1_HUMAN t_4YZ9C.pdb OTHER DFGout 6 4K7 2.46 -135.14 175.91 175.22 -93.88 -10.29 -175.57 -129.05 149.25 68.78 -96.24 -179.44 999.00 Favored SER ASP PHE GLY"
"ERN1_HUMAN t_4YZCA.pdb OTHER Active 1 STU 2.49 -149.71 -173.48 59.91 57.53 66.57 -158.70 -77.65 -2.18 -72.12 -47.99 -38.68 999.00 Allowed SER ASP PHE GLY"
"ERN1_HUMAN t_4YZCB.pdb OTHER Active 1 STU 2.49 -140.88 -173.21 62.28 59.25 72.65 -152.77 -84.99 5.47 -73.66 -53.45 -38.73 999.00 Allowed SER ASP PHE GLY"
"ERN1_HUMAN t_4YZDA.pdb OTHER DFGup 3 ADP 3.10 -141.54 169.81 176.35 75.73 4.14 -65.55 -62.03 156.85 53.73 72.64 35.34 999.00 Favored SER ASP PHE GLY"
"ERN1_HUMAN t_4YZDB.pdb OTHER DFGup 3 ADP 3.10 -141.14 169.64 176.46 69.59 15.56 -66.35 -67.10 155.41 48.05 72.26 36.18 999.00 Favored SER ASP PHE GLY"
"ERN1_HUMAN t_4YZDC.pdb OTHER DFGup 3 ADP 3.10 -142.10 170.34 175.54 76.29 5.31 -63.94 -64.38 157.32 50.81 73.42 36.42 999.00 Favored SER ASP PHE GLY"
"ERN1_HUMAN t_4Z7HA.pdb OTHER Active 1 4L5 2.90 -138.86 -45.47 74.98 -76.96 88.70 -133.56 -83.89 3.72 -86.48 -61.04 -41.62 999.00 Favored SER ASP PHE GLY"
"ERN1_HUMAN t_4Z7HB.pdb OTHER Active 1 4L5 2.90 -147.29 -25.98 85.27 -101.02 93.59 -151.02 -84.21 0.65 -79.87 -61.77 -35.99 999.00 Favored SER ASP PHE GLY"
"ERN1_HUMAN t_5HGIA.pdb OTHER Active 1 BME 2.58 -145.05 -173.56 65.68 59.17 78.02 -71.25 -93.37 15.90 -60.63 -56.22 -41.74 999.00 Allowed SER ASP PHE GLY"
"FAK1_HUMAN t_2ETMA.pdb TYR DFGin-inactive 2 7PY 2.30 -138.98 -155.32 999.00 54.94 56.46 -157.54 -78.66 -20.58 -79.71 -75.80 -7.13 999.00 Favored GLY ASP PHE GLY"
"FAK1_HUMAN t_2ETMB.pdb TYR DFGin-inactive 2 7PY 2.30 -131.42 -154.79 999.00 60.12 64.70 -157.70 -93.52 10.55 -75.26 -111.35 2.30 999.00 Allowed GLY ASP PHE GLY"
"FAK1_HUMAN t_2IJMA.pdb TYR DFGin-inactive 2 ATP 2.19 -130.43 -10.47 999.00 -96.55 92.35 -179.85 -115.07 154.39 -51.08 84.63 -9.12 999.00 Favored GLY ASP PHE GLY"
"FAK1_HUMAN t_2IJMB.pdb TYR DFGin-inactive 2 ADP 2.19 -110.69 -163.98 999.00 67.18 81.08 -151.72 -117.86 145.96 -76.26 -64.08 -51.48 999.00 Allowed GLY ASP PHE GLY"
"FAK1_HUMAN t_3BZ3A.pdb TYR DFGin-inactive 2 YAM 2.20 -79.07 -179.94 999.00 -56.76 136.16 179.99 -73.84 -38.08 -72.13 -61.01 -47.26 999.00 Favored GLY ASP PHE GLY"
"FAK1_HUMAN t_3PXKA.pdb TYR DFGin-inactive 2 PXK 1.79 -120.06 -2.66 999.00 -137.24 131.25 -167.16 -129.50 22.92 -70.60 -73.48 999.00 999.00 Favored GLY ASP PHE GLY"
"FAK1_HUMAN t_3PXKB.pdb TYR DFGin-inactive 2 PXK 1.79 -117.19 -5.57 999.00 -138.62 135.87 -169.39 -133.29 18.39 -71.12 -64.82 -34.03 999.00 Favored GLY ASP PHE GLY"
"FAK1_HUMAN t_4EBVA.pdb TYR DFGout 6 0O7 1.67 -148.70 172.24 999.00 -125.21 28.14 55.42 -145.30 162.44 59.06 -99.62 159.25 999.00 Favored GLY ASP PHE GLY"
"FAK1_HUMAN t_4EBWA.pdb TYR DFGout 6 0PF 2.65 -156.81 167.21 999.00 -119.57 38.36 51.14 -154.81 160.12 57.15 -105.09 155.13 999.00 Favored GLY ASP PHE GLY"
"FAK1_HUMAN t_4GU6A.pdb TYR DFGin-inactive 2 10N 1.95 -78.93 -178.46 999.00 -53.73 136.85 178.90 -71.81 -34.41 -61.37 -65.24 -49.07 999.00 Favored GLY ASP PHE GLY"
"FAK1_HUMAN t_4GU6B.pdb TYR DFGin-inactive 2 10N 1.95 -79.42 -179.18 999.00 -51.72 131.26 -177.87 -67.61 -33.78 -60.43 -65.79 -45.38 999.00 Favored GLY ASP PHE GLY"
"FAK1_HUMAN t_4GU9B.pdb TYR DFGin-inactive 2 4GU 2.40 -125.46 -158.21 999.00 48.46 68.24 -171.48 -94.79 10.94 -77.01 -94.22 -13.83 999.00 Allowed GLY ASP PHE GLY"
"FAK1_HUMAN t_4I4FA.pdb TYR DFGout 6 1BR 1.75 -137.20 -178.52 999.00 -131.86 30.19 68.52 -146.28 163.93 55.90 -101.83 157.04 999.00 Favored GLY ASP PHE GLY"
"FAK1_HUMAN t_4K8AA.pdb TYR DFGin-inactive 2 K8A 2.91 -121.49 -166.14 999.00 54.91 76.44 174.73 -107.94 50.53 -76.70 -142.35 999.00 999.00 Allowed GLY ASP PHE GLY"
"FAK1_HUMAN t_4K8AB.pdb TYR DFGin-inactive 2 K8A 2.91 -115.42 -153.92 999.00 47.25 77.74 -175.86 -107.14 24.83 -80.10 -112.90 -15.48 999.00 Allowed GLY ASP PHE GLY"
"FAK1_HUMAN t_4K9YA.pdb TYR DFGout 6 K9Y 2.00 -136.41 -157.12 999.00 -158.43 138.01 -159.28 -138.82 152.72 -54.45 129.52 144.15 999.00 Favored GLY ASP PHE GLY"
"FAK1_HUMAN t_4KABB.pdb TYR DFGin-inactive 2 Apo 2.71 -121.44 -160.14 999.00 49.19 75.37 -172.99 -97.32 8.38 -78.68 -102.36 -7.14 999.00 Allowed GLY ASP PHE GLY"
"FAK1_HUMAN t_4KAOA.pdb TYR DFGout 6 KAO 2.39 -134.77 -162.63 999.00 -155.58 104.46 -173.61 -106.80 12.21 -35.17 -116.56 999.00 999.00 Favored GLY ASP PHE GLY"
"FAK1_HUMAN t_4KAOB.pdb TYR DFGout 6 KAO 2.39 -133.45 -165.57 999.00 -153.35 103.95 -175.25 -106.17 16.18 -36.75 -120.73 999.00 999.00 Favored GLY ASP PHE GLY"
"FAK2_HUMAN t_3CC6A.pdb TYR DFGin-inactive 2 Apo 1.60 -87.80 -163.68 999.00 -58.20 148.29 -69.36 -56.01 147.58 -75.48 -57.08 131.04 999.00 Favored GLY ASP PHE GLY"
"FAK2_HUMAN t_3ET7A.pdb TYR DFGout 6 349 2.70 9.57 -105.90 999.00 87.77 85.39 136.39 135.69 112.36 158.35 96.58 -24.26 999.00 Outlier GLY ASP PHE GLY"
"FAK2_HUMAN t_3FZOA.pdb TYR DFGin-inactive 2 Apo 2.20 -80.38 -161.57 999.00 -55.83 145.04 -83.09 -57.20 149.86 -81.90 -63.38 124.12 999.00 Favored GLY ASP PHE GLY"
"FAK2_HUMAN t_3FZPA.pdb TYR DFGout 6 AGS 2.10 -76.25 -175.23 999.00 -102.86 78.26 56.59 -127.91 25.73 -108.67 162.91 999.00 999.00 Allowed GLY ASP PHE GLY"
"FAK2_HUMAN t_3FZRA.pdb TYR DFGout 6 3JZ 2.70 -7.42 -120.16 999.00 113.70 73.46 132.72 151.44 106.84 174.50 106.71 -16.14 999.00 Outlier GLY ASP PHE GLY"
"FAK2_HUMAN t_3FZSA.pdb TYR DFGout 6 B96 1.75 -127.46 -169.02 999.00 -143.38 93.22 -178.94 -98.46 0.96 -45.57 166.64 999.00 999.00 Favored GLY ASP PHE GLY"
"FAK2_HUMAN t_3FZTA.pdb TYR DFGout 6 4JZ 1.95 -122.92 -178.19 999.00 -149.41 88.08 -177.01 -140.65 17.06 57.63 -74.80 162.87 999.00 Allowed GLY ASP PHE GLY"
"FAK2_HUMAN t_3H3CA.pdb TYR DFGout 6 P1E 2.00 -72.33 173.51 999.00 -83.77 -75.31 16.87 -27.69 138.66 168.28 84.74 2.10 999.00 Allowed GLY ASP PHE GLY"
"FAK2_HUMAN t_4H1JA.pdb TYR DFGout 6 0YH 2.00 -124.88 177.47 999.00 -148.24 81.75 -177.58 -130.95 20.81 51.39 -75.83 155.99 999.00 Allowed GLY ASP PHE GLY"
"FAK2_HUMAN t_4H1MA.pdb TYR DFGout 6 0YJ 1.99 -135.74 -167.77 999.00 -149.11 100.03 175.70 -111.42 17.18 -25.88 -99.74 166.46 999.00 Favored GLY ASP PHE GLY"
"FAK2_HUMAN t_5TO8A.pdb TYR DFGout 6 7FM 1.98 -71.22 168.17 999.00 -83.48 -36.56 53.11 -55.53 124.39 174.57 92.63 -6.78 999.00 Favored GLY ASP PHE GLY"
"FES_HUMAN t_3BKBA.pdb TYR Active 1 STU 1.78 -130.95 -162.51 -173.68 38.67 71.72 -154.87 -85.89 14.89 -78.55 -59.73 -36.44 999.00 Allowed SER ASP PHE GLY"
"FES_HUMAN t_3CBLA.pdb TYR Active 1 STU 1.75 -129.36 -161.96 -170.18 36.65 77.41 -165.30 -90.22 19.43 -76.77 -59.89 -34.09 999.00 Outlier SER ASP PHE GLY"
"FES_HUMAN t_3CD3A.pdb TYR Active 1 STU 1.98 -131.29 -161.95 -160.92 36.94 76.93 -162.43 -87.34 20.60 -76.72 -64.78 -29.99 999.00 Outlier SER ASP PHE GLY"
"FES_HUMAN t_4E93A.pdb TYR Active 1 GUI 1.84 -147.07 -173.78 74.26 68.79 70.95 -146.05 -92.36 15.12 -73.99 -61.30 -36.23 999.00 Allowed SER ASP PHE GLY"
"FGFR1_HUMAN t_1AGWA.pdb TYR DFGup 3 SU2 2.40 -121.30 164.10 999.00 62.55 22.82 -80.79 -75.45 -18.73 57.84 -105.06 9.46 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_1AGWB.pdb TYR DFGup 3 SU2 2.40 -118.50 160.06 999.00 61.55 23.31 -75.86 -75.60 -9.50 55.77 -113.96 12.46 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_1FGIA.pdb TYR DFGup 3 SU1 2.50 -118.48 166.44 999.00 66.55 8.69 -94.72 -64.15 -34.59 60.55 -94.10 14.32 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_1FGIB.pdb TYR DFGup 3 SU1 2.50 -129.17 161.73 999.00 69.01 4.36 -97.94 -61.66 -28.64 62.66 -98.19 18.49 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_1FGKA.pdb TYR DFGup 3 Apo 2.00 -117.09 161.74 999.00 60.33 24.82 -69.09 -72.81 -22.10 56.54 -106.63 14.33 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_1FGKB.pdb TYR DFGup 3 Apo 2.00 -119.82 158.40 999.00 63.14 25.47 -72.01 -77.93 -15.95 57.74 -107.57 13.09 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_2FGIA.pdb TYR DFGup 3 PD1 2.50 -112.68 157.49 999.00 60.86 36.91 -63.65 -81.99 -32.37 53.05 -98.49 17.46 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_2FGIB.pdb TYR DFGup 3 PD1 2.50 -127.27 161.11 999.00 62.15 18.95 -78.10 -71.54 -20.98 56.37 -106.41 12.09 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_3C4FA.pdb TYR DFGup 3 C4F 2.07 -110.43 159.78 999.00 58.62 34.55 -82.11 -81.01 -11.31 51.20 -119.47 23.67 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_3C4FB.pdb TYR DFGup 3 C4F 2.07 -113.90 161.19 999.00 54.21 44.80 -97.03 -89.00 -14.41 49.12 -114.88 24.21 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_3GQIA.pdb TYR Active 1 ACP 2.50 -126.66 -175.84 999.00 60.23 72.37 -161.14 -91.06 18.34 -71.26 -64.66 -15.38 999.00 Allowed ALA ASP PHE GLY"
"FGFR1_HUMAN t_3GQLA.pdb TYR DFGup 3 GQL 2.80 -123.09 162.23 999.00 54.13 42.75 -58.97 -89.76 -13.22 56.14 -109.42 50.51 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_3GQLB.pdb TYR DFGup 3 GQL 2.80 -128.67 167.95 999.00 48.22 62.58 -62.05 -111.19 147.61 41.17 54.76 40.27 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_3GQLC.pdb TYR DFGup 3 GQL 2.80 -123.76 172.07 999.00 54.94 32.18 -60.27 -87.80 -13.93 53.46 -108.07 38.86 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_3JS2A.pdb TYR DFGup 3 VM1 2.20 -121.70 167.25 999.00 60.20 27.37 -78.97 -82.63 -17.79 54.23 -103.93 10.64 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_3JS2B.pdb TYR DFGup 3 VM1 2.20 -117.75 168.85 999.00 57.42 26.55 -73.45 -81.79 -21.61 58.35 -101.12 4.48 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_3KXXA.pdb TYR Active 1 Apo 3.20 -140.37 -169.49 999.00 63.28 50.32 -81.20 -78.15 162.72 -63.65 151.67 -37.06 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_3KXXB.pdb TYR Active 1 Apo 3.20 -138.91 177.14 999.00 64.45 63.47 -60.26 -90.75 31.90 -65.87 -71.03 -30.06 999.00 Allowed ALA ASP PHE GLY"
"FGFR1_HUMAN t_3KXXC.pdb TYR Active 1 Apo 3.20 -138.06 -172.47 999.00 62.97 62.17 -68.71 -92.85 13.54 -63.83 -69.94 -16.74 999.00 Allowed ALA ASP PHE GLY"
"FGFR1_HUMAN t_3KXXD.pdb TYR Active 1 Apo 3.20 -133.48 -161.48 999.00 51.58 74.16 -63.42 -99.72 22.61 -66.19 -66.64 -32.73 999.00 Allowed ALA ASP PHE GLY"
"FGFR1_HUMAN t_3KY2A.pdb TYR DFGup 3 Apo 2.70 -122.66 172.30 999.00 46.50 42.64 -65.45 -95.26 -13.81 55.59 -110.08 21.32 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_3KY2B.pdb TYR DFGup 3 Apo 2.70 -120.15 165.13 999.00 53.13 37.17 -63.53 -90.31 -21.74 56.99 -96.67 4.10 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_3RHXA.pdb TYR DFGup 3 3RH 2.01 -115.55 162.63 999.00 65.15 24.15 -77.11 -75.35 -9.39 51.51 -110.54 8.28 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_3RHXB.pdb TYR DFGup 3 3RH 2.01 -115.55 168.30 999.00 59.12 31.22 -79.56 -88.68 -15.11 56.21 -99.23 9.99 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_3TT0A.pdb TYR DFGup 3 07J 2.80 -115.28 155.30 999.00 53.24 40.25 -69.48 -81.26 -26.94 55.16 -91.75 21.15 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_3TT0B.pdb TYR DFGup 3 07J 2.80 -116.55 155.53 999.00 53.41 40.81 -69.98 -79.82 -25.33 49.89 -91.91 20.46 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_4F63A.pdb TYR DFGup 3 0S7 2.55 -123.64 158.75 999.00 70.03 13.49 -104.05 -68.76 -20.57 59.98 -95.76 8.85 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_4F63B.pdb TYR DFGup 3 0S7 2.55 -103.09 171.14 999.00 57.66 19.45 -94.43 -72.83 -17.01 60.61 -102.06 8.51 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_4F64A.pdb TYR DFGup 3 0S8 2.05 -126.61 159.85 999.00 67.64 19.38 -85.58 -73.34 -15.39 61.15 -112.07 14.34 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_4F64B.pdb TYR DFGup 3 0S8 2.05 -128.78 164.21 999.00 64.40 29.62 -71.52 -84.21 -15.01 59.36 -106.35 1.30 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_4NK9A.pdb TYR DFGup 3 2K5 2.57 -109.96 156.52 999.00 39.69 77.00 -53.70 -103.06 153.55 28.95 57.11 999.00 999.00 Allowed ALA ASP PHE GLY"
"FGFR1_HUMAN t_4NK9B.pdb TYR DFGup 3 2K5 2.57 -122.42 146.19 999.00 46.68 66.98 -53.50 -88.38 79.63 27.41 49.02 999.00 999.00 Allowed ALA ASP PHE GLY"
"FGFR1_HUMAN t_4NKAA.pdb TYR DFGup 3 2K7 2.19 -109.76 172.84 999.00 48.91 35.56 -96.12 -80.97 -25.78 46.12 -114.71 999.00 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_4NKSA.pdb TYR DFGup 3 2M2 2.50 -128.89 161.72 999.00 65.71 29.24 -77.52 -87.10 -15.38 56.24 -92.92 -7.73 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_4NKSB.pdb TYR DFGup 3 2M2 2.50 -121.31 176.26 999.00 64.99 19.76 -103.25 -85.14 -9.90 56.44 -103.77 -4.05 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_4RWIA.pdb TYR DFGup 3 Apo 2.29 -105.16 163.17 999.00 56.86 28.25 -68.52 -74.63 -16.97 54.33 -104.02 11.36 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_4RWIB.pdb TYR DFGup 3 Apo 2.29 -106.53 164.73 999.00 57.27 29.78 -68.16 -77.49 -18.72 57.52 -101.94 7.78 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_4RWJA.pdb TYR DFGup 3 66T 2.49 -111.13 165.76 999.00 44.31 59.11 -86.16 -104.49 -7.90 52.99 -108.96 18.95 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_4RWJB.pdb TYR DFGup 3 66T 2.49 -111.80 166.65 999.00 44.05 58.14 -88.25 -104.80 -5.63 52.59 -105.77 19.24 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_4RWKA.pdb TYR DFGup 3 66T 2.98 -119.59 171.81 999.00 43.46 42.06 -88.81 -91.21 -14.04 55.39 -97.82 1.33 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_4RWKB.pdb TYR DFGup 3 66T 2.98 -119.23 169.80 999.00 42.02 44.22 -92.47 -90.54 -9.60 54.05 -94.37 2.48 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_4RWLA.pdb TYR DFGup 3 Apo 2.19 -120.09 160.91 999.00 64.46 29.25 -77.35 -80.33 -20.09 51.64 -96.99 0.15 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_4RWLB.pdb TYR DFGup 3 3ZC 2.19 -118.62 158.93 999.00 63.81 30.96 -77.64 -76.98 152.75 46.13 75.50 -144.54 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_4UWBA.pdb TYR DFGup 3 JVT 2.31 -113.10 161.78 999.00 71.68 24.01 -97.70 -88.02 -18.31 56.33 -95.93 11.67 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_4UWBB.pdb TYR DFGup 3 JVT 2.31 -114.85 162.52 999.00 65.20 21.78 -67.02 -74.00 -17.95 55.13 -100.46 4.90 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_4UWCA.pdb TYR DFGup 3 4Y0 1.96 -114.30 167.51 999.00 64.09 17.06 -82.79 -73.34 -20.76 56.57 -95.45 0.25 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_4UWCB.pdb TYR DFGup 3 4Y0 1.96 -114.02 163.24 999.00 67.15 18.57 -75.08 -73.55 -21.43 56.41 -95.52 -0.77 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_4UWYA.pdb TYR DFGup 3 Apo 2.30 -108.11 160.93 999.00 49.49 43.37 -57.81 -87.33 -20.78 54.11 -97.05 5.75 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_4UWYB.pdb TYR DFGup 3 Apo 2.30 -107.98 162.84 999.00 51.08 42.80 -56.89 -88.16 -19.99 53.69 -94.92 5.78 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_4WUNA.pdb TYR DFGup 3 66T 1.65 -114.57 167.45 999.00 61.46 33.19 -176.34 -92.75 -3.72 56.80 -94.63 -9.79 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_4WUNB.pdb TYR DFGup 3 66T 1.65 -116.51 163.24 999.00 61.87 38.62 -159.97 -99.57 -5.59 55.66 -99.37 -2.08 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_4ZSAA.pdb TYR DFGup 3 4UT 2.00 -116.63 164.11 999.00 62.67 38.84 -155.29 -97.54 -0.77 57.67 -93.92 -12.06 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_4ZSAB.pdb TYR DFGup 3 4UT 2.00 -118.50 160.54 999.00 64.47 37.46 -158.18 -95.05 -9.42 54.69 -73.60 -19.29 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_5A46A.pdb TYR DFGup 3 38O 2.63 -118.75 162.85 999.00 58.09 28.76 -70.62 -73.23 -26.37 58.43 -96.05 5.52 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_5A46B.pdb TYR DFGup 3 38O 2.63 -120.18 161.92 999.00 66.73 19.61 -65.99 -75.16 -22.09 56.29 -97.46 -0.21 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_5A4CA.pdb TYR DFGup 3 XOJ 2.09 -116.37 165.93 999.00 49.84 42.82 -68.39 -84.98 -10.48 49.34 -124.74 35.21 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_5A4CB.pdb TYR DFGup 3 XOJ 2.09 -119.30 159.98 999.00 53.84 37.17 -71.65 -79.89 -19.97 52.55 -122.02 47.32 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_5AM6A.pdb TYR DFGup 3 38O 1.96 -112.59 159.47 999.00 61.39 32.53 -73.83 -79.00 -18.16 53.99 -102.15 12.34 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_5AM6B.pdb TYR DFGup 3 38O 1.96 -109.26 159.79 999.00 58.36 42.17 -69.58 -91.19 -11.78 51.78 -107.68 15.31 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_5AM7A.pdb TYR DFGup 3 38O 1.96 -119.95 159.98 999.00 61.99 31.32 -80.99 -78.03 -16.77 51.98 -102.85 8.08 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_5AM7B.pdb TYR DFGup 3 38O 1.96 -118.50 161.72 999.00 60.88 31.37 -80.54 -81.98 -17.65 51.46 -98.46 10.32 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_5B7VA.pdb TYR DFGup 3 LWJ 2.15 -124.04 164.11 999.00 56.04 35.20 -87.08 -84.00 -18.05 54.50 -93.93 14.99 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_5B7VB.pdb TYR DFGup 3 LWJ 2.15 -116.05 161.85 999.00 53.01 39.11 -55.37 -76.07 133.82 41.65 65.67 39.91 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_5EW8A.pdb TYR DFGup 3 5SF 1.63 -106.94 161.61 999.00 53.69 34.99 -65.02 -75.85 -13.89 56.02 -112.20 7.78 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_5EW8B.pdb TYR DFGup 3 5SF 1.63 -109.71 160.16 999.00 55.03 34.74 -65.91 -78.37 -12.83 54.67 -106.69 12.95 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_5FLFA.pdb TYR Active 1 Apo 2.58 -130.05 -173.28 999.00 57.49 81.47 -84.94 -106.51 20.58 -72.48 -65.74 -26.29 999.00 Allowed ALA ASP PHE GLY"
"FGFR1_HUMAN t_5FLFB.pdb TYR Active 1 Apo 2.58 -131.38 -174.58 999.00 57.64 70.01 -77.55 -91.26 21.64 -75.93 -69.57 -18.16 999.00 Allowed ALA ASP PHE GLY"
"FGFR1_HUMAN t_5FLFC.pdb TYR Active 1 Apo 2.58 -128.66 -179.19 999.00 56.67 76.01 -58.90 -97.53 23.97 -71.09 -64.46 -24.39 999.00 Allowed ALA ASP PHE GLY"
"FGFR1_HUMAN t_5FLFD.pdb TYR Active 1 Apo 2.58 -137.61 -174.47 999.00 56.61 77.47 -78.07 -99.52 24.90 -70.06 -64.29 -28.46 999.00 Allowed ALA ASP PHE GLY"
"FGFR1_HUMAN t_5FLFE.pdb TYR DFGup 3 Apo 2.58 -107.07 156.15 999.00 59.29 89.09 -65.15 -145.70 9.14 46.95 -107.05 -8.44 999.00 Allowed ALA ASP PHE GLY"
"FGFR1_HUMAN t_5UQ0A.pdb TYR DFGup 3 WP1 2.30 -129.53 153.98 999.00 71.74 22.00 -84.19 -75.61 2.60 58.39 -125.16 1.30 999.00 Favored ALA ASP PHE GLY"
"FGFR1_HUMAN t_5UQ0B.pdb TYR DFGup 3 WP1 2.30 -135.91 161.86 999.00 57.67 28.96 -70.33 -76.94 -27.79 58.93 -79.36 -7.25 999.00 Favored ALA ASP PHE GLY"
"FGFR2_HUMAN t_1GJOA.pdb TYR Active 1 Apo 2.4 -126.52 -173.37 999.00 57.96 76.98 -49.07 -93.75 23.86 -62.46 -64.90 -30.63 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_1OECA.pdb TYR Active 1 AA2 2.4 -124.87 -174.87 999.00 57.82 79.28 -47.12 -96.98 23.50 -57.24 -64.95 -25.08 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_2PSQA.pdb TYR Active 1 Apo 2.40 -128.88 -172.69 999.00 52.14 79.95 -65.25 -92.09 23.27 -61.01 -58.51 -25.89 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_2PSQB.pdb TYR Active 1 Apo 2.40 -134.79 -175.31 999.00 56.91 78.28 -74.33 -93.69 24.66 -64.06 -61.80 -34.08 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_2PVFA.pdb TYR Active 1 ACP 1.80 -138.90 -175.19 999.00 54.68 80.46 -169.28 -90.11 24.34 -68.93 -54.39 -36.36 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_2PVYA.pdb TYR Active 1 ACP 2.20 -142.12 -175.97 999.00 63.85 72.73 -150.41 -96.26 30.01 -66.24 -65.89 -30.70 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_2PVYB.pdb TYR Active 1 ACP 2.20 -144.29 -177.94 999.00 57.18 77.71 -154.47 -93.94 24.90 -66.64 -55.48 -34.11 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_2PVYC.pdb TYR Active 1 ACP 2.20 -131.40 -174.35 999.00 49.41 82.62 -162.19 -94.84 27.75 -66.48 -60.67 -24.91 999.00 Outlier ALA ASP PHE GLY"
"FGFR2_HUMAN t_2PVYD.pdb TYR Active 1 ACP 2.20 -139.80 -174.27 999.00 61.11 74.21 -124.71 -97.40 31.67 -66.19 -66.80 -30.86 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_2PWLA.pdb TYR Active 1 ACP 2.40 -131.62 -167.39 999.00 56.50 73.59 -149.47 -92.92 26.04 -66.45 -63.43 -20.72 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_2PWLB.pdb TYR Active 1 ACP 2.40 -131.99 -168.65 999.00 54.25 75.00 -154.64 -93.01 24.95 -67.00 -61.24 -25.57 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_2PY3A.pdb TYR Active 1 ACP 2.30 -132.08 -167.26 999.00 46.94 77.91 -170.27 -89.57 28.24 -72.09 -64.94 -12.82 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_2PY3B.pdb TYR Active 1 ACP 2.30 -135.61 -170.08 999.00 51.94 73.69 -166.97 -89.20 28.28 -72.25 -66.00 -13.11 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_2PZ5A.pdb TYR Active 1 ACP 2.40 -134.53 -165.26 999.00 46.17 76.68 -166.53 -87.85 24.63 -71.76 -57.72 -18.09 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_2PZ5B.pdb TYR Active 1 ACP 2.40 -139.04 -170.39 999.00 49.41 74.38 -171.23 -88.13 29.87 -71.02 -65.88 -12.66 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_2PZPA.pdb TYR Active 1 ACP 2.40 -137.15 -165.32 999.00 46.35 75.76 -166.49 -87.81 26.92 -71.22 -66.87 -3.89 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_2PZPB.pdb TYR Active 1 ACP 2.40 -140.34 -168.08 999.00 49.23 73.06 -167.47 -87.88 30.47 -71.44 -65.13 -14.94 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_2PZRA.pdb TYR Active 1 Apo 3.00 -124.46 -173.67 999.00 61.01 80.30 -75.56 -100.71 20.86 -69.56 -57.09 -25.79 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_2PZRB.pdb TYR Active 1 Apo 3.00 -124.12 -169.41 999.00 57.62 72.83 -147.12 -93.32 13.67 -64.53 -53.73 -21.76 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_2Q0BA.pdb TYR Active 1 Apo 2.90 -137.66 -164.22 999.00 54.32 72.62 -105.72 -95.27 25.29 -74.61 -61.27 -29.58 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_2Q0BB.pdb TYR Active 1 Apo 2.90 -133.38 -173.74 999.00 65.41 65.72 -92.11 -91.72 18.08 -63.30 -55.19 -29.46 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_3B2TA.pdb TYR Active 1 M33 1.80 -134.27 -170.95 999.00 55.39 73.13 -62.33 -95.48 19.53 -63.90 -64.79 -24.99 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_3B2TB.pdb TYR Active 1 M33 1.80 -136.04 -172.09 999.00 58.46 72.91 -63.58 -97.18 21.29 -62.90 -63.04 -25.71 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_3CLYA.pdb TYR Active 1 ACP 2.00 -138.78 -172.73 999.00 51.32 79.81 -172.58 -91.29 32.45 -69.53 -61.80 -29.32 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_3RI1A.pdb TYR Active 1 3RH 2.10 -123.25 -170.66 999.00 54.19 75.34 -158.78 -95.68 30.41 -65.51 -71.98 -31.83 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_3RI1B.pdb TYR Active 1 3RH 2.10 -125.04 -168.18 999.00 44.83 79.46 -163.18 -91.36 24.48 -67.81 -61.64 -38.06 999.00 Outlier ALA ASP PHE GLY"
"FGFR2_HUMAN t_4J95A.pdb TYR Active 1 ACP 2.38 -131.63 -174.19 999.00 63.25 76.62 -166.93 -98.28 22.24 -67.73 -64.56 -23.26 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_4J95B.pdb TYR Active 1 ACP 2.38 -131.81 -176.43 999.00 62.78 77.45 -165.94 -96.59 21.62 -69.83 -66.00 -23.33 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_4J95C.pdb TYR Active 1 ACP 2.38 -132.21 -176.57 999.00 63.58 76.11 -164.35 -98.31 23.43 -70.00 -65.85 -22.93 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_4J95D.pdb TYR Active 1 ACP 2.38 -131.90 -175.32 999.00 62.91 77.09 -164.53 -96.79 22.80 -70.51 -64.44 -23.04 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_4J96A.pdb TYR Active 1 Apo 2.30 -129.05 -173.92 999.00 55.08 75.08 -59.26 -93.95 17.06 -74.89 -64.77 -20.49 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_4J96B.pdb TYR Active 1 ACP 2.30 -135.06 -171.14 999.00 49.96 77.77 -159.60 -93.12 20.21 -76.35 -66.59 -18.83 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_4J97A.pdb TYR Active 1 ACP 2.55 -139.17 -173.58 999.00 59.76 71.54 -100.07 -95.83 23.28 -69.35 -67.55 -16.74 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_4J97B.pdb TYR Active 1 ACP 2.55 -137.22 -170.98 999.00 57.02 77.12 -93.84 -102.21 28.98 -68.30 -70.10 -17.22 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_4J97C.pdb TYR Active 1 ACP 2.55 -135.44 -176.04 999.00 59.91 78.83 -139.74 -103.05 29.57 -65.79 -73.25 -9.69 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_4J97D.pdb TYR Active 1 ACP 2.55 -140.59 -174.18 999.00 59.66 71.57 -112.94 -94.72 28.95 -66.31 -71.75 -12.94 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_4J98A.pdb TYR Active 1 Apo 2.31 -127.06 -173.95 999.00 55.53 75.98 -64.44 -94.56 21.05 -74.69 -62.08 -22.56 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_4J98B.pdb TYR Active 1 ACP 2.31 -130.07 -172.53 999.00 52.46 78.98 -156.10 -94.32 21.98 -74.93 -63.62 -22.47 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_4J99A.pdb TYR Active 1 ACP 1.85 -131.00 -174.73 999.00 58.84 77.47 -166.35 -92.76 19.31 -68.21 -60.06 -34.09 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_4J99B.pdb TYR Active 1 ACP 1.85 -133.22 -175.95 999.00 58.51 76.99 -166.20 -94.02 15.77 -67.11 -58.89 -32.86 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_4J99C.pdb TYR Active 1 ACP 1.85 -131.93 -175.57 999.00 59.19 75.72 -167.27 -91.42 19.96 -68.37 -59.99 -32.55 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_4J99D.pdb TYR Active 1 ACP 1.85 -133.65 -174.59 999.00 58.76 78.54 -168.60 -92.62 20.48 -69.06 -59.38 -33.43 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_5EG3A.pdb TYR Active 1 ACP 2.61 -138.68 -166.61 999.00 47.55 87.43 -166.42 -100.19 28.73 -74.13 -77.79 -14.97 999.00 Outlier ALA ASP PHE GLY"
"FGFR2_HUMAN t_5UGLA.pdb TYR Active 1 ANP 1.86 -137.84 -175.55 999.00 61.85 65.42 -162.44 -85.03 17.03 -72.22 -66.20 -23.32 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_5UGLB.pdb TYR Active 1 ANP 1.86 -137.56 -172.15 999.00 55.75 69.64 -64.53 -87.77 15.82 -73.37 -64.54 -22.33 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_5UGXA.pdb TYR Active 1 ACP 2.35 -131.11 -166.13 999.00 46.75 87.04 -162.32 -100.01 21.89 -71.60 -64.84 -24.56 999.00 Outlier ALA ASP PHE GLY"
"FGFR2_HUMAN t_5UGXB.pdb TYR Active 1 ACP 2.35 -132.31 -170.75 999.00 52.32 81.69 -163.60 -96.01 22.31 -67.78 -65.71 -25.28 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_5UHNA.pdb TYR Active 1 ACP 2.91 -136.85 -167.34 999.00 56.16 78.52 -79.12 -101.46 21.65 -65.03 -64.13 -30.06 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_5UHNB.pdb TYR Active 1 ACP 2.91 -136.31 -166.26 999.00 57.25 77.97 -78.36 -101.88 20.62 -64.93 -64.82 -29.86 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_5UI0A.pdb TYR Active 1 Apo 2.05 -135.65 -171.26 999.00 53.74 73.66 -65.51 -92.88 20.02 -74.82 -70.06 -15.76 999.00 Allowed ALA ASP PHE GLY"
"FGFR2_HUMAN t_5UI0B.pdb TYR Active 1 ACP 2.05 -137.01 -171.82 999.00 50.01 76.92 -159.71 -91.40 21.00 -75.97 -70.31 -15.30 999.00 Allowed ALA ASP PHE GLY"
"FGFR3_HUMAN t_4K33A.pdb TYR Active 1 ACP 2.34 -133.88 -173.58 999.00 58.49 82.81 -162.75 -96.43 27.55 -68.19 -59.33 -31.32 999.00 Allowed ALA ASP PHE GLY"
"FGFR4_HUMAN t_4QQ5A.pdb TYR DFGout 6 37O 2.20 -99.03 166.30 999.00 -153.31 109.28 -170.32 -96.99 16.78 -55.48 -130.77 29.25 999.00 Favored ALA ASP PHE GLY"
"FGFR4_HUMAN t_4QQCA.pdb TYR DFGup 3 37O 2.40 -105.45 167.65 999.00 62.39 26.26 -103.03 -78.10 -25.76 56.17 -101.81 145.27 999.00 Favored ALA ASP PHE GLY"
"FGFR4_HUMAN t_4QQJA.pdb TYR DFGup 3 Apo 1.68 -118.02 159.37 999.00 59.21 32.47 -73.23 -80.55 -12.63 51.76 -110.14 11.09 999.00 Favored ALA ASP PHE GLY"
"FGFR4_HUMAN t_4QQTA.pdb TYR DFGup 3 Apo 1.50 -114.05 158.28 999.00 58.53 36.21 -67.38 -80.45 -13.87 51.75 -109.34 19.18 999.00 Favored ALA ASP PHE GLY"
"FGFR4_HUMAN t_4QRCA.pdb TYR DFGout 6 0LI 1.90 -128.89 176.90 999.00 -168.91 140.48 44.04 58.83 41.60 -45.70 128.95 161.72 999.00 Favored ALA ASP PHE GLY"
"FGFR4_HUMAN t_4R6VA.pdb TYR DFGout 6 FI3 2.35 -104.32 159.95 999.00 -151.00 101.01 -169.44 -90.14 14.71 -52.71 -121.72 20.62 999.00 Favored ALA ASP PHE GLY"
"FGFR4_HUMAN t_4TYEA.pdb TYR DFGup 3 Apo 2.80 -91.68 -29.19 999.00 -103.09 105.00 -165.74 -71.23 -26.94 65.50 94.74 -139.66 999.00 Favored ALA ASP PHE GLY"
"FGFR4_HUMAN t_4TYGA.pdb TYR DFGup 3 Apo 2.40 -113.08 168.57 999.00 59.20 26.27 -65.40 -74.48 -27.55 55.90 -116.15 38.09 999.00 Favored ALA ASP PHE GLY"
"FGFR4_HUMAN t_4TYIA.pdb TYR DFGup 3 38O 3.40 -124.39 161.92 999.00 65.25 9.27 -56.77 -54.11 -39.50 65.74 -82.81 -10.77 999.00 Favored ALA ASP PHE GLY"
"FGFR4_HUMAN t_4TYJA.pdb TYR DFGout 6 0LI 2.45 -136.78 -177.24 999.00 -149.41 114.74 -171.16 -98.12 9.09 -61.52 80.00 -171.39 999.00 Favored ALA ASP PHE GLY"
"FGFR4_HUMAN t_4UXQA.pdb TYR DFGout 6 0LI 1.85 -132.55 -175.58 999.00 -155.02 108.27 175.58 -101.65 -37.04 -58.30 -82.36 -172.58 999.00 Favored ALA ASP PHE GLY"
"FGFR4_HUMAN t_4XCUA.pdb TYR DFGup 3 40M 1.71 -110.08 165.24 999.00 52.56 39.13 -67.98 -92.73 -5.83 54.36 -89.89 -0.57 999.00 Favored ALA ASP PHE GLY"
"FGFR4_HUMAN t_5JKGA.pdb TYR DFGup 3 6LF 2.35 -80.35 138.61 999.00 42.05 154.07 64.73 -151.25 -44.81 29.53 59.57 154.84 999.00 Outlier ALA ASP PHE GLY"
"FLT3_HUMAN t_1RJBA.pdb TYR DFGout 6 Apo 2.10 -155.80 -170.10 70.69 -125.82 107.28 -177.18 -104.29 21.23 -134.06 -54.66 -36.35 999.00 Favored CYS ASP PHE GLY"
"FLT3_HUMAN t_4RT7A.pdb TYR DFGout 6 P30 3.10 -148.57 -175.77 70.98 -147.55 109.41 -167.25 -60.95 -39.77 -70.47 49.02 -101.53 999.00 Favored CYS ASP PHE GLY"
"FLT3_HUMAN t_4XUFA.pdb TYR DFGout 6 P30 3.20 -142.96 -176.06 64.65 -145.91 109.76 -165.91 -79.71 65.34 -68.70 -88.02 125.49 999.00 Favored CYS ASP PHE GLY"
"FLT3_HUMAN t_4XUFB.pdb TYR DFGout 6 P30 3.20 -144.28 -175.75 64.79 -146.28 108.38 -165.47 -80.99 70.71 -66.92 -83.44 -47.36 999.00 Favored CYS ASP PHE GLY"
"FYN_HUMAN t_2DQ7X.pdb TYR Active 1 STU 2.80 -137.79 173.21 999.00 69.46 82.83 -165.48 -98.97 30.24 -73.66 -56.50 -37.75 999.00 Allowed ALA ASP PHE GLY"
"GAK_HUMAN t_4C57A.pdb OTHER Active 1 FEF 2.55 -112.57 -37.24 56.46 -102.06 134.46 -165.39 -132.18 22.66 -62.15 -59.69 -31.15 999.00 Favored CYS ASP PHE GLY"
"GAK_HUMAN t_4C57B.pdb OTHER Active 1 FEF 2.55 -105.05 -37.57 56.97 -101.52 133.89 -164.42 -130.59 22.86 -62.15 -60.27 -26.77 999.00 Favored CYS ASP PHE GLY"
"GAK_HUMAN t_4C58A.pdb OTHER Active 1 824 2.16 -132.90 -18.99 71.39 -98.05 88.00 -109.71 -100.85 19.45 -52.76 -74.40 -16.81 999.00 Favored CYS ASP PHE GLY"
"GAK_HUMAN t_4C59A.pdb OTHER Active 1 FEF 2.80 -134.64 -10.29 71.25 -105.21 88.44 56.13 -107.06 23.90 -59.49 -81.96 -9.96 999.00 Favored CYS ASP PHE GLY"
"GAK_HUMAN t_4O38A.pdb NA NA 0 Apo 2.10 -138.09 -2.23 66.59 -122.58 97.48 -174.19 -104.60 19.83 -56.74 -68.52 -17.08 999.00 Favored CYS ASP PHE GLY"
"GAK_HUMAN t_4O38B.pdb NA NA 0 Apo 2.10 -142.92 -2.76 69.10 -119.48 94.15 179.44 -104.79 22.23 -54.08 -69.37 -19.49 999.00 Favored CYS ASP PHE GLY"
"GAK_HUMAN t_4Y8DA.pdb OTHER Active 1 49J 2.10 -138.40 -164.24 67.81 74.62 66.05 -160.46 -93.03 16.78 -55.22 -68.17 -18.12 999.00 Allowed CYS ASP PHE GLY"
"GAK_HUMAN t_4Y8DB.pdb OTHER Active 1 49J 2.10 -140.72 -165.01 68.28 74.24 67.34 -159.20 -94.14 19.75 -54.65 -72.08 -18.15 999.00 Allowed CYS ASP PHE GLY"
"GRK4_HUMAN t_4YHJA.pdb AGC Active 1 AN2 2.60 -118.18 -176.88 -157.93 49.99 69.56 -164.34 -89.92 31.91 -74.68 -66.44 -45.24 999.00 NA SER ASP LEU GLY"
"GRK4_HUMAN t_4YHJB.pdb AGC Active 1 AN2 2.60 -128.83 178.91 92.04 61.83 67.69 -93.03 -94.53 28.76 -72.59 -65.72 -45.82 999.00 NA SER ASP LEU GLY"
"GRK5_HUMAN t_4TNBA.pdb AGC Active 1 SGV 2.11 -123.49 176.16 64.44 54.56 74.40 -78.90 -84.67 6.45 -73.74 -51.78 -34.13 999.00 NA SER ASP LEU GLY"
"GRK5_HUMAN t_4TNDA.pdb AGC Active 1 ANP 1.80 -119.90 173.84 -174.74 59.86 73.62 -62.45 -89.51 7.83 -81.78 -54.71 -33.65 999.00 NA SER ASP LEU GLY"
"GRK6_HUMAN t_2ACXA.pdb AGC Active 1 ANP 2.60 -133.77 164.85 -173.87 58.77 76.06 -171.66 -96.20 24.40 -78.59 -59.65 -24.08 999.00 NA SER ASP LEU GLY"
"GRK6_HUMAN t_2ACXB.pdb AGC Active 1 ANP 2.60 -128.37 163.89 -175.04 55.33 87.17 -173.11 -100.57 21.26 -74.38 -55.37 -30.64 999.00 NA SER ASP LEU GLY"
"GRK6_HUMAN t_3NYNA.pdb AGC Active 1 SGV 2.72 -161.03 177.64 44.93 50.75 84.34 -86.11 -106.71 25.80 -78.93 -51.76 -45.32 999.00 NA SER ASP LEU GLY"
"GRK6_HUMAN t_3NYNB.pdb AGC Active 1 SGV 2.72 -165.40 175.40 49.63 57.15 63.88 -96.77 -91.01 39.74 -70.38 -64.53 -42.79 999.00 NA SER ASP LEU GLY"
"GRK6_HUMAN t_3NYOA.pdb AGC Active 1 AMP 2.92 -150.30 176.63 57.31 46.62 93.99 -175.85 -112.67 27.88 -90.91 -53.15 -36.92 999.00 NA SER ASP LEU GLY"
"GRK6_HUMAN t_3NYOB.pdb AGC Active 1 AMP 2.92 -147.59 -176.86 56.96 49.50 66.06 -167.34 -89.46 43.72 -76.29 -61.99 -47.92 999.00 NA SER ASP LEU GLY"
"GSK3B_HUMAN t_1GNGA.pdb CMGC Active 1 Apo 2.6 -143.21 -175.96 82.15 52.67 77.40 -175.50 -90.20 24.14 -75.93 -57.16 -28.61 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_1GNGB.pdb CMGC Active 1 Apo 2.6 -137.25 -174.07 80.41 57.33 76.09 -173.36 -92.33 24.68 -67.21 -62.52 -16.23 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_1H8FA.pdb CMGC Active 1 Apo 2.8 -132.32 -174.92 -163.38 54.46 76.46 -159.93 -91.60 20.84 -72.13 -61.47 -17.96 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_1H8FB.pdb CMGC Active 1 Apo 2.8 -137.12 -175.24 -160.09 54.46 79.76 -158.69 -96.09 20.02 -75.62 -61.87 -16.44 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_1I09A.pdb CMGC Active 1 Apo 2.70 -130.75 -175.72 63.60 55.31 78.22 -167.70 -94.50 21.05 -67.38 -64.14 -7.06 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_1I09B.pdb CMGC Active 1 Apo 2.70 -135.93 178.35 73.98 61.75 84.00 -172.14 -100.66 24.77 -71.47 -64.71 -15.54 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_1J1BA.pdb CMGC Active 1 ANP 1.80 -136.79 -178.87 78.12 61.59 83.12 -173.72 -97.64 25.13 -73.89 -68.77 -13.03 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_1J1BB.pdb CMGC Active 1 ANP 1.80 -136.37 -177.02 76.41 61.53 81.88 -173.57 -98.14 27.25 -71.53 -71.34 -13.15 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_1J1CA.pdb CMGC Active 1 ADP 2.10 -139.29 -179.80 78.44 62.85 82.15 -170.54 -97.32 25.17 -73.28 -65.84 -19.89 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_1J1CB.pdb CMGC Active 1 ADP 2.10 -138.35 179.99 80.39 63.31 82.67 -166.55 -100.43 28.18 -70.09 -70.45 -13.94 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_1O9UA.pdb CMGC Active 1 Apo 2.40 -135.57 -170.81 76.89 57.66 80.30 -162.70 -97.17 18.57 -73.49 -63.85 -4.63 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_1PYXA.pdb CMGC Active 1 ANP 2.40 -138.84 -178.09 75.86 65.15 79.94 -170.40 -98.78 26.03 -70.02 -73.24 -7.58 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_1PYXB.pdb CMGC Active 1 ANP 2.40 -140.95 -178.45 76.64 65.24 80.02 -169.65 -98.14 22.34 -69.30 -68.31 -7.69 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_1Q3DA.pdb CMGC Active 1 STU 2.20 -139.51 178.31 77.23 63.93 87.17 -165.31 -99.42 23.72 -77.39 -66.27 -14.55 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_1Q3DB.pdb CMGC Active 1 STU 2.20 -137.95 177.42 79.00 64.44 87.02 -165.49 -97.97 22.58 -77.31 -63.98 -17.33 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_1Q3WA.pdb CMGC Active 1 ATU 2.30 -137.72 177.63 76.85 62.85 83.32 -161.04 -96.12 24.70 -71.76 -66.69 -10.07 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_1Q3WB.pdb CMGC Active 1 ATU 2.30 -140.47 175.49 78.70 63.80 84.71 -161.71 -97.01 22.90 -73.69 -64.83 -10.66 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_1Q41A.pdb CMGC Active 1 IXM 2.10 -140.27 177.98 73.53 63.36 85.30 -170.87 -97.70 24.93 -74.87 -64.63 -16.74 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_1Q41B.pdb CMGC Active 1 IXM 2.10 -139.74 177.73 74.70 62.57 85.87 -169.33 -97.87 24.81 -74.66 -63.82 -17.55 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_1Q4LA.pdb CMGC Active 1 679 2.77 -138.38 -176.39 64.68 57.77 86.03 -154.11 -99.53 21.23 -74.27 -64.95 -5.46 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_1Q4LB.pdb CMGC Active 1 679 2.77 -140.12 -177.16 65.23 58.73 87.15 -156.16 -99.82 20.09 -74.91 -64.59 -5.33 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_1Q5KA.pdb CMGC Active 1 TMU 1.94 -136.20 -175.74 73.60 56.25 81.92 -172.65 -94.71 24.17 -76.48 -64.33 -18.03 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_1Q5KB.pdb CMGC Active 1 TMU 1.94 -138.68 -177.16 69.97 58.88 79.46 -163.29 -94.40 28.12 -74.67 -69.40 -14.82 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_1R0EA.pdb CMGC Active 1 DFN 2.25 -134.05 -179.44 68.60 58.39 85.08 -156.56 -96.60 20.84 -81.52 -63.62 -17.58 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_1R0EB.pdb CMGC Active 1 DFN 2.25 -133.07 -177.03 67.00 55.13 85.46 -155.35 -97.09 20.86 -83.96 -65.90 -17.31 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_1UV5A.pdb CMGC Active 1 BRW 2.80 -144.27 -177.09 78.90 59.29 81.05 -173.71 -94.22 27.91 -73.97 -59.17 -36.47 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_2JLDA.pdb CMGC Active 1 AG1 2.35 -128.75 173.96 76.07 65.58 88.99 -166.51 -100.99 20.21 -78.17 -65.99 -16.50 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_2JLDB.pdb CMGC Active 1 AG1 2.35 -134.77 174.83 83.67 62.57 85.32 -162.96 -97.66 21.91 -75.13 -65.12 -17.35 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_2O5KA.pdb CMGC Active 1 HBM 3.20 -127.36 -179.87 70.20 54.97 85.30 -158.32 -97.89 27.21 -80.45 -63.82 -54.18 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_2OW3A.pdb CMGC Active 1 BIM 2.80 -145.54 -177.17 70.88 62.65 79.70 -163.34 -96.00 37.93 -60.80 -72.57 -36.66 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_2OW3B.pdb CMGC Active 1 BIM 2.80 -140.90 -178.77 85.74 62.84 80.38 -167.28 -94.89 34.13 -68.83 -79.38 -15.74 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_3DU8A.pdb CMGC Active 1 553 2.20 -138.88 -177.64 81.95 60.77 81.50 -166.49 -97.53 17.85 -75.91 -60.49 -23.71 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_3DU8B.pdb CMGC Active 1 553 2.20 -129.99 -177.11 74.72 64.67 78.31 -173.39 -91.29 21.44 -76.12 -65.59 -20.64 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_3F7ZA.pdb CMGC Active 1 34O 2.40 -134.47 172.12 85.60 69.04 81.64 -168.25 -97.31 19.48 -75.66 -68.91 -10.87 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_3F7ZB.pdb CMGC Active 1 34O 2.40 -136.71 -179.54 82.84 57.89 84.96 -173.75 -98.76 23.49 -76.75 -68.94 -21.10 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_3F88A.pdb CMGC Active 1 3HT 2.60 -137.93 -171.16 77.57 53.22 96.02 -170.29 -109.47 31.55 -82.78 -85.55 3.17 999.00 Outlier CYS ASP PHE GLY"
"GSK3B_HUMAN t_3F88B.pdb CMGC Active 1 3HT 2.60 -143.94 176.90 73.19 66.16 95.36 -179.00 -113.01 21.86 -78.35 -72.50 -7.14 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_3GB2A.pdb CMGC Active 1 G3B 2.40 -136.75 -176.83 68.16 57.75 94.40 -170.98 -109.12 24.08 -69.50 -73.15 4.86 999.00 Outlier CYS ASP PHE GLY"
"GSK3B_HUMAN t_3I4BA.pdb CMGC Active 1 Z48 2.30 -134.03 -176.39 68.35 58.74 78.17 -174.29 -93.69 24.36 -74.30 -67.57 -20.05 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_3I4BB.pdb CMGC Active 1 Z48 2.30 -135.83 -175.30 72.85 58.19 77.52 -170.80 -93.84 21.57 -74.41 -65.18 -18.85 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_3L1SA.pdb CMGC Active 1 Z92 2.90 -136.23 -175.25 73.66 59.70 68.01 -175.15 -82.47 22.03 -72.25 -66.81 -21.63 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_3L1SB.pdb CMGC Active 1 Z92 2.90 -136.59 -175.36 73.78 61.35 59.71 -173.21 -75.14 22.71 -68.58 -66.46 -23.36 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_3M1SA.pdb CMGC Active 1 DW1 3.13 -149.15 -179.03 86.96 55.77 87.86 -159.70 -101.23 23.05 -67.05 -62.43 -0.07 999.00 Outlier CYS ASP PHE GLY"
"GSK3B_HUMAN t_3M1SB.pdb CMGC Active 1 DW1 3.13 -147.85 174.33 91.47 70.88 99.61 -158.74 -120.29 19.87 -73.43 -63.51 -14.18 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_3PUPA.pdb CMGC Active 1 OS1 2.99 -143.76 172.57 75.24 64.22 94.88 -161.62 -107.49 13.55 -72.52 -52.34 -32.47 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_3PUPB.pdb CMGC Active 1 OS1 2.99 -146.62 171.74 79.86 65.60 100.12 -167.42 -113.06 21.03 -72.79 -60.03 -30.47 999.00 Outlier CYS ASP PHE GLY"
"GSK3B_HUMAN t_3Q3BA.pdb CMGC Active 1 55E 2.70 -146.53 -174.96 78.13 60.73 82.18 -155.37 -97.36 23.01 -72.08 -66.72 -7.99 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_3Q3BB.pdb CMGC Active 1 55E 2.70 -148.02 -175.07 80.85 60.11 82.70 -155.88 -96.12 20.02 -72.69 -64.84 -9.32 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_3SAYA.pdb CMGC Active 1 OFT 2.23 -134.12 -176.26 70.67 58.13 80.75 -179.62 -95.52 24.71 -74.28 -58.96 -23.56 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_3SAYB.pdb CMGC Active 1 OFT 2.23 -125.49 -174.51 66.37 59.36 82.09 -175.73 -94.04 22.40 -76.02 -68.09 -11.86 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_3SD0A.pdb CMGC Active 1 TSK 2.70 -139.26 -172.59 71.04 62.64 82.93 -164.52 -94.94 18.56 -76.12 -68.09 -17.79 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_3SD0B.pdb CMGC Active 1 TSK 2.70 -142.22 -171.32 75.36 46.97 83.21 -170.61 -91.84 32.34 -74.15 -82.62 -8.90 999.00 Outlier CYS ASP PHE GLY"
"GSK3B_HUMAN t_3ZDIA.pdb CMGC Active 1 UGJ 2.64 -139.12 169.71 88.61 59.80 93.37 -155.63 -102.54 31.01 -75.45 -74.40 -6.04 999.00 Outlier CYS ASP PHE GLY"
"GSK3B_HUMAN t_3ZRKA.pdb CMGC Active 1 ZRK 2.37 -131.72 179.91 77.94 63.14 79.55 -161.34 -95.32 25.29 -73.42 -74.16 -8.58 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_3ZRKB.pdb CMGC Active 1 ZRK 2.37 -139.43 -177.25 75.51 57.93 77.11 -165.66 -90.44 24.03 -74.06 -69.91 -16.37 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_3ZRLA.pdb CMGC Active 1 ZRL 2.48 -134.74 178.82 79.58 66.18 74.17 -172.69 -88.08 21.09 -74.01 -68.67 -8.28 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_3ZRLB.pdb CMGC Active 1 ZRL 2.48 -140.62 -176.19 76.85 56.22 79.05 -169.32 -88.78 18.98 -73.53 -67.01 -13.15 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_3ZRMA.pdb CMGC Active 1 ZRM 2.49 -131.98 -179.12 79.52 64.73 76.88 -171.43 -91.05 16.45 -74.27 -61.03 -14.48 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_3ZRMB.pdb CMGC Active 1 ZRM 2.49 -140.66 -177.65 79.64 59.27 76.66 -169.85 -89.38 25.79 -72.56 -71.40 -17.33 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_4ACCA.pdb CMGC Active 1 7YG 2.21 -136.31 179.69 77.96 61.54 88.23 -173.93 -100.03 20.60 -78.74 -65.96 -21.02 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_4ACCB.pdb CMGC Active 1 7YG 2.21 -136.61 179.64 77.53 61.72 88.29 -173.95 -99.73 21.23 -78.04 -66.10 -22.27 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_4ACDA.pdb CMGC Active 1 GR9 2.60 -142.43 176.54 77.07 66.03 88.12 -175.36 -100.29 16.96 -74.02 -64.08 -23.96 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_4ACDB.pdb CMGC Active 1 GR9 2.60 -141.99 177.81 74.64 64.11 89.28 -178.22 -100.34 16.51 -74.10 -62.46 -26.14 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_4ACGA.pdb CMGC Active 1 6LQ 2.60 -136.28 179.14 76.99 66.22 92.49 -171.25 -104.82 26.84 -74.09 -71.25 -31.71 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_4ACGB.pdb CMGC Active 1 6LQ 2.60 -135.91 178.41 76.41 67.22 92.33 -171.13 -105.79 27.09 -74.80 -71.06 -30.39 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_4ACHA.pdb CMGC Active 1 KDI 2.60 -136.86 179.50 74.82 65.63 91.14 -173.80 -104.16 25.59 -73.69 -69.42 -35.11 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_4ACHB.pdb CMGC Active 1 KDI 2.60 -136.92 178.73 75.52 65.40 91.28 -174.30 -104.58 25.62 -74.71 -68.49 -34.57 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_4AFJA.pdb CMGC Active 1 SJJ 1.98 -130.69 179.09 77.09 59.10 87.67 -171.97 -94.87 20.24 -79.15 -65.75 -20.90 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_4AFJB.pdb CMGC Active 1 SJJ 1.98 -131.50 179.00 78.05 57.72 85.76 -175.23 -93.20 22.05 -79.08 -64.36 -20.76 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_4B7TA.pdb CMGC Active 1 CWT 2.77 -139.33 -173.62 71.79 55.54 80.26 -171.46 -97.97 26.18 -75.90 -70.00 -22.22 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_4DITA.pdb CMGC Active 1 0KD 2.60 -145.38 179.73 77.83 65.96 81.38 -174.74 -105.99 22.50 -71.02 -68.29 -17.90 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_4IQ6A.pdb CMGC Active 1 IQ6 3.12 -142.09 176.34 76.54 68.24 73.00 -136.34 -88.94 16.74 -68.39 -55.57 -37.32 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_4IQ6B.pdb CMGC Active 1 IQ6 3.12 -142.55 175.52 77.55 68.99 72.09 -135.72 -88.67 16.44 -68.64 -54.23 -38.91 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_4J1RA.pdb CMGC Active 1 I5R 2.70 -140.37 -172.19 75.12 50.80 73.03 -170.63 -88.09 31.45 -71.19 -70.80 -20.50 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_4J1RB.pdb CMGC Active 1 I5R 2.70 -138.13 -172.03 77.51 51.93 73.81 -171.83 -90.72 32.77 -71.36 -71.93 -19.83 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_4J1RC.pdb CMGC Active 1 I5R 2.70 -137.55 -170.94 74.71 50.99 74.59 -170.33 -90.63 33.08 -70.71 -73.11 -20.69 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_4J1RD.pdb CMGC Active 1 I5R 2.70 -136.30 -170.01 77.75 51.30 73.44 -171.22 -90.02 32.10 -71.03 -72.81 -18.12 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_4J71A.pdb CMGC Active 1 1JX 2.31 -134.38 178.88 77.43 60.60 80.24 -169.74 -96.95 24.92 -75.27 -68.28 -15.70 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_4J71B.pdb CMGC Active 1 1JX 2.31 -140.64 179.67 78.91 59.87 90.69 -176.38 -104.79 25.38 -71.26 -66.79 -17.28 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_4NM0A.pdb CMGC Active 1 ADP 2.50 -133.44 -174.28 71.39 56.83 85.53 -172.79 -105.70 27.79 -72.67 -76.50 -2.55 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_4NM3A.pdb CMGC Active 1 ADP 2.10 -129.95 -178.06 68.66 63.22 87.88 -165.97 -103.95 21.28 -70.59 -65.46 -16.38 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_4NM5A.pdb CMGC Active 1 ADP 2.30 -136.13 -177.72 76.01 61.90 88.48 -171.50 -108.68 28.79 -72.13 -73.68 -15.48 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_4NM7A.pdb CMGC Active 1 ADP 2.30 -137.32 -178.06 73.98 62.86 88.61 -167.50 -107.34 24.61 -71.60 -69.81 -12.69 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_4PTCA.pdb CMGC Active 1 2WE 2.71 -147.74 -174.05 77.86 62.91 81.81 -160.90 -100.22 25.79 -75.70 -59.59 -43.36 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_4PTCB.pdb CMGC Active 1 2WE 2.71 -123.88 -167.90 62.30 50.39 80.97 -166.06 -94.37 28.62 -75.18 -64.17 -29.40 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_4PTEA.pdb CMGC Active 1 2WF 2.03 -141.24 178.01 179.03 58.02 89.36 -175.21 -100.26 24.32 -73.65 -68.11 -18.99 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_4PTEB.pdb CMGC Active 1 2WF 2.03 -137.08 179.45 172.32 58.45 89.07 -175.90 -101.43 27.89 -75.73 -69.84 -20.70 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_4PTGA.pdb CMGC Active 1 2WG 2.36 -132.54 179.85 75.64 66.23 92.04 -167.92 -106.71 26.93 -74.75 -68.07 -25.88 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_4PTGB.pdb CMGC Active 1 2WG 2.36 -136.24 -175.38 78.70 57.57 87.03 -168.41 -101.32 27.29 -74.59 -67.67 -26.11 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_5F94A.pdb CMGC Active 1 3UO 2.51 -132.26 -171.97 79.66 59.15 80.78 -167.37 -95.81 23.07 -70.82 -56.51 -34.30 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_5F94B.pdb CMGC Active 1 3UO 2.51 -131.46 -174.68 78.05 60.14 82.53 -170.95 -97.17 22.97 -72.10 -56.23 -35.40 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_5F95A.pdb CMGC Active 1 3UP 2.53 -130.97 -172.53 65.98 54.13 85.76 -172.26 -99.54 23.46 -72.93 -58.28 -30.12 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_5F95B.pdb CMGC Active 1 3UP 2.53 -130.18 -170.53 68.00 52.90 82.93 -171.67 -97.01 23.55 -76.12 -57.66 -29.50 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_5HLNA.pdb CMGC Active 1 65C 3.10 -145.86 177.83 84.59 61.54 84.92 -174.99 -98.60 20.20 -71.74 -61.34 -16.27 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_5HLNB.pdb CMGC Active 1 65C 3.10 -143.08 -174.58 68.65 53.05 90.38 -173.10 -103.42 32.99 -71.03 -74.69 -34.85 999.00 Outlier CYS ASP PHE GLY"
"GSK3B_HUMAN t_5HLPA.pdb CMGC Active 1 65A 2.45 -131.03 175.54 -162.07 62.46 78.76 -159.86 -95.77 20.39 -77.00 -68.09 -12.12 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_5HLPB.pdb CMGC Active 1 65A 2.45 -128.15 -178.92 -169.86 57.79 78.13 -169.55 -94.27 22.11 -75.46 -71.61 -17.19 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_5K5NA.pdb CMGC Active 1 6QH 2.20 -136.90 -178.01 74.98 58.52 81.57 -167.18 -94.04 22.58 -74.74 -66.62 -22.72 999.00 Allowed CYS ASP PHE GLY"
"GSK3B_HUMAN t_5K5NB.pdb CMGC Active 1 6QH 2.20 -135.13 -178.47 79.44 58.88 83.37 -169.28 -94.55 20.57 -73.32 -64.38 -22.38 999.00 Allowed CYS ASP PHE GLY"
"GWL_HUMAN t_5LOHA.pdb AGC DFGup 3 STU 3.10 -154.07 -179.96 -167.04 62.84 37.42 -142.90 -106.52 -23.34 59.69 -168.73 -25.52 999.00 Favored THR ASP PHE GLY"
"GWL_HUMAN t_5LOHB.pdb NA NA 0 STU 3.10 -152.82 -174.26 -174.74 66.23 69.30 -149.42 -150.63 -21.42 41.28 -90.40 22.32 999.00 Allowed THR ASP PHE GLY"
"HASP_HUMAN t_2VUWA.pdb OTHER Active 1 MPD 1.80 -126.68 172.45 60.28 73.17 94.58 -162.69 -106.18 25.32 -42.96 -59.04 -30.55 -52.93 NA ILE ASP TYR THR"
"HASP_HUMAN t_2WB8A.pdb OTHER Active 1 Apo 2.15 -120.67 176.88 67.56 68.17 91.69 -177.17 -104.25 25.95 -44.31 -56.02 -32.90 -47.22 NA ILE ASP TYR THR"
"HASP_HUMAN t_3DLZA.pdb OTHER Active 1 AMP 1.85 -120.11 174.07 62.99 73.29 91.07 -169.18 -105.88 29.09 -44.15 -57.27 -36.10 -57.72 NA ILE ASP TYR THR"
"HASP_HUMAN t_3E7VA.pdb OTHER Active 1 DZO 2.00 -130.14 169.16 63.90 72.59 84.87 -154.38 -101.27 35.49 -43.15 -62.16 -34.94 57.75 NA ILE ASP TYR THR"
"HASP_HUMAN t_3F2NA.pdb OTHER Active 1 IZZ 1.80 -132.37 169.19 60.80 74.49 87.74 -162.11 -98.14 25.15 -43.69 -56.96 -34.58 -62.54 NA ILE ASP TYR THR"
"HASP_HUMAN t_3FMDA.pdb OTHER Active 1 IQB 2.00 -134.92 173.12 64.46 69.15 93.37 -158.70 -108.37 23.17 -50.96 -58.66 -32.85 -56.70 NA ILE ASP TYR THR"
"HASP_HUMAN t_3IQ7A.pdb OTHER Active 1 5ID 2.00 -130.09 168.57 55.34 78.50 93.82 -168.99 -107.03 26.86 -42.85 -63.63 -28.13 -169.74 NA ILE ASP TYR THR"
"HASP_HUMAN t_4OUCA.pdb OTHER Active 1 5ID 1.90 -123.14 171.33 59.49 70.96 89.76 -164.50 -103.12 24.77 -42.16 -50.69 -43.23 -59.88 NA ILE ASP TYR THR"
"HASP_HUMAN t_4QTCA.pdb OTHER Active 1 38Z 1.40 -128.31 174.11 63.71 72.79 94.30 -175.95 -100.87 22.56 -48.53 -49.88 -46.29 -60.75 NA ILE ASP TYR THR"
"HASP_HUMAN t_5HTBA.pdb OTHER Active 1 Apo 1.70 -127.83 172.40 61.86 75.82 95.97 -162.77 -111.89 24.62 -46.64 -57.62 -35.98 -60.63 NA ILE ASP TYR THR"
"HASP_HUMAN t_5HTCA.pdb OTHER Active 1 MPD 1.50 -124.67 170.60 65.66 75.01 95.28 -163.76 -108.37 22.99 -43.35 -55.99 -37.67 -51.06 NA ILE ASP TYR THR"
"HCK_HUMAN t_1AD5A.pdb TYR DFGin-inactive 2 ANP 2.60 -111.52 157.79 999.00 55.79 95.52 -54.00 -99.81 -56.90 -38.94 -91.87 132.99 999.00 Outlier ALA ASP PHE GLY"
"HCK_HUMAN t_1AD5B.pdb TYR DFGin-inactive 2 ANP 2.60 -108.58 152.83 999.00 57.63 95.38 -57.08 -100.84 -57.79 -38.12 -88.91 132.42 999.00 Outlier ALA ASP PHE GLY"
"HCK_HUMAN t_1QCFA.pdb TYR DFGup 3 PP1 2.00 -122.29 162.66 999.00 66.02 14.58 -101.95 -58.80 126.21 40.88 78.66 -11.90 999.00 Favored ALA ASP PHE GLY"
"HCK_HUMAN t_2C0IA.pdb TYR DFGin-trans 4 L1G 2.30 -115.34 153.98 999.00 70.86 18.13 -82.52 -65.96 121.65 -175.65 105.93 -38.18 999.00 Favored ALA ASP PHE GLY"
"HCK_HUMAN t_2C0IB.pdb TYR DFGin-trans 4 L1G 2.30 -118.52 156.14 999.00 76.62 12.36 -73.36 -65.22 111.13 174.32 114.88 -35.20 999.00 Favored ALA ASP PHE GLY"
"HCK_HUMAN t_2C0OA.pdb TYR DFGin-trans 4 L2G 2.85 -102.83 170.82 999.00 68.32 6.07 -80.16 -62.18 117.59 178.10 105.18 -37.23 999.00 Favored ALA ASP PHE GLY"
"HCK_HUMAN t_2C0OB.pdb TYR DFGin-trans 4 L2G 2.85 -110.14 165.43 999.00 70.96 15.77 -79.80 -62.57 118.16 -176.25 90.06 -16.01 999.00 Favored ALA ASP PHE GLY"
"HCK_HUMAN t_2C0TA.pdb TYR DFGin-trans 4 L3G 2.15 -103.64 161.86 999.00 63.40 18.71 -70.56 -68.77 122.03 173.01 109.43 -49.88 999.00 Favored ALA ASP PHE GLY"
"HCK_HUMAN t_2C0TB.pdb TYR DFGin-trans 4 L3G 2.15 -104.02 163.31 999.00 58.07 34.29 -66.68 -79.80 115.20 166.00 89.11 999.00 999.00 Favored ALA ASP PHE GLY"
"HCK_HUMAN t_2HCKA.pdb TYR DFGin-inactive 2 QUE 3.00 -135.77 164.50 999.00 54.34 68.16 -49.34 -77.81 -69.03 -38.03 -94.79 122.44 999.00 Allowed ALA ASP PHE GLY"
"HCK_HUMAN t_2HCKB.pdb TYR DFGin-inactive 2 QUE 3.00 -141.08 165.94 999.00 51.22 63.51 -49.00 -82.57 -71.39 -29.57 -82.32 116.40 999.00 Favored ALA ASP PHE GLY"
"HCK_HUMAN t_2HK5A.pdb TYR Active 1 1BM 2.00 -125.02 -169.01 999.00 45.97 87.53 -145.40 -101.96 25.84 -54.91 -63.73 -34.19 999.00 Outlier ALA ASP PHE GLY"
"HCK_HUMAN t_3VRYA.pdb TYR DFGup 3 B43 2.48 -119.79 168.30 999.00 60.85 32.95 -84.15 -79.11 125.03 35.98 75.64 2.50 999.00 Favored ALA ASP PHE GLY"
"HCK_HUMAN t_3VRYB.pdb TYR DFGup 3 B43 2.48 -124.74 163.97 999.00 61.96 27.83 -79.45 -75.15 120.96 41.11 77.67 7.67 999.00 Favored ALA ASP PHE GLY"
"HCK_HUMAN t_3VRZA.pdb TYR DFGin-trans 4 VRZ 2.22 -107.47 162.37 999.00 65.35 22.28 -91.44 -66.59 118.85 172.11 104.43 -23.09 999.00 Favored ALA ASP PHE GLY"
"HCK_HUMAN t_3VRZB.pdb TYR DFGin-trans 4 VRZ 2.22 -106.90 168.11 999.00 63.91 13.81 -107.93 -60.23 119.90 -179.40 108.31 -25.61 999.00 Favored ALA ASP PHE GLY"
"HCK_HUMAN t_3VS0A.pdb TYR DFGin-trans 4 VS0 2.93 -129.57 162.09 999.00 -82.47 -42.31 -41.50 67.43 124.54 160.77 69.56 30.04 999.00 Favored ALA ASP PHE GLY"
"HCK_HUMAN t_3VS0B.pdb TYR DFGin-trans 4 VS0 2.93 -111.81 150.52 999.00 -110.05 -32.76 27.81 65.65 113.93 163.09 100.71 -23.64 999.00 Favored ALA ASP PHE GLY"
"HCK_HUMAN t_3VS1A.pdb TYR DFGin-trans 4 VSA 2.46 -69.89 118.42 999.00 -52.40 130.09 -53.03 95.28 -49.43 153.53 -76.58 -8.51 999.00 Favored ALA ASP PHE GLY"
"HCK_HUMAN t_3VS1B.pdb TYR DFGin-trans 4 VSA 2.46 -77.81 121.43 999.00 -54.04 124.90 -43.37 82.61 -74.76 150.56 -49.95 -36.42 999.00 Favored ALA ASP PHE GLY"
"HCK_HUMAN t_3VS2A.pdb TYR DFGup 3 VSB 2.61 -126.18 168.78 999.00 60.55 22.05 -66.49 -69.94 133.31 46.98 78.47 -37.43 999.00 Favored ALA ASP PHE GLY"
"HCK_HUMAN t_3VS2B.pdb TYR DFGin-trans 4 VSB 2.61 -172.83 118.29 999.00 -95.56 158.07 81.61 70.96 64.18 175.27 108.52 -126.46 999.00 Favored ALA ASP PHE GLY"
"HCK_HUMAN t_3VS3A.pdb TYR DFGup 3 VSE 2.17 -113.89 168.56 999.00 61.08 21.04 -72.91 -67.37 128.32 47.78 67.76 34.60 999.00 Favored ALA ASP PHE GLY"
"HCK_HUMAN t_3VS3B.pdb TYR DFGup 3 VSE 2.17 -119.67 171.08 999.00 60.05 22.26 -79.15 -67.93 124.86 43.01 84.86 -11.11 999.00 Favored ALA ASP PHE GLY"
"HCK_HUMAN t_3VS4A.pdb TYR DFGup 3 VSF 2.75 -129.07 156.52 999.00 78.14 7.34 -75.46 -55.38 122.06 48.26 91.70 -36.20 999.00 Favored ALA ASP PHE GLY"
"HCK_HUMAN t_3VS4B.pdb TYR DFGup 3 VSF 2.75 -120.93 167.82 999.00 61.52 15.87 -77.98 -62.01 121.50 47.25 74.96 10.77 999.00 Favored ALA ASP PHE GLY"
"HCK_HUMAN t_3VS5A.pdb TYR DFGup 3 VSG 2.85 -113.17 163.39 999.00 44.86 47.29 -24.67 -70.53 125.04 29.01 91.19 -36.07 999.00 Favored ALA ASP PHE GLY"
"HCK_HUMAN t_3VS5B.pdb TYR DFGup 3 VSG 2.85 -103.52 162.98 999.00 68.59 22.80 -86.80 -66.55 121.30 37.55 89.10 -18.63 999.00 Favored ALA ASP PHE GLY"
"HCK_HUMAN t_3VS6A.pdb TYR DFGup 3 VSH 2.37 -118.65 173.07 999.00 55.30 21.38 -74.25 -65.20 123.96 39.58 74.87 -1.14 999.00 Favored ALA ASP PHE GLY"
"HCK_HUMAN t_3VS6B.pdb TYR DFGup 3 VSH 2.37 -116.12 166.02 999.00 60.60 23.34 -73.83 -65.70 128.56 39.98 65.40 33.09 999.00 Favored ALA ASP PHE GLY"
"HCK_HUMAN t_3VS7A.pdb TYR DFGin-trans 4 KS1 3.00 -90.56 -125.12 999.00 -63.19 78.02 47.46 -85.59 139.13 138.54 73.42 14.49 999.00 Outlier ALA ASP PHE GLY"
"HCK_HUMAN t_3VS7B.pdb TYR DFGinter 5 KS1 3.00 -102.96 166.49 999.00 26.67 56.41 49.33 -48.56 110.67 13.13 46.94 38.84 999.00 Allowed ALA ASP PHE GLY"
"HCK_HUMAN t_4LUDA.pdb TYR DFGup 3 SK8 2.85 -116.29 150.30 999.00 49.83 43.35 999.00 -87.07 142.95 63.26 99.08 -26.20 999.00 Favored ALA ASP PHE GLY"
"HCK_HUMAN t_4LUDB.pdb TYR DFGup 3 SK8 2.85 -114.11 155.76 999.00 54.39 45.04 -68.57 -86.38 134.52 55.74 92.32 -27.23 999.00 Favored ALA ASP PHE GLY"
"HCK_HUMAN t_4LUEA.pdb TYR DFGup 3 VSE 3.04 -122.78 161.78 999.00 60.90 25.34 -72.22 -68.45 129.03 43.23 79.72 -15.87 999.00 Favored ALA ASP PHE GLY"
"HCK_HUMAN t_4LUEB.pdb TYR DFGup 3 VSE 3.04 -122.04 162.59 999.00 61.61 25.99 -72.08 -68.05 129.12 43.17 79.44 -16.80 999.00 Favored ALA ASP PHE GLY"
"IGF1R_HUMAN t_1JQHA.pdb TYR DFGup 3 ANP 2.10 -66.74 163.88 999.00 -59.43 151.31 61.47 -140.20 178.06 43.94 -106.76 173.09 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_1JQHB.pdb TYR DFGup 3 ANP 2.10 -65.80 164.37 999.00 -59.95 151.83 60.69 -140.79 178.22 43.72 -109.68 -174.78 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_1JQHC.pdb TYR DFGup 3 ANP 2.10 -65.47 162.75 999.00 -58.76 151.67 61.23 -140.85 179.00 43.82 -110.25 -177.70 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_1K3AA.pdb TYR Active 1 ACP 2.10 -128.42 -4.89 999.00 -126.88 131.74 -168.67 -125.91 30.60 -52.97 -55.79 -30.44 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_1M7NA.pdb TYR DFGinter 5 Apo 2.70 -63.70 150.56 999.00 -83.72 162.01 55.76 -57.57 152.80 77.55 64.94 31.06 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_1M7NB.pdb TYR DFGinter 5 Apo 2.70 -73.41 167.80 999.00 -87.89 168.42 38.46 -62.78 156.58 81.25 55.22 47.23 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_1P4OA.pdb TYR DFGinter 5 Apo 1.50 -75.54 161.78 999.00 -88.21 167.54 49.78 -62.70 158.71 79.76 58.71 28.12 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_1P4OB.pdb TYR DFGinter 5 Apo 1.50 -75.01 163.71 999.00 -90.40 168.58 49.82 -63.64 158.63 80.06 59.30 26.81 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_2OJ9A.pdb TYR DFGin-trans 4 BMI 2.00 -109.07 -162.37 999.00 -72.97 149.81 -37.30 -62.91 130.43 151.54 65.27 -124.91 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_2ZM3A.pdb TYR Active 1 575 2.50 -126.59 2.95 999.00 -143.70 130.05 -171.34 -129.18 19.25 -63.65 -55.87 -25.18 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_2ZM3B.pdb TYR Active 1 575 2.50 -122.13 -30.51 999.00 -117.43 117.58 178.25 -113.53 25.90 -66.31 -63.46 -21.67 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_2ZM3C.pdb TYR Active 1 575 2.50 -152.06 34.97 999.00 -157.78 111.58 -171.90 -117.56 21.84 -65.24 -67.25 -1.53 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_2ZM3D.pdb TYR Active 1 575 2.50 -111.37 -39.66 999.00 -105.43 131.66 -170.19 -127.15 27.82 -60.45 -65.49 -19.60 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_3D94A.pdb TYR DFGup 3 D94 2.30 -113.80 -141.34 999.00 -41.68 115.16 -166.08 -104.15 0.30 54.87 -78.60 -17.43 999.00 Allowed GLY ASP PHE GLY"
"IGF1R_HUMAN t_3F5PA.pdb TYR Active 1 741 2.90 -138.08 -25.55 999.00 -129.57 107.73 -178.63 -116.04 43.13 -49.48 -78.84 -11.03 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_3F5PB.pdb TYR Active 1 741 2.90 -147.80 -6.76 999.00 -126.36 106.68 -169.64 -113.93 18.17 -56.67 -63.89 -6.60 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_3F5PC.pdb TYR Active 1 741 2.90 -131.22 -29.73 999.00 -123.17 122.22 -175.67 -124.34 31.57 -49.44 -71.28 -4.46 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_3F5PD.pdb TYR Active 1 741 2.90 -123.52 -41.41 999.00 -120.47 118.97 171.44 -120.72 27.36 -55.76 -67.95 -13.34 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_3F5PE.pdb TYR Active 1 741 2.90 -135.55 -29.13 999.00 -118.75 122.17 -174.61 -123.59 9.66 -63.57 -57.61 -18.01 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_3F5PF.pdb TYR Active 1 741 2.90 -133.67 -29.11 999.00 -124.96 116.76 179.94 -119.77 22.17 -52.66 -62.09 -21.14 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_3F5PG.pdb TYR Active 1 741 2.90 -142.81 -22.57 999.00 -124.37 117.70 176.95 -119.97 31.07 -60.20 -73.84 -11.81 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_3F5PH.pdb TYR Active 1 741 2.90 -135.12 -37.63 999.00 -123.07 112.92 -174.51 -114.80 16.75 -50.04 -57.51 -9.94 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_3F5PI.pdb TYR Active 1 741 2.90 -144.33 -12.55 999.00 -125.23 113.81 -171.21 -116.98 15.77 -59.47 -62.17 -14.25 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_3F5PJ.pdb TYR Active 1 741 2.90 -137.35 -22.08 999.00 -131.73 119.07 177.04 -115.61 22.60 -59.79 -61.95 -18.78 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_3F5PK.pdb TYR Active 1 741 2.90 -137.37 -28.86 999.00 -125.02 120.18 174.44 -119.69 16.02 -58.54 -59.26 -20.47 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_3F5PL.pdb TYR Active 1 741 2.90 -130.07 -30.55 999.00 -132.48 115.30 164.30 -114.96 24.82 -49.96 -62.10 -19.45 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_3F5PM.pdb TYR Active 1 741 2.90 -128.57 -42.47 999.00 -122.63 116.49 178.98 -120.05 38.46 -45.67 -73.16 -23.04 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_3F5PR.pdb TYR Active 1 741 2.90 -139.02 -20.86 999.00 -125.52 103.35 -174.49 -109.46 25.06 -48.87 -58.61 -20.19 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_3F5PS.pdb TYR Active 1 741 2.90 -137.70 -25.35 999.00 -122.76 115.94 -170.63 -115.03 8.87 -55.63 -47.72 -27.80 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_3F5PT.pdb TYR Active 1 741 2.90 -141.28 -19.44 999.00 -137.81 101.17 -179.91 -103.08 11.94 -55.67 -50.99 -21.45 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_3I81A.pdb TYR DFGin-inactive 2 EBI 2.08 -69.58 174.66 999.00 -71.07 142.27 -167.80 -76.37 136.87 -48.06 70.68 14.24 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_3LVPA.pdb TYR Active 1 PDR 3.00 -121.08 43.12 999.00 -157.42 127.32 -176.08 -132.75 38.67 -55.03 -58.65 -41.19 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_3LVPB.pdb TYR Active 1 PDR 3.00 -100.74 -41.90 999.00 -105.19 149.94 175.96 -137.95 21.71 -51.27 -51.06 -10.36 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_3LVPC.pdb TYR Active 1 PDR 3.00 -128.36 8.67 999.00 -136.74 135.20 -172.21 -140.33 37.80 -52.57 -60.47 -40.06 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_3LVPD.pdb TYR Active 1 PDR 3.00 -106.86 166.89 999.00 53.44 123.04 177.83 -131.87 26.68 -58.75 -46.26 -39.91 999.00 Outlier GLY ASP PHE GLY"
"IGF1R_HUMAN t_3LW0A.pdb TYR DFGout 6 CCX 1.79 170.06 149.43 999.00 -168.41 165.04 76.28 -107.67 13.24 -51.05 90.34 111.76 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_3LW0B.pdb TYR DFGout 6 CCX 1.79 170.40 151.16 999.00 -165.88 166.28 73.26 -107.54 14.79 -51.04 88.87 109.37 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_3LW0C.pdb TYR DFGout 6 CCX 1.79 171.38 152.57 999.00 -167.30 165.11 73.34 -107.84 15.68 -48.61 88.57 109.61 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_3LW0D.pdb TYR DFGout 6 CCX 1.79 167.76 152.01 999.00 -167.75 166.50 74.96 -109.76 14.15 -54.71 89.29 110.68 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_3NW5A.pdb TYR DFGin-inactive 2 LGX 2.14 -72.76 167.90 999.00 -46.34 134.17 -179.56 -70.69 161.00 -68.04 38.81 22.78 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_3NW6A.pdb TYR DFGin-inactive 2 LGW 2.20 -74.92 163.23 999.00 -46.34 132.28 -175.95 -66.64 144.99 -61.67 60.32 24.74 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_3NW7A.pdb TYR DFGin-inactive 2 LGV 2.11 -79.76 -167.53 999.00 -73.82 143.17 -170.93 -76.00 139.22 -56.11 55.33 50.21 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_3O23A.pdb TYR DFGout 6 MQY 2.10 -141.00 -145.12 999.00 -170.58 100.65 -171.63 -44.18 -46.01 -164.93 38.60 39.09 999.00 Allowed GLY ASP PHE GLY"
"IGF1R_HUMAN t_3QQUA.pdb TYR DFGin-inactive 2 01P 2.90 -115.21 159.56 999.00 28.23 96.17 -127.34 -42.43 112.85 -71.54 68.37 -45.77 999.00 Outlier GLY ASP PHE GLY"
"IGF1R_HUMAN t_3QQUB.pdb TYR DFGin-inactive 2 01P 2.90 -33.35 160.48 999.00 -38.00 116.50 -141.78 -33.99 105.39 -74.90 61.14 -16.23 999.00 Allowed GLY ASP PHE GLY"
"IGF1R_HUMAN t_3QQUC.pdb TYR DFGin-inactive 2 01P 2.90 -97.05 150.37 999.00 14.49 98.69 -155.08 -65.59 26.11 -78.10 -140.09 16.51 999.00 Outlier GLY ASP PHE GLY"
"IGF1R_HUMAN t_3QQUD.pdb TYR DFGin-inactive 2 01P 2.90 -72.34 173.41 999.00 -41.56 112.33 -159.68 -69.50 2.90 -65.17 -113.93 14.32 999.00 Allowed GLY ASP PHE GLY"
"IGF1R_HUMAN t_4D2RA.pdb TYR DFGin-inactive 2 DYK 2.10 -69.63 163.14 999.00 -53.53 135.65 174.83 -66.93 144.52 -55.75 61.34 29.80 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_5FXQA.pdb TYR DFGin-inactive 2 GD5 2.30 -75.32 161.16 999.00 -49.48 126.99 -179.88 -61.93 123.02 -64.73 87.58 25.81 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_5FXRA.pdb TYR DFGin-inactive 2 8LN 2.40 -71.15 158.50 999.00 -48.26 129.22 -179.37 -64.13 116.22 -63.05 92.95 19.76 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_5FXSA.pdb TYR DFGin-inactive 2 OZN 1.90 -84.32 164.50 999.00 -49.67 126.87 -170.53 -62.57 125.46 -65.13 82.73 11.80 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_5HZNA.pdb TYR DFGup 3 66A 2.20 -122.68 -134.05 999.00 -48.48 117.01 -166.79 -112.60 5.35 56.52 -80.15 -12.67 999.00 Allowed GLY ASP PHE GLY"
"IGF1R_HUMAN t_5HZNB.pdb TYR DFGup 3 66A 2.20 -120.21 -145.75 999.00 -34.92 114.09 -158.09 -109.92 7.06 53.40 -86.81 -17.81 999.00 Allowed GLY ASP PHE GLY"
"IGF1R_HUMAN t_5HZNC.pdb TYR DFGup 3 66A 2.20 -117.53 -144.28 999.00 -35.18 118.62 -166.27 -116.53 5.73 57.62 -83.74 -13.78 999.00 Allowed GLY ASP PHE GLY"
"IGF1R_HUMAN t_5HZND.pdb TYR DFGup 3 66A 2.20 -120.22 -138.30 999.00 -41.84 115.15 -161.56 -111.56 6.87 52.51 -80.48 -21.35 999.00 Allowed GLY ASP PHE GLY"
"IGF1R_HUMAN t_5HZNE.pdb TYR DFGup 3 66A 2.20 -122.96 -133.86 999.00 -50.01 120.09 -169.42 -115.95 7.17 56.82 -81.95 -14.02 999.00 Favored GLY ASP PHE GLY"
"IGF1R_HUMAN t_5HZNF.pdb TYR DFGup 3 66A 2.20 -119.92 -143.89 999.00 -36.49 117.20 -159.94 -111.87 7.86 53.85 -86.50 -19.66 999.00 Allowed GLY ASP PHE GLY"
"IGF1R_HUMAN t_5HZNG.pdb TYR DFGup 3 66A 2.20 -115.26 -143.92 999.00 -37.13 121.10 -165.23 -118.99 5.40 57.60 -84.29 -13.91 999.00 Allowed GLY ASP PHE GLY"
"IGF1R_HUMAN t_5HZNH.pdb TYR DFGup 3 66A 2.20 -117.50 -139.79 999.00 -40.99 115.57 -163.71 -113.38 4.82 52.55 -79.04 -20.18 999.00 Allowed GLY ASP PHE GLY"
"IKKA_HUMAN t_5EBZA.pdb OTHER Active 1 5TJ 4.50 -157.91 159.22 -164.87 63.40 117.08 -178.15 -127.06 13.54 -58.62 -58.13 0.45 999.00 NA ILE ASP LEU GLY"
"IKKA_HUMAN t_5EBZB.pdb OTHER Active 1 5TL 4.50 -157.87 159.26 -164.45 63.18 116.99 -178.31 -127.42 13.74 -58.00 -63.40 -5.86 999.00 NA ILE ASP LEU GLY"
"IKKA_HUMAN t_5EBZC.pdb OTHER Active 1 5TL 4.50 -158.03 158.84 -163.74 63.53 116.85 -178.76 -127.53 13.60 -58.86 -63.03 -7.16 999.00 NA ILE ASP LEU GLY"
"IKKA_HUMAN t_5EBZD.pdb OTHER Active 1 5TL 4.50 -158.01 158.78 -164.32 63.82 116.90 -178.48 -127.23 14.31 -57.85 -61.36 -3.57 999.00 NA ILE ASP LEU GLY"
"IKKA_HUMAN t_5EBZE.pdb OTHER Active 1 5TL 4.50 -157.88 159.12 -164.40 63.33 117.39 -178.36 -127.87 12.94 -58.73 -62.73 -6.66 999.00 NA ILE ASP LEU GLY"
"IKKA_HUMAN t_5EBZF.pdb OTHER Active 1 5TL 4.50 -158.08 160.12 -164.99 61.90 117.05 -178.68 -126.73 13.36 -58.34 -61.26 -5.05 999.00 NA ILE ASP LEU GLY"
"IKKA_HUMAN t_5EBZG.pdb OTHER Active 1 5TL 4.50 -157.80 159.21 -164.56 63.46 116.86 -178.30 -127.09 13.56 -59.13 -60.06 -2.90 999.00 NA ILE ASP LEU GLY"
"IKKA_HUMAN t_5EBZH.pdb OTHER Active 1 5TL 4.50 -157.83 159.18 -164.08 63.36 117.10 -177.82 -127.67 13.61 -57.36 -66.24 -13.00 999.00 NA ILE ASP LEU GLY"
"IKKA_HUMAN t_5EBZI.pdb OTHER Active 1 5TL 4.50 -158.19 159.54 -163.90 62.50 117.48 -178.81 -127.54 13.61 -58.29 -61.62 -3.43 999.00 NA ILE ASP LEU GLY"
"IKKA_HUMAN t_5EBZJ.pdb OTHER Active 1 5TL 4.50 -158.16 158.89 -164.27 63.47 116.90 -178.51 -127.16 13.73 -57.99 -63.13 -6.87 999.00 NA ILE ASP LEU GLY"
"IKKA_HUMAN t_5EBZK.pdb OTHER Active 1 5TL 4.50 -158.44 159.56 -164.93 63.25 117.11 -178.38 -127.98 13.16 -58.77 -63.15 -8.10 999.00 NA ILE ASP LEU GLY"
"IKKA_HUMAN t_5EBZL.pdb OTHER Active 1 5TL 4.50 -158.28 159.67 -164.33 62.58 117.26 -178.63 -127.48 13.48 -58.33 -64.73 -7.70 999.00 NA ILE ASP LEU GLY"
"IKKB_HUMAN t_4E3CA.pdb OTHER Active 1 Apo 3.98 -102.93 -152.86 -40.61 -13.06 129.83 -170.52 -123.25 17.88 -100.19 -50.22 -6.65 999.00 NA ILE ASP LEU GLY"
"IKKB_HUMAN t_4E3CB.pdb OTHER Active 1 Apo 3.98 -105.70 -155.65 -39.51 -11.12 130.66 -169.88 -122.46 23.80 -100.14 -53.28 -19.01 999.00 NA ILE ASP LEU GLY"
"IKKB_HUMAN t_4E3CC.pdb OTHER Active 1 Apo 3.98 -106.13 -155.15 -40.75 -11.20 130.10 -170.33 -121.06 26.37 -101.17 -40.63 -84.85 999.00 NA ILE ASP LEU GLY"
"IKKB_HUMAN t_4E3CD.pdb OTHER Active 1 Apo 3.98 -105.22 -154.29 -40.34 -11.97 129.93 -169.91 -121.19 31.34 -101.99 -48.07 -73.55 999.00 NA ILE ASP LEU GLY"
"IKKB_HUMAN t_4E3CE.pdb OTHER Active 1 Apo 3.98 -103.99 -153.14 -40.54 -13.08 129.82 -170.85 -119.98 29.19 -100.57 -39.62 -60.69 999.00 NA ILE ASP LEU GLY"
"IKKB_HUMAN t_4E3CF.pdb OTHER Active 1 Apo 3.98 -105.40 -154.52 -41.26 -11.82 129.86 -170.03 -122.15 25.60 -99.53 -49.16 -47.60 999.00 NA ILE ASP LEU GLY"
"IKKB_HUMAN t_4KIKA.pdb OTHER DFGin-inactive 2 KSA 2.83 -127.42 175.38 42.35 56.24 79.77 -163.73 -104.54 41.59 -36.81 -47.21 146.93 999.00 NA ILE ASP LEU GLY"
"IKKB_HUMAN t_4KIKB.pdb OTHER Active 1 KSA 2.83 -125.89 177.85 40.82 56.56 90.99 -161.04 -106.10 30.13 -80.02 -75.62 -15.89 999.00 NA ILE ASP LEU GLY"
"ILK_HUMAN t_3KMUA.pdb TKL DFGin-trans 4 Apo 1.80 -71.11 -14.25 999.00 -91.45 11.82 -71.46 -77.85 143.33 -176.14 -85.45 146.88 -75.99 NA ALA ASP VAL LYS"
"ILK_HUMAN t_3KMWA.pdb TKL DFGin-trans 4 ATP 2.00 -72.36 0.59 999.00 -103.29 4.61 -77.97 -77.99 131.48 178.92 -84.79 144.00 -61.77 NA ALA ASP VAL LYS"
"ILK_HUMAN t_3REPA.pdb TKL DFGin-trans 4 ATP 1.80 -69.12 -5.36 999.00 -97.98 -0.92 -80.59 -69.29 125.89 -178.50 -76.70 133.66 -67.30 NA ALA ASP VAL LYS"
"INSR_HUMAN t_1GAGA.pdb TYR Active 1 Apo 2.70 -139.81 -163.26 999.00 39.43 88.76 -171.28 -105.42 34.47 -59.13 -68.06 -37.46 999.00 Outlier GLY ASP PHE GLY"
"INSR_HUMAN t_1I44A.pdb TYR DFGup 3 ACP 2.40 -58.22 -57.84 999.00 -145.22 -170.36 42.12 -78.53 6.83 58.46 123.50 176.59 999.00 Favored GLY ASP PHE GLY"
"INSR_HUMAN t_1IR3A.pdb TYR Active 1 ANP 1.90 -133.72 -168.16 999.00 47.49 85.03 -160.14 -100.31 24.55 -56.65 -58.75 -39.76 999.00 Outlier GLY ASP PHE GLY"
"INSR_HUMAN t_1IRKA.pdb TYR DFGout 6 Apo 2.10 170.35 146.41 999.00 -160.79 149.27 72.63 -78.93 -23.35 -54.12 112.57 49.95 999.00 Favored GLY ASP PHE GLY"
"INSR_HUMAN t_1P14A.pdb TYR DFGup 3 Apo 1.90 -93.62 -127.04 999.00 -78.90 153.16 -59.72 -166.80 155.94 65.23 -69.22 999.00 999.00 Favored GLY ASP PHE GLY"
"INSR_HUMAN t_1RQQA.pdb TYR Active 1 Apo 2.60 -139.28 -172.14 999.00 50.74 88.16 -166.41 -102.36 25.99 -53.39 -57.32 -43.85 999.00 Outlier GLY ASP PHE GLY"
"INSR_HUMAN t_1RQQB.pdb TYR Active 1 Apo 2.60 -137.47 -169.29 999.00 49.40 88.08 -164.30 -100.36 24.24 -56.76 -57.31 -45.09 999.00 Outlier GLY ASP PHE GLY"
"INSR_HUMAN t_2AUHA.pdb TYR Active 1 Apo 3.20 -136.61 -4.50 999.00 -122.45 138.19 -160.85 -136.10 17.12 -62.33 -54.49 -33.82 999.00 Favored GLY ASP PHE GLY"
"INSR_HUMAN t_2B4SB.pdb TYR Active 1 Apo 2.30 -125.76 6.38 999.00 -136.21 138.65 -177.01 -136.97 36.06 -54.59 -61.96 -22.32 999.00 Favored GLY ASP PHE GLY"
"INSR_HUMAN t_2B4SD.pdb TYR Active 1 Apo 2.30 -130.63 15.41 999.00 -144.67 123.76 -174.52 -125.22 40.81 -53.75 -64.15 -16.19 999.00 Favored GLY ASP PHE GLY"
"INSR_HUMAN t_2Z8CA.pdb TYR Active 1 S91 3.25 -126.25 179.94 999.00 45.56 101.56 -168.80 -113.23 32.04 -55.04 -55.67 -35.78 999.00 Outlier GLY ASP PHE GLY"
"INSR_HUMAN t_3BU3A.pdb TYR Active 1 Apo 1.65 -125.34 -173.11 999.00 49.35 91.36 -160.86 -105.79 28.85 -66.73 -61.58 -23.44 999.00 Outlier GLY ASP PHE GLY"
"INSR_HUMAN t_3BU5A.pdb TYR Active 1 ATP 2.10 -128.65 -166.61 999.00 44.46 89.62 -170.49 -102.84 23.91 -64.14 -57.54 -34.17 999.00 Outlier GLY ASP PHE GLY"
"INSR_HUMAN t_3BU6A.pdb TYR Active 1 Apo 1.95 -127.49 -6.07 999.00 -146.74 128.51 179.44 -126.41 29.26 -58.80 -62.33 -9.35 999.00 Favored GLY ASP PHE GLY"
"INSR_HUMAN t_3EKNA.pdb TYR DFGup 3 GS3 2.20 -59.57 -41.73 999.00 -156.67 -174.01 46.60 -81.37 6.69 55.60 69.24 37.13 999.00 Favored GLY ASP PHE GLY"
"INSR_HUMAN t_3ETAA.pdb TYR DFGout 6 351 2.60 -132.16 -174.22 999.00 -157.82 103.42 -169.53 -75.96 -16.05 -65.99 92.77 -168.26 999.00 Allowed GLY ASP PHE GLY"
"INSR_HUMAN t_3ETAB.pdb TYR DFGout 6 351 2.60 -133.17 -176.66 999.00 -152.03 106.94 -164.63 -74.00 -39.92 -76.22 41.66 -138.42 999.00 Favored GLY ASP PHE GLY"
"INSR_HUMAN t_4IBMA.pdb TYR DFGin-inactive 2 IR1 1.80 -75.97 163.84 999.00 -44.82 128.66 -174.70 -69.69 135.99 -62.62 60.09 44.95 999.00 Favored GLY ASP PHE GLY"
"INSR_HUMAN t_4IBMB.pdb TYR DFGin-inactive 2 IR1 1.80 -69.55 155.54 999.00 -45.68 125.45 -170.73 -61.26 129.49 -77.31 78.31 8.90 999.00 Favored GLY ASP PHE GLY"
"INSR_HUMAN t_4XLVA.pdb TYR Active 1 ACP 2.30 -129.47 -169.64 999.00 59.36 81.27 -160.00 -99.83 10.80 -58.75 -50.44 -35.11 999.00 Allowed GLY ASP PHE GLY"
"INSR_HUMAN t_5E1SA.pdb TYR DFGup 3 5JA 2.26 -82.60 -126.53 999.00 -82.76 146.71 -64.97 -146.47 173.10 61.89 -67.13 97.37 999.00 Favored GLY ASP PHE GLY"
"INSR_HUMAN t_5HHWA.pdb TYR DFGup 3 60O 1.79 -93.97 -126.87 999.00 -75.28 119.06 -174.34 -115.15 17.99 55.08 -68.62 168.95 999.00 Favored GLY ASP PHE GLY"
"IRAK4_HUMAN t_2NRUA.pdb TKL Active 1 T12 2.00 -144.55 176.60 70.30 61.07 85.80 -151.43 -109.08 12.37 -54.74 -69.16 -13.77 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_2NRUB.pdb TKL Active 1 T12 2.00 -137.23 177.47 64.26 63.64 76.52 -161.98 -99.32 24.14 -46.36 -66.32 -18.81 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_2NRUC.pdb TKL Active 1 T12 2.00 -133.20 -178.42 67.00 53.99 81.32 -162.89 -99.32 21.14 -50.22 -44.38 -46.50 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_2NRUD.pdb TKL Active 1 T12 2.00 -135.74 173.19 58.58 70.15 87.18 -161.73 -107.96 13.83 -52.23 -64.30 -20.64 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_2NRYA.pdb TKL Active 1 STU 2.15 -119.69 177.14 54.30 59.04 71.67 -160.97 -112.25 -126.04 -8.96 78.15 -70.73 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_2NRYB.pdb TKL Active 1 STU 2.15 -121.96 179.31 52.06 63.60 83.45 -151.42 -104.96 -160.16 -46.63 93.47 -69.07 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_2NRYC.pdb TKL Active 1 STU 2.15 -129.84 177.31 82.53 66.58 79.74 -165.73 -106.39 3.09 -57.25 -41.92 -44.42 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_2NRYD.pdb TKL Active 1 STU 2.15 -126.68 167.36 55.27 70.81 64.66 -161.91 -93.02 43.08 -14.62 -89.86 -18.23 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_2O8YA.pdb NA NA 0 Apo 2.40 -132.36 177.20 76.72 66.05 84.31 -155.00 -105.52 20.56 -54.58 -65.47 -21.00 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_2O8YB.pdb NA NA 0 Apo 2.40 -133.86 -178.61 63.64 62.45 89.28 -149.59 -111.41 23.76 -53.87 -69.33 -12.71 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_2OIBA.pdb TKL Active 1 Apo 2.00 -134.16 -176.24 78.20 54.91 81.05 -165.71 -100.11 21.08 -62.74 -65.55 -18.24 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_2OIBB.pdb TKL Active 1 Apo 2.00 -130.72 177.33 61.81 63.83 87.03 -85.54 -107.95 18.79 -55.55 -61.54 -32.11 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_2OIBC.pdb TKL Active 1 Apo 2.00 -128.67 178.21 83.81 61.83 75.10 -73.05 -97.03 24.29 -56.28 -70.16 -11.08 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_2OIBD.pdb TKL Active 1 Apo 2.00 -132.49 176.54 63.83 64.46 86.18 -69.73 -107.14 13.96 -54.75 -59.26 -27.45 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_2OICA.pdb TKL Active 1 STU 2.40 -120.19 -157.81 63.75 43.14 78.62 -157.27 -95.79 16.17 -68.15 -52.41 -46.70 999.00 Outlier SER ASP PHE GLY"
"IRAK4_HUMAN t_2OICB.pdb TKL Active 1 STU 2.40 -135.66 -165.03 68.05 43.25 86.38 -159.95 -100.53 27.62 -58.10 -68.68 -40.77 999.00 Outlier SER ASP PHE GLY"
"IRAK4_HUMAN t_2OICC.pdb TKL DFGin-inactive 2 STU 2.40 -134.41 -175.33 15.52 55.45 88.85 -155.08 -103.91 2.58 -60.62 -42.78 999.00 999.00 Outlier SER ASP PHE GLY"
"IRAK4_HUMAN t_2OICD.pdb TKL Active 1 STU 2.40 -128.10 -176.73 60.81 47.17 78.65 -165.52 -89.78 11.35 -61.18 -54.74 -36.59 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_2OIDA.pdb TKL DFGin-inactive 2 ANP 2.30 -127.55 175.41 63.08 65.23 82.24 -166.77 -102.20 23.20 -53.91 -64.80 -29.46 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_2OIDB.pdb TKL Active 1 ANP 2.30 -122.33 171.97 48.04 72.61 82.09 -163.06 -104.40 15.51 -60.82 -59.65 -29.07 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_2OIDC.pdb TKL Active 1 ANP 2.30 -130.34 175.53 60.96 61.03 75.52 -158.20 -96.04 32.35 -50.19 -74.66 -28.26 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_2OIDD.pdb TKL Active 1 ANP 2.30 -129.08 -176.99 52.67 59.11 109.87 -104.57 -131.33 17.49 -55.44 -68.34 -4.59 999.00 Outlier SER ASP PHE GLY"
"IRAK4_HUMAN t_4RMZA.pdb TKL Active 1 T20 2.20 -126.65 170.94 63.16 71.52 84.60 -152.19 -108.34 13.43 -52.75 -63.05 -23.58 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_4RMZB.pdb TKL Active 1 T20 2.20 -127.35 178.06 60.51 67.75 81.28 -129.77 -107.46 14.48 -48.24 -59.68 -35.70 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_4U97A.pdb TKL Active 1 STU 2.65 -133.40 -177.55 -174.52 44.48 65.75 -168.95 -75.84 30.59 -64.64 -61.20 -17.72 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_4U9AA.pdb TKL Active 1 STU 2.80 -101.05 -157.43 177.65 29.28 88.17 -162.27 -95.03 25.52 -77.27 -64.20 4.88 999.00 Outlier SER ASP PHE GLY"
"IRAK4_HUMAN t_4XS2A.pdb TKL Active 1 42P 2.73 -139.84 178.59 76.99 62.39 89.39 -144.41 -110.92 32.37 -54.70 -72.30 -32.73 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_4XS2B.pdb TKL Active 1 42P 2.73 -139.78 178.83 77.25 62.52 89.35 -144.95 -111.17 32.77 -54.77 -72.57 -32.54 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_4XS2C.pdb TKL Active 1 42P 2.73 -139.74 178.96 77.14 62.26 89.30 -144.75 -110.79 33.09 -55.03 -72.16 -33.13 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_4XS2D.pdb TKL Active 1 42P 2.73 -139.45 179.05 77.12 62.37 89.39 -144.72 -110.95 32.59 -54.63 -72.66 -32.42 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_4Y73A.pdb TKL Active 1 XPY 2.14 -135.23 179.13 61.72 58.82 74.82 -55.68 -95.45 16.11 -50.43 -56.81 -31.32 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_4Y73B.pdb TKL Active 1 XPY 2.14 -134.50 179.50 62.66 58.17 75.72 -55.58 -95.37 17.22 -50.08 -59.08 -23.84 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_4Y73C.pdb TKL Active 1 XPY 2.14 -135.94 178.89 61.16 60.17 74.49 -56.30 -95.69 17.33 -50.25 -57.09 -32.17 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_4Y73D.pdb TKL Active 1 XPY 2.14 -134.48 179.60 61.47 58.12 76.67 -56.25 -96.28 18.74 -50.59 -57.20 -32.64 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_4YO6A.pdb TKL Active 1 4GD 2.32 -129.88 177.67 67.13 60.73 83.01 -70.04 -105.77 15.84 -51.56 -61.62 -37.48 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_4YO6B.pdb TKL Active 1 4GD 2.32 -128.17 178.19 67.04 59.97 83.61 -69.63 -106.19 16.81 -51.17 -62.58 -37.15 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_4YO6C.pdb TKL Active 1 4GD 2.32 -128.27 178.26 66.86 59.76 82.73 -70.44 -103.94 17.05 -52.58 -61.58 -37.71 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_4YO6D.pdb TKL Active 1 4GD 2.32 -128.60 178.11 65.85 61.43 82.45 -70.54 -106.00 15.51 -50.34 -63.36 -35.07 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_4YP8A.pdb TKL Active 1 4GF 2.64 -130.63 178.90 71.83 61.69 76.87 -76.45 -103.51 25.65 -49.33 -67.73 -31.60 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_4YP8B.pdb TKL Active 1 4GF 2.64 -129.90 179.60 72.53 60.06 78.01 -77.20 -104.25 26.40 -49.49 -66.82 -33.20 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_4YP8C.pdb TKL Active 1 4GF 2.64 -129.80 179.56 72.38 59.29 79.07 -76.20 -103.27 26.57 -50.42 -66.34 -34.03 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_4YP8D.pdb TKL Active 1 4GF 2.64 -129.60 178.92 71.98 61.79 77.54 -78.05 -103.65 26.47 -49.81 -66.27 -34.21 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_4ZTLA.pdb TKL Active 1 4S1 2.39 -117.92 179.23 60.18 56.91 97.38 -131.25 -119.28 25.71 -52.12 -68.46 -33.89 999.00 Outlier SER ASP PHE GLY"
"IRAK4_HUMAN t_4ZTLB.pdb TKL Active 1 4S1 2.39 -117.83 179.61 59.71 56.60 97.58 -131.20 -119.38 25.85 -52.40 -68.26 -34.22 999.00 Outlier SER ASP PHE GLY"
"IRAK4_HUMAN t_4ZTLC.pdb TKL Active 1 4S1 2.39 -116.73 179.69 58.64 56.81 97.12 -132.66 -118.71 26.26 -52.88 -67.57 -34.31 999.00 Outlier SER ASP PHE GLY"
"IRAK4_HUMAN t_4ZTLD.pdb TKL Active 1 4S1 2.39 -116.14 179.02 59.12 57.27 97.66 -133.38 -119.14 26.50 -52.71 -69.01 -33.75 999.00 Outlier SER ASP PHE GLY"
"IRAK4_HUMAN t_4ZTMA.pdb TKL Active 1 4S2 2.66 -126.64 176.52 56.96 62.84 88.64 -96.16 -111.80 16.15 -53.55 -61.76 -38.98 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_4ZTMB.pdb TKL Active 1 4S2 2.66 -125.17 175.76 57.61 64.20 86.79 -97.56 -111.55 16.63 -52.24 -64.35 -38.26 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_4ZTMC.pdb TKL Active 1 4S2 2.66 -126.00 176.25 56.53 62.97 87.68 -97.10 -110.96 16.48 -53.47 -61.74 -39.22 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_4ZTMD.pdb TKL Active 1 4S2 2.66 -123.99 176.41 56.11 63.11 88.12 -97.37 -113.66 22.02 -56.57 -67.04 -38.37 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_4ZTNA.pdb TKL Active 1 4S3 2.23 -132.75 175.46 70.66 64.19 82.22 -120.71 -105.30 20.83 -51.62 -66.06 -41.86 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_4ZTNB.pdb TKL Active 1 4S3 2.23 -131.97 175.81 70.61 63.86 82.50 -121.18 -105.73 21.43 -51.61 -66.36 -41.62 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_4ZTNC.pdb TKL Active 1 4S3 2.23 -131.77 175.71 70.83 64.10 82.40 -121.11 -105.45 21.37 -51.99 -65.91 -41.88 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_4ZTND.pdb TKL Active 1 4S3 2.23 -131.51 175.84 70.58 63.94 82.46 -120.96 -105.44 21.03 -51.68 -65.64 -42.53 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_5KX7A.pdb NA NA 0 Apo 2.80 -138.21 174.65 77.49 58.54 80.99 -162.88 -106.90 34.11 -37.86 -72.02 -44.52 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_5KX7B.pdb TKL Active 1 6YD 2.80 -138.08 174.72 77.65 58.68 80.85 -162.60 -106.86 34.05 -37.95 -71.78 -44.86 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_5KX8A.pdb TKL Active 1 6YE 2.67 -136.38 -178.33 79.98 58.05 85.75 -90.16 -110.79 15.65 -44.85 -62.15 -34.75 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_5KX8B.pdb TKL Active 1 6YE 2.67 -135.87 -178.33 80.68 58.28 85.42 -90.13 -111.02 16.52 -44.93 -62.62 -35.26 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_5KX8C.pdb TKL Active 1 6YE 2.67 -135.81 -177.74 80.76 57.61 85.59 -89.55 -110.72 16.72 -45.10 -62.16 -34.84 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_5KX8D.pdb TKL Active 1 6YE 2.67 -135.88 -178.71 80.00 58.98 85.45 -90.26 -110.90 16.38 -44.37 -63.33 -35.01 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_5T1SA.pdb TKL Active 1 76Q 2.30 -131.15 172.71 68.21 63.17 85.34 -155.39 -103.46 19.54 -55.04 -62.84 -37.94 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_5T1SB.pdb TKL Active 1 76Q 2.30 -131.25 172.71 68.05 63.68 84.99 -155.16 -103.61 20.30 -55.23 -63.00 -38.49 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_5T1SC.pdb TKL Active 1 76Q 2.30 -131.13 172.83 67.74 63.72 84.63 -155.91 -102.58 19.92 -54.96 -62.62 -38.96 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_5T1SD.pdb TKL Active 1 76Q 2.30 -130.83 172.69 67.81 63.65 85.42 -155.00 -103.61 19.81 -55.02 -62.93 -38.53 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_5T1TA.pdb TKL Active 1 76P 2.34 -133.69 176.64 66.59 67.37 81.04 -117.04 -107.46 15.49 -51.04 -63.74 -32.87 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_5T1TB.pdb TKL Active 1 76P 2.34 -132.85 176.36 66.93 67.64 80.68 -116.84 -107.99 15.79 -50.67 -64.31 -32.84 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_5T1TC.pdb TKL Active 1 76P 2.34 -133.72 176.74 66.81 66.86 81.08 -116.64 -106.78 16.37 -51.19 -64.15 -32.98 999.00 Allowed SER ASP PHE GLY"
"IRAK4_HUMAN t_5T1TD.pdb TKL Active 1 76P 2.34 -132.86 176.95 67.29 67.51 80.52 -117.27 -108.05 15.37 -50.66 -64.42 -32.44 999.00 Allowed SER ASP PHE GLY"
"ITK_HUMAN t_1SM2A.pdb TYR DFGup 3 STU 2.30 -148.14 -157.93 97.41 48.22 18.04 -105.47 -92.50 -172.66 59.23 71.33 999.00 999.00 Allowed SER ASP PHE GLY"
"ITK_HUMAN t_1SNUA.pdb TYR DFGup 3 STU 2.50 -120.99 -147.12 85.84 40.06 19.74 -102.33 -95.63 161.01 65.38 81.13 999.00 999.00 Outlier SER ASP PHE GLY"
"ITK_HUMAN t_1SNXA.pdb TYR DFGup 3 Apo 3.20 -148.42 -167.43 71.72 58.84 12.72 -67.21 -82.50 -172.28 53.10 95.00 999.00 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_1SNXB.pdb TYR DFGup 3 Apo 3.20 -168.42 -173.88 42.68 67.32 2.00 -75.39 -70.49 -158.26 49.85 88.40 999.00 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_3MIYB.pdb TYR DFGup 3 B49 1.67 -119.16 168.78 -172.82 58.23 44.99 -52.75 -107.24 10.50 54.23 -87.92 999.00 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_3MJ2A.pdb TYR DFGup 3 MJG 1.90 -129.72 165.56 82.01 57.93 29.15 -69.33 -59.84 130.82 36.55 74.58 1.90 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_3QGWA.pdb TYR DFGup 3 PQC 2.10 -131.50 -179.94 -176.39 53.72 33.71 178.46 -89.76 -22.04 54.94 -84.39 999.00 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_3QGYA.pdb TYR DFGup 3 PQC 2.10 -130.21 173.57 169.73 58.11 28.44 173.24 -83.17 -21.90 53.92 -98.07 999.00 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_3QGYB.pdb TYR DFGin-inactive 2 L7O 2.10 -138.25 -166.55 72.84 61.17 71.66 -150.33 -99.61 31.81 -53.83 -71.34 20.90 999.00 Allowed SER ASP PHE GLY"
"ITK_HUMAN t_3T9TA.pdb TYR DFGup 3 IAQ 1.65 -133.25 163.34 -169.65 70.87 17.26 -65.60 -63.29 134.42 35.21 75.65 -6.18 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_3V5JA.pdb TYR DFGup 3 0F2 2.59 -118.50 160.44 -168.12 57.12 61.89 -52.16 -107.70 -6.22 47.23 -84.30 999.00 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_3V5LA.pdb TYR DFGup 3 0G1 1.86 -115.82 171.05 -169.01 48.26 46.03 -59.56 -96.00 11.29 58.99 -107.32 8.53 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_3V5LB.pdb TYR DFGup 3 0G1 1.86 -115.24 172.42 -167.81 47.56 47.26 -75.32 -97.67 7.98 59.94 -107.46 11.58 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_3V5LC.pdb TYR DFGup 3 0G1 1.86 -119.44 171.57 -172.97 47.91 45.94 -73.29 -95.36 5.98 56.70 -103.85 4.96 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_3V5LD.pdb TYR DFGup 3 0G1 1.86 -118.73 170.45 -171.14 50.60 44.64 -70.95 -96.27 5.20 58.87 -103.31 10.98 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_3V8TA.pdb TYR DFGup 3 477 2.00 -118.99 167.75 -171.40 48.92 50.16 -51.98 -99.28 5.66 54.64 -100.03 4.79 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_3V8TB.pdb TYR DFGup 3 477 2.00 -118.43 168.06 -169.78 51.05 46.58 -55.60 -97.05 4.14 57.26 -98.83 3.08 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_3V8WA.pdb TYR DFGup 3 0G2 2.27 -119.74 170.30 -163.81 58.98 32.04 -105.52 -85.98 -7.63 58.48 -70.40 999.00 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_3V8WB.pdb TYR DFGup 3 0G2 2.27 -115.35 167.75 -172.31 61.22 31.44 -90.66 -84.49 -9.66 58.04 -87.96 999.00 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_4HCTA.pdb TYR DFGup 3 18R 1.48 -128.45 162.18 82.73 70.24 18.27 -94.65 -59.19 130.98 39.75 71.98 -1.67 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_4HCUA.pdb TYR DFGup 3 13L 1.43 -122.03 165.03 75.34 71.19 16.75 -75.29 -57.21 130.81 39.30 73.41 -2.76 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_4HCVA.pdb TYR DFGup 3 13J 1.48 -134.35 168.09 77.76 71.45 14.66 -72.84 -58.48 126.29 32.98 79.44 -5.90 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_4KIOA.pdb TYR DFGup 3 G5K 2.18 -118.57 173.74 -171.47 46.97 48.98 -67.18 -104.84 13.75 51.46 -108.85 22.58 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_4KIOB.pdb TYR DFGup 3 G5K 2.18 -122.65 175.74 -168.74 45.97 47.64 -56.68 -101.29 10.85 51.73 -102.36 15.82 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_4KIOC.pdb TYR DFGup 3 G5K 2.18 -123.67 175.82 -163.22 53.76 40.53 -62.71 -101.18 11.52 53.33 -105.69 3.91 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_4KIOD.pdb TYR DFGup 3 G6K 2.18 -116.60 177.23 -169.07 41.84 49.20 -94.26 -104.11 15.36 56.01 -106.40 8.40 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_4L7SA.pdb TYR DFGup 3 G7K 2.03 -124.58 171.96 -173.89 51.27 50.74 -72.32 -109.96 5.49 56.29 -102.45 16.99 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_4L7SB.pdb TYR DFGup 3 G7K 2.03 -124.04 169.15 -168.27 48.39 47.80 -64.11 -102.48 11.10 54.90 -109.98 19.40 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_4M0YA.pdb TYR DFGup 3 M0Y 1.70 -141.59 166.37 -175.70 66.71 17.90 -68.10 -60.24 129.61 36.61 76.57 -2.13 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_4M0ZA.pdb TYR DFGup 3 M0Z 2.00 -142.86 167.53 -168.21 62.08 26.30 -63.07 -68.10 133.85 36.86 77.70 -3.03 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_4M12A.pdb TYR DFGup 3 1YZ 2.15 -141.15 169.78 -167.41 60.43 25.89 -57.24 -67.62 137.78 36.65 68.91 0.25 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_4M13A.pdb TYR DFGup 3 1E0 1.85 -140.00 164.93 -169.43 66.90 22.83 -58.89 -65.40 134.74 36.88 73.49 -6.25 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_4M14A.pdb TYR DFGup 3 QWS 1.55 -141.12 166.20 -170.50 67.89 19.31 -61.41 -65.06 134.15 34.45 77.29 -4.51 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_4M15A.pdb TYR DFGup 3 ADP 1.52 -140.10 163.56 -171.86 73.69 16.26 -66.14 -64.43 134.23 34.90 79.06 -6.92 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_4MF0A.pdb TYR DFGup 3 29Z 2.67 -144.01 170.19 -173.16 56.86 56.30 -160.12 -101.39 -51.60 26.47 -110.48 48.03 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_4MF1A.pdb TYR DFGup 3 29Y 2.11 -128.56 173.61 -171.76 47.25 44.35 -57.38 -102.29 27.31 55.57 -123.44 25.06 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_4MF1B.pdb TYR DFGup 3 29Y 2.11 -125.00 172.12 176.08 51.52 46.88 -75.07 -105.11 12.50 44.97 -92.76 -1.85 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_4PP9A.pdb TYR DFGup 3 2VT 2.58 -129.83 173.13 68.87 60.56 46.25 -57.68 -109.57 65.22 50.19 -109.61 999.00 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_4PP9B.pdb TYR DFGup 3 2VT 2.58 -138.25 168.78 63.69 63.49 44.17 -58.27 -112.32 32.87 51.01 -116.59 31.00 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_4PPAA.pdb TYR DFGup 3 2VU 2.67 -130.31 170.69 77.94 58.51 42.78 -82.02 -95.58 145.04 43.52 142.49 999.00 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_4PPAB.pdb TYR DFGup 3 2VU 2.67 -131.72 177.63 66.35 58.91 33.65 -59.57 -89.98 137.79 45.36 178.25 999.00 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_4PPBA.pdb TYR DFGup 3 2VV 2.82 -134.69 173.45 88.43 62.43 48.85 -119.84 -112.52 114.52 48.78 179.56 999.00 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_4PPBB.pdb TYR DFGup 3 2VV 2.82 -138.11 179.93 63.52 61.46 31.67 -80.93 -96.98 135.51 54.05 97.89 999.00 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_4PQNA.pdb TYR DFGup 3 2W6 1.71 -102.52 173.37 -162.22 -57.89 164.96 68.64 -164.74 161.06 47.38 138.01 999.00 999.00 Allowed SER ASP PHE GLY"
"ITK_HUMAN t_4QD6A.pdb TYR DFGup 3 30T 2.45 -132.37 -177.12 75.08 51.16 39.06 -73.58 -87.90 -18.56 45.58 -54.75 -85.22 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_4QD6B.pdb TYR DFGup 3 30T 2.45 -124.32 178.26 72.98 62.97 48.97 -80.02 -116.31 143.61 42.38 85.07 100.82 999.00 Favored SER ASP PHE GLY"
"ITK_HUMAN t_4RFMA.pdb TYR DFGup 3 3P6 2.10 -130.15 -172.90 -160.77 61.31 32.58 -158.44 -100.83 1.38 56.99 -146.83 171.85 999.00 Favored SER ASP PHE GLY"
"JAK1_HUMAN_1 t_4L00A.pdb TYR DFGin-inactive 2 Apo 1.80 -76.10 -177.46 -168.04 -75.27 165.42 70.26 -78.75 -7.84 -10.94 63.94 -153.33 999.00 NA SER ASP PRO GLY"
"JAK1_HUMAN_1 t_4L00B.pdb TYR DFGin-inactive 2 Apo 1.80 -78.39 -173.06 -166.96 -77.72 164.48 65.26 -74.46 -8.54 -12.24 63.63 -153.67 999.00 NA SER ASP PRO GLY"
"JAK1_HUMAN_1 t_4L01A.pdb TYR DFGin-inactive 2 Apo 1.90 -73.68 -179.14 -164.56 -73.88 162.16 66.64 -73.88 -15.64 -15.29 67.93 -153.15 999.00 NA SER ASP PRO GLY"
"JAK1_HUMAN_1 t_4L01B.pdb TYR DFGin-inactive 2 Apo 1.90 -76.79 -176.45 -164.64 -72.46 166.47 65.62 -77.53 -11.39 -1.00 69.21 -153.23 999.00 NA SER ASP PRO GLY"
"JAK1_HUMAN_2 t_3EYGA.pdb TYR Active 1 MI1 1.90 -124.30 8.29 999.00 -155.42 148.91 -163.02 -141.70 28.02 -64.36 -69.56 -22.85 999.00 Favored GLY ASP PHE GLY"
"JAK1_HUMAN_2 t_3EYHA.pdb TYR Active 1 IZA 2.00 -123.75 5.59 999.00 -151.23 147.59 -166.51 -137.78 30.24 -63.21 -63.71 -28.12 999.00 Favored GLY ASP PHE GLY"
"JAK1_HUMAN_2 t_4E4LA.pdb TYR Active 1 0NH 2.00 -113.29 1.59 999.00 -155.74 141.32 -167.66 -133.96 30.85 -63.32 -61.95 -29.18 999.00 Favored GLY ASP PHE GLY"
"JAK1_HUMAN_2 t_4E4LB.pdb TYR Active 1 0NH 2.00 -115.33 5.95 999.00 -154.25 143.96 -169.28 -136.29 29.84 -65.06 -63.46 -28.08 999.00 Favored GLY ASP PHE GLY"
"JAK1_HUMAN_2 t_4E4LD.pdb TYR Active 1 0NH 2.00 -114.25 -0.86 999.00 -153.63 143.22 -168.18 -135.12 28.01 -66.26 -57.65 -27.00 999.00 Favored GLY ASP PHE GLY"
"JAK1_HUMAN_2 t_4E4LE.pdb TYR Active 1 Apo 2.00 -114.09 7.30 999.00 -155.93 142.84 -168.66 -135.96 30.20 -63.54 -59.96 -28.28 999.00 Favored GLY ASP PHE GLY"
"JAK1_HUMAN_2 t_4E4NA.pdb TYR Active 1 0NL 1.90 -119.97 11.18 999.00 -158.46 140.01 -162.41 -136.48 26.74 -62.86 -63.38 -21.43 999.00 Favored GLY ASP PHE GLY"
"JAK1_HUMAN_2 t_4E4NB.pdb TYR Active 1 0NL 1.90 -119.89 9.68 999.00 -155.73 139.63 -160.98 -133.81 28.08 -62.80 -62.66 -24.74 999.00 Favored GLY ASP PHE GLY"
"JAK1_HUMAN_2 t_4E5WA.pdb TYR Active 1 0NT 1.86 -118.19 5.21 999.00 -153.91 137.29 -166.23 -129.48 26.72 -64.84 -58.90 -26.22 999.00 Favored GLY ASP PHE GLY"
"JAK1_HUMAN_2 t_4E5WB.pdb TYR Active 1 0NT 1.86 -115.01 7.48 999.00 -153.88 137.99 -165.99 -129.84 26.64 -63.60 -58.92 -27.49 999.00 Favored GLY ASP PHE GLY"
"JAK1_HUMAN_2 t_4EHZA.pdb TYR Active 1 JAK 2.17 -122.43 12.74 999.00 -158.91 149.61 -171.15 -139.36 23.82 -64.09 -61.40 -20.25 999.00 Favored GLY ASP PHE GLY"
"JAK1_HUMAN_2 t_4EHZB.pdb TYR Active 1 JAK 2.17 -116.42 3.55 999.00 -150.58 148.21 -172.92 -138.94 32.37 -67.05 -67.45 -23.21 999.00 Favored GLY ASP PHE GLY"
"JAK1_HUMAN_2 t_4EHZC.pdb TYR Active 1 JAK 2.17 -118.10 8.14 999.00 -148.22 154.05 -167.94 -141.70 25.22 -67.26 -60.11 -18.23 999.00 Favored GLY ASP PHE GLY"
"JAK1_HUMAN_2 t_4EHZD.pdb TYR Active 1 JAK 2.17 -123.90 16.49 999.00 -158.33 146.24 -170.91 -137.43 32.15 -63.92 -67.80 -20.14 999.00 Favored GLY ASP PHE GLY"
"JAK1_HUMAN_2 t_4EI4A.pdb TYR Active 1 0Q2 2.22 -125.13 21.56 999.00 -162.94 136.72 -174.46 -132.48 29.51 -61.83 -65.63 -22.01 999.00 Favored GLY ASP PHE GLY"
"JAK1_HUMAN_2 t_4EI4B.pdb TYR Active 1 0Q2 2.22 -120.17 16.10 999.00 -160.04 140.78 -169.60 -136.51 31.88 -67.65 -65.62 -28.57 999.00 Favored GLY ASP PHE GLY"
"JAK1_HUMAN_2 t_4FK6A.pdb TYR Active 1 0UJ 2.20 -112.15 2.76 999.00 -147.99 135.93 -164.63 -128.79 22.38 -66.27 -52.99 -29.38 999.00 Favored GLY ASP PHE GLY"
"JAK1_HUMAN_2 t_4FK6B.pdb TYR Active 1 0UJ 2.20 -112.06 2.82 999.00 -147.85 135.79 -164.22 -128.97 22.13 -66.41 -52.59 -30.00 999.00 Favored GLY ASP PHE GLY"
"JAK1_HUMAN_2 t_4I5CA.pdb TYR Active 1 C5I 2.10 -114.76 13.15 999.00 -159.97 138.51 -162.92 -132.47 27.57 -59.81 -57.95 -29.44 999.00 Favored GLY ASP PHE GLY"
"JAK1_HUMAN_2 t_4I5CB.pdb TYR Active 1 C5I 2.10 -117.63 20.20 999.00 -158.66 137.23 -161.09 -131.35 22.05 -60.88 -52.80 -31.37 999.00 Favored GLY ASP PHE GLY"
"JAK1_HUMAN_2 t_4IVBA.pdb TYR Active 1 1J5 1.90 -120.32 8.84 999.00 -154.45 145.05 -171.38 -134.64 25.99 -63.58 -59.46 -26.30 999.00 Favored GLY ASP PHE GLY"
"JAK1_HUMAN_2 t_4IVBB.pdb TYR Active 1 1J5 1.90 -116.64 7.79 999.00 -154.58 143.32 -167.80 -132.63 26.64 -65.29 -56.92 -32.23 999.00 Favored GLY ASP PHE GLY"
"JAK1_HUMAN_2 t_4IVCA.pdb TYR Active 1 1J6 2.35 -114.55 9.80 999.00 -157.21 145.75 -168.96 -138.31 37.41 -55.59 -64.25 -30.44 999.00 Favored GLY ASP PHE GLY"
"JAK1_HUMAN_2 t_4IVCB.pdb TYR Active 1 1J6 2.35 -119.63 6.45 999.00 -149.04 145.48 -171.49 -134.50 29.55 -62.78 -60.52 -32.82 999.00 Favored GLY ASP PHE GLY"
"JAK1_HUMAN_2 t_4IVDA.pdb TYR Active 1 15T 1.93 -118.34 8.32 999.00 -154.10 148.15 -172.66 -137.66 24.47 -61.53 -55.10 -27.32 999.00 Favored GLY ASP PHE GLY"
"JAK1_HUMAN_2 t_4IVDB.pdb TYR Active 1 15T 1.93 -112.57 2.69 999.00 -159.19 144.80 -172.70 -135.21 28.51 -63.53 -57.20 -29.80 999.00 Favored GLY ASP PHE GLY"
"JAK1_HUMAN_2 t_4K6ZA.pdb TYR Active 1 1Q3 2.73 -111.23 5.86 999.00 -148.20 138.42 -160.59 -130.88 29.96 -60.50 -54.26 -32.51 999.00 Favored GLY ASP PHE GLY"
"JAK1_HUMAN_2 t_4K77A.pdb TYR Active 1 1Q4 2.40 -120.23 6.96 999.00 -152.31 140.12 -168.50 -135.79 29.29 -59.75 -66.79 -17.33 999.00 Favored GLY ASP PHE GLY"
"JAK1_HUMAN_2 t_4K77B.pdb TYR Active 1 1Q4 2.40 -120.72 1.02 999.00 -147.43 142.05 -170.67 -133.90 36.75 -62.16 -67.04 -18.70 999.00 Favored GLY ASP PHE GLY"
"JAK1_HUMAN_2 t_5E1EA.pdb TYR Active 1 5JG 2.30 -119.29 -177.24 999.00 50.14 87.83 -164.34 -101.82 31.03 -69.10 -65.73 -25.01 999.00 Outlier GLY ASP PHE GLY"
"JAK1_HUMAN_2 t_5E1EB.pdb TYR Active 1 5JG 2.30 -133.32 28.20 999.00 -149.74 114.81 174.90 -114.52 26.08 -68.67 -63.78 -24.02 999.00 Favored GLY ASP PHE GLY"
"JAK1_HUMAN_2 t_5HX8A.pdb TYR Active 1 66P 2.20 -102.80 8.31 999.00 -149.55 137.76 -167.22 -131.60 23.75 -64.83 -55.45 -25.92 999.00 Favored GLY ASP PHE GLY"
"JAK1_HUMAN_2 t_5HX8B.pdb TYR Active 1 66P 2.20 -110.39 9.55 999.00 -150.01 136.32 -163.69 -131.00 24.63 -65.41 -57.52 -31.22 999.00 Favored GLY ASP PHE GLY"
"JAK1_HUMAN_2 t_5KHWA.pdb TYR Active 1 ADP 2.47 -113.59 -36.19 999.00 -113.49 112.52 168.44 -104.48 28.47 -57.91 -68.46 -35.54 999.00 Favored GLY ASP PHE GLY"
"JAK1_HUMAN_2 t_5KHWB.pdb TYR Active 1 ADP 2.47 -126.62 -174.03 999.00 50.59 92.23 -168.70 -105.68 28.96 -58.56 -62.71 -33.31 999.00 Outlier GLY ASP PHE GLY"
"JAK1_HUMAN_2 t_5KHXA.pdb TYR Active 1 6TE 2.40 -113.63 8.41 999.00 -153.81 134.54 -170.13 -126.52 25.20 -63.60 -59.86 -18.44 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_1 t_4FVPA.pdb TYR DFGup 3 Apo 2.01 -91.04 179.47 -167.37 -75.77 153.53 68.54 -78.27 -11.34 26.96 73.81 -158.66 999.00 NA SER ASP PRO GLY"
"JAK2_HUMAN_1 t_4FVQA.pdb TYR DFGin-inactive 2 ATP 1.75 -82.44 -178.34 75.14 -71.22 157.11 67.06 -64.23 -31.10 -17.63 77.43 -167.98 999.00 NA SER ASP PRO GLY"
"JAK2_HUMAN_1 t_4FVRA.pdb TYR DFGin-inactive 2 ATP 2.00 -77.88 -178.53 70.14 -72.68 163.95 58.21 -75.10 -27.32 -25.90 77.27 -166.63 999.00 NA SER ASP PRO GLY"
"JAK2_HUMAN_1 t_5I4NA.pdb TYR DFGin-inactive 2 ATP 1.54 -68.22 172.27 86.53 -64.35 158.19 55.53 -73.30 -26.67 -17.13 77.86 -169.16 999.00 NA SER ASP PRO GLY"
"JAK2_HUMAN_2 t_2B7AA.pdb TYR Active 1 IZA 2.00 -114.42 -2.16 999.00 -148.16 146.17 -166.99 -136.99 30.67 -60.94 -59.90 -28.96 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_2B7AB.pdb TYR Active 1 IZA 2.00 -119.31 4.30 999.00 -151.21 143.13 -167.45 -134.52 30.68 -66.16 -61.38 -27.25 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_2W1IA.pdb TYR Active 1 L0I 2.60 -142.53 -169.81 999.00 51.95 80.93 -136.96 -93.55 29.55 -62.77 -67.13 -31.26 999.00 Allowed GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_2W1IB.pdb TYR Active 1 Apo 2.60 -129.90 -167.44 999.00 53.34 77.87 -112.83 -90.81 22.63 -61.24 -65.09 -29.77 999.00 Allowed GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_2XA4A.pdb TYR Active 1 AZ5 2.04 -121.69 -5.54 999.00 -148.02 137.86 -175.58 -132.44 31.76 -64.00 -68.80 -26.41 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_2XA4B.pdb TYR Active 1 AZ5 2.04 -114.45 -6.27 999.00 -145.10 137.42 -175.69 -128.23 30.06 -67.00 -67.78 -24.86 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_3E62A.pdb TYR Active 1 Apo 1.92 -117.40 -9.53 999.00 -145.14 143.01 -168.35 -133.22 27.94 -65.67 -64.77 -25.70 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_3E63A.pdb TYR Active 1 5B2 1.90 -112.97 -9.29 999.00 -145.90 144.28 -166.35 -135.89 32.31 -63.87 -65.62 -22.80 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_3E64A.pdb TYR Active 1 5B3 1.80 -117.77 -5.82 999.00 -147.77 143.25 -168.41 -132.99 28.85 -63.09 -63.80 -22.59 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_3FUPA.pdb TYR Active 1 MI1 2.40 -116.11 -10.26 999.00 -157.35 141.86 -169.00 -130.24 26.55 -61.33 -56.12 -28.98 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_3FUPB.pdb TYR Active 1 MI1 2.40 -123.68 7.54 999.00 -151.76 141.75 -167.97 -133.35 23.57 -71.26 -52.61 -32.78 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_3IO7A.pdb TYR Active 1 1P5 2.60 -112.20 -1.33 999.00 -145.86 149.72 -167.11 -140.74 26.92 -67.02 -59.51 -22.77 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_3IOKA.pdb TYR Active 1 1P6 2.10 -121.29 -1.70 999.00 -146.24 142.21 -168.47 -132.51 26.64 -61.76 -60.36 -26.16 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_3JY9A.pdb TYR Active 1 JZH 2.10 -123.74 -155.01 999.00 17.70 87.80 -154.52 -86.91 19.56 -73.24 -50.28 -36.19 999.00 Outlier GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_3KCKA.pdb TYR Active 1 3KC 2.20 -122.36 -150.43 999.00 29.06 78.16 -166.59 -95.54 2.37 -68.40 -50.59 -18.29 999.00 Outlier GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_3KRRA.pdb TYR Active 1 DQX 1.80 -118.77 -1.29 999.00 -150.38 146.00 -170.18 -134.03 25.40 -63.67 -62.09 -27.72 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_3LPBA.pdb TYR Active 1 NVB 2.00 -118.09 3.50 999.00 -150.26 140.35 -167.71 -128.70 24.68 -63.08 -55.50 -30.54 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_3LPBB.pdb TYR Active 1 NVB 2.00 -111.17 1.20 999.00 -153.24 136.09 -164.68 -126.68 24.01 -63.38 -51.93 -31.52 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_3Q32A.pdb TYR Active 1 J2I 2.50 -114.01 9.74 999.00 -155.89 140.24 -172.03 -131.24 26.75 -60.22 -53.96 -36.86 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_3Q32B.pdb TYR Active 1 J2I 2.50 -99.12 -6.05 999.00 -150.24 138.60 -167.94 -127.29 32.30 -63.33 -58.22 -35.06 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_3RVGA.pdb TYR Active 1 17P 2.50 -117.59 -0.27 999.00 -150.31 146.05 -165.87 -143.42 33.24 -61.18 -68.54 -23.73 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_3TJCA.pdb TYR Active 1 0TP 2.40 -111.30 8.42 999.00 -150.47 142.92 -167.34 -136.05 31.05 -62.20 -58.84 -26.80 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_3TJCB.pdb TYR Active 1 0TP 2.40 -116.83 12.79 999.00 -151.30 140.35 168.24 -135.03 33.41 -68.29 -63.84 -25.04 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_3TJDA.pdb TYR Active 1 6TP 2.90 -106.43 6.89 999.00 -148.99 135.33 -164.63 -126.73 31.55 -61.76 -65.01 -17.37 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_3TJDB.pdb TYR Active 1 6TP 2.90 -115.42 19.39 999.00 -153.73 133.24 175.46 -127.06 29.72 -63.08 -60.72 -23.45 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_3UGCA.pdb TYR DFGout 6 046 1.34 -140.54 -160.06 999.00 -162.83 97.84 -159.57 -51.61 -50.91 -82.00 63.79 37.97 999.00 Allowed GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_3ZMMA.pdb TYR Active 1 F9J 2.51 -124.95 4.34 999.00 -148.67 145.34 -166.54 -139.08 35.89 -68.64 -76.61 -19.97 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_3ZMMB.pdb TYR Active 1 F9J 2.51 -118.94 2.82 999.00 -144.66 134.95 -164.19 -129.21 31.16 -71.21 -65.18 -32.45 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4AQCA.pdb TYR Active 1 88A 1.90 -119.38 0.40 999.00 -148.42 139.35 -168.60 -130.51 29.86 -64.21 -57.37 -31.25 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4AQCB.pdb TYR Active 1 88A 1.90 -123.87 -2.66 999.00 -148.46 139.41 -165.37 -132.14 28.73 -65.10 -66.78 -20.73 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4BBEA.pdb TYR Active 1 3O4 1.90 -125.96 -167.12 999.00 51.59 81.20 -170.13 -103.26 27.37 -67.93 -69.34 -30.43 999.00 Allowed GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4BBEB.pdb TYR Active 1 3O4 1.90 -127.24 -170.79 999.00 54.59 85.25 -170.22 -105.51 29.26 -65.68 -70.71 -26.53 999.00 Allowed GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4BBEC.pdb TYR Active 1 3O4 1.90 -126.47 -167.54 999.00 51.66 82.13 -168.92 -102.66 26.43 -67.04 -68.81 -26.35 999.00 Allowed GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4BBED.pdb TYR Active 1 3O4 1.90 -126.41 -167.95 999.00 52.55 81.86 -167.93 -103.58 26.57 -68.08 -68.98 -29.58 999.00 Allowed GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4BBFA.pdb TYR Active 1 O19 2.00 -122.30 157.18 999.00 62.92 103.68 -134.07 -120.22 22.79 -64.75 -48.81 -35.80 999.00 Outlier GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4BBFB.pdb TYR Active 1 O19 2.00 -105.05 -155.03 999.00 19.23 107.45 -161.70 -113.48 24.30 -68.75 -57.32 -30.90 999.00 Outlier GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4BBFC.pdb TYR Active 1 O19 2.00 -104.06 -172.71 999.00 36.65 102.22 -160.37 -115.68 23.81 -68.51 -45.09 -34.49 999.00 Outlier GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4BBFD.pdb TYR Active 1 O19 2.00 -118.85 148.22 999.00 74.03 103.63 -143.09 -117.81 24.65 -61.46 -57.35 -34.25 999.00 Allowed GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4C61A.pdb TYR Active 1 LMM 2.45 -100.54 -7.45 999.00 -142.50 135.86 -166.67 -127.77 28.68 -68.74 -61.78 -31.31 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4C61B.pdb TYR Active 1 LMM 2.45 -99.30 -7.40 999.00 -144.32 135.65 -165.92 -128.80 28.74 -68.38 -61.02 -31.61 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4C62A.pdb TYR Active 1 XWW 2.75 -113.10 -0.76 999.00 -150.56 138.69 -174.36 -131.29 30.14 -64.35 -70.55 -17.52 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4C62B.pdb TYR Active 1 XWW 2.75 -114.65 4.05 999.00 -154.84 137.08 -174.82 -130.80 31.90 -64.98 -69.55 -19.83 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4D0WA.pdb TYR Active 1 VVQ 1.77 -121.30 -6.04 999.00 -149.15 146.12 -176.76 -130.73 29.32 -66.00 -68.27 -23.85 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4D0XA.pdb TYR Active 1 953 1.82 -120.49 -3.08 999.00 -149.39 141.87 -171.74 -130.67 26.85 -63.20 -62.08 -25.83 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4D1SA.pdb TYR Active 1 BJG 1.66 -124.84 -163.08 999.00 46.78 76.66 -156.34 -90.27 22.64 -64.00 -59.76 -25.11 999.00 Allowed GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4E4MA.pdb TYR Active 1 0NH 2.25 -126.59 -156.25 999.00 24.69 86.22 -155.51 -92.79 21.68 -59.94 -63.47 -19.53 999.00 Outlier GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4E4MB.pdb TYR Active 1 0NH 2.25 -118.86 -161.22 999.00 49.89 72.56 -159.72 -97.78 25.21 -61.70 -69.81 -19.77 999.00 Allowed GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4E4MD.pdb TYR Active 1 0NH 2.25 -117.28 -162.77 999.00 35.31 82.69 -151.51 -96.58 19.04 -61.93 -70.21 -12.93 999.00 Outlier GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4E4ME.pdb TYR Active 1 0NH 2.25 -129.50 -159.29 999.00 35.40 81.51 -149.35 -94.02 23.95 -61.70 -61.45 -26.35 999.00 Outlier GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4E6DA.pdb TYR Active 1 0NU 2.22 -122.17 3.67 999.00 -153.94 144.83 -173.17 -134.33 24.12 -63.14 -55.12 -26.59 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4E6DB.pdb TYR Active 1 0NU 2.22 -117.08 8.15 999.00 -158.37 146.24 -169.04 -137.87 24.40 -65.33 -57.58 -26.98 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4E6QA.pdb TYR Active 1 0NV 1.95 -126.63 13.67 999.00 -142.90 143.86 -159.88 -137.22 22.15 -63.40 -64.63 -19.30 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4E6QB.pdb TYR Active 1 0NV 1.95 -126.94 5.34 999.00 -155.15 144.96 -175.07 -131.89 23.19 -64.06 -67.15 -25.77 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4F08A.pdb TYR Active 1 1RS 2.82 -118.75 17.85 999.00 -162.65 140.08 177.76 -138.82 36.16 -57.87 -60.80 -32.24 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4F08B.pdb TYR Active 1 1RS 2.82 -124.39 17.70 999.00 -159.69 141.68 -179.51 -138.80 37.17 -59.49 -63.71 -27.79 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4F09A.pdb TYR Active 1 JAK 2.40 -102.42 3.94 999.00 -153.27 137.83 -168.58 -131.33 32.57 -57.58 -60.59 -32.63 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4GFMA.pdb TYR Active 1 0X2 2.30 -121.50 -7.08 999.00 -143.94 139.81 -169.66 -132.82 29.98 -64.75 -66.96 -21.64 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4GMYA.pdb TYR Active 1 0X5 2.40 -129.17 -151.03 999.00 59.75 56.21 177.99 -91.96 15.73 -68.87 -64.82 -18.49 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4HGEA.pdb TYR Active 1 15V 2.30 -121.22 -0.58 999.00 -151.43 140.07 -170.53 -132.38 31.24 -63.07 -59.06 -29.74 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4HGEB.pdb TYR Active 1 15V 2.30 -123.29 3.38 999.00 -144.31 141.83 -170.69 -131.44 30.22 -70.18 -61.73 -21.13 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4IVAA.pdb TYR Active 1 1J5 1.50 -118.25 0.61 999.00 -152.56 145.51 -172.25 -135.71 29.47 -63.95 -62.06 -26.50 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4JI9A.pdb TYR Active 1 1M3 2.40 -109.56 -7.47 999.00 -150.75 140.53 -171.15 -127.24 30.43 -60.90 -52.86 -40.12 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4JI9B.pdb TYR Active 1 1M3 2.40 -116.55 -6.70 999.00 -147.25 138.80 -167.68 -124.53 33.92 -67.57 -62.36 -34.12 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4JIAA.pdb TYR Active 1 1K3 1.85 -122.42 -162.99 999.00 65.68 62.39 176.87 -96.30 10.17 -70.57 -68.57 -11.88 999.00 Allowed GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4P7EA.pdb TYR Active 1 2HB 2.40 -124.46 -1.34 999.00 -143.08 141.78 -169.38 -136.39 26.58 -62.79 -60.59 -28.13 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4P7EB.pdb TYR Active 1 2HB 2.40 -115.98 -1.14 999.00 -148.11 134.18 -158.17 -130.47 26.82 -63.33 -57.80 -28.02 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4YTCA.pdb TYR Active 1 4HW 2.16 -125.53 -176.23 999.00 51.32 90.54 -145.19 -102.78 24.36 -65.20 -53.95 -39.58 999.00 Outlier GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4YTFA.pdb TYR Active 1 4HZ 1.78 -123.61 -175.26 999.00 45.61 83.98 -166.41 -89.32 17.95 -68.66 -59.70 -25.45 999.00 Outlier GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4YTHA.pdb TYR Active 1 467 2.04 -124.84 177.05 999.00 52.04 90.62 -169.46 -96.90 16.61 -72.07 -60.81 -22.18 999.00 Outlier GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4YTIA.pdb TYR Active 1 VJK 2.52 -100.00 -39.51 999.00 -108.92 117.23 -171.88 -106.55 17.16 -70.74 -58.98 -26.30 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4ZIMA.pdb TYR Active 1 4OK 2.65 -102.10 -6.95 999.00 -147.73 147.99 -168.81 -137.32 29.43 -59.30 -55.04 -34.08 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_4ZIMB.pdb TYR Active 1 4OK 2.65 -101.85 -6.56 999.00 -147.60 146.11 -167.94 -135.69 28.41 -59.00 -55.22 -33.64 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_5AEPA.pdb TYR Active 1 QUP 1.95 -125.80 4.41 999.00 -152.09 146.72 -172.50 -137.01 29.75 -65.36 -68.46 -27.56 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_5CF4A.pdb TYR Active 1 50Y 2.38 -103.54 3.32 999.00 -156.45 145.54 -168.25 -135.47 36.21 -61.69 -61.20 -32.97 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_5CF4B.pdb TYR Active 1 50Y 2.38 -103.89 5.07 999.00 -157.69 144.02 -168.16 -135.06 35.99 -61.58 -61.54 -31.67 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_5CF5A.pdb TYR Active 1 50W 2.45 -106.12 0.47 999.00 -155.60 145.71 -167.23 -134.02 32.22 -62.65 -60.56 -30.26 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_5CF5B.pdb TYR Active 1 50W 2.45 -105.37 0.37 999.00 -155.32 144.45 -167.07 -134.00 32.18 -62.32 -61.63 -29.64 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_5CF6A.pdb TYR Active 1 50O 2.50 -104.11 1.58 999.00 -156.15 144.46 -169.07 -132.44 30.64 -62.53 -58.68 -30.08 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_5CF6B.pdb TYR Active 1 50O 2.50 -102.81 1.16 999.00 -157.33 143.82 -168.41 -132.77 30.01 -62.49 -59.70 -28.52 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_5CF8A.pdb TYR Active 1 50V 1.80 -111.49 5.32 999.00 -159.95 145.14 -171.97 -133.07 28.14 -67.95 -56.02 -28.39 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_5CF8B.pdb TYR Active 1 50V 1.80 -110.56 4.88 999.00 -158.25 144.72 -170.97 -132.60 27.56 -68.46 -58.54 -26.77 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_5HEZA.pdb TYR Active 1 1M3 2.66 -103.68 3.99 999.00 -149.85 138.25 -165.60 -131.77 28.67 -59.24 -61.18 -26.57 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_5HEZB.pdb TYR Active 1 1M3 2.66 -103.46 3.04 999.00 -148.41 138.15 -164.26 -130.73 29.04 -60.19 -60.80 -25.78 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_5HEZC.pdb TYR Active 1 1M3 2.66 -103.78 3.87 999.00 -148.73 138.92 -163.91 -132.74 28.94 -60.05 -60.03 -27.14 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_5HEZD.pdb TYR Active 1 1M3 2.66 -102.35 3.11 999.00 -149.36 138.23 -163.18 -132.18 28.55 -59.86 -59.57 -26.75 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_5L3AA.pdb TYR Active 1 6DP 1.98 -128.55 -160.97 999.00 38.38 90.00 -162.13 -102.07 29.88 -65.51 -68.23 -33.81 999.00 Outlier GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_5TQ3A.pdb TYR Active 1 7GZ 2.69 172.86 131.46 999.00 -138.37 98.37 -179.22 -97.80 27.34 -72.49 -80.90 -8.44 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_5TQ3B.pdb TYR Active 1 7GZ 2.69 175.34 157.25 999.00 -141.37 99.78 179.45 -97.38 27.05 -71.78 -80.14 -9.57 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_5TQ4A.pdb TYR Active 1 7GY 2.30 -127.00 -150.42 999.00 5.28 93.29 -164.72 -93.68 31.39 -75.47 -74.27 -14.43 999.00 Outlier GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_5TQ5A.pdb TYR Active 1 7GX 2.30 -119.29 -142.60 999.00 8.64 85.10 -144.08 -90.23 16.96 -74.81 -59.80 -25.36 999.00 Outlier GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_5TQ6A.pdb TYR Active 1 7GV 2.06 -115.86 4.10 999.00 -150.05 142.14 -172.98 -129.79 33.23 -62.77 -62.09 -22.95 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_5TQ6B.pdb TYR Active 1 7GV 2.06 -111.51 -1.05 999.00 -147.27 140.22 -163.77 -133.47 34.44 -58.44 -70.06 -25.93 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_5TQ7A.pdb TYR Active 1 7GT 2.10 -112.11 6.43 999.00 -155.19 139.86 -157.77 -132.29 31.16 -58.35 -54.46 -34.29 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_5TQ7B.pdb TYR Active 1 7GT 2.10 -110.48 5.36 999.00 -145.68 141.15 -167.06 -137.77 43.06 -60.73 -87.99 -15.61 999.00 Favored GLY ASP PHE GLY"
"JAK2_HUMAN_2 t_5TQ8A.pdb TYR Active 1 7GS 1.59 -112.88 -147.30 999.00 8.07 87.40 -159.99 -90.45 17.77 -80.70 -58.30 -25.20 999.00 Outlier GLY ASP PHE GLY"
"JAK3_HUMAN_2 t_1YVJA.pdb TYR Active 1 4ST 2.55 -117.29 -176.35 999.00 48.83 98.01 -169.43 -113.48 29.66 -72.18 -71.87 -20.65 999.00 Outlier ALA ASP PHE GLY"
"JAK3_HUMAN_2 t_3LXKA.pdb TYR Active 1 MI1 2.00 -128.17 7.21 999.00 -148.96 145.12 -167.23 -138.73 31.17 -59.44 -60.09 -27.73 999.00 Favored ALA ASP PHE GLY"
"JAK3_HUMAN_2 t_3LXLA.pdb TYR Active 1 IZA 1.74 -131.17 -163.12 999.00 63.96 61.75 172.96 -90.55 13.44 -72.73 -63.23 -20.77 999.00 Allowed ALA ASP PHE GLY"
"JAK3_HUMAN_2 t_3PJCA.pdb TYR Active 1 PJC 2.20 -131.65 -174.75 999.00 54.01 85.79 -174.48 -100.87 20.13 -79.35 -60.69 -24.31 999.00 Allowed ALA ASP PHE GLY"
"JAK3_HUMAN_2 t_3ZC6A.pdb TYR Active 1 VFC 2.42 -132.72 -176.16 999.00 56.38 83.29 -166.90 -97.56 22.76 -74.23 -62.55 -27.57 999.00 Allowed ALA ASP PHE GLY"
"JAK3_HUMAN_2 t_3ZC6B.pdb TYR Active 1 VFC 2.42 -128.91 -176.97 999.00 59.68 81.94 -163.35 -99.57 21.95 -70.79 -63.51 -20.70 999.00 Allowed ALA ASP PHE GLY"
"JAK3_HUMAN_2 t_3ZC6C.pdb TYR Active 1 VFC 2.42 -123.63 -177.73 999.00 61.09 80.96 -169.59 -97.92 27.06 -71.82 -66.74 -26.07 999.00 Allowed ALA ASP PHE GLY"
"JAK3_HUMAN_2 t_3ZC6D.pdb TYR Active 1 VFC 2.42 -134.55 -176.67 999.00 59.24 81.94 -172.25 -97.60 24.75 -74.54 -66.75 -25.03 999.00 Allowed ALA ASP PHE GLY"
"JAK3_HUMAN_2 t_3ZEPA.pdb TYR Active 1 1NX 2.35 -139.18 179.63 999.00 58.53 83.64 -161.65 -103.45 28.84 -69.55 -67.27 -39.38 999.00 Allowed ALA ASP PHE GLY"
"JAK3_HUMAN_2 t_3ZEPB.pdb TYR Active 1 1NX 2.35 -142.17 177.44 999.00 62.43 84.46 -168.60 -101.40 32.35 -67.06 -73.09 -37.80 999.00 Allowed ALA ASP PHE GLY"
"JAK3_HUMAN_2 t_3ZEPC.pdb TYR Active 1 1NX 2.35 -143.28 179.54 999.00 63.58 86.38 -162.84 -106.37 31.60 -69.59 -68.79 -32.03 999.00 Allowed ALA ASP PHE GLY"
"JAK3_HUMAN_2 t_3ZEPD.pdb TYR Active 1 1NX 2.35 -134.18 176.55 999.00 59.32 80.72 -166.37 -100.40 28.51 -68.73 -63.77 -42.01 999.00 Allowed ALA ASP PHE GLY"
"JAK3_HUMAN_2 t_4HVDA.pdb TYR Active 1 933 1.85 -128.57 -166.48 999.00 58.40 76.60 -179.42 -98.52 22.92 -71.72 -65.54 -24.61 999.00 Allowed ALA ASP PHE GLY"
"JAK3_HUMAN_2 t_4HVGA.pdb TYR Active 1 19Q 2.75 -130.38 -171.24 999.00 53.40 75.10 -166.32 -85.26 20.50 -70.14 -58.85 -29.59 999.00 Allowed ALA ASP PHE GLY"
"JAK3_HUMAN_2 t_4HVHA.pdb TYR Active 1 19R 2.30 -140.80 -174.17 999.00 54.97 86.94 -162.53 -103.30 27.43 -70.78 -59.86 -26.98 999.00 Outlier ALA ASP PHE GLY"
"JAK3_HUMAN_2 t_4HVIA.pdb TYR Active 1 19S 2.40 -133.15 -169.38 999.00 58.21 80.84 -176.23 -103.49 21.05 -69.90 -64.88 -24.02 999.00 Allowed ALA ASP PHE GLY"
"JAK3_HUMAN_2 t_4I6QA.pdb TYR Active 1 1DT 1.85 -122.28 -166.37 999.00 58.66 80.25 -176.97 -102.71 19.06 -77.28 -63.22 -27.70 999.00 Allowed ALA ASP PHE GLY"
"JAK3_HUMAN_2 t_4QPSA.pdb TYR Active 1 37Q 1.80 -130.95 -174.49 999.00 64.46 86.85 -165.36 -104.87 15.71 -78.75 -57.27 -32.25 999.00 Allowed ALA ASP PHE GLY"
"JAK3_HUMAN_2 t_4QPSC.pdb TYR Active 1 37Q 1.80 -137.29 -176.45 999.00 68.86 77.32 -58.07 -100.85 19.12 -75.63 -56.96 -26.17 999.00 Allowed ALA ASP PHE GLY"
"JAK3_HUMAN_2 t_4QT1A.pdb TYR Active 1 3C9 2.40 -139.01 177.26 999.00 52.59 80.82 -168.89 -91.97 24.19 -67.23 -57.08 -27.63 999.00 Allowed ALA ASP PHE GLY"
"JAK3_HUMAN_2 t_4RIOA.pdb TYR Active 1 3QX 2.69 -146.32 -172.55 999.00 60.58 81.96 -168.85 -101.11 19.22 -73.10 -65.81 -24.61 999.00 Allowed ALA ASP PHE GLY"
"JAK3_HUMAN_2 t_4V0GA.pdb TYR Active 1 G9B 3.00 -144.74 -176.42 999.00 39.23 85.89 -175.14 -90.58 22.35 -73.76 -61.36 -19.00 999.00 Outlier ALA ASP PHE GLY"
"JAK3_HUMAN_2 t_4V0GB.pdb TYR Active 1 G9B 3.00 -137.83 -174.70 999.00 52.03 76.69 -160.05 -96.13 37.59 -63.57 -70.37 -40.14 999.00 Allowed ALA ASP PHE GLY"
"JAK3_HUMAN_2 t_4Z16A.pdb TYR Active 1 4LH 2.90 -125.14 -170.66 999.00 46.25 83.16 -173.12 -101.01 26.28 -69.85 -68.04 -29.39 999.00 Outlier ALA ASP PHE GLY"
"JAK3_HUMAN_2 t_4Z16B.pdb TYR Active 1 4LH 2.90 -124.69 -170.14 999.00 45.79 83.30 -173.16 -100.73 26.18 -70.05 -68.32 -28.49 999.00 Outlier ALA ASP PHE GLY"
"JAK3_HUMAN_2 t_4Z16C.pdb TYR Active 1 4LH 2.90 -124.88 -171.02 999.00 46.90 83.37 -173.30 -101.00 25.72 -69.77 -68.07 -28.96 999.00 Outlier ALA ASP PHE GLY"
"JAK3_HUMAN_2 t_4Z16D.pdb TYR Active 1 4LH 2.90 -124.04 -170.47 999.00 45.90 82.70 -172.88 -99.38 24.98 -69.88 -66.51 -27.43 999.00 Outlier ALA ASP PHE GLY"
"JAK3_HUMAN_2 t_5LWMA.pdb TYR Active 1 79T 1.55 -127.82 -164.05 999.00 50.72 78.37 -164.87 -96.88 23.51 -80.93 -64.40 -25.53 999.00 Allowed ALA ASP PHE GLY"
"JAK3_HUMAN_2 t_5LWNA.pdb TYR Active 1 79R 1.60 -129.51 -162.32 999.00 48.01 73.69 -166.17 -87.99 20.08 -78.16 -61.79 -25.07 999.00 Allowed ALA ASP PHE GLY"
"JAK3_HUMAN_2 t_5TOZA.pdb TYR Active 1 7H4 1.98 -132.44 -172.63 999.00 55.15 83.46 -164.64 -97.89 23.42 -71.62 -59.44 -27.52 999.00 Allowed ALA ASP PHE GLY"
"JAK3_HUMAN_2 t_5TTSA.pdb TYR Active 1 7KU 2.34 -129.00 -169.12 999.00 47.63 82.39 -169.22 -97.89 20.58 -78.47 -59.63 -22.23 999.00 Outlier ALA ASP PHE GLY"
"JAK3_HUMAN_2 t_5TTUA.pdb TYR Active 1 7KV 1.72 -134.39 -163.89 999.00 55.38 67.57 -52.84 -87.63 14.19 -78.96 -61.35 -21.70 999.00 Allowed ALA ASP PHE GLY"
"JAK3_HUMAN_2 t_5TTVA.pdb TYR Active 1 7KX 1.93 -134.18 -173.35 999.00 47.68 81.10 -162.94 -99.61 24.50 -74.98 -61.93 -30.49 999.00 Outlier ALA ASP PHE GLY"
"KAPCA_HUMAN t_2GU8A.pdb AGC Active 1 796 2.20 -112.12 169.59 -163.64 64.50 88.46 -162.21 -98.68 25.00 -80.76 -52.72 -25.67 999.00 Allowed THR ASP PHE GLY"
"KAPCA_HUMAN t_3AGLA.pdb AGC Active 1 A03 2.10 -123.33 177.61 -168.28 64.27 83.48 -161.10 -96.43 22.52 -87.81 -58.66 -28.48 999.00 Allowed THR ASP PHE GLY"
"KAPCA_HUMAN t_3AGLB.pdb AGC Active 1 A03 2.10 -119.18 172.98 -168.56 64.02 88.93 -163.40 -97.99 24.41 -88.72 -60.29 -24.03 999.00 Allowed THR ASP PHE GLY"
"KAPCA_HUMAN t_3AGMA.pdb AGC Active 1 Apo 2.00 -121.69 165.51 -170.90 70.40 93.14 -162.57 -102.22 24.94 -68.11 -56.94 -34.42 999.00 Allowed THR ASP PHE GLY"
"KAPCA_HUMAN t_3AMAA.pdb AGC Active 1 SKE 1.75 -113.48 162.08 999.00 72.14 95.43 -152.08 -101.10 20.61 -79.98 -51.29 -34.42 999.00 Allowed ALA ASP PHE GLY"
"KAPCA_HUMAN t_3AMBA.pdb AGC Active 1 VX6 2.25 -95.22 -46.96 999.00 -99.92 115.15 -167.43 -101.03 17.81 -80.20 -53.87 -36.68 999.00 Favored ALA ASP PHE GLY"
"KAPCA_HUMAN t_3L9LA.pdb AGC Active 1 L9L 2.00 -131.39 170.83 66.14 67.16 98.73 -158.43 -112.51 31.51 -78.22 -76.66 -4.94 999.00 Allowed THR ASP PHE GLY"
"KAPCA_HUMAN t_3L9LB.pdb AGC Active 1 L9L 2.00 -126.03 169.27 69.47 70.20 93.91 -161.39 -105.70 28.15 -82.79 -68.65 -5.56 999.00 Allowed THR ASP PHE GLY"
"KAPCA_HUMAN t_3L9MA.pdb AGC Active 1 L9M 1.90 -123.44 168.24 69.06 64.30 97.86 -160.54 -112.05 32.74 -62.93 -74.17 -5.44 999.00 Outlier THR ASP PHE GLY"
"KAPCA_HUMAN t_3L9MB.pdb AGC Active 1 L9M 1.90 -124.33 166.06 69.85 67.02 98.26 -160.51 -111.86 31.74 -65.51 -67.43 -11.77 999.00 Allowed THR ASP PHE GLY"
"KAPCA_HUMAN t_3L9NA.pdb AGC Active 1 L9N 2.00 -123.73 168.01 67.51 65.98 97.53 -155.89 -115.01 25.76 -59.13 -67.04 -19.79 999.00 Outlier THR ASP PHE GLY"
"KAPCA_HUMAN t_3MVJA.pdb AGC Active 1 XFE 2.49 -115.94 169.34 64.48 72.39 84.05 -147.46 -100.35 21.05 -75.42 -48.39 -32.32 999.00 Allowed THR ASP PHE GLY"
"KAPCA_HUMAN t_3MVJB.pdb AGC Active 1 Apo 2.49 -107.37 175.14 30.95 69.89 103.09 -143.05 -126.63 31.72 -70.89 -68.93 -36.60 999.00 Allowed THR ASP PHE GLY"
"KAPCA_HUMAN t_3MVJE.pdb AGC Active 1 XFE 2.49 -120.75 173.50 54.91 75.75 91.54 -138.38 -105.06 22.02 -73.11 -48.62 -45.47 999.00 Allowed THR ASP PHE GLY"
"KAPCA_HUMAN t_3NX8A.pdb AGC Active 1 IPH 2.00 -121.44 174.32 -174.74 68.66 92.55 -157.01 -100.19 21.76 -93.89 -54.71 -29.93 999.00 Allowed THR ASP PHE GLY"
"KAPCA_HUMAN t_3OOGA.pdb AGC Active 1 Apo 2.00 -121.68 177.29 68.98 65.89 89.73 -161.33 -99.79 18.76 -88.58 -55.10 -24.51 999.00 Allowed THR ASP PHE GLY"
"KAPCA_HUMAN t_3OVVA.pdb AGC Active 1 1SB 1.58 -125.58 177.15 -158.58 63.72 85.65 -167.30 -91.96 24.89 -89.70 -58.53 -29.23 999.00 Allowed THR ASP PHE GLY"
"KAPCA_HUMAN t_3OWPA.pdb AGC Active 1 2SB 1.88 -129.78 179.39 -162.95 68.22 88.88 -160.13 -97.93 23.64 -90.56 -59.80 -24.74 999.00 Allowed THR ASP PHE GLY"
"KAPCA_HUMAN t_3OXTA.pdb AGC Active 1 3SB 2.20 -130.46 176.58 -151.52 67.73 88.77 -154.71 -96.87 20.85 -88.43 -54.78 -35.76 999.00 Allowed THR ASP PHE GLY"
"KAPCA_HUMAN t_3P0MA.pdb AGC Active 1 4SB 2.03 -120.94 -179.00 65.68 59.76 84.93 -164.02 -96.41 19.21 -90.92 -49.75 -35.94 999.00 Allowed THR ASP PHE GLY"
"KAPCA_HUMAN t_3POOA.pdb AGC Active 1 S69 1.60 -122.80 177.30 68.10 59.40 86.60 -162.46 -95.60 24.37 -92.81 -56.62 -28.28 999.00 Allowed THR ASP PHE GLY"
"KAPCA_HUMAN t_3VQHA.pdb AGC Active 1 IQB 1.95 -116.48 -175.45 63.94 66.02 75.66 -74.93 -94.13 21.69 -87.12 -59.11 -31.42 999.00 Allowed THR ASP PHE GLY"
"KAPCA_HUMAN t_4AE6A.pdb AGC Active 1 Apo 2.10 -101.98 -12.30 -132.88 -149.92 117.69 176.90 -105.35 23.12 -88.31 -56.79 -39.18 999.00 Favored THR ASP PHE GLY"
"KAPCA_HUMAN t_4AE6B.pdb AGC Active 1 Apo 2.10 -110.07 -21.15 70.83 -129.51 123.24 -146.25 -122.94 15.21 -70.57 -49.15 -40.17 999.00 Favored THR ASP PHE GLY"
"KAPCA_HUMAN t_4AE9A.pdb AGC Active 1 Apo 2.30 -108.04 1.23 59.26 -143.02 134.98 -155.66 -120.28 26.20 -82.41 -50.36 -36.25 999.00 Favored THR ASP PHE GLY"
"KAPCA_HUMAN t_4AE9B.pdb AGC Active 1 Apo 2.30 -114.89 -7.48 71.31 -130.91 125.98 -147.64 -130.51 17.00 -64.56 -52.58 -39.80 999.00 Favored THR ASP PHE GLY"
"KAPCA_HUMAN t_4UJ1A.pdb AGC Active 1 NVX 1.77 -123.57 -163.77 -172.75 61.68 70.54 -58.02 -93.61 20.56 -88.52 -64.79 -20.89 999.00 Allowed THR ASP PHE GLY"
"KAPCA_HUMAN t_4UJ2A.pdb AGC Active 1 NVV 2.02 -125.68 -160.40 -175.11 61.32 58.81 -58.53 -86.52 22.47 -87.85 -53.55 -31.61 999.00 Favored THR ASP PHE GLY"
"KAPCA_HUMAN t_4UJ9A.pdb AGC Active 1 MPD 1.87 -117.54 -171.15 72.22 58.87 71.41 -84.24 -92.01 19.16 -90.90 -56.84 -27.62 999.00 Allowed THR ASP PHE GLY"
"KAPCA_HUMAN t_4UJAA.pdb AGC Active 1 MPD 1.93 -125.31 -163.66 -173.37 62.99 64.36 -61.69 -88.84 21.72 -89.56 -55.45 -30.89 999.00 Allowed THR ASP PHE GLY"
"KAPCA_HUMAN t_4UJBA.pdb AGC Active 1 8BQ 1.95 -125.28 -161.97 -176.04 58.37 69.77 -57.32 -90.49 19.26 -92.11 -53.54 -31.37 999.00 Allowed THR ASP PHE GLY"
"KAPCA_HUMAN t_4WB5A.pdb AGC Active 1 ATP 1.64 -123.07 176.84 -167.04 68.96 79.98 -162.61 -91.47 24.90 -89.81 -60.75 -31.44 999.00 Allowed THR ASP PHE GLY"
"KAPCA_HUMAN t_4WB6A.pdb AGC Active 1 ATP 2.10 -118.37 -169.49 -174.12 51.73 82.49 -163.00 -95.56 17.74 -88.81 -42.80 -37.29 999.00 Allowed THR ASP PHE GLY"
"KAPCA_HUMAN t_4WB6B.pdb AGC Active 1 ATP 2.10 -117.82 -168.28 -170.44 53.22 78.37 -167.30 -91.32 29.38 -85.04 -60.23 -35.86 999.00 Allowed THR ASP PHE GLY"
"KAPCA_HUMAN t_4WB7A.pdb AGC Active 1 ATP 1.90 -119.03 -174.38 -167.35 59.43 77.29 -164.25 -89.12 26.43 -92.27 -60.43 -28.36 999.00 Allowed THR ASP PHE GLY"
"KAPCA_HUMAN t_4WB7B.pdb AGC Active 1 ATP 1.90 -115.90 -176.77 -165.51 62.31 75.38 -165.71 -88.94 25.23 -95.35 -56.93 -30.26 999.00 Allowed THR ASP PHE GLY"
"KAPCA_HUMAN t_4WB8A.pdb AGC Active 1 ATP 1.55 -121.48 -177.17 -167.62 62.66 77.76 -163.23 -92.00 24.61 -91.14 -58.36 -31.49 999.00 Allowed THR ASP PHE GLY"
"KAPCA_HUMAN t_5BX6A.pdb AGC Active 1 495 1.89 -119.55 164.87 -171.34 70.90 91.60 -162.06 -100.24 26.66 -88.20 -61.33 -23.30 999.00 Allowed THR ASP PHE GLY"
"KAPCA_HUMAN t_5BX7A.pdb AGC Active 1 Apo 1.89 -120.18 171.00 61.72 66.35 95.24 -157.44 -104.97 26.39 -88.48 -58.60 -27.02 999.00 Allowed THR ASP PHE GLY"
"KAPCA_HUMAN t_5IZFA.pdb AGC Active 1 Apo 2.10 -115.33 168.86 -174.81 66.71 92.74 -162.08 -104.02 26.54 -88.96 -60.28 -26.20 999.00 Allowed THR ASP PHE GLY"
"KAPCA_HUMAN t_5IZJA.pdb AGC Active 1 6J9 1.85 -111.63 172.78 51.54 71.01 87.73 -161.79 -97.75 27.06 -81.15 -58.58 -30.41 999.00 Allowed THR ASP PHE GLY"
"KAPCA_HUMAN t_5IZJB.pdb AGC Active 1 6J9 1.85 -109.03 168.99 -165.23 75.27 88.02 -167.13 -97.66 24.21 -90.88 -63.04 -24.96 999.00 Allowed THR ASP PHE GLY"
"KAPCA_HUMAN t_5J5XA.pdb AGC Active 1 6J9 2.60 -130.57 173.08 -174.06 68.75 93.04 -148.79 -105.70 27.02 -80.75 -64.31 -20.92 999.00 Allowed THR ASP PHE GLY"
"KC1A_HUMAN t_5FQDC.pdb CK1 Active 1 Apo 2.45 -125.13 -175.36 53.72 65.38 78.62 -161.59 -95.41 17.55 -66.05 -64.28 -25.66 999.00 Allowed ILE ASP PHE GLY"
"KC1A_HUMAN t_5FQDF.pdb CK1 Active 1 Apo 2.45 -126.37 -172.39 53.68 58.12 85.88 -156.96 -99.99 16.22 -66.38 -62.59 -25.41 999.00 Allowed ILE ASP PHE GLY"
"KC1D_HUMAN t_3UYSA.pdb CK1 Active 1 Apo 2.30 -135.97 -172.70 68.30 54.27 84.30 -149.66 -98.05 23.67 -74.28 -62.68 -28.34 999.00 Allowed ILE ASP PHE GLY"
"KC1D_HUMAN t_3UYSB.pdb CK1 Active 1 Apo 2.30 -123.50 -176.33 64.10 49.63 104.50 -162.89 -109.94 26.44 -69.67 -66.11 -7.60 999.00 Outlier ILE ASP PHE GLY"
"KC1D_HUMAN t_3UYSC.pdb CK1 Active 1 Apo 2.30 -134.33 -179.26 70.05 58.13 91.56 -150.01 -102.81 27.22 -71.45 -68.39 -23.04 999.00 Outlier ILE ASP PHE GLY"
"KC1D_HUMAN t_3UYSD.pdb CK1 Active 1 Apo 2.30 -135.57 176.18 60.65 66.37 85.09 -147.15 -100.11 27.45 -72.53 -71.33 -34.89 999.00 Allowed ILE ASP PHE GLY"
"KC1D_HUMAN t_3UYTA.pdb CK1 Active 1 0CK 2.00 -141.04 176.00 59.63 67.88 107.57 -152.74 -117.60 28.26 -69.32 -70.95 -30.56 999.00 Outlier ILE ASP PHE GLY"
"KC1D_HUMAN t_3UYTB.pdb CK1 Active 1 0CK 2.00 -143.81 172.32 67.04 63.48 117.06 -154.32 -123.59 20.53 -69.19 -64.95 -18.68 999.00 Outlier ILE ASP PHE GLY"
"KC1D_HUMAN t_3UYTC.pdb CK1 Active 1 0CK 2.00 -138.61 175.23 65.82 64.90 102.35 -145.79 -113.41 24.17 -70.08 -63.00 -34.89 999.00 Outlier ILE ASP PHE GLY"
"KC1D_HUMAN t_3UYTD.pdb CK1 Active 1 0CK 2.00 -125.08 171.90 58.51 69.58 107.55 -139.55 -115.57 21.99 -80.17 -71.10 -36.37 999.00 Allowed ILE ASP PHE GLY"
"KC1D_HUMAN t_3UZPA.pdb CK1 Active 1 0CK 1.94 -134.71 173.76 61.14 69.16 94.08 -152.11 -102.83 19.86 -71.94 -54.72 -37.80 999.00 Allowed ILE ASP PHE GLY"
"KC1D_HUMAN t_3UZPB.pdb CK1 Active 1 0CK 1.94 -139.61 -179.74 65.01 62.22 101.16 -151.83 -114.84 18.21 -76.57 -58.39 -26.55 999.00 Outlier ILE ASP PHE GLY"
"KC1D_HUMAN t_4HGTA.pdb CK1 Active 1 15G 1.80 -126.44 174.56 56.23 58.28 93.45 -160.87 -99.95 21.14 -73.74 -60.52 -14.71 999.00 Outlier ILE ASP PHE GLY"
"KC1D_HUMAN t_4HGTB.pdb CK1 Active 1 15G 1.80 -132.86 173.93 60.14 65.27 88.37 -157.78 -100.08 21.04 -76.29 -60.34 -23.80 999.00 Allowed ILE ASP PHE GLY"
"KC1D_HUMAN t_4HNFA.pdb CK1 Active 1 16W 2.07 -129.66 -172.38 55.27 54.62 82.38 -163.27 -100.03 27.01 -66.57 -59.67 -32.78 999.00 Allowed ILE ASP PHE GLY"
"KC1D_HUMAN t_4HNFB.pdb CK1 Active 1 16W 2.07 -134.11 -166.39 62.51 56.84 78.32 -136.76 -103.13 26.34 -78.11 -64.46 -33.33 999.00 Allowed ILE ASP PHE GLY"
"KC1D_HUMAN t_4KB8A.pdb CK1 Active 1 1QN 1.95 -126.79 172.82 67.50 67.67 98.76 -145.61 -108.66 18.09 -68.85 -60.85 -33.83 999.00 Allowed ILE ASP PHE GLY"
"KC1D_HUMAN t_4KB8B.pdb CK1 Active 1 1QO 1.95 -134.34 177.54 63.09 61.96 98.74 -147.98 -107.12 20.22 -69.35 -61.49 -33.78 999.00 Outlier ILE ASP PHE GLY"
"KC1D_HUMAN t_4KB8C.pdb CK1 Active 1 1QN 1.95 -127.94 175.55 72.32 65.00 98.72 -148.69 -108.36 19.36 -69.74 -61.97 -33.26 999.00 Outlier ILE ASP PHE GLY"
"KC1D_HUMAN t_4KB8D.pdb CK1 Active 1 1QO 1.95 -137.04 175.30 58.85 62.91 97.99 -146.69 -106.76 19.35 -69.32 -61.07 -34.42 999.00 Outlier ILE ASP PHE GLY"
"KC1D_HUMAN t_4KBAA.pdb CK1 Active 1 1QM 1.98 -128.07 172.49 60.41 64.96 105.18 -149.36 -114.89 19.11 -68.73 -62.29 -33.78 999.00 Outlier ILE ASP PHE GLY"
"KC1D_HUMAN t_4KBAB.pdb CK1 Active 1 1QM 1.98 -129.68 173.50 61.64 62.35 106.48 -121.34 -115.88 19.77 -69.82 -62.09 -34.93 999.00 Outlier ILE ASP PHE GLY"
"KC1D_HUMAN t_4KBAC.pdb CK1 Active 1 1QM 1.98 -127.95 172.77 60.54 65.32 103.98 -149.68 -113.86 19.69 -68.93 -63.16 -33.17 999.00 Outlier ILE ASP PHE GLY"
"KC1D_HUMAN t_4KBAD.pdb CK1 Active 1 1QM 1.98 -129.27 172.58 61.26 62.45 106.14 -150.57 -113.76 20.18 -69.55 -61.97 -35.21 999.00 Outlier ILE ASP PHE GLY"
"KC1D_HUMAN t_4KBCA.pdb CK1 Active 1 1QJ 1.98 -135.07 177.11 60.81 62.41 94.79 -159.42 -104.60 19.93 -70.86 -62.08 -27.61 999.00 Outlier ILE ASP PHE GLY"
"KC1D_HUMAN t_4KBCB.pdb CK1 Active 1 1QJ 1.98 -134.30 176.55 58.56 61.15 97.99 -152.99 -105.54 17.64 -69.51 -63.03 -28.59 999.00 Outlier ILE ASP PHE GLY"
"KC1D_HUMAN t_4KBKA.pdb CK1 Active 1 1QG 2.10 -131.67 175.28 65.22 64.96 97.74 -144.86 -105.99 20.76 -70.31 -60.91 -32.85 999.00 Outlier ILE ASP PHE GLY"
"KC1D_HUMAN t_4KBKB.pdb CK1 Active 1 1QG 2.10 -130.16 174.98 64.27 66.33 98.19 -150.36 -106.67 21.37 -70.37 -63.30 -31.58 999.00 Outlier ILE ASP PHE GLY"
"KC1D_HUMAN t_4KBKC.pdb CK1 Active 1 1QG 2.10 -129.84 175.62 63.62 65.38 97.51 -150.82 -107.00 21.40 -70.06 -62.98 -30.99 999.00 Outlier ILE ASP PHE GLY"
"KC1D_HUMAN t_4KBKD.pdb CK1 Active 1 1QG 2.10 -131.40 175.29 65.93 63.28 98.83 -149.36 -106.84 21.56 -70.42 -62.33 -31.87 999.00 Outlier ILE ASP PHE GLY"
"KC1D_HUMAN t_4TN6A.pdb CK1 Active 1 PFO 2.41 -131.87 176.19 64.73 68.14 89.88 -136.62 -98.76 20.74 -67.14 -60.03 -32.75 999.00 Allowed ILE ASP PHE GLY"
"KC1D_HUMAN t_4TN6B.pdb CK1 Active 1 Apo 2.41 -131.96 175.70 64.69 67.68 89.22 -137.97 -98.58 20.68 -66.94 -63.42 -31.24 999.00 Allowed ILE ASP PHE GLY"
"KC1D_HUMAN t_4TW9A.pdb CK1 Active 1 HSJ 2.40 -136.90 175.67 70.56 62.25 78.80 -164.10 -97.44 44.95 -69.09 -92.15 -19.28 999.00 Allowed ILE ASP PHE GLY"
"KC1D_HUMAN t_4TW9B.pdb CK1 Active 1 386 2.40 -131.68 171.31 60.21 75.25 83.06 -167.77 -107.12 28.16 -63.73 -70.98 -25.30 999.00 Allowed ILE ASP PHE GLY"
"KC1D_HUMAN t_4TWCA.pdb CK1 Active 1 37J 1.70 -135.41 171.44 67.40 74.67 98.91 -158.20 -108.47 20.24 -69.87 -60.13 -26.05 999.00 Allowed ILE ASP PHE GLY"
"KC1D_HUMAN t_4TWCB.pdb CK1 Active 1 37J 1.70 -137.20 168.98 64.08 78.22 98.98 -156.30 -108.32 17.17 -71.26 -60.02 -32.77 999.00 Allowed ILE ASP PHE GLY"
"KC1D_HUMAN t_5IH4A.pdb CK1 Active 1 Apo 1.90 -127.37 171.92 71.28 74.15 92.86 -159.64 -102.61 27.68 -65.63 -77.77 -29.15 999.00 Allowed ILE ASP PHE GLY"
"KC1D_HUMAN t_5IH5A.pdb CK1 Active 1 AUE 2.25 -135.97 171.39 66.50 70.53 96.88 -156.02 -108.19 25.67 -72.75 -71.30 -25.57 999.00 Allowed ILE ASP PHE GLY"
"KC1D_HUMAN t_5IH6A.pdb CK1 Active 1 AUG 2.30 -128.65 171.24 70.01 73.41 91.52 -155.17 -103.49 28.78 -67.69 -73.22 -29.90 999.00 Allowed ILE ASP PHE GLY"
"KC1D_HUMAN t_5MQVA.pdb CK1 Active 1 D5Q 2.15 -131.65 168.79 58.08 74.04 95.14 -151.96 -107.71 21.28 -68.01 -64.89 -25.36 999.00 Allowed ILE ASP PHE GLY"
"KC1D_HUMAN t_5MQVB.pdb CK1 Active 1 D5Q 2.15 -131.59 168.26 58.33 73.30 96.69 -152.58 -107.43 22.05 -66.94 -64.46 -25.60 999.00 Allowed ILE ASP PHE GLY"
"KC1D_HUMAN t_5MQVC.pdb CK1 Active 1 D5Q 2.15 -131.23 168.19 59.11 73.21 96.73 -152.30 -107.22 21.83 -66.69 -65.14 -25.72 999.00 Allowed ILE ASP PHE GLY"
"KC1D_HUMAN t_5MQVD.pdb CK1 Active 1 D5Q 2.15 -130.24 169.08 59.07 73.16 96.36 -152.30 -107.08 21.80 -66.31 -65.09 -25.84 999.00 Allowed ILE ASP PHE GLY"
"KC1D_HUMAN t_5MQVE.pdb CK1 Active 1 D5Q 2.15 -131.37 167.81 58.78 73.21 96.46 -152.39 -108.06 21.30 -66.81 -65.18 -25.24 999.00 Allowed ILE ASP PHE GLY"
"KC1D_HUMAN t_5MQVF.pdb CK1 Active 1 D5Q 2.15 -131.24 169.42 59.69 73.21 95.64 -152.31 -107.64 22.27 -67.29 -65.28 -25.59 999.00 Allowed ILE ASP PHE GLY"
"KC1E_HUMAN t_4HNIA.pdb CK1 DFGout 6 16W 2.74 -119.62 137.29 52.16 -111.96 132.82 164.72 -104.79 -19.67 -73.08 159.05 -5.43 999.00 Favored ILE ASP PHE GLY"
"KC1E_HUMAN t_4HNIB.pdb CK1 DFGout 6 16W 2.74 -116.98 143.59 56.01 -113.17 121.00 159.41 -91.50 -9.44 -70.70 143.24 6.37 999.00 Favored ILE ASP PHE GLY"
"KC1E_HUMAN t_4HOKA.pdb CK1 Active 1 Apo 2.77 -144.30 176.18 62.24 62.56 95.27 -170.80 -105.60 23.82 -58.37 -58.40 -8.30 999.00 Outlier ILE ASP PHE GLY"
"KC1E_HUMAN t_4HOKC.pdb CK1 Active 1 Apo 2.77 -135.81 -178.20 64.67 53.79 96.49 -164.85 -104.76 21.35 -59.35 -57.94 -28.53 999.00 Outlier ILE ASP PHE GLY"
"KC1E_HUMAN t_4HOKE.pdb CK1 Active 1 Apo 2.77 -140.42 -179.41 80.67 53.71 102.35 -151.22 -110.96 31.80 -57.03 -64.95 -14.45 999.00 Outlier ILE ASP PHE GLY"
"KC1E_HUMAN t_4HOKG.pdb CK1 Active 1 Apo 2.77 -133.92 176.58 68.42 60.05 93.86 -166.44 -103.19 38.13 -42.79 -56.88 -47.57 999.00 Outlier ILE ASP PHE GLY"
"KC1E_HUMAN t_4HOKI.pdb CK1 Active 1 Apo 2.77 -140.14 -174.52 75.62 52.75 91.61 -147.98 -98.23 29.39 -60.33 -67.41 -21.30 999.00 Outlier ILE ASP PHE GLY"
"KC1E_HUMAN t_4HOKK.pdb CK1 Active 1 Apo 2.77 -147.43 172.30 73.20 63.94 89.48 -165.77 -94.77 22.48 -57.66 -52.23 -13.16 999.00 Allowed ILE ASP PHE GLY"
"KC1E_HUMAN t_4HOKM.pdb CK1 Active 1 Apo 2.77 -159.36 -171.36 71.19 60.58 66.49 -156.96 -82.21 19.67 -53.16 -54.25 -26.78 999.00 Allowed ILE ASP PHE GLY"
"KC1E_HUMAN t_4HOKO.pdb CK1 Active 1 Apo 2.77 -145.58 -174.94 67.42 60.01 82.22 -156.93 -91.44 11.21 -57.34 -51.53 0.98 999.00 Allowed ILE ASP PHE GLY"
"KC1E_HUMAN t_4HOKQ.pdb CK1 Active 1 Apo 2.77 -126.36 -175.15 62.05 63.53 91.85 -153.74 -105.92 7.19 -69.03 -51.86 -14.51 999.00 Allowed ILE ASP PHE GLY"
"KC1E_HUMAN t_4HOKS.pdb CK1 Active 1 Apo 2.77 -147.67 -167.91 61.07 41.91 84.57 176.02 -90.24 3.23 -51.53 -38.99 -2.38 999.00 Outlier ILE ASP PHE GLY"
"KC1E_HUMAN t_4HOKU.pdb CK1 Active 1 Apo 2.77 -140.19 174.97 69.81 65.48 82.10 -161.87 -84.05 5.22 -55.24 -30.30 -19.38 999.00 Allowed ILE ASP PHE GLY"
"KC1E_HUMAN t_4HOKW.pdb CK1 Active 1 Apo 2.77 -129.98 -165.63 78.93 44.31 79.29 -179.66 -91.63 16.51 -55.59 -59.06 -4.45 999.00 Outlier ILE ASP PHE GLY"
"KC1G1_HUMAN t_2CMWA.pdb CK1 Active 1 OLP 1.75 -129.00 174.50 67.90 61.96 82.76 -158.64 -97.59 18.98 -76.28 -61.89 -30.48 999.00 Allowed ILE ASP PHE GLY"
"KC1G2_HUMAN t_2C47A.pdb CK1 Active 1 5ID 2.4 -129.51 170.52 61.43 64.56 87.81 -161.13 -100.85 26.44 -67.14 -61.78 -29.74 999.00 Allowed ILE ASP PHE GLY"
"KC1G2_HUMAN t_2C47B.pdb CK1 Active 1 5ID 2.4 -129.29 171.75 59.13 68.62 86.21 -156.78 -102.09 27.44 -68.82 -63.17 -29.45 999.00 Allowed ILE ASP PHE GLY"
"KC1G2_HUMAN t_2C47C.pdb CK1 Active 1 5ID 2.4 -130.48 170.20 62.13 65.54 88.28 -160.33 -102.82 30.73 -63.83 -63.01 -30.38 999.00 Allowed ILE ASP PHE GLY"
"KC1G2_HUMAN t_2C47D.pdb CK1 Active 1 5ID 2.4 -127.89 168.31 60.51 69.73 87.85 -159.17 -101.98 26.05 -68.23 -63.83 -28.51 999.00 Allowed ILE ASP PHE GLY"
"KC1G3_HUMAN t_2CHLA.pdb CK1 Active 1 DKI 1.95 -136.84 158.32 -149.07 74.61 86.85 -152.61 -100.36 20.12 -72.21 -60.51 -36.02 999.00 Allowed ILE ASP PHE ALA"
"KC1G3_HUMAN t_2IZRA.pdb CK1 Active 1 BRK 1.3 -128.52 171.86 70.95 71.42 79.77 -159.85 -99.96 17.01 -77.02 -62.88 -27.34 999.00 Allowed ILE ASP PHE ALA"
"KC1G3_HUMAN t_2IZSA.pdb CK1 Active 1 BRQ 1.95 -126.91 175.86 65.87 68.68 78.72 -158.08 -99.37 21.09 -72.17 -64.59 -32.87 999.00 Allowed ILE ASP PHE ALA"
"KC1G3_HUMAN t_2IZTA.pdb CK1 Active 1 23D 2.0 -127.03 174.12 64.85 67.98 81.44 -161.04 -96.36 17.92 -80.56 -62.78 -27.03 999.00 Allowed ILE ASP PHE ALA"
"KC1G3_HUMAN t_2IZUA.pdb CK1 Active 1 P01 1.85 -126.07 170.23 69.85 68.61 86.82 -157.72 -102.43 21.54 -74.67 -64.75 -28.19 999.00 Allowed ILE ASP PHE ALA"
"KC1G3_HUMAN t_4G16A.pdb CK1 Active 1 0VM 2.30 -124.76 175.96 63.97 53.64 88.41 -170.61 -102.12 30.25 -77.30 -67.32 -31.53 999.00 Outlier ILE ASP PHE GLY"
"KC1G3_HUMAN t_4G17A.pdb CK1 Active 1 0VN 2.10 -127.91 173.16 67.41 62.01 85.20 -153.99 -101.87 23.82 -76.29 -60.07 -25.81 999.00 Allowed ILE ASP PHE GLY"
"KC1G3_HUMAN t_4HGLA.pdb CK1 Active 1 0YO 2.40 -128.38 173.68 63.70 54.96 89.74 -172.51 -102.61 30.27 -78.36 -67.78 -30.65 999.00 Outlier ILE ASP PHE GLY"
"KC1G3_HUMAN t_4HGSA.pdb CK1 Active 1 15G 2.40 -128.44 172.62 64.25 59.54 88.79 -167.66 -103.02 29.54 -76.16 -63.06 -32.38 999.00 Allowed ILE ASP PHE GLY"
"KCC1A_HUMAN t_4FG7A.pdb CAMK Active 1 ATP 2.70 -139.63 180.00 75.20 56.19 83.32 -169.56 -95.12 23.75 -73.11 -57.62 -10.35 999.00 Allowed SER ASP PHE GLY"
"KCC1A_HUMAN t_4FG8B.pdb NA NA 0 ATP 2.20 -101.41 -28.75 61.99 -75.13 152.13 999.00 -127.77 -74.73 999.00 -143.25 999.00 999.00 Favored SER ASP PHE GLY"
"KCC1A_HUMAN t_4FGBA.pdb CAMK DFGin-inactive 2 Apo 2.60 -104.61 -8.45 72.74 -140.31 178.07 -166.49 -139.35 147.24 -56.62 -87.77 114.08 999.00 Favored SER ASP PHE GLY"
"KCC1G_HUMAN t_2JAMA.pdb CAMK DFGup 3 J60 1.7 -126.26 -80.83 57.40 -87.17 120.35 -168.08 -158.08 166.27 60.64 86.30 -162.03 999.00 Favored THR ASP PHE GLY"
"KCC1G_HUMAN t_2JAMB.pdb CAMK DFGup 3 J60 1.7 -124.16 -80.96 53.53 -87.52 122.62 -173.76 -160.92 164.98 62.24 89.71 -167.09 999.00 Favored THR ASP PHE GLY"
"KCC2A_HUMAN t_2VZ6A.pdb CAMK Active 1 FEF 2.3 -130.27 144.94 999.00 77.54 104.32 -152.10 -118.46 37.94 -78.82 -60.88 -31.43 999.00 Allowed ALA ASP PHE GLY"
"KCC2A_HUMAN t_2VZ6B.pdb CAMK Active 1 FEF 2.3 -131.91 139.25 999.00 77.58 110.81 -157.07 -122.06 32.98 -73.33 -61.55 -26.55 999.00 Allowed ALA ASP PHE GLY"
"KCC2A_HUMAN t_3SOAA.pdb CAMK DFGout 6 DB8 3.55 -98.84 109.79 999.00 -79.70 114.73 178.79 -137.04 147.51 -44.49 104.35 -23.27 999.00 Favored ALA ASP PHE GLY"
"KCC2B_HUMAN t_3BHHA.pdb CAMK Active 1 5CP 2.40 -119.86 171.13 999.00 57.51 88.26 -159.75 -99.99 29.93 -71.30 -58.72 -43.07 999.00 Allowed ALA ASP PHE GLY"
"KCC2B_HUMAN t_3BHHB.pdb CAMK Active 1 5CP 2.40 -117.24 170.83 999.00 61.20 83.15 -160.12 -97.73 36.06 -72.34 -67.64 -38.57 999.00 Allowed ALA ASP PHE GLY"
"KCC2B_HUMAN t_3BHHC.pdb CAMK Active 1 Apo 2.40 -127.34 170.73 999.00 56.69 87.94 -162.81 -95.70 30.88 -72.11 -64.42 -32.78 999.00 Allowed ALA ASP PHE GLY"
"KCC2B_HUMAN t_3BHHD.pdb CAMK Active 1 Apo 2.40 -126.24 168.25 999.00 59.11 86.81 -159.12 -95.26 32.64 -72.54 -63.08 -40.30 999.00 Allowed ALA ASP PHE GLY"
"KCC2D_HUMAN t_2VN9A.pdb CAMK Active 1 GVD 2.30 -124.97 171.69 999.00 55.16 92.46 -161.27 -101.81 28.42 -71.70 -66.44 -20.26 999.00 Outlier ALA ASP PHE GLY"
"KCC2D_HUMAN t_2VN9B.pdb CAMK Active 1 GVD 2.30 -127.40 171.91 999.00 57.34 92.44 -160.28 -101.88 22.76 -73.39 -61.03 -20.50 999.00 Outlier ALA ASP PHE GLY"
"KCC2D_HUMAN t_2WELA.pdb CAMK Active 1 K88 1.90 -134.97 -174.35 999.00 62.46 61.94 -80.38 -83.34 16.94 -77.32 -61.04 -22.20 999.00 Allowed ALA ASP PHE GLY"
"KCC2G_HUMAN t_2V7OA.pdb CAMK Active 1 DRN 2.25 -130.63 164.18 999.00 65.17 81.92 -163.01 -95.20 27.90 -70.51 -63.32 -23.54 999.00 NA ALA ASP PHE GLY"
"KIT_HUMAN t_1PKGA.pdb TYR Active 1 ADP 2.90 -130.56 -162.04 68.27 47.32 79.70 -147.00 -98.55 34.27 -69.07 -71.64 -28.08 999.00 Allowed CYS ASP PHE GLY"
"KIT_HUMAN t_1PKGB.pdb TYR Active 1 ADP 2.90 -133.99 -165.78 70.72 57.92 93.59 -161.75 -119.66 36.24 -69.79 -80.35 -20.42 999.00 Outlier CYS ASP PHE GLY"
"KIT_HUMAN t_1T45A.pdb TYR DFGout 6 Apo 1.90 -149.04 -178.28 71.55 -114.36 114.98 177.96 -104.66 13.75 -143.28 -60.23 -31.20 999.00 Favored CYS ASP PHE GLY"
"KIT_HUMAN t_1T46A.pdb TYR DFGout 6 STI 1.60 -131.87 -173.04 74.09 -155.40 102.79 -174.35 -61.54 -32.04 -84.40 52.41 -121.02 999.00 Favored CYS ASP PHE GLY"
"KIT_HUMAN t_3G0EA.pdb TYR DFGout 6 B49 1.60 -121.32 151.51 -173.78 -96.31 99.06 170.27 -97.42 -2.22 -158.13 -50.18 -44.69 999.00 Favored CYS ASP PHE GLY"
"KIT_HUMAN t_3G0FA.pdb TYR DFGout 6 B49 2.60 -133.26 143.72 -169.29 -91.40 106.09 -175.60 -85.16 9.59 -99.56 -43.90 131.31 999.00 Favored CYS ASP PHE GLY"
"KIT_HUMAN t_3G0FB.pdb TYR DFGout 6 B49 2.60 -141.94 146.98 -167.17 -101.00 117.63 -174.47 -98.43 1.55 -110.36 -37.66 131.96 999.00 Favored CYS ASP PHE GLY"
"KIT_HUMAN t_4HVSA.pdb TYR DFGout 6 647 1.90 -159.85 -170.25 72.90 -156.86 107.59 -165.03 -49.73 -38.85 -71.14 62.69 -117.38 999.00 Favored CYS ASP PHE GLY"
"KIT_HUMAN t_4U0IA.pdb TYR DFGout 6 0LI 2.00 -145.63 -174.17 72.14 -155.05 116.02 -163.41 -76.96 -26.30 -74.57 51.12 -116.39 999.00 Favored CYS ASP PHE GLY"
"KKCC2_HUMAN t_2ZV2A.pdb OTHER Active 1 609 2.40 -122.83 173.96 999.00 59.27 77.18 -168.28 -93.93 23.37 -69.55 -61.42 -10.03 999.00 Allowed ALA ASP PHE GLY"
"KKCC2_HUMAN t_5UY6A.pdb OTHER Active 1 8R4 1.70 -132.21 178.62 999.00 58.33 80.64 -161.52 -92.34 18.22 -79.37 -55.34 -33.98 999.00 Allowed ALA ASP PHE GLY"
"KKCC2_HUMAN t_5UYJA.pdb OTHER Active 1 8R7 1.60 -132.03 177.08 999.00 61.34 75.95 -159.14 -92.03 18.27 -79.73 -52.80 -33.54 999.00 Allowed ALA ASP PHE GLY"
"KPCA_HUMAN t_3IW4A.pdb AGC Active 1 LW4 2.80 -108.90 -177.51 999.00 59.01 89.41 -171.91 -106.97 24.08 -65.18 -75.60 23.88 999.00 Allowed ALA ASP PHE GLY"
"KPCA_HUMAN t_3IW4B.pdb AGC Active 1 LW4 2.80 -121.89 -178.67 999.00 60.90 102.15 -165.32 -120.42 26.87 -57.95 -64.86 -10.15 999.00 Outlier ALA ASP PHE GLY"
"KPCA_HUMAN t_3IW4C.pdb AGC Active 1 LW4 2.80 -141.97 -178.50 999.00 58.34 93.13 173.42 -108.43 30.21 -56.78 -75.06 20.61 999.00 Outlier ALA ASP PHE GLY"
"KPCA_HUMAN t_4RA4A.pdb AGC Active 1 3KZ 2.63 -123.97 -177.90 999.00 53.55 79.53 -56.96 -93.35 18.18 -63.71 -65.94 -42.11 999.00 Allowed ALA ASP PHE GLY"
"KPCB_HUMAN t_2I0EA.pdb AGC Active 1 PDS 2.60 -117.76 167.96 999.00 68.92 88.91 -153.70 -103.34 26.82 -60.17 -70.92 -19.37 999.00 Allowed ALA ASP PHE GLY"
"KPCB_HUMAN t_2I0EB.pdb AGC Active 1 PDS 2.60 -122.52 163.65 999.00 74.83 90.27 -156.17 -109.69 30.32 -58.44 -89.35 11.85 999.00 Allowed ALA ASP PHE GLY"
"KPCI_HUMAN t_1ZRZA.pdb AGC Active 1 BI1 3.00 -130.79 174.68 -160.81 64.42 118.77 -176.59 -128.09 29.21 -59.11 -95.05 36.95 999.00 NA THR ASP TYR GLY"
"KPCI_HUMAN t_3A8WA.pdb AGC Active 1 ATP 2.10 -132.69 170.50 -170.47 67.35 88.84 -155.58 -96.15 12.07 -55.54 -60.51 -20.31 999.00 NA THR ASP TYR GLY"
"KPCI_HUMAN t_3A8WB.pdb AGC Active 1 ATP 2.10 -133.61 172.59 -170.99 64.82 89.85 -163.07 -97.54 11.01 -60.43 -72.97 35.26 999.00 NA THR ASP TYR GLY"
"KPCI_HUMAN t_3A8XA.pdb AGC Active 1 Apo 2.00 -133.58 171.14 -168.28 66.22 84.75 -168.70 -94.74 12.16 -54.78 -63.18 -17.48 999.00 NA THR ASP TYR GLY"
"KPCI_HUMAN t_3A8XB.pdb AGC Active 1 Apo 2.00 -134.84 172.86 -169.07 61.28 86.64 -177.55 -89.57 25.14 -54.16 -77.52 -26.86 999.00 NA THR ASP TYR GLY"
"KPCI_HUMAN t_3ZH8A.pdb AGC Active 1 C58 2.74 -130.40 -178.04 -176.37 51.17 83.58 -179.41 -87.32 17.94 -55.88 -61.36 -13.35 999.00 NA THR ASP TYR GLY"
"KPCI_HUMAN t_3ZH8B.pdb AGC Active 1 C58 2.74 -129.64 -179.50 -173.70 51.26 83.04 -179.44 -86.80 19.26 -54.65 -61.13 -14.19 999.00 NA THR ASP TYR GLY"
"KPCI_HUMAN t_3ZH8C.pdb AGC Active 1 C58 2.74 -128.70 -178.23 -177.79 53.49 81.59 -179.39 -88.45 18.43 -56.56 -61.75 -13.27 999.00 NA THR ASP TYR GLY"
"KPCI_HUMAN t_5LI1A.pdb AGC Active 1 ANP 2.00 -129.24 177.01 -166.71 73.15 90.24 -172.82 -103.86 11.48 -51.80 -69.49 -18.95 999.00 NA THR ASP TYR GLY"
"KPCI_HUMAN t_5LI9A.pdb AGC Active 1 ACP 1.79 -139.21 172.38 -167.79 72.32 78.08 -158.26 -98.85 1.26 -55.98 -64.90 -22.82 999.00 NA THR ASP TYR GLY"
"KPCI_HUMAN t_5LIHA.pdb AGC Active 1 ADP 3.25 -129.54 178.70 -170.07 63.67 85.03 -175.09 -106.22 67.47 -39.65 -96.85 -30.08 999.00 NA THR ASP TYR GLY"
"KPCI_HUMAN t_5LIHB.pdb AGC Active 1 ADP 3.25 -129.12 178.43 -170.05 63.45 84.64 -175.16 -106.43 67.33 -39.34 -96.27 -29.70 999.00 NA THR ASP TYR GLY"
"KPCL_HUMAN t_3TXOA.pdb AGC Active 1 07U 2.05 -131.98 154.73 999.00 77.42 93.31 -166.64 -108.70 22.52 -54.45 -71.89 -20.94 999.00 Allowed ALA ASP PHE GLY"
"KPCT_HUMAN t_1XJDA.pdb AGC Active 1 STU 2.00 -132.68 162.84 999.00 69.26 95.17 -160.53 -109.82 21.11 -54.35 -64.82 -17.72 999.00 Allowed ALA ASP PHE GLY"
"KPCT_HUMAN t_2JEDA.pdb AGC Active 1 LG8 2.32 -113.41 165.45 999.00 67.51 92.51 -154.00 -102.80 25.09 -60.89 -77.82 -4.65 999.00 Allowed ALA ASP PHE GLY"
"KPCT_HUMAN t_2JEDB.pdb AGC Active 1 LG8 2.32 -116.88 164.60 999.00 69.70 89.72 -154.26 -101.77 24.59 -56.90 -65.52 -17.70 999.00 Allowed ALA ASP PHE GLY"
"KPCT_HUMAN t_4Q9ZA.pdb AGC Active 1 PZW 2.60 -129.64 170.19 999.00 59.83 78.07 -64.97 -94.43 11.42 -58.90 -65.61 -19.80 999.00 Allowed ALA ASP PHE GLY"
"KPCT_HUMAN t_4Q9ZB.pdb AGC Active 1 PZW 2.60 -122.44 171.23 999.00 60.69 80.07 -52.53 -96.96 17.42 -59.05 -66.20 -22.57 999.00 Allowed ALA ASP PHE GLY"
"KPCT_HUMAN t_4RA5A.pdb AGC Active 1 3L0 2.61 -130.78 165.45 999.00 60.39 80.62 -83.28 -96.26 13.82 -54.96 -65.05 -21.74 999.00 Allowed ALA ASP PHE GLY"
"KPCT_HUMAN t_4RA5B.pdb AGC Active 1 3L0 2.61 -124.56 172.12 999.00 61.74 74.38 -85.15 -91.64 16.00 -61.78 -61.32 -29.95 999.00 Allowed ALA ASP PHE GLY"
"KPCT_HUMAN t_5F9EA.pdb AGC Active 1 5VS 2.00 -124.46 161.06 999.00 72.19 90.67 -166.44 -101.48 15.61 -62.73 -63.75 -26.08 999.00 Allowed ALA ASP PHE GLY"
"KPCT_HUMAN t_5F9EB.pdb AGC Active 1 5VS 2.00 -118.41 165.24 999.00 62.58 88.94 -166.52 -98.54 15.44 -57.05 -59.35 -22.07 999.00 Allowed ALA ASP PHE GLY"
"KS6A1_HUMAN_1 t_2Z7QA.pdb AGC DFGup 3 ACP 2.00 -135.50 158.91 -173.38 63.16 60.22 -54.06 -125.38 -165.56 47.07 107.02 -8.16 999.00 Allowed THR ASP PHE GLY"
"KS6A1_HUMAN_1 t_2Z7RA.pdb AGC DFGup 3 STU 2.00 -135.20 169.75 -168.49 58.74 60.98 -151.35 -129.80 -169.31 56.29 123.60 -72.10 999.00 Favored THR ASP PHE GLY"
"KS6A1_HUMAN_1 t_2Z7SA.pdb AGC DFGup 3 P01 2.10 -132.65 170.38 178.88 54.19 50.67 -79.56 -114.90 -156.80 52.88 107.70 -49.27 999.00 Favored THR ASP PHE GLY"
"KS6A1_HUMAN_2 t_2WNTA.pdb AGC Active 1 Apo 2.40 -121.80 -11.42 -71.81 -135.68 111.98 175.62 -112.42 33.04 -74.33 -78.59 -9.72 999.00 Favored CYS ASP PHE GLY"
"KS6A1_HUMAN_2 t_2WNTB.pdb AGC Active 1 Apo 2.40 -122.59 -10.96 -70.13 -132.89 101.15 175.45 -101.06 29.73 -73.43 -77.87 -10.15 999.00 Favored CYS ASP PHE GLY"
"KS6A1_HUMAN_2 t_3RNYA.pdb AGC Active 1 Apo 2.70 -101.98 -18.79 -62.18 -123.21 126.93 176.46 -117.98 22.76 -72.36 -66.35 -24.26 999.00 Favored CYS ASP PHE GLY"
"KS6A1_HUMAN_2 t_3RNYB.pdb AGC Active 1 Apo 2.70 -101.12 -19.55 -62.34 -123.24 131.25 174.21 -115.75 14.72 -74.17 -51.65 -20.55 999.00 Favored CYS ASP PHE GLY"
"KS6A1_HUMAN_2 t_4NIFA.pdb AGC Active 1 Apo 2.15 -123.07 -176.31 -53.16 48.83 75.89 -160.25 -90.46 26.08 -74.37 -57.98 -21.96 999.00 Allowed CYS ASP PHE GLY"
"KS6A1_HUMAN_2 t_4NIFD.pdb AGC Active 1 Apo 2.15 -125.52 -177.68 -56.27 51.88 74.55 -158.77 -89.93 24.48 -75.12 -55.26 -23.47 999.00 Allowed CYS ASP PHE GLY"
"KS6A3_HUMAN_1 t_4NUSA.pdb AGC DFGout 6 2NK 2.39 -78.77 166.96 70.05 -80.70 -18.80 57.39 -46.38 -28.25 -66.96 -107.77 1.09 999.00 Favored THR ASP PHE GLY"
"KS6A3_HUMAN_1 t_4NW5A.pdb AGC Active 1 2NR 1.94 -125.02 -26.41 65.68 -111.79 108.76 -164.30 -107.64 13.76 -62.22 -56.95 -37.46 999.00 Favored THR ASP PHE GLY"
"KS6A3_HUMAN_1 t_4NW6A.pdb AGC Active 1 2NS 1.74 -124.61 -15.72 59.04 -125.39 119.69 -168.36 -114.94 13.35 -64.88 -57.20 -34.70 999.00 Favored THR ASP PHE GLY"
"KS6A3_HUMAN_1 t_5D9KA.pdb AGC DFGout 6 584 2.55 -70.89 175.12 64.57 -99.87 -5.61 63.81 -54.92 -40.86 -63.14 -90.54 7.62 999.00 Favored THR ASP PHE GLY"
"KS6A3_HUMAN_1 t_5D9KB.pdb AGC DFGout 6 584 2.55 -71.41 176.28 64.37 -100.09 -5.39 64.36 -52.15 -44.73 -68.97 -90.87 9.29 999.00 Favored THR ASP PHE GLY"
"KS6A3_HUMAN_1 t_5D9LA.pdb AGC DFGout 6 583 2.15 -75.23 167.70 65.38 -87.97 -6.68 57.84 -50.58 -47.94 -69.78 -91.59 11.07 999.00 Favored THR ASP PHE GLY"
"KS6A3_HUMAN_2 t_4D9TA.pdb AGC Active 1 0JG 2.40 -123.35 -26.47 -72.79 -117.77 107.61 166.28 -100.89 28.88 -70.22 -60.06 -20.69 999.00 Favored CYS ASP PHE GLY"
"KS6A3_HUMAN_2 t_4D9UA.pdb AGC Active 1 0JH 2.40 -122.70 -19.84 -73.92 -127.14 120.20 -175.94 -114.83 31.56 -71.99 -70.72 -13.62 999.00 Favored CYS ASP PHE GLY"
"KS6A3_HUMAN_2 t_4JG6A.pdb AGC Active 1 1LB 2.60 -133.62 169.30 -46.05 59.08 73.40 -164.24 -88.14 9.80 -73.94 -46.70 -31.01 999.00 Allowed CYS ASP PHE GLY"
"KS6A3_HUMAN_2 t_4JG7A.pdb AGC Active 1 1LC 3.00 -127.76 178.58 -45.87 48.18 83.86 -161.21 -95.42 34.85 -68.04 -61.14 -41.68 999.00 Outlier CYS ASP PHE GLY"
"KS6A3_HUMAN_2 t_4JG8A.pdb AGC Active 1 1LE 3.10 -128.99 -179.24 -45.01 48.20 84.47 -175.44 -98.47 34.18 -66.85 -68.75 -8.85 999.00 Outlier CYS ASP PHE GLY"
"KS6A5_HUMAN_1 t_1VZOA.pdb AGC DFGinter 5 Apo 1.8 -86.08 7.16 59.62 -135.82 179.44 -90.44 -156.19 30.86 46.84 100.81 7.87 999.00 Favored THR ASP PHE GLY"
"KS6A5_HUMAN_2 t_3KN5A.pdb AGC Active 1 ANP 2.40 -120.91 173.71 63.99 65.93 86.53 -169.08 -96.44 22.00 -72.37 -51.50 -39.94 999.00 Allowed ILE ASP PHE GLY"
"KS6A5_HUMAN_2 t_3KN5B.pdb AGC Active 1 ANP 2.40 -127.00 177.79 69.98 61.17 80.33 -160.56 -96.04 24.31 -72.94 -65.03 -20.73 999.00 Allowed ILE ASP PHE GLY"
"KS6A5_HUMAN_2 t_3KN6A.pdb AGC Active 1 Apo 2.00 -118.38 175.42 64.57 61.94 79.41 -163.40 -91.98 22.47 -72.93 -57.85 -30.07 999.00 Allowed ILE ASP PHE GLY"
"KS6A5_HUMAN_2 t_3KN6B.pdb AGC Active 1 Apo 2.00 -116.55 177.21 65.08 57.63 82.78 -161.36 -93.96 22.78 -73.97 -63.59 -27.88 999.00 Allowed ILE ASP PHE GLY"
"KS6B1_HUMAN t_3A60A.pdb AGC DFGin-inactive 2 STU 2.80 -106.88 -67.95 -37.63 -78.39 124.28 -167.53 -119.65 -133.13 -66.52 162.78 -54.09 999.00 Favored THR ASP PHE GLY"
"KS6B1_HUMAN t_3A60B.pdb NA NA 0 STU 2.80 -122.28 -155.72 59.13 -144.90 63.49 -87.82 -46.62 179.77 -128.21 -99.90 37.06 999.00 Allowed THR ASP PHE GLY"
"KS6B1_HUMAN t_3A61A.pdb AGC DFGin-inactive 2 STU 3.43 -134.06 -75.43 -58.73 -81.43 111.27 -174.81 -98.20 -179.96 -57.34 -119.84 999.00 999.00 Favored THR ASP PHE GLY"
"KS6B1_HUMAN t_3A62A.pdb AGC DFGin-inactive 2 STU 2.35 -137.83 -32.55 64.37 -98.97 101.69 -169.38 -111.01 24.20 -54.33 -75.96 -178.47 999.00 Favored THR ASP PHE GLY"
"KS6B1_HUMAN t_3WE4A.pdb AGC DFGin-inactive 2 5FI 2.00 -125.50 -18.74 52.19 -95.40 90.87 179.17 -122.57 0.99 -63.55 -120.67 -158.25 999.00 Favored THR ASP PHE GLY"
"KS6B1_HUMAN t_3WF5A.pdb AGC DFGin-inactive 2 FZ8 2.10 -129.78 -14.63 47.10 -92.31 84.53 -171.09 -117.09 2.84 -64.11 -92.77 -179.04 999.00 Favored THR ASP PHE GLY"
"KS6B1_HUMAN t_3WF6A.pdb AGC DFGin-inactive 2 FZ9 2.03 -133.25 -13.67 53.82 -102.67 94.38 -177.92 -125.01 0.93 -62.56 -85.40 -167.61 999.00 Favored THR ASP PHE GLY"
"KS6B1_HUMAN t_3WF7A.pdb AGC DFGin-inactive 2 FS9 1.85 -128.89 -10.23 46.61 -100.01 98.53 -173.04 -129.82 160.98 -61.36 73.52 -129.53 999.00 Favored THR ASP PHE GLY"
"KS6B1_HUMAN t_3WF8A.pdb AGC DFGin-inactive 2 F76 1.98 -129.90 -170.57 62.78 61.09 70.02 -172.48 -107.67 -0.54 -66.45 -118.52 -145.61 999.00 Allowed THR ASP PHE GLY"
"KS6B1_HUMAN t_3WF9A.pdb AGC DFGin-inactive 2 FS7 2.04 -128.89 -172.36 63.83 62.00 66.74 -165.75 -105.26 3.17 -59.80 -120.00 -148.86 999.00 Allowed THR ASP PHE GLY"
"KS6B1_HUMAN t_4L3JA.pdb AGC DFGin-inactive 2 5FI 2.10 -135.64 -1.10 38.77 -98.35 100.89 -146.90 -120.85 -4.31 -70.91 -115.55 -149.14 999.00 Favored THR ASP PHE GLY"
"KS6B1_HUMAN t_4L3LA.pdb AGC DFGin-inactive 2 5FI 2.10 -133.77 -15.35 53.80 -92.19 82.27 -177.87 -113.96 -4.44 -63.06 -107.98 -151.71 999.00 Favored THR ASP PHE GLY"
"KS6B1_HUMAN t_4L42A.pdb AGC DFGin-inactive 2 5FI 2.80 -94.22 -38.56 -114.60 -136.60 108.35 163.84 -136.38 3.86 -59.34 -99.16 -151.83 999.00 Favored THR ASP PHE GLY"
"KS6B1_HUMAN t_4L43A.pdb AGC DFGin-inactive 2 5FI 3.00 -152.16 178.74 176.04 68.20 63.88 -97.20 -95.21 1.24 -67.81 -112.47 -123.66 999.00 Allowed THR ASP PHE GLY"
"KS6B1_HUMAN t_4L44A.pdb AGC DFGin-inactive 2 5FI 2.90 -133.83 179.09 54.93 58.10 63.63 -99.43 -94.02 8.09 -59.79 -89.23 -144.18 999.00 Allowed THR ASP PHE GLY"
"KS6B1_HUMAN t_4L45A.pdb AGC DFGin-inactive 2 5FI 2.90 -119.30 -13.89 56.63 -120.03 100.82 -99.56 -106.51 0.71 -63.81 -106.86 -133.47 999.00 Favored THR ASP PHE GLY"
"KS6B1_HUMAN t_4L46A.pdb AGC DFGin-inactive 2 5FI 3.01 -128.60 -46.04 -107.04 -107.18 113.64 -75.75 -124.43 -8.52 -65.85 -97.38 -135.06 999.00 Favored THR ASP PHE GLY"
"KS6B1_HUMAN t_4RLOA.pdb AGC Active 1 3T3 2.53 -131.56 -63.39 -156.27 -88.21 143.03 -167.20 -127.44 172.76 -56.64 125.99 -46.29 999.00 Favored THR ASP PHE GLY"
"KS6B1_HUMAN t_4RLOB.pdb NA NA 0 STU 2.53 -86.72 160.35 58.85 -107.59 22.94 70.36 -156.62 162.76 69.35 159.54 162.04 999.00 Favored THR ASP PHE GLY"
"KS6B1_HUMAN t_4RLPA.pdb AGC DFGin-inactive 2 72B 2.79 -108.49 -71.10 -51.29 -84.84 124.39 -174.50 -121.68 51.95 -59.53 -105.18 -52.66 999.00 Favored THR ASP PHE GLY"
"KSR2_HUMAN t_2Y4IB.pdb TKL DFGup 3 ATP 3.46 -163.02 167.90 174.32 57.02 32.62 -59.98 -75.04 155.45 46.07 53.07 51.44 999.00 Favored THR ASP PHE GLY"
"KSR2_HUMAN t_5KKRB.pdb TKL DFGup 3 6U7 3.51 -128.87 179.91 -174.62 52.59 42.91 -153.83 -101.78 139.38 57.86 75.79 -29.95 999.00 Favored THR ASP PHE GLY"
"KSYK_HUMAN t_1XBAA.pdb TYR Active 1 Apo 2.00 -126.46 -176.53 -178.22 55.23 85.07 -164.85 -100.45 20.97 -70.75 -66.42 -29.64 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_1XBBA.pdb TYR Active 1 STI 1.57 -127.97 176.72 72.20 68.43 79.08 -155.37 -100.64 19.16 -69.41 -58.47 -28.28 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_1XBCA.pdb TYR Active 1 STU 2.00 -133.14 -171.26 -162.84 54.87 81.05 -160.55 -97.61 25.80 -72.31 -62.65 -30.79 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_3EMGA.pdb TYR Active 1 685 2.60 -130.99 -164.53 64.89 52.72 65.24 -70.35 -80.55 24.96 -60.34 -64.04 -22.74 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_3FQEA.pdb TYR Active 1 P5C 2.50 -134.08 -160.35 88.52 61.99 71.68 -63.40 -98.70 22.25 -70.36 -60.62 -25.49 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_3FQHA.pdb TYR Active 1 057 2.26 -136.21 -174.10 73.42 56.05 83.38 -160.21 -99.35 22.01 -70.46 -53.80 -32.58 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_3FQHB.pdb TYR Active 1 057 2.26 -135.56 -177.02 69.82 61.04 83.03 -156.28 -100.81 28.14 -70.00 -68.08 -27.21 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_3FQSA.pdb TYR Active 1 585 2.10 -130.07 -168.13 72.02 51.10 81.07 -158.74 -99.03 21.72 -72.01 -65.10 -25.58 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_3SRVA.pdb TYR Active 1 S19 1.95 -135.80 -174.11 -172.07 65.40 72.29 -60.94 -96.33 25.94 -63.77 -63.17 -26.67 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_3SRVB.pdb TYR Active 1 S19 1.95 -130.88 -172.01 -161.96 62.54 72.79 -58.85 -96.41 25.78 -66.25 -65.53 -26.26 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_3TUBA.pdb TYR DFGout 6 FPU 2.23 -126.03 171.17 66.64 -141.49 68.73 -177.09 -40.76 -49.19 -70.54 -92.64 19.77 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_3TUCA.pdb TYR DFGup 3 FPW 2.10 -114.31 165.27 69.48 53.61 40.86 -80.50 -73.07 146.25 90.45 -43.08 -55.01 999.00 Favored SER ASP PHE GLY"
"KSYK_HUMAN t_3VF8A.pdb TYR Active 1 0JE 2.08 -127.47 -170.57 -156.86 55.17 83.52 -168.32 -101.55 21.97 -71.01 -58.74 -35.77 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_3VF9A.pdb TYR Active 1 477 2.30 -128.10 -174.92 67.43 57.33 81.50 -165.67 -100.93 31.02 -68.41 -68.93 -37.63 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_4DFLA.pdb TYR Active 1 0K0 1.98 -118.03 -176.50 75.50 65.40 77.07 -153.10 -97.41 24.25 -69.74 -67.66 -27.81 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_4DFNA.pdb TYR Active 1 0K1 2.48 -130.11 -170.00 68.01 61.58 83.85 -161.50 -107.30 23.55 -65.40 -72.44 -22.41 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_4F4PA.pdb TYR Active 1 0SB 2.37 -123.91 -177.70 85.11 61.56 81.01 -138.29 -106.77 25.83 -66.78 -66.38 -31.76 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_4FL1A.pdb TYR Active 1 ANP 1.79 -122.63 -175.52 68.92 56.14 78.39 -163.57 -92.60 24.59 -72.94 -57.59 -38.39 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_4FL2A.pdb TYR DFGup 3 ANP 2.19 -115.25 163.42 66.96 55.50 31.27 -53.07 -66.70 128.22 35.57 65.67 13.58 999.00 Favored SER ASP PHE GLY"
"KSYK_HUMAN t_4FL3A.pdb TYR DFGup 3 ANP 1.90 -116.26 169.02 75.58 58.02 22.78 -63.53 -60.28 128.95 39.89 70.36 3.25 999.00 Favored SER ASP PHE GLY"
"KSYK_HUMAN t_4FYNA.pdb TYR Active 1 0VE 2.32 -125.02 -173.63 80.22 56.54 84.19 -167.42 -104.45 22.02 -64.18 -64.34 -16.63 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_4FYOA.pdb TYR Active 1 0VF 1.40 -132.65 -177.99 73.40 62.31 72.38 -71.03 -93.95 21.07 -70.62 -61.06 -25.58 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_4FZ6A.pdb TYR Active 1 0VG 1.85 -133.67 -169.72 64.87 58.51 78.14 -168.68 -100.44 26.82 -68.61 -64.07 -31.22 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_4FZ7A.pdb TYR Active 1 0VH 1.75 -130.23 -170.94 63.41 63.51 68.19 -62.56 -91.78 16.23 -70.22 -59.56 -24.99 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_4GFGA.pdb TYR Active 1 0XF 2.35 -133.43 -165.58 72.32 61.51 68.77 -67.09 -94.49 29.56 -69.20 -64.17 -30.03 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_4I0RA.pdb TYR Active 1 1B4 2.10 -120.72 -175.73 66.97 66.07 76.02 -167.63 -99.50 27.73 -66.49 -68.28 -27.84 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_4I0SA.pdb TYR Active 1 1B5 1.98 -129.31 -175.28 76.48 55.45 83.59 -155.13 -98.07 24.21 -70.45 -61.16 -27.29 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_4I0TA.pdb TYR Active 1 1B6 1.70 -133.29 -166.54 -160.17 54.19 83.03 -156.80 -99.14 23.70 -70.04 -54.74 -30.83 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_4PUZA.pdb TYR Active 1 CG9 2.08 -136.57 -176.88 70.39 64.03 77.00 -75.57 -97.70 30.01 -63.76 -65.07 -31.90 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_4PUZB.pdb TYR Active 1 CG9 2.08 -130.49 178.12 75.89 63.08 88.52 -78.68 -109.94 27.31 -61.65 -70.92 -20.81 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_4PV0A.pdb TYR Active 1 CG4 2.00 -130.20 -175.26 72.64 67.19 78.77 -165.19 -101.42 20.04 -69.30 -65.43 -27.35 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_4PX6A.pdb TYR Active 1 2X6 1.60 -133.59 -172.84 65.70 58.99 67.73 -65.91 -88.16 18.93 -72.88 -59.46 -27.38 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_4RSSA.pdb TYR Active 1 4MG 1.83 -125.48 178.88 76.23 70.66 70.70 -76.05 -93.10 15.54 -67.18 -58.15 -23.52 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_4RX7A.pdb TYR Active 1 3YV 1.80 -135.93 -162.05 -160.10 57.12 54.12 -57.62 -83.41 19.55 -69.61 -58.64 -26.39 999.00 Favored SER ASP PHE GLY"
"KSYK_HUMAN t_4RX8A.pdb TYR Active 1 3YX 1.59 -137.10 -158.33 64.99 55.58 75.60 -59.25 -100.60 22.48 -72.71 -63.46 -25.46 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_4RX9A.pdb TYR Active 1 3YT 1.75 -132.90 -177.56 -166.39 62.80 76.54 -58.51 -95.23 18.12 -71.07 -57.67 -29.79 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_4WNMA.pdb TYR Active 1 3RT 2.50 -122.67 177.89 78.32 75.24 74.19 -138.48 -103.69 21.50 -57.65 -56.82 -27.55 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_4XG2A.pdb TYR Active 1 Apo 2.21 -130.17 -179.01 74.61 62.62 77.65 -87.47 -96.13 15.71 -69.42 -62.14 -24.64 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_4XG3A.pdb TYR Active 1 X3G 2.30 -123.77 -176.77 68.06 60.27 75.05 -85.61 -93.31 14.95 -69.81 -52.39 -30.41 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_4XG3B.pdb TYR Active 1 X3G 2.30 -128.47 -176.18 70.56 59.83 77.94 -69.24 -95.45 17.96 -67.93 -55.87 -35.05 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_4XG4A.pdb TYR Active 1 X4G 2.30 -121.08 179.69 61.76 64.95 74.31 -73.87 -96.14 21.88 -66.95 -61.26 -26.23 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_4XG6A.pdb TYR Active 1 X6G 2.40 -118.59 -179.77 79.76 61.87 86.48 -80.89 -104.67 19.31 -62.45 -53.97 -29.55 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_4XG7A.pdb TYR Active 1 X7G 1.76 -121.72 -179.86 72.14 65.61 76.08 -76.23 -96.76 16.54 -66.92 -59.18 -26.50 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_4XG8A.pdb TYR Active 1 X8G 2.40 -120.10 -177.70 63.46 66.68 68.43 -72.22 -88.22 14.67 -64.12 -47.72 -34.85 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_4XG8C.pdb TYR Active 1 X8G 2.40 -112.93 -178.27 75.13 65.39 72.56 -71.30 -97.05 19.69 -66.67 -69.18 -21.23 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_4XG9A.pdb TYR Active 1 X9G 2.91 -123.40 -179.46 73.91 57.75 74.84 -72.05 -93.29 25.81 -58.96 -61.19 -36.76 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_4XG9B.pdb TYR Active 1 X9G 2.91 -128.70 -177.21 72.17 53.32 77.65 -65.96 -95.81 18.78 -62.27 -61.27 -26.97 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_4YJOA.pdb TYR Active 1 4DF 1.60 -136.58 178.54 73.60 59.60 80.74 -164.48 -95.20 22.69 -73.62 -55.94 -31.20 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_4YJPA.pdb TYR Active 1 4DL 1.83 -136.14 -172.89 69.19 58.51 69.50 -68.02 -93.91 23.37 -76.77 -63.03 -28.45 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_4YJQA.pdb TYR Active 1 4DK 1.34 -134.81 -177.18 72.05 61.30 79.20 -172.34 -100.05 24.96 -73.14 -63.45 -29.37 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_4YJRA.pdb TYR Active 1 4DJ 1.32 -132.73 -177.44 72.20 60.76 79.93 -171.16 -101.91 24.15 -73.97 -63.79 -27.15 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_4YJSA.pdb TYR Active 1 4DN 2.22 -130.56 -173.55 67.10 54.30 75.16 -75.33 -95.53 22.44 -72.13 -54.85 -38.21 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_4YJTA.pdb TYR Active 1 4DQ 1.52 -131.41 -174.52 70.57 58.98 74.01 -168.87 -96.84 25.96 -75.15 -63.20 -26.17 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_4YJUA.pdb TYR Active 1 4DO 1.67 -131.13 -166.76 66.32 55.37 68.78 -61.87 -94.00 20.14 -75.59 -57.59 -25.52 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_4YJVA.pdb TYR Active 1 4DT 1.65 -132.13 -177.62 69.92 58.91 78.21 -167.88 -97.17 24.59 -75.18 -61.16 -27.63 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_5C26A.pdb TYR Active 1 50H 1.95 -133.51 -175.01 70.52 59.85 80.76 -163.64 -95.20 23.42 -67.97 -57.34 -35.12 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_5C27A.pdb TYR Active 1 50J 2.15 -130.01 -175.63 70.80 60.42 84.22 -163.52 -100.62 25.87 -63.85 -67.67 -24.02 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_5CXHA.pdb TYR Active 1 55M 1.90 -133.45 -179.47 77.94 56.76 83.69 -156.21 -97.49 24.45 -67.25 -58.72 -36.46 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_5CXZA.pdb TYR Active 1 55U 1.70 -122.74 -171.87 66.36 60.82 74.48 -76.57 -94.02 15.57 -70.72 -56.96 -30.73 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_5CY3A.pdb TYR Active 1 55Y 1.76 -132.52 178.87 75.58 54.78 80.29 -152.50 -90.46 18.92 -69.93 -54.98 -39.21 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_5GHVA.pdb TYR Active 1 X5G 2.80 -121.36 177.90 68.19 62.24 88.63 -64.18 -109.72 41.49 -63.09 -77.60 -32.82 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_5GHVB.pdb TYR Active 1 X5G 2.80 -125.32 176.56 63.34 63.09 89.97 -63.83 -112.50 39.02 -63.93 -75.26 -45.80 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_5LMAA.pdb TYR Active 1 6ZG 1.43 -128.48 -174.51 68.83 63.52 65.54 -71.96 -91.18 18.09 -73.55 -62.63 -20.72 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_5LMBA.pdb TYR Active 1 6ZF 1.95 -131.04 -173.83 73.00 62.21 69.41 -68.46 -93.18 19.07 -69.94 -59.71 -28.52 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_5LMBB.pdb TYR Active 1 6ZF 1.95 -133.03 -174.66 69.37 62.95 72.21 -72.32 -97.04 21.40 -69.46 -62.50 -32.46 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_5T68A.pdb TYR Active 1 77V 2.93 -118.15 -175.01 78.62 54.97 90.26 -145.92 -105.15 32.00 -65.62 -80.98 -22.29 999.00 Outlier SER ASP PHE GLY"
"KSYK_HUMAN t_5T68B.pdb TYR Active 1 77V 2.93 -125.83 -173.16 63.43 53.62 72.33 -159.48 -90.41 31.35 -70.18 -69.63 -47.11 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_5TIUA.pdb TYR Active 1 7CU 1.49 -131.37 -173.29 59.72 61.96 73.64 -61.72 -95.91 19.81 -71.36 -61.21 -26.73 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_5TR6A.pdb TYR Active 1 7KG 1.93 -132.46 179.67 -172.41 59.87 74.11 -59.48 -95.87 22.50 -72.57 -67.42 -26.79 999.00 Allowed SER ASP PHE GLY"
"KSYK_HUMAN t_5TT7A.pdb TYR Active 1 7KF 1.77 -130.59 -177.31 -174.62 62.08 72.87 -62.50 -94.98 21.67 -70.04 -60.65 -26.92 999.00 Allowed SER ASP PHE GLY"
"LCK_HUMAN t_1QPCA.pdb TYR Active 1 ANP 1.60 -133.73 179.01 999.00 58.45 83.45 -167.06 -97.77 21.21 -64.78 -60.61 -36.02 999.00 Allowed ALA ASP PHE GLY"
"LCK_HUMAN t_1QPDA.pdb TYR Active 1 STU 2.00 -132.16 176.70 999.00 55.78 84.25 -166.34 -94.55 25.17 -62.22 -59.44 -39.94 999.00 Allowed ALA ASP PHE GLY"
"LCK_HUMAN t_1QPEA.pdb TYR Active 1 PP2 2.00 -142.97 -179.59 999.00 55.34 67.50 -93.53 -84.66 15.58 -62.34 -55.94 -34.40 999.00 Allowed ALA ASP PHE GLY"
"LCK_HUMAN t_1QPJA.pdb TYR Active 1 STU 2.20 -132.43 174.78 999.00 60.41 82.50 -159.17 -95.19 22.97 -60.30 -64.20 -26.92 999.00 Allowed ALA ASP PHE GLY"
"LCK_HUMAN t_2OF2A.pdb TYR Active 1 547 2.00 -130.96 179.57 999.00 52.62 99.32 -153.05 -112.16 23.28 -62.47 -56.01 -39.06 999.00 Outlier ALA ASP PHE GLY"
"LCK_HUMAN t_2OF4A.pdb TYR Active 1 979 2.70 -133.03 -179.00 999.00 53.94 89.15 -143.10 -103.28 22.83 -60.23 -57.75 -37.47 999.00 Outlier ALA ASP PHE GLY"
"LCK_HUMAN t_2OFUA.pdb TYR Active 1 1N9 2.00 -128.64 176.05 999.00 58.96 82.02 -164.64 -93.55 23.90 -58.50 -54.12 -42.17 999.00 Allowed ALA ASP PHE GLY"
"LCK_HUMAN t_2OFVA.pdb TYR DFGout 6 242 2.00 -150.80 177.86 999.00 -156.14 104.85 -175.97 -146.69 29.28 58.20 -70.73 -18.70 999.00 Favored ALA ASP PHE GLY"
"LCK_HUMAN t_2OFVB.pdb TYR DFGout 6 242 2.00 -147.07 -175.68 999.00 -160.37 105.87 179.48 -148.30 28.74 55.53 -69.36 -20.86 999.00 Allowed ALA ASP PHE GLY"
"LCK_HUMAN t_2OG8A.pdb TYR DFGout 6 1N8 2.30 -145.99 -178.53 999.00 -159.04 109.03 176.73 -91.64 -32.16 -46.17 123.25 172.46 999.00 Allowed ALA ASP PHE GLY"
"LCK_HUMAN t_2OG8B.pdb TYR DFGout 6 1N8 2.30 -151.31 173.30 999.00 -150.55 99.94 -177.29 -84.77 -22.71 -47.92 85.86 -73.77 999.00 Favored ALA ASP PHE GLY"
"LCK_HUMAN t_2PL0A.pdb TYR DFGout 6 STI 2.80 -123.84 162.35 999.00 -130.36 102.98 -178.48 -85.24 -1.42 -60.51 60.59 49.17 999.00 Favored ALA ASP PHE GLY"
"LCK_HUMAN t_2ZM1A.pdb TYR Active 1 KSF 2.10 -132.42 -160.40 999.00 31.16 87.94 -156.76 -99.23 22.12 -66.54 -69.53 -32.83 999.00 Outlier ALA ASP PHE GLY"
"LCK_HUMAN t_2ZM4A.pdb TYR Active 1 KSM 2.70 -125.56 175.79 999.00 59.92 100.91 -159.85 -115.94 31.49 -63.79 -61.96 -35.04 999.00 Outlier ALA ASP PHE GLY"
"LCK_HUMAN t_2ZYBA.pdb TYR Active 1 KSL 2.55 -123.31 -162.68 999.00 28.23 106.18 -167.04 -121.13 30.76 -59.50 -53.58 -45.20 999.00 Outlier ALA ASP PHE GLY"
"LCK_HUMAN t_3AC1A.pdb TYR Active 1 KZI 1.99 -131.43 -179.04 999.00 55.27 80.69 -163.75 -95.70 16.30 -64.84 -60.60 -33.32 999.00 Allowed ALA ASP PHE GLY"
"LCK_HUMAN t_3AC2A.pdb TYR Active 1 KSE 2.10 -135.88 168.59 999.00 64.21 84.05 -162.93 -100.33 19.65 -65.25 -57.52 -38.20 999.00 Allowed ALA ASP PHE GLY"
"LCK_HUMAN t_3AC3A.pdb TYR Active 1 KSH 2.55 -147.18 174.49 999.00 54.93 89.06 -168.26 -104.01 27.24 -57.52 -58.23 -33.69 999.00 Outlier ALA ASP PHE GLY"
"LCK_HUMAN t_3AC4A.pdb TYR Active 1 KZL 2.70 -134.03 169.20 999.00 63.34 83.39 -160.53 -101.45 27.51 -60.61 -61.04 -40.35 999.00 Allowed ALA ASP PHE GLY"
"LCK_HUMAN t_3AC5A.pdb TYR Active 1 KZM 2.50 -139.86 -178.57 999.00 59.74 72.55 -107.48 -92.85 17.45 -51.07 -47.69 -35.66 999.00 Allowed ALA ASP PHE GLY"
"LCK_HUMAN t_3AC8A.pdb TYR Active 1 KSK 2.30 -149.33 -179.38 999.00 58.90 72.00 -90.74 -93.01 13.91 -64.01 -55.95 -30.78 999.00 Allowed ALA ASP PHE GLY"
"LCK_HUMAN t_3ACJA.pdb TYR Active 1 KSS 2.20 -135.97 -178.37 999.00 54.57 81.99 -163.40 -96.03 16.90 -63.98 -59.02 -33.75 999.00 Allowed ALA ASP PHE GLY"
"LCK_HUMAN t_3ACKA.pdb TYR Active 1 KSR 2.60 -138.88 177.38 999.00 61.20 86.11 -93.65 -103.67 22.70 -60.10 -53.79 -45.16 999.00 Allowed ALA ASP PHE GLY"
"LCK_HUMAN t_3AD4A.pdb TYR Active 1 KBM 2.20 -138.52 178.45 999.00 55.92 86.09 -166.56 -102.74 22.47 -65.89 -58.98 -39.59 999.00 Allowed ALA ASP PHE GLY"
"LCK_HUMAN t_3AD5A.pdb TYR Active 1 5PB 2.00 -133.29 179.44 999.00 56.64 87.43 -166.50 -103.19 22.60 -65.27 -60.25 -39.85 999.00 Allowed ALA ASP PHE GLY"
"LCK_HUMAN t_3AD6A.pdb TYR Active 1 KSC 2.15 -137.27 174.93 999.00 63.14 87.01 -172.32 -102.48 22.79 -66.48 -62.15 -35.94 999.00 Allowed ALA ASP PHE GLY"
"LCK_HUMAN t_3B2WA.pdb TYR DFGin-inactive 2 9NH 2.30 -130.30 174.33 999.00 30.21 87.75 -57.80 -64.23 150.62 -77.42 -81.49 131.13 999.00 Outlier ALA ASP PHE GLY"
"LCK_HUMAN t_3BYMA.pdb TYR Active 1 AM0 2.00 -129.73 -173.77 999.00 43.94 88.25 -163.64 -99.66 20.32 -63.21 -52.98 -42.32 999.00 Outlier ALA ASP PHE GLY"
"LCK_HUMAN t_3BYOA.pdb TYR Active 1 AM9 2.00 -136.91 176.30 999.00 55.14 85.03 -161.50 -99.80 29.56 -57.03 -59.76 -37.97 999.00 Allowed ALA ASP PHE GLY"
"LCK_HUMAN t_3BYSA.pdb TYR DFGout 6 AM5 2.20 -142.64 -177.34 999.00 -158.61 106.94 178.57 -89.70 9.62 -49.04 52.09 70.14 999.00 Allowed ALA ASP PHE GLY"
"LCK_HUMAN t_3BYUA.pdb TYR DFGout 6 AM6 2.30 -142.61 -178.41 999.00 -160.82 101.51 -174.80 -80.81 5.49 -51.93 47.75 62.39 999.00 Allowed ALA ASP PHE GLY"
"LCK_HUMAN t_3KMMA.pdb TYR Active 1 LHL 2.80 -127.62 -179.99 999.00 60.85 89.79 -154.09 -112.63 27.13 -60.12 -61.80 -31.36 999.00 Allowed ALA ASP PHE GLY"
"LCK_HUMAN t_3KXZA.pdb TYR Active 1 925 2.37 -141.78 -179.25 999.00 62.40 72.39 -153.29 -97.39 29.20 -47.92 -58.65 -39.84 999.00 Allowed ALA ASP PHE GLY"
"LCK_HUMAN t_3LCKA.pdb TYR Active 1 Apo 1.70 -138.45 177.98 999.00 54.27 81.22 -164.35 -94.98 22.57 -60.28 -60.05 -34.54 999.00 Allowed ALA ASP PHE GLY"
"LCK_HUMAN t_3MPMA.pdb TYR DFGup 3 5LK 1.95 -117.53 162.15 999.00 59.01 39.25 -64.86 -86.66 152.81 45.47 74.24 9.24 999.00 Favored ALA ASP PHE GLY"
"LCK_HUMAN t_4C3FA.pdb TYR DFGup 3 7KW 1.72 -108.48 162.62 999.00 60.20 42.83 -65.33 -97.41 146.42 48.07 82.76 5.75 999.00 Favored ALA ASP PHE GLY"
"LIMK1_HUMAN t_3S95A.pdb TKL Active 1 STU 1.65 -132.10 176.03 999.00 61.95 79.26 -151.39 -96.74 17.57 -60.61 -67.18 -24.60 999.00 Allowed ALA ASP PHE GLY"
"LIMK1_HUMAN t_3S95B.pdb TKL Active 1 STU 1.65 -137.14 172.15 999.00 66.08 80.33 -157.09 -97.81 13.39 -57.61 -61.67 -26.71 999.00 Allowed ALA ASP PHE GLY"
"LIMK1_HUMAN t_5HVJA.pdb TKL Active 1 ANP 2.20 -132.78 -177.36 999.00 60.42 87.12 -163.77 -109.11 23.76 -51.32 -66.80 -25.97 999.00 Allowed ALA ASP PHE GLY"
"LIMK1_HUMAN t_5HVJB.pdb TKL Active 1 Apo 2.20 -141.62 -173.95 999.00 58.18 85.13 -85.60 -109.93 21.75 -52.86 -69.70 -19.16 999.00 Allowed ALA ASP PHE GLY"
"LIMK1_HUMAN t_5HVKA.pdb TKL Active 1 ANP 3.50 -145.49 176.80 999.00 65.09 82.48 -174.21 -109.22 24.72 -55.38 -71.82 -22.71 999.00 Allowed ALA ASP PHE GLY"
"LIMK1_HUMAN t_5HVKC.pdb TKL Active 1 ANP 3.50 -149.70 172.69 999.00 -101.89 169.39 56.51 -110.17 23.25 -53.65 -73.94 -25.14 999.00 Favored ALA ASP PHE GLY"
"LIMK1_HUMAN t_5L6WL.pdb TKL Active 1 AGS 2.53 -131.70 -166.54 999.00 46.73 81.92 -52.58 -92.77 15.66 -55.74 -42.71 -49.81 999.00 Outlier ALA ASP PHE GLY"
"LIMK2_HUMAN t_4TPTA.pdb TKL DFGout 6 35H 2.60 -114.55 179.85 999.00 -146.05 83.04 175.54 -70.79 -31.52 -69.92 -82.42 -2.78 999.00 Allowed ALA ASP PHE GLY"
"LIMK2_HUMAN t_4TPTB.pdb TKL DFGout 6 35H 2.60 -130.72 -177.01 999.00 -149.62 73.75 -177.38 -61.91 -29.70 -71.46 -95.71 7.22 999.00 Allowed ALA ASP PHE GLY"
"LYN_HUMAN t_3A4OX.pdb TYR Active 1 STU 3.00 -103.69 -177.97 999.00 54.14 148.85 174.25 -166.58 42.86 -83.15 -75.66 -40.91 999.00 Outlier ALA ASP PHE GLY"
"M3K12_HUMAN t_5CENA.pdb STE DFGin-inactive 2 Apo 1.70 -139.25 -167.00 -167.28 41.87 62.27 -73.16 -59.38 141.00 -70.11 -88.47 171.84 999.00 Allowed SER ASP PHE GLY"
"M3K12_HUMAN t_5CEOA.pdb STE DFGup 3 50D 2.28 -126.26 175.79 75.66 67.13 25.35 -102.33 -93.93 136.41 52.62 91.47 999.00 999.00 Favored SER ASP PHE GLY"
"M3K12_HUMAN t_5CEPA.pdb STE DFGup 3 50E 1.99 -133.93 176.34 74.51 61.46 47.99 -159.66 -122.23 164.21 62.69 70.42 999.00 999.00 Favored SER ASP PHE GLY"
"M3K12_HUMAN t_5CEQA.pdb STE DFGup 3 50F 1.91 -139.36 175.20 70.84 65.26 33.42 -158.15 -103.15 163.55 57.07 71.88 999.00 999.00 Favored SER ASP PHE GLY"
"M3K14_HUMAN t_4DN5A.pdb STE Active 1 AGS 2.50 -131.61 179.39 82.26 60.88 82.48 -173.67 -103.28 32.08 -53.67 -67.11 -18.80 999.00 Allowed CYS ASP PHE GLY"
"M3K14_HUMAN t_4DN5B.pdb STE Active 1 AGS 2.50 -145.71 -179.58 80.76 62.29 78.54 -171.56 -101.17 33.39 -57.20 -68.84 -20.53 999.00 Allowed CYS ASP PHE GLY"
"M3K14_HUMAN t_4G3DA.pdb STE Active 1 Apo 2.90 -151.07 -166.15 74.40 43.19 85.98 -166.61 -99.65 24.02 -58.33 -59.69 -25.30 999.00 Outlier CYS ASP PHE GLY"
"M3K14_HUMAN t_4G3DB.pdb STE Active 1 Apo 2.90 -145.13 -173.08 64.75 59.56 87.76 -167.78 -105.24 27.98 -64.23 -59.79 -35.39 999.00 Allowed CYS ASP PHE GLY"
"M3K14_HUMAN t_4G3DD.pdb STE Active 1 Apo 2.90 -139.99 -172.27 69.00 56.55 77.25 -165.09 -95.88 22.55 -62.07 -51.66 -29.60 999.00 Allowed CYS ASP PHE GLY"
"M3K14_HUMAN t_4G3DE.pdb STE Active 1 Apo 2.90 -137.46 -171.59 73.08 53.72 79.70 -160.77 -98.53 16.39 -64.06 -51.24 -29.35 999.00 Allowed CYS ASP PHE GLY"
"M3K14_HUMAN t_4IDTA.pdb STE Active 1 T28 2.40 -117.13 -43.28 76.15 -121.44 109.43 -173.48 -99.78 25.57 -69.58 -61.37 -16.44 999.00 Favored CYS ASP PHE GLY"
"M3K14_HUMAN t_4IDTB.pdb STE Active 1 T28 2.40 -130.31 -176.62 73.96 40.65 101.90 -163.72 -102.87 26.69 -75.47 -60.54 -17.29 999.00 Outlier CYS ASP PHE GLY"
"M3K14_HUMAN t_4IDVA.pdb STE Active 1 13V 2.90 -129.24 -176.41 63.86 63.45 58.16 -144.90 -81.23 17.99 -53.47 -59.25 -22.89 999.00 Allowed CYS ASP PHE GLY"
"M3K14_HUMAN t_4IDVB.pdb STE Active 1 13V 2.90 -149.71 -174.93 62.48 52.73 65.65 -156.45 -88.43 31.06 -55.01 -68.49 -23.24 999.00 Allowed CYS ASP PHE GLY"
"M3K14_HUMAN t_4IDVC.pdb STE Active 1 13V 2.90 -145.00 -173.66 73.57 43.00 81.66 -153.63 -93.71 20.69 -57.42 -64.60 -22.70 999.00 Outlier CYS ASP PHE GLY"
"M3K14_HUMAN t_4IDVD.pdb STE Active 1 13V 2.90 -141.29 -170.30 77.44 49.10 75.94 -151.01 -93.98 28.91 -58.52 -74.59 -18.37 999.00 Allowed CYS ASP PHE GLY"
"M3K5_HUMAN t_2CLQA.pdb STE DFGinter 5 STU 2.3 -91.43 129.79 -173.57 -141.50 7.58 76.20 -79.74 110.14 -133.11 134.93 -46.11 999.00 Allowed SER ASP PHE GLY"
"M3K5_HUMAN t_2CLQB.pdb STE DFGinter 5 STU 2.3 -97.51 126.70 178.87 -140.68 10.19 80.99 -79.57 109.56 -144.99 130.70 -46.44 999.00 Favored SER ASP PHE GLY"
"M3K5_HUMAN t_3VW6A.pdb STE Active 1 IM6 2.40 -134.44 159.83 -169.71 63.58 96.19 -163.83 -106.07 19.18 -60.21 -65.70 -26.73 999.00 Outlier SER ASP PHE GLY"
"M3K5_HUMAN t_3VW6B.pdb STE Active 1 IM6 2.40 -134.27 172.21 74.97 68.66 93.13 -160.61 -105.26 21.46 -63.33 -65.51 -28.46 999.00 Allowed SER ASP PHE GLY"
"M3K5_HUMAN t_4BF2A.pdb STE Active 1 STU 2.11 -114.32 -178.78 166.22 51.39 86.70 -161.47 -90.52 15.86 -65.31 -75.80 -2.21 999.00 Outlier SER ASP PHE GLY"
"M3K5_HUMAN t_4BF2B.pdb STE Active 1 STU 2.11 -128.56 -177.61 178.15 56.00 77.79 -146.30 -86.85 11.43 -67.64 -68.96 -19.51 999.00 Allowed SER ASP PHE GLY"
"M3K5_HUMAN t_4BHNA.pdb STE Active 1 BH9 2.30 -116.17 170.72 59.58 61.93 107.60 -143.00 -114.13 14.42 -65.20 -70.57 -20.86 999.00 Outlier SER ASP PHE GLY"
"M3K5_HUMAN t_4BHNB.pdb STE Active 1 BH9 2.30 -127.03 175.01 70.37 58.47 91.31 -152.13 -97.78 21.63 -58.81 -63.01 -40.43 999.00 Outlier SER ASP PHE GLY"
"M3K5_HUMAN t_4BIBA.pdb STE Active 1 IEO 2.43 -102.04 171.70 179.37 56.68 96.48 -57.89 -108.13 9.36 -54.57 -96.99 34.52 999.00 Outlier SER ASP PHE GLY"
"M3K5_HUMAN t_4BIBB.pdb STE Active 1 IEO 2.43 -122.91 179.28 62.87 61.63 85.04 -67.29 -100.40 15.33 -59.58 -75.40 -20.20 999.00 Allowed SER ASP PHE GLY"
"M3K5_HUMAN t_4BICA.pdb STE Active 1 IE4 2.62 -101.35 -174.96 61.91 48.41 111.05 -147.18 -118.19 17.11 -69.36 -72.31 -34.20 999.00 Outlier SER ASP PHE GLY"
"M3K5_HUMAN t_4BICB.pdb STE Active 1 Apo 2.62 -103.86 -176.18 70.10 54.26 109.04 -128.63 -118.86 13.28 -65.21 -68.93 -30.45 999.00 Outlier SER ASP PHE GLY"
"M3K5_HUMAN t_4BIDA.pdb STE Active 1 IE8 2.80 -102.58 -169.52 62.18 32.61 94.62 -151.61 -110.24 27.34 -71.77 -82.80 -25.68 999.00 Outlier SER ASP PHE GLY"
"M3K5_HUMAN t_4BIDB.pdb STE Active 1 IE8 2.80 -128.86 -175.33 60.79 60.15 79.33 -123.25 -98.82 16.42 -74.45 -71.64 -26.76 999.00 Allowed SER ASP PHE GLY"
"M3K5_HUMAN t_4BIEA.pdb STE Active 1 IE6 2.36 -106.96 -175.44 60.67 45.84 99.41 -143.35 -108.72 17.69 -58.65 -72.67 -39.67 999.00 Outlier SER ASP PHE GLY"
"M3K5_HUMAN t_4BIEB.pdb STE Active 1 IE6 2.36 -114.50 179.39 61.83 47.97 98.76 -143.63 -110.32 26.80 -56.48 -71.09 -34.19 999.00 Outlier SER ASP PHE GLY"
"M3K5_HUMAN t_5V19A.pdb STE Active 1 8V4 3.10 -132.61 160.57 -156.80 69.03 95.51 -158.84 -107.11 23.79 -57.47 -68.71 -20.94 999.00 Allowed SER ASP PHE GLY"
"M3K5_HUMAN t_5V19B.pdb STE Active 1 8V4 3.10 -112.05 157.81 151.53 57.50 105.02 -165.70 -111.03 30.04 -54.95 -71.74 -31.00 999.00 Outlier SER ASP PHE GLY"
"M3K5_HUMAN t_5V24A.pdb STE Active 1 8V7 2.50 -138.80 167.32 81.22 63.09 92.89 -158.28 -98.55 22.12 -58.79 -63.39 -34.77 999.00 Allowed SER ASP PHE GLY"
"M3K5_HUMAN t_5V24B.pdb STE Active 1 8V7 2.50 -131.95 172.61 81.86 55.98 93.05 -162.61 -102.81 24.67 -61.87 -61.85 -39.92 999.00 Outlier SER ASP PHE GLY"
"M3K7_HUMAN t_2EVAA.pdb STE DFGin-inactive 2 ADN 2.00 -146.33 -178.07 71.23 42.00 74.19 -63.76 -66.21 143.24 -56.57 -61.76 -26.80 999.00 Allowed CYS ASP PHE GLY"
"M3K7_HUMAN t_2YIYA.pdb STE DFGout 6 YIY 2.49 -124.11 -179.83 -63.45 -152.49 109.46 -163.87 -94.81 3.63 -62.49 70.84 999.00 999.00 Favored CYS ASP PHE GLY"
"M3K7_HUMAN t_4GS6A.pdb STE DFGin-inactive 2 1FM 2.20 -129.71 -179.54 71.18 41.42 77.11 -117.01 -68.79 133.52 -47.36 -63.42 999.00 999.00 Allowed CYS ASP PHE GLY"
"M3K7_HUMAN t_4L3PA.pdb STE DFGin-inactive 2 1UH 2.68 -148.00 172.22 62.53 65.41 87.54 -164.42 -93.39 -139.80 -41.70 69.31 999.00 999.00 Allowed CYS ASP PHE GLY"
"M3K7_HUMAN t_4L52A.pdb STE DFGup 3 1UL 2.54 -150.38 176.07 63.07 65.85 31.46 -159.73 -100.52 174.99 51.72 64.65 33.28 999.00 Favored CYS ASP PHE GLY"
"M3K7_HUMAN t_4L53A.pdb STE DFGup 3 1UO 2.55 -140.65 179.42 65.75 58.18 36.95 -159.92 -99.37 153.23 57.91 106.13 -69.48 999.00 Favored CYS ASP PHE GLY"
"M3K7_HUMAN t_4O91A.pdb STE DFGout 6 NG2 2.39 -145.81 -177.33 66.22 -149.93 109.80 -179.35 -88.08 -8.46 -56.50 60.29 999.00 999.00 Favored CYS ASP PHE GLY"
"M3K7_HUMAN t_5E7RA.pdb STE DFGout 6 5KW 2.11 -124.10 149.24 -168.27 -152.92 133.72 -174.30 -124.37 -9.84 -66.29 -63.63 999.00 999.00 Favored CYS ASP PHE GLY"
"M3K7_HUMAN t_5GJDA.pdb STE DFGout 6 6V3 2.79 -145.04 -172.07 78.88 -151.92 104.66 -168.13 -67.84 -21.92 -73.88 86.21 157.57 999.00 Favored CYS ASP PHE GLY"
"M3K7_HUMAN t_5GJFA.pdb STE DFGout 6 6V4 2.89 -134.05 -170.45 79.49 -157.11 87.46 -174.53 -73.06 -37.24 -173.18 68.22 76.93 999.00 Allowed CYS ASP PHE GLY"
"M3K7_HUMAN t_5JGAA.pdb STE Active 1 6KC 2.00 -138.32 -175.07 75.01 61.15 69.08 -90.83 -94.08 15.05 -80.78 -67.09 -16.82 999.00 Allowed CYS ASP PHE GLY"
"M3K7_HUMAN t_5JGBA.pdb STE DFGin-inactive 2 6JV 2.80 -145.04 -173.62 69.19 52.03 67.64 -87.47 -65.12 125.49 -67.89 -71.65 -10.72 999.00 Allowed CYS ASP PHE GLY"
"M3K7_HUMAN t_5JGDA.pdb STE Active 1 6KD 3.10 -124.56 -170.67 64.91 57.84 67.89 -73.14 -90.97 19.47 -82.68 -60.56 -14.25 999.00 Allowed CYS ASP PHE GLY"
"M3K8_HUMAN t_4Y83A.pdb STE Active 1 49B 2.89 -124.56 171.98 -63.60 65.17 92.71 173.29 -106.99 18.81 -63.41 -55.27 -38.67 999.00 Allowed VAL ASP PHE GLY"
"M3K8_HUMAN t_4Y83B.pdb STE Active 1 49B 2.89 -124.81 178.38 -69.47 58.08 91.10 176.92 -107.12 19.84 -64.13 -54.56 -39.25 999.00 Outlier VAL ASP PHE GLY"
"M3K8_HUMAN t_4Y83C.pdb STE Active 1 49B 2.89 -110.07 168.68 999.00 58.93 91.35 999.00 -105.81 14.12 -66.78 -55.13 -37.00 999.00 Outlier VAL ASP PHE GLY"
"M3K8_HUMAN t_4Y85A.pdb STE Active 1 499 2.33 -125.86 169.58 -61.27 64.81 98.75 -149.51 -111.79 16.66 -63.93 -61.46 -26.61 999.00 Outlier VAL ASP PHE GLY"
"M3K8_HUMAN t_4Y85B.pdb STE Active 1 499 2.33 -125.68 169.75 -60.14 64.01 98.83 -151.08 -111.44 16.46 -64.01 -60.33 -27.46 999.00 Outlier VAL ASP PHE GLY"
"M3K8_HUMAN t_4Y85C.pdb STE Active 1 499 2.33 -126.24 169.24 -59.55 64.19 99.79 -149.55 -112.85 16.66 -63.56 -60.44 -27.93 999.00 Outlier VAL ASP PHE GLY"
"M3K8_HUMAN t_5IU2A.pdb STE Active 1 6DA 2.70 -119.40 179.87 -57.40 58.84 91.75 -154.17 -107.91 18.69 -73.72 -63.73 -34.51 999.00 Outlier VAL ASP PHE GLY"
"M3K8_HUMAN t_5IU2B.pdb STE Active 1 6DA 2.70 -119.25 -179.93 -57.18 58.49 91.74 -153.86 -107.73 18.43 -73.76 -62.96 -35.41 999.00 Outlier VAL ASP PHE GLY"
"M3K9_HUMAN t_3DTCA.pdb STE DFGup 3 VIN 2.60 -138.85 -179.43 7.81 54.60 25.58 -161.56 -77.27 153.48 35.72 -76.96 139.78 999.00 Favored THR ASP PHE GLY"
"M3K9_HUMAN t_4UY9A.pdb STE DFGup 3 Apo 2.81 -129.00 -179.39 49.57 57.28 49.26 -92.97 -123.00 149.64 52.82 -98.75 139.36 999.00 Favored THR ASP PHE GLY"
"M3K9_HUMAN t_4UY9B.pdb STE DFGup 3 Apo 2.81 -130.03 -179.73 50.33 55.72 44.35 -92.13 -113.59 132.48 54.17 -90.07 138.48 999.00 Favored THR ASP PHE GLY"
"M3KL4_HUMAN t_4UYAA.pdb STE DFGup 3 AGS 2.80 -133.24 174.99 76.82 55.83 68.25 -172.31 -140.94 164.55 55.90 72.50 999.00 999.00 Allowed THR ASP PHE GLY"
"M4K3_HUMAN t_5J5TA.pdb STE Active 1 6G2 2.85 -133.74 -174.95 999.00 58.65 76.08 -134.79 -85.06 24.09 -77.51 -72.44 -40.90 999.00 Allowed ALA ASP PHE GLY"
"M4K4_HUMAN t_4OBOA.pdb STE DFGup 3 2QV 2.10 -140.75 160.23 125.81 72.61 57.25 -158.84 -126.56 139.45 80.20 -105.22 999.00 999.00 Allowed VAL ASP PHE GLY"
"M4K4_HUMAN t_4OBOB.pdb STE DFGout 6 Apo 2.10 -63.07 130.02 165.78 -138.08 97.98 -178.55 -103.48 31.93 -76.45 99.60 56.83 999.00 Favored VAL ASP PHE GLY"
"M4K4_HUMAN t_4OBPA.pdb STE Active 1 2QU 2.27 -128.99 169.46 -63.27 73.61 97.95 -153.90 -102.17 12.88 -74.29 -56.71 -42.38 999.00 Allowed VAL ASP PHE GLY"
"M4K4_HUMAN t_4OBPB.pdb STE DFGout 6 Apo 2.27 -62.75 128.64 165.83 -142.33 99.68 -175.96 -104.49 30.47 -74.75 95.11 56.71 999.00 Favored VAL ASP PHE GLY"
"M4K4_HUMAN t_4OBQA.pdb STE DFGup 3 2QT 2.19 -135.07 157.46 117.86 64.10 69.08 -169.06 -116.54 151.77 64.00 149.42 -65.55 999.00 Allowed VAL ASP PHE GLY"
"M4K4_HUMAN t_4OBQB.pdb STE DFGout 6 Apo 2.19 -65.51 130.16 168.47 -138.33 99.24 -173.52 -108.32 38.89 -80.43 89.60 54.09 999.00 Favored VAL ASP PHE GLY"
"M4K4_HUMAN t_4RVTA.pdb STE DFGup 3 3XM 2.40 -120.31 165.43 -61.85 61.47 67.48 -169.43 -121.07 175.59 60.61 148.11 137.07 999.00 Allowed VAL ASP PHE GLY"
"M4K4_HUMAN t_4RVTB.pdb STE DFGout 6 Apo 2.40 -62.73 125.26 177.11 -136.33 95.29 -176.60 -98.12 34.77 -72.31 97.48 47.01 999.00 Favored VAL ASP PHE GLY"
"M4K4_HUMAN t_4U3YA.pdb STE DFGinter 5 Apo 1.45 -88.95 126.21 177.64 79.25 151.15 -155.85 -137.55 35.85 48.88 105.70 -5.07 999.00 Allowed VAL ASP PHE GLY"
"M4K4_HUMAN t_4U3YB.pdb STE DFGout 6 Apo 1.45 -66.78 136.65 167.30 -142.96 93.73 -174.39 -97.22 33.22 -73.23 94.17 55.98 999.00 Favored VAL ASP PHE GLY"
"M4K4_HUMAN t_4U3ZA.pdb STE DFGinter 5 Apo 2.09 -90.29 128.60 178.38 75.49 163.31 -153.14 -152.00 31.12 43.17 119.12 -6.73 999.00 Allowed VAL ASP PHE GLY"
"M4K4_HUMAN t_4U3ZB.pdb STE DFGout 6 Apo 2.09 -61.68 132.97 169.40 -142.19 95.95 -168.74 -99.92 27.85 -75.59 76.78 -87.39 999.00 Favored VAL ASP PHE GLY"
"M4K4_HUMAN t_4U40A.pdb STE DFGup 3 ANP 2.30 -136.81 156.79 76.72 66.66 45.02 -70.33 -75.83 145.71 56.06 -61.07 117.34 999.00 Favored VAL ASP PHE GLY"
"M4K4_HUMAN t_4U40B.pdb STE DFGout 6 Apo 2.30 -58.38 130.04 178.08 -140.01 88.10 -172.57 -92.88 32.63 -76.25 100.75 53.04 999.00 Favored VAL ASP PHE GLY"
"M4K4_HUMAN t_4U41A.pdb STE DFGup 3 3C8 2.20 -138.61 161.83 -59.67 78.20 25.32 -144.95 -79.79 151.07 70.08 45.14 999.00 999.00 Allowed VAL ASP PHE GLY"
"M4K4_HUMAN t_4U41B.pdb STE DFGout 6 Apo 2.20 -62.83 130.41 174.71 -138.14 96.29 -172.16 -100.87 38.97 -65.06 95.25 62.10 999.00 Favored VAL ASP PHE GLY"
"M4K4_HUMAN t_4U42A.pdb STE DFGup 3 3C8 2.50 -125.88 165.64 -60.92 67.48 28.45 -146.24 -78.88 157.53 78.70 61.11 999.00 999.00 Favored VAL ASP PHE GLY"
"M4K4_HUMAN t_4U42B.pdb NA NA 0 3C8 2.50 -137.73 160.10 -64.93 71.56 38.31 -153.61 -85.59 128.17 56.26 25.58 81.76 999.00 Allowed VAL ASP PHE GLY"
"M4K4_HUMAN t_4U43A.pdb STE DFGup 3 3D8 2.18 -128.01 167.60 -61.70 53.50 51.22 -145.17 -89.85 159.39 63.11 62.66 20.89 999.00 Favored VAL ASP PHE GLY"
"M4K4_HUMAN t_4U43B.pdb STE DFGout 6 Apo 2.18 -57.89 125.99 173.41 -134.37 92.47 -171.82 -104.96 41.70 -78.49 90.49 59.71 999.00 Favored VAL ASP PHE GLY"
"M4K4_HUMAN t_4U44A.pdb STE Active 1 3D9 2.43 -125.41 167.75 -57.10 79.56 93.07 -147.07 -95.25 22.52 -68.79 -55.74 -54.20 999.00 Allowed VAL ASP PHE GLY"
"M4K4_HUMAN t_4U44B.pdb STE DFGout 6 Apo 2.43 -66.20 124.43 170.85 -129.83 104.41 -168.50 -108.13 36.60 -74.22 95.98 52.13 999.00 Favored VAL ASP PHE GLY"
"M4K4_HUMAN t_4U45A.pdb STE Active 1 3DC 2.58 -127.44 173.31 -62.24 65.42 104.19 -149.49 -102.34 17.87 -72.15 -63.73 -25.03 999.00 Outlier VAL ASP PHE GLY"
"M4K4_HUMAN t_4U45B.pdb STE DFGout 6 Apo 2.58 -61.13 130.93 172.10 -144.18 101.41 -178.76 -110.73 46.07 -73.52 82.10 51.39 999.00 Favored VAL ASP PHE GLY"
"M4K4_HUMAN t_4ZK5A.pdb STE Active 1 4P4 2.89 -133.99 163.84 103.11 75.07 112.74 -164.35 -118.23 20.22 -74.46 -65.42 -27.31 999.00 Allowed VAL ASP PHE GLY"
"M4K4_HUMAN t_4ZK5B.pdb STE DFGout 6 Apo 2.89 -63.17 129.26 159.37 -143.19 101.69 -178.80 -113.20 44.03 -66.20 81.02 58.34 999.00 Favored VAL ASP PHE GLY"
"M4K4_HUMAN t_4ZP5A.pdb STE DFGup 3 4QG 2.29 -132.63 160.79 -67.51 59.14 61.59 -164.92 -100.52 160.91 59.96 -124.84 999.00 999.00 Favored VAL ASP PHE GLY"
"M4K4_HUMAN t_4ZP5B.pdb STE DFGout 6 Apo 2.29 -64.64 129.53 161.21 -138.48 97.14 -172.23 -106.95 30.99 -78.85 97.40 45.95 999.00 Favored VAL ASP PHE GLY"
"M4K4_HUMAN t_5DI1A.pdb STE DFGup 3 5DF 2.90 -145.13 158.97 -74.11 72.62 52.14 -134.92 -89.58 138.35 48.52 -80.63 999.00 999.00 Allowed VAL ASP PHE GLY"
"M4K4_HUMAN t_5DI1B.pdb STE DFGout 6 Apo 2.90 -66.92 114.29 -179.64 -129.19 93.65 171.14 -101.34 19.42 -82.07 116.45 30.51 999.00 Favored VAL ASP PHE GLY"
"M4K4_HUMAN t_5J95A.pdb STE DFGup 3 6HH 2.50 -133.88 158.47 -68.55 61.32 60.72 -159.60 -96.38 151.77 58.24 -126.51 999.00 999.00 Allowed VAL ASP PHE GLY"
"M4K4_HUMAN t_5J95B.pdb STE DFGout 6 Apo 2.50 -64.70 127.34 175.07 -142.51 97.40 -178.84 -108.94 39.27 -73.78 88.01 51.68 999.00 Favored VAL ASP PHE GLY"
"MAPK2_HUMAN t_1KWPA.pdb CAMK Active 1 Apo 2.80 -126.96 -164.60 -166.01 53.04 82.72 -167.75 -89.43 29.17 -83.62 -76.67 13.08 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_1KWPB.pdb CAMK Active 1 Apo 2.80 -117.62 -155.63 179.28 68.65 73.63 -172.22 -94.91 21.14 -79.15 -59.66 -28.12 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_1NXKA.pdb CAMK Active 1 STU 2.70 -122.04 -170.72 69.44 42.13 101.90 -146.08 -103.58 19.27 -77.81 -58.05 -23.12 999.00 Outlier THR ASP PHE GLY"
"MAPK2_HUMAN t_1NXKB.pdb CAMK Active 1 STU 2.70 -128.23 177.78 65.93 53.07 102.99 -147.69 -104.87 20.25 -83.49 -56.95 -14.43 999.00 Outlier THR ASP PHE GLY"
"MAPK2_HUMAN t_1NXKC.pdb CAMK Active 1 STU 2.70 -132.88 178.12 64.27 57.45 93.72 -144.50 -100.26 25.45 -76.57 -70.87 11.41 999.00 Outlier THR ASP PHE GLY"
"MAPK2_HUMAN t_1NXKD.pdb CAMK Active 1 STU 2.70 -135.95 172.46 62.18 58.95 96.18 -157.18 -97.03 30.63 -79.39 -55.98 -37.79 999.00 Outlier THR ASP PHE GLY"
"MAPK2_HUMAN t_1NY3A.pdb CAMK Active 1 ADP 3.00 -139.10 173.48 68.09 82.71 112.46 -160.94 -121.16 20.24 -79.83 -53.90 -18.89 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_2JBOA.pdb CAMK Active 1 P4O 3.1 -128.43 174.63 58.10 76.77 105.10 -162.73 -117.18 15.67 -79.53 -58.00 -19.51 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_2JBPA.pdb CAMK Active 1 P4O 3.31 -134.01 174.94 56.07 70.90 89.10 -156.80 -93.58 24.82 -73.03 -55.40 -29.02 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_2JBPB.pdb CAMK Active 1 P4O 3.31 -138.33 174.44 57.93 73.92 84.85 -158.59 -88.85 30.14 -75.26 -64.49 -26.87 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_2JBPC.pdb CAMK Active 1 P4O 3.31 -133.27 -179.59 57.58 64.69 93.60 -150.71 -95.19 25.64 -76.04 -59.20 -26.88 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_2JBPD.pdb CAMK Active 1 P4O 3.31 -137.04 -179.28 68.55 63.96 94.49 -162.99 -97.28 21.08 -77.40 -48.41 -30.35 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_2JBPE.pdb CAMK Active 1 P4O 3.31 -136.18 175.31 63.95 73.38 80.05 -165.07 -82.47 33.79 -76.08 -62.92 -45.18 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_2JBPF.pdb CAMK Active 1 P4O 3.31 -132.14 175.05 53.98 70.52 88.42 -157.62 -92.18 24.42 -75.95 -58.05 -29.79 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_2JBPG.pdb CAMK Active 1 P4O 3.31 -138.35 174.25 57.70 71.10 87.01 -161.54 -92.88 24.68 -75.73 -62.43 -18.93 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_2JBPH.pdb CAMK Active 1 P4O 3.31 -134.91 173.25 48.09 70.11 89.67 -157.99 -96.62 27.82 -78.53 -55.43 -35.35 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_2JBPI.pdb CAMK Active 1 P4O 3.31 -140.89 171.78 58.54 69.80 89.66 -163.39 -96.12 24.29 -72.73 -46.64 -33.01 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_2JBPJ.pdb CAMK Active 1 Apo 3.31 -143.07 -174.21 89.17 50.05 100.87 -156.67 -101.07 31.74 -90.05 -83.20 -13.11 999.00 Outlier THR ASP PHE GLY"
"MAPK2_HUMAN t_2JBPK.pdb CAMK Active 1 P4O 3.31 -134.41 174.52 56.61 70.55 87.93 -158.27 -93.95 23.74 -77.65 -55.92 -30.40 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_2JBPL.pdb CAMK Active 1 P4O 3.31 -115.16 -156.79 43.58 35.97 109.77 -165.33 -107.69 6.82 -82.96 -55.20 -5.42 999.00 Outlier THR ASP PHE GLY"
"MAPK2_HUMAN t_2ONLC.pdb CAMK Active 1 Apo 4.00 -144.72 177.24 -157.08 57.71 79.97 -166.58 -93.40 20.23 -76.07 -42.18 -30.21 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_2ONLD.pdb CAMK Active 1 Apo 4.00 -137.34 177.73 139.44 67.12 69.18 -162.36 -84.36 79.91 -73.31 -108.33 -19.20 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_2OZAA.pdb CAMK Active 1 Apo 2.70 -123.56 174.70 86.02 70.31 93.69 -142.81 -101.88 20.61 -78.65 -53.09 -26.63 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_2P3GX.pdb CAMK Active 1 F10 3.80 -127.00 -179.04 93.90 63.73 79.60 -165.84 -89.45 29.22 -74.54 -65.41 -2.42 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_2PZYA.pdb CAMK Active 1 B18 2.90 -105.01 167.82 90.24 71.31 102.39 -153.87 -102.73 24.35 -75.91 -59.19 -43.56 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_2PZYB.pdb CAMK Active 1 B18 2.90 -135.80 172.19 57.66 61.17 108.35 -159.18 -113.01 27.36 -68.43 -68.83 -9.69 999.00 Outlier THR ASP PHE GLY"
"MAPK2_HUMAN t_2PZYC.pdb CAMK Active 1 STU 2.90 -137.35 155.30 60.73 89.81 83.85 -148.53 -93.72 22.45 -72.17 -71.72 3.23 999.00 Outlier THR ASP PHE GLY"
"MAPK2_HUMAN t_2PZYD.pdb CAMK Active 1 Apo 2.90 -152.15 165.56 55.01 73.89 95.41 -151.32 -98.51 24.67 -73.48 -40.73 -59.31 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3A2CA.pdb CAMK Active 1 PDY 2.90 -114.28 177.69 66.62 65.07 82.58 -69.43 -97.75 30.07 -76.27 -83.17 2.16 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3A2CB.pdb CAMK Active 1 PDY 2.90 -125.31 179.30 62.68 62.06 93.28 -57.00 -105.22 21.16 -72.52 -59.54 -21.97 999.00 Outlier THR ASP PHE GLY"
"MAPK2_HUMAN t_3A2CC.pdb CAMK Active 1 PDY 2.90 -128.23 172.99 64.82 63.84 82.21 -59.30 -94.68 28.30 -76.54 -82.33 0.96 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3A2CD.pdb CAMK Active 1 PDY 2.90 -134.57 177.49 64.31 60.21 88.03 -56.72 -99.28 27.08 -72.85 -68.90 -16.25 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3A2CE.pdb CAMK Active 1 PDY 2.90 -118.67 175.79 63.10 66.91 85.43 -71.23 -100.82 39.73 -76.98 -78.68 -21.29 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3A2CF.pdb CAMK Active 1 PDY 2.90 -127.84 179.29 64.77 59.29 93.48 -58.53 -106.61 16.66 -81.13 -68.33 3.14 999.00 Outlier THR ASP PHE GLY"
"MAPK2_HUMAN t_3A2CG.pdb CAMK Active 1 PDY 2.90 -119.40 176.45 65.33 66.39 96.57 -80.83 -109.06 20.59 -78.46 -61.32 -15.37 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3A2CH.pdb CAMK Active 1 PDY 2.90 -121.61 176.51 57.67 63.34 90.04 -62.23 -101.58 35.18 -79.86 -76.97 -23.90 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3A2CI.pdb CAMK Active 1 PDY 2.90 -125.54 174.34 64.02 66.62 96.74 -68.58 -108.15 23.99 -75.40 -70.11 2.46 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3A2CJ.pdb CAMK Active 1 PDY 2.90 -131.64 169.04 76.51 71.78 90.48 -65.46 -103.66 48.01 -82.27 -101.17 2.49 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3A2CK.pdb CAMK Active 1 PDY 2.90 -132.34 173.05 47.33 63.25 100.13 -67.14 -111.49 35.64 -77.28 -83.49 -1.14 999.00 Outlier THR ASP PHE GLY"
"MAPK2_HUMAN t_3A2CL.pdb CAMK Active 1 PDY 2.90 -139.17 172.72 71.42 64.14 88.92 -66.08 -98.62 16.83 -83.42 -70.00 7.27 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3FPMA.pdb CAMK Active 1 793 3.30 -111.72 -179.26 67.74 68.08 93.08 -159.46 -104.68 29.04 -82.82 -75.68 -5.15 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3FYJX.pdb CAMK Active 1 B97 3.80 -143.85 -168.42 98.38 50.67 86.10 -174.83 -92.87 22.40 -70.95 -62.16 -2.79 999.00 Outlier THR ASP PHE GLY"
"MAPK2_HUMAN t_3FYKX.pdb CAMK Active 1 B98 3.50 -134.91 -177.55 97.49 58.67 91.52 -163.45 -96.10 29.85 -79.63 -66.44 -8.95 999.00 Outlier THR ASP PHE GLY"
"MAPK2_HUMAN t_3GOKA.pdb CAMK Active 1 P4O 3.20 -126.66 173.46 67.40 71.03 100.18 -152.92 -103.03 25.09 -71.78 -63.73 -22.07 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3GOKB.pdb CAMK Active 1 P4O 3.20 -126.17 171.51 62.63 76.61 101.22 -152.19 -106.86 28.18 -76.52 -69.35 -20.70 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3GOKC.pdb CAMK Active 1 P4O 3.20 -127.95 171.65 67.75 72.35 100.54 -154.91 -105.39 28.03 -75.28 -70.16 -18.02 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3GOKD.pdb CAMK Active 1 P4O 3.20 -126.61 170.15 66.52 75.95 99.41 -155.59 -106.11 27.49 -73.29 -64.48 -22.43 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3GOKE.pdb CAMK Active 1 P4O 3.20 -126.74 170.85 63.98 73.30 97.67 -155.16 -100.74 25.15 -75.51 -65.37 -19.26 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3GOKF.pdb CAMK Active 1 P4O 3.20 -127.81 174.18 63.22 70.77 96.54 -154.34 -99.92 26.88 -73.89 -67.13 -18.69 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3GOKG.pdb CAMK Active 1 P4O 3.20 -127.83 169.92 67.58 76.61 97.26 -154.69 -103.10 31.58 -74.02 -69.86 -24.14 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3GOKH.pdb CAMK Active 1 P4O 3.20 -127.46 173.53 62.29 71.36 99.67 -157.82 -106.66 28.00 -75.41 -65.16 -20.52 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3GOKI.pdb CAMK Active 1 P4O 3.20 -127.80 172.16 65.33 73.24 98.64 -155.98 -103.79 25.39 -75.69 -64.94 -20.37 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3GOKJ.pdb CAMK Active 1 P4O 3.20 -125.95 171.01 66.25 73.61 99.23 -153.23 -101.23 24.32 -71.85 -63.99 -20.55 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3GOKK.pdb CAMK Active 1 P4O 3.20 -127.56 167.17 66.02 77.13 99.38 -155.35 -103.97 27.45 -75.19 -67.19 -17.05 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3GOKL.pdb CAMK Active 1 P4O 3.20 -128.34 173.44 66.86 71.11 97.89 -154.87 -103.14 25.33 -73.82 -60.73 -25.10 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3KA0A.pdb CAMK Active 1 MK3 2.90 -134.08 176.23 -161.57 64.39 97.83 -168.55 -108.29 26.10 -68.65 -54.93 -29.30 999.00 Outlier THR ASP PHE GLY"
"MAPK2_HUMAN t_3KC3A.pdb CAMK Active 1 MK2 2.90 -135.83 -176.84 -175.74 67.41 90.42 -172.45 -94.63 16.74 -68.25 -43.87 -36.08 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3KC3B.pdb CAMK Active 1 MK2 2.90 -132.95 176.52 -164.25 69.10 89.92 -169.14 -95.22 24.74 -73.72 -62.52 -14.87 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3KC3C.pdb CAMK Active 1 MK2 2.90 -138.59 -178.84 -164.47 60.43 102.92 -155.82 -104.48 17.29 -74.52 -64.83 -5.95 999.00 Outlier THR ASP PHE GLY"
"MAPK2_HUMAN t_3KC3D.pdb CAMK Active 1 MK2 2.90 -137.85 175.25 -173.92 62.05 98.89 179.51 -99.78 17.35 -73.39 -44.82 -25.59 999.00 Outlier THR ASP PHE GLY"
"MAPK2_HUMAN t_3KC3E.pdb CAMK Active 1 MK2 2.90 -128.96 -178.84 -161.10 60.99 110.54 -172.85 -118.08 18.16 -71.82 -54.02 -31.17 999.00 Outlier THR ASP PHE GLY"
"MAPK2_HUMAN t_3KC3F.pdb CAMK Active 1 MK2 2.90 -134.91 179.06 -172.32 76.74 94.95 -162.66 -104.85 22.19 -77.18 -64.73 -17.49 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3KC3G.pdb CAMK Active 1 Apo 2.90 -153.54 -179.39 -164.56 55.32 116.15 -164.39 -117.21 10.88 -68.90 -43.49 -24.71 999.00 Outlier THR ASP PHE GLY"
"MAPK2_HUMAN t_3KC3H.pdb CAMK Active 1 MK2 2.90 -138.22 -172.15 -176.25 57.06 102.02 -159.97 -106.71 27.13 -67.22 -57.12 -29.33 999.00 Outlier THR ASP PHE GLY"
"MAPK2_HUMAN t_3KC3I.pdb CAMK Active 1 MK2 2.90 -127.79 171.24 -157.58 71.82 103.13 -163.97 -106.83 28.47 -75.83 -57.44 -27.43 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3KC3J.pdb CAMK Active 1 MK2 2.90 -125.72 -175.91 -149.41 62.50 84.01 -170.93 -88.34 25.12 -78.99 -82.54 2.20 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3KC3K.pdb CAMK Active 1 MK2 2.90 -140.06 -177.82 -159.10 52.30 117.46 -163.58 -116.27 11.72 -82.87 -69.93 0.82 999.00 Outlier THR ASP PHE GLY"
"MAPK2_HUMAN t_3KC3L.pdb CAMK Active 1 MK2 2.90 -130.60 174.48 -173.85 78.68 90.77 -168.19 -100.05 26.65 -77.80 -59.12 -39.76 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3KGAA.pdb CAMK Active 1 LX9 2.55 -124.87 174.22 76.30 69.13 92.77 -157.47 -95.92 21.20 -77.40 -62.30 -18.29 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3M2WA.pdb CAMK Active 1 L8I 2.41 -122.14 170.85 73.29 75.15 88.90 -155.48 -90.92 16.74 -80.92 -57.54 -17.09 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3M42A.pdb CAMK Active 1 HGF 2.68 -127.25 170.76 63.61 71.74 101.48 -162.43 -103.88 20.74 -82.99 -61.87 -8.29 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3R2BA.pdb CAMK Active 1 05B 2.90 -133.60 172.81 85.76 62.95 100.27 -165.67 -104.13 34.38 -81.94 -71.40 -34.53 999.00 Outlier THR ASP PHE GLY"
"MAPK2_HUMAN t_3R2BB.pdb CAMK Active 1 05B 2.90 -142.12 174.13 -170.49 65.38 93.56 -163.49 -99.55 29.69 -79.32 -63.86 -41.56 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3R2BC.pdb CAMK Active 1 Apo 2.90 -145.08 171.24 -170.02 61.07 107.19 -165.28 -112.48 31.93 -75.72 -61.51 -37.72 999.00 Outlier THR ASP PHE GLY"
"MAPK2_HUMAN t_3R2BD.pdb CAMK Active 1 Apo 2.90 -145.77 167.58 -165.11 68.55 102.70 -168.59 -108.42 30.94 -77.37 -66.31 -36.82 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3R2BE.pdb CAMK Active 1 Apo 2.90 -139.57 169.58 -169.68 69.20 97.41 -162.32 -104.18 34.33 -77.12 -62.66 -38.97 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3R2BF.pdb CAMK Active 1 Apo 2.90 -142.06 170.04 -151.56 64.83 98.10 -165.75 -101.82 30.74 -77.83 -65.73 -35.20 999.00 Outlier THR ASP PHE GLY"
"MAPK2_HUMAN t_3R2BG.pdb CAMK Active 1 Apo 2.90 -137.74 173.12 -174.37 72.02 96.79 -161.19 -108.01 29.22 -78.95 -63.92 -39.05 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3R2BH.pdb CAMK Active 1 Apo 2.90 -141.51 171.12 -173.70 67.42 98.85 -164.05 -106.45 32.92 -78.30 -63.45 -39.52 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3R2BI.pdb CAMK Active 1 Apo 2.90 -144.84 172.45 -164.43 67.01 98.69 -164.23 -105.82 31.39 -78.53 -64.99 -40.45 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3R2BJ.pdb CAMK Active 1 Apo 2.90 -139.77 172.91 -173.64 64.34 98.69 -149.51 -104.15 24.87 -80.12 -58.62 -39.13 999.00 Outlier THR ASP PHE GLY"
"MAPK2_HUMAN t_3R2BK.pdb CAMK Active 1 Apo 2.90 -142.95 173.30 -168.15 64.22 96.20 -163.64 -100.22 30.49 -80.73 -63.26 -35.21 999.00 Outlier THR ASP PHE GLY"
"MAPK2_HUMAN t_3R2BL.pdb CAMK Active 1 Apo 2.90 -149.60 172.89 -169.58 62.03 95.78 -167.48 -100.19 29.14 -77.59 -62.25 -33.80 999.00 Outlier THR ASP PHE GLY"
"MAPK2_HUMAN t_3R2YA.pdb CAMK Active 1 P4O 3.00 -139.74 177.50 77.89 74.44 98.74 -173.47 -113.47 19.85 -83.80 -51.79 -25.40 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3R30A.pdb CAMK Active 1 CD2 3.20 -134.35 174.77 73.95 70.13 102.41 -159.30 -110.04 21.66 -84.24 -62.26 -28.91 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3WI6A.pdb CAMK Active 1 YRZ 2.99 -135.22 -179.22 70.43 63.44 87.83 -64.64 -99.09 27.56 -79.94 -72.50 -23.64 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3WI6B.pdb CAMK Active 1 YRZ 2.99 -134.63 176.38 71.39 65.92 88.05 -63.08 -98.56 25.21 -77.07 -67.03 -26.80 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3WI6C.pdb CAMK Active 1 YRZ 2.99 -134.82 178.56 68.18 63.89 88.03 -62.64 -96.48 23.90 -77.52 -65.28 -26.80 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3WI6D.pdb CAMK Active 1 YRZ 2.99 -134.17 179.77 71.63 62.40 89.36 -64.24 -98.36 27.45 -76.46 -69.58 -24.74 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3WI6E.pdb CAMK Active 1 YRZ 2.99 -140.33 177.61 69.96 64.15 87.54 -63.40 -97.81 28.16 -76.48 -68.94 -27.55 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_3WI6F.pdb CAMK Active 1 YRZ 2.99 -134.81 178.97 68.74 64.05 87.75 -64.74 -97.91 26.98 -78.85 -67.46 -26.99 999.00 Allowed THR ASP PHE GLY"
"MAPK2_HUMAN t_4TYHA.pdb CAMK Active 1 Apo 3.00 -142.08 171.73 76.64 54.09 110.24 -177.79 -104.93 23.53 -86.49 -64.20 -15.93 999.00 Outlier THR ASP PHE GLY"
"MAPK3_HUMAN t_3FHRA.pdb CAMK Active 1 P4O 1.90 -141.33 -177.51 -159.23 71.88 91.17 -167.39 -100.01 27.16 -69.81 -72.41 -18.72 999.00 Allowed THR ASP PHE GLY"
"MAPK3_HUMAN t_3FXWA.pdb CAMK Active 1 F10 2.00 -136.82 -179.29 -160.95 78.69 91.11 -171.50 -99.00 26.27 -68.61 -64.19 -27.58 999.00 Allowed THR ASP PHE GLY"
"MAPK3_HUMAN t_3R1NA.pdb CAMK Active 1 05B 2.09 -136.65 172.77 -152.65 78.53 90.83 -161.56 -101.61 24.05 -71.68 -63.03 -24.62 999.00 Allowed THR ASP PHE GLY"
"MAPK3_HUMAN t_3SHEA.pdb CAMK Active 1 I85 2.25 -121.00 179.17 37.97 78.73 86.25 -155.31 -103.07 28.32 -66.19 -68.68 -16.01 999.00 Allowed THR ASP PHE GLY"
"MARK1_HUMAN t_2HAKA.pdb CAMK DFGin-trans 4 Apo 2.60 -136.24 129.31 999.00 59.34 36.69 -56.59 -66.41 118.43 -178.12 88.60 11.99 999.00 Favored ALA ASP PHE GLY"
"MARK1_HUMAN t_2HAKB.pdb CAMK DFGin-trans 4 Apo 2.60 -139.21 116.18 999.00 75.91 39.74 -70.66 -67.68 126.70 172.83 81.83 9.74 999.00 Allowed ALA ASP PHE GLY"
"MARK1_HUMAN t_2HAKC.pdb CAMK DFGin-trans 4 Apo 2.60 -130.57 141.53 999.00 63.55 24.89 -63.69 -66.41 116.31 173.39 92.21 0.62 999.00 Favored ALA ASP PHE GLY"
"MARK1_HUMAN t_2HAKD.pdb CAMK DFGin-trans 4 Apo 2.60 -110.83 133.23 999.00 68.56 39.70 -71.77 -70.00 115.85 175.90 79.25 3.78 999.00 Favored ALA ASP PHE GLY"
"MARK1_HUMAN t_2HAKE.pdb CAMK DFGin-trans 4 Apo 2.60 -137.04 128.26 999.00 72.27 22.65 -55.70 -49.87 108.36 -178.27 97.34 5.36 999.00 Favored ALA ASP PHE GLY"
"MARK1_HUMAN t_2HAKF.pdb CAMK DFGin-trans 4 Apo 2.60 -131.27 137.08 999.00 60.38 30.17 -68.81 -59.51 117.20 178.22 86.88 -8.60 999.00 Favored ALA ASP PHE GLY"
"MARK1_HUMAN t_2HAKG.pdb CAMK DFGin-trans 4 Apo 2.60 -148.27 130.12 999.00 69.41 31.97 -64.94 -73.77 98.65 175.38 118.97 -22.86 999.00 Favored ALA ASP PHE GLY"
"MARK1_HUMAN t_2HAKH.pdb CAMK DFGin-trans 4 Apo 2.60 -136.86 137.15 999.00 62.15 42.54 -54.72 -77.50 119.37 169.71 79.16 4.94 999.00 Favored ALA ASP PHE GLY"
"MARK2_HUMAN t_3IECA.pdb CAMK Active 1 Apo 2.20 -126.46 175.47 999.00 61.87 79.20 -173.35 -90.98 24.63 -68.17 -64.97 -23.58 999.00 Allowed ALA ASP PHE GLY"
"MARK2_HUMAN t_3IECB.pdb CAMK Active 1 Apo 2.20 -111.66 -54.62 999.00 -113.86 100.93 158.39 -96.47 26.52 -71.31 -60.76 -30.72 999.00 Favored ALA ASP PHE GLY"
"MARK2_HUMAN t_3IECC.pdb CAMK Active 1 Apo 2.20 -129.05 171.42 999.00 70.19 76.81 -170.32 -94.18 29.06 -69.74 -70.50 -25.79 999.00 Allowed ALA ASP PHE GLY"
"MARK2_HUMAN t_3IECD.pdb CAMK Active 1 Apo 2.20 -112.94 -65.92 999.00 -95.61 101.94 163.40 -91.54 23.35 -69.72 -68.25 -21.31 999.00 Favored ALA ASP PHE GLY"
"MARK2_HUMAN t_5EAKA.pdb CAMK DFGin-inactive 2 24R 2.80 -137.50 144.67 999.00 77.80 96.56 179.94 -106.71 35.46 -65.00 -129.11 17.92 999.00 Allowed ALA ASP PHE GLY"
"MARK2_HUMAN t_5EAKB.pdb CAMK DFGin-inactive 2 24R 2.80 -115.02 -64.31 999.00 -99.02 103.98 178.82 -95.31 15.06 -78.01 -107.58 171.77 999.00 Favored ALA ASP PHE GLY"
"MARK3_HUMAN t_2QNJA.pdb CAMK DFGin-trans 4 Apo 2.70 -114.92 141.73 999.00 62.35 27.71 -60.51 -77.83 119.86 -169.72 97.66 -1.52 999.00 Favored ALA ASP PHE GLY"
"MARK3_HUMAN t_2QNJB.pdb CAMK DFGin-trans 4 Apo 2.70 -123.93 136.44 999.00 65.90 22.43 -65.32 -72.85 117.84 -164.95 84.91 12.45 999.00 Favored ALA ASP PHE GLY"
"MARK3_HUMAN t_3FE3A.pdb CAMK DFGin-trans 4 Apo 1.90 -116.89 149.77 999.00 55.84 28.12 -60.32 -81.69 122.47 -172.14 86.86 9.08 999.00 Favored ALA ASP PHE GLY"
"MARK3_HUMAN t_3FE3B.pdb CAMK DFGin-trans 4 Apo 1.90 -110.32 144.30 999.00 56.65 33.52 -57.56 -81.74 126.16 -171.02 63.70 33.92 999.00 Favored ALA ASP PHE GLY"
"MARK4_HUMAN t_5ES1A.pdb CAMK Active 1 5RC 2.80 -110.73 167.87 999.00 94.58 -106.37 -134.45 80.67 9.01 -68.50 -62.77 -44.52 999.00 Outlier ALA ASP PHE GLY"
"MELK_HUMAN t_4BKYA.pdb CAMK Active 1 82B 1.83 -126.88 173.09 64.55 62.68 72.77 -153.11 -92.82 16.58 -73.82 -58.62 -28.78 999.00 Allowed ILE ASP PHE GLY"
"MELK_HUMAN t_4BKZA.pdb CAMK Active 1 1WS 2.20 -122.33 174.71 62.44 61.26 76.55 -161.92 -93.10 28.23 -66.90 -72.53 -28.70 999.00 Allowed ILE ASP PHE GLY"
"MELK_HUMAN t_4BL1A.pdb CAMK Active 1 ANP 2.60 -114.35 -16.24 56.23 -125.00 95.88 -179.78 -105.91 21.03 -53.95 -48.24 -28.33 999.00 Favored ILE ASP PHE GLY"
"MELK_HUMAN t_4D2PA.pdb CAMK Active 1 6Z7 2.55 -121.58 -178.41 64.17 43.06 86.97 -175.60 -96.74 36.19 -72.97 -62.80 -28.71 999.00 Outlier ILE ASP PHE GLY"
"MELK_HUMAN t_4D2PB.pdb CAMK Active 1 6Z7 2.55 -116.21 -179.56 64.83 42.81 87.20 -178.12 -95.47 33.60 -73.04 -73.56 -28.67 999.00 Outlier ILE ASP PHE GLY"
"MELK_HUMAN t_4D2PC.pdb CAMK Active 1 6Z7 2.55 -121.45 -178.20 64.38 43.89 86.50 -177.10 -97.18 31.62 -72.10 -71.21 -25.60 999.00 Outlier ILE ASP PHE GLY"
"MELK_HUMAN t_4D2PD.pdb CAMK Active 1 6Z7 2.55 -121.01 -179.74 64.15 44.10 87.04 -176.85 -96.59 34.06 -72.35 -72.88 -28.11 999.00 Outlier ILE ASP PHE GLY"
"MELK_HUMAN t_4D2TA.pdb CAMK Active 1 3I7 2.70 -133.46 179.72 63.26 57.34 75.09 -158.45 -93.78 24.80 -74.04 -43.00 -42.19 999.00 Allowed ILE ASP PHE GLY"
"MELK_HUMAN t_4D2TB.pdb CAMK Active 1 3I7 2.70 -134.61 -178.28 62.66 55.43 74.94 -158.67 -94.29 23.65 -73.38 -66.68 -35.71 999.00 Allowed ILE ASP PHE GLY"
"MELK_HUMAN t_4D2TC.pdb CAMK Active 1 3I7 2.70 -134.30 179.32 64.05 57.66 74.86 -158.98 -93.89 24.89 -74.18 -70.20 -25.28 999.00 Allowed ILE ASP PHE GLY"
"MELK_HUMAN t_4D2TD.pdb CAMK Active 1 3I7 2.70 -130.90 164.86 -102.05 58.79 83.32 -147.77 -99.75 25.06 -74.42 -62.70 -39.19 999.00 Allowed ILE ASP PHE GLY"
"MELK_HUMAN t_4D2VA.pdb CAMK Active 1 45R 2.45 -128.19 -178.52 62.30 46.64 81.88 -176.01 -94.58 26.32 -70.61 -48.94 -31.90 999.00 Outlier ILE ASP PHE GLY"
"MELK_HUMAN t_4D2VB.pdb CAMK Active 1 45R 2.45 -127.52 -177.47 61.68 48.57 80.35 -174.85 -94.71 26.53 -70.26 -57.43 -34.67 999.00 Allowed ILE ASP PHE GLY"
"MELK_HUMAN t_4D2VC.pdb CAMK Active 1 45R 2.45 -127.66 -179.28 62.67 47.93 81.78 -176.17 -95.84 24.03 -71.10 -69.42 -23.29 999.00 Outlier ILE ASP PHE GLY"
"MELK_HUMAN t_4D2VD.pdb CAMK Active 1 45R 2.45 -128.10 -177.36 62.51 48.31 80.76 -175.23 -95.01 26.93 -70.74 -56.21 -36.00 999.00 Allowed ILE ASP PHE GLY"
"MELK_HUMAN t_4D2WA.pdb CAMK Active 1 NF5 1.92 -125.81 179.02 62.47 60.41 71.17 -157.82 -91.15 19.25 -79.68 -59.66 -12.40 999.00 Allowed ILE ASP PHE GLY"
"MELK_HUMAN t_4D2WB.pdb CAMK Active 1 NF5 1.92 -125.13 -179.83 62.15 60.65 70.54 -158.16 -91.09 19.49 -79.27 -68.48 -22.02 999.00 Allowed ILE ASP PHE GLY"
"MELK_HUMAN t_4D2WC.pdb CAMK Active 1 NF5 1.92 -123.78 178.57 62.44 60.71 71.48 -159.47 -90.34 19.58 -77.61 -69.33 -20.68 999.00 Allowed ILE ASP PHE GLY"
"MELK_HUMAN t_4D2WD.pdb CAMK Active 1 NF5 1.92 -128.12 -179.23 62.85 58.60 70.91 -158.83 -91.80 22.26 -80.04 -70.95 -17.87 999.00 Allowed ILE ASP PHE GLY"
"MELK_HUMAN t_4IXPA.pdb CAMK DFGinter 5 Apo 2.75 -82.60 111.73 -65.51 -97.34 24.11 999.00 -131.77 132.47 172.64 -170.05 168.42 999.00 Favored ILE ALA PHE GLY"
"MELK_HUMAN t_4UMPA.pdb CAMK Active 1 5QM 2.30 -116.73 -176.83 66.75 54.55 81.15 -153.39 -105.60 22.87 -81.89 -64.72 -26.83 999.00 Allowed ILE ASP PHE GLY"
"MELK_HUMAN t_4UMPB.pdb CAMK Active 1 5QM 2.30 -117.91 178.42 71.19 56.18 86.01 -178.89 -101.46 12.67 -79.29 -65.93 -43.06 999.00 Allowed ILE ASP PHE GLY"
"MELK_HUMAN t_4UMPC.pdb CAMK Active 1 5QM 2.30 -123.90 -179.31 64.34 56.40 85.44 -163.14 -103.48 13.91 -79.53 -60.17 -35.72 999.00 Allowed ILE ASP PHE GLY"
"MELK_HUMAN t_4UMPD.pdb CAMK Active 1 5QM 2.30 -129.02 172.81 68.51 60.53 81.98 -158.84 -101.02 13.89 -81.51 -58.84 -32.34 999.00 Allowed ILE ASP PHE GLY"
"MELK_HUMAN t_4UMQA.pdb CAMK DFGin-inactive 2 B5S 2.60 -117.95 178.26 57.04 62.23 77.51 -153.90 -76.59 -65.14 -88.24 68.26 -47.58 999.00 Allowed ILE ASP PHE GLY"
"MELK_HUMAN t_4UMRA.pdb CAMK DFGin-inactive 2 QBB 3.00 -120.80 -168.19 46.95 21.59 76.26 -36.38 -70.54 -6.71 -77.12 0.27 -64.20 999.00 Outlier ILE ASP PHE GLY"
"MELK_HUMAN t_4UMTA.pdb CAMK DFGinter 5 47W 1.98 -125.61 -174.88 62.03 -147.27 172.17 -159.84 77.11 1.23 -48.20 -66.50 145.36 999.00 Favored ILE ASP PHE GLY"
"MELK_HUMAN t_4UMUA.pdb CAMK DFGinter 5 0V0 2.02 -116.82 -162.80 53.39 -155.72 175.06 -164.16 72.48 6.02 -53.06 -72.57 148.48 999.00 Favored ILE ASP PHE GLY"
"MELK_HUMAN t_5IH8A.pdb CAMK Active 1 6BJ 1.85 -123.99 175.99 66.29 57.41 81.53 -159.66 -97.98 22.12 -78.65 -67.29 -27.18 999.00 Allowed ILE ASP PHE GLY"
"MELK_HUMAN t_5IH9A.pdb CAMK Active 1 6BF 1.79 -123.47 176.12 62.83 58.25 79.93 -155.58 -95.72 21.86 -79.01 -68.02 -25.91 999.00 Allowed ILE ASP PHE GLY"
"MELK_HUMAN t_5IHAA.pdb CAMK Active 1 6BE 1.96 -120.85 177.37 66.01 56.01 85.64 -153.19 -102.11 23.40 -78.28 -67.50 -28.50 999.00 Allowed ILE ASP PHE GLY"
"MELK_HUMAN t_5IHCA.pdb CAMK DFGin-inactive 2 6BB 2.14 -128.85 -176.92 68.31 47.36 58.34 -107.15 -59.30 135.07 -79.40 99.65 999.00 999.00 Favored ILE ASP PHE GLY"
"MELK_HUMAN t_5K00A.pdb CAMK DFGout 6 6PV 1.77 -128.13 174.10 70.28 -143.45 90.92 179.78 -73.88 -34.51 -160.58 -97.56 24.99 999.00 Favored ILE ASP PHE GLY"
"MERTK_HUMAN t_2P0CA.pdb TYR DFGup 3 ANP 2.40 -137.31 178.63 999.00 60.38 23.30 -81.62 -81.59 167.52 49.72 85.58 -47.32 999.00 Favored ALA ASP PHE GLY"
"MERTK_HUMAN t_2P0CB.pdb TYR DFGup 3 ANP 2.40 -140.56 176.92 999.00 63.41 26.36 -77.62 -92.68 153.86 48.22 87.31 -0.90 999.00 Favored ALA ASP PHE GLY"
"MERTK_HUMAN t_3BPRA.pdb TYR DFGup 3 OLP 2.80 -137.28 -178.89 999.00 61.47 12.70 -114.05 -59.71 137.05 20.34 61.12 -116.48 999.00 Favored ALA ASP PHE GLY"
"MERTK_HUMAN t_3BPRB.pdb TYR DFGup 3 OLP 2.80 -135.16 -179.33 999.00 61.27 14.89 -116.89 -59.55 138.15 20.19 59.61 -114.69 999.00 Favored ALA ASP PHE GLY"
"MERTK_HUMAN t_3BPRC.pdb TYR DFGup 3 OLP 2.80 -137.43 -178.73 999.00 62.43 10.18 -116.53 -55.96 136.37 21.77 60.84 -116.78 999.00 Favored ALA ASP PHE GLY"
"MERTK_HUMAN t_3BPRD.pdb TYR DFGup 3 OLP 2.80 -139.17 -179.70 999.00 62.56 13.25 -115.82 -60.90 135.78 20.51 61.85 -113.77 999.00 Favored ALA ASP PHE GLY"
"MERTK_HUMAN t_3BRBA.pdb TYR DFGup 3 ADP 1.90 -149.40 172.83 999.00 64.45 33.41 -72.08 -100.26 164.65 46.70 59.31 174.07 999.00 Favored ALA ASP PHE GLY"
"MERTK_HUMAN t_3BRBB.pdb TYR DFGup 3 ADP 1.90 -148.41 175.85 999.00 65.34 30.32 -74.23 -97.00 160.96 52.80 77.97 168.42 999.00 Favored ALA ASP PHE GLY"
"MERTK_HUMAN t_4M3QB.pdb TYR DFGup 3 24K 2.72 -155.47 177.82 999.00 59.99 59.96 -161.44 -123.07 100.72 28.73 73.75 999.00 999.00 Favored ALA ASP PHE GLY"
"MERTK_HUMAN t_4MHAA.pdb TYR DFGup 3 4MH 2.59 -165.24 -177.36 999.00 65.07 22.57 -161.55 -85.09 109.89 39.36 -64.41 999.00 999.00 Favored ALA ASP PHE GLY"
"MERTK_HUMAN t_5K0KA.pdb TYR DFGup 3 6Q1 2.55 -151.35 176.88 999.00 70.66 6.49 -151.60 -74.60 148.34 49.29 71.74 161.79 999.00 Favored ALA ASP PHE GLY"
"MERTK_HUMAN t_5K0XA.pdb TYR DFGup 3 K0X 2.23 -141.68 176.73 999.00 63.14 26.72 -145.26 -84.68 126.16 47.92 81.43 999.00 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_1R0PA.pdb TYR DFGup 3 KSA 1.80 -128.88 -159.66 999.00 55.85 40.31 -161.95 -140.60 160.80 73.47 57.22 -140.55 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_1R1WA.pdb TYR DFGup 3 Apo 1.80 -130.32 -160.30 999.00 52.69 47.76 -168.92 -146.14 163.98 73.82 55.31 -136.63 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_2G15A.pdb TYR DFGup 3 Apo 2.15 -126.85 -156.88 999.00 55.45 45.37 -168.60 -146.84 161.07 77.98 56.80 -133.56 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_2RFSA.pdb TYR DFGup 3 AM8 2.20 -134.87 -164.26 999.00 47.97 50.19 -160.61 -129.91 165.29 61.64 61.56 -131.34 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_2WD1A.pdb TYR DFGup 3 GBL 2.00 -130.20 -166.89 999.00 64.73 49.74 -171.99 -149.58 164.94 68.54 63.60 -135.28 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_2WGJA.pdb TYR DFGup 3 VGH 2.00 -135.64 -156.28 999.00 47.25 45.24 -162.02 -135.57 161.68 71.86 65.01 -128.24 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_2WKMA.pdb TYR DFGup 3 PFY 2.20 -142.50 -164.27 999.00 57.56 44.83 -166.88 -136.51 165.51 66.66 61.34 -132.60 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_3A4PA.pdb TYR DFGup 3 DFQ 2.54 -133.76 -165.55 999.00 69.07 42.20 -176.75 -140.64 163.84 58.10 70.79 -133.90 999.00 Allowed ALA ASP PHE GLY"
"MET_HUMAN t_3CCNA.pdb TYR DFGup 3 LKG 1.90 -129.45 -153.19 999.00 49.87 50.20 -179.95 -147.14 164.17 75.87 61.52 -123.79 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_3CD8A.pdb TYR DFGup 3 L5G 2.00 -125.86 -155.48 999.00 52.60 49.23 -179.61 -144.96 159.77 75.44 64.26 -128.52 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_3CE3A.pdb TYR DFGout 6 1FN 2.40 -152.26 -166.63 999.00 -149.35 110.68 -151.18 -63.51 88.96 -96.05 -40.83 999.00 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_3CTHA.pdb TYR DFGout 6 319 2.30 -148.14 -166.93 999.00 -151.58 110.01 -155.54 -65.32 53.26 -101.29 -176.90 999.00 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_3DKCA.pdb TYR DFGup 3 ATP 1.52 -128.07 162.72 999.00 67.52 17.44 -93.68 -61.63 130.16 44.22 80.05 -22.96 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_3DKFA.pdb TYR DFGup 3 SX8 1.80 -127.03 -153.88 999.00 49.99 55.43 176.89 -149.94 164.23 68.26 54.21 -128.07 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_3DKGA.pdb TYR DFGup 3 SX8 1.91 -129.32 -157.09 999.00 51.05 49.21 176.48 -145.73 164.84 74.13 54.80 -132.34 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_3F66A.pdb TYR DFGup 3 IHX 1.40 -128.73 -158.89 999.00 48.91 46.33 -173.78 -144.75 166.05 75.60 63.31 -132.54 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_3F66B.pdb TYR DFGup 3 IHX 1.40 -124.31 -152.81 999.00 48.56 45.62 -174.78 -143.75 164.51 77.52 58.81 -132.53 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_3F82A.pdb TYR DFGout 6 353 2.50 -148.74 -169.99 999.00 -153.97 103.18 -163.19 -56.47 -43.02 -89.77 47.08 999.00 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_3I5NA.pdb TYR DFGup 3 B2D 2.00 -127.29 -154.20 999.00 49.78 50.82 176.61 -143.79 160.70 74.39 63.42 -123.72 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_3L8VA.pdb TYR DFGout 6 L8V 2.40 -142.28 -172.04 999.00 -148.64 112.12 -160.97 -62.22 -49.07 -97.09 155.39 999.00 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_3LQ8A.pdb TYR DFGout 6 88Z 2.02 -150.04 -172.68 999.00 -147.93 116.98 -168.37 -56.24 -26.81 -85.47 59.51 -127.02 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_3Q6UA.pdb TYR DFGin-inactive 2 Apo 1.60 -141.82 -165.83 999.00 43.31 48.53 -61.50 -52.63 142.98 -41.37 -67.64 999.00 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_3Q6WA.pdb TYR Active 1 Q6W 1.75 -113.39 -31.34 999.00 -103.29 133.14 -168.49 -129.59 28.22 -65.39 -57.06 -25.47 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_3QTIA.pdb TYR DFGup 3 3QT 2.00 -128.49 -152.07 999.00 51.75 55.70 -178.88 -149.25 167.24 67.69 61.12 -130.78 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_3QTIB.pdb TYR DFGup 3 3QT 2.00 -128.93 -152.34 999.00 51.96 55.96 -179.10 -149.63 167.08 67.91 61.23 -130.09 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_3R7OA.pdb TYR Active 1 M61 2.30 -102.55 -37.50 999.00 -98.22 136.29 -161.09 -130.02 25.34 -66.33 -51.89 -36.60 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_3RHKA.pdb TYR DFGout 6 M97 1.94 -104.80 145.42 999.00 -125.14 99.21 78.37 -79.78 96.90 -47.04 -66.33 -102.39 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_3RHKB.pdb TYR DFGout 6 M97 1.94 -103.93 147.10 999.00 -123.27 84.37 83.84 -80.98 -74.06 -73.58 68.13 -76.37 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_3U6HA.pdb TYR DFGup 3 03X 2.00 -145.18 179.51 999.00 61.35 23.55 -102.92 -82.37 149.62 53.66 90.77 999.00 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_3U6IA.pdb TYR DFGup 3 044 2.10 -134.81 174.51 999.00 60.11 23.80 -85.57 -73.51 140.84 47.51 78.46 999.00 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_3VW8A.pdb TYR DFGout 6 DF6 2.10 -161.10 -169.09 999.00 -159.83 118.44 -164.08 -64.05 -25.09 -82.20 53.91 -122.37 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_3ZBXA.pdb TYR DFGup 3 6XE 2.20 -133.51 -157.08 999.00 42.71 56.94 -166.51 -148.82 166.26 77.95 53.56 -129.29 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_3ZC5A.pdb TYR DFGup 3 W9Z 2.20 -130.99 -159.68 999.00 45.53 54.41 -171.56 -146.49 156.88 75.36 59.13 -130.26 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_3ZCLA.pdb TYR DFGup 3 5TF 1.40 -130.36 -159.34 999.00 48.37 53.42 179.24 -147.62 165.56 74.19 59.57 -131.85 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_3ZXZA.pdb TYR DFGup 3 KRW 1.80 -135.70 -162.13 999.00 50.43 49.81 -164.44 -141.07 164.71 71.89 60.09 -132.88 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_3ZZEA.pdb TYR DFGup 3 6XP 1.87 -124.42 -164.46 999.00 52.89 52.20 -175.34 -144.60 167.10 70.92 57.00 -128.66 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_4AOIA.pdb TYR DFGup 3 4K0 1.90 -129.94 -161.25 999.00 48.65 52.49 -164.74 -145.16 163.96 75.39 58.24 -131.78 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_4AP7A.pdb TYR DFGup 3 F47 1.80 -138.21 -157.46 999.00 42.57 55.56 -163.64 -147.39 165.75 73.48 64.50 -135.17 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_4DEGA.pdb TYR DFGup 3 0JJ 2.00 -127.22 -154.53 999.00 52.13 48.21 176.94 -142.58 163.72 71.44 63.05 -129.17 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_4DEHA.pdb TYR DFGup 3 0JK 2.00 -118.81 -152.19 999.00 51.32 47.53 -179.43 -147.01 167.76 74.27 59.38 -132.01 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_4DEIA.pdb TYR DFGup 3 0JL 2.05 -122.36 -157.34 999.00 50.74 53.68 -177.81 -144.46 169.09 66.16 54.39 -127.42 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_4EEVA.pdb TYR DFGout 6 L1X 1.80 -151.01 -173.10 999.00 -148.12 112.44 -175.82 -69.25 -18.71 -79.80 62.90 999.00 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_4GG5A.pdb TYR DFGup 3 0J3 2.42 -122.35 -151.56 999.00 47.49 47.99 176.99 -143.94 162.14 78.18 62.50 -137.97 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_4GG7A.pdb TYR DFGup 3 0J8 2.27 -116.57 -141.80 999.00 44.89 50.78 179.58 -152.22 157.92 88.14 60.73 -133.39 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_4IWDA.pdb TYR Active 1 1JC 1.99 -108.11 -32.76 999.00 -101.31 130.91 -165.44 -125.91 29.16 -61.56 -62.52 -20.67 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_4KNBA.pdb TYR DFGup 3 1RU 2.40 -152.86 -179.43 999.00 62.04 58.91 -162.18 -149.52 152.72 61.82 75.54 -138.64 999.00 Allowed ALA ASP PHE GLY"
"MET_HUMAN t_4KNBB.pdb TYR DFGup 3 1RU 2.40 -140.53 -158.53 999.00 49.93 50.72 -163.48 -140.15 167.69 69.37 68.60 -122.43 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_4KNBC.pdb TYR DFGup 3 1RU 2.40 -156.57 -177.81 999.00 66.93 40.82 -163.66 -134.95 151.54 62.42 79.94 -136.12 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_4KNBD.pdb TYR DFGup 3 1RU 2.40 -149.27 -177.17 999.00 65.69 42.16 -156.82 -130.45 146.50 58.28 71.37 -113.28 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_4MXCA.pdb TYR DFGout 6 DWF 1.63 -151.33 -174.15 999.00 -157.04 122.42 -175.38 -67.93 -16.78 -72.47 58.23 -116.99 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_4R1VA.pdb TYR DFGup 3 GBL 1.20 -128.88 -160.49 999.00 55.59 46.44 -178.45 -145.41 164.25 73.07 59.70 -132.26 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_4R1YA.pdb TYR DFGup 3 3EH 2.00 -132.13 -159.51 999.00 51.33 47.35 172.66 -144.45 163.73 73.27 64.43 -132.68 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_4XMOA.pdb TYR DFGup 3 46G 1.75 -129.58 -158.20 999.00 50.91 49.80 -178.28 -142.14 164.63 70.00 57.35 -130.90 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_4XYFA.pdb TYR DFGup 3 44X 1.85 -129.21 -158.20 999.00 51.21 48.38 176.90 -138.69 167.76 72.03 55.52 -128.08 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_5DG5A.pdb TYR DFGout 6 5B4 2.60 -148.02 172.76 999.00 -125.93 63.02 -161.80 -65.10 -43.79 -170.00 74.01 -1.90 999.00 Allowed ALA ASP PHE GLY"
"MET_HUMAN t_5DG5B.pdb TYR DFGout 6 5B4 2.60 -148.47 172.73 999.00 -124.98 61.73 -166.14 -64.53 -43.31 -170.70 74.07 -2.17 999.00 Allowed ALA ASP PHE GLY"
"MET_HUMAN t_5EOBA.pdb TYR DFGup 3 5QQ 1.75 -127.26 -156.64 999.00 54.27 46.23 -179.67 -141.55 167.54 71.69 59.65 -131.59 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_5EYCA.pdb TYR DFGup 3 5SZ 1.80 -124.86 -162.53 999.00 54.79 49.51 -177.05 -141.17 168.10 68.49 54.48 -130.13 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_5EYDA.pdb TYR DFGup 3 5T1 1.85 -123.76 -156.52 999.00 49.64 49.98 -177.84 -139.66 165.24 70.94 56.83 -129.05 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_5HLWA.pdb TYR DFGin-trans 4 62E 1.97 -116.04 -153.09 999.00 53.73 45.99 -177.69 -117.52 136.99 172.54 55.36 -120.49 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_5HNIX.pdb TYR DFGup 3 63B 1.71 -128.76 -162.79 999.00 58.32 52.72 -176.66 -152.09 164.27 72.09 73.64 -141.33 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_5HNIY.pdb TYR DFGup 3 63B 1.71 -128.55 -162.88 999.00 56.31 57.74 -177.19 -160.13 163.56 72.78 74.96 -141.41 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_5HO6A.pdb TYR DFGup 3 63K 1.97 -140.59 -157.20 999.00 42.63 56.17 -161.42 -144.54 164.37 76.39 74.19 -133.43 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_5HOAA.pdb TYR DFGup 3 63K 2.14 -129.03 -150.38 999.00 47.03 45.17 -173.27 -132.57 158.74 62.19 76.84 -120.12 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_5HORA.pdb TYR DFGup 3 63K 2.20 -124.94 -148.72 999.00 45.84 47.68 179.40 -141.58 163.89 75.04 65.86 -137.91 999.00 Favored ALA ASP PHE GLY"
"MET_HUMAN t_5HTIA.pdb TYR DFGout 6 66L 1.66 -150.22 -171.17 999.00 -155.48 114.96 -173.12 -62.85 -20.22 -85.88 55.44 -118.13 999.00 Favored ALA ASP PHE GLY"
"MK01_HUMAN t_1PMEA.pdb CMGC Active 1 SB2 2.00 -135.99 -171.95 74.61 64.71 69.42 -168.78 -97.53 30.48 -72.15 -67.10 -32.75 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_1TVOA.pdb CMGC Active 1 FRZ 2.50 -143.01 -21.97 77.73 -99.57 92.25 -176.85 -97.24 29.08 -68.14 -57.86 -37.80 999.00 Favored CYS ASP PHE GLY"
"MK01_HUMAN t_1WZYA.pdb CMGC Active 1 F29 2.50 -125.92 -57.88 68.97 -77.68 107.86 -171.22 -107.29 23.47 -74.39 -59.33 -21.18 999.00 Favored CYS ASP PHE GLY"
"MK01_HUMAN t_2OJGA.pdb CMGC Active 1 19A 2.00 -127.45 179.26 66.70 64.17 86.13 -170.78 -104.30 28.80 -76.40 -67.49 -28.03 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_2OJIA.pdb CMGC Active 1 33A 2.60 -132.49 175.64 69.03 62.72 87.54 -166.68 -104.75 37.90 -75.77 -73.65 -20.78 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_2OJJA.pdb CMGC Active 1 82A 2.40 -134.64 171.25 69.20 66.27 85.68 -171.06 -103.18 35.03 -73.29 -71.39 -20.89 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_2Y9QA.pdb CMGC Active 1 ANP 1.55 -131.59 -173.62 73.41 71.28 62.62 -167.76 -94.20 18.46 -75.43 -60.61 -22.88 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_3I5ZA.pdb CMGC Active 1 Z48 2.20 -127.34 174.23 75.05 70.17 66.69 -167.67 -83.94 23.53 -71.71 -65.30 -33.03 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_3I60A.pdb CMGC Active 1 E86 2.50 -121.99 176.48 71.94 63.31 79.82 -165.28 -98.78 21.48 -79.50 -59.87 -40.08 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_3SA0A.pdb CMGC Active 1 NRA 1.59 -128.16 173.50 73.18 68.15 82.33 -164.41 -100.91 24.67 -75.38 -66.19 -21.63 999.00 NA NA ASP PHE GLY"
"MK01_HUMAN t_3TEIA.pdb CMGC Active 1 ANP 2.40 -130.78 -176.55 71.58 59.34 74.36 -61.99 -93.62 10.47 -71.88 -50.36 -31.13 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_3W55A.pdb CMGC Active 1 1FM 3.00 -114.49 159.81 -174.52 66.44 121.74 -148.31 -134.65 25.54 -78.61 -67.10 -27.11 999.00 Outlier CYS ASP PHE GLY"
"MK01_HUMAN t_4FMQA.pdb CMGC Active 1 ANP 2.10 -133.67 -170.96 72.63 67.67 66.11 -167.91 -98.26 21.64 -77.34 -61.30 -22.43 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4FUXA.pdb CMGC Active 1 E75 2.20 -132.01 173.18 83.44 64.20 92.43 -165.91 -107.28 29.07 -72.79 -62.92 -25.17 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4FUYA.pdb CMGC Active 1 EK2 2.00 -130.37 175.23 68.22 67.76 86.42 -161.94 -101.44 25.33 -73.01 -58.52 -28.98 999.00 NA NA ASP PHE GLY"
"MK01_HUMAN t_4FV0A.pdb CMGC Active 1 EK3 2.10 -135.41 177.44 69.91 64.34 87.13 -169.80 -103.54 24.77 -73.74 -61.64 -31.99 999.00 NA NA ASP PHE GLY"
"MK01_HUMAN t_4FV1A.pdb CMGC Active 1 EK4 1.99 -128.67 -179.94 69.60 58.70 89.27 -163.47 -103.93 26.86 -77.39 -62.56 -30.26 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4FV2A.pdb CMGC Active 1 EK5 2.00 -125.93 177.68 73.65 60.39 91.71 -165.61 -105.98 22.42 -77.76 -61.07 -31.37 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4FV3A.pdb CMGC Active 1 EK6 2.20 -128.43 176.78 74.28 62.30 92.22 -165.43 -108.69 28.98 -77.58 -64.36 -33.24 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4FV4A.pdb CMGC Active 1 EK7 2.50 -127.76 178.31 69.72 63.88 86.87 -154.67 -108.46 28.83 -78.59 -69.41 -40.13 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4FV5A.pdb CMGC Active 1 EK9 2.40 -125.91 174.50 73.73 65.80 87.03 -168.11 -106.84 28.61 -79.32 -65.59 -45.85 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4FV6A.pdb CMGC Active 1 E57 2.50 -126.86 -179.35 71.49 58.16 87.72 -172.05 -105.15 32.97 -79.42 -66.86 -48.48 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4FV7A.pdb CMGC Active 1 E94 1.90 -131.40 170.76 74.70 61.10 92.48 -168.25 -98.91 27.08 -77.24 -61.82 -27.98 999.00 Outlier CYS ASP PHE GLY"
"MK01_HUMAN t_4FV8A.pdb CMGC Active 1 E63 2.00 -127.03 -178.28 71.26 61.53 83.04 -144.18 -106.00 21.75 -77.83 -61.33 -37.29 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4FV9A.pdb CMGC Active 1 E71 2.11 -132.31 -178.12 68.69 59.19 84.25 -80.59 -105.44 23.09 -77.03 -62.47 -38.08 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4G6NA.pdb CMGC Active 1 EK0 2.00 -131.25 -179.76 71.05 63.09 82.21 -173.97 -100.94 24.93 -74.10 -63.07 -24.50 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4G6OA.pdb CMGC Active 1 E28 2.20 -132.28 171.18 81.30 68.08 92.66 -163.86 -108.93 25.24 -74.30 -63.09 -29.40 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4H3PA.pdb CMGC Active 1 ANP 2.30 -129.06 -179.27 70.67 65.08 71.95 -75.02 -98.47 28.28 -65.94 -57.11 -23.64 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4H3PD.pdb CMGC Active 1 ANP 2.30 -128.40 -178.25 66.18 63.91 70.54 -77.20 -94.42 28.00 -72.37 -60.92 -21.52 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4H3QA.pdb CMGC Active 1 ANP 2.20 -131.43 178.92 72.62 70.35 68.36 -161.01 -95.96 22.89 -69.75 -63.31 -20.78 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4IZ5A.pdb CMGC Active 1 ADP 3.19 -133.02 170.46 73.15 61.68 96.88 175.72 -113.27 30.02 -79.07 -75.09 -15.92 999.00 Outlier CYS ASP PHE GLY"
"MK01_HUMAN t_4IZ5B.pdb CMGC Active 1 ADP 3.19 -130.77 169.06 80.59 63.22 96.82 175.77 -112.33 27.90 -79.15 -73.46 -17.23 999.00 Outlier CYS ASP PHE GLY"
"MK01_HUMAN t_4IZ5C.pdb CMGC Active 1 ADP 3.19 -131.04 170.43 78.75 62.04 96.82 176.55 -112.74 28.97 -79.22 -74.24 -17.66 999.00 Outlier CYS ASP PHE GLY"
"MK01_HUMAN t_4IZ5D.pdb CMGC Active 1 ADP 3.19 -131.94 169.99 75.81 62.68 97.04 175.93 -112.71 27.71 -79.21 -72.18 -17.75 999.00 Outlier CYS ASP PHE GLY"
"MK01_HUMAN t_4IZ7A.pdb CMGC Active 1 Apo 1.80 -132.98 -178.75 71.57 63.68 80.30 -160.34 -101.41 20.31 -76.81 -60.99 -25.29 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4IZ7C.pdb CMGC Active 1 Apo 1.80 -132.66 -178.99 71.25 62.21 79.44 -144.13 -102.34 20.34 -74.76 -54.91 -29.20 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4IZAA.pdb CMGC Active 1 Apo 1.93 -129.80 -176.33 73.86 68.37 73.82 -162.78 -101.88 17.98 -79.89 -62.57 -26.19 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4IZAC.pdb CMGC Active 1 Apo 1.93 -135.47 -175.74 66.05 69.84 75.09 -163.63 -101.18 17.37 -74.53 -59.35 -25.36 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4N0SA.pdb CMGC Active 1 DHC 1.80 -128.71 171.76 73.43 67.98 85.58 -163.86 -103.31 23.70 -74.13 -64.58 -25.06 999.00 NA NA ASP PHE GLY"
"MK01_HUMAN t_4NIFB.pdb CMGC Active 1 ANP 2.15 -131.87 -169.39 72.25 69.46 63.11 -163.25 -98.39 22.67 -78.42 -63.26 -26.57 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4NIFE.pdb CMGC Active 1 ANP 2.15 -132.56 -168.43 73.52 65.69 64.40 -165.75 -97.82 21.15 -82.40 -63.57 -23.18 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4O6EA.pdb CMGC Active 1 2SH 1.95 -129.06 179.56 77.10 59.46 82.14 -157.61 -100.23 25.63 -77.13 -58.82 -35.99 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4QP1A.pdb CMGC Active 1 EMU 2.70 -131.44 175.76 73.44 65.14 79.31 -163.06 -100.67 29.11 -73.49 -63.39 -33.69 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4QP1B.pdb CMGC Active 1 EMU 2.70 -124.16 -176.15 74.95 57.52 85.86 -164.17 -105.53 31.09 -74.87 -70.35 -24.02 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4QP2A.pdb CMGC Active 1 NEP 2.23 -132.79 -177.04 72.57 60.43 76.20 -150.98 -97.46 23.39 -76.33 -63.16 -20.06 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4QP2B.pdb CMGC Active 1 NEP 2.23 -129.44 -178.45 72.98 61.58 82.09 -156.88 -103.19 25.27 -78.71 -66.07 -26.04 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4QP3A.pdb CMGC Active 1 36Q 2.60 -127.20 -175.68 72.54 56.19 83.16 -166.05 -104.19 33.90 -77.33 -70.01 -32.51 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4QP3B.pdb CMGC Active 1 36Q 2.60 -126.51 -174.44 74.49 52.27 87.63 -168.81 -103.67 26.43 -75.64 -63.66 -24.27 999.00 Outlier CYS ASP PHE GLY"
"MK01_HUMAN t_4QP4A.pdb CMGC Active 1 36O 2.20 -125.29 167.17 -66.24 64.14 90.54 -159.24 -108.17 22.64 -73.59 -64.26 -26.20 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4QP4B.pdb CMGC Active 1 36O 2.20 -131.83 174.35 -51.87 59.22 89.06 -155.70 -106.23 23.76 -71.64 -67.49 -18.31 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4QP6A.pdb CMGC Active 1 NEP 3.10 -134.22 177.23 78.14 61.25 85.89 -167.43 -106.15 27.45 -73.65 -64.17 -29.10 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4QP6B.pdb CMGC Active 1 NEP 3.10 -135.44 -176.62 66.63 58.97 85.88 -164.78 -108.92 30.36 -72.01 -72.13 -15.12 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4QP7A.pdb CMGC Active 1 363 2.25 -132.24 176.86 71.86 62.35 84.55 -155.51 -106.15 23.46 -71.52 -65.37 -26.82 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4QP7B.pdb CMGC Active 1 363 2.25 -135.45 179.04 69.63 61.44 85.62 -156.14 -106.30 24.24 -72.85 -67.13 -18.09 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4QP8A.pdb CMGC Active 1 362 2.45 -138.94 178.68 73.41 58.81 81.75 -155.56 -100.71 28.34 -75.32 -64.64 -23.90 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4QP8B.pdb CMGC Active 1 362 2.45 -132.54 -178.45 71.44 57.45 85.03 -159.07 -105.86 25.24 -74.82 -60.89 -34.16 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4QP9A.pdb CMGC Active 1 35X 2.00 -130.01 -173.87 69.62 68.18 72.94 -157.38 -105.10 24.90 -77.15 -66.80 -30.66 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4QPAA.pdb CMGC Active 1 NEP 2.85 -136.48 -177.35 72.61 57.89 81.72 -165.12 -102.92 29.56 -73.22 -68.52 -24.48 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4QPAB.pdb CMGC Active 1 NEP 2.85 -133.09 176.80 82.59 64.48 82.03 -168.73 -104.05 27.31 -75.00 -64.97 -31.40 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4QTAA.pdb CMGC Active 1 38Z 1.45 -127.55 173.09 69.96 71.55 87.55 -162.49 -104.46 22.83 -70.78 -66.50 -25.49 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4QTEA.pdb CMGC Active 1 390 1.50 -128.13 177.86 75.60 65.50 81.01 -168.07 -97.80 24.58 -78.28 -63.46 -27.51 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4XJ0A.pdb CMGC Active 1 NEP 2.58 -128.75 178.80 81.31 60.29 84.76 -157.01 -99.52 30.29 -73.08 -63.75 -36.41 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4XJ0B.pdb CMGC Active 1 41B 2.58 -132.75 176.02 83.05 57.21 85.51 -164.19 -101.01 27.49 -75.25 -64.52 -32.71 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4ZXTA.pdb CMGC Active 1 CAQ 2.00 -130.18 172.70 73.82 68.13 81.00 -170.51 -97.59 27.16 -73.02 -67.03 -23.57 999.00 NA NA ASP PHE GLY"
"MK01_HUMAN t_4ZZMA.pdb CMGC Active 1 CQ6 1.89 -126.62 -175.67 70.39 56.19 85.44 -159.45 -102.39 20.49 -74.24 -63.24 -29.03 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_4ZZNA.pdb CMGC Active 1 CQ8 1.33 -125.60 167.07 -59.43 59.42 95.38 -169.31 -102.43 18.59 -74.16 -61.10 -26.77 999.00 Outlier CYS ASP PHE GLY"
"MK01_HUMAN t_4ZZOA.pdb CMGC Active 1 CQ3 1.63 -131.29 174.97 71.46 60.67 93.93 -165.76 -105.69 18.31 -75.12 -63.58 -22.49 999.00 Outlier CYS ASP PHE GLY"
"MK01_HUMAN t_5AX3A.pdb CMGC Active 1 5ID 2.98 -127.73 -158.55 -49.15 57.94 57.38 -133.05 -96.01 22.02 -76.13 -69.99 -43.03 999.00 Favored CYS ASP PHE GLY"
"MK01_HUMAN t_5BUEA.pdb CMGC Active 1 4V8 2.40 -122.39 -177.09 66.83 63.39 82.66 -172.06 -105.25 21.87 -77.54 -61.62 -35.59 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_5BUIA.pdb CMGC Active 1 4V9 2.12 -130.14 179.54 70.24 65.08 80.01 -163.02 -99.34 20.24 -76.05 -59.57 -33.71 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_5BUJA.pdb CMGC Active 1 4VB 1.85 -125.47 -179.61 69.95 67.12 82.68 -151.05 -104.39 22.26 -76.54 -61.36 -32.85 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_5BVDA.pdb CMGC Active 1 4VF 1.90 -120.87 -174.95 68.59 58.46 83.20 -170.41 -99.85 23.45 -76.44 -56.88 -34.73 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_5BVEA.pdb CMGC Active 1 4VG 2.00 -125.14 -174.33 65.47 54.61 82.40 -168.47 -96.51 21.24 -77.71 -61.68 -24.39 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_5BVFA.pdb CMGC Active 1 4VJ 1.90 -123.99 -172.38 69.95 55.63 78.56 -171.32 -97.05 25.41 -76.60 -60.22 -26.61 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_5K4IA.pdb CMGC Active 1 6QB 1.76 -128.01 179.27 70.55 60.35 84.34 -163.49 -100.86 21.28 -79.62 -56.17 -35.31 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_5LCJA.pdb CMGC Active 1 6TS 1.78 -133.86 179.54 72.55 58.45 84.53 -160.56 -97.22 19.12 -72.67 -57.74 -29.68 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_5LCKA.pdb CMGC Active 1 6TT 1.89 -131.32 176.17 75.81 61.39 85.36 -163.77 -98.83 24.23 -71.85 -63.96 -28.09 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_5NGUA.pdb CMGC Active 1 8X2 2.74 -131.80 173.92 -98.17 54.64 63.74 -129.40 -75.39 12.59 -68.09 -57.77 -29.81 999.00 Favored CYS ASP PHE GLY"
"MK01_HUMAN t_5NHFA.pdb CMGC Active 1 8X5 2.14 -131.19 -177.21 67.65 60.40 71.65 -151.91 -95.07 17.54 -68.11 -59.29 -37.57 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_5NHHA.pdb CMGC Active 1 8XH 1.94 -123.57 -173.58 70.49 56.58 82.48 -179.37 -98.00 21.31 -74.93 -59.40 -24.92 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_5NHJA.pdb CMGC Active 1 8XE 2.12 -129.82 -179.76 74.76 60.62 76.52 -171.52 -95.65 20.88 -75.19 -59.36 -34.57 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_5NHLA.pdb CMGC Active 1 8XB 2.07 -139.35 -173.51 80.73 58.97 71.06 -171.06 -94.33 20.53 -75.84 -54.04 -36.61 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_5NHOA.pdb CMGC Active 1 8XN 2.24 -128.18 -172.82 74.89 57.63 69.41 -168.46 -93.17 16.77 -77.29 -59.66 -38.25 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_5NHPA.pdb CMGC Active 1 8XK 1.99 -133.42 177.49 78.12 61.57 77.47 -179.22 -96.31 22.53 -75.68 -59.53 -36.29 999.00 Allowed CYS ASP PHE GLY"
"MK01_HUMAN t_5NHVA.pdb CMGC Active 1 8QB 2.00 -123.56 177.95 74.88 58.61 89.38 -149.49 -103.18 22.56 -71.04 -58.62 -38.74 999.00 Allowed CYS ASP PHE GLY"
"MK03_HUMAN t_2ZOQA.pdb CMGC Active 1 5ID 2.39 -110.56 174.00 -129.52 16.56 106.82 -50.24 -100.81 23.96 -67.63 -56.96 -29.49 999.00 Outlier CYS ASP PHE GLY"
"MK03_HUMAN t_2ZOQB.pdb CMGC Active 1 5ID 2.39 -127.03 -169.72 66.84 58.48 71.42 -81.27 -96.77 32.60 -76.37 -68.28 -24.38 999.00 Allowed CYS ASP PHE GLY"
"MK03_HUMAN t_4QTBA.pdb CMGC Active 1 38Z 1.40 -128.58 172.07 73.11 72.18 87.28 -159.69 -104.63 23.53 -73.79 -64.02 -28.17 999.00 Allowed CYS ASP PHE GLY"
"MK03_HUMAN t_4QTBB.pdb CMGC Active 1 38Z 1.40 -131.41 169.89 74.29 76.08 86.94 -159.02 -105.16 21.24 -71.61 -59.53 -32.18 999.00 Allowed CYS ASP PHE GLY"
"MK06_HUMAN t_2I6LA.pdb CMGC Active 1 Apo 2.25 -132.69 -167.69 999.00 50.75 73.64 -71.77 -90.73 26.56 -69.37 -67.19 -20.15 999.00 Allowed GLY ASP PHE GLY"
"MK07_HUMAN t_4B99A.pdb CMGC Active 1 R4L 2.80 -135.50 173.50 999.00 69.93 87.25 -173.51 -107.26 19.62 -70.05 -62.03 -24.07 999.00 Allowed GLY ASP PHE GLY"
"MK07_HUMAN t_4IC7A.pdb CMGC Active 1 ANP 2.60 -112.55 -170.45 999.00 61.63 71.09 -149.68 -94.28 5.21 -74.74 -60.81 -23.83 999.00 Allowed GLY ASP PHE GLY"
"MK07_HUMAN t_4IC7D.pdb CMGC Active 1 ANP 2.60 -111.53 -167.36 999.00 56.79 75.85 -144.13 -99.22 4.74 -73.30 -57.32 -28.17 999.00 Allowed GLY ASP PHE GLY"
"MK07_HUMAN t_4IC8A.pdb CMGC DFGin-inactive 2 Apo 2.80 -92.05 155.41 999.00 51.25 -153.48 -130.77 -171.06 -173.86 -86.48 -73.92 141.82 999.00 Allowed GLY ASP PHE GLY"
"MK07_HUMAN t_4IC8B.pdb CMGC DFGin-inactive 2 Apo 2.80 -93.12 161.91 999.00 52.27 -151.76 -153.58 -177.26 -172.67 -96.28 -56.06 155.04 999.00 Allowed GLY ASP PHE GLY"
"MK07_HUMAN t_4ZSGA.pdb CMGC Active 1 4QX 1.79 -127.19 -178.81 999.00 58.34 79.98 -176.38 -94.43 20.05 -72.14 -54.89 -40.65 999.00 Allowed GLY ASP PHE GLY"
"MK07_HUMAN t_4ZSJA.pdb CMGC Active 1 4R0 2.48 -125.11 178.36 999.00 65.56 77.33 -173.32 -98.17 17.11 -70.09 -56.08 -39.22 999.00 Allowed GLY ASP PHE GLY"
"MK07_HUMAN t_4ZSLA.pdb CMGC Active 1 4QZ 2.25 -126.18 -176.15 999.00 60.71 76.14 -177.24 -96.37 17.80 -74.44 -59.31 -35.13 999.00 Allowed GLY ASP PHE GLY"
"MK07_HUMAN t_5BYYA.pdb CMGC Active 1 4WG 2.79 -135.49 173.16 999.00 64.90 86.36 -159.55 -107.09 16.04 -70.95 -67.69 -26.87 999.00 Allowed GLY ASP PHE GLY"
"MK07_HUMAN t_5BYZA.pdb CMGC Active 1 4WE 1.65 -125.64 176.26 999.00 59.17 87.69 -163.69 -101.33 15.44 -77.25 -63.60 -27.02 999.00 Allowed GLY ASP PHE GLY"
"MK08_HUMAN t_1UKHA.pdb CMGC DFGin-inactive 2 Apo 2.35 -71.02 -50.51 -146.04 -134.60 170.43 57.68 -88.06 19.74 -49.66 54.49 -119.24 999.00 Favored LEU ASP PHE GLY"
"MK08_HUMAN t_1UKIA.pdb CMGC DFGin-inactive 2 537 2.70 -77.10 -62.22 -95.76 -116.64 -161.05 42.30 -126.70 15.19 -41.28 41.85 -116.91 999.00 Allowed LEU ASP PHE GLY"
"MK08_HUMAN t_2G01A.pdb CMGC Active 1 73Q 3.50 -138.18 160.84 38.25 77.97 123.65 173.88 -129.31 5.42 -66.11 -38.69 -23.81 999.00 Outlier LEU ASP PHE GLY"
"MK08_HUMAN t_2G01B.pdb CMGC Active 1 73Q 3.50 -124.07 -159.91 -93.86 70.28 -99.12 -150.61 78.34 -8.57 -90.16 -60.67 -29.87 999.00 Outlier LEU ASP PHE GLY"
"MK08_HUMAN t_2GMXA.pdb CMGC Active 1 877 3.50 -169.50 -165.45 -150.17 17.65 94.29 -171.56 -93.02 32.73 -77.99 -74.80 -22.87 999.00 Outlier LEU ASP PHE GLY"
"MK08_HUMAN t_2GMXB.pdb CMGC Active 1 877 3.50 -106.99 -175.58 -71.43 54.57 -113.27 -114.06 110.30 -6.63 -80.54 -41.32 -39.47 999.00 Allowed LEU ASP PHE GLY"
"MK08_HUMAN t_2H96A.pdb CMGC Active 1 893 3.00 -142.04 170.53 -137.68 47.60 140.74 -135.04 -141.49 -1.19 -68.17 -55.79 -8.42 999.00 Outlier LEU ASP PHE GLY"
"MK08_HUMAN t_2H96B.pdb CMGC Active 1 893 3.00 -144.67 174.10 -170.72 54.02 123.30 -171.01 -119.25 -14.39 -81.91 -39.96 -62.72 999.00 Outlier LEU ASP PHE GLY"
"MK08_HUMAN t_2NO3A.pdb CMGC Active 1 859 3.20 -141.05 149.00 -157.56 75.76 137.70 -127.66 -138.70 16.74 -65.17 -53.98 -64.04 999.00 Allowed LEU ASP PHE GLY"
"MK08_HUMAN t_2NO3B.pdb CMGC Active 1 859 3.20 -157.76 177.06 40.87 69.61 114.65 -173.06 -132.59 1.78 -63.94 -53.18 -7.76 999.00 Outlier LEU ASP PHE GLY"
"MK08_HUMAN t_2XRWA.pdb CMGC DFGin-inactive 2 ANP 1.33 -85.35 -24.46 -75.85 -153.60 -176.99 63.31 -115.69 6.99 -55.87 88.05 -156.79 999.00 Favored LEU ASP PHE GLY"
"MK08_HUMAN t_2XS0A.pdb CMGC DFGin-inactive 2 ANP 2.60 -75.23 -22.90 -83.57 -148.15 -178.21 60.16 -116.01 26.93 -56.93 61.79 -161.42 999.00 Favored LEU ASP PHE GLY"
"MK08_HUMAN t_3ELJA.pdb CMGC DFGin-inactive 2 GS7 1.80 -96.18 -23.25 -65.09 -129.02 175.68 74.50 -123.68 12.94 -56.10 80.15 -148.42 999.00 Favored LEU ASP PHE GLY"
"MK08_HUMAN t_3O17A.pdb CMGC Active 1 Apo 3.00 -143.09 -155.12 -79.47 4.84 119.07 -160.26 -115.59 15.05 -68.47 -55.48 -42.86 999.00 Outlier LEU ASP PHE GLY"
"MK08_HUMAN t_3O17B.pdb CMGC Active 1 Apo 3.00 -141.53 176.46 172.26 56.88 126.67 -120.79 -136.57 6.23 -60.77 -50.50 -23.33 999.00 Outlier LEU ASP PHE GLY"
"MK08_HUMAN t_3O2MA.pdb CMGC Active 1 46A 2.70 -152.64 162.07 150.89 80.55 93.78 -151.26 -114.76 18.61 -55.21 -61.70 -39.93 999.00 Outlier LEU ASP PHE GLY"
"MK08_HUMAN t_3O2MB.pdb CMGC Active 1 46A 2.70 -142.37 178.22 103.98 61.34 93.10 -163.64 -105.38 24.62 -54.40 -54.82 -31.62 999.00 Outlier LEU ASP PHE GLY"
"MK08_HUMAN t_3PZEA.pdb CMGC DFGin-inactive 2 CFK 2.00 -81.13 -32.94 -82.45 -131.84 179.30 79.41 -115.74 16.98 -55.90 65.79 -99.92 999.00 Favored LEU ASP PHE GLY"
"MK08_HUMAN t_3V3VA.pdb CMGC Active 1 MYU 2.70 -143.80 -172.35 51.56 52.76 90.13 -152.37 -99.00 8.95 -53.61 -39.80 -30.72 999.00 Outlier LEU ASP PHE GLY"
"MK08_HUMAN t_3VUDA.pdb CMGC Active 1 Apo 3.50 -128.97 166.57 -97.30 47.03 116.79 -165.90 -121.87 36.89 -57.77 -73.55 -27.84 999.00 Outlier LEU ASP PHE GLY"
"MK08_HUMAN t_3VUGA.pdb CMGC Active 1 Apo 3.24 -151.28 155.65 173.61 63.84 102.62 -171.52 -110.80 4.88 -61.03 -61.18 -37.21 999.00 Outlier LEU ASP PHE GLY"
"MK08_HUMAN t_3VUHA.pdb CMGC Active 1 Apo 2.70 -148.39 170.78 -146.83 44.43 107.19 -156.82 -110.70 10.80 -54.86 -49.07 -34.51 999.00 Outlier LEU ASP PHE GLY"
"MK08_HUMAN t_3VUIA.pdb CMGC Active 1 Apo 2.80 -161.66 166.29 -148.88 49.12 98.82 -151.32 -100.90 7.49 -55.53 -57.37 -21.36 999.00 Outlier LEU ASP PHE GLY"
"MK08_HUMAN t_3VUKA.pdb CMGC Active 1 Apo 2.95 -160.03 162.59 141.01 68.63 104.55 -155.37 -110.89 -0.01 -56.62 -56.43 -11.89 999.00 Allowed LEU ASP PHE GLY"
"MK08_HUMAN t_3VULA.pdb CMGC Active 1 Apo 2.81 -85.90 163.21 -98.87 85.46 126.62 -94.96 -150.69 1.52 -21.19 -63.65 22.94 999.00 Outlier LEU ASP PHE GLY"
"MK08_HUMAN t_3VUMA.pdb CMGC Active 1 Apo 2.69 -112.58 170.27 47.57 77.89 128.75 -88.17 -145.26 34.81 -9.25 -58.07 -36.69 999.00 Outlier LEU ASP PHE GLY"
"MK08_HUMAN t_4AWIA.pdb CMGC DFGin-inactive 2 AQ2 1.91 -87.45 -25.97 -74.77 -129.33 164.61 -110.77 -108.89 6.21 -64.27 92.48 -161.86 999.00 Favored LEU ASP PHE GLY"
"MK08_HUMAN t_4E73A.pdb CMGC DFGin-inactive 2 0NR 2.27 -80.47 -42.55 -179.80 -144.37 -163.88 54.78 -110.57 6.59 -55.95 68.72 -151.83 999.00 Allowed LEU ASP PHE GLY"
"MK08_HUMAN t_4G1WA.pdb CMGC DFGin-inactive 2 G1W 2.45 -75.11 -46.15 -113.91 -144.97 -166.28 55.82 -101.85 11.40 -49.06 54.10 -150.72 999.00 Favored LEU ASP PHE GLY"
"MK08_HUMAN t_4HYSA.pdb CMGC DFGin-inactive 2 1BJ 2.42 -65.60 -42.99 -131.67 -148.15 -172.28 65.05 -105.45 11.46 -54.17 62.72 -152.88 999.00 Favored LEU ASP PHE GLY"
"MK08_HUMAN t_4HYUA.pdb CMGC DFGin-inactive 2 1BK 2.15 -80.81 -40.04 -127.63 -141.29 -176.83 58.20 -103.55 4.36 -56.87 67.68 -155.37 999.00 Favored LEU ASP PHE GLY"
"MK08_HUMAN t_4IZYA.pdb CMGC DFGin-inactive 2 1J2 2.30 -76.70 -38.96 -110.24 -145.61 -179.29 60.08 -102.39 14.52 -48.76 52.93 -142.09 999.00 Favored LEU ASP PHE GLY"
"MK08_HUMAN t_4L7FA.pdb CMGC DFGin-inactive 2 1V5 1.95 -92.78 -21.20 -66.91 -136.46 -179.86 72.62 -126.53 2.68 -61.22 123.83 92.84 999.00 Favored LEU ASP PHE GLY"
"MK08_HUMAN t_4QTDA.pdb CMGC DFGin-inactive 2 ANP 1.50 -89.71 -21.12 -69.60 -142.52 179.20 59.99 -115.45 9.22 -61.97 87.54 -156.74 999.00 Favored LEU ASP PHE GLY"
"MK08_HUMAN t_4UX9A.pdb CMGC Active 1 ANP 2.34 -106.90 -65.55 -139.47 -75.51 125.69 -171.85 -123.33 16.50 -55.70 -68.60 -34.26 999.00 Favored LEU ASP PHE GLY"
"MK08_HUMAN t_4UX9B.pdb CMGC Active 1 ANP 2.34 -95.26 -79.97 -129.00 -82.16 124.06 -170.96 -113.25 13.71 -62.20 -60.28 -32.67 999.00 Favored LEU ASP PHE GLY"
"MK08_HUMAN t_4UX9C.pdb CMGC Active 1 ANP 2.34 -110.47 -64.99 -144.80 -89.08 120.60 -179.72 -119.10 21.24 -50.94 -68.19 -26.54 999.00 Favored LEU ASP PHE GLY"
"MK08_HUMAN t_4UX9D.pdb CMGC Active 1 ANP 2.34 -120.58 -55.96 -163.66 -93.08 108.11 -164.21 -98.61 25.91 -58.89 -64.77 -33.87 999.00 Favored LEU ASP PHE GLY"
"MK08_HUMAN t_4YR8A.pdb CMGC DFGin-inactive 2 Apo 2.40 -92.43 -36.85 -89.80 -128.69 -177.97 67.43 -116.31 10.02 -57.46 79.23 -159.83 999.00 Favored LEU ASP PHE GLY"
"MK08_HUMAN t_4YR8C.pdb CMGC DFGin-inactive 2 Apo 2.40 -88.54 -41.43 -90.83 -131.52 -175.14 67.89 -114.87 11.52 -57.26 79.75 999.00 999.00 Favored LEU ASP PHE GLY"
"MK08_HUMAN t_4YR8E.pdb CMGC DFGin-inactive 2 Apo 2.40 -86.01 -36.97 -79.27 -129.23 170.40 68.74 -104.42 7.25 -60.35 81.68 -165.46 999.00 Favored LEU ASP PHE GLY"
"MK08_HUMAN t_4YR8F.pdb CMGC DFGin-inactive 2 Apo 2.40 -92.22 -40.68 -90.97 -125.11 178.17 -76.49 -117.36 11.64 -55.40 80.98 999.00 999.00 Favored LEU ASP PHE GLY"
"MK09_HUMAN t_3E7OA.pdb CMGC DFGin-inactive 2 35F 2.14 -84.40 -29.30 -132.78 -149.55 177.23 70.66 -106.24 9.74 -58.73 61.02 -143.00 999.00 Favored LEU ASP PHE GLY"
"MK09_HUMAN t_3E7OB.pdb CMGC DFGin-inactive 2 35F 2.14 -85.34 -37.58 -133.04 -133.47 175.29 60.89 -107.31 15.86 -60.52 90.38 999.00 999.00 Favored LEU ASP PHE GLY"
"MK09_HUMAN t_3NPCA.pdb CMGC DFGout 6 B96 2.35 -139.80 -172.33 50.10 -137.55 102.07 -167.49 -94.23 29.95 -157.44 -70.53 123.51 999.00 Favored LEU ASP PHE GLY"
"MK09_HUMAN t_3NPCB.pdb CMGC DFGout 6 B96 2.35 -135.89 -171.62 44.32 -135.34 101.93 -167.43 -93.50 35.83 -158.45 -76.91 126.47 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_1JNKA.pdb CMGC DFGin-inactive 2 ANP 2.30 -78.27 -57.30 -70.47 -98.47 177.54 66.69 -110.07 6.64 -65.43 91.41 -137.75 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_1PMNA.pdb CMGC DFGin-inactive 2 984 2.20 -94.08 -17.78 -55.22 -131.07 174.11 72.16 -109.18 11.87 -58.18 81.33 -155.79 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_1PMUA.pdb CMGC DFGin-inactive 2 9HP 2.70 -71.30 -47.97 -58.91 -119.25 164.64 77.27 -96.56 38.23 -56.27 37.12 -161.09 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_1PMVA.pdb CMGC DFGin-inactive 2 537 2.50 -81.64 -103.80 -68.49 -56.05 179.40 80.95 -108.33 6.75 -67.59 88.10 -161.96 999.00 Outlier LEU ASP PHE GLY"
"MK10_HUMAN t_2B1PA.pdb CMGC DFGin-inactive 2 AIZ 1.90 -99.33 -15.45 -60.95 -130.07 173.08 83.08 -117.75 9.79 -64.27 77.28 -157.18 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_2EXCX.pdb CMGC DFGin-inactive 2 JNK 2.75 -86.69 -35.55 -65.17 -120.49 171.64 83.77 -113.25 9.07 -55.77 88.89 -156.42 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_2O0UA.pdb CMGC DFGin-inactive 2 C0M 2.10 -96.16 3.75 -61.01 -155.62 163.16 78.88 -108.21 4.57 -65.52 86.18 -149.71 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_2O2UA.pdb CMGC DFGin-inactive 2 738 2.45 -96.36 -18.25 -82.32 -146.22 176.99 77.78 -117.79 12.17 -67.19 89.66 -161.36 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_2OK1A.pdb CMGC DFGin-inactive 2 33A 2.40 -92.49 -22.82 -73.81 -139.74 178.50 74.20 -118.67 10.84 -57.56 65.65 -145.56 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_2P33A.pdb CMGC DFGin-inactive 2 J07 2.40 -87.69 -46.85 -69.77 -121.28 -179.50 72.60 -108.24 17.90 -55.79 72.89 -164.07 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_2R9SA.pdb CMGC DFGin-inactive 2 UNX 2.40 -77.43 -31.00 -101.21 -148.48 -179.18 75.28 -116.22 5.55 -59.52 75.56 -150.77 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_2R9SB.pdb CMGC DFGin-inactive 2 255 2.40 -79.37 -32.15 -94.71 -143.61 -178.82 75.49 -118.89 2.06 -64.29 84.88 -147.56 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_2WAJA.pdb CMGC DFGin-inactive 2 SNB 2.40 -101.81 -14.59 -52.99 -131.00 175.50 83.51 -120.40 11.35 -59.52 88.98 -150.30 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_2ZDTA.pdb CMGC DFGin-inactive 2 46C 2.00 -92.13 -23.43 -75.09 -141.00 174.08 69.92 -115.92 11.23 -61.24 73.18 -155.13 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_2ZDUA.pdb CMGC DFGin-inactive 2 446 2.50 -92.64 -29.09 -71.38 -139.88 -177.55 66.33 -119.57 20.22 -58.46 53.32 -144.85 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_3CGFA.pdb CMGC DFGin-inactive 2 JNF 3.00 -89.61 -53.31 -59.40 -106.94 -179.49 63.75 -117.01 20.49 -50.20 76.52 -162.81 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_3CGOA.pdb CMGC DFGin-inactive 2 JNO 3.00 -83.66 -72.58 -66.51 -89.35 -177.07 61.64 -119.19 23.12 -59.67 73.73 -174.62 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_3DA6A.pdb CMGC DFGin-inactive 2 BZ9 2.00 -106.53 -2.77 -63.39 -134.72 178.16 74.64 -120.73 7.11 -54.44 77.84 -153.98 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_3FI2A.pdb CMGC DFGin-inactive 2 JK1 2.28 -97.97 -16.78 -57.91 -139.01 175.85 69.37 -116.71 9.02 -63.67 76.44 -166.14 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_3FI3A.pdb CMGC DFGin-inactive 2 JK2 2.20 -95.25 -22.44 -68.29 -138.08 179.25 68.36 -118.59 12.34 -62.43 81.05 -161.87 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_3FV8A.pdb CMGC DFGin-inactive 2 JK3 2.28 -83.17 -27.03 -66.50 -139.57 175.60 74.22 -113.26 11.78 -58.84 68.04 -169.19 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_3G90X.pdb CMGC DFGin-inactive 2 J72 2.40 -86.93 -36.26 -74.89 -125.57 173.03 76.38 -113.00 14.97 -59.65 83.13 -154.03 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_3G9LX.pdb CMGC DFGin-inactive 2 J67 2.20 -87.76 -18.00 -63.36 -139.84 174.82 79.42 -117.10 15.43 -57.82 80.82 -161.14 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_3G9NA.pdb CMGC DFGin-inactive 2 J88 2.80 -80.77 -31.45 -61.63 -126.46 165.07 85.65 -103.94 16.14 -53.88 66.49 -150.08 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_3KVXA.pdb CMGC DFGin-inactive 2 FMY 2.40 -68.70 -40.89 -66.26 -149.07 -179.99 66.49 -95.87 -1.15 -63.47 74.50 -148.35 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_3OXIA.pdb CMGC DFGup 3 SYY 2.20 -65.72 -67.29 -88.50 -149.20 -142.58 -140.32 -154.48 112.56 32.17 -52.07 999.00 999.00 Allowed LEU ASP PHE GLY"
"MK10_HUMAN t_3OY1A.pdb CMGC DFGin-inactive 2 589 1.70 -89.62 -26.59 -67.36 -122.11 179.02 75.94 -120.20 5.89 -60.17 81.86 -146.55 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_3PTGA.pdb CMGC DFGup 3 932 2.43 -76.49 -95.64 -138.43 -85.66 -153.04 22.35 -174.60 83.57 38.15 -80.20 -76.03 999.00 Allowed LEU ASP PHE GLY"
"MK10_HUMAN t_3RTPA.pdb CMGC DFGin-inactive 2 34I 2.40 -84.08 -44.73 -59.85 -108.46 176.15 63.36 -118.73 3.79 -66.53 79.07 -140.15 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_3TTIA.pdb CMGC DFGin-inactive 2 KBI 2.20 -84.84 -25.79 -61.66 -129.57 177.43 78.80 -125.34 9.46 -68.47 87.50 -161.74 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_3TTJA.pdb CMGC DFGin-inactive 2 JBI 2.10 -95.22 -16.77 -55.96 -130.99 179.26 79.28 -123.73 12.33 -63.07 77.38 -154.89 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_3V6RA.pdb CMGC Active 1 CQQ 2.60 -80.91 -43.52 -68.58 -97.10 172.04 -145.61 -129.85 -2.67 -59.62 62.49 -138.58 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_3V6RB.pdb CMGC DFGin-inactive 2 CQQ 2.60 -79.98 -42.27 -68.74 -119.01 -179.24 59.17 -116.60 11.94 -51.93 75.26 -171.94 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_3V6SA.pdb CMGC Active 1 0F0 2.97 -80.55 -45.48 -68.97 -95.35 173.24 -146.42 -129.98 -1.36 -59.90 61.29 -137.30 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_3V6SB.pdb CMGC DFGin-inactive 2 0F0 2.97 -78.89 -43.79 -69.27 -118.40 -177.54 56.77 -117.04 14.29 -51.54 72.16 -167.20 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_4H36A.pdb CMGC DFGup 3 Apo 3.00 -105.62 164.64 -65.93 61.07 38.89 -61.74 -74.13 126.15 41.86 66.43 30.07 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_4H39A.pdb CMGC DFGin-inactive 2 Apo 1.99 -135.71 177.63 33.93 67.79 58.06 -74.56 -48.04 39.40 -51.72 82.75 999.00 999.00 Allowed LEU ASP PHE GLY"
"MK10_HUMAN t_4H3BA.pdb CMGC DFGup 3 Apo 2.08 -123.44 176.66 47.92 67.23 22.90 -71.78 -66.28 128.61 45.15 81.84 0.10 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_4H3BC.pdb CMGC DFGup 3 Apo 2.08 -121.72 179.80 50.06 65.29 21.42 -72.27 -67.36 128.29 47.58 80.34 1.93 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_4KKEA.pdb CMGC DFGin-inactive 2 AMP 2.20 -84.02 -33.39 -72.85 -131.72 175.67 60.17 -114.10 11.11 -57.16 75.65 -152.91 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_4KKGA.pdb CMGC DFGin-inactive 2 Apo 2.40 -75.85 -45.12 -96.26 -131.34 176.62 80.32 -113.15 12.39 -50.57 80.13 -157.34 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_4KKHA.pdb CMGC DFGin-inactive 2 1RQ 2.00 -95.79 -15.68 -62.14 -135.53 174.07 79.81 -119.94 12.54 -58.54 78.84 -148.79 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_4U79A.pdb CMGC DFGin-inactive 2 3EL 2.23 -89.36 -23.00 -76.81 -142.11 177.19 69.98 -106.91 6.68 -68.96 89.78 -154.85 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_4W4VA.pdb CMGC DFGin-inactive 2 3H8 2.01 -93.02 -11.85 -54.10 -133.67 176.77 76.72 -119.58 8.27 -60.75 75.46 -157.38 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_4W4WA.pdb CMGC DFGin-inactive 2 3HJ 1.90 -95.32 -15.18 -61.99 -130.03 177.53 81.01 -120.00 14.90 -60.21 73.80 -145.48 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_4W4XA.pdb CMGC DFGin-inactive 2 3HN 2.65 -89.64 -15.11 -64.50 -132.25 173.80 74.65 -116.29 13.60 -56.55 62.02 -143.63 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_4W4YA.pdb CMGC DFGin-inactive 2 3HQ 2.30 -87.34 -26.79 -67.15 -126.86 -179.26 74.23 -120.49 13.19 -61.04 71.47 -157.38 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_4WHZA.pdb CMGC DFGin-inactive 2 3NL 1.79 -94.46 -12.46 -55.18 -131.06 177.50 79.76 -120.62 15.04 -59.54 70.59 -144.04 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_4X21A.pdb CMGC DFGin-inactive 2 3WH 1.95 -86.12 -29.51 -84.49 -144.63 -176.05 70.76 -119.17 12.33 -57.85 63.86 -139.05 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_4X21B.pdb CMGC DFGin-inactive 2 3WH 1.95 -86.98 -29.76 -85.01 -145.91 -175.12 64.50 -114.66 15.36 -61.62 78.32 -160.53 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_4Y46A.pdb CMGC DFGin-inactive 2 4F2 2.04 -87.73 -26.54 -75.53 -138.90 174.85 68.41 -115.05 15.81 -56.40 76.98 -156.69 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_4Y5HA.pdb CMGC DFGin-inactive 2 519 2.06 -89.60 -28.66 -76.33 -137.85 174.11 68.49 -115.43 14.06 -58.03 82.22 -166.70 999.00 Favored LEU ASP PHE GLY"
"MK10_HUMAN t_4Z9LA.pdb CMGC DFGin-inactive 2 ANP 2.10 -84.30 -25.73 -57.14 -124.66 176.36 75.10 -117.04 11.07 -59.86 64.92 -148.07 999.00 Favored LEU ASP PHE GLY"
"MK11_HUMAN t_3GC8A.pdb CMGC DFGin-inactive 2 B45 2.40 -85.82 -36.52 -109.13 -146.74 -173.56 59.02 -126.88 32.73 -44.17 81.71 23.75 999.00 Favored LEU ASP PHE GLY"
"MK11_HUMAN t_3GC8B.pdb CMGC DFGin-inactive 2 B45 2.40 -90.40 -38.26 -73.37 -140.99 -170.68 54.93 -125.05 15.37 -57.00 92.32 1.86 999.00 Favored LEU ASP PHE GLY"
"MK11_HUMAN t_3GC9A.pdb CMGC DFGin-inactive 2 B45 2.05 -99.36 135.69 -49.92 55.54 168.58 63.50 -126.65 27.36 -50.49 93.21 8.19 999.00 Outlier LEU ASP PHE GLY"
"MK11_HUMAN t_3GC9B.pdb CMGC DFGin-inactive 2 B45 2.05 -83.56 -36.13 -76.85 -149.14 -175.59 60.23 -122.51 15.87 -55.92 77.88 14.27 999.00 Favored LEU ASP PHE GLY"
"MK11_HUMAN t_3GP0A.pdb CMGC DFGout 6 NIL 1.90 -137.43 -178.20 59.95 -147.84 107.55 -176.24 -69.16 -20.40 -119.75 90.87 999.00 999.00 Favored LEU ASP PHE GLY"
"MK12_HUMAN t_1CM8A.pdb CMGC Active 1 ANP 2.40 -109.08 -177.77 -59.08 49.86 82.61 -152.71 -94.67 22.01 -80.33 -61.43 -21.22 999.00 Outlier LEU ASP PHE GLY"
"MK12_HUMAN t_1CM8B.pdb CMGC Active 1 ANP 2.40 -106.93 -177.80 -59.08 50.57 81.92 -152.40 -94.27 22.08 -80.07 -61.03 -21.75 999.00 Allowed LEU ASP PHE GLY"
"MK13_HUMAN t_3COIA.pdb CMGC DFGup 3 Apo 2.09 -109.30 158.40 -46.12 67.05 25.75 -65.74 -76.20 161.55 53.19 69.16 9.54 999.00 Favored LEU ASP PHE GLY"
"MK13_HUMAN t_4EYJA.pdb CMGC DFGout 6 N61 2.10 -119.62 169.44 -62.62 -144.63 93.70 -174.63 -65.98 -22.89 -113.66 167.63 -135.29 999.00 Favored LEU ASP PHE GLY"
"MK13_HUMAN t_4EYMA.pdb CMGC DFGup 3 0RX 2.35 -111.28 161.00 -52.38 55.40 39.77 -92.34 -81.97 162.62 49.75 62.26 29.06 999.00 Favored LEU ASP PHE GLY"
"MK13_HUMAN t_4MYGA.pdb CMGC Active 1 Apo 2.59 -125.13 168.05 -56.82 61.78 91.08 -167.50 -102.71 31.05 -70.06 -74.57 -23.37 999.00 Allowed LEU ASP PHE GLY"
"MK13_HUMAN t_4MYGB.pdb CMGC Active 1 Apo 2.59 -124.98 166.59 -57.99 60.99 90.26 -165.76 -103.94 32.51 -71.49 -75.37 -22.82 999.00 Allowed LEU ASP PHE GLY"
"MK13_HUMAN t_4YNOA.pdb CMGC DFGup 3 Apo 1.70 -106.94 159.81 -42.55 58.89 35.47 -64.31 -83.61 151.40 56.09 75.55 13.40 999.00 Favored LEU ASP PHE GLY"
"MK13_HUMAN t_5EKOA.pdb CMGC DFGup 3 N17 2.00 -108.70 155.22 -55.35 64.30 36.83 -75.02 -82.94 147.41 52.84 75.47 26.36 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_1A9UA.pdb CMGC DFGin-inactive 2 SB2 2.50 -114.41 -166.18 -69.42 12.94 87.85 -40.25 -68.21 136.55 -79.56 -65.63 -40.38 999.00 Outlier LEU ASP PHE GLY"
"MK14_HUMAN t_1BL6A.pdb CMGC DFGin-inactive 2 SB6 2.50 -145.23 -172.56 32.07 51.81 52.44 -111.10 -53.48 141.27 -75.40 -55.42 -57.89 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_1BL7A.pdb CMGC DFGin-inactive 2 SB4 2.50 -135.83 -164.98 35.02 45.25 53.09 -90.74 -57.33 172.63 -84.26 -88.13 -57.19 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_1BMKA.pdb CMGC DFGin-inactive 2 SB5 2.40 -137.23 -169.70 35.60 56.37 44.79 -96.55 -45.17 133.81 -73.64 -52.16 -75.72 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_1DI9A.pdb CMGC DFGin-inactive 2 MSQ 2.60 -140.44 -172.26 74.88 47.28 67.40 -154.88 -68.51 162.45 -75.47 -75.92 110.18 999.00 Allowed LEU ASP PHE GLY"
"MK14_HUMAN t_1KV1A.pdb CMGC DFGout 6 BMU 2.50 -159.26 -177.06 60.04 -146.06 100.86 -168.61 -75.43 -134.46 -77.91 154.13 999.00 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_1M7QA.pdb CMGC DFGin-inactive 2 DQO 2.40 -116.56 -179.84 -68.52 62.91 86.73 -76.25 -124.27 146.08 -81.44 54.78 19.36 999.00 Allowed LEU ASP PHE GLY"
"MK14_HUMAN t_1OUKA.pdb CMGC DFGin-inactive 2 084 2.50 -120.31 176.38 -66.19 71.71 79.25 -85.39 -115.84 130.75 -78.31 65.22 27.20 999.00 Allowed LEU ASP PHE GLY"
"MK14_HUMAN t_1OUYA.pdb CMGC DFGin-inactive 2 094 2.50 -127.03 171.97 -32.99 70.20 95.75 -73.02 -131.29 146.16 -78.26 57.28 32.55 999.00 Allowed LEU ASP PHE GLY"
"MK14_HUMAN t_1OVEA.pdb CMGC DFGup 3 358 2.10 -131.90 174.29 46.53 62.17 23.91 -72.38 -68.59 149.31 35.77 53.79 19.10 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_1OZ1A.pdb CMGC DFGin-inactive 2 FPH 2.10 -114.14 172.09 -89.56 85.45 88.75 -79.04 -133.95 133.92 -75.23 65.26 19.91 999.00 Outlier LEU ASP PHE GLY"
"MK14_HUMAN t_1R39A.pdb CMGC DFGin-inactive 2 Apo 2.30 -100.59 170.65 -52.45 -1.01 98.09 50.25 -65.32 170.45 -37.45 -64.26 131.70 999.00 Outlier LEU ASP PHE GLY"
"MK14_HUMAN t_1R3CA.pdb CMGC DFGin-inactive 2 Apo 2.00 -145.02 -172.93 45.08 51.61 52.85 -82.43 -55.34 152.68 -72.63 -71.81 106.36 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_1W7HA.pdb CMGC DFGin-inactive 2 3IP 2.21 -126.95 174.83 -44.45 45.33 68.52 -61.19 -59.93 158.97 -69.76 -65.47 100.89 999.00 Allowed LEU ASP PHE GLY"
"MK14_HUMAN t_1W82A.pdb CMGC DFGout 6 L10 2.2 -147.83 -178.13 62.60 -145.48 99.07 -170.17 -49.92 -42.30 -82.20 66.12 29.03 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_1W83A.pdb CMGC DFGout 6 L11 2.5 -142.16 -178.02 41.82 -126.64 107.97 -162.55 -77.03 -19.04 -93.08 -50.87 116.64 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_1W84A.pdb CMGC DFGin-inactive 2 L12 2.2 -120.78 171.91 -84.01 61.55 62.37 -96.09 -66.90 153.53 -76.54 -66.72 86.29 999.00 Allowed LEU ASP PHE GLY"
"MK14_HUMAN t_1WBNA.pdb CMGC DFGout 6 L09 2.4 -144.71 -164.96 62.98 -135.25 106.59 -164.28 -72.65 -9.67 -67.12 -55.54 132.40 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_1WBOA.pdb CMGC DFGin-inactive 2 Apo 2.16 -102.08 -162.63 -83.99 -36.62 129.23 -50.44 -76.33 147.96 -73.07 -66.99 104.73 999.00 Allowed LEU ASP PHE GLY"
"MK14_HUMAN t_1WBSA.pdb CMGC DFGout 6 LI2 1.8 -141.08 -171.86 66.70 -138.43 108.83 -166.95 -92.66 15.81 -154.82 -67.67 124.28 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_1WBTA.pdb CMGC DFGout 6 WBT 2.0 -136.66 -169.82 66.73 -139.16 111.91 -161.11 -100.89 32.01 -158.68 -84.40 113.54 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_1WBVA.pdb CMGC DFGout 6 LI3 2.0 -134.67 -171.43 54.29 -143.37 105.98 -170.55 -79.35 -25.76 -77.29 -27.16 80.55 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_1WBWA.pdb CMGC DFGin-inactive 2 LI4 2.41 -114.87 175.79 -44.91 52.98 77.01 -146.72 -65.31 9.04 -76.54 71.80 22.46 999.00 Allowed LEU ASP PHE GLY"
"MK14_HUMAN t_1YQJA.pdb CMGC DFGin-inactive 2 6NP 2.00 -138.77 -163.88 6.03 37.64 61.54 -160.78 -60.11 143.61 -63.42 -86.44 47.79 999.00 Allowed LEU ASP PHE GLY"
"MK14_HUMAN t_1ZYJA.pdb CMGC DFGup 3 BI5 2.00 -112.41 162.74 -72.21 46.49 45.81 -63.94 -86.78 159.00 43.72 65.25 17.56 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_1ZZ2A.pdb CMGC DFGup 3 B11 2.00 -120.91 149.07 -178.90 49.93 48.26 -65.30 -88.36 160.51 50.52 68.42 12.44 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_1ZZLA.pdb CMGC DFGup 3 TZY 2.00 -103.69 163.23 -38.96 58.08 31.21 -78.25 -75.39 145.76 47.86 65.89 14.83 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_2BAJA.pdb CMGC DFGout 6 1PP 2.25 -151.05 178.15 56.70 -142.32 101.21 -167.99 -49.25 -43.13 -85.45 58.02 32.94 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_2BAKA.pdb CMGC DFGout 6 AQZ 2.20 -143.44 -169.83 63.57 -148.06 89.95 -158.57 -71.47 -10.40 -58.55 74.79 999.00 999.00 Allowed LEU ASP PHE GLY"
"MK14_HUMAN t_2BALA.pdb CMGC DFGup 3 PQA 2.10 -114.21 157.24 -41.49 64.97 21.24 -60.77 -58.21 154.54 45.11 67.42 7.35 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_2BAQA.pdb CMGC DFGout 6 PQB 2.80 -89.30 142.23 -52.00 -51.16 -47.99 56.34 -140.36 153.62 -64.70 -84.86 -141.63 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_2I0HA.pdb CMGC DFGup 3 222 2.00 -106.39 160.44 -56.16 62.37 22.33 -96.77 -65.15 141.95 38.89 71.90 -3.35 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_2LGCA.pdb CMGC DFGin-inactive 2 Apo 0 -116.28 156.15 -73.64 60.42 71.21 -75.98 -53.59 154.50 -52.24 -86.07 41.21 999.00 Allowed LEU ASP PHE GLY"
"MK14_HUMAN t_2OKRA.pdb CMGC DFGin-inactive 2 Apo 2.00 -134.79 -177.83 34.65 43.57 67.67 -71.39 -61.96 143.88 -74.05 -63.83 118.16 999.00 Allowed LEU ASP PHE GLY"
"MK14_HUMAN t_2OKRD.pdb CMGC DFGin-inactive 2 Apo 2.00 -136.02 175.65 36.26 52.53 66.46 -71.24 -59.94 143.53 -75.43 -61.51 109.70 999.00 Allowed LEU ASP PHE GLY"
"MK14_HUMAN t_2ONLA.pdb CMGC DFGin-inactive 2 Apo 4.00 -139.82 -177.89 49.80 43.30 77.40 -79.09 -75.25 146.41 -69.48 -62.90 116.45 999.00 Allowed LEU ASP PHE GLY"
"MK14_HUMAN t_2ONLB.pdb CMGC DFGin-inactive 2 Apo 4.00 -141.85 -179.23 49.40 45.17 76.77 -79.82 -75.33 145.49 -71.96 -62.51 115.00 999.00 Allowed LEU ASP PHE GLY"
"MK14_HUMAN t_2QD9A.pdb CMGC DFGup 3 LGF 1.70 -108.90 149.01 164.59 74.75 24.85 -76.71 -73.04 150.78 49.52 82.09 6.16 999.00 Allowed LEU ASP PHE GLY"
"MK14_HUMAN t_2RG5A.pdb CMGC DFGup 3 279 2.40 -115.62 149.27 -60.92 66.71 28.56 -57.80 -74.99 151.50 46.30 68.05 7.04 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_2RG6A.pdb CMGC DFGup 3 287 1.72 -115.88 160.46 -55.82 63.46 25.52 -65.90 -76.40 154.40 53.76 66.13 10.52 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_2Y8OA.pdb CMGC DFGin-inactive 2 Apo 1.95 -138.40 -179.54 52.57 53.31 59.76 -72.32 -55.84 145.33 -76.41 -67.66 123.71 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_2YIXA.pdb CMGC DFGup 3 YIX 2.30 -114.67 159.00 -95.96 60.08 31.77 -82.33 -79.34 149.56 45.32 60.63 15.82 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_2ZAZA.pdb CMGC DFGup 3 GK1 1.80 -115.21 176.01 -43.93 60.90 77.68 -68.27 -123.17 161.73 6.93 78.42 12.17 999.00 Allowed LEU ASP PHE GLY"
"MK14_HUMAN t_2ZB0A.pdb CMGC DFGin-inactive 2 GK3 2.10 -137.48 -175.23 68.09 49.79 58.58 -69.93 -56.19 139.16 -75.67 -63.78 112.09 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_2ZB1A.pdb CMGC DFGin-inactive 2 GK4 2.50 -130.36 170.66 -67.61 45.62 69.74 -71.55 -60.50 135.81 -62.08 -60.16 109.20 999.00 Allowed LEU ASP PHE GLY"
"MK14_HUMAN t_3BV2A.pdb CMGC DFGout 6 P38 2.40 -130.51 -172.25 52.02 -144.12 148.36 -156.99 64.07 33.68 -44.56 -55.64 125.62 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3BV3A.pdb CMGC DFGout 6 P39 2.59 -135.61 -173.61 56.08 -142.62 155.73 -147.35 58.93 28.23 -45.50 -62.18 128.85 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3BX5A.pdb CMGC DFGup 3 304 2.40 -125.12 165.16 -32.59 58.71 24.44 -64.70 -71.05 153.46 43.26 58.14 20.76 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3C5UA.pdb CMGC DFGup 3 P41 2.80 -80.00 -52.06 -168.92 -111.84 147.21 -95.98 165.51 164.65 70.93 -178.35 -57.27 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3CTQA.pdb CMGC DFGout 6 337 1.95 -131.82 -176.80 -58.42 -153.59 135.60 -168.90 -106.93 11.31 -57.13 51.03 999.00 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3D7ZA.pdb CMGC DFGup 3 GK5 2.10 -110.03 159.11 -37.50 71.26 19.50 -72.79 -70.41 155.52 43.01 62.33 11.67 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3D83A.pdb CMGC DFGout 6 GK6 1.90 -137.20 -168.50 64.56 -140.76 108.24 -165.17 -84.28 -6.54 -76.40 -53.98 125.28 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3DS6A.pdb CMGC DFGup 3 A17 2.90 -122.93 172.78 -41.64 47.41 37.06 -84.29 -83.53 151.14 48.86 61.16 21.08 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3DS6B.pdb CMGC DFGup 3 A17 2.90 -123.61 166.73 -29.57 55.04 30.78 -83.70 -85.57 160.66 52.05 59.14 32.99 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3DS6C.pdb CMGC DFGup 3 A17 2.90 -127.14 170.92 -34.10 50.06 37.26 -83.04 -87.87 170.72 41.17 57.98 29.63 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3DS6D.pdb CMGC DFGup 3 A17 2.90 -127.49 166.89 -34.43 61.12 14.94 -97.48 -65.94 148.64 51.57 79.39 71.96 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3DT1A.pdb CMGC DFGup 3 P40 2.80 -113.30 169.92 -46.56 39.91 59.99 -63.38 -100.91 153.79 42.89 60.43 18.46 999.00 Allowed LEU ASP PHE GLY"
"MK14_HUMAN t_3E92A.pdb CMGC DFGup 3 G6A 2.00 -118.49 163.03 -41.80 66.43 15.71 -99.24 -63.59 154.48 39.97 65.39 13.16 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3E93A.pdb CMGC DFGout 6 19B 2.00 -135.96 -177.12 55.72 -132.72 104.82 -167.07 -82.95 5.62 -67.37 -52.23 119.05 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3FC1X.pdb CMGC DFGin-inactive 2 52P 2.40 -126.15 -173.98 72.28 53.20 -144.46 -64.82 158.59 119.80 -80.05 999 999 999 Allowed LEU ASP PHE GLY"
"MK14_HUMAN t_3FI4A.pdb CMGC DFGup 3 FI4 2.20 -116.74 163.09 -68.29 65.47 26.77 -60.31 -74.79 149.05 43.15 76.85 6.17 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3FKLA.pdb CMGC DFGup 3 FKL 2.00 -114.21 158.36 -80.99 70.29 22.28 -69.02 -77.15 155.33 49.53 76.32 7.80 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3FKNA.pdb CMGC DFGup 3 FKN 2.00 -103.92 161.20 -74.88 68.91 15.36 -63.51 -60.00 144.95 37.38 95.65 999.00 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3FKOA.pdb CMGC DFGup 3 FKO 2.00 -111.43 157.25 -75.30 69.47 28.28 -67.18 -72.66 144.46 41.02 70.04 9.97 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3FL4A.pdb CMGC DFGup 3 FL4 1.80 -111.14 160.33 -68.71 68.03 24.60 -66.70 -67.38 145.81 38.52 70.06 999.00 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3FLNC.pdb CMGC DFGup 3 3FN 1.90 -105.01 155.90 -75.23 66.03 26.10 -67.05 -70.99 147.21 45.85 76.16 8.95 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3FLQA.pdb CMGC DFGin-inactive 2 891 1.90 -114.46 174.18 -35.10 79.86 71.14 -148.06 -113.08 140.35 -76.79 72.50 15.29 999.00 Outlier LEU ASP PHE GLY"
"MK14_HUMAN t_3FLSA.pdb CMGC DFGup 3 FLS 2.30 -113.31 162.47 -23.26 69.62 18.66 -162.31 -67.07 146.00 47.16 71.83 9.42 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3FLWA.pdb CMGC DFGup 3 FLW 2.10 -111.59 161.12 -34.40 63.92 35.19 -67.15 -86.22 155.47 50.72 80.71 999.00 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3FLYA.pdb CMGC DFGup 3 FLY 1.80 -110.97 154.43 -31.29 66.69 35.36 -65.69 -80.35 147.83 44.06 72.05 16.50 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3FLZA.pdb CMGC DFGup 3 FLZ 2.23 -112.59 159.07 -30.70 69.00 31.93 -69.34 -85.34 150.97 47.28 71.96 20.29 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3FMHA.pdb CMGC DFGup 3 533 1.90 -105.46 156.18 -76.17 65.61 28.61 -70.99 -72.92 146.70 42.66 73.62 16.64 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3FMJA.pdb CMGC DFGin-inactive 2 FMJ 2.00 -119.97 177.66 -36.90 52.97 58.63 -155.06 -54.82 149.90 -72.62 -91.02 999.00 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3FMKA.pdb CMGC DFGup 3 FMK 1.70 -112.21 148.91 -179.24 62.87 38.55 -67.47 -78.11 150.41 42.16 69.35 15.53 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3FMMA.pdb CMGC DFGup 3 XI2 2.00 -98.73 158.89 -75.24 67.25 21.18 -72.19 -69.21 146.00 43.41 71.97 10.20 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3FMNA.pdb CMGC DFGup 3 530 1.90 -104.00 155.58 -80.58 66.06 26.63 -64.27 -71.45 145.67 42.76 83.31 999.00 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3FSFA.pdb CMGC DFGin-inactive 2 FSS 2.10 -126.88 179.79 -44.44 39.66 72.64 -50.15 -65.32 151.91 -66.95 -17.30 999.00 999.00 Allowed LEU ASP PHE GLY"
"MK14_HUMAN t_3GC7A.pdb CMGC DFGup 3 B45 1.80 -130.23 -178.34 52.65 55.86 56.48 -80.01 -136.94 164.84 71.04 67.05 10.11 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3GCPA.pdb CMGC DFGout 6 SB2 2.25 -117.40 167.73 -39.41 -120.27 32.96 66.16 -153.55 150.40 52.36 -67.27 116.67 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3GCQA.pdb CMGC DFGout 6 1BU 2.00 -139.22 -170.23 51.35 -145.47 100.53 -156.63 -65.76 -17.82 -96.71 68.14 999.00 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3GCSA.pdb CMGC DFGout 6 BAX 2.10 -148.87 -179.17 46.69 -135.94 107.60 -170.27 -69.09 -19.46 -78.64 85.40 999.00 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3GCUA.pdb CMGC DFGout 6 R48 2.10 -146.89 -162.95 59.34 -136.61 100.49 -162.63 -77.51 -11.44 -89.86 -56.49 136.99 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3GCUB.pdb CMGC DFGout 6 R48 2.10 -128.93 -177.20 -53.23 -130.80 102.91 -164.77 -75.99 -7.44 -84.42 -57.17 134.47 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3GCVA.pdb CMGC DFGout 6 SS6 2.30 -152.65 -168.85 46.33 -121.57 102.17 -128.89 -80.35 22.03 -107.58 49.46 -127.29 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3GFEA.pdb CMGC DFGup 3 P37 2.10 -115.81 165.91 -33.72 67.15 19.32 -74.42 -64.72 142.25 40.96 76.40 0.24 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3GI3A.pdb CMGC DFGout 6 B10 2.40 -144.31 -176.80 40.26 -144.29 112.58 -167.76 -73.29 53.46 -85.52 63.19 999.00 999.00 Favored LEU ASP PHE TYR"
"MK14_HUMAN t_3HEGA.pdb CMGC DFGout 6 BAX 2.20 -138.80 -176.31 54.45 -143.80 112.17 -172.21 -66.96 -96.09 -71.36 123.85 999.00 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3HL7A.pdb CMGC DFGup 3 I46 1.88 -124.26 169.99 50.97 68.59 19.02 -72.14 -68.54 146.39 46.64 77.20 -0.14 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3HLLA.pdb CMGC DFGup 3 I45 1.95 -105.06 158.53 -38.95 67.05 24.07 -64.78 -71.38 152.94 45.57 67.62 1.86 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3HP2A.pdb CMGC DFGout 6 I46 2.15 -88.93 117.94 -72.66 0.98 -90.68 174.81 -132.21 144.95 -52.20 -100.54 179.69 999.00 Outlier LEU ASP PHE GLY"
"MK14_HUMAN t_3HP5A.pdb CMGC DFGin-inactive 2 I46 2.30 -122.59 154.67 80.63 81.44 43.92 -76.46 -64.34 -69.29 -19.75 -47.63 999.00 999.00 Outlier LEU ASP PHE GLY"
"MK14_HUMAN t_3HRBA.pdb CMGC DFGup 3 I39 2.20 -109.69 159.67 -56.83 59.93 25.49 -66.76 -66.37 138.22 43.15 88.42 -1.60 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3HUBA.pdb CMGC DFGup 3 469 2.25 -115.00 158.58 65.79 74.86 37.14 -107.75 -91.14 94.51 28.86 148.44 999.00 999.00 Allowed LEU ASP PHE GLY"
"MK14_HUMAN t_3HUCA.pdb CMGC DFGout 6 G97 1.80 -109.98 165.22 -42.36 -105.07 29.10 56.86 179.21 164.67 62.51 -109.67 999.00 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3HV3A.pdb CMGC DFGout 6 R49 2.00 -138.70 -175.77 52.57 -140.22 99.93 -155.03 -64.29 -13.36 -105.43 -167.95 999.00 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3HV4A.pdb CMGC DFGout 6 L51 2.60 -142.68 -157.82 61.64 -140.72 86.19 -156.21 -62.85 -22.48 -89.50 -47.29 133.94 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3HV4B.pdb CMGC DFGout 6 L51 2.60 -145.22 -175.15 69.03 -120.91 83.86 -150.71 -51.53 -19.67 -94.18 -56.18 124.84 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3HV5A.pdb CMGC DFGout 6 R24 2.25 -149.02 -161.55 60.50 -134.00 95.31 -163.80 -72.22 -13.55 -83.45 -63.09 141.02 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3HV5B.pdb CMGC DFGout 6 R24 2.25 -143.65 -171.41 65.84 -127.53 96.09 -161.06 -68.43 -17.70 -85.04 -67.16 132.58 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3HV6A.pdb CMGC DFGout 6 R39 1.95 -136.82 -171.78 48.75 -147.81 102.78 -174.87 -62.45 -26.61 -103.66 82.93 999.00 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3HV7A.pdb CMGC DFGout 6 1AU 2.40 -135.82 -172.79 49.03 -148.85 101.39 -166.94 -62.42 -41.86 -79.38 51.75 88.51 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3HVCA.pdb CMGC DFGin-inactive 2 Apo 2.10 -117.25 162.27 -93.28 48.47 62.20 -59.28 -54.10 -25.21 -39.78 54.70 999.00 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3IPHA.pdb CMGC DFGup 3 G11 2.10 -118.72 162.68 -37.65 67.14 18.13 -76.31 -71.64 160.46 43.35 65.58 15.56 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3ITZA.pdb CMGC DFGup 3 P66 2.25 -107.88 162.29 -39.31 63.05 31.54 -75.20 -72.38 146.45 38.08 66.97 10.22 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3IW5A.pdb CMGC DFGout 6 DF3 2.50 -114.29 151.76 -49.93 -75.64 -51.48 43.02 -142.13 148.76 -58.46 -97.69 -179.22 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3IW6A.pdb CMGC DFGout 6 PP0 2.10 -107.49 146.11 -57.95 -62.17 -52.95 46.74 -135.84 140.50 -53.71 -100.49 -175.88 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3IW7A.pdb CMGC DFGout 6 IPK 2.40 -101.12 142.69 -60.66 -64.38 -57.11 51.46 -132.57 130.30 -54.39 -90.76 171.74 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3IW8A.pdb CMGC DFGout 6 HIZ 2.00 -128.76 173.10 -36.47 -144.44 96.52 -169.54 -69.07 -29.41 -95.71 -57.04 999.00 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3K3IA.pdb CMGC DFGout 6 I46 1.70 -143.80 -170.14 68.02 -141.75 114.95 -163.19 -78.13 -16.47 -85.89 49.67 999.00 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3KF7A.pdb CMGC DFGup 3 L9G 2.00 -108.16 151.36 -51.56 65.30 12.13 -72.72 -35.34 152.90 38.27 72.06 -32.20 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3KQ7A.pdb CMGC DFGout 6 KQ7 1.80 -140.53 -165.23 52.04 -137.40 105.17 -168.60 -78.84 -5.42 -71.00 -55.72 128.79 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3L8XA.pdb CMGC DFGup 3 N4D 2.40 -103.95 152.00 -119.69 54.01 30.26 -44.51 -68.58 159.05 49.47 59.18 8.70 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3LFBA.pdb CMGC DFGout 6 Z87 2.60 -137.88 -175.40 50.35 -148.68 98.32 -177.37 -75.62 80.53 -71.52 -32.83 999.00 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3LFCA.pdb CMGC DFGout 6 Z86 2.80 -140.90 172.10 46.47 -136.72 104.02 -165.51 -73.15 19.90 -102.59 31.44 999.00 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3LFEA.pdb CMGC DFGout 6 Z84 2.30 -143.40 -175.93 49.47 -148.83 101.12 -169.97 -68.76 -23.75 -73.73 55.31 999.00 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3LFFA.pdb CMGC DFGout 6 Z83 1.50 -133.71 -177.29 51.56 -147.07 100.37 -173.22 -58.11 -30.96 -79.84 67.49 999.00 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3LHJA.pdb CMGC DFGup 3 LHJ 3.31 -115.53 163.33 -36.03 63.03 29.35 -55.86 -80.08 152.10 45.37 71.46 9.36 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3MH0A.pdb NA NA 0 Apo 2.00 -94.37 151.83 -66.33 67.78 17.99 -71.77 -52.68 126.60 999.00 86.79 1.86 999.00 Favored LEU ASP ALA GLY"
"MK14_HUMAN t_3MH1A.pdb NA NA 0 Apo 2.20 -99.28 148.54 -91.19 -61.20 -25.89 59.65 178.02 164.96 999.00 -59.81 139.08 999.00 Favored LEU ASP GLY GLY"
"MK14_HUMAN t_3MH2A.pdb CMGC DFGup 3 Apo 2.30 -108.49 150.32 -68.81 80.60 9.24 -67.19 -51.09 147.81 31.57 52.63 999.00 999.00 Allowed LEU ASP TYR GLY"
"MK14_HUMAN t_3MH3A.pdb NA NA 0 Apo 2.20 -114.56 161.91 31.38 -64.07 -39.56 43.15 -151.41 141.50 -155.59 -53.62 163.24 999.00 Favored LEU ASP ARG GLY"
"MK14_HUMAN t_3MPAA.pdb CMGC DFGin-inactive 2 SB2 2.10 -133.51 -165.88 44.66 57.50 46.08 999.00 -54.80 150.63 -69.44 -42.67 999.00 999.00 Favored LEU GLY PHE GLY"
"MK14_HUMAN t_3MPTA.pdb CMGC DFGup 3 1GK 1.89 -127.10 159.43 -29.74 63.90 34.98 -68.89 -73.68 152.64 31.42 53.09 37.19 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3MVLA.pdb CMGC DFGup 3 38P 2.80 -119.04 172.25 -59.78 43.95 31.03 -54.83 -75.09 165.35 46.96 50.03 12.98 999.00 Allowed LEU ASP PHE GLY"
"MK14_HUMAN t_3MVLB.pdb CMGC DFGup 3 38P 2.80 -107.80 146.07 -69.31 75.31 -5.15 -64.83 -46.52 143.24 54.93 68.67 7.92 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3MVMA.pdb CMGC DFGup 3 39P 2.00 -109.02 158.09 -39.91 60.12 30.26 -56.85 -73.71 142.68 52.91 70.66 -1.68 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3MVMB.pdb CMGC DFGup 3 39P 2.00 -108.79 159.16 -38.68 58.87 31.39 -57.12 -73.08 137.72 52.16 71.93 9.12 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3MW1A.pdb CMGC DFGin-inactive 2 MIH 2.80 -132.64 167.75 -142.25 44.22 77.34 -75.15 -67.06 164.82 -58.68 -78.79 69.60 999.00 Allowed LEU ASP PHE GLY"
"MK14_HUMAN t_3NEWA.pdb CMGC DFGup 3 3NE 2.51 -114.35 171.80 -2.79 67.58 14.11 -81.68 -53.67 161.99 18.33 61.76 -33.22 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3NNUA.pdb CMGC DFGout 6 EDB 2.40 -144.18 -179.50 44.84 -134.32 110.11 -162.71 -98.39 16.73 -142.12 -68.15 116.21 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3NNVA.pdb CMGC DFGout 6 437 2.10 -142.53 -173.21 44.19 -145.37 106.61 -173.20 -51.30 -52.41 -96.07 66.06 29.60 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3NNWA.pdb CMGC DFGout 6 EDD 1.89 -143.48 -174.30 52.47 -141.89 103.65 -167.45 -83.15 17.02 -124.58 -65.01 104.28 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3NNXA.pdb CMGC DFGout 6 EDD 2.28 -135.56 -177.90 51.18 -139.64 108.43 -168.17 -57.96 -45.48 -86.40 59.98 25.42 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3NWWA.pdb CMGC DFGup 3 3NW 2.09 -115.85 167.04 -61.27 59.17 20.24 -59.01 -67.32 154.80 45.74 66.49 8.64 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3O8PA.pdb CMGC DFGout 6 BMU 2.10 -115.52 162.59 -45.22 -99.02 -26.56 999.00 -122.71 117.22 -68.19 -42.67 -102.69 999.00 Favored LEU GLY PHE GLY"
"MK14_HUMAN t_3O8TA.pdb NA NA 0 BMU 2.00 -137.94 -177.51 63.14 -138.80 94.71 -172.20 -70.74 -1.35 999.00 121.82 999.00 999.00 Favored LEU ASP ALA GLY"
"MK14_HUMAN t_3O8UA.pdb CMGC DFGout 6 BMU 2.10 -146.28 -170.37 58.33 -144.07 102.12 -168.97 -67.32 -15.94 -73.11 99.82 999.00 999.00 Favored LEU ASP TYR GLY"
"MK14_HUMAN t_3OBGA.pdb NA NA 0 SB2 2.80 -95.24 144.70 -117.26 58.76 33.63 -63.22 -69.05 75.12 999.00 119.99 18.42 999.00 Favored LEU ASP GLY GLY"
"MK14_HUMAN t_3OBJA.pdb NA NA 0 BMU 2.40 -154.08 -178.48 31.34 -133.45 111.96 -159.08 -61.60 -36.06 -104.69 -103.08 -92.45 999.00 Favored LEU ASP ARG GLY"
"MK14_HUMAN t_3OCGA.pdb CMGC DFGup 3 OCG 2.21 -93.67 -75.51 -58.81 -102.18 63.25 -52.14 -58.57 -80.74 42.22 -84.42 26.26 999.00 Allowed LEU ASP PHE GLY"
"MK14_HUMAN t_3OD6X.pdb CMGC Active 1 Apo 2.68 -107.31 -35.40 -75.06 -122.56 110.90 -159.87 -101.90 178.97 -55.50 116.73 -52.33 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3ODYX.pdb CMGC DFGup 3 Apo 2.20 -99.51 -49.68 -55.16 -113.87 73.80 169.05 -150.68 152.98 55.09 53.69 11.05 999.00 Allowed LEU ASP PHE GLY"
"MK14_HUMAN t_3ODZX.pdb CMGC DFGup 3 Apo 2.30 -127.92 -15.96 -71.32 -113.68 56.49 -147.38 -143.96 156.72 54.30 60.76 23.21 999.00 Allowed LEU ASP PHE GLY"
"MK14_HUMAN t_3OEFX.pdb CMGC DFGin-inactive 2 Apo 1.60 -108.10 167.46 -50.26 -157.05 -159.45 -165.63 61.30 35.38 -34.32 64.11 24.96 999.00 Allowed LEU ASP PHE GLY"
"MK14_HUMAN t_3PG3A.pdb CMGC DFGout 6 DG7 2.00 -137.95 -176.41 47.29 -143.40 105.36 -173.39 -78.55 -12.23 -75.37 62.41 999.00 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3QUDA.pdb CMGC DFGout 6 N3F 2.00 -93.70 153.31 -55.32 -68.53 -47.26 57.27 -136.83 128.36 -58.02 -94.96 -166.56 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3QUEA.pdb CMGC DFGout 6 3FF 2.70 -82.34 155.91 -69.13 -75.36 -54.19 45.40 -130.98 134.23 -51.22 -97.10 -170.33 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3RINA.pdb CMGC DFGup 3 I2O 2.20 -113.94 158.62 -52.25 70.68 16.94 -95.20 -65.05 140.89 33.49 69.91 1.97 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3ROCA.pdb CMGC DFGup 3 29B 1.70 -116.37 161.82 51.36 65.61 26.81 -62.92 -75.69 149.71 49.46 59.80 17.51 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3S3IA.pdb CMGC DFGup 3 CQ0 1.80 -112.55 160.41 -46.56 67.12 22.46 -82.84 -69.87 149.56 37.15 76.62 -7.05 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3S4QA.pdb CMGC DFGup 3 NK0 2.27 -109.00 159.87 -45.21 64.86 29.38 -60.65 -78.94 147.54 44.68 62.54 17.37 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3U8WA.pdb CMGC DFGup 3 09J 2.15 -112.00 165.83 -45.07 69.85 20.22 -161.32 -68.94 147.03 41.68 71.44 7.86 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3UVPA.pdb CMGC DFGup 3 048 2.40 -128.96 167.42 63.60 69.28 45.05 -78.73 -117.31 80.38 39.33 -113.85 -175.48 999.00 Allowed LEU ASP PHE GLY"
"MK14_HUMAN t_3UVQA.pdb CMGC DFGup 3 FS8 2.20 -108.32 165.22 -47.15 59.31 36.84 -62.18 -101.83 71.98 57.46 163.25 167.21 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3UVRA.pdb CMGC DFGout 6 06F 2.10 -148.63 178.58 67.15 -133.58 101.13 -168.09 -89.93 -1.80 -164.41 -54.07 127.43 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3ZS5A.pdb CMGC DFGout 6 SB2 1.60 -115.23 172.43 -44.77 -122.64 34.92 57.69 -156.59 162.58 53.95 -91.32 146.87 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3ZSGA.pdb CMGC DFGout 6 T75 1.89 -112.43 162.65 -43.95 -112.70 28.80 60.99 -156.42 165.55 53.65 -94.27 155.48 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3ZSIA.pdb CMGC DFGout 6 52P 2.40 -99.20 157.47 -73.03 -83.15 -44.90 51.80 -141.72 118.49 -40.83 -93.18 -169.83 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_3ZYAA.pdb CMGC DFGin-inactive 2 2A8 1.90 -120.59 153.72 -166.31 52.17 73.60 -69.76 -57.01 142.44 -53.39 -77.09 179.76 999.00 Allowed LEU ASP PHE GLY"
"MK14_HUMAN t_4A9YA.pdb CMGC DFGout 6 AQZ 2.20 -143.44 -169.83 63.57 -148.06 89.95 -158.57 -71.47 -10.40 -58.55 74.79 999.00 999.00 Allowed LEU ASP PHE GLY"
"MK14_HUMAN t_4AA0A.pdb CMGC DFGout 6 AA0 1.80 -143.29 -166.02 64.67 -144.52 110.61 -163.88 -86.90 -1.55 -70.88 54.59 999.00 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_4AA4A.pdb CMGC DFGup 3 QC0 2.30 -110.80 162.09 -47.76 67.43 15.58 -63.88 -63.60 154.39 40.31 76.39 7.99 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_4AA5A.pdb CMGC DFGup 3 NQB 2.38 -114.98 160.36 -47.01 74.12 14.23 -70.92 -68.36 156.82 48.18 73.29 -0.12 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_4AACA.pdb CMGC DFGup 3 AAV 2.50 -109.23 158.48 -46.12 65.38 19.57 -56.12 -65.63 151.46 45.41 69.09 20.40 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_4DLIA.pdb CMGC DFGout 6 IRG 1.91 -104.35 150.38 -49.29 -72.99 -47.19 58.80 -137.87 126.63 -45.20 -44.68 999.00 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_4EH2A.pdb CMGC DFGup 3 0OK 2.00 -117.77 162.53 24.37 72.25 21.21 -65.92 -57.68 163.33 30.99 92.77 999.00 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_4EH3A.pdb NA NA 0 NAR 2.40 -93.82 152.82 -41.91 -77.75 -36.62 74.87 -150.98 113.73 999.00 -75.87 -166.36 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_4EH4A.pdb CMGC DFGout 6 IRG 2.50 -91.38 145.16 -48.57 -57.67 -46.96 60.05 -148.80 133.97 -70.12 -106.02 178.48 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_4EH7A.pdb NA NA 0 IRG 2.10 -98.80 137.88 -44.20 -63.06 -45.20 999.00 -156.87 139.65 999.00 98.20 999.00 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_4EH9A.pdb CMGC DFGout 6 IRG 2.10 -97.43 159.62 -56.88 -62.39 -60.39 47.46 -150.17 147.16 64.13 -78.55 25.38 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_4EHVA.pdb CMGC DFGout 6 IRG 1.60 -99.66 162.39 -54.69 -69.65 -55.96 48.28 -152.93 157.54 62.41 -108.28 -179.85 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_4F9WA.pdb CMGC DFGup 3 LM4 2.00 -80.56 176.25 -70.46 -63.08 105.01 52.67 -100.67 2.86 54.43 130.90 -79.75 999.00 Allowed LEU ASP PHE GLY"
"MK14_HUMAN t_4F9YA.pdb CMGC DFGup 3 LM3 1.85 -102.47 160.66 -60.45 29.84 64.94 61.59 -90.68 149.13 35.57 57.69 21.05 999.00 Allowed LEU ASP PHE GLY"
"MK14_HUMAN t_4FA2A.pdb CMGC DFGin-inactive 2 SB0 2.00 -98.50 119.77 -70.96 -70.74 -31.65 -80.78 -138.39 143.99 -48.73 107.89 75.12 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_4GEOA.pdb CMGC DFGout 6 Apo 1.66 -99.32 157.72 -44.96 -78.78 -32.79 52.19 -149.86 149.23 159.19 -8.24 -58.02 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_4KINA.pdb CMGC DFGup 3 1M8 1.97 -112.02 159.57 -49.11 58.81 31.66 -61.16 -80.14 161.81 51.27 70.16 3.93 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_4KINB.pdb CMGC DFGup 3 1M8 1.97 -111.87 160.83 -47.32 58.71 31.21 -63.59 -82.04 162.47 50.96 67.70 5.12 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_4KINC.pdb CMGC DFGup 3 1M8 1.97 -112.11 159.90 -43.36 56.46 32.64 -60.43 -82.66 164.96 50.19 66.15 5.74 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_4KIND.pdb CMGC DFGup 3 1M8 1.97 -113.21 160.81 -48.69 57.45 29.93 -62.43 -79.54 159.49 50.89 72.38 0.37 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_4KIPA.pdb CMGC DFGup 3 1R9 2.27 -114.35 163.58 -53.25 55.69 23.59 -71.38 -69.03 154.59 54.99 55.03 29.96 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_4KIPB.pdb CMGC DFGup 3 1R9 2.27 -114.06 163.77 -53.66 56.19 23.50 -71.84 -69.66 154.52 55.08 56.31 29.93 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_4KIQA.pdb CMGC DFGup 3 1RA 2.50 -118.44 161.53 -43.69 57.66 30.73 -57.05 -79.18 161.60 47.69 67.81 7.92 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_4KIQB.pdb CMGC DFGup 3 1RA 2.50 -116.22 159.75 -45.19 58.95 30.66 -58.07 -78.92 159.94 47.84 67.40 8.92 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_4KIQC.pdb CMGC DFGup 3 1RA 2.50 -118.65 158.68 -45.78 59.63 31.16 -57.80 -79.37 160.29 48.35 66.40 9.60 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_4KIQD.pdb CMGC DFGup 3 1RA 2.50 -118.21 159.79 -44.84 57.74 31.43 -58.15 -79.52 160.77 46.80 66.38 10.79 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_4L8MA.pdb CMGC DFGout 6 F46 2.10 -110.27 165.15 -85.40 -109.71 -18.28 -157.80 -95.67 105.76 169.67 -90.48 163.88 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_4ZTHA.pdb CMGC DFGin-inactive 2 VVT 2.15 -89.81 123.11 -84.42 -77.66 -39.38 -79.27 -125.64 120.65 -61.72 -83.65 -144.05 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_5ETAA.pdb CMGC DFGin-inactive 2 Apo 2.80 -141.34 172.07 51.06 57.42 75.53 -70.78 -79.23 159.97 -54.83 -79.14 999.00 999.00 Allowed LEU ASP PHE GLY"
"MK14_HUMAN t_5ETAB.pdb CMGC DFGin-inactive 2 Apo 2.80 -141.37 173.41 50.69 57.64 76.86 -172.54 -79.23 160.65 -55.86 -78.72 999.00 999.00 Allowed LEU ASP PHE GLY"
"MK14_HUMAN t_5ETCA.pdb CMGC DFGin-inactive 2 Apo 2.42 -109.71 177.12 -73.68 57.85 82.74 -69.53 -103.20 -87.05 -87.47 -30.98 -89.75 999.00 Allowed LEU ASP PHE GLY"
"MK14_HUMAN t_5ETFA.pdb CMGC DFGin-inactive 2 Apo 2.40 -113.02 169.41 -35.36 60.38 71.24 -145.50 -66.87 139.90 -67.74 -72.94 138.11 999.00 Allowed LEU ASP PHE GLY"
"MK14_HUMAN t_5ETIA.pdb CMGC DFGup 3 Apo 2.80 -119.92 157.69 -44.66 69.55 37.39 -71.55 -94.79 139.80 47.08 84.22 5.94 999.00 Allowed LEU ASP PHE GLY"
"MK14_HUMAN t_5ML5A.pdb CMGC DFGout 6 1VI 1.90 -111.38 159.45 -45.43 -109.37 34.78 62.79 -164.26 172.15 56.11 -90.55 999.00 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_5TBEA.pdb CMGC DFGup 3 78L 2.44 -93.86 144.40 -52.57 61.92 30.14 -66.17 -73.12 151.99 64.34 84.25 2.96 999.00 Favored LEU ASP PHE GLY"
"MK14_HUMAN t_5TCOA.pdb CMGC DFGup 3 79Q 2.10 -107.53 157.63 -54.60 61.21 34.18 -61.16 -83.50 153.09 46.35 65.06 36.30 999.00 Favored LEU ASP PHE GLY"
"MKNK1_HUMAN t_2HW6A.pdb CAMK DFGout 6 Apo 2.50 -147.58 179.65 63.85 -118.64 97.91 168.83 -107.71 35.68 -86.71 -82.20 122.22 -72.03 NA CYS ASP PHE ASP"
"MKNK1_HUMAN t_2HW6B.pdb CAMK DFGout 6 Apo 2.50 -152.41 173.81 62.33 -112.09 89.93 -179.50 -108.33 40.51 -82.05 -86.36 127.18 -84.44 NA CYS ASP PHE ASP"
"MKNK2_HUMAN t_2AC3A.pdb CAMK DFGout 6 Apo 2.10 -144.34 -174.64 66.25 -154.74 105.59 -169.35 -90.28 11.37 -70.77 -131.99 29.93 -136.01 NA CYS ASP PHE ASP"
"MKNK2_HUMAN t_2AC5A.pdb CAMK DFGout 6 Apo 3.20 -149.30 171.15 73.53 -112.61 -96.85 -106.85 89.22 178.68 -64.67 -123.52 999.00 999.00 NA CYS ASP PHE GLY"
"MKNK2_HUMAN t_2HW7A.pdb CAMK DFGup 3 STU 2.71 -153.19 172.75 67.58 68.08 27.17 -131.69 -77.67 175.80 23.88 81.51 999.00 999.00 NA CYS ASP PHE GLY"
"MLKL_HUMAN t_4M67A.pdb OTHER DFGin-inactive 2 Apo 1.90 -139.35 178.31 999.00 78.88 30.57 999.00 -63.50 142.96 -43.65 -163.25 152.38 62.97 NA ALA GLY PHE GLU"
"MLKL_HUMAN t_4MWIA.pdb OTHER DFGin-inactive 2 PXN 1.70 -145.14 176.53 999.00 81.44 24.59 999.00 -54.34 137.54 -43.47 -155.26 156.89 65.37 NA ALA GLY PHE GLU"
"MLKL_HUMAN t_5KO1A.pdb OTHER DFGin-inactive 2 6UY 2.16 -140.43 -174.34 999.00 76.64 35.27 999.00 -54.74 138.73 -45.14 -152.70 153.45 65.36 NA ALA GLY PHE GLU"
"MLTK_HUMAN t_5HESA.pdb STE DFGup 3 032 2.14 -149.35 -178.78 39.32 72.09 18.34 -147.16 -79.34 -13.46 42.53 -105.88 8.45 999.00 Favored CYS ASP PHE GLY"
"MLTK_HUMAN t_5HESB.pdb STE DFGup 3 032 2.14 -143.55 177.69 49.64 72.44 21.12 -158.14 -87.13 -28.81 42.53 -79.60 999.00 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_1S9JA.pdb STE DFGup 3 ATP 2.40 -128.27 177.34 63.18 60.27 51.11 -61.38 -106.66 166.24 42.92 -88.36 87.04 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_2P55A.pdb STE DFGup 3 ATP 2.80 -134.26 -173.98 59.71 50.89 43.70 -57.05 -95.44 166.27 41.98 -87.86 76.38 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_3DV3A.pdb STE DFGup 3 MEK 2.30 -133.11 -177.93 60.34 60.72 33.17 -60.41 -89.53 161.32 45.51 -72.93 66.61 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_3DY7A.pdb STE DFGup 3 1CX 2.70 -135.89 -175.83 62.10 54.32 45.86 -65.32 -100.94 164.75 46.29 -87.95 76.53 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_3E8NA.pdb STE DFGup 3 VRA 2.50 -141.12 177.39 74.04 57.46 45.28 -67.26 -100.81 153.07 46.05 -71.68 93.24 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_3EQBA.pdb STE DFGup 3 ATP 2.62 -126.17 -166.88 55.07 50.51 41.28 -65.25 -103.18 173.97 44.20 -86.48 70.57 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_3EQCA.pdb STE DFGup 3 3BM 1.80 -144.70 165.12 -166.03 66.98 30.90 -62.34 -83.70 156.47 44.91 -79.51 70.25 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_3EQDA.pdb STE DFGup 3 AGS 2.10 -148.21 169.16 74.17 61.02 42.85 -72.85 -94.75 116.91 42.06 -43.96 123.69 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_3EQFA.pdb STE DFGup 3 KSA 2.70 -153.31 163.28 79.29 80.08 34.97 -161.06 -102.10 118.02 52.88 -46.85 139.99 999.00 Allowed CYS ASP PHE GLY"
"MP2K1_HUMAN t_3EQGA.pdb STE DFGup 3 4BM 2.50 -138.24 179.16 76.96 59.32 28.53 -61.42 -81.52 153.57 35.79 -71.71 64.11 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_3EQHA.pdb STE DFGup 3 ADP 2.00 -141.56 168.48 71.34 59.78 36.07 -76.67 -79.98 154.57 28.67 -78.74 88.90 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_3EQIA.pdb STE DFGup 3 ADP 1.90 -145.52 171.20 76.32 59.50 41.13 -75.18 -92.75 128.73 41.62 -58.68 127.01 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_3MBLA.pdb STE DFGup 3 ADP 2.60 -137.83 175.18 -170.46 58.36 36.62 -60.18 -88.63 159.57 41.81 -90.36 101.23 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_3ORNA.pdb STE DFGup 3 3OR 2.80 -141.23 -171.82 65.67 51.16 43.88 -66.46 -94.53 165.91 40.22 -82.67 73.43 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_3OS3A.pdb STE DFGup 3 ATP 2.80 -145.25 170.02 78.69 62.26 36.95 -81.33 -93.76 158.55 44.17 -73.74 106.90 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_3PP1A.pdb STE DFGup 3 IZG 2.70 -142.75 -172.34 66.59 57.20 29.70 -64.30 -83.53 161.91 45.17 -94.11 95.50 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_3SLSA.pdb STE DFGup 3 ANP 2.30 -137.77 176.04 -146.38 54.13 43.69 -64.37 -94.25 127.93 47.60 -65.93 145.26 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_3SLSB.pdb STE DFGup 3 77D 2.30 -142.39 174.27 -154.68 56.23 41.77 -67.25 -94.30 130.27 43.81 -64.42 146.59 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_3V01A.pdb STE DFGup 3 ATP 2.71 -142.04 -173.42 56.68 54.62 34.92 -63.74 -91.84 163.80 47.04 -88.05 74.97 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_3V04A.pdb STE DFGup 3 V04 2.70 -140.01 -177.50 63.34 54.19 36.32 -59.72 -92.65 163.30 43.13 -92.67 75.17 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_3VVHA.pdb STE DFGup 3 ATP 2.00 -137.49 173.55 -165.29 63.42 33.16 -68.92 -82.98 158.75 37.52 -83.80 69.68 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_3VVHB.pdb STE DFGup 3 ATP 2.00 -134.84 175.56 -151.68 59.49 35.54 -61.12 -88.00 165.30 42.28 -92.69 76.31 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_3VVHC.pdb STE DFGup 3 ATP 2.00 -136.03 173.22 75.32 62.37 33.83 -66.20 -87.30 164.68 43.72 -81.04 61.46 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_3W8QA.pdb STE DFGout 6 AGS 2.20 -62.00 160.73 -72.36 -84.07 71.50 -178.31 -96.97 162.25 62.13 71.71 27.99 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_3WIGA.pdb STE DFGup 3 ANP 2.70 -143.20 168.24 -151.69 56.99 43.32 -71.54 -87.67 167.58 35.15 -81.13 80.94 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_3ZLSA.pdb STE DFGup 3 92P 2.50 -142.41 168.78 69.44 61.53 49.04 -78.99 -105.62 135.14 48.51 -55.31 109.52 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_3ZLWA.pdb STE DFGup 3 MT8 2.12 -141.92 175.38 68.16 52.46 41.70 -81.89 -90.57 130.63 42.72 -63.12 114.24 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_3ZLXA.pdb STE DFGup 3 5EZ 2.20 -137.37 173.39 73.53 56.88 45.70 -137.44 -94.70 137.58 39.96 -59.73 119.21 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_3ZLYA.pdb STE DFGup 3 YSO 2.11 -136.47 174.91 69.91 53.81 50.98 -177.08 -96.93 123.03 39.11 -57.93 125.27 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_3ZM4A.pdb STE DFGup 3 22T 2.37 -136.85 171.86 75.81 55.07 56.58 177.18 -104.79 123.36 45.03 -61.01 124.17 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_4AN2A.pdb STE DFGup 3 ACP 2.50 -122.72 179.03 64.94 56.76 40.27 -62.73 -92.47 167.60 39.18 -89.17 72.92 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_4AN3A.pdb STE DFGup 3 5Y0 2.10 -129.11 178.33 59.70 68.62 31.00 -65.83 -85.56 168.04 44.08 -96.22 75.37 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_4AN9A.pdb STE DFGup 3 ACP 2.80 -147.69 174.86 74.23 72.24 33.78 -63.91 -84.97 163.60 42.20 -96.70 81.81 999.00 Allowed CYS ASP PHE GLY"
"MP2K1_HUMAN t_4ANBA.pdb STE DFGup 3 ACP 2.20 -107.52 172.16 75.14 64.25 39.22 -70.14 -93.80 160.35 38.36 -83.37 73.97 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_4ARKA.pdb STE DFGup 3 M3K 2.60 -143.72 -171.53 70.86 62.76 23.92 -79.52 -76.16 159.48 42.79 -85.41 75.29 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_4LMNA.pdb STE DFGup 3 ANP 2.80 -150.33 -178.47 68.29 56.49 30.28 -67.44 -84.68 155.33 45.41 -80.49 74.38 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_4MNEA.pdb STE DFGup 3 573 2.85 -143.57 179.98 74.52 54.71 28.12 -64.42 -81.45 161.62 52.58 -81.82 73.11 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_4MNED.pdb STE DFGup 3 573 2.85 -124.77 174.07 -156.83 56.37 33.23 -69.57 -88.42 154.28 50.46 -72.99 74.09 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_4MNEE.pdb STE DFGup 3 573 2.85 -139.16 176.14 -155.71 61.56 40.21 -61.21 -96.22 153.08 47.96 -69.83 64.66 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_4MNEH.pdb STE DFGup 3 ACP 2.85 -149.04 175.21 -156.49 52.80 36.27 -66.19 -93.36 158.04 54.00 -78.56 56.89 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_4U7ZA.pdb STE DFGup 3 ANP 2.81 -143.36 -175.82 60.14 52.48 38.77 -64.27 -93.24 161.29 44.22 -81.82 73.65 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_4U80A.pdb STE DFGup 3 3EX 2.80 -137.92 -179.32 60.53 57.28 41.81 -66.36 -100.24 164.43 49.51 -82.10 69.88 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_4U81A.pdb STE DFGup 3 ANP 2.70 -142.15 -179.16 55.53 57.69 35.97 -65.10 -93.93 164.87 44.17 -87.34 72.88 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_5BX0A.pdb STE DFGup 3 4W5 2.93 -136.75 170.45 -175.65 43.33 54.62 -87.67 -106.60 136.84 50.08 -61.40 106.14 999.00 Favored CYS ASP PHE GLY"
"MP2K1_HUMAN t_5EYMA.pdb STE DFGup 3 5U5 2.70 -122.82 146.93 134.26 60.89 74.83 -170.06 -99.88 172.07 67.76 -95.94 104.22 999.00 Allowed CYS ASP PHE GLY"
"MP2K1_HUMAN t_5EYMB.pdb STE DFGup 3 5U5 2.70 -139.65 138.02 160.01 62.03 82.00 -175.20 -101.78 135.67 62.02 -72.97 85.82 999.00 Allowed CYS ASP PHE GLY"
"MP2K1_HUMAN t_5HZEA.pdb NA NA 0 E62 2.40 -116.13 117.24 176.20 -152.58 137.84 -168.26 -122.40 13.77 47.76 -84.92 19.16 999.00 Favored CYS ASP PHE GLY"
"MP2K2_HUMAN t_1S9IA.pdb STE DFGup 3 5EA 3.20 -139.35 -174.92 64.53 56.53 21.25 -54.09 -79.18 150.57 47.40 -79.78 85.30 999.00 Favored CYS ASP PHE GLY"
"MP2K2_HUMAN t_1S9IB.pdb STE DFGup 3 5EA 3.20 -139.50 161.78 -169.78 56.63 60.41 -54.61 -106.41 150.16 37.66 -78.89 77.22 999.00 Favored CYS ASP PHE GLY"
"MP2K4_HUMAN t_3ALNA.pdb STE DFGup 3 ANP 2.30 -161.79 169.90 85.34 72.83 15.08 -83.33 -92.65 122.07 60.80 121.04 -111.78 999.00 Favored CYS ASP PHE GLY"
"MP2K4_HUMAN t_3ALNB.pdb STE DFGup 3 ANP 2.30 -140.61 159.97 83.48 87.68 22.29 -90.94 -95.58 159.53 58.75 94.54 -147.07 999.00 Allowed CYS ASP PHE GLY"
"MP2K4_HUMAN t_3ALOA.pdb STE DFGup 3 ANP 2.60 -112.63 -177.70 67.43 66.87 21.64 -92.40 -92.78 167.26 50.78 73.25 -126.22 999.00 Favored CYS ASP PHE GLY"
"MP2K4_HUMAN t_3VUTA.pdb NA NA 0 Apo 3.50 -103.79 -141.68 -171.97 -52.28 82.00 999.00 -141.23 -92.91 -71.06 50.20 -94.03 999.00 Outlier CYS ASP PHE GLY"
"MP2K4_HUMAN t_3VUTB.pdb NA NA 0 Apo 3.50 -128.56 -156.44 -23.75 -160.59 121.90 -3.59 -143.27 36.00 92.04 89.83 -111.69 999.00 Favored CYS ASP PHE GLY"
"MP2K6_HUMAN t_3ENMA.pdb STE DFGinter 5 Apo 2.35 -72.49 127.31 -63.67 -73.60 -5.03 64.30 -145.36 172.66 75.36 -81.90 71.71 999.00 Favored CYS ASP PHE GLY"
"MP2K6_HUMAN t_3ENMB.pdb STE DFGup 3 Apo 2.35 -76.12 120.81 -62.33 -66.53 1.55 62.63 -153.89 168.42 61.25 -71.07 67.09 999.00 Allowed CYS ASP PHE GLY"
"MP2K6_HUMAN t_3ENMC.pdb STE DFGinter 5 Apo 2.35 -62.87 122.86 -52.45 -68.86 -8.42 67.87 -137.51 177.59 64.53 -78.92 64.12 999.00 Favored CYS ASP PHE GLY"
"MP2K6_HUMAN t_3ENMD.pdb STE DFGinter 5 Apo 2.35 -70.69 125.22 -54.50 -79.69 12.01 84.25 -158.35 166.41 66.05 -77.05 78.93 999.00 Favored CYS ASP PHE GLY"
"MP2K6_HUMAN t_3VN9A.pdb STE DFGin-inactive 2 ANK 2.60 -156.07 167.46 91.26 49.00 65.80 -59.92 -66.48 -73.06 -112.71 -116.82 -30.69 999.00 Allowed CYS ASP PHE GLY"
"MP2K7_HUMAN t_2DYLA.pdb STE Active 1 Apo 2.45 -110.02 167.25 160.07 -3.36 131.78 115.11 -126.60 56.74 -17.21 -75.23 24.88 999.00 Outlier CYS ASP PHE GLY"
"MP2K7_HUMAN t_3WZUA.pdb STE DFGout 6 1FM 3.01 -93.21 113.50 -146.75 -84.79 103.01 33.63 -136.53 -104.85 -144.58 104.11 999.00 999.00 Favored CYS ASP PHE GLY"
"MP2K7_HUMAN t_5B2KA.pdb STE DFGout 6 Apo 2.75 -145.83 -155.95 43.81 -124.88 167.55 53.83 76.18 128.08 -149.66 -109.75 999.00 999.00 Favored CYS ASP PHE GLY"
"MP2K7_HUMAN t_5B2LA.pdb STE DFGout 6 Apo 2.10 -76.42 153.92 167.53 -65.24 -15.09 57.05 -85.10 122.54 173.16 62.66 24.87 999.00 Favored CYS ASP PHE GLY"
"MRCKB_HUMAN t_3QFVA.pdb AGC Active 1 NM7 2.65 -155.19 -177.74 999.00 51.28 74.88 -149.91 -100.37 20.93 -68.98 -84.81 1.25 999.00 Allowed ALA ASP PHE GLY"
"MRCKB_HUMAN t_3QFVB.pdb AGC Active 1 NM7 2.65 -146.97 -178.37 999.00 51.28 77.86 -162.96 -102.62 32.39 -57.18 -92.75 5.29 999.00 Allowed ALA ASP PHE GLY"
"MRCKB_HUMAN t_3TKUA.pdb AGC Active 1 M77 2.15 -143.03 175.96 999.00 52.00 80.00 -167.34 -94.25 18.87 -54.70 -66.87 -0.48 999.00 Allowed ALA ASP PHE GLY"
"MRCKB_HUMAN t_3TKUB.pdb AGC Active 1 M77 2.15 -146.49 178.94 999.00 50.88 78.82 -165.41 -93.20 17.60 -55.89 -66.39 -1.64 999.00 Allowed ALA ASP PHE GLY"
"MRCKB_HUMAN t_4UAKA.pdb AGC Active 1 ADP 1.73 -126.72 169.93 999.00 71.38 81.16 -172.70 -99.08 14.06 -59.97 -73.11 -5.49 999.00 Allowed ALA ASP PHE GLY"
"MRCKB_HUMAN t_4UALA.pdb AGC Active 1 3FV 1.71 -128.08 170.49 999.00 58.98 78.48 -155.88 -90.49 11.60 -57.40 -65.56 -5.61 999.00 Allowed ALA ASP PHE GLY"
"MYLK4_HUMAN t_2X4FA.pdb CAMK Active 1 16X 2.67 -114.66 5.89 49.27 -145.33 138.85 173.09 -130.88 35.13 -61.33 -58.11 -36.25 999.00 Favored ILE ASP PHE GLY"
"MYLK4_HUMAN t_2X4FB.pdb CAMK Active 1 16X 2.67 -116.69 3.08 48.33 -141.87 144.10 173.35 -136.91 36.18 -58.64 -63.70 -27.81 999.00 Favored ILE ASP PHE GLY"
"NEK1_HUMAN t_4APCA.pdb NEK DFGinter 5 Apo 2.10 -56.68 136.95 999.00 -75.01 -38.62 -160.66 -63.00 130.10 -155.14 112.68 -15.38 999.00 Favored GLY ASP PHE GLY"
"NEK1_HUMAN t_4APCB.pdb NEK DFGinter 5 Apo 2.10 -57.56 133.97 999.00 -72.59 -37.71 -155.28 -61.03 130.49 -157.04 110.45 -15.35 999.00 Favored GLY ASP PHE GLY"
"NEK1_HUMAN t_4B9DA.pdb NEK DFGinter 5 CK7 1.90 -64.99 139.97 999.00 -87.17 -44.29 53.04 -54.26 126.10 -166.85 121.24 -18.43 999.00 Favored GLY ASP PHE GLY"
"NEK1_HUMAN t_4B9DB.pdb NEK DFGinter 5 CK7 1.90 -65.91 139.95 999.00 -87.40 -46.26 51.74 -48.37 128.67 -169.58 118.23 -19.27 999.00 Favored GLY ASP PHE GLY"
"NEK2_HUMAN t_2JAVA.pdb NA NA 0 5Z5 2.2 -67.84 137.07 999.00 -47.91 123.82 175.70 -62.38 -34.36 -65.56 -68.10 -29.73 999.00 Favored GLY ASP PHE GLY"
"NEK2_HUMAN t_2W5AA.pdb NEK DFGin-trans 4 ADP 1.55 -79.33 164.60 999.00 -62.63 148.06 58.98 -64.75 -38.52 -172.87 112.80 109.42 999.00 Favored GLY ASP PHE GLY"
"NEK2_HUMAN t_2W5BA.pdb NEK DFGinter 5 AGS 2.40 -133.83 63.68 999.00 -87.27 106.81 174.68 -95.01 50.38 -152.49 -49.73 -30.43 999.00 Favored GLY ASP PHE GLY"
"NEK2_HUMAN t_2W5HA.pdb NEK DFGinter 5 Apo 2.33 -145.65 64.72 999.00 -76.43 122.69 177.52 -111.22 46.99 -159.66 -55.26 -23.60 999.00 Favored GLY ASP PHE GLY"
"NEK2_HUMAN t_2XK3A.pdb NA NA 0 XK3 2.20 -94.05 -173.77 999.00 -100.72 -8.50 73.96 -116.45 79.33 59.95 109.73 999.00 999.00 Favored GLY ASP PHE GLY"
"NEK2_HUMAN t_2XK4A.pdb NA NA 0 OL2 2.10 -87.35 -167.87 999.00 -104.53 4.44 66.94 -54.71 129.97 -69.50 106.00 -17.16 999.00 Favored GLY ASP PHE GLY"
"NEK2_HUMAN t_2XNMA.pdb NA NA 0 WGZ 1.85 -87.66 -171.62 999.00 -108.98 105.08 164.00 -67.65 -12.79 -161.88 -63.34 -25.82 999.00 Favored GLY ASP PHE GLY"
"NEK2_HUMAN t_2XNNA.pdb NA NA 0 430 2.50 -93.42 -163.67 999.00 -136.67 147.71 89.53 -84.19 109.67 999.00 -141.46 999.00 999.00 Favored GLY ASP PHE GLY"
"NEK2_HUMAN t_2XNPA.pdb NEK DFGout 6 WCX 1.98 -95.35 -164.16 999.00 -102.37 5.74 67.26 -53.45 134.47 -76.46 83.70 -21.34 999.00 Favored GLY ASP PHE GLY"
"NEK2_HUMAN t_4A4XA.pdb NEK DFGout 6 JUP 2.40 -93.96 -162.76 999.00 -102.06 4.60 73.74 -57.69 130.72 -73.65 93.45 -18.37 999.00 Favored GLY ASP PHE GLY"
"NEK2_HUMAN t_4AFEA.pdb NEK DFGout 6 GGY 2.60 -88.89 -167.34 999.00 -104.34 -6.76 79.30 -46.92 133.48 -72.66 83.66 -6.30 999.00 Favored GLY ASP PHE GLY"
"NEK2_HUMAN t_5M53A.pdb NEK DFGin-inactive 2 7GJ 1.90 -144.18 -170.40 999.00 48.39 59.82 -82.93 -59.96 141.68 -79.95 -69.29 124.95 999.00 Favored GLY ASP PHE GLY"
"NEK7_HUMAN t_5DE2A.pdb NEK DFGout 6 Apo 2.78 -128.71 -164.34 999.00 -159.50 105.37 -158.37 -134.07 13.97 44.97 -53.82 999.00 999.00 NA GLY ASP LEU GLY"
"NTRK1_HUMAN t_4AOJA.pdb TYR DFGin-inactive 2 V4Z 2.75 -111.01 -17.59 999.00 -143.65 144.56 -166.48 -112.78 -7.22 -62.22 -118.40 999.00 999.00 Favored GLY ASP PHE GLY"
"NTRK1_HUMAN t_4AOJC.pdb TYR DFGin-inactive 2 V4Z 2.75 -113.19 -25.62 999.00 -134.51 155.24 -169.13 -115.74 26.53 -64.85 85.56 -93.23 999.00 Favored GLY ASP PHE GLY"
"NTRK1_HUMAN t_4F0IA.pdb TYR DFGout 6 Apo 2.30 168.39 147.48 999.00 -150.94 -178.96 64.97 -114.81 17.79 -63.66 77.13 17.47 999.00 Favored GLY ASP PHE GLY"
"NTRK1_HUMAN t_4F0IB.pdb TYR DFGout 6 Apo 2.30 166.77 148.13 999.00 -155.20 178.65 67.73 -114.65 15.86 -59.99 73.52 24.03 999.00 Favored GLY ASP PHE GLY"
"NTRK1_HUMAN t_4GT5A.pdb TYR DFGout 6 Apo 2.40 159.18 156.80 999.00 -162.78 171.41 65.99 -110.03 15.13 -52.90 73.61 34.65 999.00 Favored GLY ASP PHE GLY"
"NTRK1_HUMAN t_4PMMA.pdb TYR DFGout 6 31V 2.00 -133.39 -162.47 999.00 -156.69 94.03 -177.99 -92.32 -31.80 -50.50 59.04 -8.11 999.00 Allowed GLY ASP PHE GLY"
"NTRK1_HUMAN t_4PMPA.pdb TYR DFGout 6 31W 1.80 -133.07 -157.41 999.00 -173.02 103.23 -169.41 -69.92 -32.30 -71.95 77.21 -47.77 999.00 Allowed GLY ASP PHE GLY"
"NTRK1_HUMAN t_4PMSA.pdb TYR DFGout 6 31X 2.80 -132.53 -155.21 999.00 -159.81 97.47 -171.33 -105.96 141.73 -41.92 -75.28 -27.15 999.00 Allowed GLY ASP PHE GLY"
"NTRK1_HUMAN t_4YNEA.pdb TYR DFGin-inactive 2 4EK 2.02 -116.63 -25.81 999.00 -138.60 132.11 -157.79 -91.58 -8.60 -67.43 65.27 48.21 999.00 Favored GLY ASP PHE GLY"
"NTRK1_HUMAN t_5H3QA.pdb TYR DFGout 6 7HF 2.10 172.54 156.20 999.00 -157.42 160.27 71.72 -99.42 18.03 -64.85 79.34 29.53 999.00 Favored GLY ASP PHE GLY"
"NTRK1_HUMAN t_5JFSA.pdb TYR DFGout 6 6K0 2.07 -135.78 -160.79 999.00 -157.80 107.94 -173.95 -107.29 3.52 -37.65 106.09 999.00 999.00 Favored GLY ASP PHE GLY"
"NTRK1_HUMAN t_5JFVA.pdb TYR DFGout 6 6K1 1.59 -141.49 -159.88 999.00 -155.63 106.71 -175.57 -102.46 5.30 -38.91 88.83 999.00 999.00 Favored GLY ASP PHE GLY"
"NTRK1_HUMAN t_5JFWA.pdb TYR DFGout 6 6K2 1.52 -133.87 -158.09 999.00 -156.48 107.58 -171.23 -101.75 3.00 -38.22 71.46 999.00 999.00 Favored GLY ASP PHE GLY"
"NTRK1_HUMAN t_5JFXA.pdb TYR DFGout 6 6K4 1.63 -133.93 -162.44 999.00 -154.96 107.90 -174.44 -100.10 17.67 -40.12 66.02 999.00 999.00 Favored GLY ASP PHE GLY"
"NTRK1_HUMAN t_5KMIA.pdb TYR DFGout 6 6UE 1.87 161.70 152.82 999.00 -154.44 168.23 64.91 -105.90 25.96 -54.72 65.13 30.03 999.00 Favored GLY ASP PHE GLY"
"NTRK1_HUMAN t_5KMJA.pdb TYR DFGout 6 6UF 2.04 156.95 152.70 999.00 -155.53 161.92 73.61 -106.31 28.25 -51.86 67.14 26.58 999.00 Favored GLY ASP PHE GLY"
"NTRK1_HUMAN t_5KMKA.pdb TYR DFGout 6 6UG 2.24 155.22 152.09 999.00 -152.95 175.76 63.99 -116.50 20.54 -51.85 75.77 21.78 999.00 Favored GLY ASP PHE GLY"
"NTRK1_HUMAN t_5KMLA.pdb TYR DFGout 6 6UH 2.01 158.78 154.45 999.00 -158.96 169.20 65.24 -111.22 29.56 -51.33 65.81 21.73 999.00 Favored GLY ASP PHE GLY"
"NTRK1_HUMAN t_5KMMA.pdb TYR DFGout 6 6UJ 2.12 157.75 155.47 999.00 -160.65 165.53 66.76 -107.16 26.91 -53.00 71.22 15.53 999.00 Favored GLY ASP PHE GLY"
"NTRK1_HUMAN t_5KMNA.pdb TYR DFGout 6 6UK 2.14 154.25 154.53 999.00 -157.99 168.93 64.56 -109.63 31.29 -46.46 68.75 19.87 999.00 Favored GLY ASP PHE GLY"
"NTRK1_HUMAN t_5KMOA.pdb TYR DFGout 6 6UM 2.67 -138.60 -165.09 999.00 -158.70 98.28 -169.18 -111.53 -171.05 -19.59 156.97 999.00 999.00 Allowed GLY ASP PHE GLY"
"NTRK2_HUMAN t_4ASZA.pdb TYR DFGout 6 Apo 1.70 169.91 150.03 999.00 -158.03 163.01 72.78 -111.91 26.04 -51.79 68.76 31.86 999.00 Favored GLY ASP PHE GLY"
"NTRK2_HUMAN t_4AT3A.pdb TYR DFGin-inactive 2 LTI 1.77 -152.47 -173.26 999.00 72.75 -62.96 -176.45 65.97 17.50 -49.21 77.57 6.13 999.00 Allowed GLY ASP PHE GLY"
"NTRK2_HUMAN t_4AT4A.pdb TYR DFGout 6 T6E 2.36 -138.29 -173.80 999.00 -150.68 91.46 -166.20 -46.67 -53.94 -82.97 56.91 31.29 999.00 Allowed GLY ASP PHE GLY"
"NTRK2_HUMAN t_4AT5A.pdb TYR DFGout 6 MUJ 1.71 -135.29 -156.17 999.00 -157.85 106.39 -170.32 -62.18 -33.06 -171.73 59.17 49.65 999.00 Favored GLY ASP PHE GLY"
"NTRK3_HUMAN t_3V5QA.pdb TYR DFGout 6 0F4 2.20 -132.36 -165.44 999.00 -144.82 95.88 -165.88 -96.41 3.29 -46.00 91.98 172.16 999.00 Favored GLY ASP PHE GLY"
"NTRK3_HUMAN t_3V5QB.pdb TYR DFGout 6 0F4 2.20 -135.25 -169.71 999.00 -138.44 98.72 -165.66 -97.87 13.27 -48.24 74.47 173.23 999.00 Favored GLY ASP PHE GLY"
"NTRK3_HUMAN t_4YMJA.pdb TYR DFGout 6 4EJ 2.00 -126.49 -163.20 999.00 -152.79 99.38 -168.67 -106.72 134.29 -52.25 -69.49 999.00 999.00 Favored GLY ASP PHE GLY"
"NTRK3_HUMAN t_4YMJB.pdb TYR DFGout 6 4EJ 2.00 -122.58 -165.17 999.00 -152.59 102.66 -171.91 -109.77 132.49 -51.19 -63.91 -38.69 999.00 Favored GLY ASP PHE GLY"
"OXSR1_HUMAN t_2VWIA.pdb STE DFGup 3 ANP 2.15 -61.12 158.63 999.00 -55.33 143.64 64.25 -131.38 -0.25 74.35 -56.09 -46.63 999.00 Favored ALA ASP PHE GLY"
"OXSR1_HUMAN t_2VWIB.pdb STE DFGin-trans 4 ANP 2.15 -100.12 160.62 999.00 80.18 12.16 -70.53 -59.65 137.65 171.85 96.87 -127.71 999.00 Allowed ALA ASP PHE GLY"
"OXSR1_HUMAN t_2VWIC.pdb STE DFGin-trans 4 ANP 2.15 -96.88 164.91 999.00 72.62 17.82 -74.56 -61.86 137.01 171.23 96.61 -124.99 999.00 Favored ALA ASP PHE GLY"
"OXSR1_HUMAN t_2VWID.pdb STE DFGin-trans 4 ANP 2.15 -101.53 161.01 999.00 73.33 15.95 -76.57 -58.71 139.74 167.15 94.08 -129.88 999.00 Favored ALA ASP PHE GLY"
"OXSR1_HUMAN t_3DAKA.pdb STE DFGin-trans 4 ANP 2.25 -100.05 163.47 999.00 76.14 16.69 -76.10 -60.43 136.35 171.30 96.82 -127.27 999.00 Favored ALA ASP PHE GLY"
"OXSR1_HUMAN t_3DAKB.pdb STE DFGin-trans 4 ANP 2.25 -104.19 159.61 999.00 79.04 11.13 -80.74 -51.85 136.58 175.96 96.29 -131.56 999.00 Allowed ALA ASP PHE GLY"
"OXSR1_HUMAN t_3DAKC.pdb STE DFGin-trans 4 ANP 2.25 -99.20 165.37 999.00 77.37 13.39 -79.09 -54.54 139.93 174.91 90.17 -129.86 999.00 Allowed ALA ASP PHE GLY"
"OXSR1_HUMAN t_3DAKD.pdb STE DFGin-trans 4 ANP 2.25 -91.03 168.10 999.00 66.26 18.90 -70.76 -59.72 133.05 178.75 94.14 -120.83 999.00 Favored ALA ASP PHE GLY"
"PAK1_HUMAN t_1F3MC.pdb STE DFGup 3 Apo 2.30 -130.69 -178.93 -170.43 61.52 34.01 -162.42 -100.36 7.29 52.85 -172.51 -176.79 999.00 Favored THR ASP PHE GLY"
"PAK1_HUMAN t_1F3MD.pdb STE DFGup 3 Apo 2.30 -127.20 -174.60 -168.95 57.45 35.15 -160.36 -100.82 10.99 56.37 -171.98 -168.94 999.00 Favored THR ASP PHE GLY"
"PAK1_HUMAN t_1YHVA.pdb STE Active 1 Apo 1.80 -139.85 -179.78 -165.27 64.56 87.28 -158.98 -101.42 22.96 -73.20 -64.81 -17.52 999.00 Allowed THR ASP PHE GLY"
"PAK1_HUMAN t_1YHWA.pdb STE Active 1 Apo 1.80 -141.68 -177.39 -165.48 63.66 87.43 -160.85 -101.17 24.71 -71.37 -65.30 -14.17 999.00 Allowed THR ASP PHE GLY"
"PAK1_HUMAN t_2HY81.pdb STE Active 1 1ST 2.00 -141.78 -175.36 -160.88 62.14 82.54 -164.51 -97.23 31.89 -72.86 -72.79 -7.49 999.00 Allowed THR ASP PHE GLY"
"PAK1_HUMAN t_3FXZA.pdb STE Active 1 FLL 1.64 -134.07 171.19 -165.44 67.36 85.95 -164.58 -96.55 21.63 -72.40 -69.48 -8.28 999.00 Allowed THR ASP PHE GLY"
"PAK1_HUMAN t_3FY0A.pdb STE Active 1 DW1 2.35 -135.95 -166.52 -166.34 41.90 84.48 -159.71 -96.20 21.00 -78.25 -64.78 -10.19 999.00 Outlier THR ASP PHE GLY"
"PAK1_HUMAN t_3Q4ZA.pdb STE Active 1 ANP 1.89 -129.51 -163.34 5.49 61.16 72.70 -170.58 -92.36 13.64 -64.19 -60.98 -29.05 999.00 Allowed THR ASP PHE GLY"
"PAK1_HUMAN t_3Q52A.pdb STE Active 1 Apo 1.80 -142.68 170.45 -161.26 70.54 81.20 -173.95 -91.09 21.62 -71.68 -69.11 -6.04 999.00 Allowed THR ASP PHE GLY"
"PAK1_HUMAN t_3Q53A.pdb STE Active 1 ATP 2.09 -131.45 -173.50 -165.18 59.16 73.64 -158.03 -91.66 12.90 -71.24 -60.70 -19.45 999.00 Allowed THR ASP PHE GLY"
"PAK1_HUMAN t_4DAWA.pdb STE Active 1 0H2 2.00 -145.20 -172.15 -165.54 68.39 87.64 -156.93 -98.50 24.49 -67.96 -67.79 -11.04 999.00 Allowed THR ASP PHE GLY"
"PAK1_HUMAN t_4EQCA.pdb STE Active 1 XR1 2.01 -136.97 172.69 -167.74 66.86 72.14 -73.10 -90.96 15.29 -70.67 -52.55 -25.21 999.00 Allowed THR ASP PHE GLY"
"PAK1_HUMAN t_4O0RA.pdb STE Active 1 X4Z 2.40 -136.30 -173.62 -163.60 66.36 84.46 -174.05 -105.39 22.76 -72.00 -66.77 -24.69 999.00 Allowed THR ASP PHE GLY"
"PAK1_HUMAN t_4O0RB.pdb STE DFGin-inactive 2 Apo 2.40 -142.20 148.85 -41.64 68.84 100.38 -77.04 -113.28 -26.08 -54.27 -85.93 999.00 999.00 Allowed THR ASP PHE GLY"
"PAK1_HUMAN t_4O0TA.pdb STE Active 1 2OL 2.60 -138.22 179.55 -168.22 54.94 78.71 -153.49 -95.64 34.57 -73.89 -68.01 -23.94 999.00 Allowed THR ASP PHE GLY"
"PAK1_HUMAN t_4P90A.pdb STE Active 1 2K0 2.49 -137.24 -168.24 -165.98 58.21 82.51 -174.65 -98.29 19.10 -76.34 -65.86 -25.12 999.00 Allowed THR ASP PHE GLY"
"PAK1_HUMAN t_4ZJIA.pdb STE DFGout 6 4OQ 1.99 -124.97 172.50 67.61 -139.36 60.86 176.31 -76.03 -0.32 -69.45 -101.26 2.80 999.00 Allowed THR ASP PHE GLY"
"PAK1_HUMAN t_4ZJIB.pdb STE DFGout 6 4OQ 1.99 -122.92 169.11 65.07 -135.24 63.34 177.30 -78.41 -1.06 -70.57 -102.36 3.63 999.00 Allowed THR ASP PHE GLY"
"PAK1_HUMAN t_4ZJIC.pdb STE DFGout 6 4OQ 1.99 -121.34 171.95 66.73 -130.53 60.36 -178.91 -81.42 -2.48 -69.04 -101.22 4.13 999.00 Allowed THR ASP PHE GLY"
"PAK1_HUMAN t_4ZJID.pdb STE DFGout 6 4OQ 1.99 -123.79 172.69 67.62 -134.24 62.09 175.58 -78.42 -2.15 -70.76 -100.20 2.83 999.00 Allowed THR ASP PHE GLY"
"PAK1_HUMAN t_4ZJJA.pdb STE DFGout 6 4OR 2.20 -121.36 171.39 64.79 -136.52 66.57 177.59 -79.19 -3.74 -68.86 -99.90 1.26 999.00 Allowed THR ASP PHE GLY"
"PAK1_HUMAN t_4ZJJB.pdb STE DFGout 6 4OR 2.20 -119.98 170.60 65.47 -136.12 65.83 175.84 -79.75 -2.79 -68.64 -99.75 -0.39 999.00 Allowed THR ASP PHE GLY"
"PAK1_HUMAN t_4ZJJC.pdb STE DFGout 6 4OR 2.20 -117.77 169.12 66.57 -137.06 67.46 -179.43 -83.77 26.95 -68.60 -146.22 999.00 999.00 Allowed THR ASP PHE GLY"
"PAK1_HUMAN t_4ZJJD.pdb STE DFGout 6 4OR 2.20 -122.32 164.61 74.88 -155.36 60.52 -175.55 -68.64 -25.56 -57.99 -82.13 -4.09 999.00 Allowed THR ASP PHE GLY"
"PAK1_HUMAN t_4ZLOA.pdb STE DFGout 6 4PV 2.50 -124.60 -179.12 62.49 -146.96 -83.67 -148.59 75.06 -28.02 -54.25 125.51 999.00 999.00 Allowed THR ASP PHE GLY"
"PAK1_HUMAN t_4ZLOB.pdb STE Active 1 Apo 2.50 -137.08 -173.11 -164.56 61.05 83.47 -72.32 -102.20 28.22 -67.81 -67.62 -48.02 999.00 Allowed THR ASP PHE GLY"
"PAK1_HUMAN t_4ZY4A.pdb STE Active 1 4T3 2.60 -139.61 -171.70 -168.28 61.38 95.09 -168.07 -118.76 13.68 -71.33 -63.21 -19.72 999.00 Outlier THR ASP PHE GLY"
"PAK1_HUMAN t_4ZY4B.pdb STE DFGup 3 4T3 2.60 -139.31 -177.64 -173.77 54.76 56.52 -90.25 -140.44 155.12 67.53 -101.58 132.30 999.00 Favored THR ASP PHE GLY"
"PAK1_HUMAN t_4ZY5A.pdb STE Active 1 4T5 2.35 -140.17 -173.05 -169.57 62.59 82.17 -170.45 -105.05 12.61 -71.71 -64.62 -16.81 999.00 Allowed THR ASP PHE GLY"
"PAK1_HUMAN t_4ZY5B.pdb STE DFGup 3 4T5 2.35 -144.29 -172.26 -174.01 51.40 58.74 -87.91 -146.66 154.07 70.19 -108.47 142.01 999.00 Favored THR ASP PHE GLY"
"PAK1_HUMAN t_4ZY6A.pdb STE Active 1 4T6 2.15 -124.33 -176.78 -169.69 68.33 82.33 -167.05 -102.24 16.72 -69.65 -64.18 -39.65 999.00 Allowed THR ASP PHE GLY"
"PAK1_HUMAN t_4ZY6B.pdb STE DFGup 3 4T6 2.15 -137.91 -177.42 -165.32 63.64 58.47 -164.91 -130.73 45.63 56.20 125.57 96.44 999.00 Allowed THR ASP PHE GLY"
"PAK1_HUMAN t_5DEWA.pdb STE Active 1 59N 1.90 -126.68 -174.13 -167.69 62.46 84.63 176.57 -103.79 30.00 -71.86 -74.87 -6.56 999.00 Allowed THR ASP PHE GLY"
"PAK1_HUMAN t_5DEWB.pdb STE DFGup 3 59N 1.90 -137.59 -178.20 -174.10 69.90 51.85 -158.23 -141.47 -178.05 59.67 -122.21 139.25 999.00 Allowed THR ASP PHE GLY"
"PAK1_HUMAN t_5DEYA.pdb STE Active 1 59T 2.10 -131.17 -174.83 -171.76 50.94 92.91 177.58 -106.34 27.37 -71.94 -72.54 -10.75 999.00 Outlier THR ASP PHE GLY"
"PAK1_HUMAN t_5DEYB.pdb STE DFGup 3 59T 2.10 -123.28 170.32 -173.22 -82.44 174.77 -95.55 -121.32 55.90 7.62 -96.27 -43.80 999.00 Favored THR ASP PHE GLY"
"PAK1_HUMAN t_5DFPA.pdb STE Active 1 59U 2.20 -140.36 175.29 -165.10 61.17 77.15 -158.15 -92.32 18.96 -78.63 -52.60 -30.80 999.00 Allowed THR ASP PHE GLY"
"PAK1_HUMAN t_5IMEA.pdb STE Active 1 6BZ 2.22 -137.85 -179.77 -166.95 51.89 81.37 -70.58 -98.00 22.92 -75.81 -62.11 -18.36 999.00 Allowed THR ASP PHE GLY"
"PAK1_HUMAN t_5KBQA.pdb STE Active 1 IPV 2.58 -137.24 -172.79 -163.65 54.36 86.23 -173.25 -100.20 16.93 -62.97 -62.93 -35.45 999.00 Allowed THR ASP PHE GLY"
"PAK1_HUMAN t_5KBRA.pdb STE Active 1 IPW 2.36 -141.54 -170.24 -162.76 54.39 91.67 -177.57 -104.29 18.59 -66.54 -60.50 -23.35 999.00 Outlier THR ASP PHE GLY"
"PAK4_HUMAN t_2BVAA.pdb STE Active 1 Apo 2.3 -117.28 -176.72 -136.88 56.67 71.45 -87.64 -91.29 35.11 -70.75 -69.66 -2.88 999.00 Allowed SER ASP PHE GLY"
"PAK4_HUMAN t_2BVAB.pdb STE DFGin-inactive 2 Apo 2.3 -131.90 -158.23 -138.65 65.56 44.23 -83.82 -84.50 26.92 -66.61 -60.80 -21.65 999.00 Favored SER ASP PHE GLY"
"PAK4_HUMAN t_2CDZA.pdb STE Active 1 23D 2.3 -131.94 -172.66 -168.02 60.58 61.39 -103.57 -89.88 16.96 -73.67 -67.64 -14.16 999.00 Allowed SER ASP PHE GLY"
"PAK4_HUMAN t_2J0IA.pdb STE Active 1 Apo 1.6 -134.38 -165.79 -160.28 58.37 60.73 -98.42 -88.31 13.33 -80.21 -62.30 -23.31 999.00 Favored SER ASP PHE GLY"
"PAK4_HUMAN t_2Q0NA.pdb STE Active 1 Apo 1.75 -132.39 -178.12 -168.62 60.08 59.86 -69.40 -83.05 16.15 -75.19 -58.26 -18.77 999.00 Favored SER ASP PHE GLY"
"PAK4_HUMAN t_2X4ZA.pdb STE Active 1 X4Z 2.10 -132.04 -174.00 175.07 55.33 65.82 -70.12 -89.06 22.52 -73.70 -56.58 -18.70 999.00 Allowed SER ASP PHE GLY"
"PAK4_HUMAN t_4APPA.pdb STE Active 1 N53 2.20 -133.61 -169.74 65.10 57.80 63.71 -77.51 -88.96 22.55 -75.85 -58.73 -21.00 999.00 Allowed SER ASP PHE GLY"
"PAK4_HUMAN t_4FIEA.pdb STE Active 1 ANP 3.11 -142.70 -177.81 -167.89 63.71 67.71 -56.02 -92.96 13.52 -64.74 -64.20 -6.96 999.00 Allowed SER ASP PHE GLY"
"PAK4_HUMAN t_4FIEB.pdb STE Active 1 ANP 3.11 -142.22 -177.61 -167.44 63.60 67.53 -56.01 -92.68 13.47 -64.62 -64.01 -7.25 999.00 Allowed SER ASP PHE GLY"
"PAK4_HUMAN t_4FIFA.pdb STE Active 1 ANP 2.60 -134.29 -172.63 -175.83 55.82 65.63 -69.80 -91.15 11.06 -60.39 -61.37 -20.56 999.00 Allowed SER ASP PHE GLY"
"PAK4_HUMAN t_4FIFB.pdb STE Active 1 ANP 2.60 -129.04 -170.32 -173.03 52.25 68.50 -65.84 -93.48 10.47 -58.06 -63.15 -14.95 999.00 Allowed SER ASP PHE GLY"
"PAK4_HUMAN t_4FIGA.pdb STE Active 1 ANP 3.01 -134.39 -166.22 -167.73 59.03 57.30 -60.89 -88.33 9.09 -61.08 -61.52 -20.69 999.00 Favored SER ASP PHE GLY"
"PAK4_HUMAN t_4FIGB.pdb STE Active 1 ANP 3.01 -136.06 -40.25 74.97 -82.38 70.24 -74.64 -85.49 12.44 -54.74 -66.75 -24.29 999.00 Favored SER ASP PHE GLY"
"PAK4_HUMAN t_4FIHA.pdb STE DFGin-inactive 2 Apo 1.97 -136.50 -176.90 82.08 57.50 65.29 -66.85 -90.70 14.95 -74.42 -54.71 -25.43 999.00 Allowed SER ASP PHE GLY"
"PAK4_HUMAN t_4FIIA.pdb STE DFGin-inactive 2 Apo 2.00 -132.46 178.76 -161.98 60.32 61.72 -68.68 -80.43 12.88 -71.32 -61.88 -21.80 999.00 Allowed SER ASP PHE GLY"
"PAK4_HUMAN t_4FIJA.pdb STE DFGin-inactive 2 Apo 2.30 -121.82 -176.73 -162.14 65.34 67.51 -83.40 -99.57 14.76 -78.22 -61.36 -22.92 999.00 Allowed SER ASP PHE GLY"
"PAK4_HUMAN t_4JDHA.pdb STE DFGin-inactive 2 Apo 2.00 -133.98 -173.50 -165.95 58.61 59.96 -79.22 -88.46 17.71 -74.61 -64.19 -20.68 999.00 Favored SER ASP PHE GLY"
"PAK4_HUMAN t_4JDIA.pdb STE Active 1 ANP 1.85 -134.26 177.84 72.75 63.74 71.60 -174.15 -94.63 13.76 -70.26 -54.09 -28.78 999.00 Allowed SER ASP PHE GLY"
"PAK4_HUMAN t_4JDJA.pdb STE DFGin-inactive 2 Apo 2.30 -135.05 -172.80 74.56 53.99 73.89 -169.08 -92.87 18.89 -75.84 -56.86 -29.71 999.00 Allowed SER ASP PHE GLY"
"PAK4_HUMAN t_4JDKA.pdb STE DFGin-inactive 2 Apo 2.40 -140.41 175.97 -167.22 48.45 79.61 -171.90 -91.40 8.03 -75.71 -60.42 -13.20 999.00 Allowed SER ASP PHE GLY"
"PAK4_HUMAN t_4L67A.pdb STE DFGin-inactive 2 Apo 2.80 -151.60 -168.49 177.39 51.99 67.40 -80.57 -93.37 11.40 -70.81 -58.56 -33.05 999.00 Allowed SER ASP PHE GLY"
"PAK4_HUMAN t_4NJDA.pdb STE Active 1 NJD 2.50 -137.65 -170.81 152.74 59.80 63.93 -78.77 -89.24 10.28 -71.62 -51.48 -35.57 999.00 Allowed SER ASP PHE GLY"
"PAK4_HUMAN t_4O0VA.pdb STE Active 1 2OL 2.80 -129.94 -179.13 -172.80 52.91 70.51 -151.69 -91.00 31.73 -70.70 -68.74 -11.51 999.00 Allowed SER ASP PHE GLY"
"PAK4_HUMAN t_4O0XA.pdb STE Active 1 2OQ 2.48 -143.47 175.21 176.18 50.70 80.03 -158.26 -96.78 29.20 -71.42 -65.03 -22.84 999.00 Allowed SER ASP PHE GLY"
"PAK4_HUMAN t_4O0YA.pdb STE Active 1 2OO 2.20 -135.09 176.54 176.41 49.34 78.82 -153.73 -92.44 20.74 -71.15 -54.10 -29.84 999.00 Allowed SER ASP PHE GLY"
"PAK4_HUMAN t_4XBRA.pdb STE Active 1 ATP 2.94 -142.03 -22.21 151.24 -111.42 72.52 -135.75 -86.53 10.52 -49.25 -46.90 -40.61 999.00 Allowed SER ASP PHE GLY"
"PAK4_HUMAN t_4XBUA.pdb STE Active 1 Apo 2.06 -134.74 -171.40 -158.39 58.19 68.09 -87.23 -90.96 10.77 -77.62 -57.40 -26.07 999.00 Allowed SER ASP PHE GLY"
"PAK4_HUMAN t_5BMSA.pdb STE Active 1 4T6 2.90 -127.90 -156.82 -174.79 35.44 78.39 -72.89 -99.01 8.44 -60.77 -63.09 -11.48 999.00 Outlier SER ASP PHE GLY"
"PAK4_HUMAN t_5I0BA.pdb STE Active 1 67U 3.09 -124.90 -168.49 -167.75 59.71 54.11 -90.04 -85.47 7.59 -69.64 -49.21 -28.70 999.00 Favored SER ASP PHE GLY"
"PAK6_HUMAN t_2C30A.pdb STE Active 1 Apo 1.6 -134.68 -166.38 55.49 59.62 59.69 -71.39 -84.14 17.27 -75.05 -48.96 -37.47 999.00 Favored SER ASP PHE GLY"
"PAK6_HUMAN t_4KS7A.pdb STE Active 1 X4Z 1.40 -131.54 -164.01 -175.99 58.93 57.96 -76.26 -84.09 9.42 -60.13 -61.97 -36.29 999.00 Favored SER ASP PHE GLY"
"PAK6_HUMAN t_4KS8A.pdb STE Active 1 B49 1.95 -140.05 -170.21 -165.36 63.34 61.54 -85.46 -88.99 6.98 -60.70 -57.75 -32.95 999.00 Allowed SER ASP PHE GLY"
"PAK7_HUMAN t_2F57A.pdb STE Active 1 TRS 1.80 -132.22 -179.07 78.17 54.47 81.54 -172.48 -94.02 25.24 -74.81 -59.96 -25.13 999.00 Allowed SER ASP PHE GLY"
"PAK7_HUMAN t_2F57B.pdb STE Active 1 23D 1.80 -129.70 -174.39 73.77 58.71 69.50 -70.93 -94.94 19.10 -76.15 -55.51 -32.95 999.00 Allowed SER ASP PHE GLY"
"PASK_HUMAN t_3DLSA.pdb CAMK Active 1 ADP 2.30 -129.00 178.93 51.39 63.52 79.22 -170.45 -101.01 26.99 -77.58 -70.94 -15.45 999.00 Allowed ILE ASP PHE GLY"
"PASK_HUMAN t_3DLSB.pdb CAMK Active 1 ADP 2.30 -126.51 179.42 54.49 61.40 80.56 -166.77 -98.15 22.24 -75.62 -72.83 -6.92 999.00 Allowed ILE ASP PHE GLY"
"PASK_HUMAN t_3DLSC.pdb CAMK Active 1 ADP 2.30 -121.19 -179.02 52.79 61.84 81.91 -171.56 -99.99 24.36 -80.88 -70.45 -24.81 999.00 Allowed ILE ASP PHE GLY"
"PASK_HUMAN t_3DLSD.pdb CAMK Active 1 ADP 2.30 -119.77 -174.41 58.98 57.11 82.45 -159.03 -96.60 20.06 -76.60 -63.20 -13.74 999.00 Allowed ILE ASP PHE GLY"
"PASK_HUMAN t_3DLSE.pdb CAMK Active 1 ADP 2.30 -115.00 172.33 58.99 61.50 82.91 -168.98 -98.36 26.76 -72.81 -61.94 -22.56 999.00 Allowed ILE ASP PHE GLY"
"PASK_HUMAN t_3DLSF.pdb CAMK Active 1 ADP 2.30 -120.79 -179.44 56.78 54.79 74.60 -160.52 -87.64 27.81 -79.68 -72.72 -14.25 999.00 Allowed ILE ASP PHE GLY"
"PDPK1_HUMAN t_1H1WA.pdb AGC Active 1 ATP 2.00 -145.29 -169.99 -171.25 71.90 72.17 -167.83 -105.79 -0.05 -70.74 -58.32 -31.94 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_1OKYA.pdb AGC Active 1 STU 2.3 -149.02 -170.89 -167.28 70.63 80.44 -161.90 -102.77 23.81 -73.15 -69.21 -20.29 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_1OKZA.pdb AGC Active 1 UCN 2.51 -141.60 -164.77 -175.21 67.58 76.79 -163.16 -103.77 11.10 -72.18 -63.70 2.10 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_1UU3A.pdb AGC Active 1 LY4 1.7 -134.44 -173.43 -164.84 74.32 74.07 -164.76 -109.72 0.58 -76.61 -63.96 -27.18 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_1UU7A.pdb AGC Active 1 BI2 1.9 -136.50 -171.94 -172.08 74.33 73.77 -166.17 -109.82 -2.66 -72.62 -53.83 -39.15 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_1UU8A.pdb AGC Active 1 BI1 2.5 -136.36 -165.42 -175.58 63.11 71.91 -171.51 -101.87 2.51 -71.40 -58.04 -33.98 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_1UU9A.pdb AGC Active 1 BI3 1.95 -137.56 -169.14 -174.22 68.79 72.56 -165.23 -103.81 -0.33 -74.13 -59.48 -32.25 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_1UVRA.pdb AGC Active 1 BI8 2.81 -141.69 -169.25 178.47 62.76 72.50 -177.98 -105.38 8.59 -59.10 -59.97 -35.67 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_1Z5MA.pdb AGC Active 1 LI8 2.17 -143.10 -166.03 -171.06 70.11 70.42 -170.12 -106.54 10.64 -74.44 -57.95 -38.77 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_2BIYA.pdb AGC Active 1 ATP 1.95 -141.34 -175.80 -168.30 82.88 67.68 -168.33 -104.99 1.68 -76.98 -61.69 -33.08 999.00 Outlier THR ASP PHE GLY"
"PDPK1_HUMAN t_2PE0A.pdb AGC Active 1 39Z 2.35 -130.01 -179.51 -172.10 78.79 74.81 -163.60 -107.05 5.20 -73.43 -55.75 -29.67 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_2PE1A.pdb AGC Active 1 517 2.14 -139.37 -175.89 -172.38 73.17 71.38 -158.91 -105.24 7.71 -73.11 -52.94 -40.91 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_2PE2A.pdb AGC Active 1 464 2.13 -135.74 -175.87 -169.44 78.54 72.06 -159.91 -109.66 0.44 -72.71 -54.23 -35.80 999.00 Outlier THR ASP PHE GLY"
"PDPK1_HUMAN t_2R7BA.pdb AGC Active 1 253 2.70 -133.92 -179.49 -175.39 77.80 81.48 -147.07 -108.23 21.99 -68.86 -68.63 -11.06 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_2XCHA.pdb AGC Active 1 CKG 2.00 -129.57 177.24 67.69 73.12 77.10 -165.80 -102.14 9.90 -74.85 -57.40 -39.90 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_2XCKA.pdb AGC Active 1 MH4 2.30 -138.16 -175.20 164.95 71.01 75.51 -170.99 -104.62 7.05 -73.58 -56.01 -44.12 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_3H9OA.pdb AGC Active 1 9BD 2.30 -131.96 -168.70 -170.78 66.59 79.55 -157.99 -104.55 18.14 -76.67 -72.19 -11.10 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_3HRCA.pdb AGC Active 1 ATP 1.91 -136.90 -178.20 -163.72 71.82 74.56 -157.83 -104.52 6.99 -73.11 -65.45 -24.45 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_3HRFA.pdb AGC Active 1 P47 1.90 -133.76 -176.07 -171.82 75.24 77.14 -159.56 -110.86 6.57 -72.50 -63.86 -22.78 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_3IONA.pdb AGC Active 1 8H1 2.40 -129.57 -169.53 -169.21 64.07 80.16 -167.43 -106.21 22.88 -74.12 -68.81 -24.39 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_3IOPA.pdb AGC Active 1 8I1 2.20 -125.32 -165.98 -167.16 58.15 80.10 -165.25 -105.21 23.33 -74.26 -73.19 -11.30 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_3NAXA.pdb AGC DFGout 6 MP7 1.75 -103.05 154.82 60.09 -117.93 140.26 171.79 -115.31 34.42 -88.40 93.29 8.77 999.00 Favored THR ASP PHE GLY"
"PDPK1_HUMAN t_3NAYA.pdb AGC Active 1 MP6 2.60 -146.81 -173.06 -165.29 72.18 70.71 -150.03 -103.71 5.05 -63.03 -60.86 -27.84 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_3NAYB.pdb AGC Active 1 MP6 2.60 -131.67 -178.38 -159.93 72.04 77.10 -160.04 -107.83 17.46 -60.35 -69.45 -28.41 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_3NUNA.pdb AGC Active 1 JMZ 2.20 -136.66 178.66 -164.47 75.32 84.77 -160.33 -114.39 16.23 -66.32 -60.38 -36.06 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_3NUSA.pdb AGC Active 1 Apo 2.75 -134.91 -176.74 -169.86 67.75 79.21 -168.49 -106.94 14.48 -66.29 -56.67 -43.73 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_3NUUA.pdb AGC Active 1 Apo 1.98 -135.11 176.47 -170.79 77.66 76.30 -175.12 -106.60 4.55 -70.42 -54.90 -35.16 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_3NUYA.pdb AGC Active 1 Apo 2.10 -136.78 -175.64 -169.14 72.15 77.51 -173.12 -106.41 8.12 -74.11 -50.90 -42.85 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_3ORXA.pdb AGC Active 1 1F8 2.20 -138.50 -175.67 -153.60 62.89 74.04 -155.27 -93.72 13.51 -84.11 -62.85 -23.96 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_3ORXB.pdb AGC Active 1 1F8 2.20 -140.71 -175.67 -156.43 59.45 71.05 -163.16 -92.15 14.24 -80.24 -63.73 -16.60 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_3ORXC.pdb AGC Active 1 1F8 2.20 -135.92 -176.43 -153.51 63.80 71.67 -158.80 -93.37 13.74 -79.35 -62.66 -20.99 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_3ORXD.pdb AGC Active 1 1F8 2.20 -134.43 -170.10 -160.49 60.82 71.91 -156.84 -91.57 12.89 -81.98 -67.50 -17.42 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_3ORXE.pdb AGC Active 1 1F8 2.20 -125.32 -158.70 -175.34 61.44 56.04 -112.38 -85.00 10.31 -80.63 -55.11 -32.28 999.00 Favored THR ASP PHE GLY"
"PDPK1_HUMAN t_3ORXF.pdb AGC Active 1 1F8 2.20 -124.98 -165.06 -165.75 64.25 56.62 -120.43 -90.24 13.88 -86.43 -58.82 -32.54 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_3ORXG.pdb AGC Active 1 1F8 2.20 -124.39 -160.13 -167.46 59.74 58.38 -110.35 -84.99 8.29 -89.38 -58.25 -35.02 999.00 Favored THR ASP PHE GLY"
"PDPK1_HUMAN t_3ORXH.pdb AGC Active 1 1F8 2.20 -123.35 -162.29 -176.67 62.40 60.33 -119.50 -89.78 14.61 -76.53 -55.84 -32.23 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_3ORZA.pdb AGC Active 1 BI4 2.00 -134.95 -167.36 -161.91 70.13 66.17 -164.84 -101.25 1.00 -66.24 -61.00 -29.30 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_3ORZB.pdb AGC Active 1 BI4 2.00 -139.37 -168.66 -171.18 74.13 69.93 -164.18 -111.20 3.07 -75.39 -63.42 -24.85 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_3ORZC.pdb AGC Active 1 BI4 2.00 -134.09 -170.50 -167.04 76.78 69.35 -164.69 -110.25 1.33 -72.07 -56.68 -30.45 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_3ORZD.pdb AGC Active 1 2A2 2.00 -139.64 -168.42 -171.51 74.41 69.05 -163.62 -110.31 3.30 -74.64 -63.52 -24.85 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_3OTUA.pdb AGC Active 1 J30 2.10 -147.17 -166.49 -163.84 62.46 61.60 -166.98 -95.60 10.21 -69.04 -63.32 -24.58 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_3PWYA.pdb AGC Active 1 SYP 3.50 -124.66 -178.37 -158.61 67.94 96.32 -178.13 -130.63 11.45 -59.42 -64.95 -30.99 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_3QC4A.pdb AGC DFGout 6 MP7 1.80 -116.80 146.55 -164.23 -96.95 143.55 175.35 -123.01 29.24 -110.18 113.43 -5.45 999.00 Favored THR ASP PHE GLY"
"PDPK1_HUMAN t_3QC4B.pdb AGC DFGout 6 MP7 1.80 -112.54 150.75 -169.37 -96.78 153.44 173.35 -131.50 34.05 -124.83 107.66 4.90 999.00 Favored THR ASP PHE GLY"
"PDPK1_HUMAN t_3QCQA.pdb AGC Active 1 3Q0 2.50 -130.06 -172.38 -171.59 67.80 84.83 -171.99 -116.18 10.10 -69.09 -59.96 -35.96 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_3QCSA.pdb AGC Active 1 3Q1 2.49 -129.14 -172.51 -169.86 69.93 84.26 -179.30 -118.55 4.78 -76.99 -59.77 -28.43 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_3QCXA.pdb AGC Active 1 3Q2 2.30 -128.85 -170.94 -166.79 71.81 79.29 178.12 -115.35 7.30 -75.88 -60.78 -28.85 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_3QCYA.pdb AGC Active 1 3Q3 2.20 -136.96 -173.17 -162.79 71.00 75.15 -176.42 -110.34 14.28 -75.83 -62.72 -28.35 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_3QD0A.pdb AGC Active 1 3Q4 1.99 -135.98 -173.18 -162.59 73.58 73.02 -177.14 -106.33 12.12 -78.50 -54.82 -35.97 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_3QD3A.pdb AGC Active 1 3Q5 2.00 -136.15 -173.34 -167.15 75.02 78.89 -178.12 -114.87 7.79 -75.77 -60.85 -30.05 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_3QD4A.pdb AGC Active 1 3Q6 2.30 -137.75 -173.40 -166.17 72.99 75.87 178.13 -110.65 10.32 -74.82 -64.37 -29.26 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_3RCJA.pdb AGC Active 1 3RC 1.70 -128.98 -167.62 -165.43 59.75 67.16 -150.90 -93.26 12.14 -73.18 -60.52 -37.36 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_3RWPA.pdb AGC Active 1 ABQ 1.92 -138.04 -171.82 -168.88 73.20 68.87 -175.84 -101.83 0.78 -75.75 -67.11 -24.98 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_3RWQA.pdb AGC Active 1 3RW 2.55 -143.63 -172.61 -161.69 68.49 70.31 -165.46 -102.01 3.32 -70.94 -56.63 -39.17 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_3SC1A.pdb AGC Active 1 3S1 2.70 -125.87 175.61 -173.03 82.16 80.60 -171.16 -113.34 8.38 -69.13 -53.01 -47.25 999.00 Outlier THR ASP PHE GLY"
"PDPK1_HUMAN t_4A06A.pdb AGC Active 1 ATP 2.00 -135.75 -177.15 -170.44 74.21 74.69 -163.10 -110.24 11.84 -75.04 -68.22 -22.48 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_4A07A.pdb AGC Active 1 ATP 1.85 -135.36 -178.93 -168.13 76.04 72.42 -154.45 -108.98 8.67 -73.73 -64.40 -21.91 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_4AW0A.pdb AGC Active 1 ATP 1.43 -134.80 177.30 -168.83 78.65 76.22 -160.68 -106.34 8.56 -76.51 -69.65 -19.41 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_4AW1A.pdb AGC Active 1 21O 1.68 -137.24 -178.27 -167.93 69.01 84.67 -172.01 -105.36 17.04 -73.95 -62.76 -26.70 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_4CT1A.pdb AGC Active 1 ATP 1.85 -141.69 -172.45 -168.72 72.40 72.06 -161.54 -107.01 8.08 -75.06 -62.71 -20.08 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_4CT2A.pdb AGC Active 1 ATP 1.25 -136.26 -174.98 -173.28 71.74 69.09 -124.10 -102.02 6.43 -69.25 -63.75 -21.62 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_4RQKA.pdb AGC Active 1 ATP 1.55 -139.09 -177.07 -166.27 75.22 72.89 -155.21 -105.28 7.41 -72.72 -64.74 -21.37 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_4RQVA.pdb AGC Active 1 R2S 1.50 -139.41 -174.90 -164.97 68.77 75.30 -88.25 -102.04 7.90 -74.20 -65.15 -21.55 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_4RRVA.pdb AGC Active 1 ATP 1.41 -136.59 -175.98 -166.06 74.61 72.79 -158.73 -106.53 5.81 -73.42 -68.14 -17.81 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_4XX9A.pdb AGC Active 1 ATP 1.40 -138.45 -176.22 -164.27 74.83 73.71 -158.04 -104.65 7.91 -77.42 -69.03 -20.45 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_5ACKA.pdb AGC Active 1 ATP 1.24 -135.33 179.85 -165.10 72.25 79.02 -78.81 -106.02 4.10 -72.06 -66.95 -18.77 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_5HKMA.pdb AGC Active 1 61Y 2.10 -122.57 -157.06 -167.55 51.69 73.84 -176.37 -100.66 14.05 -78.83 -62.55 -33.65 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_5HNGA.pdb AGC Active 1 62O 3.01 -131.38 -170.33 -172.18 61.06 71.90 176.37 -92.72 10.41 -72.01 -55.23 -43.33 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_5HO7A.pdb AGC Active 1 63L 3.00 -138.46 -177.99 -175.25 80.01 72.18 -118.03 -103.19 8.64 -66.44 -61.00 -44.94 999.00 Outlier THR ASP PHE GLY"
"PDPK1_HUMAN t_5HO8A.pdb AGC Active 1 63E 2.70 -137.80 179.64 -175.36 80.30 69.70 -155.52 -100.28 11.28 -63.37 -58.66 -47.26 999.00 Outlier THR ASP PHE GLY"
"PDPK1_HUMAN t_5LVLA.pdb AGC Active 1 537 1.40 -130.65 -179.05 -166.18 78.14 78.24 -168.12 -107.57 5.80 -72.72 -64.19 -24.01 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_5LVMA.pdb AGC Active 1 ADE 1.26 -134.30 -178.76 -165.23 71.85 81.78 -74.34 -107.90 3.01 -75.18 -68.47 -15.36 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_5LVNA.pdb AGC Active 1 ADN 1.38 -138.60 -175.43 -165.88 73.38 75.08 -160.70 -105.58 5.37 -74.44 -63.77 -19.58 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_5LVOA.pdb AGC Active 1 ATP 1.09 -134.81 179.90 -167.32 79.17 70.12 -157.68 -103.54 0.27 -73.32 -64.66 -19.63 999.00 Outlier THR ASP PHE GLY"
"PDPK1_HUMAN t_5LVPA.pdb AGC Active 1 ATP 2.50 -144.95 -168.85 -177.05 66.04 77.76 -165.77 -108.21 11.21 -77.98 -63.07 -32.41 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_5LVPB.pdb AGC Active 1 ATP 2.50 -137.23 -179.69 -173.52 80.14 74.16 -174.23 -105.47 15.39 -64.98 -59.91 -31.46 999.00 Outlier THR ASP PHE GLY"
"PDPK1_HUMAN t_5LVPC.pdb AGC Active 1 ATP 2.50 -132.15 -176.82 -175.63 71.96 84.01 -165.70 -116.54 7.63 -68.51 -60.24 -24.47 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_5LVPD.pdb AGC Active 1 ATP 2.50 -146.99 -174.21 -170.72 74.17 81.53 -164.08 -113.80 3.98 -71.99 -56.12 -25.71 999.00 Allowed THR ASP PHE GLY"
"PDPK1_HUMAN t_5MRDA.pdb AGC Active 1 S26 1.41 -133.70 -177.15 -167.07 74.26 73.88 -164.83 -105.91 9.04 -70.62 -68.30 -19.64 999.00 Allowed THR ASP PHE GLY"
"PGFRA_HUMAN t_5K5XA.pdb TYR DFGout 6 Apo 2.17 -153.24 -177.14 67.34 -114.02 113.86 -179.07 -108.10 22.87 -144.26 -59.52 -34.36 999.00 Favored CYS ASP PHE GLY"
"PHKG2_HUMAN t_2Y7JA.pdb CAMK Active 1 B49 2.50 -136.31 -170.12 66.90 54.72 70.84 -83.64 -92.34 20.76 -75.87 -61.84 -24.15 999.00 Allowed SER ASP PHE GLY"
"PHKG2_HUMAN t_2Y7JB.pdb CAMK Active 1 B49 2.50 -134.50 -166.04 66.56 48.29 72.47 -176.43 -89.51 24.68 -77.46 -61.58 -27.13 999.00 Allowed SER ASP PHE GLY"
"PHKG2_HUMAN t_2Y7JC.pdb CAMK Active 1 B49 2.50 -128.05 -166.62 60.87 49.55 75.22 -71.23 -93.07 22.53 -75.41 -62.64 -24.55 999.00 Allowed SER ASP PHE GLY"
"PHKG2_HUMAN t_2Y7JD.pdb CAMK Active 1 B49 2.50 -131.71 -173.29 68.73 54.45 74.23 -67.25 -92.52 24.81 -76.42 -62.64 -24.75 999.00 Allowed SER ASP PHE GLY"
"PIM1_HUMAN t_1XQZA.pdb CAMK Active 1 Apo 2.10 -132.57 173.57 58.59 55.56 88.88 -169.27 -95.21 18.47 -71.52 -59.24 -7.60 999.00 Outlier ILE ASP PHE GLY"
"PIM1_HUMAN t_1XR1A.pdb CAMK Active 1 ANP 2.10 -138.08 176.98 66.68 59.76 85.29 -164.53 -96.48 16.86 -72.05 -61.38 -7.20 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_1XWSA.pdb CAMK Active 1 BI1 1.80 -129.52 166.94 48.96 66.18 81.12 -164.88 -88.87 13.42 -75.54 -63.85 -15.24 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_1YHSA.pdb CAMK Active 1 STU 2.15 -129.30 165.17 58.72 65.10 87.94 -167.60 -99.17 21.62 -76.50 -67.32 -11.81 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_1YI3A.pdb CAMK Active 1 LY2 2.50 -128.80 165.02 65.83 59.99 85.35 -165.35 -95.16 30.74 -72.14 -66.22 -20.24 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_1YI4A.pdb CAMK Active 1 ADN 2.40 -134.71 164.96 62.87 59.09 80.84 179.95 -89.84 21.91 -72.88 -64.72 -12.26 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_1YWVA.pdb CAMK Active 1 Apo 2.00 -128.69 170.20 59.29 59.43 82.40 -164.24 -93.39 16.91 -75.26 -65.52 -15.88 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_1YXSA.pdb CAMK Active 1 Apo 2.20 -127.75 171.68 58.74 59.04 88.64 -170.01 -95.72 24.49 -74.24 -71.91 -12.04 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_1YXTA.pdb CAMK Active 1 ANP 2.00 -131.77 177.02 52.51 66.44 83.65 -169.60 -99.67 19.68 -72.49 -65.75 -15.36 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_1YXUA.pdb CAMK Active 1 AMP 2.24 -128.47 170.01 54.15 62.88 77.73 -159.06 -90.34 20.21 -72.39 -74.65 1.61 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_1YXUB.pdb CAMK Active 1 AMP 2.24 -120.28 167.93 64.38 65.74 85.44 -158.59 -95.35 14.02 -74.61 -64.69 -9.26 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_1YXUC.pdb CAMK Active 1 AMP 2.24 -134.93 167.85 59.32 62.61 83.13 -169.09 -95.59 21.38 -79.91 -81.76 7.87 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_1YXUD.pdb CAMK Active 1 AMP 2.24 -126.02 169.07 65.42 67.73 73.32 -152.52 -88.52 13.92 -70.94 -70.30 -2.84 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_1YXVA.pdb CAMK Active 1 LI6 2.00 -131.29 169.92 57.88 60.91 79.91 -66.23 -90.90 14.68 -75.03 -64.33 -11.63 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_1YXXA.pdb CAMK Active 1 LI7 2.00 -118.81 172.49 67.21 62.90 83.77 -162.68 -93.81 24.33 -77.07 -77.25 -2.79 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_2BIKB.pdb CAMK Active 1 BI1 1.8 -129.61 166.23 50.66 65.30 82.24 -164.57 -90.44 20.49 -75.73 -71.94 -11.77 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_2BILB.pdb CAMK Active 1 BI1 2.55 -131.58 166.01 55.58 69.49 82.95 -163.55 -91.33 19.52 -73.84 -74.94 -10.90 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_2BZHB.pdb CAMK Active 1 HB1 1.90 -128.95 169.69 54.92 62.17 81.59 -167.93 -86.24 13.93 -72.13 -66.51 -13.61 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_2BZIB.pdb CAMK Active 1 DW2 1.90 -123.35 165.31 56.32 66.44 86.10 -165.30 -93.23 22.21 -73.69 -70.39 -16.55 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_2BZJA.pdb CAMK Active 1 ME3 2.05 -129.11 166.61 53.84 64.12 83.60 -161.75 -93.33 13.15 -76.82 -69.00 -14.90 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_2BZKB.pdb CAMK Active 1 ANP 2.45 -123.90 174.73 68.98 64.62 79.15 -162.10 -87.52 17.23 -73.03 -67.56 -17.56 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_2C3IB.pdb CAMK Active 1 IYZ 1.90 -127.29 169.86 57.61 65.30 82.01 -163.35 -93.78 15.96 -73.97 -64.91 -18.90 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_2J2IB.pdb CAMK Active 1 LY4 1.9 -124.70 164.20 57.66 69.65 81.08 -164.79 -88.54 16.67 -72.52 -63.86 -22.27 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_2O3PA.pdb CAMK Active 1 QUE 2.24 -130.87 170.42 57.18 60.68 81.70 -68.25 -94.25 20.47 -77.67 -71.97 -12.71 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_2O63A.pdb CAMK Active 1 IMD 2.00 -133.36 172.37 57.07 63.29 75.16 -74.40 -88.33 15.09 -73.93 -67.46 -7.74 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_2O64A.pdb CAMK Active 1 MYU 2.44 -128.74 172.16 59.21 61.55 79.90 -170.60 -92.51 15.56 -74.81 -62.98 -16.59 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_2O65A.pdb CAMK Active 1 MYF 2.85 -134.92 170.05 54.73 60.04 89.26 -162.36 -101.39 10.56 -72.69 -63.94 -9.85 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_2OBJA.pdb CAMK Active 1 VRV 2.50 -135.07 165.88 59.84 65.60 81.54 -171.81 -93.29 20.78 -68.84 -60.08 -19.35 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_2OI4X.pdb CAMK Active 1 JM1 2.20 -128.05 160.81 56.70 73.34 71.79 -167.34 -86.15 11.97 -72.74 -76.67 -11.12 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_2XIXA.pdb CAMK Active 1 Apo 2.40 -127.69 172.44 59.36 53.45 84.97 -170.37 -93.48 22.66 -71.19 -73.49 -9.52 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_2XIYA.pdb CAMK Active 1 Apo 2.20 -122.40 177.21 56.18 60.37 73.44 -72.60 -90.34 13.95 -76.00 -69.70 -11.93 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_2XIZA.pdb CAMK Active 1 Apo 2.21 -122.53 175.84 65.31 58.29 84.59 -165.40 -93.21 17.51 -77.49 -67.85 -13.60 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_2XJ0A.pdb CAMK Active 1 XJ0 3.10 -134.60 165.42 60.86 58.43 101.55 176.89 -112.31 25.87 -69.44 -70.79 -14.24 999.00 Outlier ILE ASP PHE GLY"
"PIM1_HUMAN t_2XJ1A.pdb CAMK Active 1 XJ1 2.13 -129.26 177.60 57.05 56.18 82.32 -161.40 -92.12 21.06 -76.39 -73.34 -11.65 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_2XJ2A.pdb CAMK Active 1 985 2.20 -122.01 176.12 62.08 56.87 82.18 -164.82 -90.57 18.97 -73.59 -71.87 -10.27 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_3A99A.pdb CAMK Active 1 ANP 1.60 -128.38 171.56 60.29 60.88 87.36 -165.88 -96.69 22.08 -71.45 -65.77 -9.32 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_3BGPA.pdb CAMK Active 1 VX1 2.80 -126.45 157.08 58.04 77.58 91.73 -166.84 -104.18 28.83 -66.63 -65.20 -26.62 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_3BGQA.pdb CAMK Active 1 VX2 2.00 -129.20 172.21 57.03 56.91 80.32 -170.30 -93.95 24.99 -72.53 -68.36 -10.96 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_3BGZA.pdb CAMK Active 1 VX3 2.40 -127.06 169.09 56.92 64.51 80.00 -168.83 -92.05 15.98 -75.14 -68.66 -13.13 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_3BWFA.pdb CAMK Active 1 DWC 2.35 -130.12 160.73 62.22 70.45 85.64 -165.28 -95.53 18.08 -72.67 -68.61 -18.23 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_3C4EA.pdb CAMK Active 1 C4E 1.98 -128.36 166.00 55.51 69.44 82.57 -165.70 -93.66 21.55 -73.38 -72.41 -9.29 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_3C4EB.pdb CAMK Active 1 C4E 1.98 -125.64 167.01 55.63 68.67 82.63 -165.99 -92.07 15.66 -74.86 -64.59 -9.18 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_3C4EC.pdb CAMK Active 1 C4E 1.98 -128.71 171.79 61.13 61.44 83.01 -158.53 -93.51 22.09 -74.78 -74.41 -9.32 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_3C4ED.pdb CAMK Active 1 C4E 1.98 -130.16 172.86 56.06 60.00 79.46 -162.08 -88.45 15.31 -78.03 -75.02 -5.96 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_3CXWA.pdb CAMK Active 1 7CP 2.10 -123.74 175.98 67.23 66.31 77.59 -166.32 -92.48 20.43 -73.05 -73.18 -11.77 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_3CY2A.pdb CAMK Active 1 MB9 2.01 -126.39 176.22 69.68 64.43 78.31 -170.44 -92.71 18.88 -71.83 -67.97 -11.94 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_3CY3A.pdb CAMK Active 1 JN5 2.15 -119.65 175.11 58.06 56.76 74.95 -162.75 -82.19 12.46 -74.21 -70.59 -7.42 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_3DCVA.pdb CAMK Active 1 55E 2.70 -130.44 168.15 62.59 69.00 78.27 -166.59 -92.81 18.92 -74.44 -63.87 -15.26 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_3F2AA.pdb CAMK Active 1 985 1.90 -128.58 176.63 64.70 59.06 83.27 -157.80 -93.88 21.67 -71.97 -68.70 -6.58 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_3JPVA.pdb CAMK Active 1 1DR 2.35 -120.09 164.65 56.20 68.15 86.82 -163.16 -92.47 13.62 -70.01 -67.44 -13.69 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_3JXWA.pdb CAMK Active 1 LXG 2.80 -134.39 162.63 59.89 73.18 86.78 -157.97 -94.37 16.23 -76.28 -67.17 -7.06 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_3JY0A.pdb CAMK Active 1 LYG 2.40 -136.01 169.04 52.34 67.17 86.04 -162.90 -88.47 12.37 -74.79 -62.59 -8.99 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_3JYAA.pdb CAMK Active 1 LWG 2.10 -132.93 173.52 55.67 45.26 85.30 -167.21 -90.19 14.40 -74.27 -67.73 -13.79 999.00 Outlier ILE ASP PHE GLY"
"PIM1_HUMAN t_3MA3A.pdb CAMK Active 1 01I 2.30 -126.50 170.51 55.25 60.71 85.70 -168.45 -91.60 21.03 -71.10 -71.67 -14.93 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_3QF9A.pdb CAMK Active 1 NM8 2.20 -120.86 169.09 61.56 67.17 78.80 -163.76 -88.91 16.35 -71.57 -67.57 -12.23 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_3R00A.pdb CAMK Active 1 UNJ 2.10 -129.22 179.95 52.80 62.82 78.65 -159.96 -92.72 17.70 -75.08 -65.25 -12.63 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_3R01A.pdb CAMK Active 1 UNE 2.60 -135.58 167.70 61.07 70.72 75.76 -164.90 -84.81 17.12 -74.11 -68.66 -10.33 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_3R02A.pdb CAMK Active 1 UNM 1.95 -128.59 175.61 59.18 56.98 87.34 -166.82 -90.54 17.62 -74.29 -74.54 -7.10 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_3R04A.pdb CAMK Active 1 UNQ 1.70 -119.90 174.30 56.55 65.65 74.29 -160.68 -82.32 14.39 -72.33 -62.04 -16.66 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_3T9IA.pdb CAMK Active 1 3T9 2.60 -132.79 172.97 60.00 59.68 82.28 -169.43 -96.52 17.88 -72.33 -65.29 -19.80 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_3UIXA.pdb CAMK Active 1 Q17 2.20 -133.24 170.02 55.87 65.66 77.51 -164.34 -87.00 13.04 -71.28 -68.85 -14.63 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_3UMWA.pdb CAMK Active 1 596 2.08 -128.62 168.79 57.19 67.20 80.33 -169.84 -91.49 18.97 -72.23 -67.05 -11.79 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_3UMXA.pdb CAMK Active 1 Q18 2.55 -128.16 168.06 54.73 66.14 83.76 -179.41 -95.41 17.63 -79.75 -66.76 -16.50 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_3VBQA.pdb CAMK Active 1 0F5 1.85 -127.74 179.21 56.54 57.71 76.68 -159.86 -85.87 12.65 -73.75 -69.05 -5.81 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_3VBTA.pdb CAMK Active 1 0F9 2.23 -130.22 172.67 53.06 63.38 71.28 -75.29 -82.68 17.11 -73.49 -76.37 -5.28 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_3VBVA.pdb CAMK Active 1 0FK 2.08 -132.04 170.03 51.62 63.72 81.25 -158.87 -91.06 16.50 -74.29 -71.82 -8.45 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_3VBWA.pdb CAMK Active 1 0FN 2.48 -127.48 167.59 52.50 67.98 79.38 -153.11 -86.00 16.64 -66.60 -60.96 -19.42 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_3VBXA.pdb CAMK Active 1 0FO 2.03 -132.05 169.88 49.22 71.35 70.31 -78.27 -85.77 14.83 -71.73 -65.15 -16.65 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_3VBYA.pdb CAMK Active 1 0FR 2.27 -131.04 168.96 59.59 66.50 79.71 -164.40 -89.46 18.35 -72.42 -74.21 -13.58 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_3VC4A.pdb CAMK Active 1 0FS 2.23 -139.76 164.89 62.15 72.12 84.01 -162.68 -96.15 20.11 -71.57 -72.41 -2.95 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_3WE8A.pdb CAMK Active 1 RUI 1.95 -133.30 170.65 51.15 67.15 73.60 -69.67 -87.76 10.98 -72.07 -66.06 -8.33 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_4A7CA.pdb CAMK Active 1 E46 2.30 -131.70 167.70 61.19 66.83 79.68 -163.71 -90.94 18.71 -69.84 -69.71 -11.43 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_4ALUA.pdb CAMK Active 1 79O 2.60 -129.32 164.21 63.27 71.56 87.89 -173.67 -98.98 24.37 -76.10 -80.34 2.09 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_4ALVA.pdb CAMK Active 1 R9P 2.59 -137.55 165.76 56.06 68.15 83.91 -163.74 -91.39 16.31 -72.40 -60.67 -18.49 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_4ALWA.pdb CAMK Active 1 HY7 1.92 -122.84 171.94 55.28 71.08 81.53 -177.28 -94.34 18.94 -68.21 -59.16 -19.51 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_4AS0A.pdb CAMK Active 1 RPS 2.30 -125.07 170.08 63.25 63.94 84.56 -165.12 -93.77 23.60 -72.24 -74.78 -13.33 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_4BZNA.pdb CAMK Active 1 UGX 1.90 -123.80 168.51 60.47 64.98 88.02 -157.85 -96.41 24.66 -70.16 -70.97 -12.36 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_4BZOA.pdb CAMK Active 1 676 2.10 -127.92 165.55 57.17 68.23 84.93 -159.17 -95.82 20.98 -73.67 -74.17 -6.75 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_4DTKA.pdb CAMK Active 1 7LI 1.86 -128.44 173.66 67.36 63.30 87.82 -160.76 -95.77 17.23 -74.30 -64.06 -18.24 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_4ENXA.pdb CAMK Active 1 Z20 2.80 -124.24 174.93 64.71 56.98 87.77 -163.84 -99.30 21.70 -74.01 -77.99 -5.49 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_4ENYA.pdb CAMK Active 1 J19 2.80 -126.80 176.28 61.97 56.21 81.83 -170.42 -92.04 22.97 -74.87 -75.25 -11.55 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_4GW8A.pdb CAMK Active 1 3RA 2.00 -126.35 165.64 58.78 61.98 83.71 -166.99 -89.28 16.06 -74.08 -67.90 -17.64 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_4I41A.pdb CAMK Active 1 MIX 2.70 -121.89 -36.73 46.36 -115.79 100.83 -174.48 -88.37 10.14 -70.92 -54.50 -25.76 999.00 Favored ILE ASP PHE GLY"
"PIM1_HUMAN t_4IAAA.pdb CAMK Active 1 RTZ 2.85 -118.68 -143.61 61.08 -58.07 140.84 118.17 -104.96 12.52 -80.11 -63.68 -38.86 999.00 Favored ILE ASP PHE GLY"
"PIM1_HUMAN t_4JX3A.pdb CAMK Active 1 Apo 2.50 -127.77 159.49 58.95 82.11 81.62 -168.78 -96.34 22.08 -81.09 -66.25 -18.55 999.00 Outlier ILE ASP PHE GLY"
"PIM1_HUMAN t_4JX7A.pdb CAMK Active 1 1N6 2.40 -127.30 170.31 59.34 63.67 82.00 -166.37 -92.89 12.22 -76.31 -67.51 -14.48 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_4K0YA.pdb CAMK Active 1 1OA 1.95 -121.95 171.40 60.52 62.44 86.55 -168.12 -95.97 17.73 -72.33 -70.62 -9.04 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_4K18A.pdb CAMK Active 1 1OB 2.05 -127.20 170.24 59.55 67.72 77.43 -169.57 -90.60 24.15 -69.70 -68.81 -16.09 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_4K1BA.pdb CAMK Active 1 1OC 2.08 -132.60 164.85 64.03 70.09 79.66 -162.75 -92.85 21.55 -71.65 -65.30 -17.95 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_4LL5A.pdb CAMK Active 1 SK8 2.00 -130.07 167.42 63.01 64.67 85.24 -160.83 -96.82 19.10 -74.56 -67.07 -17.76 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_4LM5A.pdb CAMK Active 1 Q17 2.25 -129.35 170.18 50.30 65.50 81.38 -159.65 -93.64 15.12 -73.97 -63.92 -18.18 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_4LMUA.pdb CAMK Active 1 QUE 2.38 -125.87 174.46 59.01 58.23 85.27 -163.76 -97.39 18.45 -74.26 -68.42 -9.71 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_4MBIA.pdb CAMK Active 1 26K 2.30 -131.90 168.17 58.78 61.58 68.34 -61.58 -79.62 15.20 -72.79 -64.79 -12.96 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_4MBLA.pdb CAMK Active 1 26L 2.60 -140.95 162.29 50.26 61.87 87.21 -164.66 -100.37 23.65 -71.41 -75.86 -10.74 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_4MEDA.pdb CAMK Active 1 RTX 2.80 -126.62 -29.56 57.24 -113.50 103.07 -173.99 -87.87 9.31 -73.15 -73.75 -11.92 999.00 Favored ILE ASP PHE GLY"
"PIM1_HUMAN t_4MTAA.pdb CAMK Active 1 2D2 2.20 -121.42 177.88 67.28 55.51 82.59 -165.43 -93.50 16.82 -78.51 -72.13 -10.85 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_4N6YA.pdb CAMK Active 1 2HV 2.60 -124.00 165.48 59.17 60.81 90.48 -169.53 -100.89 18.31 -73.12 -74.63 -13.49 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_4N6ZA.pdb CAMK Active 1 2HW 2.20 -127.00 169.99 58.95 59.25 83.93 -168.81 -97.98 18.71 -74.33 -72.36 -9.22 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_4N70A.pdb CAMK Active 1 2HX 2.10 -137.91 169.51 50.01 64.35 80.84 -170.41 -93.82 21.17 -71.87 -75.45 -5.24 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_4RBLA.pdb CAMK Active 1 3O7 2.55 -123.30 -48.98 52.61 -102.91 101.36 175.68 -86.62 10.99 -71.76 -66.88 -9.50 999.00 Favored ILE ASP PHE GLY"
"PIM1_HUMAN t_4RC2A.pdb CAMK Active 1 3O8 2.10 -124.34 -31.64 46.85 -113.66 105.82 166.85 -88.18 13.25 -71.99 -66.50 -15.85 999.00 Favored ILE ASP PHE GLY"
"PIM1_HUMAN t_4RC3A.pdb CAMK Active 1 3OA 2.34 -124.16 -44.56 47.56 -102.50 107.85 165.40 -86.07 9.81 -75.99 -67.04 -12.99 999.00 Favored ILE ASP PHE GLY"
"PIM1_HUMAN t_4RC4A.pdb CAMK Active 1 3OK 2.65 -123.21 -33.67 50.10 -113.37 104.40 -178.85 -91.19 9.05 -75.11 -71.21 -6.49 999.00 Favored ILE ASP PHE GLY"
"PIM1_HUMAN t_4RPVA.pdb CAMK Active 1 3UR 3.05 -145.64 161.41 63.48 70.00 88.32 -149.05 -103.96 21.08 -79.53 -81.22 11.09 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_4TY1A.pdb CAMK Active 1 38W 2.70 -133.06 165.36 51.51 66.16 78.67 -169.60 -91.01 18.00 -70.98 -66.37 -16.99 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_4WRSA.pdb CAMK Active 1 3U1 2.20 -131.21 168.18 55.62 62.17 84.36 -170.22 -94.96 19.34 -75.69 -73.22 -12.09 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_4WSYA.pdb CAMK Active 1 3U5 2.30 -127.32 -178.16 56.31 57.51 65.14 -132.97 -84.22 18.49 -73.99 -69.71 -14.58 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_4WT6A.pdb CAMK Active 1 3U6 2.30 -129.29 179.15 54.62 54.09 72.68 -161.05 -88.34 20.54 -75.45 -73.41 -15.17 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_4XH6A.pdb CAMK Active 1 HUL 2.04 -113.06 -75.74 54.71 -81.90 104.37 176.37 -86.83 17.15 -73.76 -66.64 -16.94 999.00 Favored ILE ASP PHE GLY"
"PIM1_HUMAN t_4XHKB.pdb CAMK Active 1 3YR 1.90 -126.47 167.47 56.85 62.75 73.26 -164.27 -75.98 8.57 -70.82 -72.33 -9.85 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_5C1QB.pdb CAMK Active 1 4YK 3.00 -134.36 156.38 72.99 72.07 106.74 -164.79 -112.64 17.24 -57.99 -59.73 -41.79 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_5DGZA.pdb CAMK Active 1 L20 2.50 -128.70 169.78 62.04 60.96 88.69 -172.67 -102.50 22.84 -75.35 -73.89 -14.62 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_5DHJA.pdb CAMK Active 1 5E5 2.46 -132.42 165.98 54.93 68.76 75.24 -164.95 -89.57 23.33 -74.73 -66.64 -15.55 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_5DIAA.pdb CAMK Active 1 5E6 1.96 -131.46 162.72 58.57 65.63 95.79 -171.46 -106.01 22.44 -71.69 -70.58 -13.58 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_5DWRA.pdb CAMK Active 1 5H7 2.00 -131.51 168.20 61.26 64.53 84.94 -173.47 -98.36 18.04 -74.37 -66.33 -15.26 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_5EOLA.pdb CAMK Active 1 5QO 2.20 -125.22 171.86 60.88 59.50 80.03 -157.09 -92.51 22.53 -74.99 -70.94 -14.06 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_5IISA.pdb CAMK Active 1 6CB 2.10 -128.82 173.30 58.15 61.30 84.08 -171.21 -98.55 16.12 -75.09 -69.42 -13.25 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_5IPJA.pdb CAMK Active 1 6CD 2.10 -129.07 166.18 57.17 63.45 89.81 -159.49 -98.32 24.18 -73.48 -69.52 -15.71 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_5KZIA.pdb CAMK Active 1 6YN 2.10 -125.21 171.61 55.38 59.72 76.31 -167.88 -89.63 23.42 -72.50 -76.31 -14.49 999.00 Allowed ILE ASP PHE GLY"
"PIM1_HUMAN t_5V82A.pdb CAMK Active 1 96Y 1.89 -125.83 171.25 54.23 64.18 78.88 -164.45 -91.75 19.70 -73.61 -68.26 -20.75 999.00 Allowed ILE ASP PHE GLY"
"PIM2_HUMAN t_2IWIA.pdb CAMK Active 1 HB1 2.80 -110.78 164.83 62.98 68.71 90.45 -168.99 -99.67 29.14 -72.87 -61.48 -39.75 999.00 Allowed ILE ASP PHE GLY"
"PIM2_HUMAN t_2IWIB.pdb CAMK Active 1 HB1 2.80 -118.62 161.54 67.45 68.45 93.38 -160.45 -100.11 25.44 -67.69 -61.93 -35.09 999.00 Allowed ILE ASP PHE GLY"
"PIM2_HUMAN t_4X7QA.pdb CAMK Active 1 3YR 2.33 -126.02 166.01 49.58 65.05 79.80 -162.30 -95.44 6.57 -78.19 -72.80 17.09 999.00 Allowed ILE ASP PHE GLY"
"PIM2_HUMAN t_4X7QB.pdb CAMK Active 1 3YR 2.33 -129.33 168.30 50.86 68.53 75.11 -170.77 -88.31 11.07 -76.75 -55.64 -17.45 999.00 Allowed ILE ASP PHE GLY"
"PKN1_HUMAN t_4OTDA.pdb AGC Active 1 Apo 2.00 -114.17 -18.52 999.00 -138.57 150.89 -173.40 -133.31 23.64 -61.40 -66.20 -19.01 999.00 Favored ALA ASP PHE GLY"
"PKN1_HUMAN t_4OTGA.pdb AGC Active 1 2V9 2.60 -116.70 -25.18 999.00 -127.18 113.93 -171.30 -111.61 25.53 -56.28 -62.83 -32.81 999.00 Favored ALA ASP PHE GLY"
"PKN1_HUMAN t_4OTHA.pdb AGC DFGup 3 DRN 1.80 -95.05 155.94 999.00 62.92 34.95 -153.67 -89.81 -14.42 67.04 -76.58 -15.48 999.00 Favored ALA ASP PHE GLY"
"PKN1_HUMAN t_4OTIA.pdb AGC DFGup 3 MI1 1.93 -100.87 152.40 999.00 49.28 49.70 -80.20 -84.24 -8.36 65.53 -86.88 -16.27 999.00 Favored ALA ASP PHE GLY"
"PKN2_HUMAN t_4CRSA.pdb AGC Active 1 AGS 2.75 -120.55 175.31 999.00 66.40 80.82 -169.45 -96.20 27.19 -49.78 -62.58 -30.59 999.00 Allowed ALA ASP PHE GLY"
"PLK1_HUMAN t_2OU7A.pdb OTHER Active 1 ANP 2.40 -126.48 177.93 999.00 64.03 83.88 -169.69 -94.41 31.25 -66.09 -69.65 -29.61 999.00 Allowed GLY ASP PHE GLY"
"PLK1_HUMAN t_2OWBA.pdb OTHER Active 1 626 2.10 -131.66 -172.68 999.00 54.99 82.46 -160.23 -94.96 27.98 -70.55 -70.41 -17.82 999.00 Allowed GLY ASP PHE GLY"
"PLK1_HUMAN t_2RKUA.pdb OTHER Active 1 R78 1.95 -134.23 -169.53 999.00 54.11 79.05 -163.74 -86.69 25.71 -76.22 -64.55 -26.04 999.00 Allowed GLY ASP PHE GLY"
"PLK1_HUMAN t_2V5QA.pdb OTHER Active 1 Apo 2.30 -129.11 -167.08 999.00 62.90 75.19 176.21 -93.89 21.77 -68.50 -61.88 -28.75 999.00 Allowed GLY ASP PHE GLY"
"PLK1_HUMAN t_2V5QB.pdb OTHER Active 1 Apo 2.30 -131.35 -166.95 999.00 60.98 77.54 -176.91 -92.90 32.26 -73.74 -68.21 -26.29 999.00 Allowed GLY ASP PHE GLY"
"PLK1_HUMAN t_2YACA.pdb OTHER Active 1 937 2.20 -136.28 -176.48 999.00 54.61 87.65 -160.52 -92.89 28.27 -70.12 -75.60 -9.88 999.00 Outlier GLY ASP PHE GLY"
"PLK1_HUMAN t_3FC2A.pdb OTHER Active 1 IBI 2.45 -136.27 -169.17 999.00 47.83 83.27 -150.08 -92.74 30.49 -69.04 -72.19 -20.76 999.00 Outlier GLY ASP PHE GLY"
"PLK1_HUMAN t_3KB7A.pdb OTHER Active 1 NMM 2.50 -133.88 179.21 999.00 62.13 88.76 -160.28 -94.80 24.77 -71.13 -72.99 -6.68 999.00 Allowed GLY ASP PHE GLY"
"PLK1_HUMAN t_3THBA.pdb OTHER Active 1 3TA 2.50 -135.90 -170.43 999.00 55.12 75.44 -62.96 -87.10 14.19 -69.80 -65.03 -8.68 999.00 Allowed GLY ASP PHE GLY"
"PLK1_HUMAN t_4A4LA.pdb OTHER Active 1 939 2.35 -141.65 -176.07 999.00 58.69 82.82 -158.26 -91.40 34.17 -70.06 -71.42 -15.94 999.00 Allowed GLY ASP PHE GLY"
"PLK1_HUMAN t_4A4OA.pdb OTHER Active 1 664 2.70 -140.88 173.59 999.00 55.03 90.93 -152.42 -98.48 26.64 -72.17 -77.04 -1.22 999.00 Outlier GLY ASP PHE GLY"
"PLK1_HUMAN t_4J52A.pdb OTHER Active 1 1J3 2.30 -132.18 -178.29 999.00 57.06 88.44 -158.93 -99.87 23.50 -69.12 -66.33 -8.37 999.00 Allowed GLY ASP PHE GLY"
"PLK1_HUMAN t_4J53A.pdb OTHER Active 1 1J4 2.50 -129.33 -169.33 999.00 44.36 85.29 -153.25 -91.21 24.87 -68.17 -64.67 -23.27 999.00 Outlier GLY ASP PHE GLY"
"PLK1_HUMAN t_5TA6A.pdb OTHER Active 1 79D 2.50 -129.78 178.93 999.00 63.78 86.58 -159.30 -95.79 28.62 -67.84 -68.79 -23.41 999.00 Allowed GLY ASP PHE GLY"
"PLK1_HUMAN t_5TA8A.pdb OTHER Active 1 79C 2.60 -141.05 -172.70 999.00 51.44 90.39 -177.61 -96.65 41.29 -69.29 -72.36 -19.58 999.00 Outlier GLY ASP PHE GLY"
"PLK2_HUMAN t_4I5MA.pdb OTHER Active 1 R78 1.80 -135.01 -176.43 999.00 62.08 78.64 -150.17 -90.58 19.38 -53.56 -51.39 -30.56 999.00 Allowed GLY ASP PHE GLY"
"PLK2_HUMAN t_4I5PA.pdb OTHER Active 1 1D1 1.74 -142.11 -161.55 999.00 51.84 81.20 -166.06 -93.91 52.61 -68.70 -99.63 -9.17 999.00 Allowed GLY ASP PHE GLY"
"PLK2_HUMAN t_4I6BA.pdb OTHER Active 1 11G 1.80 -134.57 -163.73 999.00 55.50 80.24 -166.07 -89.11 19.77 -65.94 -44.87 -31.03 999.00 Allowed GLY ASP PHE GLY"
"PLK2_HUMAN t_4I6FA.pdb OTHER Active 1 1C7 2.90 -142.39 -159.55 999.00 46.54 77.38 -168.07 -93.64 46.65 -79.08 -92.77 -15.21 999.00 Allowed GLY ASP PHE GLY"
"PLK2_HUMAN t_4I6HA.pdb OTHER Active 1 1C8 1.91 -134.64 -170.69 999.00 56.44 76.81 -157.47 -81.66 177.53 -71.18 131.85 -47.24 999.00 Allowed GLY ASP PHE GLY"
"PLK3_HUMAN t_4B6LA.pdb OTHER Active 1 9ZP 1.90 -126.60 -175.09 999.00 59.05 88.67 -164.35 -95.27 20.82 -66.49 -57.77 -31.13 999.00 Allowed GLY ASP PHE GLY"
"PLK4_HUMAN t_3COKA.pdb OTHER Active 1 ANP 2.25 -124.33 169.71 999.00 62.14 91.39 999.00 -100.74 17.43 -67.94 -56.38 -36.59 999.00 Allowed ALA ASP PHE GLY"
"PLK4_HUMAN t_3COKB.pdb OTHER Active 1 ANP 2.25 -133.98 164.52 999.00 62.60 97.55 -157.29 -104.69 14.18 -58.97 -54.49 -38.93 999.00 Outlier ALA ASP PHE GLY"
"PLK4_HUMAN t_4JXFA.pdb OTHER DFGup 3 631 2.40 -95.45 -28.92 999.00 -121.17 110.48 -171.98 -136.08 55.10 41.09 69.31 11.24 999.00 Favored ALA ASP PHE GLY"
"PMYT1_HUMAN t_3P1AA.pdb OTHER Active 1 Apo 1.70 -133.67 -162.14 999.00 57.49 68.87 -73.95 -85.75 17.71 -58.50 -60.51 -27.31 999.00 Allowed GLY ASP PHE GLY"
"PRP4B_HUMAN t_4IANA.pdb CMGC Active 1 Apo 2.44 -138.34 -172.07 65.95 58.10 77.70 -167.44 -93.01 29.52 -69.70 -84.32 6.55 999.00 Allowed CYS ASP PHE GLY"
"PRP4B_HUMAN t_4IANB.pdb CMGC Active 1 Apo 2.44 -132.06 -176.26 91.82 53.02 86.34 -166.62 -102.13 35.00 -69.93 -78.75 -8.05 999.00 Outlier CYS ASP PHE GLY"
"PRP4B_HUMAN t_4IFCA.pdb CMGC Active 1 ADP 2.13 -122.34 -179.44 97.04 58.78 82.84 -173.76 -100.36 25.81 -71.85 -70.56 -26.85 999.00 Allowed CYS ASP PHE GLY"
"PRP4B_HUMAN t_4IFCB.pdb CMGC Active 1 ADP 2.13 -121.40 176.18 -50.45 59.37 85.71 -176.24 -102.24 24.11 -70.48 -69.58 -26.75 999.00 Allowed CYS ASP PHE GLY"
"PRP4B_HUMAN t_4IIRA.pdb CMGC Active 1 ANP 2.00 -120.15 -179.97 98.89 56.52 83.50 -174.72 -99.71 23.13 -70.28 -67.88 -30.45 999.00 Allowed CYS ASP PHE GLY"
"PRP4B_HUMAN t_4IIRB.pdb CMGC Active 1 ANP 2.00 -118.90 -178.73 92.87 57.44 86.54 -175.05 -103.99 25.40 -66.96 -68.60 -33.52 999.00 Allowed CYS ASP PHE GLY"
"PRP4B_HUMAN t_4IJPA.pdb CMGC Active 1 1EH 2.25 -120.06 -179.16 81.68 57.38 89.44 -149.95 -104.98 30.04 -67.26 -72.70 -40.95 999.00 Outlier CYS ASP PHE GLY"
"PRP4B_HUMAN t_4IJPB.pdb CMGC Active 1 1EH 2.25 -123.21 -178.60 87.41 59.49 88.40 -169.93 -104.97 29.36 -64.50 -75.18 -41.11 999.00 Allowed CYS ASP PHE GLY"
"PTK6_HUMAN t_5D7VA.pdb TYR DFGup 3 CXM 2.33 -121.17 164.98 999.00 61.70 29.26 -64.26 -66.79 129.56 42.92 71.64 0.24 999.00 Favored GLY ASP PHE GLY"
"PTK6_HUMAN t_5D7VB.pdb TYR DFGup 3 CXM 2.33 -123.84 157.17 999.00 63.50 26.60 -65.58 -59.01 130.96 40.78 77.35 -12.88 999.00 Favored GLY ASP PHE GLY"
"PTK6_HUMAN t_5D7VC.pdb TYR DFGup 3 CXM 2.33 -115.22 156.92 999.00 69.89 24.95 -75.68 -59.08 133.80 39.70 65.48 1.59 999.00 Favored GLY ASP PHE GLY"
"PTK6_HUMAN t_5D7VD.pdb TYR DFGup 3 CXM 2.33 -117.20 161.17 999.00 62.83 23.44 -64.94 -54.93 120.63 38.15 76.32 -1.11 999.00 Favored GLY ASP PHE GLY"
"PTK6_HUMAN t_5DA3A.pdb TYR DFGup 3 58V 1.70 -119.58 158.24 999.00 62.77 25.40 -67.95 -54.45 129.45 40.01 74.24 -5.85 999.00 Favored GLY ASP PHE GLY"
"PTK6_HUMAN t_5H2UA.pdb TYR DFGup 3 1N1 2.24 -115.64 172.29 999.00 65.40 13.68 -100.93 -58.11 130.19 47.47 66.95 -1.55 999.00 Favored GLY ASP PHE GLY"
"PTK6_HUMAN t_5H2UB.pdb TYR DFGup 3 1N1 2.24 -112.65 168.56 999.00 69.96 13.65 -101.86 -58.16 126.09 44.90 70.73 0.83 999.00 Favored GLY ASP PHE GLY"
"PTK6_HUMAN t_5H2UC.pdb TYR DFGup 3 1N1 2.24 -101.45 165.16 999.00 71.26 11.92 -102.75 -56.69 126.69 46.27 72.38 -1.52 999.00 Favored GLY ASP PHE GLY"
"PTK6_HUMAN t_5H2UD.pdb TYR DFGup 3 1N1 2.24 -112.69 164.13 999.00 73.66 11.66 -115.30 -56.95 123.76 42.37 73.24 2.90 999.00 Favored GLY ASP PHE GLY"
"RAF1_HUMAN t_3OMVA.pdb TKL Active 1 SM5 4.00 -72.21 -157.91 999.00 -69.66 158.48 54.07 -112.98 18.16 -61.11 -38.58 -34.67 999.00 Favored GLY ASP PHE GLY"
"RAF1_HUMAN t_3OMVB.pdb TKL Active 1 SM5 4.00 -128.39 -171.16 999.00 47.94 84.96 -173.73 -94.99 35.58 -74.66 -60.14 -20.40 999.00 Outlier GLY ASP PHE GLY"
"RET_HUMAN t_2IVSA.pdb TYR Active 1 ACK 2.00 -136.64 -179.92 -165.56 61.36 73.25 -60.98 -96.71 13.58 -75.16 -58.36 -35.10 999.00 Allowed SER ASP PHE GLY"
"RET_HUMAN t_2IVSB.pdb TYR Active 1 ACK 2.00 -130.31 -178.60 -159.62 63.61 66.83 -62.43 -91.01 11.69 -77.75 -55.42 -31.63 999.00 Allowed SER ASP PHE GLY"
"RET_HUMAN t_2IVTA.pdb TYR Active 1 AMP 2.60 -135.28 176.38 -169.80 61.74 80.35 -170.82 -103.80 14.48 -78.27 -59.35 -34.22 999.00 Allowed SER ASP PHE GLY"
"RET_HUMAN t_2IVUA.pdb TYR Active 1 ZD6 2.50 -133.69 176.40 -164.54 56.86 72.43 -64.31 -91.96 6.47 -72.20 -52.58 -36.04 999.00 Allowed SER ASP PHE GLY"
"RET_HUMAN t_2IVVA.pdb TYR Active 1 PP1 2.25 -143.26 -177.22 175.14 58.23 69.51 -65.25 -89.74 15.05 -71.55 -63.28 -29.44 999.00 Allowed SER ASP PHE GLY"
"RET_HUMAN t_2X2KA.pdb TYR Active 1 X2K 2.60 -126.80 -165.99 68.39 45.14 90.60 -167.40 -107.19 8.08 -78.06 -50.91 -36.72 999.00 Outlier SER ASP PHE GLY"
"RET_HUMAN t_2X2LA.pdb TYR Active 1 X2L 2.00 -129.30 -171.62 49.99 59.90 73.29 -58.93 -95.53 14.01 -70.71 -51.34 -44.83 999.00 Allowed SER ASP PHE GLY"
"RET_HUMAN t_2X2MA.pdb TYR Active 1 X2M 2.50 -132.67 176.36 168.70 64.55 83.00 -169.76 -104.45 14.26 -78.32 -56.16 -36.12 999.00 Allowed SER ASP PHE GLY"
"RET_HUMAN t_2X2MB.pdb TYR Active 1 X2M 2.50 -134.89 -176.53 -178.36 54.09 78.78 -57.96 -94.93 13.98 -69.06 -53.01 -42.72 999.00 Allowed SER ASP PHE GLY"
"RET_HUMAN t_4CKIA.pdb TYR Active 1 ADN 2.12 -138.54 -174.56 -172.06 59.44 75.33 -60.01 -100.13 17.86 -74.49 -62.32 -29.89 999.00 Allowed SER ASP PHE GLY"
"RET_HUMAN t_4CKJA.pdb TYR Active 1 ADN 1.65 -136.45 179.94 -171.60 61.97 74.36 -68.26 -98.54 13.05 -75.38 -60.16 -30.45 999.00 Allowed SER ASP PHE GLY"
"RET_HUMAN t_5AMNA.pdb TYR Active 1 DTQ 2.57 -129.43 -171.58 67.22 56.53 78.50 -65.24 -104.21 12.33 -75.67 -59.77 -21.45 999.00 Allowed SER ASP PHE GLY"
"RET_HUMAN t_5FM2A.pdb TYR Active 1 PP1 3.30 -137.30 -177.67 176.79 58.65 81.36 999.00 -104.82 16.84 -66.12 -64.40 -27.29 999.00 Allowed SER ASP PHE GLY"
"RET_HUMAN t_5FM3A.pdb TYR Active 1 PP1 2.95 -140.16 -175.85 174.37 58.02 73.83 -74.01 -96.76 15.59 -66.87 -66.17 -20.62 999.00 Allowed SER ASP PHE GLY"
"RIOK1_HUMAN t_4OTPA.pdb RIO Active 1 ADP 2.70 -135.43 177.37 71.39 63.63 70.90 -161.95 -122.71 22.43 -56.96 -54.30 -51.23 17.07 NA ILE NA VAL SER"
"RIPK1_HUMAN t_4ITHA.pdb TKL DFGout 6 RCM 2.25 -124.75 172.61 999.00 -138.52 68.83 179.10 -68.90 -22.32 -64.41 -91.08 2.63 999.00 NA ALA ASP LEU GLY"
"RIPK1_HUMAN t_4ITHB.pdb TKL DFGout 6 RCM 2.25 -124.36 170.86 999.00 -137.50 68.03 177.81 -69.04 -21.25 -51.13 -88.43 4.74 999.00 NA ALA ASP LEU GLY"
"RIPK1_HUMAN t_4ITIA.pdb TKL DFGout 6 1HW 2.86 -119.43 171.26 999.00 -131.66 70.89 -172.14 -77.17 -1.85 -58.70 -111.13 12.26 999.00 NA ALA ASP LEU GLY"
"RIPK1_HUMAN t_4ITIB.pdb TKL DFGout 6 1HW 2.86 -133.09 173.97 999.00 -136.84 74.76 -168.53 -71.43 -1.82 -61.94 -118.78 6.06 999.00 NA ALA ASP LEU GLY"
"RIPK1_HUMAN t_4ITJA.pdb TKL DFGout 6 1HX 1.80 -136.21 158.68 999.00 -113.07 65.66 178.90 -67.84 -29.40 -64.15 -82.31 2.16 999.00 NA ALA ASP LEU GLY"
"RIPK1_HUMAN t_4ITJB.pdb TKL DFGout 6 1HX 1.80 -128.80 163.06 999.00 -112.87 67.55 177.22 -67.91 -19.71 -61.14 -88.95 2.61 999.00 NA ALA ASP LEU GLY"
"RIPK1_HUMAN t_4NEUA.pdb TKL DFGout 6 Q1A 2.57 -112.81 174.67 999.00 -146.73 69.35 -159.10 -53.09 -37.40 -80.61 -96.20 -2.88 999.00 NA ALA ASP LEU GLY"
"RIPK1_HUMAN t_4NEUB.pdb TKL DFGout 6 Q1A 2.57 -120.37 176.59 999.00 -145.51 75.89 -171.77 -65.90 -31.98 -76.41 -94.08 3.73 999.00 NA ALA ASP LEU GLY"
"RIPK1_HUMAN t_5HX6A.pdb TKL DFGout 6 65U 2.23 -114.19 174.68 999.00 -134.77 71.49 -168.19 -76.01 -22.49 -53.86 -90.93 8.33 999.00 NA ALA ASP LEU GLY"
"RIPK1_HUMAN t_5HX6B.pdb TKL DFGout 6 65U 2.23 -110.38 176.92 999.00 -138.54 63.22 -175.57 -70.61 -22.27 -53.84 -89.45 7.40 999.00 NA ALA ASP LEU GLY"
"RIPK2_HUMAN t_5AR2A.pdb TKL Active 1 Apo 2.44 -127.39 -176.34 999.00 62.29 78.63 -166.89 -95.92 24.67 -71.69 -59.05 -44.06 999.00 Allowed ALA ASP PHE GLY"
"RIPK2_HUMAN t_5AR2B.pdb TKL Active 1 Apo 2.44 -121.69 177.71 999.00 61.52 80.59 -163.11 -98.21 20.92 -73.20 -54.70 -35.02 999.00 Allowed ALA ASP PHE GLY"
"RIPK2_HUMAN t_5AR3A.pdb TKL Active 1 ACP 3.23 -133.06 175.57 999.00 72.21 76.22 -169.00 -97.68 34.33 -66.10 -66.80 -37.45 999.00 Allowed ALA ASP PHE GLY"
"RIPK2_HUMAN t_5AR3B.pdb TKL Active 1 ACP 3.23 -128.30 176.07 999.00 65.89 78.18 -159.51 -98.93 35.27 -65.35 -68.50 -48.73 999.00 Allowed ALA ASP PHE GLY"
"RIPK2_HUMAN t_5AR4A.pdb TKL DFGup 3 SB2 2.70 -139.44 166.55 999.00 61.79 49.70 -55.95 -115.34 148.12 54.62 62.76 37.44 999.00 Favored ALA ASP PHE GLY"
"RIPK2_HUMAN t_5AR4B.pdb TKL DFGup 3 SB2 2.70 -133.47 172.28 999.00 57.96 41.33 -54.67 -105.09 150.43 49.26 68.15 19.98 999.00 Favored ALA ASP PHE GLY"
"RIPK2_HUMAN t_5AR5A.pdb TKL Active 1 IQ7 2.66 -126.78 179.70 999.00 62.83 81.23 -67.71 -103.15 21.12 -67.31 -56.68 -44.57 999.00 Allowed ALA ASP PHE GLY"
"RIPK2_HUMAN t_5AR5B.pdb TKL Active 1 IQ7 2.66 -142.57 -179.66 999.00 67.74 82.81 -73.75 -106.87 40.74 -61.89 -72.90 -50.53 999.00 Allowed ALA ASP PHE GLY"
"RIPK2_HUMAN t_5AR7A.pdb TKL DFGout 6 SR8 2.71 -113.57 174.49 999.00 -138.79 94.11 -165.47 -69.85 134.62 -84.77 -123.28 75.74 999.00 Favored ALA ASP PHE GLY"
"RIPK2_HUMAN t_5AR7B.pdb TKL DFGout 6 SR8 2.71 -122.13 179.26 999.00 -147.55 96.17 -163.83 -66.24 -16.50 -84.69 58.12 999.00 999.00 Favored ALA ASP PHE GLY"
"RIPK2_HUMAN t_5AR8B.pdb TKL DFGin-inactive 2 XYW 2.79 -138.31 -177.14 999.00 57.04 46.94 -141.73 -53.34 139.40 -63.62 -77.08 61.52 999.00 Favored ALA ASP PHE GLY"
"RIPK2_HUMAN t_5J79A.pdb TKL Active 1 6GE 2.69 -120.61 -169.70 999.00 53.91 72.98 -56.81 -94.40 19.44 -73.84 -56.88 -46.76 999.00 Allowed ALA ASP PHE GLY"
"RIPK2_HUMAN t_5J79B.pdb TKL Active 1 6GE 2.69 -127.33 -171.46 999.00 58.85 71.25 -70.61 -93.64 17.03 -71.84 -55.97 -36.72 999.00 Allowed ALA ASP PHE GLY"
"RIPK2_HUMAN t_5J7BA.pdb TKL DFGup 3 6GD 2.53 -129.50 168.28 999.00 62.72 43.39 -61.05 -109.78 148.82 51.70 70.80 38.22 999.00 Favored ALA ASP PHE GLY"
"RIPK2_HUMAN t_5J7BB.pdb TKL DFGup 3 6GD 2.53 -120.37 168.03 999.00 63.65 41.49 -58.56 -105.99 152.64 50.12 73.69 5.94 999.00 Favored ALA ASP PHE GLY"
"RN5A_HUMAN t_4OAUC.pdb OTHER Active 1 ADP 2.60 -152.65 -178.01 999.00 59.94 103.57 179.08 -125.28 12.02 -54.80 -75.27 8.75 68.02 NA ALA ASP PHE ASP"
"RN5A_HUMAN t_4OAVB.pdb OTHER Active 1 ACP 2.10 -139.89 -178.49 999.00 65.72 91.23 -172.61 -114.95 14.68 -50.88 -77.15 3.66 74.14 NA ALA ASP PHE ASP"
"RN5A_HUMAN t_4OAVD.pdb OTHER Active 1 PUP 2.10 -138.73 -178.08 999.00 64.75 95.22 -173.56 -118.81 15.03 -53.04 -77.36 4.47 70.42 NA ALA ASP PHE ASP"
"ROCK1_HUMAN t_2ESMA.pdb AGC Active 1 M77 3.20 -120.71 175.28 999.00 52.59 92.90 -80.86 -113.76 23.07 -57.08 -55.47 -15.75 999.00 Outlier ALA ASP PHE GLY"
"ROCK1_HUMAN t_2ESMB.pdb AGC Active 1 M77 3.20 -120.69 -179.64 999.00 48.00 93.77 -83.55 -115.66 13.54 -59.37 -64.56 23.15 999.00 Outlier ALA ASP PHE GLY"
"ROCK1_HUMAN t_2ETKA.pdb AGC Active 1 HFS 2.96 -116.56 151.40 999.00 65.53 106.25 -166.93 -118.97 38.30 -56.79 -62.56 -30.06 999.00 Outlier ALA ASP PHE GLY"
"ROCK1_HUMAN t_2ETKB.pdb AGC Active 1 HFS 2.96 -119.11 154.82 999.00 65.31 101.08 -171.58 -117.09 36.11 -57.95 -68.46 -4.90 999.00 Outlier ALA ASP PHE GLY"
"ROCK1_HUMAN t_2ETRA.pdb AGC Active 1 Y27 2.60 -115.36 151.27 999.00 66.21 120.59 -174.19 -135.52 23.79 -57.51 -59.36 -26.29 999.00 Outlier ALA ASP PHE GLY"
"ROCK1_HUMAN t_2ETRB.pdb AGC Active 1 Y27 2.60 -117.80 150.59 999.00 66.35 120.26 -172.25 -134.91 36.09 -53.82 -76.48 0.91 999.00 Outlier ALA ASP PHE GLY"
"ROCK1_HUMAN t_2V55A.pdb AGC Active 1 ANP 3.7 -137.31 -177.32 999.00 60.22 109.92 175.78 -132.78 24.24 -69.09 -53.90 -52.21 999.00 Outlier ALA ASP PHE GLY"
"ROCK1_HUMAN t_2V55C.pdb AGC Active 1 ANP 3.7 -137.61 -177.46 999.00 62.19 108.48 175.21 -130.26 22.69 -68.65 -54.96 -50.69 999.00 Outlier ALA ASP PHE GLY"
"ROCK1_HUMAN t_3D9VA.pdb AGC Active 1 H52 3.30 -97.18 154.70 999.00 64.92 125.92 173.21 -138.01 39.08 -61.94 -71.67 -6.66 999.00 Outlier ALA ASP PHE GLY"
"ROCK1_HUMAN t_3D9VB.pdb AGC Active 1 H52 3.30 -106.40 155.80 999.00 65.25 114.94 -179.42 -130.49 38.79 -59.33 -71.84 5.40 999.00 Outlier ALA ASP PHE GLY"
"ROCK1_HUMAN t_3NCZA.pdb AGC Active 1 3NC 3.00 -116.13 -12.60 999.00 -138.49 134.33 171.67 -126.49 14.39 -63.23 -51.46 -39.60 999.00 Favored ALA ASP PHE GLY"
"ROCK1_HUMAN t_3NCZB.pdb AGC Active 1 3NC 3.00 -114.81 -16.71 999.00 -131.54 138.93 -178.12 -136.08 17.21 -61.80 -58.31 -38.41 999.00 Favored ALA ASP PHE GLY"
"ROCK1_HUMAN t_3NCZC.pdb AGC Active 1 3NC 3.00 -116.06 -7.78 999.00 -136.41 136.70 178.60 -131.85 24.81 -53.01 -58.58 -34.93 999.00 Favored ALA ASP PHE GLY"
"ROCK1_HUMAN t_3NCZD.pdb AGC Active 1 3NC 3.00 -130.27 7.56 999.00 -144.38 127.22 -174.58 -129.12 19.37 -55.72 -57.08 -39.13 999.00 Favored ALA ASP PHE GLY"
"ROCK1_HUMAN t_3NDMA.pdb AGC Active 1 Apo 3.30 -120.92 -34.01 999.00 -109.21 148.30 -152.01 -142.32 4.66 -55.48 -63.87 57.88 999.00 Favored ALA ASP PHE GLY"
"ROCK1_HUMAN t_3NDMB.pdb AGC Active 1 3ND 3.30 -135.58 -20.20 999.00 -111.56 137.69 -153.96 -126.93 16.18 -59.09 -51.58 28.79 999.00 Favored ALA ASP PHE GLY"
"ROCK1_HUMAN t_3NDMC.pdb AGC Active 1 3ND 3.30 -126.81 -28.66 999.00 -112.04 139.01 -121.33 -136.26 9.01 -61.37 -64.39 58.33 999.00 Favored ALA ASP PHE GLY"
"ROCK1_HUMAN t_3NDMD.pdb AGC Active 1 3ND 3.30 -131.84 -23.52 999.00 -116.90 142.90 -127.37 -139.50 15.30 -51.60 -65.57 50.20 999.00 Favored ALA ASP PHE GLY"
"ROCK1_HUMAN t_3TV7A.pdb AGC Active 1 07Q 2.75 -126.37 -171.06 999.00 45.93 69.47 -174.50 -88.79 8.65 -58.61 -54.55 -19.41 999.00 Allowed ALA ASP PHE GLY"
"ROCK1_HUMAN t_3TV7B.pdb AGC Active 1 07Q 2.75 -126.44 -172.47 999.00 48.78 75.26 -174.29 -91.38 11.08 -48.31 -51.11 -22.91 999.00 Allowed ALA ASP PHE GLY"
"ROCK1_HUMAN t_3TV7C.pdb AGC Active 1 07Q 2.75 -112.84 -173.20 999.00 51.36 70.59 -158.74 -91.12 10.05 -48.03 -58.11 -16.40 999.00 Allowed ALA ASP PHE GLY"
"ROCK1_HUMAN t_3TV7D.pdb AGC Active 1 07Q 2.75 -132.63 -173.07 999.00 50.91 76.20 -165.63 -95.16 10.34 -49.34 -52.24 -21.03 999.00 Allowed ALA ASP PHE GLY"
"ROCK1_HUMAN t_3TWJA.pdb AGC Active 1 07R 2.90 -143.98 -170.73 999.00 43.77 70.91 -176.87 -91.22 6.86 -63.87 -47.01 -46.97 999.00 Allowed ALA ASP PHE GLY"
"ROCK1_HUMAN t_3TWJB.pdb AGC DFGout 6 Apo 2.90 -140.06 177.70 999.00 -137.99 117.88 -137.31 -134.18 -179.66 -92.47 -75.11 143.72 999.00 Favored ALA ASP PHE GLY"
"ROCK1_HUMAN t_3TWJC.pdb AGC Active 1 07R 2.90 -145.98 165.65 999.00 60.98 69.01 -142.40 -57.54 -10.46 -147.65 -68.95 18.63 999.00 Allowed ALA ASP PHE GLY"
"ROCK1_HUMAN t_3TWJD.pdb AGC DFGout 6 Apo 2.90 -126.19 176.06 999.00 -134.69 123.85 -157.22 -143.33 -165.46 -75.05 -95.63 -168.69 999.00 Favored ALA ASP PHE GLY"
"ROCK1_HUMAN t_3V8SA.pdb AGC Active 1 0HD 2.29 -131.48 179.49 999.00 60.56 71.59 -71.54 -93.46 10.79 -54.85 -59.14 -15.72 999.00 Allowed ALA ASP PHE GLY"
"ROCK1_HUMAN t_3V8SB.pdb AGC Active 1 0HD 2.29 -129.18 179.73 999.00 58.59 76.67 -63.31 -94.53 12.08 -56.35 -47.55 -31.22 999.00 Allowed ALA ASP PHE GLY"
"ROCK1_HUMAN t_3V8SC.pdb AGC Active 1 0HD 2.29 -131.98 178.49 999.00 61.35 70.47 -69.50 -92.71 10.99 -58.26 -57.80 -20.04 999.00 Allowed ALA ASP PHE GLY"
"ROCK1_HUMAN t_3V8SD.pdb AGC Active 1 0HD 2.29 -134.51 177.58 999.00 58.21 76.44 -67.67 -93.55 11.57 -56.33 -46.69 -30.73 999.00 Allowed ALA ASP PHE GLY"
"ROCK1_HUMAN t_4W7PA.pdb AGC Active 1 3J7 2.80 -131.37 -179.70 999.00 54.98 77.49 -161.20 -91.45 17.35 -57.87 -69.87 -11.96 999.00 Allowed ALA ASP PHE GLY"
"ROCK1_HUMAN t_4W7PB.pdb AGC Active 1 3J7 2.80 -133.95 174.80 999.00 56.49 83.90 178.55 -98.37 33.02 -57.85 -69.99 -15.43 999.00 Allowed ALA ASP PHE GLY"
"ROCK1_HUMAN t_4W7PC.pdb AGC Active 1 3J7 2.80 -124.29 179.55 999.00 53.16 87.63 -168.55 -105.46 23.03 -54.52 -67.28 -3.66 999.00 Outlier ALA ASP PHE GLY"
"ROCK1_HUMAN t_4W7PD.pdb AGC Active 1 3J7 2.80 -140.16 -177.49 999.00 56.40 77.40 -169.36 -95.55 16.83 -58.99 -61.76 -14.54 999.00 Allowed ALA ASP PHE GLY"
"ROCK1_HUMAN t_4YVCA.pdb AGC Active 1 4KH 3.20 -131.76 179.42 999.00 49.77 78.93 -163.27 -95.60 35.97 -50.27 -52.77 -39.18 999.00 Allowed ALA ASP PHE GLY"
"ROCK1_HUMAN t_4YVCB.pdb AGC Active 1 4KH 3.20 -134.50 170.02 999.00 59.90 81.36 -179.03 -101.68 32.70 -55.58 -59.59 -31.22 999.00 Allowed ALA ASP PHE GLY"
"ROCK1_HUMAN t_4YVEA.pdb AGC Active 1 4KK 3.40 -135.64 174.22 999.00 57.59 62.43 168.59 -84.04 54.40 -38.51 -64.48 -38.80 999.00 Favored ALA ASP PHE GLY"
"ROCK1_HUMAN t_4YVEB.pdb AGC Active 1 4KK 3.40 -142.14 177.58 999.00 55.86 66.02 -167.59 -91.52 48.83 -49.05 -71.77 -55.61 999.00 Allowed ALA ASP PHE GLY"
"ROCK1_HUMAN t_5BMLA.pdb AGC Active 1 4TW 2.95 -136.49 -178.02 999.00 52.13 80.36 -171.50 -99.00 17.99 -57.51 -59.83 -6.40 999.00 Allowed ALA ASP PHE GLY"
"ROCK1_HUMAN t_5BMLB.pdb AGC Active 1 4TW 2.95 -147.29 171.68 999.00 63.05 85.91 -170.43 -106.58 29.50 -55.07 -62.79 -25.28 999.00 Allowed ALA ASP PHE GLY"
"ROCK1_HUMAN t_5HVUA.pdb AGC Active 1 65R 2.80 -144.74 -177.29 999.00 55.19 80.19 -165.75 -106.17 33.07 -54.69 -64.00 -11.52 999.00 Allowed ALA ASP PHE GLY"
"ROCK1_HUMAN t_5HVUB.pdb AGC Active 1 65R 2.80 -150.89 173.02 999.00 62.47 81.93 -170.07 -106.01 31.59 -54.69 -65.10 -10.16 999.00 Allowed ALA ASP PHE GLY"
"ROCK2_HUMAN t_4L6QA.pdb AGC Active 1 1WU 2.79 -116.24 -49.26 999.00 -107.42 128.65 176.65 -126.53 33.80 -55.91 -72.51 -17.08 999.00 Favored ALA ASP PHE GLY"
"ROCK2_HUMAN t_4L6QB.pdb AGC Active 1 1WU 2.79 -107.89 -62.84 999.00 -88.91 144.11 -174.35 -141.38 24.95 -61.67 -69.98 -11.38 999.00 Favored ALA ASP PHE GLY"
"ROCK2_HUMAN t_4WOTA.pdb AGC Active 1 3SG 2.93 -135.15 -10.54 999.00 -134.18 128.85 -179.18 -131.21 28.86 -49.70 -62.43 -34.81 999.00 Favored ALA ASP PHE GLY"
"ROCK2_HUMAN t_4WOTB.pdb AGC Active 1 3SG 2.93 -121.13 -29.80 999.00 -129.21 101.55 177.56 -100.78 25.46 -52.73 -60.30 -29.87 999.00 Favored ALA ASP PHE GLY"
"ROCK2_HUMAN t_4WOTC.pdb AGC Active 1 3SG 2.93 -155.51 37.10 999.00 -162.61 126.29 176.16 -126.90 37.75 -52.73 -72.63 -40.02 999.00 Favored ALA ASP PHE GLY"
"ROCK2_HUMAN t_4WOTD.pdb AGC Active 1 3SG 2.93 -118.95 -34.53 999.00 -121.92 101.65 -178.93 -103.92 33.39 -50.14 -70.08 -28.10 999.00 Favored ALA ASP PHE GLY"
"ROCK2_HUMAN t_5U7QA.pdb AGC Active 1 Apo 3.15 -118.36 -30.42 999.00 -115.41 138.21 -163.75 -136.15 22.42 -57.18 -67.40 -9.26 999.00 Favored ALA ASP PHE GLY"
"ROCK2_HUMAN t_5U7QB.pdb AGC Active 1 Apo 3.15 -117.96 -31.04 999.00 -114.26 137.05 -164.28 -135.87 23.66 -55.85 -71.28 -7.94 999.00 Favored ALA ASP PHE GLY"
"ROCK2_HUMAN t_5U7QC.pdb AGC Active 1 Apo 3.15 -118.63 -30.94 999.00 -114.61 137.98 -163.23 -135.58 22.36 -57.34 -68.79 -8.95 999.00 Favored ALA ASP PHE GLY"
"ROCK2_HUMAN t_5U7QD.pdb AGC Active 1 Apo 3.15 -117.71 -31.11 999.00 -114.94 137.38 -164.33 -136.25 22.50 -56.37 -69.58 -9.32 999.00 Favored ALA ASP PHE GLY"
"ROCK2_HUMAN t_5U7RA.pdb AGC Active 1 81G 3.33 -124.63 -51.32 999.00 -100.72 98.60 -159.76 -98.24 10.08 -58.42 -53.64 -30.46 999.00 Favored ALA ASP PHE GLY"
"ROCK2_HUMAN t_5U7RB.pdb AGC Active 1 81G 3.33 -141.67 175.80 999.00 55.92 92.75 -174.95 -111.87 4.38 -58.32 -69.51 58.86 999.00 Outlier ALA ASP PHE GLY"
"ROCK2_HUMAN t_5U7RC.pdb AGC Active 1 81G 3.33 -130.79 -53.46 999.00 -103.00 94.35 -154.09 -95.40 17.92 -59.01 -67.70 -17.71 999.00 Favored ALA ASP PHE GLY"
"ROCK2_HUMAN t_5U7RD.pdb AGC Active 1 81G 3.33 -137.08 -44.47 999.00 -96.67 83.50 -168.85 -88.71 16.86 -56.16 -55.20 -36.02 999.00 Favored ALA ASP PHE GLY"
"RON_HUMAN t_3PLSA.pdb TYR DFGup 3 ANP 2.24 -158.57 169.48 999.00 54.59 28.32 -61.89 -75.35 163.89 46.83 77.37 8.52 999.00 Favored ALA ASP PHE GLY"
"ROR2_HUMAN t_3ZZWA.pdb TYR DFGinter 5 Apo 2.90 -96.26 113.39 160.01 -93.32 36.03 -149.24 -147.10 160.62 50.38 174.42 -162.29 999.00 NA SER ASP LEU GLY"
"ROR2_HUMAN t_3ZZWB.pdb TYR DFGout 6 Apo 2.90 -137.63 -157.96 90.89 -151.07 33.95 36.57 -68.82 -19.67 62.17 -42.24 -63.28 999.00 NA SER ASP LEU GLY"
"ROR2_HUMAN t_4GT4A.pdb TYR DFGinter 5 Apo 2.41 -93.63 118.82 178.68 -119.62 62.60 52.80 -106.26 -3.31 -81.72 61.49 39.96 999.00 NA SER ASP LEU GLY"
"ROR2_HUMAN t_4GT4B.pdb TYR DFGinter 5 Apo 2.41 -90.97 100.97 178.42 -99.93 70.26 999.00 -110.46 -11.91 -62.14 61.11 43.70 999.00 NA SER ASP LEU GLY"
"ROS1_HUMAN t_3ZBFA.pdb TYR Active 1 VGH 2.20 -129.20 -37.89 999.00 -114.96 123.51 -179.05 -118.46 31.45 -62.49 -62.84 -16.22 999.00 Favored GLY ASP PHE GLY"
"ROS1_HUMAN t_4UXLA.pdb TYR Active 1 5P8 2.40 -141.28 11.28 999.00 -144.64 99.59 174.58 -104.62 30.22 -52.82 -59.55 -21.12 999.00 Favored GLY ASP PHE GLY"
"SGK1_HUMAN t_2R5TA.pdb AGC DFGinter 5 ANP 1.90 -86.81 -16.11 58.79 -72.23 135.27 -172.14 -125.93 19.98 58.21 102.41 6.10 999.00 Favored THR ASP PHE GLY"
"SGK1_HUMAN t_3HDMA.pdb AGC DFGinter 5 MMG 2.60 -83.69 -7.67 58.58 -69.64 128.27 171.05 -122.00 7.16 59.84 118.70 -0.26 999.00 Favored THR ASP PHE GLY"
"SGK1_HUMAN t_3HDNA.pdb AGC DFGinter 5 GMG 3.10 -80.54 -17.10 60.79 -64.87 127.60 -167.82 -123.33 -4.99 55.69 125.66 15.12 999.00 Favored THR ASP PHE GLY"
"SLK_HUMAN t_2J51A.pdb STE Active 1 DKI 2.1 -130.29 -176.20 999.00 60.35 77.99 -163.18 -96.39 29.31 -61.76 -66.28 -25.16 999.00 Allowed ALA ASP PHE GLY"
"SLK_HUMAN t_2JFLA.pdb STE Active 1 DKI 2.20 -134.77 -178.01 999.00 59.51 81.31 -161.39 -99.12 26.03 -62.02 -61.53 -25.79 999.00 Allowed ALA ASP PHE GLY"
"SLK_HUMAN t_2JFMA.pdb STE Active 1 Apo 2.85 -136.32 -161.30 999.00 40.73 88.44 -147.83 -104.12 26.02 -64.03 -52.36 -40.51 999.00 Outlier ALA ASP PHE GLY"
"SLK_HUMAN t_2UV2A.pdb STE Active 1 GVD 2.30 -137.66 176.51 999.00 65.12 88.84 -156.27 -105.81 29.35 -60.68 -57.85 -30.06 999.00 Allowed ALA ASP PHE GLY"
"SLK_HUMAN t_4USFA.pdb STE DFGinter 5 6UI 1.75 -118.00 -164.71 999.00 -148.30 161.27 -160.17 67.05 10.53 -51.53 -64.08 155.61 999.00 Favored ALA ASP PHE GLY"
"SLK_HUMAN t_4USFB.pdb STE DFGinter 5 6UI 1.75 -116.21 -167.42 999.00 -147.45 163.24 -163.22 64.68 16.15 -53.57 -69.77 155.47 999.00 Favored ALA ASP PHE GLY"
"SRC_HUMAN t_1FMKA.pdb TYR DFGin-inactive 2 Apo 1.50 -131.88 -175.61 999.00 39.94 53.61 -69.09 -49.66 137.57 -79.54 -71.71 58.39 999.00 Favored ALA ASP PHE GLY"
"SRC_HUMAN t_1KSWA.pdb TYR DFGup 3 NBS 2.80 -129.50 168.32 999.00 63.74 34.11 -73.32 -78.37 132.40 38.38 94.47 -78.18 999.00 Favored ALA ASP PHE GLY"
"SRC_HUMAN t_1Y57A.pdb TYR Active 1 MPZ 1.91 -133.70 -170.11 999.00 51.17 73.45 -150.77 -91.42 23.83 -69.70 -66.22 -17.04 999.00 Allowed ALA ASP PHE GLY"
"SRC_HUMAN t_1YI6A.pdb TYR Active 1 Apo 2.00 -129.15 -166.84 999.00 39.02 80.23 -155.95 -93.65 18.03 -60.69 -55.12 -26.94 999.00 Outlier ALA ASP PHE GLY"
"SRC_HUMAN t_1YI6B.pdb TYR Active 1 Apo 2.00 -133.62 -169.54 999.00 50.10 70.85 -75.27 -90.75 21.66 -72.07 -57.18 -30.60 999.00 Allowed ALA ASP PHE GLY"
"SRC_HUMAN t_2BDFA.pdb TYR Active 1 24A 2.10 -131.19 -174.26 999.00 56.97 71.08 -57.68 -89.63 7.82 -72.04 -52.36 -37.05 999.00 Allowed ALA ASP PHE GLY"
"SRC_HUMAN t_2BDFB.pdb TYR Active 1 24A 2.10 -132.18 -172.85 999.00 56.18 69.21 -57.86 -88.99 14.38 -60.24 -56.38 -39.66 999.00 Allowed ALA ASP PHE GLY"
"SRC_HUMAN t_2BDJA.pdb TYR Active 1 HET 2.50 -117.21 -177.04 999.00 63.12 77.03 -68.45 -102.72 31.26 -56.26 -68.47 -21.60 999.00 Allowed ALA ASP PHE GLY"
"SRC_HUMAN t_2H8HA.pdb TYR DFGup 3 H8H 2.20 -115.02 164.45 999.00 78.38 19.69 -156.08 -80.31 138.38 38.07 107.74 -33.28 999.00 Allowed ALA ASP PHE GLY"
"SRC_HUMAN t_2SRCA.pdb TYR DFGup 3 ANP 1.50 -121.57 173.69 999.00 47.37 36.61 -69.57 -81.71 143.04 40.42 86.49 -40.25 999.00 Favored ALA ASP PHE GLY"
"SRC_HUMAN t_4K11A.pdb TYR DFGup 3 0J9 2.30 -124.71 165.07 999.00 63.77 30.28 -83.88 -76.74 132.40 29.66 90.09 -30.68 999.00 Favored ALA ASP PHE GLY"
"SRC_HUMAN t_4MXOA.pdb TYR Active 1 DB8 2.10 -136.90 -177.13 999.00 60.12 67.19 -149.65 -88.03 17.90 -60.61 -39.42 -49.94 999.00 Allowed ALA ASP PHE GLY"
"SRC_HUMAN t_4MXOB.pdb TYR Active 1 DB8 2.10 -143.72 -172.08 999.00 53.42 74.90 -142.75 -94.49 12.14 -60.63 -48.25 -39.95 999.00 Allowed ALA ASP PHE GLY"
"SRC_HUMAN t_4MXXA.pdb TYR Active 1 DB8 2.60 -149.63 -161.02 -171.47 61.34 50.36 -166.46 -80.35 24.46 -58.89 -67.00 2.61 999.00 Favored THR ASP PHE GLY"
"SRC_HUMAN t_4MXXB.pdb TYR DFGinter 5 DB8 2.60 -85.26 126.66 160.59 -111.41 38.59 50.13 -113.36 121.97 179.81 122.67 -27.98 999.00 Favored THR ASP PHE GLY"
"SRC_HUMAN t_4MXYA.pdb TYR Active 1 DB8 2.58 -142.71 170.69 999.00 62.92 55.81 -156.68 -70.38 28.69 -72.33 -59.00 -6.93 999.00 Allowed ALA ASP PHE GLY"
"SRC_HUMAN t_4MXYB.pdb TYR Active 1 DB8 2.58 -129.70 -177.98 999.00 52.18 75.64 -145.51 -95.73 22.49 -66.58 -64.77 -0.77 999.00 Allowed ALA ASP PHE GLY"
"SRC_HUMAN t_4MXZA.pdb TYR Active 1 DB8 2.58 -142.71 170.69 999.00 62.92 55.81 -156.68 -70.38 28.69 -72.33 -59.00 -6.93 999.00 Allowed ALA ASP PHE GLY"
"SRC_HUMAN t_4MXZB.pdb TYR Active 1 DB8 2.58 -129.70 -177.98 999.00 52.18 75.64 -145.51 -95.73 22.49 -66.58 -64.77 -0.77 999.00 Allowed ALA ASP PHE GLY"
"SRPK1_HUMAN t_1WAKA.pdb CMGC Active 1 Apo 1.73 -123.04 -174.53 999.00 53.60 68.87 -61.21 -86.12 19.08 -87.57 -61.65 -18.59 999.00 NA ALA ASP LEU GLY"
"SRPK1_HUMAN t_1WBPA.pdb CMGC Active 1 ADP 2.4 -120.67 177.07 999.00 55.56 73.10 -78.84 -93.76 28.87 -62.55 -60.73 -41.56 999.00 NA ALA ASP LEU GLY"
"SRPK1_HUMAN t_3BEGA.pdb CMGC Active 1 ANP 2.90 -114.75 -153.40 999.00 34.03 76.78 -160.33 -81.10 -2.35 -91.70 -69.78 18.60 999.00 NA ALA ASP LEU GLY"
"SRPK1_HUMAN t_4WUAA.pdb CMGC Active 1 CIT 2.00 -127.41 -171.16 999.00 54.67 65.84 -59.75 -81.44 11.81 -89.36 -66.92 -14.14 999.00 NA ALA ASP LEU GLY"
"SRPK1_HUMAN t_5MY8A.pdb CMGC Active 1 RXZ 1.70 -117.01 177.70 999.00 44.66 98.46 -169.07 -100.63 22.95 -87.19 -66.19 -13.65 999.00 NA ALA ASP LEU GLY"
"SRPK2_HUMAN t_2X7GA.pdb CMGC Active 1 PVB 2.50 -128.74 -179.38 999.00 66.38 58.38 -61.07 -81.25 14.80 -80.82 -63.89 -26.93 999.00 NA ALA ASP LEU GLY"
"SRPK2_HUMAN t_5MYVA.pdb CMGC Active 1 W4A 2.90 -133.44 -174.66 999.00 58.64 65.34 -61.44 -91.14 13.07 -87.53 -64.27 -23.25 999.00 NA ALA ASP LEU GLY"
"SRPK2_HUMAN t_5MYVB.pdb CMGC Active 1 W4A 2.90 -132.07 -175.27 999.00 57.32 67.22 -61.81 -90.78 14.60 -87.67 -64.27 -22.78 999.00 NA ALA ASP LEU GLY"
"SRPK2_HUMAN t_5MYVC.pdb CMGC Active 1 W4A 2.90 -132.32 -176.35 999.00 57.89 66.74 -60.55 -90.70 15.50 -87.90 -64.20 -23.57 999.00 NA ALA ASP LEU GLY"
"SRPK2_HUMAN t_5MYVD.pdb CMGC Active 1 W4A 2.90 -133.22 -174.98 999.00 56.82 67.21 -61.02 -92.02 16.80 -87.91 -66.03 -22.02 999.00 NA ALA ASP LEU GLY"
"ST17B_HUMAN t_3LM0A.pdb CAMK Active 1 EBD 2.35 -126.98 173.64 -59.78 57.16 80.89 -149.78 -91.07 16.40 -74.33 -59.00 -30.12 999.00 Allowed VAL ASP PHE GLY"
"ST17B_HUMAN t_3LM5A.pdb CAMK Active 1 QUE 2.29 -129.37 -179.17 -64.03 62.65 64.00 -73.63 -84.27 20.31 -71.27 -59.90 -27.84 999.00 Allowed VAL ASP PHE GLY"
"ST32A_HUMAN t_4FR4A.pdb OTHER Active 1 STU 2.29 -131.25 -171.35 -161.04 55.78 77.24 -162.59 -91.34 23.49 -77.72 -52.69 -37.55 165.94 NA THR ASP PHE ASN"
"ST32A_HUMAN t_4FR4B.pdb OTHER Active 1 STU 2.29 -130.96 -173.30 -162.02 57.56 78.45 -165.52 -91.72 35.39 -78.33 -62.63 -37.57 176.89 NA THR ASP PHE ASN"
"ST32A_HUMAN t_4FR4C.pdb OTHER Active 1 STU 2.29 -132.55 -169.94 -161.40 52.70 78.99 -163.48 -90.59 33.36 -77.92 -66.68 -30.49 168.10 NA THR ASP PHE ASN"
"ST32A_HUMAN t_4FR4D.pdb OTHER Active 1 STU 2.29 -131.97 -171.70 -160.80 54.80 77.69 -161.56 -90.01 30.97 -77.21 -59.06 -35.09 157.79 NA THR ASP PHE ASN"
"ST32A_HUMAN t_4FR4E.pdb OTHER Active 1 STU 2.29 -131.83 -175.28 -159.12 57.93 79.71 -163.17 -93.49 35.43 -77.64 -67.04 -30.64 178.63 NA THR ASP PHE ASN"
"ST32A_HUMAN t_4FR4F.pdb OTHER Active 1 STU 2.29 -133.23 -172.43 -161.98 54.72 79.35 -161.07 -94.13 35.94 -76.34 -61.65 -33.95 -177.80 NA THR ASP PHE ASN"
"STK10_HUMAN t_2J7TA.pdb STE Active 1 274 2.0 -130.09 176.00 999.00 61.22 79.66 -160.05 -92.73 22.98 -72.34 -62.29 -51.64 999.00 Allowed ALA ASP PHE GLY"
"STK10_HUMAN t_4AOTA.pdb STE DFGout 6 GW8 2.33 -81.39 137.18 999.00 -62.72 -41.15 48.30 -135.69 144.39 -176.77 -158.35 166.82 999.00 Favored ALA ASP PHE GLY"
"STK10_HUMAN t_4AOTB.pdb STE DFGout 6 GW8 2.33 -79.07 142.27 999.00 -66.18 -41.08 49.77 -134.82 146.45 176.21 -162.33 170.05 999.00 Favored ALA ASP PHE GLY"
"STK10_HUMAN t_4BC6A.pdb STE Active 1 XZN 2.20 -115.09 176.12 999.00 50.40 84.67 -76.93 -96.27 32.82 -77.21 -68.76 -52.68 999.00 Outlier ALA ASP PHE GLY"
"STK10_HUMAN t_4EQUA.pdb STE DFGout 6 G6I 2.00 -131.84 175.99 999.00 -151.30 132.04 -166.06 -118.64 177.72 -46.29 76.44 -131.55 999.00 Favored ALA ASP PHE GLY"
"STK10_HUMAN t_4EQUB.pdb STE DFGout 6 1PE 2.00 -133.34 178.10 999.00 -152.05 130.97 -164.98 -119.26 176.28 -45.82 77.47 -131.53 999.00 Favored ALA ASP PHE GLY"
"STK10_HUMAN t_4USDA.pdb STE DFGout 6 R09 3.05 -127.04 147.32 999.00 -89.98 -48.64 -164.46 52.72 44.33 -158.50 133.39 -8.67 999.00 Favored ALA ASP PHE GLY"
"STK10_HUMAN t_4USDB.pdb STE DFGout 6 R09 3.05 -127.61 146.51 999.00 -89.65 -49.07 -164.32 53.01 44.05 -158.41 133.19 -10.36 999.00 Favored ALA ASP PHE GLY"
"STK10_HUMAN t_4USEA.pdb STE Active 1 R09 2.65 -124.05 -47.72 999.00 -111.48 110.58 -156.63 -107.35 33.14 -73.72 -74.03 -29.20 999.00 Favored ALA ASP PHE GLY"
"STK10_HUMAN t_4USEB.pdb STE Active 1 R09 2.65 -123.57 -47.98 999.00 -110.92 111.07 -155.53 -107.58 33.14 -73.27 -75.10 -28.60 999.00 Favored ALA ASP PHE GLY"
"STK10_HUMAN t_5AJQA.pdb STE DFGin-inactive 2 DB8 2.20 -120.53 174.18 999.00 81.31 -56.33 -176.95 57.24 29.35 -72.17 102.54 -17.23 999.00 Allowed ALA ASP PHE GLY"
"STK10_HUMAN t_5AJQB.pdb STE DFGin-inactive 2 DB8 2.20 -120.58 173.37 999.00 83.23 -57.90 -173.32 53.23 23.50 -71.23 -62.88 -49.74 999.00 Allowed ALA ASP PHE GLY"
"STK11_HUMAN t_2WTKC.pdb CAMK Active 1 ANP 2.65 -119.65 -175.86 -162.30 56.02 66.22 999.00 -90.24 25.82 -48.79 -80.49 -8.15 999.00 NA SER ALA LEU GLY"
"STK11_HUMAN t_2WTKF.pdb CAMK Active 1 ANP 2.65 -119.12 -173.27 -165.69 54.49 62.80 999.00 -80.34 19.17 -64.17 -48.37 -46.42 999.00 NA SER ALA LEU GLY"
"STK16_HUMAN t_2BUJA.pdb OTHER Active 1 STU 2.6 -135.88 -178.46 58.70 61.94 77.27 -162.89 -105.15 26.12 -43.51 -83.87 1.27 999.00 NA MET ASP LEU GLY"
"STK16_HUMAN t_2BUJB.pdb OTHER Active 1 STU 2.6 -129.18 -175.67 53.94 64.00 67.21 -164.32 -107.35 -12.78 -39.94 -59.58 -39.19 999.00 NA MET ASP LEU GLY"
"STK24_HUMAN t_3A7FA.pdb STE Active 1 Apo 1.55 -129.82 171.05 999.00 61.49 83.18 -80.18 -95.15 22.47 -71.63 -53.79 -26.88 999.00 Allowed ALA ASP PHE GLY"
"STK24_HUMAN t_3A7GA.pdb STE Active 1 Apo 2.00 -137.30 176.72 999.00 45.55 67.22 -152.08 -68.16 -49.20 -72.33 47.03 -45.59 999.00 Allowed ALA ASP PHE GLY"
"STK24_HUMAN t_3A7GB.pdb STE Active 1 Apo 2.00 -136.12 175.51 999.00 55.36 75.30 -174.01 -91.46 26.34 -75.77 -60.00 -23.60 999.00 Allowed ALA ASP PHE GLY"
"STK24_HUMAN t_3A7HA.pdb STE Active 1 ATP 1.96 -135.27 174.99 999.00 54.45 64.85 -152.26 -70.67 -58.11 -72.21 45.94 -45.02 999.00 Allowed ALA ASP PHE GLY"
"STK24_HUMAN t_3A7HB.pdb STE Active 1 ATP 1.96 -138.10 177.77 999.00 56.46 71.77 -168.47 -87.81 21.18 -78.14 -54.83 -28.21 999.00 Allowed ALA ASP PHE GLY"
"STK24_HUMAN t_3A7IA.pdb STE Active 1 Apo 1.45 -139.67 169.85 999.00 69.57 79.78 -165.70 -97.19 20.64 -68.58 -61.27 -25.51 999.00 Allowed ALA ASP PHE GLY"
"STK24_HUMAN t_3A7JA.pdb STE Active 1 ADP 1.50 -138.66 168.25 999.00 71.48 79.52 -156.59 -101.18 20.07 -73.02 -64.30 -27.68 999.00 Allowed ALA ASP PHE GLY"
"STK24_HUMAN t_3CKXA.pdb STE Active 1 STU 2.70 -132.76 176.65 999.00 58.64 84.14 -161.73 -98.56 27.31 -69.23 -58.51 -32.01 999.00 Allowed ALA ASP PHE GLY"
"STK24_HUMAN t_3ZHPC.pdb STE DFGin-inactive 2 Apo 2.90 -141.17 168.41 999.00 51.79 82.94 -53.87 -71.63 165.78 -72.99 -80.08 -153.38 999.00 Allowed ALA ASP PHE GLY"
"STK24_HUMAN t_3ZHPD.pdb STE DFGin-inactive 2 Apo 2.90 -141.24 167.95 999.00 51.54 82.97 -53.50 -70.70 165.43 -73.55 -77.80 -153.84 999.00 Allowed ALA ASP PHE GLY"
"STK24_HUMAN t_4O27B.pdb STE Active 1 ADP 3.19 -148.39 -173.29 999.00 56.22 -124.13 -171.09 31.76 82.18 64.73 98.87 -78.63 999.00 Allowed ALA ASP PHE GLY"
"STK24_HUMAN t_4QMLA.pdb STE Active 1 ANP 1.88 -130.36 172.26 999.00 70.83 79.31 -163.21 -104.56 19.97 -74.07 -61.28 -25.30 999.00 Allowed ALA ASP PHE GLY"
"STK24_HUMAN t_4QMMA.pdb STE Active 1 35R 1.85 -136.15 172.53 999.00 56.68 85.67 -156.00 -97.17 29.37 -72.09 -60.60 -24.20 999.00 Allowed ALA ASP PHE GLY"
"STK24_HUMAN t_4QMNA.pdb STE Active 1 DB8 2.09 -132.68 174.27 999.00 64.77 80.03 -170.55 -95.86 31.00 -74.84 -57.23 -28.98 999.00 Allowed ALA ASP PHE GLY"
"STK24_HUMAN t_4QMOA.pdb STE Active 1 34L 1.90 -133.22 172.49 999.00 62.82 87.78 -161.11 -99.90 25.42 -81.16 -54.00 -30.83 999.00 Allowed ALA ASP PHE GLY"
"STK24_HUMAN t_4QMPA.pdb STE Active 1 DKI 2.00 -138.56 169.54 999.00 58.44 76.68 -157.74 -89.88 22.69 -82.96 -60.10 -26.09 999.00 Allowed ALA ASP PHE GLY"
"STK24_HUMAN t_4QMQA.pdb STE Active 1 34U 1.77 -135.19 170.43 999.00 56.02 86.06 -160.35 -96.16 25.66 -77.31 -60.00 -25.03 999.00 Allowed ALA ASP PHE GLY"
"STK24_HUMAN t_4QMSA.pdb STE Active 1 1N1 1.88 -133.64 170.37 999.00 59.14 88.68 -162.11 -100.46 27.95 -72.62 -60.55 -24.39 999.00 Allowed ALA ASP PHE GLY"
"STK24_HUMAN t_4QMTA.pdb STE Active 1 H1N 1.50 -135.79 169.94 999.00 68.23 92.23 -160.19 -111.24 19.34 -69.31 -60.26 -31.45 999.00 Allowed ALA ASP PHE GLY"
"STK24_HUMAN t_4QMUA.pdb STE Active 1 SKE 1.55 -136.05 168.26 999.00 67.36 81.39 -80.15 -100.22 19.92 -70.26 -62.59 -26.50 999.00 Allowed ALA ASP PHE GLY"
"STK24_HUMAN t_4QMVA.pdb STE Active 1 34W 2.40 -132.70 169.15 999.00 64.18 83.56 -162.21 -96.30 28.17 -71.31 -49.32 -35.76 999.00 Allowed ALA ASP PHE GLY"
"STK24_HUMAN t_4QMWA.pdb STE Active 1 KS1 1.60 -132.93 168.59 999.00 70.43 85.78 -166.99 -111.75 18.04 -71.11 -58.56 -33.71 999.00 Allowed ALA ASP PHE GLY"
"STK24_HUMAN t_4QMXA.pdb STE Active 1 H8H 1.88 -132.04 170.35 999.00 59.97 85.71 -161.85 -98.54 25.19 -77.09 -58.11 -25.48 999.00 Allowed ALA ASP PHE GLY"
"STK24_HUMAN t_4QMYA.pdb STE Active 1 STU 1.88 -133.46 171.21 999.00 64.89 84.44 -170.37 -97.39 25.80 -73.21 -58.52 -26.19 999.00 Allowed ALA ASP PHE GLY"
"STK24_HUMAN t_4QMZA.pdb STE Active 1 B49 1.88 -133.12 166.11 999.00 69.29 93.82 -170.14 -111.90 23.72 -70.92 -59.75 -26.01 999.00 Allowed ALA ASP PHE GLY"
"STK24_HUMAN t_4QNAA.pdb STE Active 1 X11 1.85 -130.08 169.67 999.00 67.96 80.07 -150.13 -98.11 24.59 -72.80 -61.08 -22.93 999.00 Allowed ALA ASP PHE GLY"
"STK24_HUMAN t_4QO9A.pdb STE Active 1 627 2.20 -145.53 175.73 999.00 60.06 84.25 -170.32 -107.38 23.34 -78.70 -57.82 -35.43 999.00 Allowed ALA ASP PHE GLY"
"STK24_HUMAN t_4QO9B.pdb STE Active 1 627 2.20 -138.85 179.77 999.00 59.49 78.90 -161.84 -100.60 29.26 -74.03 -61.75 -32.26 999.00 Allowed ALA ASP PHE GLY"
"STK24_HUMAN t_4U8ZA.pdb STE Active 1 3FE 1.63 -128.46 174.13 999.00 66.33 76.27 -146.58 -95.10 25.28 -77.68 -59.52 -28.23 999.00 Allowed ALA ASP PHE GLY"
"STK24_HUMAN t_4W8DA.pdb STE Active 1 3JA 1.77 -129.43 167.72 999.00 65.77 94.02 -152.18 -104.88 25.37 -71.62 -56.82 -28.32 999.00 Allowed ALA ASP PHE GLY"
"STK24_HUMAN t_4W8EA.pdb STE Active 1 3JB 1.79 -133.41 172.79 999.00 62.42 84.32 -158.51 -98.98 25.34 -71.44 -66.01 -31.48 999.00 Allowed ALA ASP PHE GLY"
"STK25_HUMAN t_2XIKA.pdb STE Active 1 J60 1.97 -126.85 168.64 999.00 66.32 89.08 -149.99 -101.99 19.12 -63.34 -54.59 -29.34 999.00 Allowed ALA ASP PHE GLY"
"STK25_HUMAN t_4NZWB.pdb STE DFGinter 5 J60 3.58 -75.37 -140.52 999.00 -158.86 -45.92 999.00 -65.09 119.31 -42.71 113.99 -12.04 999.00 Allowed ALA ALA PHE GLY"
"STK26_HUMAN t_3GGFA.pdb STE DFGin-trans 4 GVD 2.35 -107.22 8.37 999.00 -96.79 1.86 66.11 -77.61 129.15 -177.77 -169.36 -175.41 999.00 Favored ALA ASP PHE GLY"
"STK26_HUMAN t_3GGFB.pdb STE DFGin-trans 4 GVD 2.35 -107.29 8.99 999.00 -94.47 -5.73 67.56 -73.18 129.60 -179.92 -158.41 -173.99 999.00 Favored ALA ASP PHE GLY"
"STK26_HUMAN t_4FZAB.pdb STE DFGout 6 Apo 3.15 -60.73 149.70 999.00 -73.37 -24.99 999.00 -40.55 -54.12 178.93 -75.71 -10.72 999.00 Favored ALA ALA PHE GLY"
"STK26_HUMAN t_4FZDB.pdb STE DFGout 6 Apo 3.25 -64.55 145.41 999.00 -66.64 -33.20 999.00 -25.25 -70.24 -163.65 -59.56 -38.18 999.00 Favored ALA ALA PHE GLY"
"STK26_HUMAN t_4FZFB.pdb STE DFGinter 5 DKI 3.64 -57.67 114.34 999.00 -69.71 -9.89 999.00 -61.30 -25.77 -89.12 -63.64 -36.73 999.00 Favored ALA ALA PHE GLY"
"STK3_HUMAN t_4LG4A.pdb STE DFGin-inactive 2 Apo 2.42 -149.16 171.47 999.00 46.67 61.42 -63.12 -60.76 152.50 -68.85 -79.20 173.30 999.00 Favored ALA ASP PHE GLY"
"STK3_HUMAN t_4LG4B.pdb STE DFGin-inactive 2 Apo 2.42 -140.23 165.66 999.00 50.98 86.77 -69.87 -80.55 176.11 -54.23 -53.23 999.00 999.00 Outlier ALA ASP PHE GLY"
"STK3_HUMAN t_4LG4C.pdb STE DFGin-inactive 2 Apo 2.42 -145.61 169.49 999.00 51.26 57.21 -57.53 -59.21 151.15 -72.06 -86.77 150.03 999.00 Favored ALA ASP PHE GLY"
"STK3_HUMAN t_4LG4E.pdb STE DFGin-inactive 2 Apo 2.42 -130.34 173.18 999.00 47.80 59.45 -58.33 -58.96 151.46 -80.35 -84.54 152.08 999.00 Favored ALA ASP PHE GLY"
"STK3_HUMAN t_4LGDA.pdb STE DFGin-inactive 2 ANP 3.05 -145.51 -179.32 999.00 43.92 67.60 -64.30 -70.28 152.22 -78.39 -80.60 163.89 999.00 Allowed ALA ASP PHE GLY"
"STK3_HUMAN t_4LGDB.pdb STE DFGin-inactive 2 ANP 3.05 -138.63 169.82 999.00 44.76 62.14 -75.24 -62.34 151.87 -74.35 -88.90 160.76 999.00 Favored ALA ASP PHE GLY"
"STK3_HUMAN t_4LGDC.pdb STE DFGin-inactive 2 ANP 3.05 -149.79 166.59 999.00 51.16 65.48 -59.52 -62.66 153.37 -75.99 -77.51 169.29 999.00 Allowed ALA ASP PHE GLY"
"STK3_HUMAN t_4LGDD.pdb STE DFGin-inactive 2 ANP 3.05 -143.34 170.38 999.00 44.57 62.90 -69.46 -62.30 161.34 -80.54 -101.40 151.86 999.00 Allowed ALA ASP PHE GLY"
"STK3_HUMAN t_5DH3A.pdb STE Active 1 5BS 2.47 -145.27 166.52 999.00 56.19 58.23 -168.00 -79.01 55.94 -50.76 -65.37 -40.95 999.00 Favored ALA ASP PHE GLY"
"STK3_HUMAN t_5DH3B.pdb STE Active 1 5BS 2.47 -107.95 -47.89 999.00 -103.08 119.04 -156.67 -112.25 18.03 -69.32 -61.57 -41.17 999.00 Favored ALA ASP PHE GLY"
"STK40_HUMAN t_5L2QA.pdb CAMK Active 1 Apo 2.53 -130.46 179.68 73.46 54.94 74.14 -65.99 -97.33 23.86 -69.14 -74.13 -21.81 47.50 NA THR ASN PHE CYS"
"STK40_HUMAN t_5L2QB.pdb CAMK Active 1 Apo 2.53 -131.09 171.21 63.19 59.13 69.56 -59.04 -85.33 7.69 -80.63 -62.72 161.77 41.54 NA THR ASN PHE CYS"
"STK40_HUMAN t_5L2QC.pdb CAMK Active 1 Apo 2.53 -133.53 -179.25 63.29 57.55 64.68 -66.46 -82.36 26.00 -69.64 -68.27 -15.56 -34.08 NA THR ASN PHE CYS"
"STK40_HUMAN t_5L2QD.pdb CAMK Active 1 Apo 2.53 -120.14 167.59 -46.66 66.18 61.65 -54.52 -79.70 21.56 -89.08 -59.45 158.53 -57.89 NA THR ASN PHE CYS"
"STK4_HUMAN t_3COMA.pdb STE Active 1 Apo 2.20 -125.31 176.70 999.00 66.24 69.78 -71.31 -88.93 18.52 -68.71 -65.51 -12.42 999.00 Allowed ALA ASP PHE GLY"
"STK4_HUMAN t_3COMB.pdb STE Active 1 Apo 2.20 -134.02 172.51 999.00 66.98 78.38 -158.59 -93.12 23.84 -67.20 -56.94 -29.01 999.00 Allowed ALA ASP PHE GLY"
"STRAA_HUMAN t_2WTKB.pdb STE DFGout 6 ANP 2.65 -139.76 129.84 -75.27 -84.62 137.87 -135.04 -117.01 -150.70 64.89 71.30 24.70 999.00 NA TYR LEU SER GLY"
"STRAA_HUMAN t_2WTKE.pdb STE DFGout 6 ANP 2.65 -123.27 139.12 -63.29 -94.91 131.86 -150.81 -114.44 -147.78 59.36 66.20 35.42 999.00 NA TYR LEU SER GLY"
"STRAA_HUMAN t_3GNIB.pdb STE DFGout 6 ATP 2.35 -125.13 133.12 -60.50 -80.26 129.07 -131.45 -109.40 -155.47 58.21 74.82 29.59 999.00 NA TYR LEU SER GLY"
"TBK1_HUMAN t_4EUTA.pdb OTHER Active 1 BX7 2.60 -159.21 -168.27 -155.78 61.82 56.98 -171.95 -82.73 42.55 -64.34 -64.33 -31.47 999.00 Favored THR ASP PHE GLY"
"TBK1_HUMAN t_4EUTB.pdb OTHER Active 1 BX7 2.60 -146.54 -168.92 -154.39 58.35 68.75 -177.14 -93.82 31.12 -74.56 -61.30 -33.66 999.00 Allowed THR ASP PHE GLY"
"TBK1_HUMAN t_4EUUA.pdb OTHER Active 1 BX7 1.80 -149.43 -171.74 -165.92 60.76 75.14 -171.24 -94.26 22.10 -75.53 -56.89 -31.62 999.00 Allowed THR ASP PHE GLY"
"TBK1_HUMAN t_4EUUB.pdb OTHER Active 1 BX7 1.80 -149.70 -169.25 -164.98 59.25 76.49 -173.16 -95.29 24.74 -73.13 -60.34 -24.84 999.00 Allowed THR ASP PHE GLY"
"TBK1_HUMAN t_4IM0A.pdb OTHER DFGup 3 1FV 2.40 -149.80 171.47 -164.11 60.77 53.05 -174.30 -106.94 124.05 23.00 102.88 999.00 999.00 Favored THR ASP PHE GLY"
"TBK1_HUMAN t_4IM2A.pdb OTHER DFGup 3 BX7 2.50 -136.29 173.74 -163.33 65.76 52.99 -175.70 -108.01 125.12 18.77 108.04 999.00 999.00 Allowed THR ASP PHE GLY"
"TBK1_HUMAN t_4IM3A.pdb OTHER DFGup 3 BX7 3.34 -150.29 172.36 -165.84 61.64 53.34 -174.03 -107.02 123.71 23.07 -109.42 999.00 999.00 Favored THR ASP PHE GLY"
"TBK1_HUMAN t_4IW0A.pdb OTHER Active 1 BX7 4.00 -155.40 -171.43 -177.63 57.36 68.21 -172.94 -92.32 33.19 -66.77 -70.62 -23.66 999.00 Allowed THR ASP PHE GLY"
"TBK1_HUMAN t_4IWOA.pdb OTHER DFGup 3 1H4 2.61 -153.66 168.75 -170.24 57.37 50.69 -152.58 -116.36 158.83 39.02 92.31 6.53 999.00 Favored THR ASP PHE GLY"
"TBK1_HUMAN t_4IWPA.pdb OTHER DFGup 3 BX7 3.06 -134.47 -56.19 165.42 -87.26 102.19 -173.13 -162.17 172.62 51.09 74.44 12.62 999.00 Favored THR ASP PHE GLY"
"TBK1_HUMAN t_4IWQA.pdb OTHER DFGup 3 1FV 3.00 -151.29 -54.29 166.03 -82.86 74.19 -166.00 -133.54 165.87 51.02 72.55 18.95 999.00 Favored THR ASP PHE GLY"
"TGFR1_HUMAN t_1B6CB.pdb TKL Active 1 Apo 2.60 -130.85 -177.22 999.00 52.76 80.25 -155.56 -95.39 25.62 -59.69 -64.73 -15.72 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_1B6CD.pdb TKL Active 1 Apo 2.60 -130.98 -177.22 999.00 52.75 80.20 -155.47 -95.36 25.61 -59.46 -64.60 -15.86 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_1B6CF.pdb TKL Active 1 Apo 2.60 -130.95 -177.22 999.00 52.75 80.16 -155.34 -95.33 25.59 -59.63 -64.71 -15.72 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_1B6CH.pdb TKL Active 1 Apo 2.60 -131.06 -177.20 999.00 52.80 80.25 -155.77 -95.23 25.42 -59.65 -64.70 -15.83 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_1IASA.pdb TKL Active 1 Apo 2.90 -151.40 164.92 999.00 72.01 89.00 -159.98 -106.88 22.49 -48.11 -60.75 -26.30 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_1IASB.pdb TKL Active 1 Apo 2.90 -150.80 165.68 999.00 71.57 88.89 -159.16 -106.55 22.01 -47.84 -60.99 -25.46 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_1IASC.pdb TKL Active 1 Apo 2.90 -150.32 164.64 999.00 71.45 89.01 -158.72 -106.93 23.23 -47.40 -61.25 -25.68 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_1IASD.pdb TKL Active 1 Apo 2.90 -152.15 165.76 999.00 70.86 87.81 -159.34 -105.23 21.50 -47.09 -60.27 -25.55 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_1IASE.pdb TKL Active 1 Apo 2.90 -151.37 165.13 999.00 70.83 89.40 -158.73 -106.93 22.03 -48.04 -61.72 -24.36 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_1PY5A.pdb TKL Active 1 PY1 2.30 -139.21 -176.21 999.00 51.44 62.71 -67.00 -91.28 17.79 -53.01 -57.71 -31.71 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_1RW8A.pdb TKL Active 1 580 2.40 -123.88 -176.48 999.00 52.01 78.54 -161.16 -101.64 16.56 -52.81 -62.05 -25.00 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_1VJYA.pdb TKL Active 1 460 2.00 -131.99 -168.33 999.00 46.79 72.13 -100.59 -95.22 6.99 -52.08 -49.89 -32.30 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_2WOTA.pdb TKL Active 1 ZZG 1.85 -130.28 -169.42 999.00 60.14 61.42 -149.71 -92.38 8.12 -56.84 -64.53 -24.37 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_2WOUA.pdb TKL Active 1 ZZF 2.30 -133.44 -169.55 999.00 51.08 62.38 -75.29 -92.03 13.33 -61.72 -62.74 -28.00 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_2X7OA.pdb TKL Active 1 ZOP 3.70 -128.15 169.95 999.00 59.52 88.41 -174.47 -108.37 28.13 -70.76 -69.27 -30.40 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_2X7OB.pdb TKL Active 1 ZOP 3.70 -128.21 169.79 999.00 59.70 88.27 -174.48 -108.23 28.29 -70.74 -69.26 -30.90 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_2X7OC.pdb TKL Active 1 ZOP 3.70 -127.98 170.10 999.00 59.32 88.48 -175.07 -108.47 28.34 -70.46 -69.08 -31.33 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_2X7OD.pdb TKL Active 1 ZOP 3.70 -128.05 169.94 999.00 59.43 88.42 -174.78 -108.43 28.26 -70.91 -69.37 -30.82 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_2X7OE.pdb TKL Active 1 ZOP 3.70 -128.11 169.87 999.00 59.80 88.28 -174.51 -108.31 28.26 -70.65 -69.21 -30.85 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_3FAAA.pdb TKL Active 1 55F 3.35 -165.76 163.42 999.00 74.28 54.12 -155.81 -79.68 24.08 -42.95 -56.64 -51.34 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_3FAAB.pdb TKL Active 1 55F 3.35 -136.49 -176.23 999.00 60.00 54.87 -98.37 -81.43 12.93 -52.02 -52.52 -45.28 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_3FAAC.pdb TKL Active 1 55F 3.35 -126.21 176.43 999.00 50.63 78.48 -158.21 -102.56 30.07 -39.67 -66.36 -17.89 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_3FAAD.pdb TKL Active 1 55F 3.35 -151.48 176.65 999.00 62.92 64.19 -151.43 -91.00 27.01 -57.82 -66.62 -19.33 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_3FAAE.pdb TKL Active 1 55F 3.35 -131.46 -168.00 999.00 37.35 86.29 -145.81 -107.68 25.95 -63.06 -65.86 -19.59 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_3GXLA.pdb TKL Active 1 QIG 1.80 -117.01 -170.62 999.00 33.64 86.84 73.32 -102.58 15.81 -47.99 -62.08 -23.54 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_3HMMA.pdb TKL Active 1 855 1.70 -127.07 -168.92 999.00 53.99 65.86 -157.23 -95.00 13.13 -54.32 -60.46 -23.32 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_3KCFA.pdb TKL Active 1 JZO 2.80 -150.68 165.14 999.00 67.98 79.38 175.49 -90.01 14.03 -50.76 -44.06 -39.88 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_3KCFB.pdb TKL Active 1 JZO 2.80 -135.27 -176.57 999.00 58.41 88.08 -163.56 -103.93 28.47 -44.94 -62.84 -35.83 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_3KCFC.pdb TKL Active 1 JZO 2.80 -135.30 165.05 999.00 69.27 88.38 -171.53 -106.61 31.53 -58.00 -58.82 -55.66 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_3KCFD.pdb TKL Active 1 JZO 2.80 -135.89 -173.82 999.00 57.16 75.27 -165.98 -93.53 22.18 -61.12 -63.24 -14.31 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_3KCFE.pdb TKL Active 1 JZO 2.80 -143.19 -179.91 999.00 57.86 88.26 -163.20 -108.00 21.94 -52.33 -69.37 -7.32 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_3TZMA.pdb TKL Active 1 085 1.70 -122.55 -169.80 999.00 59.25 59.25 -170.71 -91.38 11.51 -55.40 -64.07 -23.92 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_4X0MA.pdb TKL Active 1 3WA 1.68 -128.26 -179.78 999.00 55.39 57.49 -66.67 -85.93 12.46 -62.01 -63.64 -28.12 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_4X2FA.pdb TKL Active 1 3WJ 1.49 -129.61 -169.67 999.00 49.38 56.70 -78.37 -81.84 7.00 -56.79 -60.27 -24.32 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_4X2GA.pdb TKL Active 1 3WK 1.51 -126.41 -164.74 999.00 48.25 54.97 -53.77 -83.21 5.58 -53.53 -59.33 -23.49 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_4X2JA.pdb TKL Active 1 3WN 1.69 -129.52 -176.52 999.00 54.04 62.43 -79.62 -89.07 7.15 -59.42 -58.81 -23.33 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_4X2KA.pdb TKL Active 1 3WO 1.69 -129.52 -176.52 999.00 54.04 62.43 -79.62 -89.07 7.15 -59.42 -58.81 -23.33 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_4X2NA.pdb TKL Active 1 Apo 1.80 -127.57 -171.49 999.00 51.61 55.62 -64.34 -81.71 7.98 -53.56 -57.66 -30.68 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_5E8SA.pdb TKL Active 1 Apo 1.45 -130.71 -170.34 999.00 50.18 56.35 -93.17 -81.52 7.16 -57.44 -59.68 -25.77 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_5E8TA.pdb TKL Active 1 Apo 1.70 -129.72 -170.39 999.00 54.33 58.58 -60.53 -85.47 9.01 -50.83 -56.68 -27.35 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_5E8UA.pdb TKL Active 1 Apo 2.03 -134.56 -172.65 69.32 56.08 81.92 -153.26 -101.20 16.45 -67.48 -57.91 -29.21 999.00 NA CYS ASP PHE GLY"
"TGFR1_HUMAN t_5E8WA.pdb TKL Active 1 STU 1.86 -115.94 -168.57 999.00 48.02 66.79 -161.26 -87.78 6.94 -56.37 -53.88 -34.63 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_5E8XA.pdb TKL Active 1 STU 1.45 -131.98 177.85 68.42 68.88 84.87 -161.03 -101.87 20.90 -61.26 -60.94 -22.77 999.00 NA CYS ASP PHE GLY"
"TGFR1_HUMAN t_5E8ZA.pdb TKL Active 1 5L4 1.51 -131.71 -172.46 999.00 57.22 65.08 -156.97 -93.04 9.51 -54.67 -62.73 -21.76 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_5E90A.pdb TKL Active 1 5L4 2.05 -132.50 -170.96 68.78 59.11 73.90 -173.19 -100.07 11.61 -66.93 -58.83 -27.51 999.00 NA CYS ASP PHE GLY"
"TGFR1_HUMAN t_5FRIA.pdb TKL Active 1 ZUQ 2.00 -129.49 -173.23 999.00 60.99 71.41 -122.03 -101.18 12.35 -52.70 -67.89 -22.54 999.00 NA ALA ASP LEU GLY"
"TGFR1_HUMAN t_5USQA.pdb TKL Active 1 8LY 2.55 -128.65 -178.50 999.00 58.77 56.73 -82.78 -84.75 2.30 -51.43 -59.49 -22.92 999.00 NA ALA ASP LEU GLY"
"TGFR2_HUMAN t_5E8VA.pdb TKL Active 1 Apo 1.69 -147.35 -173.83 68.74 59.37 66.89 -86.11 -91.31 13.79 -64.81 -56.78 -28.25 999.00 Allowed CYS ASP PHE GLY"
"TGFR2_HUMAN t_5E8YA.pdb TKL Active 1 STU 2.05 -147.57 -29.87 64.93 -96.99 88.30 179.55 -98.30 19.65 -59.19 -63.26 -27.99 999.00 Favored CYS ASP PHE GLY"
"TGFR2_HUMAN t_5E91A.pdb TKL Active 1 5L4 2.42 -147.15 -171.89 68.26 61.44 64.77 -155.27 -93.03 17.55 -61.58 -55.73 -31.34 999.00 Allowed CYS ASP PHE GLY"
"TGFR2_HUMAN t_5E92A.pdb TKL Active 1 ANP 2.08 -134.98 178.11 77.58 63.02 87.10 -169.39 -105.31 16.80 -59.27 -60.65 -26.07 999.00 Allowed CYS ASP PHE GLY"
"TIE2_HUMAN t_1FVRA.pdb TYR DFGinter 5 Apo 2.20 -70.31 127.70 999.00 -127.01 36.70 47.30 -94.94 138.28 -174.99 67.01 29.16 999.00 Favored ALA ASP PHE GLY"
"TIE2_HUMAN t_1FVRB.pdb TYR DFGinter 5 Apo 2.20 -71.49 125.05 999.00 -125.15 43.50 47.61 -101.23 137.48 -176.29 68.45 28.29 999.00 Favored ALA ASP PHE GLY"
"TIE2_HUMAN t_2OO8X.pdb TYR DFGout 6 RAJ 2.20 -141.22 -175.17 999.00 -157.18 106.21 -171.09 -93.01 -5.93 -53.82 100.20 167.99 999.00 Favored ALA ASP PHE GLY"
"TIE2_HUMAN t_2OSCA.pdb TYR DFGout 6 MUH 2.80 -142.38 -172.79 999.00 -162.13 104.70 -170.13 -90.69 -7.86 -51.76 108.94 160.73 999.00 Allowed ALA ASP PHE GLY"
"TIE2_HUMAN t_2P4IA.pdb TYR DFGout 6 MR9 2.50 -136.33 173.57 999.00 -145.13 113.97 172.80 -102.76 17.92 -58.50 -72.29 179.25 999.00 Favored ALA ASP PHE GLY"
"TIE2_HUMAN t_2P4IB.pdb TYR DFGout 6 MR9 2.50 -139.32 -178.12 999.00 -154.88 99.13 -161.66 -89.76 -137.57 -55.12 -63.50 135.48 999.00 Favored ALA ASP PHE GLY"
"TIE2_HUMAN t_2WQBA.pdb TYR DFGinter 5 QQ1 2.95 -94.97 119.30 999.00 -85.35 13.76 43.61 -87.17 146.43 -20.68 49.11 64.28 999.00 Favored ALA ASP PHE GLY"
"TIE2_HUMAN t_3L8PA.pdb TYR DFGup 3 0CE 2.40 -131.84 173.10 999.00 50.03 38.31 -150.20 -83.93 143.23 46.55 -61.57 145.14 999.00 Favored ALA ASP PHE GLY"
"TIE2_HUMAN t_4X3JA.pdb TYR DFGout 6 3WR 2.50 -141.85 178.60 999.00 -157.11 97.13 -166.03 -145.58 158.62 57.11 -143.95 999.00 999.00 Allowed ALA ASP PHE GLY"
"TNI3K_HUMAN t_4YFFA.pdb TKL Active 1 4CV 3.07 -127.50 175.45 999.00 57.03 94.25 -160.01 -101.90 21.42 -74.93 -67.56 -12.17 999.00 Outlier ALA ASP PHE GLY"
"TNI3K_HUMAN t_4YFFB.pdb TKL Active 1 4CV 3.07 -128.81 174.12 999.00 57.63 94.34 -162.79 -99.96 21.09 -74.46 -67.41 -10.85 999.00 Outlier ALA ASP PHE GLY"
"TNI3K_HUMAN t_4YFFC.pdb TKL Active 1 4CV 3.07 -137.58 177.82 999.00 57.61 83.14 -166.82 -93.55 21.92 -76.97 -61.79 -21.26 999.00 Allowed ALA ASP PHE GLY"
"TNI3K_HUMAN t_4YFFD.pdb TKL Active 1 4CV 3.07 -138.20 176.22 999.00 59.04 82.09 -167.96 -92.71 22.90 -75.75 -62.12 -21.89 999.00 Allowed ALA ASP PHE GLY"
"TNI3K_HUMAN t_4YFIA.pdb TKL Active 1 4CW 2.70 -134.82 175.81 999.00 58.05 92.29 -162.70 -99.43 27.84 -74.02 -68.68 -26.97 999.00 Outlier ALA ASP PHE GLY"
"TNI3K_HUMAN t_4YFIB.pdb TKL Active 1 4CW 2.70 -121.51 176.97 999.00 56.86 87.22 -162.44 -99.76 31.07 -75.86 -68.86 -25.65 999.00 Allowed ALA ASP PHE GLY"
"TNI3K_HUMAN t_4YFIC.pdb TKL Active 1 4CW 2.70 -119.09 170.12 999.00 62.74 94.43 -166.78 -102.42 18.40 -75.37 -60.64 -21.52 999.00 Outlier ALA ASP PHE GLY"
"TNI3K_HUMAN t_4YFID.pdb TKL Active 1 4CW 2.70 -132.35 -176.26 999.00 57.38 76.37 -158.07 -86.60 32.19 -72.26 -68.28 -29.31 999.00 Allowed ALA ASP PHE GLY"
"TNIK_HUMAN t_2X7FA.pdb STE Active 1 824 2.80 -125.99 176.14 -60.82 61.06 100.62 -168.04 -114.36 23.29 -71.42 -68.06 -48.71 999.00 Outlier VAL ASP PHE GLY"
"TNIK_HUMAN t_2X7FB.pdb STE Active 1 824 2.80 -125.83 175.94 -60.73 61.26 100.49 -168.30 -113.30 24.31 -71.67 -68.53 -48.23 999.00 Outlier VAL ASP PHE GLY"
"TNIK_HUMAN t_2X7FC.pdb STE Active 1 824 2.80 -124.83 175.82 -60.44 60.67 100.54 -168.21 -112.74 22.90 -72.05 -67.62 -48.04 999.00 Outlier VAL ASP PHE GLY"
"TNIK_HUMAN t_2X7FD.pdb STE Active 1 824 2.80 -124.52 178.83 -61.37 56.73 102.03 -168.15 -114.10 22.83 -72.81 -65.43 -48.94 999.00 Outlier VAL ASP PHE GLY"
"TNIK_HUMAN t_5AX9A.pdb STE Active 1 4KT 2.40 -130.68 -179.45 -63.55 62.79 86.08 -152.04 -93.54 16.34 -70.67 -65.72 -27.27 999.00 Allowed VAL ASP PHE GLY"
"TNIK_HUMAN t_5AX9B.pdb STE Active 1 4KT 2.40 -131.19 168.22 -52.16 66.98 91.57 -155.42 -89.13 13.91 -71.95 -49.78 -38.59 999.00 Allowed VAL ASP PHE GLY"
"TNIK_HUMAN t_5AX9C.pdb STE Active 1 4KT 2.40 -133.32 178.39 -64.04 62.63 91.53 -147.11 -88.19 15.48 -75.81 -57.13 -35.24 999.00 Allowed VAL ASP PHE GLY"
"TNIK_HUMAN t_5CWZA.pdb STE DFGup 3 Apo 2.90 -131.91 171.38 -69.82 52.83 50.01 -79.37 -93.75 159.26 56.55 73.68 -18.05 999.00 Favored VAL ASP PHE GLY"
"TNIK_HUMAN t_5CWZB.pdb STE DFGup 3 Apo 2.90 -127.32 168.86 -55.63 49.80 48.44 -71.07 -92.85 156.84 61.45 77.68 -28.79 999.00 Favored VAL ASP PHE GLY"
"TNIK_HUMAN t_5CWZC.pdb STE DFGup 3 Apo 2.90 -127.65 168.75 -77.08 47.36 57.36 -67.35 -101.13 171.81 53.60 67.59 -60.96 999.00 Favored VAL ASP PHE GLY"
"TNIK_HUMAN t_5D7AA.pdb STE DFGup 3 58C 2.90 -137.98 163.35 -61.03 59.47 46.88 -91.63 -103.50 159.44 54.57 54.49 36.60 999.00 Favored VAL ASP PHE GLY"
"TNIK_HUMAN t_5D7AB.pdb STE DFGup 3 58C 2.90 -135.26 165.91 -58.27 56.77 52.65 -81.88 -104.96 159.49 52.18 62.53 15.12 999.00 Favored VAL ASP PHE GLY"
"TNIK_HUMAN t_5D7AC.pdb STE DFGup 3 58C 2.90 -145.00 158.45 -64.45 58.44 71.59 -72.26 -125.18 156.41 52.46 72.23 999.00 999.00 Allowed VAL ASP PHE GLY"
"TOPK_HUMAN t_5J0AA.pdb NA NA 0 HC4 2.74 -120.79 178.25 63.88 63.09 46.29 -159.68 -77.68 127.39 174.07 -94.67 -173.92 999.00 NA CYS ASP VAL GLY"
"TOPK_HUMAN t_5J0AB.pdb NA NA 0 HC4 2.74 -128.23 177.12 72.83 70.11 37.23 -154.75 -75.08 133.11 177.08 -120.72 -176.82 999.00 NA CYS ASP VAL GLY"
"TRIB1_HUMAN t_5CEKA.pdb CAMK DFGinter 5 Apo 2.80 -98.30 87.13 173.46 -82.09 -7.31 58.98 -109.34 16.03 -60.05 61.56 55.92 -169.82 NA GLU SER LEU GLU"
"TRIB1_HUMAN t_5CEMA.pdb CAMK DFGinter 5 Apo 2.10 -85.09 104.76 -153.01 -111.15 5.27 66.26 -105.23 15.53 -59.76 60.68 52.65 -51.23 NA GLU SER LEU GLU"
"TTBK1_HUMAN t_4BTJA.pdb CK1 Active 1 ADP 2.16 -122.10 167.57 -53.40 65.72 92.18 -169.45 -107.56 12.90 -50.11 -64.35 -28.24 999.00 Allowed LEU ASP PHE GLY"
"TTBK1_HUMAN t_4BTJB.pdb CK1 Active 1 ATP 2.16 -122.50 168.87 -46.42 60.13 88.32 -177.90 -98.50 13.52 -52.93 -64.80 -32.08 999.00 Allowed LEU ASP PHE GLY"
"TTBK1_HUMAN t_4BTKA.pdb CK1 Active 1 DTQ 2.00 -121.58 166.53 -40.70 53.71 97.08 -155.83 -99.31 18.46 -55.24 -59.83 -26.45 999.00 Outlier LEU ASP PHE GLY"
"TTBK1_HUMAN t_4BTMA.pdb CK1 Active 1 F8E 2.54 -87.52 -38.67 -60.50 -130.07 153.66 -166.67 -137.47 17.34 -53.39 -55.70 -37.62 999.00 Favored LEU ASP PHE GLY"
"TTBK1_HUMAN t_4BTMB.pdb CK1 Active 1 F8E 2.54 -86.00 -41.31 -59.22 -128.74 151.97 -167.94 -135.56 18.33 -54.05 -66.18 -30.12 999.00 Favored LEU ASP PHE GLY"
"TTBK1_HUMAN t_4NFMA.pdb CK1 Active 1 Apo 2.12 -120.45 172.19 -45.34 50.52 99.13 -156.64 -99.16 15.78 -55.43 -58.69 -37.54 999.00 Outlier LEU ASP PHE GLY"
"TTBK1_HUMAN t_4NFNA.pdb CK1 Active 1 2KC 1.42 -120.21 155.41 -51.39 74.73 104.40 -158.18 -104.98 16.04 -54.18 -59.69 -28.44 999.00 Allowed LEU ASP PHE GLY"
"TYK2_HUMAN_1 t_3ZONA.pdb TYR DFGup 3 IK1 2.15 -83.00 173.19 89.71 -63.79 153.59 64.92 -76.60 -5.72 26.45 67.78 -154.96 999.00 NA SER ASP PRO GLY"
"TYK2_HUMAN_1 t_4OLIA.pdb TYR DFGup 3 2TT 2.80 -75.62 172.27 -153.16 -62.14 146.11 73.48 -80.13 1.54 28.43 73.70 -138.51 999.00 NA SER ASP PRO GLY"
"TYK2_HUMAN_1 t_4WOVA.pdb TYR DFGup 3 3SM 1.80 -80.61 171.86 164.25 -64.92 152.16 68.84 -79.11 3.77 29.39 64.38 -148.78 999.00 NA SER ASP PRO GLY"
"TYK2_HUMAN_1 t_4WOVB.pdb TYR DFGup 3 3SM 1.80 -81.65 173.40 106.79 -64.99 150.29 69.54 -78.59 4.38 29.78 64.13 -150.46 999.00 NA SER ASP PRO GLY"
"TYK2_HUMAN_1 t_5C01A.pdb TYR DFGup 3 UNL 2.15 -78.77 168.17 78.10 -59.24 158.86 66.05 -78.02 -0.60 29.97 70.42 -143.99 999.00 NA SER ASP PRO GLY"
"TYK2_HUMAN_1 t_5C01B.pdb TYR DFGup 3 UNL 2.15 -83.70 167.93 77.59 -60.35 156.95 68.29 -77.32 1.62 26.13 64.91 -141.32 999.00 NA SER ASP PRO GLY"
"TYK2_HUMAN_1 t_5C03A.pdb TYR DFGup 3 AGS 1.90 -83.95 173.20 65.82 -65.18 161.11 62.52 -79.19 -4.82 20.13 66.66 -148.87 999.00 NA SER ASP PRO GLY"
"TYK2_HUMAN_1 t_5C03B.pdb TYR DFGup 3 AGS 1.90 -71.71 164.10 -168.66 -66.46 161.05 63.96 -81.88 0.62 24.72 67.10 -147.89 999.00 NA SER ASP PRO GLY"
"TYK2_HUMAN_1 t_5TKDA.pdb TYR DFGup 3 7GL 1.92 -67.28 165.41 166.36 -61.22 150.10 68.43 -77.82 2.52 30.65 70.21 -152.23 999.00 NA SER ASP PRO GLY"
"TYK2_HUMAN_1 t_5TKDB.pdb TYR DFGup 3 7GL 1.92 -66.94 165.28 166.92 -61.59 149.65 68.51 -77.95 1.27 30.48 72.45 -154.15 999.00 NA SER ASP PRO GLY"
"TYK2_HUMAN_2 t_3LXNA.pdb TYR Active 1 MI1 2.50 -117.22 6.43 999.00 -151.99 138.13 -158.19 -128.50 13.86 -62.01 -49.51 -27.30 999.00 Favored GLY ASP PHE GLY"
"TYK2_HUMAN_2 t_3LXPA.pdb TYR Active 1 IZA 1.65 -125.50 -162.28 999.00 32.55 69.75 -157.89 -75.82 18.56 -73.83 -52.21 -34.45 999.00 Allowed GLY ASP PHE GLY"
"TYK2_HUMAN_2 t_3NYXA.pdb TYR DFGin-inactive 2 TZ1 2.50 -116.42 -161.28 999.00 41.94 77.53 -159.47 -90.21 20.16 -75.73 -58.42 -17.94 999.00 Allowed GLY ASP PHE GLY"
"TYK2_HUMAN_2 t_3NZ0A.pdb TYR Active 1 IZA 2.00 -133.50 -159.40 999.00 28.25 83.31 -161.53 -90.15 26.53 -73.73 -67.87 -23.75 999.00 Outlier GLY ASP PHE GLY"
"TYK2_HUMAN_2 t_4GFOA.pdb TYR Active 1 0X2 2.30 -119.78 -165.50 999.00 41.77 76.89 -159.32 -90.36 18.74 -73.87 -57.96 -31.66 999.00 Allowed GLY ASP PHE GLY"
"TYK2_HUMAN_2 t_4GIHA.pdb TYR Active 1 0X5 2.00 -120.12 -171.24 999.00 42.72 89.72 -159.48 -99.48 23.50 -74.71 -62.66 -22.02 999.00 Outlier GLY ASP PHE GLY"
"TYK2_HUMAN_2 t_4GIIA.pdb TYR Active 1 0X6 2.31 -81.32 -98.06 999.00 -79.51 140.47 113.50 -122.09 30.11 -68.24 -62.79 -33.67 999.00 Favored GLY ASP PHE GLY"
"TYK2_HUMAN_2 t_4GJ2A.pdb TYR Active 1 0XH 2.40 -116.63 -15.75 999.00 -127.48 110.21 164.10 -106.00 26.35 -65.14 -63.09 -27.63 999.00 Favored GLY ASP PHE GLY"
"TYK2_HUMAN_2 t_4GJ3A.pdb TYR Active 1 0XP 2.50 -94.99 -66.73 999.00 -87.42 118.12 169.55 -113.24 27.64 -69.80 -63.93 -25.46 999.00 Favored GLY ASP PHE GLY"
"TYK2_HUMAN_2 t_4GVJA.pdb TYR Active 1 ADP 2.03 -125.02 -169.63 999.00 58.36 84.39 -165.35 -100.69 24.14 -65.83 -57.37 -28.39 999.00 Allowed GLY ASP PHE GLY"
"TYK2_HUMAN_2 t_4PY1A.pdb TYR Active 1 2YK 2.16 -113.00 -22.05 999.00 -124.58 117.58 174.35 -104.91 28.19 -69.32 -57.37 -32.87 999.00 Favored GLY ASP PHE GLY"
"TYK2_HUMAN_2 t_5F1ZA.pdb TYR Active 1 5U3 2.65 -129.21 -165.98 999.00 40.57 85.30 -158.15 -97.36 33.47 -75.88 -65.00 -27.84 999.00 Outlier GLY ASP PHE GLY"
"TYK2_HUMAN_2 t_5F20A.pdb TYR Active 1 5U4 2.91 -113.76 -158.58 999.00 31.37 78.87 -169.51 -88.81 21.85 -75.61 -44.98 -45.07 999.00 Outlier GLY ASP PHE GLY"
"ULK1_HUMAN t_4WNOA.pdb OTHER Active 1 3RF 1.56 -117.92 169.23 999.00 64.82 74.59 -66.64 -94.16 20.87 -77.86 -63.58 -24.12 999.00 Allowed ALA ASP PHE GLY"
"ULK1_HUMAN t_4WNPA.pdb OTHER Active 1 3RJ 1.88 -119.62 166.83 999.00 68.99 82.04 -155.75 -103.28 16.68 -80.00 -62.68 -23.57 999.00 Allowed ALA ASP PHE GLY"
"ULK1_HUMAN t_4WNPB.pdb OTHER Active 1 3RJ 1.88 -123.02 171.74 999.00 60.50 83.99 -166.64 -103.74 20.66 -77.33 -62.77 -26.16 999.00 Allowed ALA ASP PHE GLY"
"ULK1_HUMAN t_4WNPC.pdb OTHER Active 1 3RJ 1.88 -127.52 176.20 999.00 60.90 81.21 -159.38 -99.97 16.67 -77.52 -53.97 -30.67 999.00 Allowed ALA ASP PHE GLY"
"ULK1_HUMAN t_4WNPD.pdb OTHER Active 1 3RJ 1.88 -124.35 171.88 999.00 65.62 80.64 -164.91 -102.55 20.79 -81.24 -65.51 -24.96 999.00 Allowed ALA ASP PHE GLY"
"ULK1_HUMAN t_5CI7A.pdb OTHER Active 1 51W 1.74 -127.47 -179.94 999.00 57.14 69.38 -66.12 -92.10 19.85 -79.03 -64.71 -26.63 999.00 Allowed ALA ASP PHE GLY"
"VGFR1_HUMAN t_3HNGA.pdb TYR DFGout 6 8ST 2.70 -131.85 179.18 80.99 -151.28 112.52 -173.54 -67.68 -32.60 -85.76 67.44 -119.27 999.00 Favored CYS ASP PHE GLY"
"VGFR2_HUMAN t_2OH4A.pdb TYR DFGout 6 GIG 2.05 -132.56 177.83 -55.12 -150.32 97.21 -176.88 -58.35 -39.74 -76.43 57.41 37.59 999.00 Favored CYS ASP PHE GLY"
"VGFR2_HUMAN t_2P2HA.pdb TYR DFGup 3 994 1.95 -120.41 168.69 -167.56 57.69 43.26 -74.28 -102.90 -14.88 60.31 -108.37 28.23 999.00 Favored CYS ASP PHE GLY"
"VGFR2_HUMAN t_2P2IA.pdb TYR DFGout 6 608 2.40 -140.93 -165.47 79.27 -165.77 112.91 -165.51 -76.35 -20.96 -78.04 -89.38 -168.29 999.00 Allowed CYS ASP PHE GLY"
"VGFR2_HUMAN t_2QU5A.pdb TYR DFGout 6 276 2.95 -148.41 -172.65 77.98 -150.44 108.82 -171.75 -78.67 -16.46 -79.73 -99.10 -166.37 999.00 Favored CYS ASP PHE GLY"
"VGFR2_HUMAN t_2QU6A.pdb TYR DFGout 6 857 2.10 -132.33 -170.96 76.72 -155.68 103.69 -172.53 -71.23 -21.04 -72.38 -49.97 999.00 999.00 Favored CYS ASP PHE GLY"
"VGFR2_HUMAN t_2RL5A.pdb TYR DFGout 6 2RL 2.65 -145.52 -175.29 76.59 -148.94 113.12 -168.88 -80.10 -11.03 -70.31 69.24 57.01 999.00 Favored CYS ASP PHE GLY"
"VGFR2_HUMAN t_2XIRA.pdb TYR DFGout 6 00J 1.50 -148.96 -178.59 75.46 -143.70 112.05 -163.27 -61.16 -32.50 -81.75 54.10 -120.81 999.00 Favored CYS ASP PHE GLY"
"VGFR2_HUMAN t_3B8QB.pdb TYR DFGout 6 900 2.75 -136.11 -171.44 70.99 -160.46 118.34 -169.49 -80.89 -45.78 -69.15 123.21 999.00 999.00 Favored CYS ASP PHE GLY"
"VGFR2_HUMAN t_3B8RA.pdb TYR DFGup 3 887 2.70 -147.03 169.14 72.47 57.72 43.23 -75.92 -97.38 156.82 47.06 58.99 37.46 999.00 Favored CYS ASP PHE GLY"
"VGFR2_HUMAN t_3B8RB.pdb TYR DFGup 3 887 2.70 -153.22 176.24 74.59 49.58 49.35 -74.41 -108.05 150.47 48.34 69.58 35.59 999.00 Favored CYS ASP PHE GLY"
"VGFR2_HUMAN t_3BE2A.pdb TYR DFGout 6 RAJ 1.75 -134.77 177.84 -54.54 -152.38 97.12 -177.20 -77.56 -8.09 -57.31 76.23 999.00 999.00 Favored CYS ASP PHE GLY"
"VGFR2_HUMAN t_3CJGA.pdb TYR Active 1 KIM 2.25 -120.87 -162.33 72.34 48.62 86.90 -103.96 -107.49 22.63 -57.31 -76.15 -15.35 999.00 Outlier CYS ASP PHE GLY"
"VGFR2_HUMAN t_3CP9A.pdb TYR DFGout 6 C19 2.50 -128.38 -176.59 83.16 -155.06 99.20 -171.13 -63.71 -9.83 -81.33 -54.74 999.00 999.00 Favored CYS ASP PHE GLY"
"VGFR2_HUMAN t_3CP9B.pdb TYR DFGout 6 C19 2.50 -132.78 -171.11 79.87 -162.19 105.06 -173.75 -62.20 -28.82 -78.08 49.44 -85.97 999.00 Allowed CYS ASP PHE GLY"
"VGFR2_HUMAN t_3CPBB.pdb TYR DFGout 6 C92 2.70 -145.98 -173.36 66.57 -148.63 122.86 -169.02 -90.74 -55.36 -79.35 148.12 999.00 999.00 Favored CYS ASP PHE GLY"
"VGFR2_HUMAN t_3CPCB.pdb TYR DFGout 6 C52 2.40 -131.81 -178.96 80.55 -148.20 107.16 -165.37 -69.26 -53.88 -86.24 111.79 999.00 999.00 Favored CYS ASP PHE GLY"
"VGFR2_HUMAN t_3DTWB.pdb TYR DFGout 6 A96 2.90 -136.40 -166.85 65.37 -159.11 106.24 -165.23 -84.42 -81.00 -64.85 174.86 139.27 999.00 Allowed CYS ASP PHE GLY"
"VGFR2_HUMAN t_3EFLA.pdb TYR DFGout 6 706 2.20 -138.70 -172.73 82.11 -156.19 97.31 -175.87 -59.62 -16.86 -74.17 69.08 999.00 999.00 Allowed CYS ASP PHE GLY"
"VGFR2_HUMAN t_3EFLB.pdb TYR DFGout 6 706 2.20 -141.18 -175.12 79.13 -153.13 108.88 -170.53 -69.52 -34.80 -79.79 138.85 999.00 999.00 Favored CYS ASP PHE GLY"
"VGFR2_HUMAN t_3EWHA.pdb TYR DFGout 6 K11 1.60 -133.51 -179.18 63.61 -135.68 102.63 -174.10 -69.42 -9.89 -79.18 67.90 33.30 999.00 Favored CYS ASP PHE GLY"
"VGFR2_HUMAN t_3U6JA.pdb TYR DFGout 6 03X 2.15 -144.73 -178.44 74.12 -146.43 121.95 -169.20 -64.91 -27.78 -77.63 52.91 -122.32 999.00 Favored CYS ASP PHE GLY"
"VGFR2_HUMAN t_3VHEA.pdb TYR DFGout 6 42Q 1.55 -150.73 179.83 76.94 -145.04 104.69 -174.77 -59.58 -35.02 -84.56 53.50 -124.68 999.00 Favored CYS ASP PHE GLY"
"VGFR2_HUMAN t_3VHKA.pdb TYR DFGout 6 BPK 2.49 -142.40 -168.15 73.88 -154.09 113.08 -169.46 -66.93 -34.21 -80.52 55.05 -115.27 999.00 Favored CYS ASP PHE GLY"
"VGFR2_HUMAN t_3VNTA.pdb TYR DFGout 6 0JA 1.64 -132.51 -178.87 75.09 -142.50 104.51 -170.16 -68.93 -32.94 -140.98 58.13 -122.25 999.00 Favored CYS ASP PHE GLY"
"VGFR2_HUMAN t_3VO3A.pdb TYR DFGout 6 0KF 1.52 -126.51 161.82 179.12 -134.40 99.77 -171.52 -70.02 -34.71 -144.46 59.75 -120.64 999.00 Favored CYS ASP PHE GLY"
"VGFR2_HUMAN t_3WZDA.pdb TYR DFGup 3 LEV 1.57 -131.31 171.10 70.49 64.85 24.46 -79.84 -69.94 137.00 45.38 79.76 6.07 999.00 Favored CYS ASP PHE GLY"
"VGFR2_HUMAN t_3WZEA.pdb TYR DFGout 6 BAX 1.90 -149.66 178.05 79.02 -142.36 106.00 -173.11 -66.68 -30.22 -81.57 48.88 -116.04 999.00 Favored CYS ASP PHE GLY"
"VGFR2_HUMAN t_4AG8A.pdb TYR DFGout 6 AXI 1.95 -143.73 -179.63 77.38 -144.13 113.54 -165.85 -60.29 -33.15 -84.78 54.27 -121.76 999.00 Favored CYS ASP PHE GLY"
"VGFR2_HUMAN t_4AGCA.pdb TYR DFGout 6 AXI 2.00 -142.12 -174.95 75.77 -148.17 116.11 -176.49 -63.10 -37.04 -80.58 58.38 -117.24 999.00 Favored CYS ASP PHE GLY"
"VGFR2_HUMAN t_4AGDA.pdb TYR DFGout 6 B49 2.81 -138.97 169.28 70.60 -127.21 103.67 173.12 -55.76 -25.29 -93.79 52.19 -127.76 999.00 Favored CYS ASP PHE GLY"
"VGFR2_HUMAN t_4ASDA.pdb TYR DFGout 6 BAX 2.03 -143.46 -179.32 73.57 -143.69 107.55 -176.00 -61.83 -34.31 -82.57 55.63 -120.33 999.00 Favored CYS ASP PHE GLY"
"VGFR2_HUMAN t_4ASEA.pdb TYR DFGout 6 AV9 1.83 -131.19 172.62 -58.43 -143.20 109.65 -174.19 -69.48 -29.52 -84.63 50.58 -120.82 999.00 Favored CYS ASP PHE GLY"
"VGFR2_HUMAN t_5EW3A.pdb TYR DFGout 6 5T2 2.50 -139.41 -178.74 85.91 -147.64 111.79 -153.96 -72.43 -36.01 -83.95 -76.07 999.00 999.00 Favored CYS ASP PHE GLY"
"VGFR2_HUMAN t_5EW3B.pdb TYR DFGout 6 5T2 2.50 -138.44 -179.67 85.85 -148.64 111.68 -153.70 -70.99 -37.04 -84.01 -74.61 999.00 999.00 Favored CYS ASP PHE GLY"
"VRK1_HUMAN t_2KTYA.pdb CK1 Active 1 Apo 0 -113.21 -167.01 -49.64 65.59 61.77 -47.54 -73.38 -2.99 -87.86 -54.79 -21.35 999.00 NA VAL ASP TYR GLY"
"VRK1_HUMAN t_2KULA.pdb CK1 Active 1 Apo 0 -141.27 -172.16 85.25 68.80 65.44 176.30 -88.51 16.58 -70.38 -70.38 -26.54 999.00 NA VAL ASP TYR GLY"
"VRK1_HUMAN t_2LAVA.pdb CK1 Active 1 Apo 0 -112.70 169.34 -63.42 59.59 76.32 -92.89 -63.98 -59.98 -92.96 58.43 20.30 999.00 NA VAL ASP TYR GLY"
"VRK1_HUMAN t_2RSVA.pdb CK1 Active 1 Apo 0 -86.91 179.24 -71.68 62.47 111.61 -102.14 -145.45 -57.35 -79.79 -58.44 -23.65 999.00 NA VAL ASP TYR GLY"
"VRK1_HUMAN t_3OP5A.pdb CK1 Active 1 REB 2.40 -114.83 176.37 -57.84 71.07 96.32 -161.86 -120.15 18.34 -62.31 -64.09 -28.66 999.00 NA VAL ASP TYR GLY"
"VRK1_HUMAN t_3OP5B.pdb CK1 Active 1 REB 2.40 -113.98 175.95 -58.62 71.36 96.03 -160.99 -119.18 18.92 -62.18 -64.51 -28.60 999.00 NA VAL ASP TYR GLY"
"VRK1_HUMAN t_3OP5C.pdb CK1 Active 1 REB 2.40 -113.56 176.42 -58.40 69.77 97.18 -159.88 -118.65 20.02 -63.54 -64.39 -26.22 999.00 NA VAL ASP TYR GLY"
"VRK1_HUMAN t_3OP5D.pdb CK1 Active 1 REB 2.40 -112.84 176.13 -58.41 70.97 97.27 -161.49 -119.84 19.70 -62.64 -64.37 -27.21 999.00 NA VAL ASP TYR GLY"
"VRK1_HUMAN t_5UKFA.pdb CK1 Active 1 8E1 2.40 -119.33 173.44 -60.16 75.62 89.70 -154.63 -116.09 14.41 -61.69 -54.63 -38.09 999.00 NA VAL ASP TYR GLY"
"VRK1_HUMAN t_5UKFB.pdb CK1 Active 1 8E1 2.40 -121.10 172.72 -50.31 70.21 89.55 -176.05 -108.11 26.27 -65.91 -70.34 -38.73 999.00 NA VAL ASP TYR GLY"
"VRK1_HUMAN t_5UKFC.pdb CK1 Active 1 8E1 2.40 -114.47 177.85 -57.03 73.16 91.75 -153.92 -116.11 13.57 -63.30 -56.35 -31.57 999.00 NA VAL ASP TYR GLY"
"VRK1_HUMAN t_5UKFD.pdb CK1 Active 1 8E1 2.40 -113.79 177.58 -57.68 70.62 89.80 -155.66 -108.84 24.38 -64.19 -64.56 -29.84 999.00 NA VAL ASP TYR GLY"
"VRK1_HUMAN t_5UVFA.pdb CK1 Active 1 7DZ 2.00 -116.04 174.60 -57.97 69.36 93.64 -172.21 -111.58 17.20 -63.13 -59.95 -29.32 999.00 NA VAL ASP TYR GLY"
"VRK1_HUMAN t_5UVFB.pdb CK1 Active 1 7DZ 2.00 -115.72 176.83 -63.67 71.89 96.34 -159.82 -118.38 14.08 -64.34 -59.20 -30.59 999.00 NA VAL ASP TYR GLY"
"VRK1_HUMAN t_5UVFC.pdb CK1 Active 1 7DZ 2.00 -113.11 179.98 -55.31 62.05 87.83 -154.46 -103.98 18.05 -66.14 -56.34 -38.94 999.00 NA VAL ASP TYR GLY"
"VRK1_HUMAN t_5UVFD.pdb CK1 Active 1 7DZ 2.00 -114.08 178.78 -57.26 62.45 88.69 -162.04 -103.84 26.03 -67.24 -61.86 -39.29 999.00 NA VAL ASP TYR GLY"
"VRK2_HUMAN t_2V62A.pdb CK1 Active 1 Apo 1.7 -126.41 177.82 999.00 61.38 82.17 -163.37 -97.93 25.97 -69.25 -60.52 -27.75 999.00 NA ALA ASP TYR GLY"
"VRK2_HUMAN t_2V62B.pdb CK1 Active 1 Apo 1.7 -125.06 178.48 999.00 58.36 82.78 -162.66 -95.01 25.08 -67.81 -65.52 -19.53 999.00 NA ALA ASP TYR GLY"
"VRK2_HUMAN t_5UU1A.pdb CK1 Active 1 7DZ 2.00 -105.19 5.88 999.00 -139.88 132.85 -168.80 -129.79 29.78 -61.72 -64.09 -29.26 999.00 NA ALA ASP TYR GLY"
"VRK3_HUMAN t_2JIIA.pdb CK1 Active 1 Apo 2.00 -126.84 -158.77 999.00 59.24 60.83 999.00 -88.16 20.40 -63.86 -53.12 -27.84 999.00 NA ALA GLY TYR GLY"
"VRK3_HUMAN t_2JIIB.pdb CK1 Active 1 Apo 2.00 -126.24 -160.06 999.00 62.27 57.97 999.00 -88.32 21.34 -63.17 -56.16 -25.40 999.00 NA ALA GLY TYR GLY"
"WEE1_HUMAN t_1X8BA.pdb OTHER Active 1 824 1.81 -126.43 -167.25 999.00 53.00 80.95 -164.91 -90.04 18.86 -57.84 -66.08 -12.51 999.00 NA GLY ASP LEU GLY"
"WEE1_HUMAN t_2IN6A.pdb OTHER Active 1 839 1.90 -135.94 -163.41 999.00 52.05 80.24 -164.55 -88.15 20.28 -60.35 -61.66 -14.22 999.00 NA GLY ASP LEU GLY"
"WEE1_HUMAN t_2IO6A.pdb OTHER Active 1 330 2.20 -134.30 -167.25 999.00 54.06 80.30 -157.86 -91.69 21.97 -59.01 -69.77 -12.79 999.00 NA GLY ASP LEU GLY"
"WEE1_HUMAN t_2Z2WA.pdb OTHER Active 1 770 2.22 -127.20 -168.54 999.00 50.21 77.07 -167.29 -84.46 18.96 -53.98 -65.25 -14.03 999.00 NA GLY ASP LEU GLY"
"WEE1_HUMAN t_3BI6A.pdb OTHER Active 1 396 2.20 -134.62 -165.44 999.00 49.64 74.99 -155.50 -87.88 24.59 -57.69 -63.10 -13.20 999.00 NA GLY ASP LEU GLY"
"WEE1_HUMAN t_3BIZA.pdb OTHER Active 1 61E 2.20 -132.13 -162.36 999.00 51.65 78.80 -161.92 -89.72 21.45 -58.76 -56.68 -19.87 999.00 NA GLY ASP LEU GLY"
"WEE1_HUMAN t_3CQEA.pdb OTHER Active 1 P91 2.50 -127.94 -172.98 999.00 50.42 71.96 -153.91 -79.58 20.18 -53.84 -62.62 -13.42 999.00 NA GLY ASP LEU GLY"
"WEE1_HUMAN t_3CR0A.pdb OTHER Active 1 809 2.30 -130.19 -169.36 999.00 53.76 78.89 -161.36 -88.41 20.87 -62.17 -66.43 -13.48 999.00 NA GLY ASP LEU GLY"
"WNK1_HUMAN t_4PWNA.pdb OTHER DFGin-inactive 2 Apo 1.84 -116.39 -167.62 999.00 52.88 34.89 -67.79 -53.75 -53.18 -61.10 -76.44 5.08 999.00 NA GLY ASP LEU GLY"
"WNK1_HUMAN t_5TF9A.pdb OTHER DFGin-inactive 2 7AV 2.50 -124.64 -165.55 999.00 44.55 74.84 -154.12 -89.65 28.72 -85.90 -66.62 -24.43 999.00 NA GLY ASP LEU GLY"
"WNK1_HUMAN t_5TF9B.pdb OTHER DFGin-inactive 2 7AV 2.50 -133.03 -172.37 999.00 51.00 69.56 -66.38 -83.56 20.62 -94.40 -66.79 -27.18 999.00 NA GLY ASP LEU GLY"
"ZAP70_HUMAN t_1U59A.pdb TYR Active 1 STU 2.30 -132.39 179.56 76.32 60.62 79.93 -169.94 -93.19 26.52 -73.75 -61.38 -30.96 999.00 Allowed SER ASP PHE GLY"
"ZAP70_HUMAN t_2OZOA.pdb TYR DFGup 3 ANP 2.60 -127.74 179.11 69.09 42.00 48.00 -60.43 -92.66 86.41 47.34 138.54 -47.20 999.00 Favored SER ASP PHE GLY"
